Citrus Sinensis ID: 017029

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------38
Protein Sequence
MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Secondary Structure (PSIPRED)
ccccccccccccccccccccEEEccccccccccccccccccccccccccHHcccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHHcccccccccHHHHHccccccccccccccccccccccccccccHHHHHHHHHccccHHHHHHHHHcccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccEEEEEcccccEEEEcccccccccccccccccccccccccccccccccccccccEEEEEEEEEcccccccccccccccccccHHHHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
cEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHcccccccccEEHHHHHHHHHHHHHcccccccccHHHHHHHHHcccEEccccccHHHHHHHHHHHcccccccccHHHHHccccHcccccHHccccccccccccccccHHHHHHHHHccccHHHHHHHHHcccccHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccHcccHcccccccccHHHHHHHHHHHHHHcccEEEEcccEEEEEEEcccccccccccccccccccccccccccccccccccccccEEEEEEEEEEEccccEEEEcccccccHHHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
mvvhrdlkpenllldskwnvkiadfglsnimrdghflktscgspnyaapevisgklyagpevdvwsCGVILYALLcgtlpfddenipNLFKKIkggiytlpshlspgardliprmlivdpmkritipeirqhpwfqahlprylavpppdtmqQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNrfrvssgylgaEFQETMesgfnrlhpiepavspvahrapgfmdyqgmglrgqlpyerkwalglqsrahpREIMTEVLKALQELNVGWKkighynmkcrwipgisghhegmvnnplhsnhyfgdesaiiendgvvkspnvVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Flexible Loop (DISEMBL)
mvvhrdlkpenllldskwNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGiytlpshlspgarDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIEndgvvkspnvVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Low Complexity Region (SEG)
MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQflfldlcaaflaqlRVL
Disordered region (IsUnstruct)
**********NLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP**********IDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQL***
Disordered Region (DISOPRED)
MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV**********KIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLD*******************************************************************************ALQELNVGWKKIGHYNMK*************************************VKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Disordered Region (DISEMBL)
MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Disordered Region (DISPRO)
MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVS******************************************************ALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGH******************SAIIE**GVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	379	2.2.26 [Sep-21-2011]
Q38997	535	SNF1-related protein kina	yes	no	0.992	0.702	0.860	0.0
P92958	512	SNF1-related protein kina	no	no	0.989	0.732	0.781	1e-178
Q02723	502	Carbon catabolite-derepre	N/A	no	0.960	0.725	0.690	1e-145
Q5RD00	552	5'-AMP-activated protein	yes	no	0.852	0.585	0.433	3e-75
Q09137	552	5'-AMP-activated protein	yes	no	0.839	0.576	0.427	5e-75
P54646	552	5'-AMP-activated protein	yes	no	0.852	0.585	0.427	7e-75
Q28948	552	5'-AMP-activated protein	yes	no	0.852	0.585	0.427	8e-75
Q00372	612	Carbon catabolite-derepre	yes	no	0.870	0.539	0.408	2e-74
Q8BRK8	552	5'-AMP-activated protein	yes	no	0.852	0.585	0.427	1e-73
Q5RDH5	554	5'-AMP-activated protein	no	no	0.854	0.584	0.435	3e-73

>sp|Q38997|KIN10_ARATH SNF1-related protein kinase catalytic subunit alpha KIN10 OS=Arabidopsis thaliana GN=KIN10 PE=1 SV=2

 Score =  690 bits (1781), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 326/379 (86%), Positives = 350/379 (92%), Gaps = 3/379 (0%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 160 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 219

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML+VDP
Sbjct: 220 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDP 279

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+EV+ MGFD+N L+ESLR
Sbjct: 280 MKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQEVINMGFDRNHLIESLR 339

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR QN+ TV YYL+LDNRFR SSGYLGAEFQETME G  R+HP E   SPV+HR PG M+
Sbjct: 340 NRTQNDGTVTYYLILDNRFRASSGYLGAEFQETME-GTPRMHPAESVASPVSHRLPGLME 398

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQ+LNV WKKIGHYNMKCRW+P  
Sbjct: 399 YQGVGLRSQYPVERKWALGLQSRAHPREIMTEVLKALQDLNVCWKKIGHYNMKCRWVPNS 458

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
           S   +GM++N +H N+YFGDES+IIEN+  VKSPNVVKFE+QLYKTRD+KYLLDLQRVQG
Sbjct: 459 SA--DGMLSNSMHDNNYFGDESSIIENEAAVKSPNVVKFEIQLYKTRDDKYLLDLQRVQG 516

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 517 PQFLFLDLCAAFLAQLRVL 535

Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN10 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P92958|KIN11_ARATH SNF1-related protein kinase catalytic subunit alpha KIN11 OS=Arabidopsis thaliana GN=KIN11 PE=1 SV=1

 Score =  623 bits (1607), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 296/379 (78%), Positives = 329/379 (86%), Gaps = 4/379 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDS+ N+KIADFGLSN+MRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 138 MVVHRDLKPENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 197

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS  ARDLIPRMLIVDP
Sbjct: 198 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSSEARDLIPRMLIVDP 257

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           +KRITIPEIRQH WFQ HLPRYLAV PPDT++QAKKI+EEI++EVV MGFD+NQ++ESLR
Sbjct: 258 VKRITIPEIRQHRWFQTHLPRYLAVSPPDTVEQAKKINEEIVQEVVNMGFDRNQVLESLR 317

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR QN+ATV YYLLLDNRFRV SGYL +EFQET +SG N +   E   SPV H  P  +D
Sbjct: 318 NRTQNDATVTYYLLLDNRFRVPSGYLESEFQETTDSGSNPMRTPEAGASPVGHWIPAHVD 377

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           + G+G R Q+P +RKWALGLQS AHPREIM EVLKALQELNV WKKIGHYNMKCRW+PG+
Sbjct: 378 HYGLGARSQVPVDRKWALGLQSHAHPREIMNEVLKALQELNVCWKKIGHYNMKCRWVPGL 437

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
           +     MVNN LH    F DES+IIE+D  + SP V+KFE+QLYK R+EKYLLD+QRV G
Sbjct: 438 ADGQNTMVNNQLH----FRDESSIIEDDCAMTSPTVIKFELQLYKAREEKYLLDIQRVNG 493

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFL +LRV+
Sbjct: 494 PQFLFLDLCAAFLTELRVI 512

Catalytic subunit of the probable trimeric SNF1-related protein kinase (SnRK) complex, which may play a role in a signal transduction cascade regulating gene expression and carbohydrate metabolism in higher plants. The SnRK complex may also be involved in the regulation of fatty acid synthesis by phosphorylation of acetyl-CoA carboxylase and in assimilation of nitrogen by phosphorylating nitrate reductase. In vitro, KIN11 exhibits kinase activity on sucrose phosphate synthase and the kinase activity is inhibited by PRL1. May be a subunit of a SCF ubiquitin ligase complex and thus be involved in proteasomal ubiquitination. Involved in innate antiviral defenses.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q02723|RKIN1_SECCE Carbon catabolite-derepressing protein kinase OS=Secale cereale GN=RKIN1 PE=2 SV=1

 Score =  516 bits (1329), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 263/381 (69%), Positives = 295/381 (77%), Gaps = 17/381 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKPENLLLDSK+NVK+ADFGLSN+M DGHFLKTSCGS NYAAPEVISGKLYAGPE
Sbjct: 136 VVHRDLKPENLLLDSKYNVKLADFGLSNVMHDGHFLKTSCGSLNYAAPEVISGKLYAGPE 195

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           +DVWSCGVILYALLCG +PFDD+NIPNLFKKIKGG Y LP +LS   RDLI RMLIVDPM
Sbjct: 196 IDVWSCGVILYALLCGAVPFDDDNIPNLFKKIKGGTYILPIYLSDLVRDLISRMLIVDPM 255

Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRN 181
           KRITI EIR+H WFQ  LPRYLAVPPPD MQQAK IDE+ L++VVK+G+D++ + ESL N
Sbjct: 256 KRITIGEIRKHSWFQNRLPRYLAVPPPDMMQQAKMIDEDTLRDVVKLGYDKDHVCESLCN 315

Query: 182 RLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDY 241
           RLQNE TVAYYLLLDNRFR +SGYLGA +Q+ MES          A        PG  D 
Sbjct: 316 RLQNEETVAYYLLLDNRFRATSGYLGAHYQQPMES----------ASPSTRSYLPGSNDS 365

Query: 242 QGMGLRGQLPYERKWALGL-QSRAHPREIMTEVLKALQELNVGWKKIGH-YNMKCRWIPG 299
           QG GLR     ERKWALGL QSRA PR IM EVLKAL+ELNV WKK G  YNMKCRW PG
Sbjct: 366 QGSGLRPYYRVERKWALGLQQSRAPPRAIMIEVLKALKELNVCWKKNGDCYNMKCRWCPG 425

Query: 300 ISGHHEGMVNNPLHSNHYFGDESAIIEN-DGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV 358
                + +    L +NH F D+ AI +N D   + P V+KFE+QLYKT+D+KYLLD+QRV
Sbjct: 426 FPRVSDML----LDANHSFVDDCAIKDNGDANSRLPAVIKFEIQLYKTKDDKYLLDMQRV 481

Query: 359 QGPQFLFLDLCAAFLAQLRVL 379
            GPQ LFL+ CAAFL  LRVL
Sbjct: 482 TGPQLLFLEFCAAFLTNLRVL 502

Essential for release from glucose repression.

Secale cereale (taxid: 4550)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5RD00|AAPK2_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Pongo abelii GN=PRKAA2 PE=2 SV=1

 Score =  282 bits (721), Expect = 3e-75,   Method: Compositional matrix adjust.
 Identities = 162/374 (43%), Positives = 220/374 (58%), Gaps = 51/374 (13%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSNIM DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 134 MVVHRDLKPENVLLDAHMNAKIADFGLSNIMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct: 254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query: 180 -RNRLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 235
                Q++  VAY+L++DNR    + S  YL +          + +H I P + P   R 
Sbjct: 312 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERM 370

Query: 236 PGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGW 284
           P            +D         L  ++ KW LG++S++ P +IM EV +A+++L+  W
Sbjct: 371 PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEW 430

Query: 285 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 344
           K +  Y+++ R              NP+  N+                    VK  +QLY
Sbjct: 431 KVVNAYHLRVRR------------KNPVTGNY--------------------VKMSLQLY 458

Query: 345 KTRDEKYLLDLQRV 358
              +  YLLD + +
Sbjct: 459 LVDNRSYLLDFKSI 472

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q09137|AAPK2_RAT 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Rattus norvegicus GN=Prkaa2 PE=1 SV=1

 Score =  281 bits (719), Expect = 5e-75,   Method: Compositional matrix adjust.
 Identities = 162/379 (42%), Positives = 222/379 (58%), Gaps = 61/379 (16%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 134 MVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct: 254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query: 180 -RNRLQNEATVAYYLLLDNR--------FRVSSGYLGAEFQETMESGFNRLHPIEPAVSP 230
                Q++  VAY+L++DNR        F ++S      F + M      +H I P + P
Sbjct: 312 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDMA-----MH-IPPGLKP 365

Query: 231 VAHRAPGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQE 279
              R P            +D         L  ++ KW LG++S++ P +IM EV +A+++
Sbjct: 366 HPERMPPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQ 425

Query: 280 LNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKF 339
           L+  WK +  Y+++ R              NP+  N+                    VK 
Sbjct: 426 LDFEWKVVNAYHLRVRR------------KNPVTGNY--------------------VKM 453

Query: 340 EVQLYKTRDEKYLLDLQRV 358
            +QLY   +  YLLD + +
Sbjct: 454 SLQLYLVDNRSYLLDFKSI 472

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P54646|AAPK2_HUMAN 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Homo sapiens GN=PRKAA2 PE=1 SV=2

 Score =  281 bits (718), Expect = 7e-75,   Method: Compositional matrix adjust.
 Identities = 160/374 (42%), Positives = 219/374 (58%), Gaps = 51/374 (13%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 134 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct: 254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query: 180 -RNRLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 235
                Q++  VAY+L++DNR    + S  YL +          + +H I P + P   R 
Sbjct: 312 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERM 370

Query: 236 PGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGW 284
           P            +D         L  ++ KW LG++S++ P +IM EV +A+++L+  W
Sbjct: 371 PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEW 430

Query: 285 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 344
           K +  Y+++ R    ++G                                N VK  +QLY
Sbjct: 431 KVVNAYHLRVRRKNPVTG--------------------------------NYVKMSLQLY 458

Query: 345 KTRDEKYLLDLQRV 358
              +  YLLD + +
Sbjct: 459 LVDNRSYLLDFKSI 472

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q28948|AAPK2_PIG 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Sus scrofa GN=PRKAA2 PE=2 SV=2

 Score =  281 bits (718), Expect = 8e-75,   Method: Compositional matrix adjust.
 Identities = 160/374 (42%), Positives = 221/374 (59%), Gaps = 51/374 (13%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 134 MVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct: 254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query: 180 RN-RLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 235
            +   Q++  VAY+L++DNR    + S  YL +          + +H I P + P   R 
Sbjct: 312 YSGDPQDQLAVAYHLVIDNRRIMNQASEFYLASSPPTGSFMDDSAMH-IPPGLKPHPERM 370

Query: 236 PGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGW 284
           P            +D         L  ++ KW LG++S++ P +IM EV +A+++L+  W
Sbjct: 371 PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEW 430

Query: 285 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 344
           K +  Y+++ R    ++G                                N VK  +QLY
Sbjct: 431 KVVNAYHLRVRRKNPVTG--------------------------------NYVKMSLQLY 458

Query: 345 KTRDEKYLLDLQRV 358
              +  YLLD + +
Sbjct: 459 LVDNRSYLLDFKSI 472

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Sus scrofa (taxid: 9823)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q00372|SNF1_CANGA Carbon catabolite-derepressing protein kinase OS=Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) GN=SNF1 PE=3 SV=2

 Score =  280 bits (715), Expect = 2e-74,   Method: Compositional matrix adjust.
 Identities = 177/433 (40%), Positives = 228/433 (52%), Gaps = 103/433 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 157 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 216

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA DLI RMLIV+P+
Sbjct: 217 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGASDLIKRMLIVNPL 276

Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ------------AKKIDEEILKEVVK-M 168
            RI+I EI Q  WF+  L  YL   P D  QQ             ++ID+E++  + K M
Sbjct: 277 NRISIHEIMQDEWFKVDLAEYLV--PQDLKQQEQFNKKSGNEENVEEIDDEMVVTLSKTM 334

Query: 169 GFDQNQLVESLRNRLQ----NEATVAYYLLLDNRFRVS---------------------- 202
           G+D++++ E+L +       NE   AY L+ DN+  +                       
Sbjct: 335 GYDKDEIYEALESSEDTPAYNEIRNAYILIKDNKSLIKDMKQDNNVTQELDTFLSQSPPT 394

Query: 203 -----SGYLGAEFQETMESGFNRLH-------------------------PIEPAVSPVA 232
                 G   +E Q+   SG  RL                           I P   P  
Sbjct: 395 FQQNGDGMKASEDQKKKHSG-RRLASSVTQQRTFHQPPFMDQSKEEDSTISILPTSLPQI 453

Query: 233 HRAPGFMDYQGMGLRGQLP------YERKWALGLQSRAHPREIMTEVLKALQELNVGWKK 286
           HRA   M  QG+    ++        + +W  G++SR++P ++M E+  AL+ L   W K
Sbjct: 454 HRAN--MLAQGLPAASKISPLVTKKSKTRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAK 511

Query: 287 IGH---YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQL 343
                 + ++ RW                    Y  DES +IE DGV K PN++K  +QL
Sbjct: 512 PSEEDLWTIRVRW-------------------KYDSDESRLIE-DGVKKIPNLMKIVIQL 551

Query: 344 YKTRDEKYLLDLQ 356
           ++     YL+D +
Sbjct: 552 FQIETNNYLVDFK 564

Essential for release from glucose repression. It interacts and has functional relationship to the regulatory protein SNF4. Could phosphorylates CAT8.

Candida glabrata (strain ATCC 2001 / CBS 138 / JCM 3761 / NBRC 0622 / NRRL Y-65) (taxid: 284593)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8BRK8|AAPK2_MOUSE 5'-AMP-activated protein kinase catalytic subunit alpha-2 OS=Mus musculus GN=Prkaa2 PE=1 SV=3

 Score =  277 bits (708), Expect = 1e-73,   Method: Compositional matrix adjust.
 Identities = 160/374 (42%), Positives = 218/374 (58%), Gaps = 51/374 (13%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 134 MVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPDYLNRSVATLLMHMLQVDP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct: 254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query: 180 -RNRLQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 235
                Q++  VAY+L++DNR    + S  YL +          + +H I P + P   R 
Sbjct: 312 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERM 370

Query: 236 PGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGW 284
           P            +D         L  ++ KW LG++S++   +IM EV +A+++L   W
Sbjct: 371 PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKACDIMAEVYRAMKQLGFEW 430

Query: 285 KKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLY 344
           K +  Y+++ R              NP+  N+                    VK  +QLY
Sbjct: 431 KVVNAYHLRVRR------------KNPVTGNY--------------------VKMSLQLY 458

Query: 345 KTRDEKYLLDLQRV 358
                 YLLD + +
Sbjct: 459 LVDSRSYLLDFKSI 472

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5RDH5|AAPK1_PONAB 5'-AMP-activated protein kinase catalytic subunit alpha-1 (Fragment) OS=Pongo abelii GN=PRKAA1 PE=2 SV=2

 Score =  276 bits (705), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 160/367 (43%), Positives = 215/367 (58%), Gaps = 43/367 (11%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 140 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 199

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS GVILYALLCGTLPFDD+++P LFKKI  GI+  P +L+P    L+  ML VDP
Sbjct: 200 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDP 259

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           MKR TI +IR+H WF+  LP+YL   P D    +  ID+E LKEV  K    + +++  L
Sbjct: 260 MKRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCL 317

Query: 180 RNR-LQNEATVAYYLLLDNRFRVSSG---YLGAEFQETM--ESGFNRLHPIE-PAVSPVA 232
            NR  Q+   VAY+L++DNR  ++     YL     ++   +    R HP   P +    
Sbjct: 318 YNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAET 377

Query: 233 HRAPGFMD-YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYN 291
            RA   +D       + Q   + KW LG++S++ P +IM EV +A+++L+  WK +  Y 
Sbjct: 378 PRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYY 437

Query: 292 MKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKY 351
           ++ R              NP+ S +                     K  +QLY+     Y
Sbjct: 438 LRVRR------------KNPVTSTY--------------------SKMSLQLYQVDSRTY 465

Query: 352 LLDLQRV 358
           LLD + +
Sbjct: 466 LLDFRSI 472

Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.

Pongo abelii (taxid: 9601)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 6

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	379
449454522	515	PREDICTED: SNF1-related protein kinase c	1.0	0.735	0.915	0.0
1743009	504	SNF1-related protein kinase [Cucumis sat	1.0	0.751	0.912	0.0
224080209	515	predicted protein [Populus trichocarpa]	1.0	0.735	0.889	0.0
224103305	420	predicted protein [Populus trichocarpa]	1.0	0.902	0.891	0.0
396924947	510	sucrose non-fermenting 1 [Mesembryanthem	0.994	0.739	0.891	0.0
157383335	515	sucrose non-fermenting-1-related protein	1.0	0.735	0.873	0.0
62857006	516	Ser/Thr protein kinase [Lotus japonicus]	0.997	0.732	0.884	0.0
356568694	514	PREDICTED: SNF1-related protein kinase c	0.997	0.735	0.886	0.0
225452903	508	PREDICTED: SNF1-related protein kinase c	0.981	0.732	0.883	0.0
147772897	495	hypothetical protein VITISV_034707 [Viti	0.981	0.751	0.883	0.0

>gi|449454522|ref|XP_004145003.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] gi|449474166|ref|XP_004154092.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus] gi|449498915|ref|XP_004160670.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Cucumis sativus]

 Score =  736 bits (1899), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 347/379 (91%), Positives = 363/379 (95%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 137 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS GAR+LIP ML+VDP
Sbjct: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSSGARELIPSMLVVDP 256

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE+IL+EVVKMGFD+NQLVESLR
Sbjct: 257 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEDILQEVVKMGFDRNQLVESLR 316

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QNEATVAYYLLLDNRFRVSSGYLGAEFQETME+GFNR+HP +P    V HR PG+MD
Sbjct: 317 NRIQNEATVAYYLLLDNRFRVSSGYLGAEFQETMETGFNRMHPSDPTNPAVGHRLPGYMD 376

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMGLR Q P ERKWALGLQSRAHPREIMTEVLKAL+ELNV WKKIGHYNMKCRW+PGI
Sbjct: 377 YQGMGLRAQFPVERKWALGLQSRAHPREIMTEVLKALRELNVAWKKIGHYNMKCRWLPGI 436

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGM+NNP+HSNHYFGDES IIENDGVVKSPNV+KFEVQLYKTR+EKYLLDLQRVQG
Sbjct: 437 PGHHEGMINNPVHSNHYFGDESTIIENDGVVKSPNVIKFEVQLYKTREEKYLLDLQRVQG 496

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 497 PQFLFLDLCAAFLAQLRVL 515

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|1743009|emb|CAA71142.1| SNF1-related protein kinase [Cucumis sativus]

 Score =  735 bits (1897), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/379 (91%), Positives = 363/379 (95%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 126 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 185

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS GAR+LIP ML+VDP
Sbjct: 186 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSSGARELIPSMLVVDP 245

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE+IL+EVVKMGFD+NQLVESLR
Sbjct: 246 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEDILQEVVKMGFDRNQLVESLR 305

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QNEATVAYYLLLDNRFRVSSGYLGAEFQETME+GFNR+HP +P    V HR PG+MD
Sbjct: 306 NRIQNEATVAYYLLLDNRFRVSSGYLGAEFQETMETGFNRMHPSDPTNPAVGHRLPGYMD 365

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMGLR Q P ERKWALGLQSRAHPREIMTEVLKAL+ELNV WKKIGHYNMKCRW+PGI
Sbjct: 366 YQGMGLRAQFPVERKWALGLQSRAHPREIMTEVLKALRELNVAWKKIGHYNMKCRWLPGI 425

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGM+NNP+HSNHYFGD+S IIENDGVVKSPNV+KFEVQLYKTR+EKYLLDLQRVQG
Sbjct: 426 PGHHEGMINNPVHSNHYFGDKSTIIENDGVVKSPNVIKFEVQLYKTREEKYLLDLQRVQG 485

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 486 PQFLFLDLCAAFLAQLRVL 504

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224080209|ref|XP_002306053.1| predicted protein [Populus trichocarpa] gi|222849017|gb|EEE86564.1| predicted protein [Populus trichocarpa]

 Score =  713 bits (1840), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/379 (88%), Positives = 352/379 (92%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 137 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML+VDP
Sbjct: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDP 256

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQH WFQA LPRYLAVPPPDTMQQAKKIDEEIL+EV+KMGFD+NQL+ESLR
Sbjct: 257 MKRMTIPEIRQHQWFQARLPRYLAVPPPDTMQQAKKIDEEILQEVIKMGFDRNQLIESLR 316

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QNE TVAYYLLLDNRFRVS+GYLGAEFQETME  FN +H  E +     HR PGFMD
Sbjct: 317 NRMQNEGTVAYYLLLDNRFRVSNGYLGAEFQETMECAFNGMHQNESSSPAGGHRLPGFMD 376

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMGL+ Q   ERKWALGLQSRAHPREIMTEVLKALQELNV WKKIG YNMKCRWIPG 
Sbjct: 377 YQGMGLKSQFLVERKWALGLQSRAHPREIMTEVLKALQELNVSWKKIGQYNMKCRWIPGT 436

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGMVN+P+H+NH+FGDE  IIENDGV  SPNVVKFEVQLYKTRDEKYLLDLQRVQG
Sbjct: 437 PGHHEGMVNDPVHTNHFFGDEPTIIENDGVTNSPNVVKFEVQLYKTRDEKYLLDLQRVQG 496

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 497 PQFLFLDLCAAFLAQLRVL 515

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224103305|ref|XP_002334067.1| predicted protein [Populus trichocarpa] gi|222839758|gb|EEE78081.1| predicted protein [Populus trichocarpa]

 Score =  712 bits (1837), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/379 (89%), Positives = 354/379 (93%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 42  MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 101

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK GIYTLPSHLSPGARDLIPRML+VDP
Sbjct: 102 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKDGIYTLPSHLSPGARDLIPRMLVVDP 161

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQH WFQA LPRYLAVPPPDT+QQAKKIDEEIL++VVKMGFD+ QL+ESLR
Sbjct: 162 MKRMTIPEIRQHQWFQARLPRYLAVPPPDTLQQAKKIDEEILQDVVKMGFDRIQLIESLR 221

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QNEATVAYYLLLDNRFRVS+GYLGAEFQETME+ FNR+HP EP      HR PGFMD
Sbjct: 222 NRMQNEATVAYYLLLDNRFRVSNGYLGAEFQETMETAFNRMHPNEPLSPAGGHRLPGFMD 281

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMGL+ Q P ERKWALGLQSRAHPREIMTEVLKALQELNV WKKIG YNMKCRWIPG 
Sbjct: 282 YQGMGLKSQFPVERKWALGLQSRAHPREIMTEVLKALQELNVCWKKIGQYNMKCRWIPGT 341

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGMVN+P H NH+FGDE  IIENDG++ SPNVVKFEVQLYKTRDEKYLLDLQRVQG
Sbjct: 342 PGHHEGMVNHPAHYNHFFGDEPTIIENDGIINSPNVVKFEVQLYKTRDEKYLLDLQRVQG 401

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 402 PQFLFLDLCAAFLAQLRVL 420

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|396924947|gb|AFN89137.1| sucrose non-fermenting 1 [Mesembryanthemum crystallinum]

 Score =  707 bits (1826), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 338/379 (89%), Positives = 356/379 (93%), Gaps = 2/379 (0%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDS  NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 134 MVVHRDLKPENLLLDSHHNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML+VDP
Sbjct: 194 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK+DE+IL+EVV+MGFD+NQL+ESLR
Sbjct: 254 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKVDEDILQEVVRMGFDRNQLIESLR 313

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NRLQNE TVAYYLL DNRFRVSSGYLGAEFQET+E  FNR+H  E A    A R  G +D
Sbjct: 314 NRLQNEGTVAYYLLFDNRFRVSSGYLGAEFQETVE--FNRMHLNEVAAPAAAQRFHGHVD 371

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQELNV WKKIGHYNMKCRWIPGI
Sbjct: 372 YQGVGLRSQFPVERKWALGLQSRAHPREIMTEVLKALQELNVSWKKIGHYNMKCRWIPGI 431

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGMVNNP+H++HYFGDES+IIENDGV++SPNVVKFEVQLYKTR+EKYLLDLQRVQG
Sbjct: 432 PGHHEGMVNNPVHNDHYFGDESSIIENDGVLRSPNVVKFEVQLYKTREEKYLLDLQRVQG 491

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQ LFLDLCAAFLAQLRVL
Sbjct: 492 PQMLFLDLCAAFLAQLRVL 510

Source: Mesembryanthemum crystallinum

Species: Mesembryanthemum crystallinum

Genus: Mesembryanthemum

Family: Aizoaceae

Order: Caryophyllales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|157383335|gb|ABV49061.1| sucrose non-fermenting-1-related protein kinase 1 [Malus hupehensis]

 Score =  700 bits (1807), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/379 (87%), Positives = 354/379 (93%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSN+MRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 137 MVVHRDLKPENLLLDSKCNVKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML+VDP
Sbjct: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDP 256

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQH WFQAHLPRYLAV PPDT+QQAKKIDEEIL+EVVKMGFD+N LVESLR
Sbjct: 257 MKRMTIPEIRQHAWFQAHLPRYLAVSPPDTIQQAKKIDEEILQEVVKMGFDRNLLVESLR 316

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
            R+QNE TVAYYLLLD RFRVSSGYLGAEFQET++ GFNR+   E A SPV HR PG+M+
Sbjct: 317 GRVQNEGTVAYYLLLDIRFRVSSGYLGAEFQETVDCGFNRMQQSETAASPVGHRLPGYME 376

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMG R Q P ERKWALGLQSRAHPREIMTEVLKALQEL V WKKIGHYNMKCRW+PG 
Sbjct: 377 YQGMGFRPQFPVERKWALGLQSRAHPREIMTEVLKALQELQVCWKKIGHYNMKCRWVPGT 436

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GH+EGM++N +HSN+YFGDES+IIENDGV++ PNVVKFEVQL+KTR+EKYLLDLQRVQG
Sbjct: 437 PGHNEGMIDNSVHSNNYFGDESSIIENDGVMRMPNVVKFEVQLFKTREEKYLLDLQRVQG 496

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 497 PQFLFLDLCAAFLAQLRVL 515

Source: Malus hupehensis

Species: Malus hupehensis

Genus: Malus

Family: Rosaceae

Order: Rosales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|62857006|dbj|BAD95888.1| Ser/Thr protein kinase [Lotus japonicus]

 Score =  699 bits (1805), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/380 (88%), Positives = 355/380 (93%), Gaps = 2/380 (0%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 138 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 197

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML+VDP
Sbjct: 198 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDP 257

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQHPWFQA LPRYLAVPPPDTMQQAKKIDEE+++EVV MGFD+NQL+ESLR
Sbjct: 258 MKRMTIPEIRQHPWFQARLPRYLAVPPPDTMQQAKKIDEEVVQEVVNMGFDRNQLIESLR 317

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QNE TVAYYLLLDNRFRVSSGYLGAEFQETM+SGFN++HP E A S V HR PG++D
Sbjct: 318 NRIQNEGTVAYYLLLDNRFRVSSGYLGAEFQETMDSGFNQMHPGEVASSVVGHRIPGYID 377

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           Y G+G+R Q P ERKWALGLQSRAHPREIMTEVLKALQELNV WKKIGHYNMKCRW+ GI
Sbjct: 378 YPGVGMRPQFPVERKWALGLQSRAHPREIMTEVLKALQELNVCWKKIGHYNMKCRWVAGI 437

Query: 301 SGHHEGMV-NNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ 359
            GHHEGMV NN  HSNHYFGD+S+IIEND  V S NVVKFEVQLYKTR+EKYLLDLQRVQ
Sbjct: 438 PGHHEGMVNNNTAHSNHYFGDDSSIIENDA-VPSSNVVKFEVQLYKTREEKYLLDLQRVQ 496

Query: 360 GPQFLFLDLCAAFLAQLRVL 379
           G QFLFLDLCAAFLAQLRVL
Sbjct: 497 GAQFLFLDLCAAFLAQLRVL 516

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356568694|ref|XP_003552545.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10-like [Glycine max]

 Score =  697 bits (1798), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/379 (88%), Positives = 353/379 (93%), Gaps = 1/379 (0%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct: 137 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 196

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP ML+VDP
Sbjct: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPGMLVVDP 256

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           M+R+TIPEIRQHPWFQA LPRYLAVPPPDTMQQAKKIDEEIL+EVVKMGFD+NQLVESL 
Sbjct: 257 MRRMTIPEIRQHPWFQARLPRYLAVPPPDTMQQAKKIDEEILQEVVKMGFDRNQLVESLG 316

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QNE TVAYYLLLDNRFRVSSGYLGAEFQETM+SGFN++H  E A S V +R PG+M+
Sbjct: 317 NRIQNEGTVAYYLLLDNRFRVSSGYLGAEFQETMDSGFNQMHSSELASSVVGNRFPGYME 376

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           Y G+G R Q P ERKWALGLQSRAHPREIMTEVLKALQELNV WKKIGHYNMKCRW+ GI
Sbjct: 377 YPGVGSRQQFPVERKWALGLQSRAHPREIMTEVLKALQELNVCWKKIGHYNMKCRWVAGI 436

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGMVNN +HSNHYFGD+S IIEND V  S NVVKFEVQLYKTR+EKYLLDLQRVQG
Sbjct: 437 PGHHEGMVNNNVHSNHYFGDDSNIIENDAVSTS-NVVKFEVQLYKTREEKYLLDLQRVQG 495

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 496 PQFLFLDLCAAFLAQLRVL 514

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452903|ref|XP_002283999.1| PREDICTED: SNF1-related protein kinase catalytic subunit alpha KIN10 [Vitis vinifera]

 Score =  693 bits (1789), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/379 (88%), Positives = 351/379 (92%), Gaps = 7/379 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG+LYAGP
Sbjct: 137 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGRLYAGP 196

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS GARDLIPRMLIVDP
Sbjct: 197 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSTGARDLIPRMLIVDP 256

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+EVVKMGFD+N LVESLR
Sbjct: 257 MKRMTIPEIRQHPWFQAHLPRYLAVPPPDTIQQAKKIDEEILQEVVKMGFDRNLLVESLR 316

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QN+ATVAYYLLLDNRFRVSSGYLGAEFQE++E  FNR          V  R PG++D
Sbjct: 317 NRVQNDATVAYYLLLDNRFRVSSGYLGAEFQESLEYQFNR-----SEAGAVGQRFPGYVD 371

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMGLR Q P ERKWALGLQSRA PR+IMTEVLKALQELNV WKKIGHYNMKCRWIPGI
Sbjct: 372 YQGMGLRTQFPAERKWALGLQSRAQPRQIMTEVLKALQELNVCWKKIGHYNMKCRWIPGI 431

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGMVNNP+HSNH+FGDE AI+ENDGV  S NVVKFEVQLYKTR+EKYLLDLQRVQG
Sbjct: 432 PGHHEGMVNNPVHSNHFFGDEPAIVENDGV--SRNVVKFEVQLYKTREEKYLLDLQRVQG 489

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 490 PQFLFLDLCAAFLAQLRVL 508

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772897|emb|CAN60476.1| hypothetical protein VITISV_034707 [Vitis vinifera]

 Score =  693 bits (1788), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/379 (88%), Positives = 351/379 (92%), Gaps = 7/379 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG+LYAGP
Sbjct: 124 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGRLYAGP 183

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS GARDLIPRMLIVDP
Sbjct: 184 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSTGARDLIPRMLIVDP 243

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           MKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+EVVKMGFD+N LVESLR
Sbjct: 244 MKRMTIPEIRQHPWFQAHLPRYLAVPPPDTIQQAKKIDEEILQEVVKMGFDRNLLVESLR 303

Query: 181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
           NR+QN+ATVAYYLLLDNRFRVSSGYLGAEFQE++E  FNR          V  R PG++D
Sbjct: 304 NRVQNDATVAYYLLLDNRFRVSSGYLGAEFQESLEYQFNR-----SEAGAVGQRFPGYVD 358

Query: 241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
           YQGMGLR Q P ERKWALGLQSRA PR+IMTEVLKALQELNV WKKIGHYNMKCRWIPGI
Sbjct: 359 YQGMGLRTQFPAERKWALGLQSRAQPRQIMTEVLKALQELNVCWKKIGHYNMKCRWIPGI 418

Query: 301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
            GHHEGMVNNP+HSNH+FGDE AI+ENDGV  S NVVKFEVQLYKTR+EKYLLDLQRVQG
Sbjct: 419 PGHHEGMVNNPVHSNHFFGDEPAIVENDGV--SRNVVKFEVQLYKTREEKYLLDLQRVQG 476

Query: 361 PQFLFLDLCAAFLAQLRVL 379
           PQFLFLDLCAAFLAQLRVL
Sbjct: 477 PQFLFLDLCAAFLAQLRVL 495

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	379
TAIR|locus:2102132	535	KIN10 "AT3G01090" [Arabidopsis	0.992	0.702	0.823	8e-172
TAIR|locus:2094672	512	KIN11 "SNF1 kinase homolog 11"	0.944	0.699	0.779	8.2e-154
TAIR|locus:2175663	494	SnRK1.3 "SNF1-related protein	0.815	0.625	0.605	5.5e-113
DICTYBASE|DDB_G0277905	727	snfA "AMP-activated protein ki	0.522	0.272	0.613	5.6e-78
UNIPROTKB|Q5RD00	552	PRKAA2 "5'-AMP-activated prote	0.802	0.550	0.470	3.7e-74
UNIPROTKB|F1MQV7	524	PRKAA2 "Uncharacterized protei	0.794	0.574	0.481	4.7e-74
RGD|620893	552	Prkaa2 "protein kinase, AMP-ac	0.796	0.547	0.476	4.7e-74
UNIPROTKB|E1C754	552	PRKAA2 "Uncharacterized protei	0.794	0.545	0.476	5.9e-74
UNIPROTKB|F1NLY6	564	PRKAA2 "Uncharacterized protei	0.794	0.533	0.476	5.9e-74
UNIPROTKB|F1PIW7	462	PRKAA2 "Uncharacterized protei	0.794	0.651	0.481	7.6e-74

TAIR|locus:2102132 KIN10 "AT3G01090" [Arabidopsis thaliana (taxid:3702)]

 Score = 1670 (592.9 bits), Expect = 8.0e-172, P = 8.0e-172
 Identities = 312/379 (82%), Positives = 336/379 (88%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPENLLLDSK NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct:   160 MVVHRDLKPENLLLDSKCNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 219

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML+VDP
Sbjct:   220 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLVVDP 279

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
             MKR+TIPEIRQHPWFQAHLPRYLAVPPPDT+QQAKKIDEEIL+EV+ MGFD+N L+ESLR
Sbjct:   280 MKRVTIPEIRQHPWFQAHLPRYLAVPPPDTVQQAKKIDEEILQEVINMGFDRNHLIESLR 339

Query:   181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
             NR QN+ TV YYL+LDNRFR SSGYLGAEFQETME G  R+HP E   SPV+HR PG M+
Sbjct:   340 NRTQNDGTVTYYLILDNRFRASSGYLGAEFQETME-GTPRMHPAESVASPVSHRLPGLME 398

Query:   241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
             YQG+GLR Q P ERKWALGLQSRAHPREIMTEVLKALQ+LNV WKKIGHYNMKCRW+P  
Sbjct:   399 YQGVGLRSQYPVERKWALGLQSRAHPREIMTEVLKALQDLNVCWKKIGHYNMKCRWVPNS 458

Query:   301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
             S   +GM++N +H N+YFGDES+IIEN+  VKSPNVVKFE+QLYKTRD+KYLLDLQRVQG
Sbjct:   459 SA--DGMLSNSMHDNNYFGDESSIIENEAAVKSPNVVKFEIQLYKTRDDKYLLDLQRVQG 516

Query:   361 PQXXXXXXXXXXXXXXRVL 379
             PQ              RVL
Sbjct:   517 PQFLFLDLCAAFLAQLRVL 535

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0000152 "nuclear ubiquitin ligase complex" evidence=IPI

GO:0003006 "developmental process involved in reproduction" evidence=IMP

GO:0010050 "vegetative phase change" evidence=IMP

GO:0010260 "organ senescence" evidence=IMP

GO:0080022 "primary root development" evidence=IMP

GO:0009594 "detection of nutrient" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=IMP

GO:0010182 "sugar mediated signaling pathway" evidence=IMP

GO:0006007 "glucose catabolic process" evidence=RCA

GO:0006486 "protein glycosylation" evidence=RCA

TAIR|locus:2094672 KIN11 "SNF1 kinase homolog 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1500 (533.1 bits), Expect = 8.2e-154, P = 8.2e-154
 Identities = 282/362 (77%), Positives = 313/362 (86%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPENLLLDS+ N+KIADFGLSN+MRDGHFLKTSCGSPNYAAPEVISGKLYAGP
Sbjct:   138 MVVHRDLKPENLLLDSRCNIKIADFGLSNVMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 197

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS  ARDLIPRMLIVDP
Sbjct:   198 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSSEARDLIPRMLIVDP 257

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
             +KRITIPEIRQH WFQ HLPRYLAV PPDT++QAKKI+EEI++EVV MGFD+NQ++ESLR
Sbjct:   258 VKRITIPEIRQHRWFQTHLPRYLAVSPPDTVEQAKKINEEIVQEVVNMGFDRNQVLESLR 317

Query:   181 NRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGFMD 240
             NR QN+ATV YYLLLDNRFRV SGYL +EFQET +SG N +   E   SPV H  P  +D
Sbjct:   318 NRTQNDATVTYYLLLDNRFRVPSGYLESEFQETTDSGSNPMRTPEAGASPVGHWIPAHVD 377

Query:   241 YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGI 300
             + G+G R Q+P +RKWALGLQS AHPREIM EVLKALQELNV WKKIGHYNMKCRW+PG+
Sbjct:   378 HYGLGARSQVPVDRKWALGLQSHAHPREIMNEVLKALQELNVCWKKIGHYNMKCRWVPGL 437

Query:   301 SGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG 360
             +     MVNN LH    F DES+IIE+D  + SP V+KFE+QLYK R+EKYLLD+QRV G
Sbjct:   438 ADGQNTMVNNQLH----FRDESSIIEDDCAMTSPTVIKFELQLYKAREEKYLLDIQRVNG 493

Query:   361 PQ 362
             PQ
Sbjct:   494 PQ 495

GO:0004672 "protein kinase activity" evidence=IEA;ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2175663 SnRK1.3 "SNF1-related protein kinase 1.3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1013 (361.7 bits), Expect = 5.5e-113, Sum P(2) = 5.5e-113
 Identities = 198/327 (60%), Positives = 244/327 (74%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             M+VHRDLKPEN+LLDS+ N+KI DFGLSN+M DGHFLKTSCGSPNYAAPEVISGK Y GP
Sbjct:   137 MIVHRDLKPENVLLDSQCNIKIVDFGLSNVMHDGHFLKTSCGSPNYAAPEVISGKPY-GP 195

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             +VD+WSCGVILYALLCGTLPFDDENIPN+F+KIK G+YTLP+HLS  ARDLIPRML+VDP
Sbjct:   196 DVDIWSCGVILYALLCGTLPFDDENIPNVFEKIKRGMYTLPNHLSHFARDLIPRMLMVDP 255

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
               RI+I EIRQHPWF  HLP YL++PP DT+ QAKKI+EEI++ VV +GFD+N +V+SL 
Sbjct:   256 TMRISITEIRQHPWFNNHLPLYLSIPPLDTIDQAKKIEEEIIQNVVNIGFDRNHVVDSLA 315

Query:   181 NRLQNEATVAYYLLLDNRFR--VSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRAPGF 238
             NR+QNEATVAY+L+LDNR +  V +    ++F+E  +  FN   P++   S V H     
Sbjct:   316 NRIQNEATVAYHLILDNRNQNSVPNDPFQSKFKEISDGIFNSTLPVQNITSHVGHSFSAL 375

Query:   239 MDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIP 298
               Y   GL+  +  ++ W LGLQS+  P +IMTE+ KALQ L + WKKIG YN+KCRW+ 
Sbjct:   376 --Y---GLKSNVKDDKTWTLGLQSQGSPYDIMTEIFKALQNLKICWKKIGLYNIKCRWVR 430

Query:   299 GISGHHEGMVNNPLHSNHYFGDESAII 325
               +           + NH   DE AII
Sbjct:   431 SFA----------YYKNHTIEDECAII 447

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030003 "cellular cation homeostasis" evidence=RCA

DICTYBASE|DDB_G0277905 snfA "AMP-activated protein kinase alpha subunit" [Dictyostelium discoideum (taxid:44689)]

 Score = 644 (231.8 bits), Expect = 5.6e-78, Sum P(3) = 5.6e-78
 Identities = 124/202 (61%), Positives = 157/202 (77%)

Query:     1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
             MVVHRDLKPENLLLD     +KIADFGLSN+M+DG FLKTSCGSPNYAAPEVISGKLYAG
Sbjct:   149 MVVHRDLKPENLLLDPINKCIKIADFGLSNMMQDGDFLKTSCGSPNYAAPEVISGKLYAG 208

Query:    60 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             PEVDVWSCGVILYA LC  LPFDDE+IP LFKKI+ G++++P  +SP   DLI +ML+VD
Sbjct:   209 PEVDVWSCGVILYAFLCAKLPFDDESIPMLFKKIREGVFSIPDFVSPSCADLIKKMLVVD 268

Query:   120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKM--GFDQNQLVE 177
             P+KRITI EIR HPWFQ  LP+YL+ P     +  + I+  IL E+V++    D+ +++E
Sbjct:   269 PVKRITIHEIRNHPWFQVKLPKYLSSPHTFLSKSIQTINNSILNEMVQVYAPIDRERIIE 328

Query:   178 SLRNRLQ-NEATVAYYLLLDNR 198
              L+   + N+  V+Y+LL+D++
Sbjct:   329 ELQKSGEVNDLIVSYHLLVDSK 350

GO:0046956 "positive phototaxis" evidence=IMP

GO:0008283 "cell proliferation" evidence=IMP

GO:0007005 "mitochondrion organization" evidence=IMP

GO:0006754 "ATP biosynthetic process" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0007165 "signal transduction" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|Q5RD00 PRKAA2 "5'-AMP-activated protein kinase catalytic subunit alpha-2" [Pongo abelii (taxid:9601)]

 Score = 715 (256.8 bits), Expect = 3.7e-74, Sum P(2) = 3.7e-74
 Identities = 152/323 (47%), Positives = 209/323 (64%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPEN+LLD+  N KIADFGLSNIM DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct:   134 MVVHRDLKPENVLLDAHMNAKIADFGLSNIMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct:   194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 253

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
             +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct:   254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query:   180 RNR-LQNEATVAYYLLLDNRF---RVSSGYLGAEFQETMESGFNRLHPIEPAVSPVAHRA 235
              +   Q++  VAY+L++DNR    + S  YL +          + +H I P + P   R 
Sbjct:   312 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPSGSFMDDSAMH-IPPGLKPHPERM 370

Query:   236 PGF----------MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGW 284
             P            +D         L  ++ KW LG++S++ P +IM EV +A+++L+  W
Sbjct:   371 PPLIADSPKARCPLDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDFEW 430

Query:   285 KKIGHYNMKCRWIPGISGHHEGM 307
             K +  Y+++ R    ++G++  M
Sbjct:   431 KVVNAYHLRVRRKNPVTGNYVKM 453

GO:0003682 "chromatin binding" evidence=ISS

GO:0004679 "AMP-activated protein kinase activity" evidence=ISS

GO:0008610 "lipid biosynthetic process" evidence=ISS

GO:0010508 "positive regulation of autophagy" evidence=ISS

GO:0031669 "cellular response to nutrient levels" evidence=ISS

GO:0032007 "negative regulation of TOR signaling cascade" evidence=ISS

GO:0035174 "histone serine kinase activity" evidence=ISS

GO:0035404 "histone-serine phosphorylation" evidence=ISS

GO:0042149 "cellular response to glucose starvation" evidence=ISS

GO:0042593 "glucose homeostasis" evidence=ISS

GO:0042752 "regulation of circadian rhythm" evidence=ISS

GO:0043066 "negative regulation of apoptotic process" evidence=ISS

GO:0045821 "positive regulation of glycolysis" evidence=ISS

GO:0055089 "fatty acid homeostasis" evidence=ISS

GO:2000505 "regulation of energy homeostasis" evidence=ISS

UNIPROTKB|F1MQV7 PRKAA2 "Uncharacterized protein" [Bos taurus (taxid:9913)]

 Score = 714 (256.4 bits), Expect = 4.7e-74, Sum P(2) = 4.7e-74
 Identities = 157/326 (48%), Positives = 217/326 (66%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct:   106 MVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 165

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct:   166 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 225

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
             +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct:   226 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 283

Query:   180 RNR-LQNEATVAYYLLLDNRF---RVSSGYLGAE-----FQE--TME--SGFNRLHP--I 224
              +   Q++  VAY+L++DNR    + S  YL +      F +  TM    G  + HP  +
Sbjct:   284 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDSTMHIPPGL-KPHPERM 342

Query:   225 EPAV--SPVAHRAPGFMDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELN 281
              P +  SP A R P  +D         L  ++ KW LG++S++ P +IM EV +A+++L+
Sbjct:   343 PPLIADSPKA-RCP--LDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLD 399

Query:   282 VGWKKIGHYNMKCRWIPGISGHHEGM 307
               WK +  Y+++ R    ++G++  M
Sbjct:   400 FEWKVVNAYHLRVRRRNPVTGNYVKM 425

GO:0003682 "chromatin binding" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0042752 "regulation of circadian rhythm" evidence=IEA

GO:0042593 "glucose homeostasis" evidence=IEA

GO:0042149 "cellular response to glucose starvation" evidence=IEA

GO:0035174 "histone serine kinase activity" evidence=IEA

GO:0032007 "negative regulation of TOR signaling cascade" evidence=IEA

GO:0010508 "positive regulation of autophagy" evidence=IEA

GO:0008610 "lipid biosynthetic process" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004679 "AMP-activated protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

RGD|620893 Prkaa2 "protein kinase, AMP-activated, alpha 2 catalytic subunit" [Rattus norvegicus (taxid:10116)]

 Score = 714 (256.4 bits), Expect = 4.7e-74, Sum P(2) = 4.7e-74
 Identities = 155/325 (47%), Positives = 215/325 (66%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPEN+LLD++ N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct:   134 MVVHRDLKPENVLLDAQMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 193

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct:   194 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSIATLLMHMLQVDP 253

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
             +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct:   254 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 311

Query:   180 RNR-LQNEATVAYYLLLDNRF---RVSSGYLGAE-----FQETMESGFN---RLHP--IE 225
              +   Q++  VAY+L++DNR    + S  YL +      F + M        + HP  + 
Sbjct:   312 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDMAMHIPPGLKPHPERMP 371

Query:   226 PAV--SPVAHRAPGFMDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNV 282
             P +  SP A R P  +D         L  ++ KW LG++S++ P +IM EV +A+++L+ 
Sbjct:   372 PLIADSPKA-RCP--LDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDF 428

Query:   283 GWKKIGHYNMKCRWIPGISGHHEGM 307
              WK +  Y+++ R    ++G++  M
Sbjct:   429 EWKVVNAYHLRVRRKNPVTGNYVKM 453

GO:0003682 "chromatin binding" evidence=IEA;ISO;ISS

GO:0004672 "protein kinase activity" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISO;IDA

GO:0004679 "AMP-activated protein kinase activity" evidence=IEA;ISO;IMP;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA;IDA

GO:0005634 "nucleus" evidence=IEA;ISO;TAS

GO:0005654 "nucleoplasm" evidence=TAS

GO:0005737 "cytoplasm" evidence=IDA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0006633 "fatty acid biosynthetic process" evidence=IEA

GO:0006695 "cholesterol biosynthetic process" evidence=IEA

GO:0006914 "autophagy" evidence=IEA

GO:0006950 "response to stress" evidence=ISO;IDA

GO:0008610 "lipid biosynthetic process" evidence=IEA;ISO;ISS

GO:0010508 "positive regulation of autophagy" evidence=IEA;ISO;ISS

GO:0014823 "response to activity" evidence=IDA

GO:0016055 "Wnt receptor signaling pathway" evidence=IEA

GO:0016324 "apical plasma membrane" evidence=IDA

GO:0019216 "regulation of lipid metabolic process" evidence=IDA

GO:0030674 "protein binding, bridging" evidence=IDA

GO:0031000 "response to caffeine" evidence=IDA

GO:0031588 "AMP-activated protein kinase complex" evidence=IDA

GO:0031669 "cellular response to nutrient levels" evidence=ISO;ISS

GO:0032007 "negative regulation of TOR signaling cascade" evidence=IEA;ISO;ISS

GO:0035174 "histone serine kinase activity" evidence=IEA;ISO;ISS

GO:0035404 "histone-serine phosphorylation" evidence=ISS

GO:0042149 "cellular response to glucose starvation" evidence=IEA;ISO;ISS

GO:0042593 "glucose homeostasis" evidence=IEA;ISO;ISS

GO:0042752 "regulation of circadian rhythm" evidence=IEA;ISO;ISS

GO:0043066 "negative regulation of apoptotic process" evidence=IEA;ISO;ISS

GO:0043234 "protein complex" evidence=IDA

GO:0045821 "positive regulation of glycolysis" evidence=IDA

GO:0046872 "metal ion binding" evidence=IEA

GO:0047322 "[hydroxymethylglutaryl-CoA reductase (NADPH)

GO:0048511 "rhythmic process" evidence=IEA

GO:0050405 "[acetyl-CoA carboxylase

GO:0051291 "protein heterooligomerization" evidence=IDA

GO:0055089 "fatty acid homeostasis" evidence=IDA

GO:0071417 "cellular response to organic nitrogen" evidence=IEP

GO:2000505 "regulation of energy homeostasis" evidence=IDA

UNIPROTKB|E1C754 PRKAA2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 710 (255.0 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
 Identities = 155/325 (47%), Positives = 216/325 (66%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct:   135 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 194

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct:   195 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 254

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
             +KR TI +IR+H WF+  LP YL   P D    A  ID++ ++EV  K    +++++ SL
Sbjct:   255 LKRATIKDIREHEWFKEELPSYLF--PEDPSYDATVIDDDAVREVCEKFECTESEVMNSL 312

Query:   180 RNR-LQNEATVAYYLLLDNRF---RVSSGYL------GAEFQETME--SGFNRLHP--IE 225
              +   Q++  VAY+L++DNR    + S  YL      G+   +TM    G  + HP  + 
Sbjct:   313 YSGDPQDQLAVAYHLVIDNRRIMNQASEFYLASSPPTGSFMDDTMHIPPGV-KPHPERMP 371

Query:   226 PAV--SPVAHRAPGFMDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNV 282
             P +  SP A R P  +D         L  ++ KW LG++S++ P +IM EV +A+++L+ 
Sbjct:   372 PLIADSPKA-RCP--LDALNTTKPKPLTVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDF 428

Query:   283 GWKKIGHYNMKCRWIPGISGHHEGM 307
              WK +  Y+++ R    ++G++  M
Sbjct:   429 EWKVVNSYHLRVRRKNPVTGNYVKM 453

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

UNIPROTKB|F1NLY6 PRKAA2 "Uncharacterized protein" [Gallus gallus (taxid:9031)]

 Score = 710 (255.0 bits), Expect = 5.9e-74, Sum P(2) = 5.9e-74
 Identities = 155/325 (47%), Positives = 216/325 (66%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct:   147 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 206

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct:   207 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 266

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
             +KR TI +IR+H WF+  LP YL   P D    A  ID++ ++EV  K    +++++ SL
Sbjct:   267 LKRATIKDIREHEWFKEELPSYLF--PEDPSYDATVIDDDAVREVCEKFECTESEVMNSL 324

Query:   180 RNR-LQNEATVAYYLLLDNRF---RVSSGYL------GAEFQETME--SGFNRLHP--IE 225
              +   Q++  VAY+L++DNR    + S  YL      G+   +TM    G  + HP  + 
Sbjct:   325 YSGDPQDQLAVAYHLVIDNRRIMNQASEFYLASSPPTGSFMDDTMHIPPGV-KPHPERMP 383

Query:   226 PAV--SPVAHRAPGFMDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNV 282
             P +  SP A R P  +D         L  ++ KW LG++S++ P +IM EV +A+++L+ 
Sbjct:   384 PLIADSPKA-RCP--LDALNTTKPKPLTVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLDF 440

Query:   283 GWKKIGHYNMKCRWIPGISGHHEGM 307
              WK +  Y+++ R    ++G++  M
Sbjct:   441 EWKVVNSYHLRVRRKNPVTGNYVKM 465

GO:0005524 "ATP binding" evidence=IEA

GO:0003682 "chromatin binding" evidence=IEA

GO:0004679 "AMP-activated protein kinase activity" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0008610 "lipid biosynthetic process" evidence=IEA

GO:0010508 "positive regulation of autophagy" evidence=IEA

GO:0032007 "negative regulation of TOR signaling cascade" evidence=IEA

GO:0035174 "histone serine kinase activity" evidence=IEA

GO:0042149 "cellular response to glucose starvation" evidence=IEA

GO:0042593 "glucose homeostasis" evidence=IEA

GO:0042752 "regulation of circadian rhythm" evidence=IEA

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

UNIPROTKB|F1PIW7 PRKAA2 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 712 (255.7 bits), Expect = 7.6e-74, Sum P(2) = 7.6e-74
 Identities = 157/326 (48%), Positives = 216/326 (66%)

Query:     1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
             MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct:    44 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 103

Query:    61 EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct:   104 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 163

Query:   121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
             +KR TI +IR+H WF+  LP YL   P D    A  ID+E +KEV  K    +++++ SL
Sbjct:   164 LKRATIKDIREHEWFKQDLPSYLF--PEDPSYDANVIDDEAVKEVCEKFECTESEVMNSL 221

Query:   180 RNR-LQNEATVAYYLLLDNRF---RVSSGYLGAE-----FQE--TME--SGFNRLHP--I 224
              +   Q++  VAY+L++DNR    + S  YL +      F +  TM    G  + HP  +
Sbjct:   222 YSGDPQDQLAVAYHLIIDNRRIMNQASEFYLASSPPTGSFMDDSTMHIPPGL-KPHPERM 280

Query:   225 EPAV--SPVAHRAPGFMDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELN 281
              P +  SP A R P  +D         L  ++ KW LG++S++ P +IM EV +A+++L+
Sbjct:   281 PPLIADSPKA-RCP--LDALNTTKPKSLAVKKAKWHLGIRSQSKPYDIMAEVYRAMKQLD 337

Query:   282 VGWKKIGHYNMKCRWIPGISGHHEGM 307
               WK +  Y+++ R    ++G++  M
Sbjct:   338 FEWKVVNAYHLRVRRKNPVTGNYVKM 363

GO:0043066 "negative regulation of apoptotic process" evidence=IEA

GO:0042752 "regulation of circadian rhythm" evidence=IEA

GO:0042593 "glucose homeostasis" evidence=IEA

GO:0042149 "cellular response to glucose starvation" evidence=IEA

GO:0035174 "histone serine kinase activity" evidence=IEA

GO:0032007 "negative regulation of TOR signaling cascade" evidence=IEA

GO:0010508 "positive regulation of autophagy" evidence=IEA

GO:0008610 "lipid biosynthetic process" evidence=IEA

GO:0005634 "nucleus" evidence=IEA

GO:0004679 "AMP-activated protein kinase activity" evidence=IEA

GO:0003682 "chromatin binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q38997	KIN10_ARATH	2, ., 7, ., 1, 1, ., 1	0.8601	0.9920	0.7028	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.991
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: estExt_fgenesh4_pg.C_9860004 hypothetical protein (421 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	379
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-58
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-50
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-48
cd12122	132	cd12122, AMPKA_C, C-terminal regulatory domain of	2e-40
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-39
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	7e-39
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-37
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	8e-37
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-35
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-33
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	4e-33
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	5e-31
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-31
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-30
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-30
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-30
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-29
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-29
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-29
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-28
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	5e-28
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-27
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-27
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-27
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-27
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	5e-26
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-26
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-26
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-25
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	5e-25
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-25
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-25
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-24
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-24
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-24
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	4e-24
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	1e-23
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-23
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-23
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	6e-23
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-23
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	8e-23
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	3e-22
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-22
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	6e-22
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	7e-22
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-21
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-21
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-21
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-21
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-21
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-20
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-20
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-20
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-20
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-20
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	6e-20
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	6e-20
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	6e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	7e-20
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	8e-20
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	8e-20
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-19
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-19
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	2e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	3e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	3e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	8e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-19
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-18
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-18
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-18
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-18
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-18
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-18
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-18
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-18
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-18
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	9e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-17
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-17
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	5e-17
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	7e-17
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-16
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-16
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-16
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-16
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-16
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	5e-16
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-16
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	7e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	7e-16
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-16
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	8e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-16
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-15
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-15
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-15
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-15
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-15
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-15
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-15
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	3e-15
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	4e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-15
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-15
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	7e-15
pfam02149	46	pfam02149, KA1, Kinase associated domain 1	1e-14
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-14
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-14
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-14
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-14
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-14
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	3e-14
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-14
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-14
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-14
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	2e-13
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-13
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	3e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	3e-13
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-13
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	6e-13
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	7e-13
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	9e-13
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-12
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	3e-12
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	5e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	6e-12
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-12
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-12
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-11
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-11
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-11
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-11
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-11
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	6e-11
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	7e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-10
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-10
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-10
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	3e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-10
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-10
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-10
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	7e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	9e-10
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-09
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-09
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-09
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-09
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	4e-09
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-09
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-09
cd12200	102	cd12200, AMPKA2_C, C-terminal regulatory domain of	5e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-09
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-09
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-09
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-09
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-08
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-08
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-08
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-08
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	2e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	6e-08
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	6e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	7e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-08
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	1e-07
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	1e-07
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-07
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-07
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-07
cd12199	96	cd12199, AMPKA1_C, C-terminal regulatory domain of	3e-07
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-07
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	3e-07
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-07
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	5e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-07
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	6e-07
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	8e-07
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	9e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	9e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-06
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-06
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-06
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-06
pfam00627	37	pfam00627, UBA, UBA/TS-N domain	3e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-06
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-06
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	3e-06
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-06
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-06
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	6e-06
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-06
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	7e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	8e-06
smart00165	37	smart00165, UBA, Ubiquitin associated domain	8e-06
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	9e-06
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-05
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-05
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-05
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-05
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-05
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-05
cd00194	38	cd00194, UBA, Ubiquitin Associated domain	2e-05
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	3e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-05
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	4e-05
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-05
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	5e-05
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-05
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-05
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-04
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-04
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-04
cd12120	95	cd12120, AMPKA_C_like, C-terminal regulatory domai	1e-04
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-04
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	2e-04
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-04
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-04
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-04
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-04
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-04
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-04
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	6e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	7e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-04
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	9e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	0.001
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.002
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	0.002
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	0.004

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  190 bits (484), Expect = 2e-58
 Identities = 71/138 (51%), Positives = 89/138 (64%), Gaps = 5/138 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPEN+LLD   +VK+ADFGL+  +  G  L T  G+P Y APEV+ GK Y G  
Sbjct: 118 IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGY-GKA 176

Query: 62  VDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLI 117
           VD+WS GVILY LL G  PF  D+ +  LFKKI       P     +SP A+DLI ++L+
Sbjct: 177 VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLV 236

Query: 118 VDPMKRITIPEIRQHPWF 135
            DP KR+T  E  QHP+F
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  170 bits (432), Expect = 1e-50
 Identities = 71/142 (50%), Positives = 86/142 (60%), Gaps = 8/142 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLKPEN+LLD    VKIADFGL+  +++    L T  G+P Y APEV+ G    GP
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLP----SHLSPGARDLIP 113
           +VDVWS GVILY LL G  PF  ENI +   L ++I G          S  S  A+DLI 
Sbjct: 179 KVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIK 238

Query: 114 RMLIVDPMKRITIPEIRQHPWF 135
           + L  DP KR T  EI QHPWF
Sbjct: 239 KCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  163 bits (414), Expect = 5e-48
 Identities = 63/138 (45%), Positives = 86/138 (62%), Gaps = 5/138 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD+  ++K+ DFGL+  +  +G    T CG+P Y APEV+ GK Y G 
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GK 172

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD WS GV+LY +L G  PF  E+   +++KI       P  LSP ARDLI  +L  DP
Sbjct: 173 AVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDP 232

Query: 121 MKRIT---IPEIRQHPWF 135
            KR+      EI+ HP+F
Sbjct: 233 TKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|213378 cd12122, AMPKA_C, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha catalytic subunit

 Score =  139 bits (351), Expect = 2e-40
 Identities = 55/143 (38%), Positives = 72/143 (50%), Gaps = 30/143 (20%)

Query: 253 ERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPL 312
           ER+W LG++S++HP EIM EV +AL+ L   WKKI  Y++KCRW   + G   G      
Sbjct: 1   ERRWHLGIRSQSHPHEIMLEVYRALKALGFEWKKISPYHIKCRWKNPVVGKPGGS----- 55

Query: 313 HSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV-------------- 358
                   ES+  +  G  + P VVK E+QLYK  D KYLLD Q +              
Sbjct: 56  ------SGESSSADGPGAARQPTVVKMELQLYKVDDNKYLLDFQSLDYEEERTGPGESAE 109

Query: 359 -----QGPQFLFLDLCAAFLAQL 376
                 G  FLF DLCA  + +L
Sbjct: 110 DAEPQVGSTFLFFDLCAKLITEL 132

AMPK, a serine/threonine protein kinase (STK), catalyzes the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. It acts as a sensor for the energy status of the cell and is activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. AMPK is a heterotrimer of three subunits: alpha, beta, and gamma. Co-expression of the three subunits is required for kinase activity; in the absence of one, the other two subunits get degraded. The AMPK alpha subunit is the catalytic subunit and it contains an N-terminal kinase domain and a C-terminal regulatory domain (RD). Vertebrates contain two isoforms of the alpha subunit, alpha1 and alpha2, which are encoded by different genes, PRKAA1 and PRKAA2, respectively. The C-terminal RD of the AMPK alpha subunit is involved in AMPK heterotrimer formation. It mainly interacts with the C-terminal region of the beta subunit to form a tight alpha-beta complex that is associated with the gamma subunit. The AMPK alpha subunit RD also contains an auto-inhibitory region that interacts with the kinase domain; this inhibition is negated by the interaction with the AMPK gamma subunit. AMPK is conserved throughout evolution; the AMPK alpha subunit homologs in yeast and plants are called Snf1 and SnRK1 (Snf1 related kinase), respectively. Length = 132

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  141 bits (357), Expect = 3e-39
 Identities = 62/141 (43%), Positives = 86/141 (60%), Gaps = 8/141 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPENLLLDS   +KI DFG +  ++   +  T CG+P Y APE+I  K Y G  
Sbjct: 122 IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTY--TLCGTPEYLAPEIILSKGY-GKA 178

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ G+++Y +L G  PF D+N   +++KI  G    PS  SP A+DLI  +L VD  
Sbjct: 179 VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLT 238

Query: 122 KRI-----TIPEIRQHPWFQA 137
           KR+      + +I+ HPWF  
Sbjct: 239 KRLGNLKNGVNDIKNHPWFAG 259

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  139 bits (353), Expect = 7e-39
 Identities = 51/159 (32%), Positives = 84/159 (52%), Gaps = 26/159 (16%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---------------------RDGHFLKTS 40
           ++HRDLKPEN+LLD   ++KI DFG + ++                     ++     + 
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 41  CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL 100
            G+  Y +PE+++ K  AG   D+W+ G I+Y +L G  PF   N    F+KI    Y+ 
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241

Query: 101 PSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF 135
           P +  P A+DLI ++L++DP  R+ +     E++ HP+F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  135 bits (343), Expect = 1e-37
 Identities = 52/134 (38%), Positives = 76/134 (56%), Gaps = 3/134 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP+N+ L S   VK+ DFG+S ++       KT  G+P Y +PE+   K Y   
Sbjct: 124 ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY-NY 182

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVD 119
           + D+WS G +LY L     PF+ EN+  L  KI  G Y  +PS  S   R+L+  +L  D
Sbjct: 183 KSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKD 242

Query: 120 PMKRITIPEIRQHP 133
           P +R +I +I Q P
Sbjct: 243 PEERPSIAQILQSP 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  133 bits (338), Expect = 8e-37
 Identities = 59/148 (39%), Positives = 83/148 (56%), Gaps = 15/148 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-------NIMRDGHFLKTS--CGSPNYAAPEVI 52
           ++HRDLKP+N+L+DS  ++K+ DFGLS        I  +    +     G+P+Y APEVI
Sbjct: 114 IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVI 173

Query: 53  SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARD 110
            G+ +    VD WS G ILY  L G  PF  E    +F+ I  G    P    +S  A D
Sbjct: 174 LGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAID 232

Query: 111 LIPRMLIVDPMKRI---TIPEIRQHPWF 135
           LI ++L+ DP KR+   +I EI+ HP+F
Sbjct: 233 LISKLLVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  130 bits (330), Expect = 1e-35
 Identities = 60/144 (41%), Positives = 86/144 (59%), Gaps = 10/144 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLLLDS   VK+ DFG +  ++ G    T CG+P Y APE+I  K Y    
Sbjct: 114 IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY-DFS 172

Query: 62  VDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           VD WS G++LY LL G  PF  DDE+   ++  I  G   L  P+++   A+DLI ++L 
Sbjct: 173 VDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLR 232

Query: 118 VDPMKRI-----TIPEIRQHPWFQ 136
            +P +R+      I +I++H WF 
Sbjct: 233 RNPEERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  124 bits (314), Expect = 2e-33
 Identities = 52/140 (37%), Positives = 76/140 (54%), Gaps = 7/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRD+K  N+L+DS   VK+ADFG +  + D   G    +  G+P + APEVI G+ Y 
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY- 180

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYT-LPSHLSPGARDLIPRM 115
           G   D+WS G  +  +  G  P+ +    +  L+K    G    +P HLS  A+D + + 
Sbjct: 181 GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKC 240

Query: 116 LIVDPMKRITIPEIRQHPWF 135
           L  DP KR T  E+ QHP+ 
Sbjct: 241 LRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  122 bits (308), Expect = 4e-33
 Identities = 55/134 (41%), Positives = 69/134 (51%), Gaps = 33/134 (24%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAG 59
           ++HRDLKPEN+LLDS    VK+ADFGLS ++      LKT  G+P Y APEV+ GK Y  
Sbjct: 113 IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYS 172

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            + D+WS GVILY L                               P  +DLI +ML  D
Sbjct: 173 EKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKD 201

Query: 120 PMKRITIPEIRQHP 133
           P KR +  EI +H 
Sbjct: 202 PEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  118 bits (298), Expect = 5e-31
 Identities = 51/134 (38%), Positives = 73/134 (54%), Gaps = 3/134 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGP 60
           V+HRDLKP N+ LD+  NVK+ DFGL+ I+        +  G+P Y +PE ++   Y   
Sbjct: 131 VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYD-E 189

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
           + D+WS G ++Y L   + PF   N   L  KIK G +  +P   S    ++I  ML VD
Sbjct: 190 KSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVD 249

Query: 120 PMKRITIPEIRQHP 133
           P KR +  E+ Q P
Sbjct: 250 PDKRPSTEELLQLP 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  119 bits (299), Expect = 9e-31
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 15/192 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++KIADFG+    +  G    T CG+P+Y APE++S + Y GP
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GP 175

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PF+ ++   LF+ I       P  LS  A+ ++   L  +P
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235

Query: 121 MKRITIP-----EIRQHPWFQ----AHLPRYLAVPPPDTMQQAKK----IDEEILKEVVK 167
            KR+        +I+ HP+F+      L R    PP     + +      D+E  KE   
Sbjct: 236 EKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGRFDVSNFDDEFTKEKPV 295

Query: 168 MGFDQNQLVESL 179
           +      ++ ++
Sbjct: 296 LTPPDEAIIRNI 307

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  118 bits (297), Expect = 2e-30
 Identities = 62/157 (39%), Positives = 88/157 (56%), Gaps = 13/157 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLLLD+K +VK+ DFG +  + D  F  T CG+P Y APEVI  K + G  
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTF--TLCGTPEYLAPEVIQSKGH-GKA 195

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV+LY  + G  PF D+    +++KI  G    P+     ARDL+  +L  D  
Sbjct: 196 VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHT 255

Query: 122 KRI-TIP----EIRQHPWFQAH-----LPRYLAVPPP 148
           KR+ T+     +++ HP+F          RY   P P
Sbjct: 256 KRLGTLKGGVADVKNHPYFHGANWDKLYARYYPAPIP 292

Length = 329

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  117 bits (295), Expect = 3e-30
 Identities = 66/197 (33%), Positives = 102/197 (51%), Gaps = 14/197 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V++RDLKPEN+LLD + ++ + DFGL  + M+D     T CG+P Y APE++ G  Y   
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT-K 172

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PF DEN+  +++KI       P      A+DL+  +L  DP
Sbjct: 173 AVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDP 232

Query: 121 MKRITI---PEIRQHPWFQAHLPRYL---AVPPP-----DTMQQAKKIDEEILKEV-VKM 168
            +R+      EI+ HP+F     + L    + PP      +       DEE  +E  +  
Sbjct: 233 TRRLGYNGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSSAIDTSNFDEEFTREKPIDS 292

Query: 169 GFDQNQLVESLRNRLQN 185
             D + L E+++ +   
Sbjct: 293 VVDDSHLSETVQQQFGG 309

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  116 bits (291), Expect = 3e-30
 Identities = 56/142 (39%), Positives = 76/142 (53%), Gaps = 11/142 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KPENLL+D   ++K+ DFGLS   R+G   K   G+P+Y APE I G       
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGV-GDDKM 173

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 117
            D WS G +++  L G  PF  E    +F  I       P       SP A DLI R+L 
Sbjct: 174 SDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC 233

Query: 118 VDPMKRI---TIPEIRQHPWFQ 136
           +DP KR+      EI+ HP+F+
Sbjct: 234 MDPAKRLGANGYQEIKSHPFFK 255

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  116 bits (291), Expect = 1e-29
 Identities = 59/140 (42%), Positives = 82/140 (58%), Gaps = 7/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 174

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234

Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        EI +H +F
Sbjct: 235 KQRLGGGPEDAKEIMEHRFF 254

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  114 bits (287), Expect = 3e-29
 Identities = 56/140 (40%), Positives = 87/140 (62%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPEN+LLD + ++K+ DFG +  +RD  +  T CG+P Y APEVI  K +    
Sbjct: 122 IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTW--TLCGTPEYLAPEVIQSKGH-NKA 178

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ G+++Y +L G  PF D+N   +++KI  G    P HL   A+DLI ++L+VD  
Sbjct: 179 VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRT 238

Query: 122 KRI-----TIPEIRQHPWFQ 136
           +R+        +++ H WF+
Sbjct: 239 RRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  113 bits (284), Expect = 4e-29
 Identities = 45/139 (32%), Positives = 72/139 (51%), Gaps = 6/139 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP+N+LLD + +V I DF ++  +       ++ G+P Y APEV+  + Y    
Sbjct: 121 IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVA 179

Query: 62  VDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
           VD WS GV  Y  L G  P+          +  K +      P+  S  A D I ++L  
Sbjct: 180 VDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLER 239

Query: 119 DPMKRI--TIPEIRQHPWF 135
           DP KR+   + +++ HP+F
Sbjct: 240 DPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  113 bits (285), Expect = 2e-28
 Identities = 58/169 (34%), Positives = 83/169 (49%), Gaps = 37/169 (21%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------------------------- 35
           +HRD+KP+N+L+D+  ++K+ADFGL   M                               
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182

Query: 36  ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK 92
                 ++ G+P+Y APEV+ G  Y G E D WS GVILY +L G  PF  + +   + K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241

Query: 93  IKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQ 136
           I     +L  P    +SP A DLI R L+ DP  R+    EI+ HP+F+
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  111 bits (279), Expect = 5e-28
 Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 15/190 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RDLK +N+LLD   ++KIADFG+   N+  +G    T CG+P+Y APE++ G+ Y  
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK-ASTFCGTPDYIAPEILKGQKYNE 175

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD WS GV+LY +L G  PF  E+   LF  I       P  +S  A+D + ++   D
Sbjct: 176 -SVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERD 234

Query: 120 PMKRITIP-EIRQHPWFQA----HLPRYLAVPPP-----DTMQQAKKIDEEILKEVVKMG 169
           P KR+ +  +IRQHP+F+      L +   +PPP      +   A   D E   E V++ 
Sbjct: 235 PTKRLGVDGDIRQHPFFRGIDWERLEKR-EIPPPFKPKVKSPSDASNFDREFTNEKVRLS 293

Query: 170 FDQNQLVESL 179
               +L+ S+
Sbjct: 294 PVDKKLLASM 303

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  108 bits (273), Expect = 1e-27
 Identities = 48/136 (35%), Positives = 70/136 (51%), Gaps = 4/136 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+K  N+LL S   VK+ DFGLS  + D     T  G+P + APEVI+GK Y   +
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYK 177

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGARDLIPRMLIV 118
            D+WS G+    L  G  P+ +        KI   G   L  P   S   +D + + L  
Sbjct: 178 ADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQK 237

Query: 119 DPMKRITIPEIRQHPW 134
           +P KR T  ++ +HP+
Sbjct: 238 NPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  111 bits (278), Expect = 2e-27
 Identities = 53/158 (33%), Positives = 75/158 (47%), Gaps = 23/158 (14%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDG-------HFLKTSCGSPNYAAPEVIS 53
           ++HRD+KPEN+LLD     VK+ DFGL+ ++ D            TS G+P Y APEV+ 
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181

Query: 54  GKL--YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--------- 102
           G    YA    D+WS G+ LY LL G  PF+ E   +   +    I  LP+         
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSP 241

Query: 103 ----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +S  A DL+ ++L  DP  R++      H    
Sbjct: 242 SNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA 279

Length = 384

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  110 bits (275), Expect = 2e-27
 Identities = 66/196 (33%), Positives = 110/196 (56%), Gaps = 14/196 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +V+RDLK +N+LLD+  ++KIADFG+   N++ D     T CG+P+Y APE++ G+ Y  
Sbjct: 117 IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAK-TCTFCGTPDYIAPEILLGQKY-N 174

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD WS GV+LY +L G  PF   +   LF+ I+      P  L+  A+D++ ++ + +
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234

Query: 120 PMKRITIP-EIRQHPWFQ----AHLPRYLAVPP-PDTMQQA---KKIDEEILKEVVKMGF 170
           P +R+ +  +IRQHP+F+    + L      PP    ++ A      D+E L E  ++  
Sbjct: 235 PERRLGVKGDIRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSV 294

Query: 171 DQNQLVESL-RNRLQN 185
               L+ S+ +N  +N
Sbjct: 295 TDRMLINSMDQNMFEN 310

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  110 bits (275), Expect = 2e-27
 Identities = 60/140 (42%), Positives = 83/140 (59%), Gaps = 7/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G 
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GR 175

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 176 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDP 235

Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        EI QH +F
Sbjct: 236 KQRLGGGPDDAKEIMQHKFF 255

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  106 bits (265), Expect = 5e-26
 Identities = 55/142 (38%), Positives = 85/142 (59%), Gaps = 9/142 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RDLK +N++LD++ ++KIADFG+   NI   G   +T CG+P+Y APE+I+ + Y G
Sbjct: 122 IIYRDLKLDNVMLDAEGHIKIADFGMCKENIF-GGKTTRTFCGTPDYIAPEIIAYQPY-G 179

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD W+ GV+LY +L G  PFD E+   LF+ I     + P  LS  A  +   +L   
Sbjct: 180 KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKH 239

Query: 120 PMKRITI-----PEIRQHPWFQ 136
           P KR+        +IR+H +F+
Sbjct: 240 PAKRLGCGPTGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  105 bits (264), Expect = 7e-26
 Identities = 61/158 (38%), Positives = 86/158 (54%), Gaps = 23/158 (14%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI--------MRDGH-------FL-KTSCGSPN 45
           +VHRDLKP+NLL+ S  ++K+ DFGLS I        + +GH       FL K  CG+P 
Sbjct: 122 IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPE 181

Query: 46  YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH-- 103
           Y APEVI  + Y  P VD W+ G+ILY  L G +PF  +    LF ++       P    
Sbjct: 182 YIAPEVILRQGYGKP-VDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDE 240

Query: 104 -LSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQA 137
            L   A+DLI R+L  +P++R+      E++QH +F  
Sbjct: 241 ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG 278

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  104 bits (263), Expect = 7e-26
 Identities = 53/174 (30%), Positives = 78/174 (44%), Gaps = 50/174 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLKP+N+L++    +K+ADFGL+           + G P            Y APE
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLA----------RAFGIPLRTYTHEVVTLWYRAPE 168

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFK--KIKG--------GIYT 99
           ++ G  +    VD+WS G I   ++ G   F  D  I  LFK  +I G        G+  
Sbjct: 169 ILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTK 228

Query: 100 LPSH------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           LP +                  L P   DL+ +ML  +P KRI+  E  +HP+F
Sbjct: 229 LPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  105 bits (263), Expect = 1e-25
 Identities = 57/143 (39%), Positives = 84/143 (58%), Gaps = 11/143 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVI--SGKLYA 58
           +++RDLKPEN+LLD++ +VK+ DFGL    + +G    T CG+  Y APE++  SG    
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH--- 177

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
           G  VD WS G ++Y +L G  PF  EN      KI  G   LP +L+P ARDL+ ++L  
Sbjct: 178 GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237

Query: 119 DPMKRI-----TIPEIRQHPWFQ 136
           +P  R+        E++ HP+F+
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFR 260

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  103 bits (258), Expect = 2e-25
 Identities = 47/133 (35%), Positives = 73/133 (54%), Gaps = 3/133 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLK  N+LL +   VKI D G+S +++  +  KT  G+P+Y APEV  G+ Y+   
Sbjct: 124 ILHRDLKSANILLVANDLVKIGDLGISKVLK-KNMAKTQIGTPHYMAPEVWKGRPYSYKS 182

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDP 120
            D+WS G +LY +     PF+  ++ +L  K++ G Y  +P   S   ++ I  ML V P
Sbjct: 183 -DIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKP 241

Query: 121 MKRITIPEIRQHP 133
             R    +I   P
Sbjct: 242 KLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (259), Expect = 2e-25
 Identities = 54/141 (38%), Positives = 77/141 (54%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP NLL++SK  VKIADFG+S ++ +      T  G+  Y +PE I G+ Y+  
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLF---KKI-KGGIYTLPSHL-SPGARDLIPRM 115
             D+WS G+ L     G  PF     P+ F   + I  G   +LP+   SP  RD I   
Sbjct: 181 A-DIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISAC 239

Query: 116 LIVDPMKRITIPEIRQHPWFQ 136
           L  DP KR +  E+ QHP+ +
Sbjct: 240 LQKDPKKRPSAAELLQHPFIK 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  102 bits (256), Expect = 3e-25
 Identities = 52/135 (38%), Positives = 73/135 (54%), Gaps = 3/135 (2%)

Query: 1   MVVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++HRDLK +N+LLD    V KI DFG+S I+       T  G+P Y +PE+  GK Y  
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY-N 179

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIV 118
            + D+W+ G +LY L      F+  N+P L  KI  G +  +    SP  R LI  ML +
Sbjct: 180 QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNL 239

Query: 119 DPMKRITIPEIRQHP 133
           DP KR  + +I   P
Sbjct: 240 DPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  102 bits (257), Expect = 5e-25
 Identities = 55/146 (37%), Positives = 75/146 (51%), Gaps = 10/146 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA- 58
           +++RD+K EN+LLDS+ +V + DFGLS         +    CG+  Y APEVI G     
Sbjct: 126 IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGH 185

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPR 114
              VD WS GV+ + LL G  PF  +   N   +I   I       P  +S  ARD I +
Sbjct: 186 DKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQK 245

Query: 115 MLIVDPMKRI---TIPEIRQHPWFQA 137
           +L  DP KR+      EI+ HP+FQ 
Sbjct: 246 LLEKDPKKRLGANGADEIKNHPFFQG 271

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  103 bits (257), Expect = 7e-25
 Identities = 54/142 (38%), Positives = 84/142 (59%), Gaps = 8/142 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLD + + K+ADFG+    + +G    T CG+P+Y APE++   LY GP
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GP 175

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +LCG  PF+ EN  +LF+ I       P+ LS  A D++   +  +P
Sbjct: 176 SVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNP 235

Query: 121 MKRITI------PEIRQHPWFQ 136
             R+          I +HP+F+
Sbjct: 236 TMRLGSLTLGGEEAILRHPFFK 257

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  102 bits (256), Expect = 9e-25
 Identities = 54/124 (43%), Positives = 76/124 (61%), Gaps = 2/124 (1%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 116 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 174

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 234

Query: 121 MKRI 124
            +R+
Sbjct: 235 KQRL 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  102 bits (255), Expect = 1e-24
 Identities = 58/142 (40%), Positives = 81/142 (57%), Gaps = 7/142 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +V+RDLK ENL+LD   ++KI DFGL    + D   +KT CG+P Y APEV+    Y G 
Sbjct: 116 IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GR 174

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LS  A+ L+  +LI DP
Sbjct: 175 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDP 234

Query: 121 MKRI-----TIPEIRQHPWFQA 137
            KR+        EI +H +F  
Sbjct: 235 NKRLGGGPDDAKEIMRHSFFTG 256

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 2e-24
 Identities = 58/146 (39%), Positives = 84/146 (57%), Gaps = 15/146 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +HRDLKPEN L+D+  ++K+ DFGLS  I+   +   +  GSP+Y APEV+ GK Y    
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLSKGIVTYAN---SVVGSPDYMAPEVLRGKGY-DFT 178

Query: 62  VDVWSCGVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSH-LSPGARDLIP 113
           VD WS G +LY  LCG  PF         EN+    + ++  +Y  P   LS  A DLI 
Sbjct: 179 VDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLIT 238

Query: 114 RMLIVDPMKRI-TIPEIRQHPWFQAH 138
           ++ I DP +R  ++ +I+ HP+F+  
Sbjct: 239 KL-INDPSRRFGSLEDIKNHPFFKEV 263

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  101 bits (253), Expect = 2e-24
 Identities = 59/189 (31%), Positives = 101/189 (53%), Gaps = 13/189 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RDLK +N++LD   ++KIADFG+   N+  D     T CG+P+Y APE++ G  Y  
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR-ASTFCGTPDYIAPEILQGLKYTF 175

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD WS GV+LY +L G  PF  ++   LF+ I+      P  ++  ++D++ ++   D
Sbjct: 176 -SVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234

Query: 120 PMKRITIP-EIRQHPWFQ----AHLPRYLAVPPPDTMQQA----KKIDEEILKEVVKMGF 170
           P +R+ +   IR HP+F+      L +    PP     ++       D E L E  ++ +
Sbjct: 235 PTRRLGVVGNIRGHPFFKTINWTALEKRELDPPFKPKVKSPSDYSNFDREFLSEKPRLSY 294

Query: 171 DQNQLVESL 179
               L++S+
Sbjct: 295 SDKNLIDSM 303

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  101 bits (252), Expect = 4e-24
 Identities = 60/161 (37%), Positives = 88/161 (54%), Gaps = 14/161 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +V+RD+K EN+LLDS+ +V + DFGLS   +  +     + CG+  Y APE+I GK   G
Sbjct: 126 IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHG 185

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----TLPSHLSPGARDLIPRM 115
             VD WS G++++ LL G  PF  E   N   ++   I       PS + P A+DL+ ++
Sbjct: 186 KAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKL 245

Query: 116 LIVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 148
           L  DP KR+        EI++HP+F+      LA   V PP
Sbjct: 246 LRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPP 286

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  100 bits (250), Expect = 1e-23
 Identities = 58/179 (32%), Positives = 82/179 (45%), Gaps = 48/179 (26%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------------FLKTSC------ 41
           +HRD+KP+NLLLD+K ++K++DFGL   ++  H               FL          
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 42  ------------------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD 83
                             G+P+Y APEV     Y   E D WS GVI+Y +L G  PF  
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 84  ENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIP---EIRQHPWF 135
           +N    ++KI     TL       LSP A+DLI R+   +  +R+      EI+ HP+F
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFF 299

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 53/141 (37%), Positives = 80/141 (56%), Gaps = 7/141 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           M+VHRD+K  N+L DS  NVK+ DFG    L  I   G  +K+  G+P + +PEVISG+ 
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARDLIPR 114
           Y G + DVWS G  +  +L    P+ + E +  +FK   +     LPSH+SP AR+ + R
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRR 242

Query: 115 MLIVDPMKRITIPEIRQHPWF 135
             + +  KR +  E+ +H + 
Sbjct: 243 TFVENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 98.0 bits (244), Expect = 2e-23
 Identities = 58/159 (36%), Positives = 87/159 (54%), Gaps = 13/159 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPEN+LLD   NV+I+D GL+  ++ G  +K   G+P Y APEV+ G++Y    
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFS- 174

Query: 62  VDVWSCGVILYALLCGTLPFDD--ENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
           VD ++ G  LY ++ G  PF    E +    L ++        P   SP A+DL   +L 
Sbjct: 175 VDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQ 234

Query: 118 VDPMKRI-----TIPEIRQHPWFQA-HLPRYLA--VPPP 148
            DP KR+     +  E+R+HP F+  +  R  A  + PP
Sbjct: 235 KDPEKRLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 98.1 bits (244), Expect = 4e-23
 Identities = 57/141 (40%), Positives = 86/141 (60%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N++LDS+ ++KIADFG+    M DG   +T CG+P+Y APE+I+ + Y G 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GK 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PFD E+   LF+ I     + P  LS  A  +   ++   P
Sbjct: 181 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 240

Query: 121 MKRITI-PE----IRQHPWFQ 136
            KR+   PE    IR+H +F+
Sbjct: 241 SKRLGCGPEGERDIREHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 96.2 bits (240), Expect = 6e-23
 Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 9/144 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + +    KT  G+ +Y APE I G  Y   +
Sbjct: 122 IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS-LAKTFVGTSSYMAPERIQGNDY-SVK 179

Query: 62  VDVWSCGVILYALLCGTLPFDDENIP-----NLFKKI-KGGIYTLPSH-LSPGARDLIPR 114
            D+WS G+ L  L  G  P+  EN P      L + I       LPS   SP  +D +  
Sbjct: 180 SDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNL 239

Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
            LI DP +R +  E+ +HP+ + +
Sbjct: 240 CLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 96.5 bits (240), Expect = 7e-23
 Identities = 51/145 (35%), Positives = 72/145 (49%), Gaps = 12/145 (8%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGL-----SNIMRDGHFLKTSCGSPNYAAPEVISGK 55
           ++HRD+K  NLL+DS    ++IADFG      +     G F     G+  + APEV+ G+
Sbjct: 124 IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE 183

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYT--LPSHLSPGARD 110
            Y G   DVWS G ++  +     P++ E   N   L  KI        +P HLSPG RD
Sbjct: 184 QY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRD 242

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           +  R L + P  R    E+ +HP F
Sbjct: 243 VTLRCLELQPEDRPPSRELLKHPVF 267

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 96.5 bits (241), Expect = 8e-23
 Identities = 53/144 (36%), Positives = 80/144 (55%), Gaps = 5/144 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ADFG +  +      + S  G+P + APEVI  K Y GP
Sbjct: 137 VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GP 195

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   +  G  P+  E  +  LF     GI  L  P   SP  +D + + L+
Sbjct: 196 KVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 118 VDPMKRITIPEIRQHPWFQAHLPR 141
            DP KR +  E+ QHP+ +   P+
Sbjct: 256 KDPEKRPSAEELLQHPFLKKACPK 279

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 96.6 bits (240), Expect = 2e-22
 Identities = 55/141 (39%), Positives = 85/141 (60%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N++LDS+ ++KIADFG+    M DG   KT CG+P+Y APE+I+ + Y G 
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GK 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++   P
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240

Query: 121 MKRITI-PE----IRQHPWFQ 136
            KR+   PE    I++H +F+
Sbjct: 241 GKRLGCGPEGERDIKEHAFFR 261

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 94.4 bits (235), Expect = 3e-22
 Identities = 47/134 (35%), Positives = 69/134 (51%), Gaps = 3/134 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGP 60
           ++HRD+K  N+ L     +K+ DFG+S I+   + +  +  G+P Y +PE+  G  Y   
Sbjct: 122 ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF- 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVD 119
           + D+W+ G +LY LL     FD  N  NL  KI  G YT + S  S     L+  +L  D
Sbjct: 181 KSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQD 240

Query: 120 PMKRITIPEIRQHP 133
           P KR T  E+   P
Sbjct: 241 PEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 95.3 bits (237), Expect = 4e-22
 Identities = 51/143 (35%), Positives = 83/143 (58%), Gaps = 9/143 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V++RDLK +N+LLD++ + K+ADFG+    + +G    T CG+P+Y APE++    Y GP
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GP 175

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV++Y ++ G  PF+ +N  +LF+ I       P  LS  A  ++   +  +P
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235

Query: 121 MKRI-------TIPEIRQHPWFQ 136
            KR+           I+QHP+F+
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFK 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 93.6 bits (233), Expect = 6e-22
 Identities = 49/134 (36%), Positives = 74/134 (55%), Gaps = 2/134 (1%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
            VHRD+K  N+L+D+   VK+ADFG++  + +  F K+  GSP + APEVI+ +   G  
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182

Query: 62  VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
            D+WS G  +  +  G  P+   E +  +FK  +      +P HLS  A+D I + L  D
Sbjct: 183 ADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRD 242

Query: 120 PMKRITIPEIRQHP 133
           P  R T  E+ +HP
Sbjct: 243 PSLRPTAAELLEHP 256

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 94.9 bits (236), Expect = 7e-22
 Identities = 47/144 (32%), Positives = 69/144 (47%), Gaps = 12/144 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTS-CGSPNYAAPEVI-----SGK 55
           VHRD+KPEN+L+D   ++K+ADFG +  +  +         G+P+Y APEV+      GK
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGK 183

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSHL--SPGARDL 111
              G E D WS GVI Y ++ G  PF +      +  I         P     S    DL
Sbjct: 184 GTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDL 243

Query: 112 IPRMLIVDPMKRITIPEIRQHPWF 135
           I + L+    +R+    +  HP+F
Sbjct: 244 I-QSLLCGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 92.4 bits (230), Expect = 1e-21
 Identities = 49/145 (33%), Positives = 74/145 (51%), Gaps = 11/145 (7%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLKTSCGSPNYAAPEVISGK 55
            +VHRD+KP N+ LD    +K+ DFG +  +++     G  +++  G+P Y APEVI+G 
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 56  LYAGPE--VDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLPSH--LSPGAR 109
              G     D+WS G ++  +  G  P+   D     +F    G    +P    LSP  +
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGK 238

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D + R L  DP KR T  E+ QHP+
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 58/162 (35%), Positives = 75/162 (46%), Gaps = 30/162 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGP 60
           +VHRDLKP+N+L+ S   VKIADFGL+ I        TS   +  Y APEV+    YA P
Sbjct: 128 IVHRDLKPQNILVTSDGQVKIADFGLARIY-SFEMALTSVVVTLWYRAPEVLLQSSYATP 186

Query: 61  EVDVWSCGVILY------ALLCGT--------------LPFDDENIPN-LFKKIKGGIYT 99
            VD+WS G I         L  GT              LP ++E   N    +     YT
Sbjct: 187 -VDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYT 245

Query: 100 LPS------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
             S       +     DL+ +ML  +P KRI+  E  QHP+F
Sbjct: 246 PRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 92.9 bits (231), Expect = 3e-21
 Identities = 51/140 (36%), Positives = 73/140 (52%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RDLKPEN+LLDS+ +V + DFGL    I        T CG+P Y APEV+  + Y  
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKT-TSTFCGTPEYLAPEVLRKQPY-D 174

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD W  G +LY +L G  PF   +   ++  I      L  ++S  AR L+  +L  D
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKD 234

Query: 120 PMKRI----TIPEIRQHPWF 135
             KR+       EI+ H +F
Sbjct: 235 RTKRLGAKDDFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 58/171 (33%), Positives = 81/171 (47%), Gaps = 37/171 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN--------IMRDGHFLKT-------------- 39
           +V+RDLKPEN+LL    ++ ++DF LS         + +                     
Sbjct: 124 IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSE 183

Query: 40  -------SC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK 91
                  S  G+  Y APEVISG  + G  VD W+ G++LY +L GT PF   N    F 
Sbjct: 184 EPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFS 242

Query: 92  KIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRI----TIPEIRQHPWFQ 136
            I     T P    +S  ARDLI ++L+ DP KR+       EI+QHP+F+
Sbjct: 243 NILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 91.5 bits (228), Expect = 4e-21
 Identities = 51/177 (28%), Positives = 75/177 (42%), Gaps = 53/177 (29%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YAAPEVI 52
           ++HRD+K  N+L+++   +K+ADFGL+          T   S +         Y  PE++
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPY-------TKRNSADYTNRVITLWYRPPELL 173

Query: 53  SG-KLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIPNLF 90
            G   Y GPEVD+WS G IL  L                     LCG+    DEN P + 
Sbjct: 174 LGATRY-GPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP--TDENWPGVS 230

Query: 91  KKIKGGIYTLPSH------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           K                        + P A DL+ ++L +DP KRI+  +  QH +F
Sbjct: 231 KLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 90.8 bits (226), Expect = 5e-21
 Identities = 45/138 (32%), Positives = 69/138 (50%), Gaps = 7/138 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K  N+L      VK+ADFG++  +        +  G+P + APEVI      G 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMS---GA 176

Query: 61  EV--DVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
               D+WS G  +  LL G  P+ D N +  LF+ ++     LP  +SP  +D + +   
Sbjct: 177 STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236

Query: 118 VDPMKRITIPEIRQHPWF 135
            DP  R T  ++ +HPW 
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 55/146 (37%), Positives = 82/146 (56%), Gaps = 13/146 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFL-KTSCGSPNYAAPEVI---SGKLY 57
           +HRD+KP+N+LLD   ++K+ADFG    M  +G     T+ G+P+Y +PEV+    G  Y
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI---KGGIYTLPS--HLSPGARDLI 112
            G E D WS GV LY +L G  PF  +++   + KI   K  + T P    +S  A+DLI
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSL-TFPDDIEISKQAKDLI 282

Query: 113 PRMLIVDPMK--RITIPEIRQHPWFQ 136
              L    ++  R  + EI+ HP+F+
Sbjct: 283 CAFLTDREVRLGRNGVDEIKSHPFFK 308

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 59/162 (36%), Positives = 85/162 (52%), Gaps = 22/162 (13%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 58
           +V+RDLK +NLLLD++  VKIADFGL    M  G   +TS  CG+P + APEV++   Y 
Sbjct: 122 IVYRDLKLDNLLLDTEGFVKIADFGLCKEGM--GFGDRTSTFCGTPEFLAPEVLTETSY- 178

Query: 59  GPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              VD W  GV++Y +L G  PF  DDE    +F  I       P  LS  A  ++ R+L
Sbjct: 179 TRAVDWWGLGVLIYEMLVGESPFPGDDEE--EVFDSIVNDEVRYPRFLSREAISIMRRLL 236

Query: 117 IVDPMKRI-----TIPEIRQHPWF-----QAHLPRYLAVPPP 148
             +P +R+        ++++ P+F        L R   + PP
Sbjct: 237 RRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLAR--KIKPP 276

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 12/147 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RD+K EN+LLDS  +V + DFGLS      +     + CG+  Y AP+++ G     
Sbjct: 126 IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGH 185

Query: 60  PE-VDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
            + VD WS GV++Y LL G  PF    +  +   + ++I       P  +S  A+D+I R
Sbjct: 186 DKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQR 245

Query: 115 MLIVDPMKRI-----TIPEIRQHPWFQ 136
           +L+ DP KR+        EI++HP+FQ
Sbjct: 246 LLMKDPKKRLGCGPSDADEIKKHPFFQ 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 89.7 bits (223), Expect = 2e-20
 Identities = 52/168 (30%), Positives = 71/168 (42%), Gaps = 37/168 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKLYAGP 60
           ++HRDLKPENLL++++  +K+ADFGL+          T       Y APE++ G      
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYST 178

Query: 61  EVDVWSCGVILYALL------------------CGTL---------------PFDDENIP 87
            VD+WS G I   LL                    TL                    + P
Sbjct: 179 PVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP 238

Query: 88  NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
              KK    +  L  + SP A DL+ +ML  DP KRIT  +   HP+F
Sbjct: 239 ---KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 57/173 (32%), Positives = 78/173 (45%), Gaps = 49/173 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLKP NLL+ S   +K+ADFGL+           S GSPN           Y APE
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLA----------RSFGSPNRKMTHQVVTRWYRAPE 172

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGT--LPFD-----------------DENIPNL-- 89
           ++ G  + G  VD+WS G I   LL     LP D                 +EN P +  
Sbjct: 173 LLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTS 232

Query: 90  ------FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                 FK      +  +    S  A DL+ R+L ++P KRIT  +  +HP+F
Sbjct: 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 89.6 bits (222), Expect = 4e-20
 Identities = 49/140 (35%), Positives = 77/140 (55%), Gaps = 6/140 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +V+RDLKPEN+LLD+  ++ + DFGLS   + D     T CG+  Y APEV+  +     
Sbjct: 117 IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTK 176

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH-LSPGARDLIPRMLIVD 119
            VD WS GV+++ + CG  PF  E+   +++ I  G    P + LS   R  +  +L  +
Sbjct: 177 HVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRN 236

Query: 120 PMKRI----TIPEIRQHPWF 135
           P  R+       E+++HP+F
Sbjct: 237 PQHRLGAHRDAVELKEHPFF 256

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 88.7 bits (220), Expect = 5e-20
 Identities = 51/141 (36%), Positives = 80/141 (56%), Gaps = 11/141 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL S   VK++DFG  + + ++    K+  G+P + APEVIS   Y G 
Sbjct: 136 VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GT 194

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K+I+     LP  L      SP  R  + R
Sbjct: 195 EVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRD---NLPPKLKNLHKVSPRLRSFLDR 251

Query: 115 MLIVDPMKRITIPEIRQHPWF 135
           ML+ DP +R T  E+  HP+ 
Sbjct: 252 MLVRDPAQRATAAELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 89.1 bits (222), Expect = 6e-20
 Identities = 50/173 (28%), Positives = 74/173 (42%), Gaps = 41/173 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           V+HRDLKP N+L++S  ++KI DFGL+  + D    +    +       Y APE++    
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGV-DPDEDEKGFLTEYVVTRWYRAPELLLSSS 182

Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIK 94
                +D+WS G I   LL     F                      D + I +  +K +
Sbjct: 183 RYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITS--EKAR 240

Query: 95  GGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             + +LP              SP A DL+ +ML+ DP KRIT  E   HP+  
Sbjct: 241 NYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLA 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 88.5 bits (220), Expect = 6e-20
 Identities = 53/168 (31%), Positives = 78/168 (46%), Gaps = 36/168 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAG 59
           ++HRDLKP NLL+ +   +KIADFGL+ +  +      S    +  Y APE++ G     
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 60  PEVDVWSCGVILYALLCGTLPFDDEN-------------IPNLFKKIKGGIYTLPSH--- 103
           P VD+W+ G I   LL G+  F  EN              PN   +   G+ +LP +   
Sbjct: 180 PGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNE--ETWPGLTSLPDYNKI 237

Query: 104 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                            SP A DL+  +L+ DP KR++  E  +HP+F
Sbjct: 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 89.1 bits (221), Expect = 6e-20
 Identities = 52/143 (36%), Positives = 82/143 (57%), Gaps = 13/143 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ + +   
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 177

Query: 61  EVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
             D WS GV+++ +L G+LPF   D +    +  K K G   +P  LSP A+ L+  +  
Sbjct: 178 SADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLG---MPQFLSPEAQSLLRALFK 234

Query: 118 VDPMKRI-----TIPEIRQHPWF 135
            +P  R+      + EI++HP+F
Sbjct: 235 RNPANRLGAGPDGVEEIKRHPFF 257

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 88.4 bits (219), Expect = 7e-20
 Identities = 48/148 (32%), Positives = 74/148 (50%), Gaps = 16/148 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 60
           ++HRD+KP N+L++    VK+ DFG+S  +      KT+ G  +Y APE I      GP 
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNL-VASLAKTNIGCQSYMAPERIKS---GGPN 179

Query: 61  -------EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK----GGIYTLPSHLSPGAR 109
                  + DVWS G+ +  +  G  P+  E   N+F ++     G   TLPS  S  A+
Sbjct: 180 QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQ 239

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQA 137
           D + + L   P +R T  ++ +HPW   
Sbjct: 240 DFVAKCLNKIPNRRPTYAQLLEHPWLVK 267

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 89.1 bits (221), Expect = 8e-20
 Identities = 51/147 (34%), Positives = 81/147 (55%), Gaps = 15/147 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SGKL 56
           VHRD+KP+N+LLD   ++++ADFG    +     ++++   G+P+Y +PE++     GK 
Sbjct: 124 VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKG 183

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGARDL 111
             GPE D WS GV +Y +L G  PF  E++   + KI      +  P     +S  A+DL
Sbjct: 184 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDL 243

Query: 112 IPRMLIVDPMKRI---TIPEIRQHPWF 135
           I R LI  P  R+    + + + HP+F
Sbjct: 244 I-RRLICSPETRLGRNGLQDFKDHPFF 269

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 87.6 bits (217), Expect = 8e-20
 Identities = 46/124 (37%), Positives = 66/124 (53%), Gaps = 3/124 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+K  NL LD+  NVKI D G++ ++ D  +F  T  G+P Y +PE+   K Y   
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY-NE 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVD 119
           + DVW+ GV+LY    G  PFD  N   L  KI  G++  +    S     LI + L  D
Sbjct: 181 KSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKD 240

Query: 120 PMKR 123
             +R
Sbjct: 241 YRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 53/149 (35%), Positives = 83/149 (55%), Gaps = 15/149 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVIS----GKL 56
           VHRD+KP+N+LLD   ++++ADFG    M     +++S   G+P+Y +PE++     G  
Sbjct: 124 VHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMG 183

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPSHL---SPGARDL 111
             GPE D WS GV +Y +L G  PF  E++   + KI      +  PSH+   S  A+DL
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDL 243

Query: 112 IPRMLIVDPMKRI---TIPEIRQHPWFQA 137
           I R LI    +R+    I + ++H +F+ 
Sbjct: 244 IQR-LICSRERRLGQNGIEDFKKHAFFEG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 88.1 bits (218), Expect = 2e-19
 Identities = 48/139 (34%), Positives = 74/139 (53%), Gaps = 8/139 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPENLLLD    +K+ DFG + ++    +  T CG+P Y APE++   +  G  
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY--TLCGTPEYIAPEILL-NVGHGKA 208

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
            D W+ G+ +Y +L G  PF       +++KI  GI   P  L    + L+ ++L  D  
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLT 268

Query: 122 KRI-----TIPEIRQHPWF 135
           KR          +++HPWF
Sbjct: 269 KRYGNLKKGAQNVKEHPWF 287

Length = 340

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 57/170 (33%), Positives = 83/170 (48%), Gaps = 42/170 (24%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI----MRD-GHFLKTSCGSPNYAAPEVISG-K 55
           V+HRDLKP+NLL+D +  +K+ADFGL+      +R   H + T      Y APE++ G +
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLW----YRAPEILLGSR 175

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFK--KIKG--------GIYTLPSH 103
            Y+ P VD+WS G I +A +    P    D  I  LF+  +  G        G+ +LP +
Sbjct: 176 QYSTP-VDIWSIGCI-FAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDY 233

Query: 104 ------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                             L     DL+ +ML+ DP KRI+     QHP+F
Sbjct: 234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.7 bits (214), Expect = 3e-19
 Identities = 53/143 (37%), Positives = 81/143 (56%), Gaps = 5/143 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 194

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LSP  RD + R L 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLE 254

Query: 118 VDPMKRITIPEIRQHPWFQAHLP 140
           +D  KR +  E+ QHP+ +   P
Sbjct: 255 MDVEKRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 86.6 bits (214), Expect = 3e-19
 Identities = 56/160 (35%), Positives = 88/160 (55%), Gaps = 10/160 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + I +D    K+  G+P + APEVIS   Y G 
Sbjct: 138 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GT 196

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLI 117
           EVD+WS G+++  ++ G  P+  ++     K+++            +SP  RD + RML 
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 118 VDPMKRITIPEIRQHPW-FQAHLPRYLAVPPPDTMQQAKK 156
            +P +R T  E+  HP+  Q  LP  L VP    +QQ +K
Sbjct: 257 REPQERATAQELLDHPFLLQTGLPECL-VP---LIQQYRK 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 87.2 bits (216), Expect = 3e-19
 Identities = 54/166 (32%), Positives = 91/166 (54%), Gaps = 21/166 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLD++ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G 
Sbjct: 117 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GF 175

Query: 61  EVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSV 235

Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQA----HLPRYLAVPP 147
           +   L  DP +R+         +I+ HP+F+      L +   +PP
Sbjct: 236 LKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPP 281

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 56/160 (35%), Positives = 85/160 (53%), Gaps = 14/160 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD+  NV+I+D GL+  ++DG    K   G+P + APE++ G+ Y   
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY-DF 176

Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRML 116
            VD ++ GV LY ++    PF    E + N  L ++I     T P   SP ++     +L
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL 236

Query: 117 IVDPMKRI-----TIPEIRQHPWFQAHLPRYL---AVPPP 148
             DP KR+         +R HP F+    R L    +PPP
Sbjct: 237 AKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPP 276

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 85.2 bits (211), Expect = 7e-19
 Identities = 51/151 (33%), Positives = 78/151 (51%), Gaps = 6/151 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL-YAGP 60
           V+HRD+KP N+L++    VK+ DFG+S  + D        G   Y APE I+ +L   G 
Sbjct: 125 VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 184

Query: 61  EV--DVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPSH-LSPGARDLIPRM 115
           +V  DVWS G+ +  L  G  P+D    P   L + ++     LP+   SP  +D + + 
Sbjct: 185 DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKC 244

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           L  +  +R   PE+ QHP+F+ HL +   V 
Sbjct: 245 LKKNYKERPNYPELLQHPFFELHLSKNTDVA 275

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 85.9 bits (212), Expect = 8e-19
 Identities = 62/202 (30%), Positives = 106/202 (52%), Gaps = 25/202 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G 
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GF 175

Query: 61  EVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  +
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 235

Query: 112 IPRMLIVDPMKRI-TIPE-----IRQHPWFQA----HLPRYLAVPP--PDTMQQ--AKKI 157
           +   L  DP +R+   P+     I+ HP+F+      + +   VPP  P+   +      
Sbjct: 236 LKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNISGEFGLDNF 295

Query: 158 DEEILKEVVKMGFDQNQLVESL 179
           D +   E V++  D + +V  +
Sbjct: 296 DAQFTNEPVQLTPDDDDIVRKI 317

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 53/140 (37%), Positives = 76/140 (54%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL--SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +V+RDLKPEN+LLDS+ ++ + DFGL   NI  +G    T CG+P Y APEV+  + Y  
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGT-TSTFCGTPEYLAPEVLHKQPY-D 174

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD W  G +LY +L G  PF   N   ++  I      L  +++  AR L+  +L  D
Sbjct: 175 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 234

Query: 120 PMKRI----TIPEIRQHPWF 135
             KR+       EI+ H +F
Sbjct: 235 RTKRLGAKDDFMEIKNHIFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 85.8 bits (212), Expect = 1e-18
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 11/145 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKLY 57
           +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  Y
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 223

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLIP 113
            G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI 
Sbjct: 224 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 283

Query: 114 RMLIVDPMK--RITIPEIRQHPWFQ 136
             L    ++  R  + EI++H +F+
Sbjct: 284 AFLTDREVRLGRNGVEEIKRHLFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 63/215 (29%), Positives = 94/215 (43%), Gaps = 48/215 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEV-ISGKL 56
           V+HRDLKP NLLL++  ++KI DFGL+ I    H    FL     +  Y APE+ ++ K 
Sbjct: 127 VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKG 186

Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIK 94
           Y    +D+WS G IL  +L     F                      D   I +   + +
Sbjct: 187 YT-KAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS--LRAR 243

Query: 95  GGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPR- 141
             I +LP            +  P A DL+ +ML  +P KRIT+ E   HP+ +  H P  
Sbjct: 244 NYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDPSD 303

Query: 142 --YLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 174
                 P P   +    + +E LKE++   F++  
Sbjct: 304 EPVAEEPFPFDFELFDDLPKEKLKELI---FEEIM 335

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 85.3 bits (211), Expect = 2e-18
 Identities = 58/188 (30%), Positives = 81/188 (43%), Gaps = 57/188 (30%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-----------------------------NIMRD 33
           +HRD+KP+N+L+D   ++K++DFGLS                             ++  D
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182

Query: 34  GHFLKTS-------------------CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 74
              L  S                    G+P+Y APE+   + Y G E D WS G I++  
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFEC 241

Query: 75  LCGTLPFDDENIPNLFKKIKGGIYTL--PS--HLSPGARDLIPRMLIVDPMKRI---TIP 127
           L G  PF  EN    ++KI     TL  P   HLS  A DLI R LI +   R+      
Sbjct: 242 LIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLI-RRLITNAENRLGRGGAH 300

Query: 128 EIRQHPWF 135
           EI+ HP+F
Sbjct: 301 EIKSHPFF 308

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 86.1 bits (213), Expect = 2e-18
 Identities = 48/126 (38%), Positives = 71/126 (56%), Gaps = 5/126 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRD+K  N+LL S   VK+ DFG S +          +T CG+P Y APE+   K Y+
Sbjct: 164 MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS 223

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 117
             + D++S GV+LY LL    PFD EN+  +  K   G Y  LP  +SP  ++++  +L 
Sbjct: 224 -KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLS 282

Query: 118 VDPMKR 123
            DP +R
Sbjct: 283 SDPKRR 288

Length = 496

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 83.6 bits (206), Expect = 2e-18
 Identities = 53/142 (37%), Positives = 80/142 (56%), Gaps = 8/142 (5%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           M+VHRD+K  N+L DS  NVK+ DFG    L  I   G  +++  G+P + +PEVISG+ 
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARDLIPR 114
           Y G + DVWS G  +  +L    P+ + E +  +FK   +     LPSH+S  ARD +  
Sbjct: 186 Y-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-G 243

Query: 115 MLIVDPMKRITIPEIRQHPWFQ 136
            + V+   R +  E+ +HP+ Q
Sbjct: 244 CIFVEARHRPSAEELLRHPFAQ 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 83.7 bits (207), Expect = 2e-18
 Identities = 46/159 (28%), Positives = 80/159 (50%), Gaps = 13/159 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPEN+LLD   +++I+D GL+  + +G  ++   G+  Y APEV+  + Y    
Sbjct: 123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181

Query: 62  VDVWSCGVILYALLCGTLPFD--DENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
            D W  G ++Y ++ G  PF    E +    + +++K          S  AR +  ++L 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 118 VDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 148
            DP  R+        E++ HP+F+    + L    + PP
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 54/149 (36%), Positives = 83/149 (55%), Gaps = 15/149 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT-SCGSPNYAAPEVIS----GKL 56
           VHRD+KP+N+L+D   ++++ADFG    +M DG    + + G+P+Y +PE++     GK 
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKG 183

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPSH---LSPGARDL 111
             GPE D WS GV +Y +L G  PF  E++   + KI      +  P+    +S  A+DL
Sbjct: 184 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDL 243

Query: 112 IPRMLIVDPMKRI---TIPEIRQHPWFQA 137
           I R LI     R+    I + +QHP+F  
Sbjct: 244 I-RRLICSREHRLGQNGIEDFKQHPFFTG 271

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 51/141 (36%), Positives = 72/141 (51%), Gaps = 18/141 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTS-----CGSPNYAAPEVISG 54
           ++HRD+KP N+ + +   VK+ D GL      G F   KT+      G+P Y +PE I  
Sbjct: 127 IMHRDIKPANVFITATGVVKLGDLGL------GRFFSSKTTAAHSLVGTPYYMSPERIHE 180

Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYT-LPS-HLSPGARD 110
             Y   + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LP+ H S   RD
Sbjct: 181 NGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRD 239

Query: 111 LIPRMLIVDPMKRITIPEIRQ 131
           L+ R +  DP KR  I  + Q
Sbjct: 240 LVSRCINPDPEKRPDISYVLQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 84.7 bits (209), Expect = 4e-18
 Identities = 51/146 (34%), Positives = 83/146 (56%), Gaps = 11/146 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKL 56
           ++HRD+KP+N+LLD   ++K+ADFG    M +   ++  T+ G+P+Y +PEV+    G  
Sbjct: 163 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDG 222

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGARDLI 112
           Y G E D WS GV L+ +L G  PF  +++   + KI     +L       +S  A++LI
Sbjct: 223 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLI 282

Query: 113 PRMLIVDPMK--RITIPEIRQHPWFQ 136
              L    ++  R  + EI+QHP+F+
Sbjct: 283 CAFLTDREVRLGRNGVEEIKQHPFFK 308

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 83.5 bits (206), Expect = 4e-18
 Identities = 51/152 (33%), Positives = 84/152 (55%), Gaps = 11/152 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K+  G+P + APE+IS +L  GP
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS-RLPYGP 195

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPKLKNLHKVSPSLKGFLDR 252

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAGPPSCIVP 284

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 84.0 bits (208), Expect = 5e-18
 Identities = 53/169 (31%), Positives = 79/169 (46%), Gaps = 32/169 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP NLLL++  ++KI DFGL+    + G F+     +  Y APE++        
Sbjct: 129 VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT 188

Query: 61  EVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-KKIKGGIYTL 100
            +DVWS G I   LL     F                    +E++  +  +K +  I +L
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248

Query: 101 P-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
           P            H +P A DL+ +ML+ DP KRIT+ E   HP+  + 
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 83.0 bits (205), Expect = 5e-18
 Identities = 52/143 (36%), Positives = 80/143 (55%), Gaps = 5/143 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 194

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254

Query: 118 VDPMKRITIPEIRQHPWFQAHLP 140
           +D  KR +  E+ QHP+ +   P
Sbjct: 255 MDVEKRGSAKELLQHPFLKIAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 63/221 (28%), Positives = 91/221 (41%), Gaps = 63/221 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 139 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 197

Query: 62  VDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGIYTLPS 102
           VD+WS G I+  ++ GT+ F                    DE +  L   ++  +   P 
Sbjct: 198 VDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPK 257

Query: 103 H-------LSPG-----------------ARDLIPRMLIVDPMKRITIPEIRQHP----W 134
           +       L P                  ARDL+ +ML++DP KRI++ +  QHP    W
Sbjct: 258 YAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317

Query: 135 FQAHLPRYLAVPPPDTMQQAKKID----------EEILKEV 165
           +    P  +  PPP        ID          E I KEV
Sbjct: 318 YD---PSEVEAPPP--APYDHSIDEREHTVEEWKELIYKEV 353

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 82.5 bits (203), Expect = 1e-17
 Identities = 51/143 (35%), Positives = 80/143 (55%), Gaps = 5/143 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 194

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 195 KVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLE 254

Query: 118 VDPMKRITIPEIRQHPWFQAHLP 140
           +D  +R +  E+ QHP+ +   P
Sbjct: 255 MDVDRRGSAKELLQHPFLKLAKP 277

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.6 bits (201), Expect = 1e-17
 Identities = 49/148 (33%), Positives = 78/148 (52%), Gaps = 18/148 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GP 60
           +V+RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y   P
Sbjct: 123 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182

Query: 61  EVDVWSCGVILYALLCGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSPGARDLIP 113
             D W+ G +LY ++ G  PF         E +  L K+++          SP AR L  
Sbjct: 183 --DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---EEYSEKFSPDARSLCK 237

Query: 114 RMLIVDPMKRI-----TIPEIRQHPWFQ 136
            +L  DP +R+        E+++HP F+
Sbjct: 238 MLLCKDPKERLGCQGGGAREVKEHPLFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 52/164 (31%), Positives = 87/164 (53%), Gaps = 19/164 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLD+  ++K+ D+G+    +  G    T CG+PNY APE++ G+ Y G 
Sbjct: 117 IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GF 175

Query: 61  EVDVWSCGVILYALLCGTLPFD------DENIPN-LFKKIKGGIYTLPSHLSPGARDLIP 113
            VD W+ GV+++ ++ G  PFD      D N  + LF+ I      +P  LS  A  ++ 
Sbjct: 176 SVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLK 235

Query: 114 RMLIVDPMKRI------TIPEIRQHPWFQA----HLPRYLAVPP 147
             L  DP +R+         +I+ H +F++     L +    PP
Sbjct: 236 GFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPP 279

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 80.7 bits (200), Expect = 5e-17
 Identities = 65/228 (28%), Positives = 96/228 (42%), Gaps = 62/228 (27%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YAAPEVI 52
           V+HRDLKP N+LL+S   VK+ADFGL+  + +   L+ +  +P          Y APE++
Sbjct: 128 VIHRDLKPSNILLNSDCRVKLADFGLARSLSE---LEENPENPVLTDYVATRWYRAPEIL 184

Query: 53  SGKLYAGPEVDVWSCGVILYALLCG--------TL-----------------------PF 81
            G       VD+WS G IL  +L G        TL                       PF
Sbjct: 185 LGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244

Query: 82  DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 140
               + +L  + +  +  L    S  A DL+ ++L+ +P KR+T  E  +HP+  Q H P
Sbjct: 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHNP 304

Query: 141 RYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL--VESLRNRLQNE 186
                            DE +L   + +  D N    V   RN+L  E
Sbjct: 305 ----------------SDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 80.5 bits (199), Expect = 7e-17
 Identities = 65/226 (28%), Positives = 98/226 (43%), Gaps = 61/226 (26%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEV-ISGK 55
           V+HRDLKP NLL+++   +KI DFGL+    +       F+     +  Y APE+ +S +
Sbjct: 126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQ 185

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF-------------------DDE------------ 84
            Y    +DVWS G IL  LL     F                   D+E            
Sbjct: 186 SYT-KAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN 244

Query: 85  ---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 141
              ++PN+ KK    I+   + L   A DL+ ++L  DP KRI++ E  +HP        
Sbjct: 245 YIRSLPNIPKKPFESIFPNANPL---ALDLLEKLLAFDPTKRISVEEALEHP-------- 293

Query: 142 YLAV-PPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNE 186
           YLA+   PD        DE + ++     F+    +E LR+ +  E
Sbjct: 294 YLAIWHDPD--------DEPVCQKPFDFSFESEDSMEELRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 48/179 (26%), Positives = 71/179 (39%), Gaps = 57/179 (31%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLK  NLLL+++  +KI DFGL+             GSP            Y APE
Sbjct: 127 ILHRDLKTSNLLLNNRGILKICDFGLAR----------EYGSPLKPYTQLVVTLWYRAPE 176

Query: 51  VISGKLYAGPEVDVWSCGVILYALL---------------------CGTLPFDDENIPNL 89
           ++ G       +D+WS G I   LL                      GT P  ++  P  
Sbjct: 177 LLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGT-P-TEKIWPGF 234

Query: 90  FK--KIKGGIYTLPSHLSPGAR-----------DLIPRMLIVDPMKRITIPEIRQHPWF 135
            +    K   +T   +     +           DL+ R+L  DP KRI+  +  +HP+F
Sbjct: 235 SELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 80.1 bits (197), Expect = 1e-16
 Identities = 60/201 (29%), Positives = 87/201 (43%), Gaps = 46/201 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205

Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265

Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325

Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P     PPP      K++DE
Sbjct: 326 DPSEAEAPPPKIPD--KQLDE 344

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 49/154 (31%), Positives = 73/154 (47%), Gaps = 24/154 (15%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP N+L++S+  +K+ DFG+S    N + D     T  G+  Y +PE I G  Y
Sbjct: 125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGKY 179

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------------TLPS-HL 104
              + DVWS G+ +  L  G  PF   NI +  +    GI              LPS   
Sbjct: 180 T-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDF 238

Query: 105 SPGARDLIPRMLIVDPMKRITIPEI-RQHPWFQA 137
               RD +   L+ DP +R T  ++    P+ QA
Sbjct: 239 PEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 79.0 bits (194), Expect = 1e-16
 Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 5/159 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.6 bits (194), Expect = 2e-16
 Identities = 58/176 (32%), Positives = 81/176 (46%), Gaps = 54/176 (30%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           V+HRDLKP+NLL+D+K  +K+ADFGL+           + G P            Y APE
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLAR----------AFGIPVRVYTHEVVTLWYRAPE 171

Query: 51  VISG-KLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDD----- 83
           V+ G   Y+ P VD+WS G I   +                     + GT P +D     
Sbjct: 172 VLLGSPRYSTP-VDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGT-PTEDVWPGV 229

Query: 84  ENIP---NLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            ++P   N F K K G   +   +L     DL+ +MLI DP KRI+  +   HP+F
Sbjct: 230 TSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 78.0 bits (192), Expect = 2e-16
 Identities = 44/141 (31%), Positives = 71/141 (50%), Gaps = 9/141 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-------IMRDGHFLKTSCGSPNYAAPEVISG 54
           ++HRD+K  N+L+D+K  +KI+DFG+S          +      +  GS  + APEV+  
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186

Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIP 113
             Y   + D+WS G ++  +L G  PF D        KI       +PS++S  A D + 
Sbjct: 187 TSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLE 245

Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           +   +D  KR T  E+ +HP+
Sbjct: 246 KTFEIDHNKRPTAAELLKHPF 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 49/152 (32%), Positives = 68/152 (44%), Gaps = 7/152 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 60
           V+HRD+KP N+LLD+  NVK+ DFG+S  + D      S G   Y APE I         
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKY 195

Query: 61  --EVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLPSH--LSPGARDLIPR 114
               DVWS G+ L  L  G  P+         L K ++    +LP +   SP     +  
Sbjct: 196 DIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDL 255

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
            L  D  KR    E+ QHP+ + +    + V 
Sbjct: 256 CLTKDHRKRPKYRELLQHPFIRRYETAEVDVA 287

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 44/137 (32%), Positives = 71/137 (51%), Gaps = 4/137 (2%)

Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAG 59
           ++HRD+K +N+ L     V K+ DFG++  + D   L  +C G+P Y +PE+   + Y  
Sbjct: 122 ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNN 181

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
            + D+WS G +LY L     PF+  N+  L  KI +G    +  + S   R LI ++  V
Sbjct: 182 -KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKV 240

Query: 119 DPMKRITIPEIRQHPWF 135
            P  R +I  I + P+ 
Sbjct: 241 SPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 49/139 (35%), Positives = 73/139 (52%), Gaps = 6/139 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLDS+ +V + DFGL    +       T CG+P Y APEV+  + Y   
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY-DR 175

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  G +LY +L G  PF   ++  ++  I      LP   +  A DL+  +L  D 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQ 235

Query: 121 MKRI----TIPEIRQHPWF 135
            +R+       EI+ H +F
Sbjct: 236 RRRLGAKADFLEIKNHVFF 254

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 77.5 bits (191), Expect = 3e-16
 Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 3/130 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDL P N++L     V I DFGL+   +    L +  G+  Y+ PE++  + Y G +
Sbjct: 135 IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEK 193

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHL-SPGARDLIPRMLIVD 119
            DVW+ G ILY +     PF   N+ +L  KI   +Y  LP  + S    D+I   L  D
Sbjct: 194 ADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPD 253

Query: 120 PMKRITIPEI 129
              R  I ++
Sbjct: 254 AEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 21/145 (14%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL+ +   K+ADFG+S  + D      T  G+P + APEVI    Y   +
Sbjct: 121 IHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NNK 179

Query: 62  VDVWSCGVILYALLCGTLPFDDEN-------IPNL----FKKIKGGIYTLPSHLSPGARD 110
            D+WS G+    +  G  P+ D +       IPN                P   SP   D
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSD--------PEKWSPEFND 231

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
            + + L+ DP +R +  ++ QHP+ 
Sbjct: 232 FVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 51/164 (31%), Positives = 72/164 (43%), Gaps = 33/164 (20%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP N+L++   ++KI DFGL+ I      +     +  Y APE++        E
Sbjct: 129 VVHRDLKPSNILINENCDLKICDFGLARIQD--PQMTGYVSTRYYRAPEIMLTWQKYDVE 186

Query: 62  VDVWSCGVILYAL---------------------LCGTLPFD------DEN----IPNLF 90
           VD+WS G I   +                     L GT P D       EN    + +L 
Sbjct: 187 VDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246

Query: 91  KKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 134
           K+          +  P A DL+ +ML+ DP KRI+  E   HP+
Sbjct: 247 KREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 77.1 bits (190), Expect = 5e-16
 Identities = 48/147 (32%), Positives = 73/147 (49%), Gaps = 16/147 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           V+HRDLK  N+LL    +VK+ADFG+S      + +   F+    G+P + APEV++ + 
Sbjct: 124 VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFI----GTPYWMAPEVVACET 179

Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGAR 109
           +       + D+WS G+ L  L     P  + N +  L K +K    TL  PS  S    
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           D +   L+ DP  R T  E+ +HP+  
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVS 266

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 76.6 bits (189), Expect = 6e-16
 Identities = 45/144 (31%), Positives = 67/144 (46%), Gaps = 11/144 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKLY 57
           +HRD+K  N+LL    +VKIADFG+S  + DG        KT  G+P + APEV+     
Sbjct: 124 IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHG 183

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGA-----RDL 111
              + D+WS G+    L  G  P+     +  L   ++    +L +           R +
Sbjct: 184 YDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKM 243

Query: 112 IPRMLIVDPMKRITIPEIRQHPWF 135
           I   L  DP KR T  E+ +H +F
Sbjct: 244 ISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 76.8 bits (190), Expect = 7e-16
 Identities = 56/164 (34%), Positives = 74/164 (45%), Gaps = 34/164 (20%)

Query: 4   HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI--SGKLYAGPE 61
           HRDLKPENLL+     VKIADFGL+  +R          +  Y APE++  S   Y+ P 
Sbjct: 122 HRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS-YSSP- 179

Query: 62  VDVWSCGVI---LYAL---------------LCGTL-PFDDENIPNLFK----------- 91
           VD+W+ G I   LY L               +C  L     ++ P  +K           
Sbjct: 180 VDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ 239

Query: 92  KIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                ++ L  + SP A DLI  ML  DP KR T  +  QHP+F
Sbjct: 240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.7 bits (189), Expect = 7e-16
 Identities = 51/149 (34%), Positives = 72/149 (48%), Gaps = 22/149 (14%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP N+LL  K  VK+ DFG+S     G  +     T  G+  Y APE I GK Y
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPERIQGKPY 180

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK-KIKGGIYTLPSHL---SPGA----- 108
           +    DVWS G+ L  +     PF  E  P L   ++   I  +P+      PG      
Sbjct: 181 S-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWS 239

Query: 109 ---RDLIPRMLIVDPMKRITIPEIRQHPW 134
              +D I + L  DP +R T  ++ +HPW
Sbjct: 240 EEFKDFIKQCLEKDPTRRPTPWDMLEHPW 268

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 76.6 bits (188), Expect = 7e-16
 Identities = 50/138 (36%), Positives = 76/138 (55%), Gaps = 8/138 (5%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           M+VHRD+K  N+L DS  NVK+ DFG    L  I   G  +K+  G+P + +PEVISG+ 
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARDLIPR 114
           Y G + D+WS G  +  +L    P+ + E +  +FK   +     LP H+S   RD + R
Sbjct: 186 Y-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKR 244

Query: 115 MLIVDPMKRITIPEIRQH 132
           +  V+   R +  E+ +H
Sbjct: 245 IF-VEAKLRPSADELLRH 261

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 76.4 bits (189), Expect = 8e-16
 Identities = 46/147 (31%), Positives = 68/147 (46%), Gaps = 24/147 (16%)

Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYA 58
           ++H D+K EN+L D +K  + + D+GL  I+  G     SC  G+ +Y +PE I G  Y 
Sbjct: 130 IIHNDIKLENVLYDRAKDRIYLCDYGLCKII--GT---PSCYDGTLDYFSPEKIKGHNYD 184

Query: 59  GPEVDVWSCGVILYALLCGTLPFD---DENI------PNLFKKIKGGIYTLPSHLSPGAR 109
               D W+ GV+ Y LL G  PF    DE +          KK+         ++S  A 
Sbjct: 185 -VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL-----PFIKNVSKNAN 238

Query: 110 DLIPRMLIVDPMKR-ITIPEIRQHPWF 135
           D +  ML  +   R     EI +HP+ 
Sbjct: 239 DFVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.0 bits (189), Expect = 8e-16
 Identities = 49/152 (32%), Positives = 84/152 (55%), Gaps = 11/152 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL S   +K++DFG  + + ++    K+  G+P + APEVIS +L  G 
Sbjct: 139 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVIS-RLPYGT 197

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      ++I+     LP  +      S   R  +  
Sbjct: 198 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---NLPPRVKDSHKVSSVLRGFLDL 254

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           ML+ +P +R T  E+ QHP+ +   P    VP
Sbjct: 255 MLVREPSQRATAQELLQHPFLKLAGPPSCIVP 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 57/185 (30%), Positives = 74/185 (40%), Gaps = 53/185 (28%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK------------------------ 38
           +HRD+KP+N+L+D   ++K+ DFGL    R  H  K                        
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 39  --------------TSC------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT 78
                           C      G+PNY APEV+    Y     D WS GVILY +L G 
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 241

Query: 79  LPFDDENIPNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRI---TIPEIRQ 131
            PF  +       K+     TL  PS   LS  A DLI R L      R+      EI+ 
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKA 300

Query: 132 HPWFQ 136
           HP+F+
Sbjct: 301 HPFFK 305

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 60/200 (30%), Positives = 88/200 (44%), Gaps = 45/200 (22%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------------------------- 35
           +HRD+KP+NLLLD+K +VK++DFGL   ++  H                           
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 36  ---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI 86
                       ++ G+P+Y APEV     Y     D WS GVI+Y +L G  PF  E  
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 87  PNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAHL 139
              ++K+     TL  P    +S  A+DLI R    D   RI    + EI+ HP+F+   
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVD 300

Query: 140 PRYLAVPPPDTMQQAKKIDE 159
             ++   P     + K ID+
Sbjct: 301 WGHIRERPAAIPIEIKSIDD 320

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 76.6 bits (188), Expect = 1e-15
 Identities = 50/141 (35%), Positives = 75/141 (53%), Gaps = 6/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +V+RDLKPEN+LLDS+ +V + DFGL    +       T CG+P Y APEVI  + Y   
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN- 175

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  G +LY +L G  PF   ++  ++  I      L    S  A  ++  +L  D 
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDR 235

Query: 121 MKRI----TIPEIRQHPWFQA 137
            +R+       EI++HP+F++
Sbjct: 236 QRRLGAKEDFLEIQEHPFFES 256

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 53/167 (31%), Positives = 79/167 (47%), Gaps = 36/167 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 121 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 59  GPEVDVWSCGVILYALLC--GTLPFDDENIPNLFK----------KIKGGIYTLPSH--- 103
              VD+WS G I   ++      P D E I  LF+           +  G+ +LP +   
Sbjct: 179 STAVDIWSLGCIFAEMVTRRALFPGDSE-IDQLFRIFRTLGTPDEVVWPGVTSLPDYKPS 237

Query: 104 ---------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                          L    RDL+ +ML  DP KRI+      HP+F
Sbjct: 238 FPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 75.6 bits (186), Expect = 2e-15
 Identities = 51/174 (29%), Positives = 77/174 (44%), Gaps = 50/174 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           V+HRDLKP+NLL++ +  +K+ADFGL+           + G P            Y AP+
Sbjct: 121 VLHRDLKPQNLLINKRGELKLADFGLAR----------AFGIPVNTFSNEVVTLWYRAPD 170

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKG--------GIYT 99
           V+ G       +D+WS G I+  ++ G   F   ++E+      +I G        GI  
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQ 230

Query: 100 LPS------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           LP                   H  P   DL+ R+L ++P  RI+  +  QHPWF
Sbjct: 231 LPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 57/201 (28%), Positives = 86/201 (42%), Gaps = 46/201 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 198

Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258

Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ E  QHP+    +
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318

Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 319 DPAEVEAPPPQIYD--KQLDE 337

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 51/146 (34%), Positives = 77/146 (52%), Gaps = 16/146 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSC-GSPNYAAPEVI--SGKL 56
           ++HRDLK +NLL+D+    KI+DFG+S    D   +    S  GS  + APEVI    + 
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188

Query: 57  YAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLP-------SHLSPGA 108
           Y+  +VD+WS G ++  +  G  P+ D+E I  +FK   G   + P        +LSP A
Sbjct: 189 YSA-KVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK--LGNKRSAPPIPPDVSMNLSPVA 245

Query: 109 RDLIPRMLIVDPMKRITIPEIRQHPW 134
            D +     ++P  R T  E+ QHP+
Sbjct: 246 LDFLNACFTINPDNRPTARELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 43/145 (29%), Positives = 77/145 (53%), Gaps = 12/145 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GP 60
           +V+RDLKPEN+LLD + +++I+D GL+  + +G  ++   G+  Y APEVI+ + Y   P
Sbjct: 123 IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182

Query: 61  EVDVWSCGVILYALLCGTLPFD--DENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRML 116
             D W  G ++Y ++ G  PF    E +    + +++K          S  A+ +   +L
Sbjct: 183 --DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240

Query: 117 IVDPMKRITI-----PEIRQHPWFQ 136
             +P +R+         ++QHP F+
Sbjct: 241 TKNPKERLGCRGNGAAGVKQHPIFK 265

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 41/143 (28%), Positives = 75/143 (52%), Gaps = 9/143 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K  N+L+ +  NVK+ DFG++ ++      + T  G+P + APEVI+   Y   
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIPRM 115
           + D+WS G+ +Y +  G  P+ D    + F+ +     + P     +  S   R+ +   
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDV---DAFRAMMLIPKSKPPRLEDNGYSKLLREFVAAC 238

Query: 116 LIVDPMKRITIPEIRQHPWFQAH 138
           L  +P +R++  E+ +  W +AH
Sbjct: 239 LDEEPKERLSAEELLKSKWIKAH 261

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 53/168 (31%), Positives = 78/168 (46%), Gaps = 33/168 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+ ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLAR-HTD-DEMTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 62  VDVWSCGVILYALLCG-TL-PFDDEN-----I--------PNLFKKI-----KGGIYTLP 101
           VD+WS G I+  LL G TL P  D       I          L +KI     +  I +LP
Sbjct: 197 VDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLP 256

Query: 102 SH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
                         +P A DL+ +ML++DP KRIT  E   HP+   +
Sbjct: 257 QMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEY 304

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.5 bits (183), Expect = 4e-15
 Identities = 59/172 (34%), Positives = 85/172 (49%), Gaps = 43/172 (25%)

Query: 2   VVHRDLKPENLLLDSKWN-VKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISG- 54
           V+HRDLKP+NLL+D + N +K+ADFGL+      +    H + T      Y APE++ G 
Sbjct: 123 VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLW----YRAPEILLGS 178

Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPF--DDENIPNLFK--KIKG--------GIYTLPS 102
           + Y+ P VD+WS G I +A +    P    D  I  LFK  +I G        G+ +LP 
Sbjct: 179 RHYSTP-VDIWSVGCI-FAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 103 H------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           +                  L P   DL+ +ML +DP KRIT     +H +F+
Sbjct: 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288

Length = 294

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.2 bits (185), Expect = 5e-15
 Identities = 48/175 (27%), Positives = 75/175 (42%), Gaps = 34/175 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI--MRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++HRD+KP NLL++S   +KI DFGL+ +    +   +     +  Y APE++ G  +  
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183

Query: 60  PEVDVWSCGVILYALLCGTLPFD----------------DENIPNLFKKIKGG------- 96
             VD+WS G I   LL   + F                   ++  +    +G        
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243

Query: 97  ---------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY 142
                    +YTL S  +  A  L+ RML+ DP KRI+  +   HP+      RY
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGRLRY 298

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 45/124 (36%), Positives = 63/124 (50%), Gaps = 3/124 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+ L     VK+ DFG + ++   G +  T  G+P Y  PE+     Y   
Sbjct: 121 VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN- 179

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVD 119
           + D+WS G ILY L     PF   +  NL  K+ +G    LPSH S   R LI +M   +
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRN 239

Query: 120 PMKR 123
           P  R
Sbjct: 240 PRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 73.9 bits (181), Expect = 5e-15
 Identities = 49/139 (35%), Positives = 75/139 (53%), Gaps = 8/139 (5%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           M+VHRD+K  N+L DS  NVK+ DFG S     I   G  +K+  G+P + +PEVISG+ 
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG 185

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFK-KIKGGIYTLPSHLSPGARDLIPR 114
           Y G + DVWS    +  +L    P+ + E +  +FK   +     LP  +S   RD + +
Sbjct: 186 Y-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL-K 243

Query: 115 MLIVDPMKRITIPEIRQHP 133
            + V+  +R T   + +HP
Sbjct: 244 QIFVEEKRRPTAEFLLRHP 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.7 bits (181), Expect = 6e-15
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 3/134 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGP 60
           ++HRD+K +N+ L     +K+ DFG++ ++     L  +C G+P Y +PE+   + Y   
Sbjct: 122 ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNN- 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
           + D+W+ G +LY +      F+  N+ NL  KI  G Y  + SH S   R+L+ ++   +
Sbjct: 181 KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRN 240

Query: 120 PMKRITIPEIRQHP 133
           P  R ++  I +  
Sbjct: 241 PRDRPSVNSILEKN 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 74.3 bits (183), Expect = 7e-15
 Identities = 44/180 (24%), Positives = 76/180 (42%), Gaps = 48/180 (26%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------------YAA 48
            ++HRD+K  N+L+D++  +KIADFGL+             G               Y  
Sbjct: 135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRP 194

Query: 49  PEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIP 87
           PE++ G+      VD+W  G +   +                     LCGT    +E  P
Sbjct: 195 PELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP--TEETWP 252

Query: 88  NLFKKIKG--GIYTLPSH----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
             ++ + G  G+++  ++          L P   DL+ ++L +DP KR+T  +  +HP+F
Sbjct: 253 G-WRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|190228 pfam02149, KA1, Kinase associated domain 1

 Score = 66.8 bits (164), Expect = 1e-14
 Identities = 19/46 (41%), Positives = 31/46 (67%), Gaps = 1/46 (2%)

Query: 334 PNVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV 378
           P+VVKFE+++ K      Y +D +R+ GPQ+ + DL A  L++LR+
Sbjct: 1   PSVVKFEIEVCKLPRLGLYGVDFKRLSGPQWQYKDLAAKILSELRL 46

Length = 46

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 45/159 (28%), Positives = 82/159 (51%), Gaps = 13/159 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
            V+RDLKPEN+LLD   +++I+D GL+  + +G  ++   G+  Y APEV++ + Y    
Sbjct: 123 TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLS 181

Query: 62  VDVWSCGVILYALLCGTLPF--DDENIP--NLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
            D W  G ++Y ++ G  PF    E +    + +++        +  S  A+ +   +L 
Sbjct: 182 PDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLT 241

Query: 118 VDPMKRITIP-----EIRQHPWFQ-AHLPRYLA--VPPP 148
            DP +R+        E+++HP+F+  +  R  A  + PP
Sbjct: 242 KDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPP 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 72.7 bits (179), Expect = 2e-14
 Identities = 46/176 (26%), Positives = 71/176 (40%), Gaps = 56/176 (31%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-------------YAA 48
           + HRD+KPEN+L+     +K+ADFG             SC                 Y A
Sbjct: 121 IFHRDIKPENILIKDD-ILKLADFG-------------SCRGIYSKPPYTEYISTRWYRA 166

Query: 49  PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNL------------ 89
           PE +    Y GP++D+W+ G + + +L     F   N       I ++            
Sbjct: 167 PECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKF 226

Query: 90  ---------FKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                    F   KG G+  L  + S    DL+ ++L  DP +RIT  +  +HP+F
Sbjct: 227 RKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 52/161 (32%), Positives = 72/161 (44%), Gaps = 28/161 (17%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  Y APEV+    YA P 
Sbjct: 129 IVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATP- 187

Query: 62  VDVWSCGVILY------ALLCGT--------------LPFDDE-----NIP--NLFKKIK 94
           VD+WS G I         L CG               LP +D+      +P      +  
Sbjct: 188 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGP 247

Query: 95  GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
             + ++   +      L+  ML  +P KRI+     QHP+F
Sbjct: 248 RPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 44/190 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 144 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYK-EN 202

Query: 62  VDVWSCGVILYALLCGTLPFDD-------------------ENIPNLFKKIKGGIYTLPS 102
           VD+WS G I+  L+ G++ F                     E +  L   ++  +   P 
Sbjct: 203 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQ 262

Query: 103 H-------LSPG----------------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
           +       L P                 ARDL+ +ML++DP KRI++ E  +HP+    +
Sbjct: 263 YPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322

Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 323 DPAEAEAPPP 332

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 55/186 (29%), Positives = 75/186 (40%), Gaps = 45/186 (24%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           ++HRDLK  NLLL  K  +KIADFGL+     G   K    +P      Y APE++ G  
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLAR--TYGLPAKPM--TPKVVTLWYRAPELLLGCT 184

Query: 57  YAGPEVDVWSCGVILYALL------------------CGTLPFDDENI-PNLFKKIKGGI 97
                +D+W+ G IL  LL                     L   +E+I P        G 
Sbjct: 185 TYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGK 244

Query: 98  YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH-LPRYLAV 145
           +TLP             LS     L+  +L+ DP KR T  E  +  +F+   LP     
Sbjct: 245 FTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC---- 300

Query: 146 PPPDTM 151
             P+ M
Sbjct: 301 -EPEMM 305

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 72.9 bits (179), Expect = 3e-14
 Identities = 53/173 (30%), Positives = 76/173 (43%), Gaps = 34/173 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKL---- 56
           +VHRD+KP NLL++S  NVKIADFG+S I+ +      +S G+  Y +PE I+  L    
Sbjct: 189 IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGA 248

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL------------PSHL 104
           Y G   D+WS GV +     G  PF       + +  +G   +L            P+  
Sbjct: 249 YDGYAGDIWSLGVSILEFYLGRFPF------GVGR--QGDWASLMCAICMSQPPEAPATA 300

Query: 105 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF---------QAHLPRYLAVPPP 148
           S   R  I   L  +P KR +  ++ QHP+                 L  PP 
Sbjct: 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQPGQGQGGPNLHQLLPPPR 353

Length = 353

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 72.3 bits (177), Expect = 3e-14
 Identities = 46/159 (28%), Positives = 84/159 (52%), Gaps = 13/159 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RD+KPEN+LLD + N +++D GL+  ++DG  +    G+  Y APE++  + Y+ P 
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP- 174

Query: 62  VDVWSCGVILYALLCGTLPFDD--ENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRML 116
           VD ++ G  +Y ++ G  PF D  E +       + ++  +     + +  ++D+    L
Sbjct: 175 VDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFL 234

Query: 117 IVDPMKRITIPEI----RQHPWFQA-HLPRYLA--VPPP 148
              P  R+   E     R+H +F+  + PR  A  +PPP
Sbjct: 235 AKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 3e-14
 Identities = 44/140 (31%), Positives = 68/140 (48%), Gaps = 6/140 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGP 60
           +HRD+K  N+LL  + +VK+ADFG+S  +      K  T  G+P + APEVI    Y   
Sbjct: 120 IHRDIKAANILLSEEGDVKLADFGVSGQLTS-TMSKRNTFVGTPFWMAPEVIKQSGYDE- 177

Query: 61  EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHL-SPGARDLIPRMLIV 118
           + D+WS G+    L  G  P  D   +  LF   K    +L  +  S   +D +   L  
Sbjct: 178 KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNK 237

Query: 119 DPMKRITIPEIRQHPWFQAH 138
           DP +R +  E+ +H + +  
Sbjct: 238 DPKERPSAKELLKHKFIKKA 257

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 71.5 bits (175), Expect = 3e-14
 Identities = 44/135 (32%), Positives = 74/135 (54%), Gaps = 4/135 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           ++HRDLK +N+ L +   +KI DFG+S ++     L T+  G+P Y +PE +  + Y   
Sbjct: 127 ILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY-DS 184

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVD 119
           + D+WS G ILY + C    F+ +N  ++  +I +G   +LP   S     ++  ML  D
Sbjct: 185 KSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKD 244

Query: 120 PMKRITIPEIRQHPW 134
           P  R +  EI ++P+
Sbjct: 245 PSLRPSAAEILRNPF 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 73.1 bits (179), Expect = 4e-14
 Identities = 59/202 (29%), Positives = 98/202 (48%), Gaps = 16/202 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLYA 58
           ++HRDLK  N+ L     +K+ DFG S    D   L  +   CG+P Y APE+   K Y+
Sbjct: 190 MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS 249

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 117
             + D+WS GVILY LL    PF   +   + +++  G Y   P  +S G + L+  +L 
Sbjct: 250 -KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLS 308

Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID----EEILKEVVKMGFDQN 173
            +P  R T  ++           +Y+A    D ++ ++ I     EEIL+++ + G ++ 
Sbjct: 309 KNPALRPTTQQL-----LHTEFLKYVANLFQDIVRHSETISPHDREEILRQLQESG-ERA 362

Query: 174 QLVESLR-NRLQNEATVAYYLL 194
               S+R   + ++ T   YL 
Sbjct: 363 PPPSSIRYGVVTSDVTHGGYLY 384

Length = 478

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 71.4 bits (175), Expect = 5e-14
 Identities = 53/169 (31%), Positives = 70/169 (41%), Gaps = 40/169 (23%)

Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGK 55
           V+HRDLKP+NLL+D  K  +KIAD GL       +    H + T      Y APEV+ G 
Sbjct: 131 VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLW----YRAPEVLLGS 186

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIK----------GGI------- 97
            +    VD+WS G I   +      F  D  +  L    K           G+       
Sbjct: 187 THYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWH 246

Query: 98  -----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                        +P  LSP   DL+ +ML  DP KRI+      HP+F
Sbjct: 247 EFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 69.5 bits (171), Expect = 1e-13
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 7/135 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSP-NYAAPEVISGKLYAG 59
            +HRDL   N L+     VKI+DFGLS ++  D ++ K     P  + APE +    +  
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF-T 181

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+   +   + + +K G Y L  P +  P   DL+ +  
Sbjct: 182 SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQPPNCPPELYDLMLQCW 240

Query: 117 IVDPMKRITIPEIRQ 131
             DP  R T  E+ +
Sbjct: 241 AEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 70.2 bits (172), Expect = 2e-13
 Identities = 50/168 (29%), Positives = 72/168 (42%), Gaps = 40/168 (23%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +HRD+K  N+LL++K  +K+ADFGL+ +    +         +  Y  PE++ G+   GP
Sbjct: 138 LHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGP 197

Query: 61  EVDVWSCGVILYAL---------------------LCGTLPFDDENIPNLFKKIKGGIYT 99
            +DVWSCG IL  L                     LCG+ P      P++ K       T
Sbjct: 198 AIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGS-P-CPAVWPDVIKLP--YFNT 253

Query: 100 LP-------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 134
           +              S +   A DL+  ML +DP KR T  E    PW
Sbjct: 254 MKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 69.3 bits (170), Expect = 3e-13
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 14/146 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+LLD   N+K+ DFG+S  + D    KT   G   Y APE I      G 
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS-IAKTRDAGCRPYMAPERIDPSARDGY 187

Query: 61  EV--DVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY--------TLPSHLSPGARD 110
           +V  DVWS G+ LY +  G  P+   N  ++F ++   +         +     SP   +
Sbjct: 188 DVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVVKGDPPILSNSEEREFSPSFVN 245

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ 136
            I   LI D  KR    E+ +HP+ +
Sbjct: 246 FINLCLIKDESKRPKYKELLEHPFIK 271

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 62/200 (31%), Positives = 90/200 (45%), Gaps = 45/200 (22%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLK--------------------- 38
           +HRD+KP+NLLLDSK +VK++DFGL   ++  H   F +                     
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 39  ------------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI 86
                       ++ G+P+Y APEV     Y     D WS GVI+Y +L G  PF  E  
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 87  PNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIVDPMKRITIP---EIRQHPWFQAHL 139
              +KK+     TL  P    +S  A+DLI R    +   RI  P   EI+ +P+F+   
Sbjct: 242 QETYKKVMNWKETLIFPPEVPISEKAKDLILR-FCCEWEHRIGAPGVEEIKTNPFFEGVD 300

Query: 140 PRYLAVPPPDTMQQAKKIDE 159
             ++   P     + K ID+
Sbjct: 301 WEHIRERPAAIPIEIKSIDD 320

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 52/192 (27%), Positives = 82/192 (42%), Gaps = 35/192 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 141 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 198

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL----------------- 104
           VD+WS G I+  LL G   F   +  +  K I   + T  + L                 
Sbjct: 199 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 258

Query: 105 --------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP- 148
                         +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P 
Sbjct: 259 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPY 318

Query: 149 DTMQQAKKIDEE 160
           D   +++ +  +
Sbjct: 319 DQSFESRDLLID 330

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 68.0 bits (167), Expect = 5e-13
 Identities = 42/135 (31%), Positives = 64/135 (47%), Gaps = 7/135 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLYAG 59
            +HRDL   N L+     VKI+DFGLS  + D  + K   G  P  + APE +    +  
Sbjct: 124 FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEGKF-T 182

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+   +   + + +K G Y L  P +  P    L+ +  
Sbjct: 183 SKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKG-YRLPKPPNCPPELYKLMLQCW 241

Query: 117 IVDPMKRITIPEIRQ 131
             DP  R T  E+ +
Sbjct: 242 AEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 48/178 (26%), Positives = 71/178 (39%), Gaps = 43/178 (24%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN------IMRDGHFLKTSCGSPN---------Y 46
            +HRDL P N+ ++SK   KIADFGL+               +T               Y
Sbjct: 140 FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWY 199

Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------- 93
            APE++ G       VD+WS G I   LL G   F  EN  +   +I             
Sbjct: 200 RAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWP 259

Query: 94  ---KGGIYTLPSHLSP------------GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
              K  +YT  +   P             A DL+  +L ++P++RI+  E  +H +F+
Sbjct: 260 QAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFK 317

Length = 335

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 68.0 bits (166), Expect = 7e-13
 Identities = 54/166 (32%), Positives = 76/166 (45%), Gaps = 28/166 (16%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKLY 57
           VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+   + 
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVA 172

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIP 113
                D +S G +L+ LL G  PF      +   +I     T    LP   SP  R L+ 
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK-HEIDRMTLTMAVELPDSFSPELRSLLE 231

Query: 114 RMLIVDPMKRITI-----PEIRQHP------WFQAHLPRYLAVPPP 148
            +L  D  +R+        E+++HP      W    L +Y   PPP
Sbjct: 232 GLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKY---PPP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (166), Expect = 8e-13
 Identities = 47/145 (32%), Positives = 68/145 (46%), Gaps = 16/145 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           V+HRD+K +N+LL     VK+ DFG+S      + R      T  G+P + APEVI+   
Sbjct: 134 VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN----TFIGTPYWMAPEVIACDE 189

Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGAR 109
                     DVWS G+    L  G  P  D + +  LFK  +    TL  P + S    
Sbjct: 190 QPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFN 249

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D I   LI +  +R  + E+ +HP+
Sbjct: 250 DFISECLIKNYEQRPFMEELLEHPF 274

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 68.5 bits (167), Expect = 9e-13
 Identities = 58/199 (29%), Positives = 88/199 (44%), Gaps = 37/199 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+ ++    ++I DFGL+    D   +     +  Y APE++   ++    
Sbjct: 139 IIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQT 196

Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKGG-----IYTLP 101
           VD+WS G I+  LL G   F   +                P + KKI        I +LP
Sbjct: 197 VDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLP 256

Query: 102 SHL------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPR-YLAVPP 147
            H+            +P A DL+ +ML++D  KRI+  E   HP+F Q H P       P
Sbjct: 257 -HMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEP 315

Query: 148 PDTMQQAKKIDEEILKEVV 166
            D   + K+   E  KE+ 
Sbjct: 316 YDESPENKERTIEEWKELT 334

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 1e-12
 Identities = 40/135 (29%), Positives = 73/135 (54%), Gaps = 3/135 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLK +N+ L     +K+ D G++ ++ +      T  G+P Y +PE+ S K Y   
Sbjct: 123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY-NY 181

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
           + DVW+ G  +Y +      F+ +++ +L ++ I+G +  +P   SP   +LI  ML   
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241

Query: 120 PMKRITIPEIRQHPW 134
           P KR ++  I + P+
Sbjct: 242 PEKRPSVKSILRQPY 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 61/206 (29%), Positives = 88/206 (42%), Gaps = 46/206 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG---SPNYAAPEVISGKLYA 58
           ++HRDLKP NL ++    +KI DFGL+      H      G   +  Y APEVI   ++ 
Sbjct: 138 IIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPEVILNWMHY 192

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKI-----KGGIY 98
              VD+WS G I+  +L G   F  ++                P   +K+     K  I 
Sbjct: 193 NQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIK 252

Query: 99  TLPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVP 146
           +LP              SP A DL+ +ML +D  KR+T  E  +HP+F            
Sbjct: 253 SLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQ 312

Query: 147 PP--DTMQQAK-KIDE---EILKEVV 166
            P  D+++  K  +DE    I KEV 
Sbjct: 313 QPYDDSLENEKLSVDEWKKHIYKEVK 338

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 57/216 (26%), Positives = 84/216 (38%), Gaps = 59/216 (27%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-----SNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           V+HRDLKP NLL++    ++I DFG+     S+     +F+     +  Y APE+    L
Sbjct: 128 VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPEL----L 183

Query: 57  YAGPE----VDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------- 93
            + PE    +D+WS G I   +L     F  +N  +  K I                   
Sbjct: 184 LSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243

Query: 94  -KGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 141
            +  I  LP              SP A DL+ +ML  DP +RIT+ +  QHP+   +   
Sbjct: 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY--- 300

Query: 142 YLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVE 177
                 PD        DE          F+  +L  
Sbjct: 301 ----HDPD--------DEPTCPPPFDFDFEAIELSR 324

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 47/190 (24%), Positives = 69/190 (36%), Gaps = 58/190 (30%)

Query: 2   VVHRDLKPENLLLDSKWN----VKIADFGLSNIMRDGHFLKTSCGSPN------YAAPEV 51
           V+HRDLKP N+L+  +      VKI D GL+ +      LK             Y APE+
Sbjct: 129 VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAP--LKPLADLDPVVVTIWYRAPEL 186

Query: 52  ISGKLYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFK--------KIKG---- 95
           + G  +    +D+W+ G I   LL     F          N F+        ++ G    
Sbjct: 187 LLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE 246

Query: 96  ----GIYTLPSH--------------------------LSPGARDLIPRMLIVDPMKRIT 125
                I  +P +                                DL+ ++L  DP KRIT
Sbjct: 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT 306

Query: 126 IPEIRQHPWF 135
             E  +HP+F
Sbjct: 307 AEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 65.3 bits (160), Expect = 5e-12
 Identities = 42/139 (30%), Positives = 69/139 (49%), Gaps = 12/139 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG-SPN-YAAPEVISGKLYA 58
            VHRDL   N L+     VKI+DFGLS ++  D ++ K + G  P  + APE +   ++ 
Sbjct: 126 FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF- 184

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPN--LFKKIKGGIYTL--PSHLSPGARDLIP 113
             + DVWS GV+L+ +   G  P+    + N  + + ++ G Y L  P +      +L+ 
Sbjct: 185 TSKSDVWSFGVLLWEIFTLGATPY--PGLSNEEVLEYLRKG-YRLPKPEYCPDELYELML 241

Query: 114 RMLIVDPMKRITIPEIRQH 132
               +DP  R T  E+ + 
Sbjct: 242 SCWQLDPEDRPTFSELVER 260

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 49/178 (27%), Positives = 76/178 (42%), Gaps = 51/178 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           ++HRD+K  N+L+     +K+ADFGL+       F  +    PN          Y  PE+
Sbjct: 140 ILHRDMKAANILITKDGILKLADFGLARA-----FSLSKNSKPNRYTNRVVTLWYRPPEL 194

Query: 52  ISGKLYAGPEVDVWSCGVI---------------------LYALLCGTL-----PFDDEN 85
           + G+   GP +D+W  G I                     L + LCG++     P   + 
Sbjct: 195 LLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWP-GVDK 253

Query: 86  IPNLFKKI---KGGIYTLPSHLSP-----GARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           +  LFKK+   +G    +   L P      A DLI ++L++DP KRI       H +F
Sbjct: 254 LE-LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 6e-12
 Identities = 46/176 (26%), Positives = 69/176 (39%), Gaps = 50/176 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------YAAPEVI 52
           ++HRD+KPEN+L+     +K+ DFG +  +R          +           Y APE++
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRAR-------PASPLTDYVATRWYRAPELL 173

Query: 53  SGKLYAGPEVDVWSCGVILYALL---------------------CGTLP----------- 80
            G    G  VDVW+ G I+  LL                      G LP           
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233

Query: 81  -FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            F     P    + +      P  +S  A D +   L +DP +R+T  E+ QHP+F
Sbjct: 234 RFAGVAFPEP-SQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 64.9 bits (158), Expect = 7e-12
 Identities = 33/80 (41%), Positives = 49/80 (61%), Gaps = 2/80 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++++  VK+ DFG+S  + +    KT  G+  Y APE ISG+ Y G  
Sbjct: 116 ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY-GIH 173

Query: 62  VDVWSCGVILYALLCGTLPF 81
            DVWS G+    L  G  P+
Sbjct: 174 SDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 66.4 bits (162), Expect = 8e-12
 Identities = 39/97 (40%), Positives = 56/97 (57%), Gaps = 4/97 (4%)

Query: 42  GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP 101
           G+P+Y APE++ GK + GP VD W+ GV L+  L G  PF+DE    +F+ I       P
Sbjct: 542 GTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 102 ---SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                LS  A++ I  +L +DP KR  + E++QHP F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 64.3 bits (156), Expect = 1e-11
 Identities = 45/138 (32%), Positives = 68/138 (49%), Gaps = 3/138 (2%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL  + +VK+ADFG++  + D    + T  G+P + APEVI    Y   +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS-K 181

Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  D + +  LF   K    TL    S   ++ I   L  DP
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDP 241

Query: 121 MKRITIPEIRQHPWFQAH 138
             R T  E+ +H +   +
Sbjct: 242 SFRPTAKELLKHKFIVKN 259

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 41/170 (24%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISG-K 55
           V+HRDLKP+NLL++    +K+ADFGL+        +   C S       Y  P+V+ G K
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLAR----AFGIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG--------GIYTLP-- 101
           LY+   +D+WS G I   L     P     D ++      ++ G        G+  LP  
Sbjct: 176 LYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY 234

Query: 102 ----------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                             L+   RDL+  +L+ +P++RI+  E  QHP+F
Sbjct: 235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 45/172 (26%), Positives = 74/172 (43%), Gaps = 39/172 (22%)

Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGK 55
           V+HRDLKP N+ ++++  V KI DFGL+ I+ D H+     L     +  Y +P ++   
Sbjct: 135 VLHRDLKPANVFINTEDLVLKIGDFGLARIV-DPHYSHKGYLSEGLVTKWYRSPRLLLSP 193

Query: 56  LYAGPEVDVWSCGVILYALLCG------------------TLPFDDEN--------IPNL 89
                 +D+W+ G I   +L G                  ++P   E         IP+ 
Sbjct: 194 NNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSF 253

Query: 90  FKKIKGGIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
            +   G         LP  ++P A D + ++L  +PM R+T  E   HP+  
Sbjct: 254 VRNDGGEPRRPLRDLLPG-VNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 47/142 (33%), Positives = 72/142 (50%), Gaps = 12/142 (8%)

Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVIS-GKLYA 58
           +VHRD+K +N+L+++   V KI+DFG S  +       +T  G+  Y APEVI  G    
Sbjct: 129 IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYT----LPSHLSPGARDLI 112
           G   D+WS G  +  +  G  PF +   P   +FK    G++     +P  LS  A++ I
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKV---GMFKIHPEIPESLSAEAKNFI 245

Query: 113 PRMLIVDPMKRITIPEIRQHPW 134
            R    DP KR +  ++ Q P+
Sbjct: 246 LRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 64.2 bits (156), Expect = 2e-11
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 33/166 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+   +    +     +  Y APEVI   ++    
Sbjct: 139 IIHRDLKPGNLAVNEDCELKILDFGLAR--QTDSEMTGYVVTRWYRAPEVILNWMHYTQT 196

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTLP 101
           VD+WS G I+  +L G   F   +  +   +I                    K  +  LP
Sbjct: 197 VDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLP 256

Query: 102 -----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                       + +P A +++ +ML++D   RIT  E   HP+F+
Sbjct: 257 RFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFE 302

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 44/132 (33%), Positives = 65/132 (49%), Gaps = 3/132 (2%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL  + +VK+ADFG++  + D    + T  G+P + APEVI    Y   +
Sbjct: 123 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF-K 181

Query: 62  VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  D   +  LF   K    TL    S   ++ +   L  DP
Sbjct: 182 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDP 241

Query: 121 MKRITIPEIRQH 132
             R T  E+ +H
Sbjct: 242 RFRPTAKELLKH 253

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 62.4 bits (152), Expect = 6e-11
 Identities = 47/171 (27%), Positives = 75/171 (43%), Gaps = 42/171 (24%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKLYAGP 60
            +HRD+KPEN+L+  +  +K+ DFG + I+       T   +   Y APE++ G    GP
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGP 180

Query: 61  EVDVWSCGVILYALLCG------------------TLPFDDENIP---NLFKK---IKGG 96
            VDVW+ G +   LL G                  TL    + IP    +F      KG 
Sbjct: 181 PVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL---GDLIPRHQQIFSTNQFFKG- 236

Query: 97  IYTLPS------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
             ++P             ++S  A   +   L +DP +R++  E+ +HP+F
Sbjct: 237 -LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 58/189 (30%), Positives = 80/189 (42%), Gaps = 55/189 (29%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGL----------------SNIMRD------------- 33
           +HRD+KP+N+L+D   ++K+ DFGL                S+I +D             
Sbjct: 123 IHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSN 182

Query: 34  ---GHFLKT----------SC------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 74
              G  LKT           C      G+PNY APEV+  K Y     D WS GVIL+ +
Sbjct: 183 CRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEM 241

Query: 75  LCGTLPFDDENIPNLFKKIKGGIYTL--PSH--LSPGARDLIPRMLIV--DPMKRITIPE 128
           L G  PF          K+     TL  P    LSP A DLI ++     + + R    +
Sbjct: 242 LVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301

Query: 129 IRQHPWFQA 137
           I+ HP+F  
Sbjct: 302 IKAHPFFSE 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 61.9 bits (150), Expect = 7e-11
 Identities = 45/143 (31%), Positives = 69/143 (48%), Gaps = 8/143 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGK----L 56
           ++HRD+K  N+LL ++  VK+ DFG+S  +      + TS G+P + APEVI+ +     
Sbjct: 149 IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDY 208

Query: 57  YAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 113
                 DVWS G+    L  G  P FD   +  LFK  +    TL  P          I 
Sbjct: 209 SYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFIS 268

Query: 114 RMLIVDPMKRITIPEIRQHPWFQ 136
           + LI D   R ++  + +HP+ +
Sbjct: 269 QCLIKDFEARPSVTHLLEHPFIK 291

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 32/103 (31%), Positives = 56/103 (54%), Gaps = 4/103 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
            +HRDL   N+L+      K+ADFGL+ ++++  +L +    P  + APE  S   ++  
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST- 183

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
           + DVWS G++LY +   G +P+   N   ++ +I  G Y +P 
Sbjct: 184 KSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPC 225

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 31/79 (39%), Positives = 47/79 (59%), Gaps = 7/79 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSP-NYAAPEVIS-GKL 56
            +HRDL   N+L++S+  VKI+DFGL+ ++   +D +++K    SP  + APE +   K 
Sbjct: 130 YIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF 189

Query: 57  YAGPEVDVWSCGVILYALL 75
            +    DVWS GV LY L 
Sbjct: 190 SS--ASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 61.2 bits (149), Expect = 1e-10
 Identities = 47/142 (33%), Positives = 67/142 (47%), Gaps = 12/142 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG- 59
            +HRD+K  N+LL    +VK+ADFG+S  +       K+  G+P + APEV + +   G 
Sbjct: 122 KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY 181

Query: 60  -PEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHL------SPGARDL 111
             + D+W+ G+    L     P FD   +  LF   K      P  L      SP   D 
Sbjct: 182 DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNF--PPPKLKDKEKWSPVFHDF 239

Query: 112 IPRMLIVDPMKRITIPEIRQHP 133
           I + L  DP KR T  ++ QHP
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 61.3 bits (149), Expect = 1e-10
 Identities = 47/133 (35%), Positives = 69/133 (51%), Gaps = 7/133 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
           +HRDL   N+LL     VKI DFGL+ +IM D +++ K +   P  + APE I   +Y  
Sbjct: 163 IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYT- 221

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRML 116
            E DVWS G++L+ +   G+ P+    + + F K IK G     P H      D++    
Sbjct: 222 FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCW 281

Query: 117 IVDPMKRITIPEI 129
             DP+KR T  +I
Sbjct: 282 DADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 60.6 bits (148), Expect = 1e-10
 Identities = 35/104 (33%), Positives = 53/104 (50%), Gaps = 6/104 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYA 58
            VHRDL   N L+     VKI+DFGLS +I  D ++ K   G     + APE +    + 
Sbjct: 123 FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGKFT 182

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
             + DVWS GV+L+ +   G  P+   +   + + ++ G Y LP
Sbjct: 183 -SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-YRLP 224

Length = 258

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 46/127 (36%), Positives = 63/127 (49%), Gaps = 6/127 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           V+HRD+KP N+ + +   VK+ D GL            S  G+P Y +PE I    Y   
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NF 185

Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARDLIPRML 116
           + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LPS H S   R L+   +
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245

Query: 117 IVDPMKR 123
             DP KR
Sbjct: 246 NPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 54/168 (32%), Positives = 76/168 (45%), Gaps = 32/168 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKLY 57
           VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+     
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGTA 172

Query: 58  AGPEVDVWSCGVILYALLCGTLPF------DDENIPNLFKKIKGGIYTLPSHLSPGARDL 111
                D +S G +L+ LL G  PF      D   I  +   +      LP   SP  + L
Sbjct: 173 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN---VELPDSFSPELKSL 229

Query: 112 IPRMLIVDPMKRITI-----PEIRQHP------WFQAHLPRYLAVPPP 148
           +  +L  D  KR+        E+++H       W Q +L +Y   PPP
Sbjct: 230 LEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYLQKY---PPP 274

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 60.0 bits (145), Expect = 3e-10
 Identities = 33/70 (47%), Positives = 43/70 (61%), Gaps = 1/70 (1%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y APEV+    YA P 
Sbjct: 131 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP- 189

Query: 62  VDVWSCGVIL 71
           VD+WS G I 
Sbjct: 190 VDLWSVGCIF 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 53/189 (28%), Positives = 75/189 (39%), Gaps = 55/189 (29%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----------------------TS 40
           +HRD+KP+N+L+D   ++K+ DFGL    R  H  K                       +
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182

Query: 41  C--------------------------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL 74
           C                          G+PNY APEV+    Y     D WS GVILY +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEM 241

Query: 75  LCGTLPFDDEN-IPNLFKKIKGGI---YTLPSHLSPGARDLIPRML--IVDPMKRITIPE 128
           L G  PF  +  +    K I           + LSP A DLI ++     D + +    E
Sbjct: 242 LVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADE 301

Query: 129 IRQHPWFQA 137
           I+ HP+F+ 
Sbjct: 302 IKAHPFFKT 310

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 5e-10
 Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 6/135 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           V+HRD+KP N+ + +   VK+ D GL            S  G+P Y +PE I    Y   
Sbjct: 127 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NF 185

Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARDLIPRML 116
           + D+WS G +LY +     PF  D  N+ +L +KI+   Y  LP+ H S   R+L+   +
Sbjct: 186 KSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245

Query: 117 IVDPMKRITIPEIRQ 131
             DP +R  I  + Q
Sbjct: 246 YPDPDQRPDIGYVHQ 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 59.2 bits (143), Expect = 7e-10
 Identities = 44/180 (24%), Positives = 73/180 (40%), Gaps = 39/180 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           V+HRDLKP+NLL++ +  +K+ADFGL+        + T   S       Y  P+++ G  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR----AKSIPTKTYSNEVVTLWYRPPDILLGST 180

Query: 57  YAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGI 97
               ++D+W  G I Y +  G   F                    +E  P +    +   
Sbjct: 181 DYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKS 240

Query: 98  YTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           Y  P +           L     +L+ ++L  +  KRI+  E  +HP+F     R   +P
Sbjct: 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHKLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 58.3 bits (141), Expect = 7e-10
 Identities = 44/148 (29%), Positives = 67/148 (45%), Gaps = 30/148 (20%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLY 57
           +V RDL P N+LLD + ++++  F   + + D      SC        Y APEV  G   
Sbjct: 106 IVCRDLNPNNILLDDRGHIQLTYFSRWSEVED------SCDGEAVENMYCAPEV-GGISE 158

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARDLI 112
                D WS G IL+ LL G           L +    GI T     +P  +S  AR L+
Sbjct: 159 ETEACDWWSLGAILFELLTGK---------TLVECHPSGINTHTTLNIPEWVSEEARSLL 209

Query: 113 PRMLIVDPMKRI-----TIPEIRQHPWF 135
            ++L  +P +R+      + +I+ HP+F
Sbjct: 210 QQLLQFNPTERLGAGVAGVEDIKSHPFF 237

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 58.4 bits (141), Expect = 9e-10
 Identities = 31/111 (27%), Positives = 58/111 (52%), Gaps = 6/111 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     VK++DFG++  + D  +  +S G+     +++PEV S   Y+
Sbjct: 121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TSSTGTKFPVKWSSPEVFSFSKYS 179

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA 108
             + DVWS GV+++ +   G  P+++ +   + + I  G       L+  +
Sbjct: 180 S-KSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQS 229

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 47/138 (34%), Positives = 66/138 (47%), Gaps = 8/138 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 60
           +HRD+K  N+LL ++  VK+ DFG+S  +        TS G+P + APEVI+ +      
Sbjct: 146 IHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDST 205

Query: 61  ---EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
                DVWS G+    L  G  P  D   +  LFK  +    TL  P   S    D I +
Sbjct: 206 YDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRK 265

Query: 115 MLIVDPMKRITIPEIRQH 132
            L  D  KR T+ ++ QH
Sbjct: 266 CLTKDYEKRPTVSDLLQH 283

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 46/176 (26%), Positives = 68/176 (38%), Gaps = 46/176 (26%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--------CGSPNYAAPEVIS 53
           V HRDLKP+N+L ++   +KI DFGL+ +     F  T           +  Y APE + 
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARV----AFNDTPTAIFWTDYVATRWYRAPE-LC 178

Query: 54  GKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------- 104
           G  ++   P +D+WS G I   +L G   F  +N+ +    I   + T            
Sbjct: 179 GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE 238

Query: 105 ------------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                    P A  L+ R+L  DP  R T  E    P+F+
Sbjct: 239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 42/173 (24%), Positives = 78/173 (45%), Gaps = 40/173 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y   +
Sbjct: 121 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYT-VQ 178

Query: 62  VDVWSCGVILYALLCGTLPF---DDENIPNLF-KKIKGG--------------------- 96
            D+WS G+ L  +  G  P    D + +  +F + +  G                     
Sbjct: 179 SDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238

Query: 97  IY------------TLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           I+             LPS   S   +D + + L  +P +R  + E+ +HP+ +
Sbjct: 239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIK 291

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 3/132 (2%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL     VK+ADFG++  + D    + +  G+P + APEVI    Y   +
Sbjct: 123 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-K 181

Query: 62  VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  +   +  LF   K    TL  + S   ++ +   L  +P
Sbjct: 182 ADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 241

Query: 121 MKRITIPEIRQH 132
             R T  E+ +H
Sbjct: 242 SFRPTAKELLKH 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 44/166 (26%), Positives = 69/166 (41%), Gaps = 32/166 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           ++HRD+KPEN+L+     VK+ DFG +  +     + T    +  Y APE++ G    G 
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGR 180

Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIK------------------GGIYTLP 101
            VD+W+ G ++  +L G   F  D +I  L+  IK                       LP
Sbjct: 181 AVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240

Query: 102 S------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                         LS    DL  + L +DP  R +  ++  H +F
Sbjct: 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.4 bits (138), Expect = 4e-09
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 7/113 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 182

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
            D+WS G+ L  +  G  P     IP    K    ++  P    P   +  PR
Sbjct: 183 SDIWSMGLSLVEMAIGRYP-----IPPPDAKELELMFGCPVEGDPAESETSPR 230

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 56.3 bits (136), Expect = 5e-09
 Identities = 42/131 (32%), Positives = 63/131 (48%), Gaps = 5/131 (3%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  + D  + K S G  P  + APE I+ + +   
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSA 188

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I  G    +P +  P    L+ +    
Sbjct: 189 S-DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 247

Query: 119 DPMKRITIPEI 129
           DP KR    E+
Sbjct: 248 DPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 56.6 bits (136), Expect = 5e-09
 Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 16/145 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVI---- 52
           ++HRDLK  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+    
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCET 179

Query: 53  SGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGAR 109
           S       + DVWS G+ L  +     P  + N   +  KI K    TL  PS  S   +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D + + L  +   R T  ++ QHP+
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPF 264

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|213385 cd12200, AMPKA2_C, C-terminal regulatory domain of 5'-AMP-activated serine/threonine kinase, subunit alpha

 Score = 53.2 bits (127), Expect = 5e-09
 Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 38/128 (29%)

Query: 255 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 314
           KW LG++S++ P +IM EV +A+++L+  WK +  Y+++ R              NP+  
Sbjct: 7   KWHLGIRSQSKPYDIMAEVYRAMKQLDFEWKVVNPYHLRVR------------RKNPVTG 54

Query: 315 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFL------FLDL 368
           N+                    VK  +QLY+  +  YLLD + +     L      F ++
Sbjct: 55  NY--------------------VKMSLQLYQVDNRSYLLDFKSIDDEPRLGSHTMDFFEM 94

Query: 369 CAAFLAQL 376
           CA+ +  L
Sbjct: 95  CASLITTL 102

AMPK, a serine/threonine protein kinase (STK), catalyzes the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. It acts as a sensor for the energy status of the cell and is activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. AMPK is a heterotrimer of three subunits: alpha, beta, and gamma. Co-expression of the three subunits is required for kinase activity; in the absence of one, the other two subunits get degraded. The AMPK alpha subunit is the catalytic subunit and it contains an N-terminal kinase domain and a C-terminal regulatory domain (RD). Vertebrates contain two isoforms of the alpha subunit, alpha1 and alpha2, which are encoded by different genes, PRKAA1 and PRKAA2, respectively, and show varying expression patterns. AMPKalpha2 shows cytoplasmic and nuclear localization, whereas AMPKalpha1 is localized only in the cytoplasm. The C-terminal RD of the AMPK alpha 1 subunit is involved in AMPK heterotrimer formation. It mainly interacts with the C-terminal region of the beta subunit to form a tight alpha-beta complex that is associated with the gamma subunit. The AMPK alpha subunit RD also contains an auto-inhibitory region that interacts with the kinase domain; this inhibition is negated by the interaction with the AMPK gamma subunit. Length = 102

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 56.1 bits (135), Expect = 5e-09
 Identities = 41/151 (27%), Positives = 68/151 (45%), Gaps = 27/151 (17%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-------------SNIMRDGHFLKTSCGSPNYAA 48
           VVHRD+K  N++L     +K+ DFG              SN+++  H      G+P + A
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH------GTPYWMA 176

Query: 49  PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSH 103
           PEVI+   Y G + D+WS G  ++ +  G  P    ++  L         +G +  LP  
Sbjct: 177 PEVINESGY-GRKSDIWSIGCTVFEMATGKPPL--ASMDRLAAMFYIGAHRGLMPRLPDS 233

Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPW 134
            S  A D +   L  D  +R +  ++ +H +
Sbjct: 234 FSAAAIDFVTSCLTRDQHERPSALQLLRHDF 264

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 56.9 bits (137), Expect = 5e-09
 Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 7/133 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
           +HRDL   N+LL     VKI DFGL+ +I +D  ++ K S   P  + APE I  K+Y  
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYT- 254

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P    ++    
Sbjct: 255 TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACW 314

Query: 117 IVDPMKRITIPEI 129
             DP +R T   +
Sbjct: 315 QGDPKERPTFSAL 327

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 28/79 (35%), Positives = 48/79 (60%), Gaps = 2/79 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 182

Query: 62  VDVWSCGVILYALLCGTLP 80
            D+WS G+ L  L  G  P
Sbjct: 183 SDIWSMGLSLVELAIGRYP 201

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 55.8 bits (134), Expect = 7e-09
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 7/105 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSP-NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D   G +  +    P  + APE I+ + + 
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
               DVWS G++++ ++  G  P+ D +   + K I  G + LP+
Sbjct: 189 SAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLPA 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 45/145 (31%), Positives = 71/145 (48%), Gaps = 16/145 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGK- 55
           ++HRDLK  N+LL    ++K+ADFG+S      + R   F+    G+P + APEV+  + 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCET 186

Query: 56  LYAGP---EVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYTL--PSHLSPGAR 109
           +   P   + D+WS G+ L  +     P  + N   +  KI K    TL  PS  S   R
Sbjct: 187 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFR 246

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D +   L   P  R +  ++ +HP+
Sbjct: 247 DFLKTALDKHPETRPSAAQLLEHPF 271

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 35/103 (33%), Positives = 58/103 (56%), Gaps = 6/103 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG--SP-NYAAPEVISGKLYAG 59
           VHRDL   N+L++S    K++DFGLS  + D     T+ G   P  + APE I+ + +  
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT- 186

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
              DVWS G++++ ++  G  P+ D +  ++ K ++ G Y LP
Sbjct: 187 SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDG-YRLP 228

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 27/85 (31%), Positives = 47/85 (55%), Gaps = 6/85 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
            +HRDL   N L+     VK++DFGL+  + D  +  +S G+     +A PEV     ++
Sbjct: 121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFS 179

Query: 59  GPEVDVWSCGVILYALL-CGTLPFD 82
             + DVWS GV+++ +   G +P++
Sbjct: 180 S-KSDVWSFGVLMWEVFSEGKMPYE 203

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 29/76 (38%), Positives = 47/76 (61%), Gaps = 5/76 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           VHRDL   N+L++S+  VKI DFGL+ ++   ++ + ++    SP +  APE ++   ++
Sbjct: 130 VHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFS 189

Query: 59  GPEVDVWSCGVILYAL 74
               DVWS GV+LY L
Sbjct: 190 -VASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 47/176 (26%), Positives = 73/176 (41%), Gaps = 50/176 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA---------PEVI 52
           ++HRDLKP+NLL+     +K+ADFGL+           S  S  Y++         P+V+
Sbjct: 124 ILHRDLKPQNLLISYLGELKLADFGLAR--------AKSIPSQTYSSEVVTLWYRPPDVL 175

Query: 53  SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG-----------GIYTL 100
            G       +D+W  G I   +L G   F    ++    +KI             G+  L
Sbjct: 176 LGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235

Query: 101 PSH-------------------LS--PGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           P++                   LS  P A DL  +ML++ P  RI+  +   HP+F
Sbjct: 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 43/180 (23%), Positives = 74/180 (41%), Gaps = 39/180 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           V+HRDLKP+NLL++ +  +K+ADFGL+        + T   S       Y  P+V+ G  
Sbjct: 125 VLHRDLKPQNLLINERGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGSS 180

Query: 57  YAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGI 97
               ++D+W  G I + +  G   F                    +E  P +    +   
Sbjct: 181 EYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKN 240

Query: 98  YTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           Y  P +           L     +L+ + L  +  KRI+  E  +H +F++   R  ++P
Sbjct: 241 YNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGTRIHSLP 300

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 46/127 (36%), Positives = 65/127 (51%), Gaps = 7/127 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
           VHRDL   N+LL     VKI DFGL+ +IM D +++ K S   P  + APE I   LY  
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRML 116
              DVWS G++L+ +   G  P+    + + F  KIK G     P H +    D++ +  
Sbjct: 319 LS-DVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCW 377

Query: 117 IVDPMKR 123
             +P KR
Sbjct: 378 NSEPEKR 384

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 45/139 (32%), Positives = 71/139 (51%), Gaps = 13/139 (9%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
           +HRDL   N+LL     VKI DFGL+ +I +D  ++ K     P  + APE I  ++Y  
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT- 259

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P   ++   ML
Sbjct: 260 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTP---EMYQTML 316

Query: 117 IV---DPMKRITIPEIRQH 132
                +P +R T  E+ +H
Sbjct: 317 DCWHGEPSQRPTFSELVEH 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 53.5 bits (128), Expect = 4e-08
 Identities = 50/168 (29%), Positives = 75/168 (44%), Gaps = 35/168 (20%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAG 59
           +VHRD+KPENLL+     +K+ DFG +  + +G     +    +  Y +PE++ G  Y G
Sbjct: 121 IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-G 179

Query: 60  PEVDVWSCGVILYALLCGTLPFDDEN-IPNLF--KKIKGGI--------YTLP------- 101
             VD+WS G IL  L  G   F  E+ I  LF  +K+ G +        Y+ P       
Sbjct: 180 KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF 239

Query: 102 ---SH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
              +H           LS    DL+  +L ++P  R    +   HP F
Sbjct: 240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 54.2 bits (130), Expect = 5e-08
 Identities = 43/119 (36%), Positives = 64/119 (53%), Gaps = 9/119 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
           VHRDL   N+L+     VKI DFGL+ +IMRD +++ K S   P  + APE I   LY  
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTT 320

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL--PSHLSPGARDLIPR 114
              DVWS G++L+ +   G  P+ +  +   F   IK G Y +  P+H S    +++ +
Sbjct: 321 LS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG-YRMAKPAHASDEIYEIMQK 377

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 53.1 bits (127), Expect = 6e-08
 Identities = 41/134 (30%), Positives = 65/134 (48%), Gaps = 6/134 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+  K  +KI+DFG+S    DG +  T         + APE ++   Y+ 
Sbjct: 116 IHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSS 175

Query: 60  PEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGA-RDLIPRMLI 117
            E DVWS G++L+ A   G +P+ + +     + I+ G+      L P A   L+ R   
Sbjct: 176 -ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWE 234

Query: 118 VDPMKRITIPEIRQ 131
            DP +R +   + Q
Sbjct: 235 YDPGQRPSFSTVHQ 248

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 53.0 bits (127), Expect = 6e-08
 Identities = 35/112 (31%), Positives = 61/112 (54%), Gaps = 8/112 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSP-NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D     +       P  + APE I+ + + 
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS-PGA 108
               DVWS G++++ ++  G  P+ + +  ++ K I+ G Y LP+ +  P A
Sbjct: 188 SAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAA 237

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 52.8 bits (127), Expect = 7e-08
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDEN---IPNLFKK 92
             + DVWS GV ++ L+  G  P++      IP+L +K
Sbjct: 190 H-KSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.4 bits (128), Expect = 7e-08
 Identities = 46/135 (34%), Positives = 68/135 (50%), Gaps = 7/135 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYAG 59
           +HRDL   N+LL      KI DFGL+ +I  D ++ +K +   P  + APE I   +Y  
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRML 116
            E DVWS G++L+ +   G+ P+    + + F K IK G   L P        D++    
Sbjct: 296 -ESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCW 354

Query: 117 IVDPMKRITIPEIRQ 131
             DP+KR T  +I Q
Sbjct: 355 DADPLKRPTFKQIVQ 369

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 53.0 bits (127), Expect = 7e-08
 Identities = 42/134 (31%), Positives = 68/134 (50%), Gaps = 8/134 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
           +VHRDL   N+L+     +KI+DFGLS ++  +  ++K S G     + A E +   +Y 
Sbjct: 148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT 207

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS GV+L+ ++  G  P+       LF  +K G Y +  P + S    +L+   
Sbjct: 208 -TQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTG-YRMERPENCSEEMYNLMLTC 265

Query: 116 LIVDPMKRITIPEI 129
              +P KR T  +I
Sbjct: 266 WKQEPDKRPTFADI 279

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 31/108 (28%), Positives = 57/108 (52%), Gaps = 6/108 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+ S   VK++DFG++  + D  +  +S G+     ++ PEV +   Y+ 
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSS 180

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 106
            + DVWS GV+++ +   G +PF+ ++   + + I  G       L+ 
Sbjct: 181 -KSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLAS 227

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.6 bits (126), Expect = 1e-07
 Identities = 34/78 (43%), Positives = 44/78 (56%), Gaps = 7/78 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNY-AAPE-VISGKLY 57
           VHRDL   N+L++S+  VKI DFGL+  +      + +K    SP +  APE +I  K Y
Sbjct: 131 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFY 190

Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 191 IAS--DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 38/160 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTS---------------C 41
           V+HRDLKP+N+LL     V I D+G + I +         +                   
Sbjct: 134 VLHRDLKPDNILLGLFGEVVILDWGAA-IFKKLEEEDLLDIDVDERNICYSSMTIPGKIV 192

Query: 42  GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYT 99
           G+P+Y APE + G   A    D+++ GVILY +L  + P+  +      +KI  +  I +
Sbjct: 193 GTPDYMAPERLLGV-PASESTDIYALGVILYQMLTLSFPYRRKK----GRKISYRDVILS 247

Query: 100 LPSHLSPGARDLIP-------RMLIVDPMKRI-TIPEIRQ 131
            P  ++P  R++ P       + L VDP +R  ++ E++Q
Sbjct: 248 -PIEVAP-YREIPPFLSQIAMKALAVDPAERYSSVQELKQ 285

Length = 932

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 41/169 (24%), Positives = 67/169 (39%), Gaps = 39/169 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           ++HRDLKP+NLL++ K  +K+ADFGL+        + T   S       Y  P+V+ G  
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLAR----AKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 57  YAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGI 97
                +D+W  G ILY +  G   F                    +E  P +    +   
Sbjct: 180 EYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRS 239

Query: 98  YTLPSHLSPGARDLIPR-----------MLIVDPMKRITIPEIRQHPWF 135
           Y  P + +    +  PR           +L+ +   RI+     +H +F
Sbjct: 240 YLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 33/107 (30%), Positives = 59/107 (55%), Gaps = 6/107 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+D +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFSS 180

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 105
            + DVW+ GV+++ +   G +P++  N     +K+  G+     HL+
Sbjct: 181 -KSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 37/101 (36%), Positives = 55/101 (54%), Gaps = 11/101 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGS--PNYAAPEVISGKL 56
           +HRDL   N+L+     +KIADFGL+   RD H    + KT+ G     + APE +  ++
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLA---RDVHNIDYYKKTTNGRLPVKWMAPEALFDRV 212

Query: 57  YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 213 YTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 51.6 bits (123), Expect = 2e-07
 Identities = 35/98 (35%), Positives = 55/98 (56%), Gaps = 5/98 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
           +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y  
Sbjct: 162 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTH 221

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
            + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 222 -QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 258

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 37/99 (37%), Positives = 54/99 (54%), Gaps = 6/99 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
           +HRDL   N+LL     VKI DFGL+ +I +D  ++ K     P  + APE I  K+Y  
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYT- 253

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGG 96
            + DVWS GV+L+ +   G  P+    I   F +++K G
Sbjct: 254 TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEG 292

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 51.4 bits (123), Expect = 2e-07
 Identities = 34/137 (24%), Positives = 59/137 (43%), Gaps = 10/137 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N +L     V +ADFGLS  +  G + +    +     + A E ++ ++Y  
Sbjct: 135 IHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT- 193

Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 115
            + DVW+ GV ++ +   G  P+   ++  I +      G     P        DL+   
Sbjct: 194 SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL--RHGNRLKQPEDCLDELYDLMYSC 251

Query: 116 LIVDPMKRITIPEIRQH 132
              DP  R T  ++R+ 
Sbjct: 252 WRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|213384 cd12199, AMPKA1_C, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha 1 catalytic subunit

 Score = 48.2 bits (114), Expect = 3e-07
 Identities = 31/126 (24%), Positives = 52/126 (41%), Gaps = 36/126 (28%)

Query: 255 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 314
           KW LG++S++ P +IM EV +A+++L+  WK +  Y ++ R              NP+ S
Sbjct: 3   KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVR------------RKNPVTS 50

Query: 315 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ----GPQFLFLDLCA 370
                                  K  +QLY+     YLLD + +          F ++CA
Sbjct: 51  TF--------------------SKMSLQLYQVDSRTYLLDFRSIDDEITSHTIEFFEMCA 90

Query: 371 AFLAQL 376
             +  L
Sbjct: 91  NLIKIL 96

AMPK, a serine/threonine protein kinase (STK), catalyzes the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. It acts as a sensor for the energy status of the cell and is activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. AMPK is a heterotrimer of three subunits: alpha, beta, and gamma. Co-expression of the three subunits is required for kinase activity; in the absence of one, the other two subunits get degraded. The AMPK alpha subunit is the catalytic subunit and it contains an N-terminal kinase domain and a C-terminal regulatory domain (RD). Vertebrates contain two isoforms of the alpha subunit, alpha1 and alpha2, which are encoded by different genes, PRKAA1 and PRKAA2, respectively, and show varying expression patterns. AMPKalpha1 is the predominant isoform expressed in bone; it plays a role in bone remodeling in response to hormonal regulation. It is selectively regulated by nucleoside diphosphate kinase (NDPK)-A in an AMP-independent manner. AMPKalpha1 impacts the regulation of fat metabolism through its in vivo target, acetyl coenzyme A carboxylase (ACC). It also mediates the vasoprotective effects of estrogen through phosphorylation of another in vivo substrate, RhoA. The C-terminal RD of the AMPK alpha 1 subunit is involved in AMPK heterotrimer formation. It mainly interacts with the C-terminal region of the beta subunit to form a tight alpha-beta complex that is associated with the gamma subunit. The AMPK alpha subunit RD also contains an auto-inhibitory region that interacts with the kinase domain; this inhibition is negated by the interaction with the AMPK gamma subunit. Length = 96

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 50.8 bits (122), Expect = 3e-07
 Identities = 41/135 (30%), Positives = 63/135 (46%), Gaps = 11/135 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGS-P-NYAAPEVIS-GKLY 57
           VHRDL   N+LL ++   KI+DFG+S  +  G  ++  T+ G  P  + APE I+ GK  
Sbjct: 117 VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS 176

Query: 58  AGPEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
           +  + DVWS GV L+ A   G  P+ +     +   ++ G   L  P         ++  
Sbjct: 177 S--KSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESG-ERLPRPEECPQEIYSIMLS 233

Query: 115 MLIVDPMKRITIPEI 129
                P  R T  E+
Sbjct: 234 CWKYRPEDRPTFSEL 248

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 28/77 (36%), Positives = 38/77 (49%), Gaps = 6/77 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVI-SGKLY 57
            VHRDL   N L+     VKI+DFGLS  +    + +    S     +  PE I  GK  
Sbjct: 145 FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF- 203

Query: 58  AGPEVDVWSCGVILYAL 74
              E D+WS GV+L+ +
Sbjct: 204 -TTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 38/101 (37%), Positives = 56/101 (55%), Gaps = 11/101 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGS-P-NYAAPEVISGKL 56
           +HRDL   N+L+     +KIADFGL+   RD H    + KT+ G  P  + APE +  ++
Sbjct: 154 IHRDLAARNVLVTEDHVMKIADFGLA---RDIHHIDYYRKTTNGRLPVKWMAPEALFDRV 210

Query: 57  YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 211 YTH-QSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 5/98 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
           +HRDL   N+L+     +KIADFGL+ ++    ++ KT+ G     + APE +  ++Y  
Sbjct: 159 IHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTH 218

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
            + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 219 -QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 50.5 bits (120), Expect = 5e-07
 Identities = 43/175 (24%), Positives = 70/175 (40%), Gaps = 36/175 (20%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLKP+NLL+     +K+ADFGL+       H       +  Y  P+V+ G      
Sbjct: 124 ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYST 183

Query: 61  EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKI-----------KGGIYTLPSHLSP-- 106
            +D+W  G I   ++ G   F   ++I +  ++I             G+++LP H  P  
Sbjct: 184 CLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP-HFKPER 242

Query: 107 --------------------GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 141
                                A DL  ++L   P  R++      H +F    PR
Sbjct: 243 FTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 50.6 bits (121), Expect = 5e-07
 Identities = 29/71 (40%), Positives = 44/71 (61%), Gaps = 9/71 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYA 58
           +HRD+K  N+LL     VK+ADFG ++++   +   +  G+P + APEVI     G+ Y 
Sbjct: 137 IHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMAPEVILAMDEGQ-YD 192

Query: 59  GPEVDVWSCGV 69
           G +VDVWS G+
Sbjct: 193 G-KVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.3 bits (122), Expect = 6e-07
 Identities = 36/115 (31%), Positives = 52/115 (45%), Gaps = 21/115 (18%)

Query: 2   VVHRDLKPENLLLDSKWN-----------------VKIADFGLSNIMRDGHFLKTSCGSP 44
           V+HRDLKP+N+ L +                     KI DFGLS  +       +  G+P
Sbjct: 146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTP 205

Query: 45  NYAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGG 96
            Y +PE++    K Y   + D+W+ G I+Y L  G  PF    N   L  ++K G
Sbjct: 206 YYWSPELLLHETKSY-DDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRG 259

Length = 1021

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.6 bits (121), Expect = 6e-07
 Identities = 24/75 (32%), Positives = 42/75 (56%), Gaps = 3/75 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+K EN+ ++    V I D G +   +    FL  + G+    APEV++   Y   
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA-GTVETNAPEVLARDKY-NS 235

Query: 61  EVDVWSCGVILYALL 75
           + D+WS G++L+ +L
Sbjct: 236 KADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 50.0 bits (119), Expect = 6e-07
 Identities = 31/102 (30%), Positives = 56/102 (54%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 125 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-I 183

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++LY ++  G +P+   +  ++   ++ G Y +P
Sbjct: 184 KSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMP 224

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 47/184 (25%), Positives = 72/184 (39%), Gaps = 40/184 (21%)

Query: 2   VVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRDLKP+NLL+D   + +K+ DFG +  +  G    +   S  Y APE++ G      
Sbjct: 191 ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTT 250

Query: 61  EVDVWSCGVIL------YALLCGTLPFD-------------------------DENIPNL 89
            +D+WS G I+      Y +  G    D                         D   P++
Sbjct: 251 HIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDV 310

Query: 90  FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA------HLPRYL 143
             K K      P      A + I + L  +P+KR+   E    P+F         LP+Y+
Sbjct: 311 --KPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRDPCIKLPKYI 368

Query: 144 AVPP 147
              P
Sbjct: 369 DKLP 372

Length = 440

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 49.5 bits (118), Expect = 9e-07
 Identities = 36/137 (26%), Positives = 61/137 (44%), Gaps = 10/137 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
            +HRDL   N +L+    V +ADFGLS  +  G + +  C S     + A E ++  +Y 
Sbjct: 134 FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYT 193

Query: 59  GPEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
               DVW+ GV ++ ++  G  P+   ++  I N    IKG     P        +L+ +
Sbjct: 194 -THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL--IKGNRLKQPPDCLEDVYELMCQ 250

Query: 115 MLIVDPMKRITIPEIRQ 131
               +P  R +   +R 
Sbjct: 251 CWSPEPKCRPSFQHLRD 267

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 49.6 bits (118), Expect = 9e-07
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 9/89 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL     VK+ DFG+S  + R      T  G+P + APEVI+      P
Sbjct: 142 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD--ENP 199

Query: 61  EV------DVWSCGVILYALLCGTLPFDD 83
           +       D+WS G+    +  G  P  D
Sbjct: 200 DATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 49.3 bits (117), Expect = 1e-06
 Identities = 31/102 (30%), Positives = 57/102 (55%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+ +    KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 124 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-I 182

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 223

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 25/87 (28%), Positives = 44/87 (50%), Gaps = 12/87 (13%)

Query: 2   VVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTS--------CGSPNYAAPE 50
           +VHRDLKP+N+++     + + K+ DFG+  ++        +         G+P Y APE
Sbjct: 100 IVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPE 159

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCG 77
            + G+    P  D+++ G+I    L G
Sbjct: 160 QLRGEPVT-PNSDLYAWGLIFLECLTG 185

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 49.7 bits (118), Expect = 1e-06
 Identities = 50/174 (28%), Positives = 77/174 (44%), Gaps = 30/174 (17%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLY 57
           ++HRD+K  N+LL     VK+ADFG ++I    +   +  G+P + APEVI     G+ Y
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPEVILAMDEGQ-Y 201

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK-KIKGGIYTLPSHLSPGA-------- 108
            G +VDVWS G+    L         E  P LF       +Y +  + SP          
Sbjct: 202 DG-KVDVWSLGITCIELA--------ERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDY 252

Query: 109 -RDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEI 161
            R+ +   L   P  R T  E+ +H +     P  + +   D +Q+ K    E+
Sbjct: 253 FRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETVLI---DLIQRTKDAVREL 303

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 49.2 bits (118), Expect = 1e-06
 Identities = 25/77 (32%), Positives = 38/77 (49%), Gaps = 7/77 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAG 59
            +HRDL   N+L+      KIADFGL+ ++ D  +  +     P  + APE      Y  
Sbjct: 124 YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAA---NYGR 180

Query: 60  PEV--DVWSCGVILYAL 74
             +  DVWS G++L  +
Sbjct: 181 FTIKSDVWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 49.2 bits (117), Expect = 1e-06
 Identities = 33/98 (33%), Positives = 55/98 (56%), Gaps = 5/98 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGS--PNYAAPEVISGKLYAG 59
           +HRDL   N+L+     +KIADFGL+  + D  ++ KTS G     + APE +  ++Y  
Sbjct: 156 IHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTH 215

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
            + DVWS G++++ +   G  P+    +  LFK ++ G
Sbjct: 216 -QSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG 252

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 31/89 (34%), Positives = 47/89 (52%), Gaps = 7/89 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD  + VK+ADFGL+  + D  +      T    P  + A E +  + +
Sbjct: 120 VHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF 179

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDEN 85
              + DVWS GV+L+ L+  G  P+ D +
Sbjct: 180 T-TKSDVWSFGVLLWELMTRGAPPYPDVD 207

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 48.5 bits (116), Expect = 2e-06
 Identities = 47/176 (26%), Positives = 69/176 (39%), Gaps = 50/176 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYA---------APEVI 52
           V+HRDLKP+NLL+  +  +K+ADFGL+           S  S  Y+          P+V+
Sbjct: 124 VLHRDLKPQNLLISERGELKLADFGLAR--------AKSVPSKTYSNEVVTLWYRPPDVL 175

Query: 53  SGKLYAGPEVDVWSCGVILYALLCGTLPF--------------------DDENIPNL--- 89
            G       +D+W  G I Y +  G   F                     +E  P +   
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235

Query: 90  --FKKIKGGIYT---LPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
             FK      Y    L +H       P   +L  + L  +P KRI+  E  +HP+F
Sbjct: 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 47.9 bits (114), Expect = 2e-06
 Identities = 31/102 (30%), Positives = 55/102 (53%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 182

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  ++  G +P+     P + + ++ G Y +P
Sbjct: 183 KSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMP 223

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|201355 pfam00627, UBA, UBA/TS-N domain

 Score = 43.2 bits (103), Expect = 3e-06
 Identities = 13/37 (35%), Positives = 22/37 (59%)

Query: 157 IDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYL 193
           IDEE++K++ +MGF + +  ++LR    N      YL
Sbjct: 1   IDEELIKQLREMGFSREEAKKALRATNGNVERAVEYL 37

This small domain is composed of three alpha helices. This family includes the previously defined UBA and TS-N domains. The UBA-domain (ubiquitin associated domain) is a novel sequence motif found in several proteins having connections to ubiquitin and the ubiquitination pathway. The structure of the UBA domain consists of a compact three helix bundle. This domain is found at the N terminus of EF-TS hence the name TS-N. The structure of EF-TS is known and this domain is implicated in its interaction with EF-TU. The domain has been found in non EF-TS proteins such as alpha-NAC and MJ0280. Length = 37

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 42/136 (30%), Positives = 69/136 (50%), Gaps = 9/136 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYAG 59
           +HRD+   N+LL      KI DFGL+ +IM D ++ +K +   P  + APE I   +Y  
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYT- 292

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL--PSHLSPGARDLIPRM 115
            + DVWS G++L+ +   G  P+    + + F K +K G Y +  P    P    ++   
Sbjct: 293 VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRG-YQMSRPDFAPPEIYSIMKMC 351

Query: 116 LIVDPMKRITIPEIRQ 131
             ++P +R T  +I Q
Sbjct: 352 WNLEPTERPTFSQISQ 367

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 32/78 (41%), Positives = 42/78 (53%), Gaps = 7/78 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNY-AAPEVI-SGKLY 57
           +HRDL   N+LLD+   VKI DFGL+  + +GH    ++    SP +  A E +   K  
Sbjct: 129 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFS 188

Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 189 YAS--DVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 3e-06
 Identities = 25/74 (33%), Positives = 44/74 (59%), Gaps = 4/74 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           ++HRD+K EN+L++   ++ + DFG +   R      F     G+ +  APEV++G  Y 
Sbjct: 281 IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT 340

Query: 59  GPEVDVWSCGVILY 72
            P VD+WS G++++
Sbjct: 341 -PSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 47.6 bits (113), Expect = 3e-06
 Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 8/88 (9%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-----P-NYAAPEVISGKL 56
           VHRDL   N+L++S    K++DFGLS  + D     T   S     P  + APE I+ + 
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK 187

Query: 57  YAGPEVDVWSCGVILYALLC-GTLPFDD 83
           +     DVWS G++++ ++  G  P+ D
Sbjct: 188 FTSAS-DVWSYGIVMWEVMSYGERPYWD 214

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 47.4 bits (112), Expect = 4e-06
 Identities = 43/146 (29%), Positives = 66/146 (45%), Gaps = 20/146 (13%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL    +VK+ADFG+S  I       K+  G+P + APEV + +   G  
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYN 187

Query: 62  --VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARD-------- 110
              D+W+ G+    L     P FD   +  LF      + T  +   P  +D        
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALF------LMTKSNFQPPKLKDKMKWSNSF 241

Query: 111 --LIPRMLIVDPMKRITIPEIRQHPW 134
              +   L  +P KR T  ++ QHP+
Sbjct: 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 47.4 bits (112), Expect = 5e-06
 Identities = 30/72 (41%), Positives = 43/72 (59%), Gaps = 9/72 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLY 57
           ++HRD+K  N+LL     VK+ DFG ++IM   +      G+P + APEVI     G+ Y
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPEVILAMDEGQ-Y 191

Query: 58  AGPEVDVWSCGV 69
            G +VDVWS G+
Sbjct: 192 DG-KVDVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 47.0 bits (112), Expect = 6e-06
 Identities = 39/134 (29%), Positives = 61/134 (45%), Gaps = 10/134 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VHRDL   N ++     VKI DFG++ +I    ++ K   G  P  + APE +   ++  
Sbjct: 141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT- 199

Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 115
            + DVWS GV+L+ +      P+    +E +      I GG   LP +      +L+   
Sbjct: 200 TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV--IDGGHLDLPENCPDKLLELMRMC 257

Query: 116 LIVDPMKRITIPEI 129
              +P  R T  EI
Sbjct: 258 WQYNPKMRPTFLEI 271

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 47.3 bits (112), Expect = 6e-06
 Identities = 29/71 (40%), Positives = 42/71 (59%), Gaps = 9/71 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYA 58
           +HRD+K  N+LL     VK+ADFG ++     +   +  G+P + APEVI     G+ Y 
Sbjct: 143 IHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPEVILAMDEGQ-YD 198

Query: 59  GPEVDVWSCGV 69
           G +VDVWS G+
Sbjct: 199 G-KVDVWSLGI 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 46.9 bits (111), Expect = 7e-06
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGS-P-NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +   D ++   S G  P  + APE I+ + ++
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 59  GPEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 96
               DVWS G+ ++ A   G  P+     P +   I+ G
Sbjct: 177 S-RSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG 214

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 46.7 bits (111), Expect = 7e-06
 Identities = 39/135 (28%), Positives = 59/135 (43%), Gaps = 8/135 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPE-VISGKLYA 58
           VHRDL   N L+     VKI DFG+S  +   D + +      P  +  PE ++  K   
Sbjct: 144 VHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTT 203

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP-GARDLIPRML 116
             E DVWS GV+L+ +   G  P+   +   + + I  G         P    D++    
Sbjct: 204 --ESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCW 261

Query: 117 IVDPMKRITIPEIRQ 131
             DP +RI I +I +
Sbjct: 262 KRDPQQRINIKDIHE 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 24/80 (30%), Positives = 46/80 (57%), Gaps = 7/80 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+K EN+ ++   +V + DFG +    +I  + ++     G+    APE+++   Y
Sbjct: 203 IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYY--GWAGTIATNAPELLARDPY 260

Query: 58  AGPEVDVWSCGVILYALLCG 77
            GP VD+WS G++L+ +   
Sbjct: 261 -GPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|197551 smart00165, UBA, Ubiquitin associated domain

 Score = 42.1 bits (100), Expect = 8e-06
 Identities = 13/37 (35%), Positives = 23/37 (62%)

Query: 158 DEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLL 194
           DEE + ++++MGF + + +++LR    N    A YLL
Sbjct: 1   DEEKIDQLLEMGFSREEALKALRAANGNVERAAEYLL 37

Present in Rad23, SNF1-like kinases. The newly-found UBA in p62 is known to bind ubiquitin. Length = 37

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 46.5 bits (110), Expect = 9e-06
 Identities = 33/133 (24%), Positives = 68/133 (51%), Gaps = 9/133 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++  +
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TK 179

Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 118
            DVWS G++L+ +   G +P+    + ++  +++ G Y +  P    P   D++ +   +
Sbjct: 180 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCWHL 238

Query: 119 DPMKRITIPEIRQ 131
           D   R +  ++R+
Sbjct: 239 DAATRPSFLQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 46.2 bits (109), Expect = 1e-05
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 9/89 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL     VK+ DFG+S  + R      T  G+P + APEVI+      P
Sbjct: 132 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD--ENP 189

Query: 61  EV------DVWSCGVILYALLCGTLPFDD 83
           +       D+WS G+    +  G  P  D
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 4/107 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDL   N+L+      K++DFGL+ +   G  +  S     + APE +  K ++  +
Sbjct: 121 LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSS-K 177

Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 107
            DVWS GV+L+ +   G  P+   ++  + + ++ G    P    P 
Sbjct: 178 SDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA 224

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 37/129 (28%), Positives = 65/129 (50%), Gaps = 9/129 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 124 IHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 182

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS G++L  L+  G +P+   N   + ++++ G Y +  P        +L+ +  
Sbjct: 183 -KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQCW 240

Query: 117 IVDPMKRIT 125
             DP +R T
Sbjct: 241 KKDPEERPT 249

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 33/104 (31%), Positives = 52/104 (50%), Gaps = 6/104 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           V+H+D+   N ++D +  VKI D  LS  +   D H L  +   P  + A E +  K Y+
Sbjct: 138 VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS 197

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS GV+L+ L+  G  P+ + +   +   +K G Y L 
Sbjct: 198 SAS-DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDG-YRLA 239

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 45.9 bits (109), Expect = 1e-05
 Identities = 37/134 (27%), Positives = 65/134 (48%), Gaps = 9/134 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
            VHRDL   N+L+      K++DFGL+     G     S   P  + APE +  K ++  
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ---DSGKLPVKWTAPEALREKKFST- 178

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           + DVWS G++L+ +   G +P+    + ++   ++ G Y +  P    P    ++     
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKDCWE 237

Query: 118 VDPMKRITIPEIRQ 131
           +DP KR T  ++R+
Sbjct: 238 LDPAKRPTFKQLRE 251

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 14/29 (48%), Positives = 25/29 (86%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI 30
           ++HRDLKP+N+L+ ++ ++K+ DFGLS +
Sbjct: 125 IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 6/106 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPNYAAPEVISGKLY 57
           ++HRD+K EN+ LD   N  + DFG +  + D H     C    G+    +PE+++   Y
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAACKL-DAHPDTPQCYGWSGTLETNSPELLALDPY 264

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 103
              + D+WS G++L+ +    +    + + +   +++  I  +  H
Sbjct: 265 CA-KTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309

Length = 392

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 37/134 (27%), Positives = 66/134 (49%), Gaps = 7/134 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M    +   +    P  + APE ++   ++  
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI- 184

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           + DVW+ GV+L+ +   G  P+   ++  +++ ++ G Y +  P    P   +L+     
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRACWQ 243

Query: 118 VDPMKRITIPEIRQ 131
            +P  R +  EI Q
Sbjct: 244 WNPSDRPSFAEIHQ 257

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|238116 cd00194, UBA, Ubiquitin Associated domain

 Score = 40.5 bits (96), Expect = 2e-05
 Identities = 12/37 (32%), Positives = 22/37 (59%)

Query: 158 DEEILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLL 194
           DEE L+++++MGF + +  ++LR    N      +LL
Sbjct: 1   DEEKLEQLLEMGFSREEARKALRATNNNVERAVEWLL 37

The UBA domain is a commonly occurring sequence motif in some members of the ubiquitination pathway, UV excision repair proteins, and certain protein kinases. Although its specific role is so far unknown, it has been suggested that UBA domains are involved in conferring protein target specificity. The domain, a compact three helix bundle, has a conserved GFP-loop and the proline is thought to be critical for binding. The UBA domain is distinct from the conserved three helical domain seen in the N-terminus of EF-TS and eukaryotic NAC proteins. Length = 38

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 44.8 bits (106), Expect = 3e-05
 Identities = 26/74 (35%), Positives = 38/74 (51%), Gaps = 6/74 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLYA 58
           +HRDL   N L+     +KI+DFG+S     G +   S G       + APE ++   Y 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSREEEGGIY-TVSDGLKQIPIKWTAPEALNYGRYT 173

Query: 59  GPEVDVWSCGVILY 72
             E DVWS G++L+
Sbjct: 174 S-ESDVWSYGILLW 186

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 41/147 (27%), Positives = 64/147 (43%), Gaps = 23/147 (15%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPE-VISGKLYA 58
           VHRDL   N L+ + + +KIADFG+S  +  G + +    +     + A E ++ GK   
Sbjct: 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTT 210

Query: 59  GPEVDVWSCGVILYAL--LCGTLPF----DDENIPN---LFKKIKGGIYTLPSHLSPGAR 109
               DVW+ GV L+ +  LC   P+    D++ I N    F+     IY   + L P   
Sbjct: 211 AS--DVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSP- 267

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                  +   M R    +I+  P F 
Sbjct: 268 -------VFKLMMRCWSRDIKDRPTFN 287

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 38/141 (26%), Positives = 58/141 (41%), Gaps = 16/141 (11%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP----NYAAPEVISGKLYA 58
           VHRDL   N L+   + +KIADFG+S  +    + +   G       + A E +    + 
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQ-GRAPLPIRWMAWESVLLGKFT 210

Query: 59  GPEVDVWSCGVILYAL--LCGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSP-GA 108
             + DVW+ GV L+ +  LC   P++        EN  + F+     IY       P   
Sbjct: 211 -TKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDI 269

Query: 109 RDLIPRMLIVDPMKRITIPEI 129
            +L+      D   R T  EI
Sbjct: 270 YELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 44.4 bits (105), Expect = 4e-05
 Identities = 30/78 (38%), Positives = 38/78 (48%), Gaps = 10/78 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAPEVISGKL 56
           VHRDL   N L+     VKIADFGLS  +    + K    S N      +  PE I    
Sbjct: 152 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK---ASENDAIPIRWMPPESIFYNR 208

Query: 57  YAGPEVDVWSCGVILYAL 74
           Y   E DVW+ GV+L+ +
Sbjct: 209 YT-TESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 44.7 bits (105), Expect = 4e-05
 Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 55/189 (29%)

Query: 2   VVHRDLKPENLLL----DSKWNVKIADFGLSNI----MRDGHFLKTSCGSPNYAAPEVIS 53
           V+HRDLKP N+L+      +  VKIAD G + +    ++    L     +  Y APE++ 
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188

Query: 54  GKLYAGPEVDVWSCGVILYALLCG-------------TLPFDDENIPNLFK-------KI 93
           G  +    +D+W+ G I   LL               + P+  + +  +F        K 
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 248

Query: 94  KGGIYTLPSH-------------------------LSPGAR--DLIPRMLIVDPMKRITI 126
              I  +P H                         + P ++   L+ ++L +DP+KRIT 
Sbjct: 249 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 308

Query: 127 PEIRQHPWF 135
            +  Q P+F
Sbjct: 309 EQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 44.3 bits (104), Expect = 4e-05
 Identities = 33/134 (24%), Positives = 62/134 (46%), Gaps = 6/134 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N +L+   NV +ADFGLS  + +G + +    +     + A E ++ ++Y  
Sbjct: 134 IHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT- 192

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYTLPSHLSPGARDLIPRMLI 117
            + DVWS GV ++ +   G  P+       ++  ++ G     P     G   L+    +
Sbjct: 193 TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWL 252

Query: 118 VDPMKRITIPEIRQ 131
           ++P  R +   +R 
Sbjct: 253 LNPKDRPSFETLRC 266

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 44.7 bits (105), Expect = 5e-05
 Identities = 46/173 (26%), Positives = 77/173 (44%), Gaps = 11/173 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 189

Query: 59  GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
             + DVWS GV ++ L+  G  P+D      IP+L +  KG     P   +     ++ +
Sbjct: 190 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLE--KGERLPQPPICTIDVYMVMVK 246

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLP-RYLAVPPPDTMQQAKKIDEEILKEVV 166
             ++D   R    E+       A  P RYL +   D M+     D +  + ++
Sbjct: 247 CWMIDADSRPKFKELAAEFSRMARDPQRYLVIQGDDRMKLPSPNDSKFFQNLL 299

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 5/85 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++        + G      + A E I  ++Y 
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYT 189

Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 190 H-QSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 44.0 bits (104), Expect = 6e-05
 Identities = 26/82 (31%), Positives = 43/82 (52%), Gaps = 4/82 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N+L+      K+ADFGL+  I  D +  +     P  + APE      ++  
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS-I 183

Query: 61  EVDVWSCGVILYALLC-GTLPF 81
           + DVWS G++L  ++  G +P+
Sbjct: 184 KSDVWSFGILLTEIVTYGRMPY 205

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 43.5 bits (102), Expect = 8e-05
 Identities = 41/140 (29%), Positives = 61/140 (43%), Gaps = 12/140 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL    +VK+ADFG+ + I       K+  G+P + APEV + +   G  
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYN 187

Query: 62  --VDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYTLPSHL------SPGARDLI 112
              D+W+ G+    L     P FD   +  LF   K      P  L      S    + +
Sbjct: 188 QLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQ--PPKLKDKTKWSSTFHNFV 245

Query: 113 PRMLIVDPMKRITIPEIRQH 132
              L  +P KR T   +  H
Sbjct: 246 KISLTKNPKKRPTAERLLTH 265

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 31/98 (31%), Positives = 53/98 (54%), Gaps = 8/98 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHR+L   N+LL S   V+IADFG+++++   D  +  +   +P  + A E I    Y 
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 92
             + DVWS GV ++ ++  G  P+       +P+L +K
Sbjct: 190 H-QSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 43.4 bits (102), Expect = 1e-04
 Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 4/96 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           +HRDL   N+L+   +  KIADFGLS   ++ +  KT    P  + A E ++  +Y    
Sbjct: 146 IHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TN 203

Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
            DVWS GV+L+ ++  G  P+       L++K+  G
Sbjct: 204 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 239

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 33/98 (33%), Positives = 52/98 (53%), Gaps = 8/98 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ S  +VKI DFGL+ ++   +  +       P  + A E I  + + 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFT 189

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 92
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 190 H-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 42.7 bits (100), Expect = 1e-04
 Identities = 27/74 (36%), Positives = 41/74 (55%), Gaps = 7/74 (9%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----YAAPEVISGKLYA 58
           +HRDL   N L+     +KI+DFG+S    DG +  +S G       + APE ++   Y+
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY--SSSGLKQIPIKWTAPEALNYGRYS 172

Query: 59  GPEVDVWSCGVILY 72
             E DVWS G++L+
Sbjct: 173 S-ESDVWSYGILLW 185

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|213376 cd12120, AMPKA_C_like, C-terminal regulatory domain of 5'-AMP-activated protein kinase (AMPK) alpha subunit and similar domains

 Score = 40.2 bits (94), Expect = 1e-04
 Identities = 22/127 (17%), Positives = 42/127 (33%), Gaps = 39/127 (30%)

Query: 255 KWALGLQSRAHPREIMTEVLKALQELNVGWKK-----IGHYNMKCRWIPGISGHHEGMVN 309
           KW L + SR  P EI   + K L+    GW K     I ++ +  + +            
Sbjct: 3   KWELEIHSRIDPSEIYEGIHKVLE----GWGKNLVFRITNFIITGKLV------------ 46

Query: 310 NPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLC 369
                             +  +       FE+++Y+     +++D ++  G    F  L 
Sbjct: 47  ------------------NDHILFLRSTLFEIEVYEVGPGLFMVDFKKKTGSTKTFTKLA 88

Query: 370 AAFLAQL 376
                +L
Sbjct: 89  TKIQIKL 95

This family is composed of AMPKs, microtubule-associated protein/microtubule affinity regulating kinases (MARKs), yeast Kcc4p-like proteins, plant calcineurin B-Like (CBL)-interacting protein kinases (CIPKs), and similar proteins. They are serine/threonine protein kinases (STKs) that catalyze the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. AMPKs act as sensors for the energy status of the cell and are activated by cellular stresses that lead to ATP depletion such as hypoxia, heat shock, and glucose deprivation, among others. MARKs phosphorylate the tau protein and related microtubule-associated proteins (MAPs) on tubulin binding sites to induce detachment from microtubules, and are involved in the regulation of cell shape and polarity, cell cycle control, transport, and the cytoskeleton. Kcc4p and related proteins are septin-associated proteins that are involved in septin organization and in the yeast morphogenesis checkpoint coordinating the cell cycle with bud formation. CIPKs interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. All members of this family contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain which is also called kinase associated domain 1 (KA1) in some cases. The C-terminal regulatory domain serves as a protein interaction domain in AMPKs and CIPKs. In MARKs and Kcc4p-like proteins, this domain binds phospholipids and may be involved in membrane localization. Length = 95

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 24/76 (31%), Positives = 34/76 (44%), Gaps = 9/76 (11%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAPEVISGKL 56
           +HRDL   N+LL S   VKI DFGL   +             +      + APE +  + 
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM--EEHLKVPFAWCAPESLRTRT 176

Query: 57  YAGPEVDVWSCGVILY 72
           ++    DVW  GV L+
Sbjct: 177 FSHAS-DVWMFGVTLW 191

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 26/74 (35%), Positives = 42/74 (56%), Gaps = 5/74 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +  D ++ K          + APE ++   ++
Sbjct: 117 VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFS 176

Query: 59  GPEVDVWSCGVILY 72
             + DVWS GV+++
Sbjct: 177 S-KSDVWSFGVLMW 189

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 29/84 (34%), Positives = 44/84 (52%), Gaps = 8/84 (9%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE     LY   
Sbjct: 124 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYGRF 180

Query: 61  EV--DVWSCGVILYALLC-GTLPF 81
            +  DVWS G++L  L   G +P+
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 17/120 (14%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS---PNYAAPEVISGKLYAG 59
           VH+DL   N+L+  + +VKI+D GLS  +    + +    S     +  PE I    ++ 
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205

Query: 60  PEVDVWSCGVILYALLC-GTLP---FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 115
            + D+WS GV+L+ +   G  P   F ++ +  + +K           L P + D  PRM
Sbjct: 206 -DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK---------RQLLPCSEDCPPRM 255

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 29/84 (34%), Positives = 45/84 (53%), Gaps = 8/84 (9%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+      KIADFGL+ ++ D  +  +     P  + APE     LY   
Sbjct: 124 IHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPE---AALYGRF 180

Query: 61  EV--DVWSCGVILYALLC-GTLPF 81
            +  DVWS G++L  L+  G +P+
Sbjct: 181 TIKSDVWSFGILLTELVTKGRVPY 204

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 6/97 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL   N+L+      KIADFGLS    +  ++K + G     + A E ++  +Y   
Sbjct: 141 IHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPVRWMAIESLNYSVYT-T 197

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS GV+L+ ++  G  P+       L++K+  G
Sbjct: 198 KSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 234

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 49/189 (25%), Positives = 76/189 (40%), Gaps = 55/189 (29%)

Query: 2   VVHRDLKPENLLL----DSKWNVKIADFGLSNI----MRDGHFLKTSCGSPNYAAPEVIS 53
           V+HRDLKP N+L+      +  VKIAD G + +    ++    L     +  Y APE++ 
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188

Query: 54  GKLYAGPEVDVWSCGVILYALLCG-------------TLPF------------------D 82
           G  +    +D+W+ G I   LL               + PF                  D
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKD 248

Query: 83  DENI------PNLFKKIKGGIYTLPS--------HLSPGARD--LIPRMLIVDPMKRITI 126
            E+I      P L K  +   Y   S         + P ++   L+ ++L +DP KRIT 
Sbjct: 249 WEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITS 308

Query: 127 PEIRQHPWF 135
            +  Q P+F
Sbjct: 309 EQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 39/145 (26%), Positives = 62/145 (42%), Gaps = 12/145 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAG 59
           VHRDL   N ++   + VKI DFG++ +I    ++ K   G     + APE +   ++  
Sbjct: 141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT- 199

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 117
              D+WS GV+L+ +      P+   +   + K +  GG    P +      DL+     
Sbjct: 200 TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQ 259

Query: 118 VDPMKRITIPEIRQ------HPWFQ 136
            +P  R T  EI        HP F 
Sbjct: 260 FNPKMRPTFLEIVNLLKDDLHPSFP 284

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.0 bits (98), Expect = 3e-04
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 6/97 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL   N+L+   +  KIADFGLS       ++K + G     + A E ++  +Y   
Sbjct: 134 IHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIESLNYSVYT-T 190

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             DVWS GV+L+ ++  G  P+       L++K+  G
Sbjct: 191 NSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 227

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 3e-04
 Identities = 54/223 (24%), Positives = 81/223 (36%), Gaps = 81/223 (36%)

Query: 2   VVHRDLKPENLLLDSK----------------WNVKIADFGLSNIMRDGHFLKTSCGSPN 45
           ++H DLKPEN+L+++                   V+I D G      + H       + +
Sbjct: 253 LMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLG--GCCDERHSRTAIVSTRH 310

Query: 46  YAAPEVI--SGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIP--NLFKKIKGGI--- 97
           Y +PEV+   G +Y+    D+WS G I+Y L  G L +D  +N+   +L +K  G +   
Sbjct: 311 YRSPEVVLGLGWMYS---TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSE 367

Query: 98  ----------------------YTLPSHLSPGAR--------------DLIPRMLIVDPM 121
                                  T P HL+  AR              DLI  +L  D  
Sbjct: 368 WAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQ 427

Query: 122 KRIT-------------IPEIRQHPWFQAHLPRYLAVPPPDTM 151
           KR+               PE RQHP    +      + P   M
Sbjct: 428 KRLNARQMTTHPYVLKYYPECRQHP---NYPDNRSMLRPTPIM 467

Length = 467

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 41.7 bits (98), Expect = 3e-04
 Identities = 34/132 (25%), Positives = 62/132 (46%), Gaps = 6/132 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VHRDL   N L+ S+  VK++   LS  +   + + L+ +     + APE +    ++  
Sbjct: 139 VHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFS-T 197

Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLI 117
           + DVWS GV+++ +   G LPF   +   +  +++ G     +P         L+ R   
Sbjct: 198 KSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWA 257

Query: 118 VDPMKRITIPEI 129
           V+P  R +  E+
Sbjct: 258 VNPKDRPSFSEL 269

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 41.0 bits (96), Expect = 5e-04
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 13/140 (9%)

Query: 3   VHRDLKPENLLLDSKWN-----VKIADFGLS-NIMRDGHFLKTSCGSPN--YAAPE-VIS 53
           +HRDL   N L+  K       VKI DFGL+ +I +  ++ K   G     + APE ++ 
Sbjct: 128 IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD 187

Query: 54  GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIK-GGIYTLPSHLSPGARDL 111
           GK     + DVWS GV+++ +L  G  P+   N   + + +  GG    P +       L
Sbjct: 188 GKFTT--QSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQL 245

Query: 112 IPRMLIVDPMKRITIPEIRQ 131
           +      DP +R T   I++
Sbjct: 246 MTNCWAQDPSERPTFDRIQE 265

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.1 bits (94), Expect = 6e-04
 Identities = 26/83 (31%), Positives = 40/83 (48%), Gaps = 7/83 (8%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEV 62
           +HR  K  N+LL   W+  +   G           + S   P + APEVI G+ Y   + 
Sbjct: 33  LHRQAKSGNILL--TWDGLLKLDGSVAFK----TPEQSRPDPYFMAPEVIQGQSY-TEKA 85

Query: 63  DVWSCGVILYALLCGTLPFDDEN 85
           D++S G+ LY  L   LP+++E 
Sbjct: 86  DIYSLGITLYEALDYELPYNEER 108

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 41.2 bits (96), Expect = 7e-04
 Identities = 23/51 (45%), Positives = 28/51 (54%), Gaps = 2/51 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG--SPNYAAPE 50
           +VHRD+KPENLL+     VKI DFG +  M  G       G   P Y+ PE
Sbjct: 330 IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE 380

Length = 507

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 40.7 bits (95), Expect = 8e-04
 Identities = 32/96 (33%), Positives = 46/96 (47%), Gaps = 12/96 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVI-SGKLYA 58
           VHRDL   N L+     +KIADFG+S  +  G + +    +     + A E I  GK   
Sbjct: 160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTT 219

Query: 59  GPEVDVWSCGVILYALL--CGTLPF----DDENIPN 88
               DVW+ GV L+ +L  C   P+    D++ I N
Sbjct: 220 AS--DVWAFGVTLWEILMLCKEQPYGELTDEQVIEN 253

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 40.4 bits (94), Expect = 9e-04
 Identities = 30/85 (35%), Positives = 44/85 (51%), Gaps = 7/85 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVIS-GKLY 57
           VVH+DL   N+L+  K NVKI+D GL   +    + K    S     + +PE I  GK  
Sbjct: 145 VVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS 204

Query: 58  AGPEVDVWSCGVILYALLC-GTLPF 81
              + D+WS GV+L+ +   G  P+
Sbjct: 205 I--DSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 26/76 (34%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           VHRDL   N L+ +   VKI DFG+S  +    + +    +     +  PE I  + +  
Sbjct: 145 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT- 203

Query: 60  PEVDVWSCGVILYALL 75
            E DVWS GVIL+ + 
Sbjct: 204 TESDVWSFGVILWEIF 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 39.6 bits (92), Expect = 0.002
 Identities = 24/75 (32%), Positives = 40/75 (53%), Gaps = 4/75 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAG 59
           VHRDL   N ++   + VKI DFG++ +I    ++ K   G     + +PE +   ++  
Sbjct: 141 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT- 199

Query: 60  PEVDVWSCGVILYAL 74
              DVWS GV+L+ +
Sbjct: 200 TYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 39.7 bits (92), Expect = 0.002
 Identities = 25/78 (32%), Positives = 42/78 (53%), Gaps = 5/78 (6%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYA 58
            ++HRD+K EN+ L+    + + DFG +         F     G+    +PE+++G  Y 
Sbjct: 287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYC 346

Query: 59  GPEV-DVWSCGVILYALL 75
             E+ D+WSCG+IL  +L
Sbjct: 347 --EITDIWSCGLILLDML 362

Length = 501

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 38.9 bits (90), Expect = 0.002
 Identities = 25/76 (32%), Positives = 37/76 (48%), Gaps = 4/76 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           VHRDL   N L+     VKI DFG+S  +    + +    +     +  PE I  + +  
Sbjct: 142 VHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT- 200

Query: 60  PEVDVWSCGVILYALL 75
            E DVWS GV+L+ + 
Sbjct: 201 TESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 38.7 bits (90), Expect = 0.004
 Identities = 34/117 (29%), Positives = 52/117 (44%), Gaps = 15/117 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPE-VISGKLYA 58
           VHRDL   N L+   + +KIADFG+S  +  G + +    +  P  + + E ++ GK   
Sbjct: 152 VHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTT 211

Query: 59  GPEVDVWSCGVILYALL--CGTLPFDD-------ENIPNLFKKIKGGIYTLPSHLSP 106
               DVW+ GV L+ +L  C   P+         EN    F+     +Y     L P
Sbjct: 212 AS--DVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCP 266

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	379
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	99.98
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
KOG0586	596	consensus Serine/threonine protein kinase [General	99.97
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.95
KOG0578	550	consensus p21-activated serine/threonine protein k	99.95
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.95
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.95
KOG0198	313	consensus MEKK and related serine/threonine protei	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.94
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.94
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.94
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.94
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.94
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.94
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.94
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.94
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.94
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.94
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.94
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.94
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.94
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.94
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.94
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.94
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.94
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.94
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.94
PTZ00284	467	protein kinase; Provisional	99.94
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.94
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.94
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.93
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.93
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.93
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.93
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.93
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.93
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.93
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.93
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.93
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.93
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.93
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.93
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.93
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.93
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.93
KOG0595	429	consensus Serine/threonine-protein kinase involved	99.93
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.93
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.93
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.93
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.93
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.93
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.93
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.93
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.93
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.93
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.93
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.93
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	99.92
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.92
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.92
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.92
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.92
KOG0610	459	consensus Putative serine/threonine protein kinase	99.92
PTZ00283	496	serine/threonine protein kinase; Provisional	99.92
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.92
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.92
KOG0589	426	consensus Serine/threonine protein kinase [General	99.92
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.92
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.92
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.92
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.92
KOG0192	362	consensus Tyrosine kinase specific for activated (	99.92
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.92
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.92
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.92
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.92
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.92
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.92
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.92
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.92
PTZ00267	478	NIMA-related protein kinase; Provisional	99.92
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.92
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.92
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.92
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.92
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.92
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.91
PHA03212	391	serine/threonine kinase US3; Provisional	99.91
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.91
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.91
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.91
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.91
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.91
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.91
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.91
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.91
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.91
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.91
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.91
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.91
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.91
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.91
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.91
PHA03207	392	serine/threonine kinase US3; Provisional	99.91
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.9
PHA02988	283	hypothetical protein; Provisional	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.9
PHA03209	357	serine/threonine kinase US3; Provisional	99.9
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.9
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.9
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.9
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.9
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.9
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.9
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.9
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.9
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.9
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.9
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.9
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.9
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.9
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.9
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.89
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.89
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.89
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.89
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.89
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.89
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.89
PHA03211	461	serine/threonine kinase US3; Provisional	99.89
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.89
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.89
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.89
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.89
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.89
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.89
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.89
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.89
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.89
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.89
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.89
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.89
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.89
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.89
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.89
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.89
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.89
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.89
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.89
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.89
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.89
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.89
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.89
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.89
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.89
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.89
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.89
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.89
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.89
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.89
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.89
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.89
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.89
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.88
PHA03210	501	serine/threonine kinase US3; Provisional	99.88
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.88
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.88
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.88
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.88
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.88
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.88
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.88
KOG0584	632	consensus Serine/threonine protein kinase [General	99.88
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.88
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.88
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.88
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.88
PHA02882	294	putative serine/threonine kinase; Provisional	99.88
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.88
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.88
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.88
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.88
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.88
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.88
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.88
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.88
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.88
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.88
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.88
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.88
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.88
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.88
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.88
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.88
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.88
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.88
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.88
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.87
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.87
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.87
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.87
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.87
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.87
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.87
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.87
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.87
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.87
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.87
PLN00009	294	cyclin-dependent kinase A; Provisional	99.87
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.87
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.87
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.87
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.87
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.87
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.87
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.87
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.87
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.87
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.87
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.87
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.87
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.87
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.87
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.87
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.87
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.87
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.87
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.87
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.87
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.87
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.87
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.87
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.87
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.87
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.87
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.86
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.86
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.86
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.86
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.86
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.86
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.86
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.86
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.86
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.86
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.86
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.86
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.86
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.86
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.86
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.86
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.86
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.86
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.86
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.86
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.86
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.86
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.86
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.86
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.86
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.86
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.86
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.86
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.86
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.86
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.86
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.86
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.86
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.86
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.86
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.86
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.85
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.85
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.85
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.85
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.85
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.85
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.85
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.85
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.85
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.85
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.85
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.85
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.85
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.85
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.85
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.85
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.85
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.85
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.85
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.85
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.85
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.85
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.85
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.85
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.85
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.85
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.85
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.85
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.85
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.85
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.85
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.85
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.85
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.84
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.84
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.84
PLN00181	793	protein SPA1-RELATED; Provisional	99.84
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.84
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.84
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.84
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.84
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.84
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.84
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.84
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.84
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.84
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.84
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.84
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.84
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.84
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.84
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.83
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.83
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.83
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.83
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.83
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.83
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.83
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.83
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.83
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.83
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.83
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.83
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.83
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.83
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.83
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.82
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.82
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.82
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.82
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.82
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.82
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.82
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.82
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.82
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.82
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.81
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.81
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.81
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.81
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.81
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.81
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.8
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.8
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.8
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.79
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.79
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.79
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.79
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.78
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.77
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.77
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.77
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.77
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.76
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.76
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.76
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.74
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.72
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.72
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.7
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.7
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.67
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.67
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.66
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.64
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.61
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.61
KOG3653	534	consensus Transforming growth factor beta/activin	99.61
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.59
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.55
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.53
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.51
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.48
KOG1152	772	consensus Signal transduction serine/threonine kin	99.47
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.47
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.45
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.45
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.39
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.31
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.31
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.22
PF02149	47	KA1: Kinase associated domain 1; InterPro: IPR0017	99.11
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.08
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	98.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	98.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	98.84
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	98.72
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.71
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	98.69
PRK12274	218	serine/threonine protein kinase; Provisional	98.59
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	98.58
PRK09188	365	serine/threonine protein kinase; Provisional	98.54
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	98.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.27
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	98.14
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.03
COG4248	637	Uncharacterized protein with protein kinase and he	97.59
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	97.41
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	97.38
smart00090	237	RIO RIO-like kinase.	97.33
PRK10345	210	hypothetical protein; Provisional	97.16
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	96.82
PRK14879	211	serine/threonine protein kinase; Provisional	96.77
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	96.65
PRK09605	535	bifunctional UGMP family protein/serine/threonine	96.64
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	96.53
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	96.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	95.83
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	95.79
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	95.28
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	94.82
KOG0576	829	consensus Mitogen-activated protein kinase kinase	94.25
KOG3087	229	consensus Serine/threonine protein kinase [General	94.05
KOG1243	690	consensus Protein kinase [General function predict	92.78
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	92.76
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	92.6
PF01636	239	APH: Phosphotransferase enzyme family This family	92.57
KOG1093	725	consensus Predicted protein kinase (contains TBC a	92.27
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	92.27
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	92.07
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	91.7
PF08587	46	UBA_2: Ubiquitin associated domain (UBA) ; InterPr	91.6
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	91.31
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	91.31
PRK10271	188	thiK thiamine kinase; Provisional	91.22
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	91.01
PRK05231	319	homoserine kinase; Provisional	90.73
COG0478	304	RIO-like serine/threonine protein kinase fused to	90.52
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	89.86
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	89.71
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	89.36
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	89.06
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	89.0
COG2334	331	Putative homoserine kinase type II (protein kinase	87.83
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	87.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	87.49
PLN02236	344	choline kinase	87.11
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	84.19
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	84.04
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	83.36
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	82.55
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	82.5
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	81.96
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	81.13
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	81.03
PRK06148	1013	hypothetical protein; Provisional	80.71
PHA03111	444	Ser/Thr kinase; Provisional	80.48

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-40  Score=334.02  Aligned_cols=203  Identities=49%  Similarity=0.843  Sum_probs=181.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||||+|||..++|||+|||+|..-..+..+.|.||+|+|+|||++.|..|.|.++||||||||||.||+|++|
T Consensus       132 ~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LP  211 (786)
T KOG0588|consen  132 NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLP  211 (786)
T ss_pred             cceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCC
Confidence            38999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc--CcccCCCCC-----Chhhh
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL--PRYLAVPPP-----DTMQQ  153 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~--~~~l~~~~~-----~~~~~  153 (379)
                      |++++...+..++.+|.|.+|..++.++++||.+||.+||.+|+|.+||++|||+....  +.....+.+     .....
T Consensus       212 FdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~~~~~~~~~~~~~i~s~ps  291 (786)
T KOG0588|consen  212 FDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLPSSKSLRPPVSVPILSIPS  291 (786)
T ss_pred             CCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCChhhhcCCCcccceeecCC
Confidence            99999999999999999999999999999999999999999999999999999998652  222122222     12233


Q ss_pred             hcccCHHHHHHHHHc--CCCHHHHHHHHHhcccChHHHHHHHHhhccccccC
Q 017029          154 AKKIDEEILKEVVKM--GFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSS  203 (379)
Q Consensus       154 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~y~ll~~~~~~~~~  203 (379)
                      ...||+.+++-|.-.  +-+.+.+.+.|.+...|....-|.||++.+.+.+.
T Consensus       292 ~~~IDp~Il~~l~iLwc~~d~~kl~~kLls~~~n~EK~~Y~LLl~~k~r~~~  343 (786)
T KOG0588|consen  292 IQEIDPLILQHLCILWCGRDPEKLVEKLLSPDDNDEKTLYFLLLRRKRRDSS  343 (786)
T ss_pred             cccCCHHHHhhhhheeecCChHHHHHHHcCCCcchhHHHHHHHHHhhccchh
Confidence            568999999999765  45889999999999999999999999999877543

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=284.41  Aligned_cols=198  Identities=39%  Similarity=0.676  Sum_probs=170.1

Q ss_pred             EEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |||||||||||.+- .-|-|||+|||+++.+..++.+.|.||+..|.|||++.|..|+.+++||||||||||.|+||++|
T Consensus       139 VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~P  218 (864)
T KOG4717|consen  139 VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPP  218 (864)
T ss_pred             hhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCc
Confidence            79999999998764 56999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCcccC-CCCCChhhhhcccCH
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLA-VPPPDTMQQAKKIDE  159 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l~-~~~~~~~~~~~~~~~  159 (379)
                      |...+..+....|....|+.|.+++.++++||..||+.||.+|.|.+||..++|++...+.... +|-.........-..
T Consensus       219 FqeANDSETLTmImDCKYtvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~~sT~iPLvsr~~L~ee~Ha  298 (864)
T KOG4717|consen  219 FQEANDSETLTMIMDCKYTVPSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRGLSTAIPLVSRHHLPEEAHA  298 (864)
T ss_pred             cccccchhhhhhhhcccccCchhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCCccccCceeehhhCChHHHH
Confidence            9999999999999999999999999999999999999999999999999999999976543222 221111111222233


Q ss_pred             HHHHHHHHcCC-CHHHHHHHHHhcccChHHHHHHHHhhccc
Q 017029          160 EILKEVVKMGF-DQNQLVESLRNRLQNEATVAYYLLLDNRF  199 (379)
Q Consensus       160 ~~~~~~~~~~~-~~~~~~~~l~~~~~~~~~~~y~ll~~~~~  199 (379)
                      .+++.|+.-.+ +++++.+.|.++.+|..+++|+||.....
T Consensus       299 ~IIq~Mv~G~IAs~e~Il~aLe~n~YNhiTATYfLLAEr~L  339 (864)
T KOG4717|consen  299 TIIQQMVAGAIASEEDILRALENNEYNHITATYFLLAERVL  339 (864)
T ss_pred             HHHHHHhcccccCHHHHHHHHhccccchhhhHHHHHHHHHH
Confidence            46677765444 78899999999999999999999988653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.4e-35  Score=279.56  Aligned_cols=137  Identities=43%  Similarity=0.793  Sum_probs=124.1

Q ss_pred             EEecCCCCCCeEEcCC---CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCC--CCCccceeeehhHHHHHhh
Q 017029            2 VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~---~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiWSlGvilyellt   76 (379)
                      |+||||||||||+..+   ..+||+|||+|+....+.+++|.||||.|.|||++.++.+  ++.++|+||+||+||.+++
T Consensus       297 I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLs  376 (475)
T KOG0615|consen  297 IIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLS  376 (475)
T ss_pred             cccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEec
Confidence            8999999999999776   7899999999999999999999999999999999986654  3558999999999999999


Q ss_pred             CCCCCCCCChHH-HHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPN-LFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~-~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |.+||.+..... +.++|.+|.|.+-    ..+|+++.+||.+||.+||++|||++|+|+||||+..
T Consensus       377 G~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  377 GYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             cCCCcccccCCccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            999998865444 8999999998764    3589999999999999999999999999999999854

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-34  Score=281.10  Aligned_cols=137  Identities=63%  Similarity=1.096  Sum_probs=132.8

Q ss_pred             CEEecCCCCCCeEEcCC-CcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSK-WNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||||||++.+ +++||+|||+++.. ..+..+.+.|||+.|+|||++.+.. |.+.++|||||||+||.|++|
T Consensus       140 gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G  219 (370)
T KOG0583|consen  140 GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCG  219 (370)
T ss_pred             CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhC
Confidence            38999999999999999 99999999999998 5778899999999999999999988 999999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCCCCC-ChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      +.||++.+...++.+|..+.+.+|..+ |+++++|+.+||..||.+|+|+.+++.||||+.
T Consensus       220 ~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  220 RLPFDDSNVPNLYRKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             CCCCCCccHHHHHHHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999 999999999999999999999999999999997

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-33  Score=282.90  Aligned_cols=137  Identities=45%  Similarity=0.806  Sum_probs=130.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|||||||..|+||+++.+|||+|||+|.... +++...|.||||+|.|||++..... +.++||||+||++|.||+|++
T Consensus       138 ~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~P  216 (592)
T KOG0575|consen  138 GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRP  216 (592)
T ss_pred             CceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCC
Confidence            48999999999999999999999999999887 4467789999999999999998877 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...+..+.+.+|....|.+|..+|.++++||.+||..||.+|||+++++.|+||+..
T Consensus       217 PFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  217 PFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             CcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999544

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=99.98  E-value=4.5e-33  Score=265.62  Aligned_cols=136  Identities=37%  Similarity=0.635  Sum_probs=125.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      +||||||||+|||+++.|.|||||||.|..+.+. ...+.+||..|||||.+.+..| +.++||||||+.++|+++|+.|
T Consensus       199 ~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP  276 (364)
T KOG0581|consen  199 KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFP  276 (364)
T ss_pred             CeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCC
Confidence            5999999999999999999999999999998776 6689999999999999999988 7899999999999999999999


Q ss_pred             CCCC-----ChHHHHHHHhcCc-cCCCCC-CChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDE-----NIPNLFKKIKGGI-YTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |...     +..+++..|..+. ..+|.. +|+++++||..||++||.+|+|++|+++|||++..
T Consensus       277 ~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~  341 (364)
T KOG0581|consen  277 YPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKF  341 (364)
T ss_pred             CCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhc
Confidence            9874     6778888888754 567776 99999999999999999999999999999999865

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-32  Score=262.44  Aligned_cols=138  Identities=43%  Similarity=0.789  Sum_probs=126.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||||||||.+|+++|+|||+|+.. ..+....+.|||+.|||||++.+..| +.++|+||+|+++|+|++|.+
T Consensus       145 gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~p  223 (357)
T KOG0598|consen  145 GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKP  223 (357)
T ss_pred             CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCC
Confidence            3899999999999999999999999999954 45566678899999999999999988 799999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCC----ChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRI----TIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rp----t~~ell~hp~f~~~~  139 (379)
                      ||.+.+.....++|..+.. ..|..++.+++++++++|..||.+|.    .+.+|.+||||....
T Consensus       224 PF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~in  288 (357)
T KOG0598|consen  224 PFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGIN  288 (357)
T ss_pred             CCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCC
Confidence            9999999999999999984 45556999999999999999999996    688999999998653

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=271.00  Aligned_cols=138  Identities=38%  Similarity=0.722  Sum_probs=127.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--------------cccccCCCCccCcccccCCCCCCCccceee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWS   66 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--------------~~~~~gt~~y~APE~l~~~~~~~~~~DiWS   66 (379)
                      .||||||||||||||.+|++||+|||.++.+.+...              ..+++||..|.+||++..... ++.+|+|+
T Consensus       194 GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWA  272 (604)
T KOG0592|consen  194 GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWA  272 (604)
T ss_pred             CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHH
Confidence            389999999999999999999999999988753221              145789999999999988765 89999999


Q ss_pred             ehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           67 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        67 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||||||.|+.|.+||.+.+.-.++++|....|.+|+.+++.+++||+++|..||.+|+|+.+|.+||||....
T Consensus       273 lGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vd  345 (604)
T KOG0592|consen  273 LGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVD  345 (604)
T ss_pred             HHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999998654

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=2.9e-32  Score=253.04  Aligned_cols=134  Identities=43%  Similarity=0.810  Sum_probs=127.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |++|||||||||+|.+|.+||+|||+++.....  .-|.||||.|+|||+++++.| +.++|+|||||++|||++|.+||
T Consensus       165 iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF  241 (355)
T KOG0616|consen  165 IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPF  241 (355)
T ss_pred             eeeccCChHHeeeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCC
Confidence            799999999999999999999999999987654  568899999999999999998 89999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           82 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      .+.+...++++|..+.+.+|+.+++++++||+++|++|-.+|.     ...+|..||||+..
T Consensus       242 ~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v  303 (355)
T KOG0616|consen  242 YDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGV  303 (355)
T ss_pred             cCCChHHHHHHHHhCcccCCcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccc
Confidence            9999999999999999999999999999999999999999994     56799999999865

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=1e-31  Score=243.81  Aligned_cols=137  Identities=51%  Similarity=0.872  Sum_probs=127.3

Q ss_pred             CEEecCCCCCCeEEcCC---CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~---~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|||||+||+|+|+.+.   .-+||+|||++....++.......|||.|||||++....| +..+|||++|||||-|+.|
T Consensus       130 ~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G  208 (355)
T KOG0033|consen  130 GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVG  208 (355)
T ss_pred             CceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhC
Confidence            48999999999999653   4699999999999988777788899999999999998888 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++||.+++...+++.|..+.+.+|+    .+++++++|+++||..||.+|+|+.|+|+|||+.+.
T Consensus       209 ~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  209 YPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             CCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            9999999999999999999998875    689999999999999999999999999999999854

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=1.2e-31  Score=246.56  Aligned_cols=137  Identities=46%  Similarity=0.813  Sum_probs=125.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc------CCCCCCCccceeeehhHHHHHh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS------GKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~~DiWSlGvilyell   75 (379)
                      ||||||||||||++++.++||+|||++.....|..++..||||.|.|||.+.      ..+| +.++|+||||||+|-++
T Consensus       144 IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLL  222 (411)
T KOG0599|consen  144 IVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLL  222 (411)
T ss_pred             hhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHH
Confidence            8999999999999999999999999999999999999999999999999985      2344 78999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      .|.+||......-..+.|..|.|.+.    ..+|...++||.+||++||.+|+|++|+|.||||.+..
T Consensus       223 aGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~  290 (411)
T KOG0599|consen  223 AGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA  290 (411)
T ss_pred             cCCCchhHHHHHHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence            99999998777777889999998774    35899999999999999999999999999999997654

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=3.5e-31  Score=265.75  Aligned_cols=198  Identities=39%  Similarity=0.664  Sum_probs=174.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|||||||++||||+.+.++||+|||+++.+..+..+.+.||++.|+|||++.|..|.++++|+||+|+++|.|++|.+|
T Consensus       175 ~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLP  254 (596)
T KOG0586|consen  175 NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLP  254 (596)
T ss_pred             ceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccc
Confidence            38999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCcccCCCCCChhhhhcccCHH
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEE  160 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l~~~~~~~~~~~~~~~~~  160 (379)
                      |++.+..++...+..+.+.+|..++.+++++|+++|.++|.+|+++++++.|.|.......-...  +........++..
T Consensus       255 FDG~~lk~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~~~l~--p~~e~~~~~~~~~  332 (596)
T KOG0586|consen  255 FDGQNLKELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEARLLA--PLIERSTPFILAK  332 (596)
T ss_pred             cCCcccccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhhhhhh--cccccCccchhhH
Confidence            99999999999999999999999999999999999999999999999999999998765441111  1111122233444


Q ss_pred             HHHHHHHcCCCHHHHHHHHHhcccChHHHHHHHHhhcccc
Q 017029          161 ILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFR  200 (379)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~~~~~~  200 (379)
                      -+..|..+|+..+.+.++|.+...++...+|.|+-....+
T Consensus       333 r~~~m~~~G~~~~~i~~sL~~~k~d~i~a~y~ll~~~~~~  372 (596)
T KOG0586|consen  333 RILHMNSIGHRRLKIEESLAKQKFDDINATYLLLGYRKQR  372 (596)
T ss_pred             HHHHHHhhccchhhHHHHHhhhhHHHHHHHHhhcchhhhc
Confidence            4456778999999999999999999999999888776543

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.3e-31  Score=266.12  Aligned_cols=138  Identities=38%  Similarity=0.670  Sum_probs=130.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|||||||.+|||||.+|++||+|||+++.- ..+....|.||||.|+|||++.+..| +.++|+|||||++|||+.|+.
T Consensus       488 ~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~  566 (694)
T KOG0694|consen  488 GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGES  566 (694)
T ss_pred             CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCC
Confidence            4899999999999999999999999999875 36677889999999999999999998 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~~  139 (379)
                      ||.+++..+++..|....+.+|.++|.++.++++++|.+||++|...     ++|+.||||+...
T Consensus       567 PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~  631 (694)
T KOG0694|consen  567 PFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSID  631 (694)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCC
Confidence            99999999999999999999999999999999999999999999965     6899999998653

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=4.4e-30  Score=254.35  Aligned_cols=139  Identities=42%  Similarity=0.735  Sum_probs=119.2

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccC----------------------Cc------------------------
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD----------------------GH------------------------   35 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~----------------------~~------------------------   35 (379)
                      +|||||||+|+|||..|++||+|||||+-...                      ..                        
T Consensus       262 yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nr  341 (550)
T KOG0605|consen  262 YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNR  341 (550)
T ss_pred             cccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhh
Confidence            69999999999999999999999999853210                      00                        


Q ss_pred             --ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhhh
Q 017029           36 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGAR  109 (379)
Q Consensus        36 --~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~  109 (379)
                        .....+|||-|+|||++.++.| +..+|+||||||+||||.|.+||.++++.+.+++|.+-.  ..+|  ..++++++
T Consensus       342 r~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~  420 (550)
T KOG0605|consen  342 RQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAK  420 (550)
T ss_pred             hhhhhcccCCccccchHHHhcCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHH
Confidence              0122369999999999999998 899999999999999999999999999999999998765  4555  45789999


Q ss_pred             cccccccCCCCCCCCC---hhhhhcCchhhhccCcc
Q 017029          110 DLIPRMLIVDPMKRIT---IPEIRQHPWFQAHLPRY  142 (379)
Q Consensus       110 ~Li~~mL~~dP~~Rpt---~~ell~hp~f~~~~~~~  142 (379)
                      |||.+||. ||.+|..   ++||.+||||+......
T Consensus       421 DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~~  455 (550)
T KOG0605|consen  421 DLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWDH  455 (550)
T ss_pred             HHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcch
Confidence            99999999 9999995   89999999999765443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=4.4e-30  Score=237.18  Aligned_cols=130  Identities=38%  Similarity=0.677  Sum_probs=119.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||.||+|+.+|.+||+|||+++.+.... +..+.+|||.||+||++.+.+| +.++||||+||++|||+.-++|
T Consensus       149 VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~P  227 (375)
T KOG0591|consen  149 VMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSP  227 (375)
T ss_pred             eeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCC
Confidence            8999999999999999999999999999986653 4567799999999999999998 7999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC-CC-CCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           81 FDDENIPNLFKKIKGGIYT-LP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |.+++.-++.++|.++.++ +| ..+|.++..+|..|+.+||..||+.     +|++.+
T Consensus       228 F~g~n~~~L~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~d  281 (375)
T KOG0591|consen  228 FYGDNLLSLCKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQD  281 (375)
T ss_pred             cccccHHHHHHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHH
Confidence            9999999999999999886 77 7899999999999999999999987     555543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=1.9e-29  Score=242.32  Aligned_cols=137  Identities=52%  Similarity=0.892  Sum_probs=130.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      +|+|||||.+|||+|.|+++||+|||+++.+.++.+++|+||+|.|++||++.|..|.|+++|.|||||+||-|+.|..|
T Consensus       173 rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMP  252 (668)
T KOG0611|consen  173 RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMP  252 (668)
T ss_pred             cceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccc
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |+|.+-..+.++|.+|.|.-|.. +.++..||+.||.+||++|.|+++|-.|-|++-.
T Consensus       253 FDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNwg  309 (668)
T KOG0611|consen  253 FDGRDHKRLVRQISRGAYREPET-PSDASGLIRWMLMVNPERRATIEDIASHWWVNWG  309 (668)
T ss_pred             cCCchHHHHHHHhhcccccCCCC-CchHHHHHHHHHhcCcccchhHHHHhhhheeecc
Confidence            99999999999999999987764 5678899999999999999999999999998744

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=5.7e-29  Score=247.93  Aligned_cols=136  Identities=35%  Similarity=0.658  Sum_probs=119.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|||||||.+|||++.+|.+||+|||+|....... .-.+.+|||+|||||++..+.| |+++||||||+++.||+-|++
T Consensus       389 gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEP  467 (550)
T KOG0578|consen  389 GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEP  467 (550)
T ss_pred             ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCC
Confidence            38999999999999999999999999998876654 5567899999999999999988 999999999999999999999


Q ss_pred             CCCCCChHH-HHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           80 PFDDENIPN-LFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~-~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ||-.++.-. ++.--.+|..  ..|+.+|+.+++|+.+||++|+.+|+++.|||+||||+.
T Consensus       468 PYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~  528 (550)
T KOG0578|consen  468 PYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKM  528 (550)
T ss_pred             CccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhh
Confidence            998655444 4433345544  457889999999999999999999999999999999964

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.2e-29  Score=244.96  Aligned_cols=139  Identities=44%  Similarity=0.772  Sum_probs=126.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc------CCcccccccCCCCccCcccccC---CCCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR------DGHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~------~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiWSlGvil   71 (379)
                      .||||||||.|+||+++|++||+|||.+....      ....+...+|||.|+|||.+.+   ..+.+.+.||||+||+|
T Consensus       230 giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL  309 (576)
T KOG0585|consen  230 GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL  309 (576)
T ss_pred             CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence            48999999999999999999999999998762      2234556789999999999987   56778999999999999


Q ss_pred             HHHhhCCCCCCCCChHHHHHHHhcCccCCCCC--CChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           72 YALLCGTLPFDDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        72 yelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |.|+.|+.||.++...+++.+|.+....+|..  +.+.+++||.+||.+||.+|+++.+|..|||.....
T Consensus       310 YCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g  379 (576)
T KOG0585|consen  310 YCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG  379 (576)
T ss_pred             HHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence            99999999999999999999999999888865  799999999999999999999999999999998664

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.95  E-value=6.3e-29  Score=231.49  Aligned_cols=137  Identities=29%  Similarity=0.548  Sum_probs=117.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      +|||||||||||++.+|.+||||||+++... .++..+..+.|.+|+|||.+.|...+|+.+||||+||++.||++|.+-
T Consensus       122 ~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL  201 (396)
T KOG0593|consen  122 CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPL  201 (396)
T ss_pred             eecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcC
Confidence            7999999999999999999999999999987 677788889999999999999966669999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-------------------CCC------------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-------------------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-------------------~~p------------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |+|.+.-++.-.|.....                   .+|            +.++.-+.+|+++||..||.+|++.+++
T Consensus       202 ~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~ql  281 (396)
T KOG0593|consen  202 WPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQL  281 (396)
T ss_pred             CCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHH
Confidence            999877666555533211                   112            1356678899999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      +.|+||...
T Consensus       282 l~H~yFd~~  290 (396)
T KOG0593|consen  282 LHHPYFDGF  290 (396)
T ss_pred             hcChHHHHH
Confidence            999999543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-29  Score=230.70  Aligned_cols=136  Identities=41%  Similarity=0.803  Sum_probs=123.4

Q ss_pred             EEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            2 VVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      |.||||||||+|...   |..+||+|||+++.......+.|.|-||.|.|||++....| +..+|+||+||++|-|+||.
T Consensus       182 IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGy  260 (400)
T KOG0604|consen  182 IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGY  260 (400)
T ss_pred             hhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCC
Confidence            789999999999975   45799999999999887788899999999999999988887 78999999999999999999


Q ss_pred             CCCCCCC----hHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDEN----IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~----~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +||....    .+....+|..|.|.+|.    .+|+.++++|+++|..+|.+|.|+++++.|||+...
T Consensus       261 PPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  261 PPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             CcccccCCccCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            9997754    34567899999999985    479999999999999999999999999999999854

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.95  E-value=2.9e-28  Score=236.72  Aligned_cols=137  Identities=43%  Similarity=0.750  Sum_probs=123.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++... .+......+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       115 ~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~  193 (323)
T cd05571         115 DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL  193 (323)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCC-CccccCcccchhhhhhhcCCC
Confidence            48999999999999999999999999987532 2333456689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+..+...+|..+++++.+||.+||..||.+||     ++.++++||||...
T Consensus       194 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         194 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999988888888888888889999999999999999999999999     89999999999754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-28  Score=235.36  Aligned_cols=140  Identities=34%  Similarity=0.558  Sum_probs=116.1

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccC----CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRD----GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+|||++. ++.+||+|||++.....    ........||+.|||||++......++++||||+||++.||+
T Consensus       137 g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~  216 (313)
T KOG0198|consen  137 GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEML  216 (313)
T ss_pred             CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEecc
Confidence            4899999999999999 79999999999987653    122345689999999999986434356999999999999999


Q ss_pred             hCCCCCCC-CChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           76 CGTLPFDD-ENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        76 tG~~Pf~~-~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ||..||.. ....+..-.+...  .+.+|..+|+++++||.+|+.+||.+|||++++|+|||.+...+
T Consensus       217 Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  217 TGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             CCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999987 3444433344332  35788999999999999999999999999999999999987644

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=8.3e-28  Score=228.82  Aligned_cols=137  Identities=35%  Similarity=0.602  Sum_probs=115.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccC---CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~---~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      |+||||||.|+|++.+..+||||||+++....   ...++..+.|.+|+|||++....-++.++||||+|||+.||++|+
T Consensus       146 ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gk  225 (359)
T KOG0660|consen  146 VIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGK  225 (359)
T ss_pred             ccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCC
Confidence            79999999999999999999999999998853   556678889999999998876555589999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCc-----------------------cCCC--------CCCChhhhcccccccCCCCCCCCChh
Q 017029           79 LPFDDENIPNLFKKIKGGI-----------------------YTLP--------SHLSPGARDLIPRMLIVDPMKRITIP  127 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-----------------------~~~p--------~~~s~~~~~Li~~mL~~dP~~Rpt~~  127 (379)
                      +-|.|.+.-...+.|..-.                       ...|        ++.++.+.+|+.+||.+||.+|+|++
T Consensus       226 plFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~  305 (359)
T KOG0660|consen  226 PLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAE  305 (359)
T ss_pred             CCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHH
Confidence            9999976555544442211                       1111        36789999999999999999999999


Q ss_pred             hhhcCchhhhc
Q 017029          128 EIRQHPWFQAH  138 (379)
Q Consensus       128 ell~hp~f~~~  138 (379)
                      |+++|||+...
T Consensus       306 eAL~hPYl~~~  316 (359)
T KOG0660|consen  306 EALAHPYLAPY  316 (359)
T ss_pred             HHhcChhhhhh
Confidence            99999999865

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.94  E-value=7.4e-28  Score=234.54  Aligned_cols=135  Identities=41%  Similarity=0.758  Sum_probs=123.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.......  .+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       138 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p  214 (329)
T PTZ00263        138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPP  214 (329)
T ss_pred             CeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCC
Confidence            38999999999999999999999999998764432  35689999999999988877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+.+.....+++..+...+|..++..+++||.+||+.||.+|++     +++++.||||+..
T Consensus       215 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        215 FFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             CCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            999888888899999988899999999999999999999999997     7999999999753

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=9.5e-28  Score=231.81  Aligned_cols=137  Identities=39%  Similarity=0.735  Sum_probs=122.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.... .....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       113 ~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~  191 (312)
T cd05585         113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLP  191 (312)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCC-CCccceechhHHHHHHHhCCC
Confidence            389999999999999999999999999976432 233345689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC---ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp---t~~ell~hp~f~~~  138 (379)
                      ||.+.+....++.+..+...+|..++++++++|.+||..||.+||   ++.+++.||||...
T Consensus       192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         192 PFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            999999989999998888889999999999999999999999997   57899999999854

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.94  E-value=1.1e-27  Score=228.12  Aligned_cols=137  Identities=30%  Similarity=0.583  Sum_probs=118.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.............|++.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus       122 ~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~p  200 (285)
T cd05631         122 RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSP  200 (285)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCC
Confidence            489999999999999999999999999987655555556789999999999988777 7899999999999999999999


Q ss_pred             CCCCCh----HHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+...    ......+......++..++.++.+||++||+.||.+|||     ++++++||||...
T Consensus       201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~  267 (285)
T cd05631         201 FRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI  267 (285)
T ss_pred             CCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence            987543    233444455556677889999999999999999999997     8999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.94  E-value=1.2e-27  Score=232.24  Aligned_cols=137  Identities=39%  Similarity=0.750  Sum_probs=123.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.... .+......+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       116 ~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~  194 (320)
T cd05590         116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHA  194 (320)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCC
Confidence            38999999999999999999999999987542 2333445689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh------hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~------~ell~hp~f~~~  138 (379)
                      ||.+.+...+...+..+...+|..++.+++++|.+||+.||.+|+++      +++++||||+..
T Consensus       195 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         195 PFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999999999999988888899999999999999999999999998      899999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=237.18  Aligned_cols=137  Identities=49%  Similarity=0.833  Sum_probs=126.3

Q ss_pred             CEEecCCCCCCeEEcCC----CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~----~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||||+|+...    +.+|++|||++.....+....+.||||.|+|||++.+..| +.++|+||+||++|.|++
T Consensus       155 gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~  233 (382)
T KOG0032|consen  155 GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLS  233 (382)
T ss_pred             CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhh
Confidence            38999999999999653    4799999999999888778899999999999999998888 899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.+....+.+|..+.+.++    +.++..++++|.+||..||.+|+|+.++++|||++..
T Consensus       234 G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  234 GVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             CCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999988765    3579999999999999999999999999999999864

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.94  E-value=4.8e-28  Score=219.25  Aligned_cols=136  Identities=42%  Similarity=0.757  Sum_probs=128.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|+|++.+|.+||+|||.+.... ...-.|.|||.-|.+||+..+..+ +..+|+|++|++.||++.|.+|
T Consensus       144 ~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~h-d~~Vd~w~lgvl~yeflvg~pp  221 (281)
T KOG0580|consen  144 RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGH-DKFVDLWSLGVLCYEFLVGLPP  221 (281)
T ss_pred             CcccCCCCHHHhccCCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCc-cchhhHHHHHHHHHHHHhcCCc
Confidence            48999999999999999999999999997754 445678999999999999999988 6899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |...+..+.+++|.+..+.+|+.++.+++|+|.+||..+|.+|.+..|++.|||+...
T Consensus       222 Fes~~~~etYkrI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  222 FESQSHSETYKRIRKVDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             hhhhhhHHHHHHHHHccccCCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            9999999999999999999999999999999999999999999999999999999753

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.94  E-value=1.7e-27  Score=232.03  Aligned_cols=136  Identities=42%  Similarity=0.739  Sum_probs=122.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       115 ~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~  193 (328)
T cd05593         115 KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL  193 (328)
T ss_pred             CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCC-CccCCccccchHHHHHhhCCC
Confidence            489999999999999999999999999876422 233345689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~  137 (379)
                      ||.+.+.......+..+...+|..+++++.+||.+||..||.+|+     ++.++++||||..
T Consensus       194 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         194 PFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999988888888888888889999999999999999999999997     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.2e-27  Score=228.74  Aligned_cols=134  Identities=42%  Similarity=0.793  Sum_probs=122.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.+|.+||+|||++......  ..+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       121 ~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~p  197 (291)
T cd05612         121 EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPP  197 (291)
T ss_pred             CeeecCCCHHHeEECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence            3899999999999999999999999999876443  235679999999999988776 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhh
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQA  137 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~  137 (379)
                      |.+.+.....+.+..+...+|..+++.+++||++||+.||.+|++     ++++++||||+.
T Consensus       198 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         198 FFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            999998888999998888899999999999999999999999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.94  E-value=1.3e-27  Score=232.21  Aligned_cols=137  Identities=44%  Similarity=0.754  Sum_probs=123.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++... ......+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 ~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~  194 (325)
T cd05594         116 NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL  194 (325)
T ss_pred             CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCC-CCccccccccceeeeeccCCC
Confidence            38999999999999999999999999987532 3334455689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+......+|..+++++.++|.+||+.||.+|+     ++.++++||||...
T Consensus       195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~  258 (325)
T cd05594         195 PFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI  258 (325)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence            999988888888888888889999999999999999999999997     89999999999853

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.6e-28  Score=235.03  Aligned_cols=167  Identities=31%  Similarity=0.527  Sum_probs=137.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||.|||||+|||+|+.|+|+|+|+|++..+..++..+..+||..|||||++.++.| +..+|+||+||++|+|+.|+.|
T Consensus       307 ~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sP  385 (591)
T KOG0986|consen  307 RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSP  385 (591)
T ss_pred             ceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCc
Confidence            589999999999999999999999999999999998888899999999999999987 7899999999999999999999


Q ss_pred             CCCCC----hHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhccCccc--------
Q 017029           81 FDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAHLPRYL--------  143 (379)
Q Consensus        81 f~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~~~~~l--------  143 (379)
                      |....    .+++-+.+......+|..+|++++++.+.+|.+||.+|..     ++++.+||||+....+.+        
T Consensus       386 Fr~~KeKvk~eEvdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PP  465 (591)
T KOG0986|consen  386 FRQRKEKVKREEVDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPP  465 (591)
T ss_pred             hhhhhhhhhHHHHHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCC
Confidence            97643    3355566677777888999999999999999999999995     568999999997532211        


Q ss_pred             CCCCCChhhhhcccCHHHHHHHHHc
Q 017029          144 AVPPPDTMQQAKKIDEEILKEVVKM  168 (379)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~  168 (379)
                      ..|++........+|-+.+..+...
T Consensus       466 fiPdp~aVyakDv~DIeqFs~VKGV  490 (591)
T KOG0986|consen  466 FIPDPGAVYAKDVLDIEQFSTVKGV  490 (591)
T ss_pred             CCCCccccchhhhhhhhhcccccce
Confidence            1334444555555555555555433

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.94  E-value=1.8e-27  Score=233.37  Aligned_cols=135  Identities=36%  Similarity=0.685  Sum_probs=122.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++......  ..+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       151 ~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~P  227 (340)
T PTZ00426        151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPP  227 (340)
T ss_pred             CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCC
Confidence            3899999999999999999999999999876432  245689999999999988766 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.+.....+.+..+...+|..+++.++++|++||+.||.+|+     |++++++||||...
T Consensus       228 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        228 FYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             CCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99988888889999998889999999999999999999999996     89999999999853

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.94  E-value=2.5e-27  Score=229.79  Aligned_cols=137  Identities=37%  Similarity=0.669  Sum_probs=123.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... .....+.+|++.|+|||++.+..+ +.++||||+||++|+|++|+.
T Consensus       116 ~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~  194 (321)
T cd05591         116 GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQP  194 (321)
T ss_pred             CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCC-CCccceechhHHHHHHhcCCC
Confidence            389999999999999999999999999876432 233445689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-------ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-------TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-------t~~ell~hp~f~~~  138 (379)
                      ||.+.+.....+.+..+...+|..++.++.++|.+||+.||.+|+       +++++++||||...
T Consensus       195 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~  260 (321)
T cd05591         195 PFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEI  260 (321)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCC
Confidence            999999999999999888888999999999999999999999999       89999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1.3e-27  Score=224.37  Aligned_cols=138  Identities=43%  Similarity=0.744  Sum_probs=129.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccc-ccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~-~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||.||||.+|+|+|.+|++||+|||+++. +..+...+|.||||.|.|||++....| +.++|+|.+||++|||+||++
T Consensus       288 ~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRL  366 (516)
T KOG0690|consen  288 NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRL  366 (516)
T ss_pred             CeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccC
Confidence            389999999999999999999999999986 366778899999999999999999888 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~~  139 (379)
                      ||...+-..++.-|..+...+|..++++++.|+..+|.+||.+|..     +.||++|+||....
T Consensus       367 PFyn~dh~kLFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~  431 (516)
T KOG0690|consen  367 PFYNKDHEKLFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVD  431 (516)
T ss_pred             cccccchhHHHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCC
Confidence            9999999999999999999999999999999999999999999984     78999999998653

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.94  E-value=2.7e-27  Score=218.01  Aligned_cols=137  Identities=32%  Similarity=0.524  Sum_probs=117.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC--CCCCCccceeeehhHHHHHhhCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      |||||+||+|||+|..|++|+||||++..+.+..-.+...|.+.|||||.+.-.  .-+...+||||||++++||+||+.
T Consensus       213 viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~y  292 (391)
T KOG0983|consen  213 VIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQY  292 (391)
T ss_pred             eeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccC
Confidence            899999999999999999999999999998887777778999999999998532  223689999999999999999999


Q ss_pred             CCCCC-ChHHHHHHHhcCccC-CCC--CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDE-NIPNLFKKIKGGIYT-LPS--HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~-~~~~~~~~i~~~~~~-~p~--~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+. ...+...+|.+...+ +|.  .+|+.+.+|+..||.+|+.+||...++++|||+...
T Consensus       293 Py~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  293 PYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             CCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            99984 344666777665443 332  489999999999999999999999999999999754

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.94  E-value=8.9e-28  Score=238.68  Aligned_cols=138  Identities=34%  Similarity=0.639  Sum_probs=128.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +|+|||+||.|||++..|.+|+||||+++.+..+... +...|||.|||||++.+..| +..+|.||+|||+||+++|++
T Consensus       120 rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~P  198 (808)
T KOG0597|consen  120 RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQP  198 (808)
T ss_pred             CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCC
Confidence            5899999999999999999999999999999776544 45579999999999999888 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||...++..+.+.|.......|...+.++++|+..+|.+||.+|+|+.+++.|||.+...
T Consensus       199 PF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~  258 (808)
T KOG0597|consen  199 PFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKI  258 (808)
T ss_pred             CchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhh
Confidence            999999999999999999999999999999999999999999999999999999998653

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.94  E-value=2.7e-27  Score=229.33  Aligned_cols=137  Identities=35%  Similarity=0.681  Sum_probs=122.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... .....+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 ~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~  194 (316)
T cd05620         116 GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCC
Confidence            489999999999999999999999999875322 223456689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-~ell~hp~f~~~  138 (379)
                      ||.+.+...+.+.+......+|..++.+++++|.+||..||.+|+++ +++++||||+..
T Consensus       195 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         195 PFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            99999988888888888888888999999999999999999999998 589999999754

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.94  E-value=4.3e-27  Score=228.49  Aligned_cols=137  Identities=40%  Similarity=0.715  Sum_probs=122.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       120 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~  198 (323)
T cd05584         120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAP  198 (323)
T ss_pred             CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCC
Confidence            389999999999999999999999999875432 233345689999999999988766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+..+...+|..+++++.++|.+||+.||.+||     ++++++.||||...
T Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         199 PFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence            999998888888898888899999999999999999999999999     89999999999753

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.94  E-value=2.6e-27  Score=225.14  Aligned_cols=134  Identities=34%  Similarity=0.506  Sum_probs=112.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.............|++.|+|||++.+..+ +.++||||+||++|+|++|.+|
T Consensus       130 ~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~  208 (290)
T cd07862         130 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPL  208 (290)
T ss_pred             CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCC
Confidence            389999999999999999999999999987655544456679999999999987776 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc---------------------------CCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           81 FDDENIPNLFKKIKGGIY---------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~---------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |.+.+..+...++.....                           .+.+.+++.+++|+.+||+.||++|||+.|+++||
T Consensus       209 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp  288 (290)
T cd07862         209 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  288 (290)
T ss_pred             cCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCC
Confidence            998876666555543211                           01124677889999999999999999999999999


Q ss_pred             hh
Q 017029          134 WF  135 (379)
Q Consensus       134 ~f  135 (379)
                      ||
T Consensus       289 ~f  290 (290)
T cd07862         289 YF  290 (290)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.94  E-value=3.6e-27  Score=228.85  Aligned_cols=137  Identities=38%  Similarity=0.679  Sum_probs=123.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       121 ~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~  199 (323)
T cd05616         121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA  199 (323)
T ss_pred             CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCC
Confidence            38999999999999999999999999997543 2333456689999999999998877 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~  138 (379)
                      ||.+.+...+...+......+|..++.++.+++.+||+.||.+|++.     .++++||||+..
T Consensus       200 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~  263 (323)
T cd05616         200 PFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  263 (323)
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCC
Confidence            99999998999999988888999999999999999999999999985     799999999743

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=3.2e-27  Score=239.61  Aligned_cols=138  Identities=28%  Similarity=0.487  Sum_probs=113.6

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++ .+||+|||+++....+....+.+||+.|+|||++.+...++.++||||+||++|+|++|.+
T Consensus       190 ~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~  269 (440)
T PTZ00036        190 FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP  269 (440)
T ss_pred             CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            489999999999999665 6999999999877655555567899999999998775444889999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-----------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-----------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+...++....                             ..+|...++++.+||.+||.+||.+|||+.|++
T Consensus       270 pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l  349 (440)
T PTZ00036        270 IFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEAL  349 (440)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence            999876655444442210                             012445678999999999999999999999999


Q ss_pred             cCchhhhc
Q 017029          131 QHPWFQAH  138 (379)
Q Consensus       131 ~hp~f~~~  138 (379)
                      +||||...
T Consensus       350 ~hp~f~~~  357 (440)
T PTZ00036        350 ADPFFDDL  357 (440)
T ss_pred             CChhHHhh
Confidence            99999864

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.94  E-value=4.5e-27  Score=228.31  Aligned_cols=137  Identities=39%  Similarity=0.696  Sum_probs=122.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.... ........+||+.|+|||++.+..+ +.++|+||+||++|+|++|+.
T Consensus       121 ~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~  199 (324)
T cd05587         121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQP  199 (324)
T ss_pred             CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCC
Confidence            48999999999999999999999999987532 2233445689999999999998877 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~  138 (379)
                      ||.+.+..+....+......+|..++.++.+++.+||..||.+|++.     +++++||||+..
T Consensus       200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         200 PFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999988899999988888999999999999999999999999987     799999999753

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=231.93  Aligned_cols=138  Identities=36%  Similarity=0.506  Sum_probs=122.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      +.||||||||||+..+..|||+|||+|+.......++..+.|.+|+|||++....+++.++|+||+|||++|+++-++-|
T Consensus       131 fFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLF  210 (538)
T KOG0661|consen  131 FFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLF  210 (538)
T ss_pred             cccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccC
Confidence            57999999999999889999999999999999889999999999999999988888899999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCc-------------------cCCC-----------CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           82 DDENIPNLFKKIKGGI-------------------YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~-------------------~~~p-----------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .|.+..+..-+|..-.                   +.+|           +..+.++.++|.+||.+||.+|||+.|+++
T Consensus       211 PG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~  290 (538)
T KOG0661|consen  211 PGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQ  290 (538)
T ss_pred             CCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhc
Confidence            9998877776664311                   2222           246889999999999999999999999999


Q ss_pred             Cchhhhcc
Q 017029          132 HPWFQAHL  139 (379)
Q Consensus       132 hp~f~~~~  139 (379)
                      ||||+...
T Consensus       291 ~pffq~~~  298 (538)
T KOG0661|consen  291 HPFFQVGR  298 (538)
T ss_pred             Cccccccc
Confidence            99998654

>PTZ00284 protein kinase; Provisional

Probab=99.94  E-value=2.2e-27  Score=242.21  Aligned_cols=139  Identities=29%  Similarity=0.460  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCC----------------cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccce
Q 017029            1 MVVHRDLKPENLLLDSKW----------------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDV   64 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----------------~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~Di   64 (379)
                      .||||||||+|||++.++                .+||+|||.+.....  .....+||+.|+|||++.+..| +.++||
T Consensus       252 gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~-~~~~Di  328 (467)
T PTZ00284        252 HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGW-MYSTDM  328 (467)
T ss_pred             CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCC-CcHHHH
Confidence            389999999999998765                499999998764322  2345689999999999998877 789999


Q ss_pred             eeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC------------------------------------------
Q 017029           65 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS------------------------------------------  102 (379)
Q Consensus        65 WSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~------------------------------------------  102 (379)
                      ||+||++|||++|+.||++.+..+....+......+|.                                          
T Consensus       329 wSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  408 (467)
T PTZ00284        329 WSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREV  408 (467)
T ss_pred             HHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhh
Confidence            99999999999999999887655444333222111110                                          


Q ss_pred             CCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCcc
Q 017029          103 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY  142 (379)
Q Consensus       103 ~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~  142 (379)
                      ..++.+.+||.+||++||.+|||++|+++||||....+..
T Consensus       409 ~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~~~  448 (467)
T PTZ00284        409 IRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYPEC  448 (467)
T ss_pred             hchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCCcc
Confidence            0134567999999999999999999999999999765543

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.94  E-value=3.9e-27  Score=228.87  Aligned_cols=137  Identities=42%  Similarity=0.741  Sum_probs=122.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.... ........+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       115 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~  193 (323)
T cd05595         115 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL  193 (323)
T ss_pred             CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCC
Confidence            48999999999999999999999999987532 2233345689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+......+|..++++++++|.+||..||.+|+     ++.++++||||...
T Consensus       194 Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         194 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence            999988888888888888888999999999999999999999998     89999999999753

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.94  E-value=5.7e-27  Score=227.54  Aligned_cols=137  Identities=36%  Similarity=0.646  Sum_probs=122.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.... ......+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       121 ~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~  199 (324)
T cd05589         121 KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGES  199 (324)
T ss_pred             CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCC
Confidence            48999999999999999999999999987532 2233446689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+..+....+..+...+|..++.++.++|.+||+.||.+||     ++.++++||||+..
T Consensus       200 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         200 PFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            999999888888898888888999999999999999999999999     68999999999753

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-27  Score=230.88  Aligned_cols=136  Identities=29%  Similarity=0.449  Sum_probs=117.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +.+|||||+.|||+..+|.+|++|||++..++.... ..|.+|||.|||||++.+..| +.++||||||++.+||++|.+
T Consensus       131 ~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y-~~KADIWSLGITaiEla~GeP  209 (467)
T KOG0201|consen  131 KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGY-DTKADIWSLGITAIELAKGEP  209 (467)
T ss_pred             ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhccccc-cchhhhhhhhHHHHHHhcCCC
Confidence            469999999999999999999999999988766543 378899999999999998777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |+.+.++......|-+.. +.+...+|+.+++|+..||++||+.|||+.++++|+|++.
T Consensus       210 P~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  210 PHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             CCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence            999887755433343322 2334578999999999999999999999999999999986

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.93  E-value=9.3e-27  Score=225.60  Aligned_cols=137  Identities=40%  Similarity=0.742  Sum_probs=121.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 ~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~  194 (316)
T cd05592         116 GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCC
Confidence            4899999999999999999999999999765332 33345689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChh-hhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP-EIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~-ell~hp~f~~~  138 (379)
                      ||.+.+...+...+......+|..++.++.++|.+||..||.+||++. ++++||||...
T Consensus       195 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         195 PFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            999999888888888888888889999999999999999999999875 89999999753

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.1e-27  Score=228.30  Aligned_cols=138  Identities=36%  Similarity=0.651  Sum_probs=120.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.... ......+.+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       116 ~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~  195 (330)
T cd05586         116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWS  195 (330)
T ss_pred             CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCC
Confidence            48999999999999999999999999987643 23334567899999999999766544789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCC-CCChhhhcccccccCCCCCCCC----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVDPMKRI----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~Li~~mL~~dP~~Rp----t~~ell~hp~f~~~  138 (379)
                      ||.+.+.....+.+..+...+|. .++++++++|.+||..||.+||    ++.++++||||...
T Consensus       196 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         196 PFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            99999888888888888777775 4799999999999999999998    68999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.93  E-value=6.9e-27  Score=222.90  Aligned_cols=139  Identities=32%  Similarity=0.526  Sum_probs=121.1

Q ss_pred             CEEecCCCCCCeEEcCC-CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||.|||+|.+ |.+||||||.|+....++...+...|..|+|||.+.|...++.+.||||+||++.||+.|++
T Consensus       145 ~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~p  224 (364)
T KOG0658|consen  145 GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQP  224 (364)
T ss_pred             CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCc
Confidence            48999999999999976 99999999999999888877788899999999999988777999999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-----------------cC------------CCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-----------------YT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-----------------~~------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      -|.|++..++...|.+-.                 ..            +....++++.+|+.++|.++|.+|.|+.|++
T Consensus       225 lFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l  304 (364)
T KOG0658|consen  225 LFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEAL  304 (364)
T ss_pred             ccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHh
Confidence            999988777666653211                 11            1134688999999999999999999999999


Q ss_pred             cCchhhhcc
Q 017029          131 QHPWFQAHL  139 (379)
Q Consensus       131 ~hp~f~~~~  139 (379)
                      .||||.+-.
T Consensus       305 ~h~fFdelr  313 (364)
T KOG0658|consen  305 AHPFFDELR  313 (364)
T ss_pred             cchhhHHhh
Confidence            999998653

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.93  E-value=8.6e-27  Score=226.21  Aligned_cols=136  Identities=37%  Similarity=0.644  Sum_probs=121.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~  194 (323)
T cd05575         116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLP  194 (323)
T ss_pred             CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCC-CccccccccchhhhhhhcCCC
Confidence            389999999999999999999999999875432 233345689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh----hhhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~----~ell~hp~f~~  137 (379)
                      ||.+.+..+....+..+...+++.++..+.++|.+||+.||.+||++    .++++||||..
T Consensus       195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         195 PFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            99999988888999888888888899999999999999999999998    59999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.93  E-value=9.6e-27  Score=220.86  Aligned_cols=134  Identities=32%  Similarity=0.495  Sum_probs=108.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+||+++.++.+||+|||++.......  ......|++.|+|||++.+..+ +.++|+||+||++|+|++|+
T Consensus       120 ~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~  198 (287)
T cd07848         120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQ  198 (287)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCC
Confidence            48999999999999999999999999998764332  2234578999999999988776 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccC-------------------C-------------CCCCChhhhcccccccCCCCCCCCCh
Q 017029           79 LPFDDENIPNLFKKIKGGIYT-------------------L-------------PSHLSPGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~-------------------~-------------p~~~s~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      .||.+.+..+....+.....+                   .             ...++.++.+||++||++||.+|||+
T Consensus       199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~  278 (287)
T cd07848         199 PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT  278 (287)
T ss_pred             CCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence            999887654433332211100                   1             11367889999999999999999999


Q ss_pred             hhhhcCchh
Q 017029          127 PEIRQHPWF  135 (379)
Q Consensus       127 ~ell~hp~f  135 (379)
                      +++++||||
T Consensus       279 ~~~l~hp~f  287 (287)
T cd07848         279 EQCLNHPAF  287 (287)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.93  E-value=1.4e-26  Score=227.96  Aligned_cols=139  Identities=33%  Similarity=0.567  Sum_probs=111.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.............||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       143 ~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~p  221 (359)
T cd07876         143 GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVI  221 (359)
T ss_pred             CcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCC
Confidence            489999999999999999999999999986654444456689999999999988877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcC----------------------ccC--------------------CCCCCChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGG----------------------IYT--------------------LPSHLSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~----------------------~~~--------------------~p~~~s~~~~~Li~~mL~~  118 (379)
                      |.+.+....+..+...                      ...                    .+...++.+++||.+||..
T Consensus       222 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  301 (359)
T cd07876         222 FQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVI  301 (359)
T ss_pred             CCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhcc
Confidence            9876544332222110                      000                    0112357789999999999


Q ss_pred             CCCCCCChhhhhcCchhhhccC
Q 017029          119 DPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ||.+|||+.|+++||||.....
T Consensus       302 dP~~R~t~~e~l~hp~~~~~~~  323 (359)
T cd07876         302 DPDKRISVDEALRHPYITVWYD  323 (359)
T ss_pred             CcccCCCHHHHhcCchhhhhcC
Confidence            9999999999999999986543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.93  E-value=9.5e-27  Score=229.53  Aligned_cols=137  Identities=34%  Similarity=0.576  Sum_probs=113.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||+++............|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       146 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~p  224 (364)
T cd07875         146 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVL  224 (364)
T ss_pred             CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCC
Confidence            489999999999999999999999999987655544556689999999999988777 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCC------------------------------------------CCCCChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGGIYTL------------------------------------------PSHLSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~------------------------------------------p~~~s~~~~~Li~~mL~~  118 (379)
                      |.+.+....+.++.......                                          ....+..+++||.+||+.
T Consensus       225 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~  304 (364)
T cd07875         225 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  304 (364)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCc
Confidence            99877666555543211100                                          011245788999999999


Q ss_pred             CCCCCCChhhhhcCchhhhc
Q 017029          119 DPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+|||+.++++||||...
T Consensus       305 dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         305 DASKRISVDEALQHPYINVW  324 (364)
T ss_pred             CcccCCCHHHHhcCcccccc
Confidence            99999999999999999854

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.93  E-value=8.9e-27  Score=225.76  Aligned_cols=137  Identities=39%  Similarity=0.723  Sum_probs=122.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.... ......+.+|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       116 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~  194 (318)
T cd05570         116 GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQS  194 (318)
T ss_pred             CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCC
Confidence            48999999999999999999999999987532 2233345679999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~  138 (379)
                      ||.+.+.......+......+|..++.++.+||.+||..||.+|||+     .+++.||||+..
T Consensus       195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~  258 (318)
T cd05570         195 PFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI  258 (318)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999888888888888888888999999999999999999999999     999999999753

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.93  E-value=1.2e-26  Score=225.69  Aligned_cols=138  Identities=39%  Similarity=0.654  Sum_probs=116.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.++.+||+|||+++......  .....+||+.|+|||++.+....+.++||||+||++|+|++|.
T Consensus       125 ~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~  204 (332)
T cd05614         125 GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGA  204 (332)
T ss_pred             CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCC
Confidence            37999999999999999999999999998653322  2234679999999999987654578999999999999999999


Q ss_pred             CCCCCC----ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           79 LPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      .||...    ........+......+|..+++.++++|.+||+.||++||     +++++++||||+..
T Consensus       205 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         205 SPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999643    3344556666667778888999999999999999999999     78899999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.93  E-value=1.1e-26  Score=225.16  Aligned_cols=137  Identities=38%  Similarity=0.709  Sum_probs=121.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... .....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       116 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~  194 (316)
T cd05619         116 GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQS  194 (316)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCC
Confidence            489999999999999999999999999875322 223345679999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChh-hhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP-EIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~-ell~hp~f~~~  138 (379)
                      ||.+.+..++.+.+......+|..++.+++++|.+||..||.+|+++. ++++||||+..
T Consensus       195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         195 PFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence            999988888888888777778888999999999999999999999996 89999999864

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.93  E-value=1.6e-26  Score=225.30  Aligned_cols=137  Identities=36%  Similarity=0.666  Sum_probs=116.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++... ......+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       116 ~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~  194 (329)
T cd05618         116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCC-CCccceecccHHHHHHhhCCC
Confidence            38999999999999999999999999987532 2333456689999999999988777 789999999999999999999


Q ss_pred             CCCC---------CChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC------hhhhhcCchhhhc
Q 017029           80 PFDD---------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT------IPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt------~~ell~hp~f~~~  138 (379)
                      ||..         .....+.+.+......+|..++..+.++|.+||+.||.+|+|      +.++++||||+..
T Consensus       195 Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         195 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             CCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9952         122335566777778889999999999999999999999998      5799999999753

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.3e-26  Score=223.26  Aligned_cols=137  Identities=42%  Similarity=0.709  Sum_probs=128.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      ||.||||.+||++|.+|++||+|||+++.- .++...+|.||||.|+|||++.-..| +.++|+||+||+||||+.|++|
T Consensus       471 IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpP  549 (683)
T KOG0696|consen  471 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPP  549 (683)
T ss_pred             eeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCC
Confidence            899999999999999999999999999864 45567789999999999999998888 8999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhcc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAHL  139 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~~  139 (379)
                      |++++..++++.|......+|..+|.++.++++..|.+.|.+|..+     ++|..||||+...
T Consensus       550 FdGeDE~elF~aI~ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iD  613 (683)
T KOG0696|consen  550 FDGEDEDELFQAIMEHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRID  613 (683)
T ss_pred             CCCCCHHHHHHHHHHccCcCcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhcc
Confidence            9999999999999999999999999999999999999999999965     5799999998654

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.93  E-value=1.4e-26  Score=225.63  Aligned_cols=136  Identities=36%  Similarity=0.685  Sum_probs=116.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.. ..+....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       116 ~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~  194 (329)
T cd05588         116 GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRS  194 (329)
T ss_pred             CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCC-CCccceechHHHHHHHHHCCC
Confidence            3899999999999999999999999998753 23344456789999999999998777 789999999999999999999


Q ss_pred             CCCCC---------ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC------hhhhhcCchhhh
Q 017029           80 PFDDE---------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT------IPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt------~~ell~hp~f~~  137 (379)
                      ||+..         ......+.+......+|..++.++.++|.+||+.||.+|+|      ++++++||||..
T Consensus       195 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         195 PFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             CcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            99631         22335666777778889999999999999999999999997      789999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.93  E-value=8.4e-27  Score=222.40  Aligned_cols=135  Identities=28%  Similarity=0.515  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++..... .......|++.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       123 ~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~  202 (288)
T cd07871         123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP  202 (288)
T ss_pred             CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999998765332 233455789999999998765444789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-------------------cCC-----------CCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-------------------YTL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-------------------~~~-----------p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+.+..+....+....                   +.+           .+.++.++++||.+||++||.+|||++|+
T Consensus       203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~  282 (288)
T cd07871         203 MFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA  282 (288)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence            998877665544432211                   001           12467889999999999999999999999


Q ss_pred             hcCchh
Q 017029          130 RQHPWF  135 (379)
Q Consensus       130 l~hp~f  135 (379)
                      ++||||
T Consensus       283 l~hp~f  288 (288)
T cd07871         283 LRHSYF  288 (288)
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.93  E-value=1.2e-26  Score=223.66  Aligned_cols=138  Identities=42%  Similarity=0.734  Sum_probs=125.7

Q ss_pred             CEEecCCCCCCeEEcCC------CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSK------WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~------~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .||||||||.||||+..      -.+||+|||+++.+..+....|.||||.|||||++....| +.|+|+||+|+|+|++
T Consensus       129 ~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~Y-dAKADLWSiG~Ilyq~  207 (429)
T KOG0595|consen  129 NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQY-DAKADLWSIGTILYQC  207 (429)
T ss_pred             CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccc-cchhhHHHHHHHHHHH
Confidence            38999999999999875      4589999999999999999999999999999999988888 6899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccC---CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ++|+.||+..+..+++..+..+...   ++..++....+++...|..+|.+|.+..+-+.|+++....
T Consensus       208 l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  208 LTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            9999999999999999998877643   3457888899999999999999999999999999987653

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.93  E-value=1.7e-26  Score=226.84  Aligned_cols=138  Identities=33%  Similarity=0.581  Sum_probs=111.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||+++............|++.|+|||++.+..+ +.++||||+||++|+|++|+.|
T Consensus       139 givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p  217 (355)
T cd07874         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKIL  217 (355)
T ss_pred             CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence            379999999999999999999999999987655544556789999999999988777 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc---------------------------C---------------CCCCCChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGGIY---------------------------T---------------LPSHLSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~---------------------------~---------------~p~~~s~~~~~Li~~mL~~  118 (379)
                      |.+.+....+..+.....                           .               .+...+.++++||.+||..
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  297 (355)
T cd07874         218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  297 (355)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcC
Confidence            988765443332211100                           0               0112356788999999999


Q ss_pred             CCCCCCChhhhhcCchhhhcc
Q 017029          119 DPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+|||+.|+++||||....
T Consensus       298 dP~~Rps~~ell~hp~~~~~~  318 (355)
T cd07874         298 DPAKRISVDEALQHPYINVWY  318 (355)
T ss_pred             CchhcCCHHHHhcCcchhccc
Confidence            999999999999999998553

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.93  E-value=1.9e-26  Score=218.64  Aligned_cols=134  Identities=35%  Similarity=0.534  Sum_probs=111.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.............|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       128 ~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~  206 (288)
T cd07863         128 CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPL  206 (288)
T ss_pred             CeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcC
Confidence            389999999999999999999999999987755444455678999999999987776 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc------------------c---------CCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           81 FDDENIPNLFKKIKGGI------------------Y---------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~------------------~---------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |.+........++....                  +         ...+.++..+.++|.+||+.||.+|||+.|++.||
T Consensus       207 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp  286 (288)
T cd07863         207 FCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHP  286 (288)
T ss_pred             cCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCC
Confidence            98876665554443210                  0         01124677889999999999999999999999999


Q ss_pred             hh
Q 017029          134 WF  135 (379)
Q Consensus       134 ~f  135 (379)
                      ||
T Consensus       287 ~f  288 (288)
T cd07863         287 FF  288 (288)
T ss_pred             CC
Confidence            98

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.93  E-value=1.5e-26  Score=223.84  Aligned_cols=137  Identities=35%  Similarity=0.657  Sum_probs=122.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       118 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~  196 (318)
T cd05582         118 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSL  196 (318)
T ss_pred             CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCC
Confidence            3899999999999999999999999999765443 23345689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+......+|..+++++.++|.+||+.||.+|||     +.+++.||||...
T Consensus       197 p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         197 PFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCC
Confidence            9999888888888888888899999999999999999999999999     6779999999753

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=3.2e-26  Score=223.78  Aligned_cols=136  Identities=42%  Similarity=0.785  Sum_probs=117.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc------------------------------ccccccCCCCccCcc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH------------------------------FLKTSCGSPNYAAPE   50 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~------------------------------~~~~~~gt~~y~APE   50 (379)
                      .|+||||||+|||++.++.+||+|||++.......                              ......||+.|+|||
T Consensus       121 giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  200 (350)
T cd05573         121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPE  200 (350)
T ss_pred             CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            48999999999999999999999999998664432                              233457999999999


Q ss_pred             cccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhc--CccCCCC--CCChhhhcccccccCCCCCCCCC-
Q 017029           51 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPS--HLSPGARDLIPRMLIVDPMKRIT-  125 (379)
Q Consensus        51 ~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~Li~~mL~~dP~~Rpt-  125 (379)
                      ++.+..+ +.++||||+||++|+|++|..||.+.+......++..  ....+|.  .+++++.+||.+||. ||.+|++ 
T Consensus       201 ~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s  278 (350)
T cd05573         201 VLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGS  278 (350)
T ss_pred             HHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCC
Confidence            9998877 7899999999999999999999999888777777776  4444554  359999999999997 9999999 


Q ss_pred             hhhhhcCchhhhc
Q 017029          126 IPEIRQHPWFQAH  138 (379)
Q Consensus       126 ~~ell~hp~f~~~  138 (379)
                      ++++++||||+..
T Consensus       279 ~~~ll~hp~~~~~  291 (350)
T cd05573         279 FEEIKSHPFFKGI  291 (350)
T ss_pred             HHHHhcCCCcCCC
Confidence            9999999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.93  E-value=2.7e-26  Score=222.96  Aligned_cols=136  Identities=37%  Similarity=0.647  Sum_probs=120.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.... .....+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~  194 (325)
T cd05602         116 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLP  194 (325)
T ss_pred             CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCC-CCccccccccHHHHHHhcCCC
Confidence            389999999999999999999999999875432 233456689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChh----hhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP----EIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~----ell~hp~f~~  137 (379)
                      ||.+.+..+.+..+......+++.++..+.++|.+||+.||.+|+++.    ++++|+||..
T Consensus       195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         195 PFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence            999998888888888877788888999999999999999999999876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.93  E-value=3.2e-26  Score=221.88  Aligned_cols=136  Identities=36%  Similarity=0.631  Sum_probs=120.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|.+||+|||++..... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~  194 (321)
T cd05603         116 NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLP  194 (321)
T ss_pred             CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCC
Confidence            489999999999999999999999999875422 223345689999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh----hhhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~----~ell~hp~f~~  137 (379)
                      ||.+.+.......+......+|...+..+.++|.+||+.||.+|+++    .++++|+||..
T Consensus       195 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         195 PFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            99999988888999888888888899999999999999999999976    49999999974

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.93  E-value=1.8e-26  Score=221.49  Aligned_cols=138  Identities=26%  Similarity=0.427  Sum_probs=106.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       123 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  202 (303)
T cd07869         123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA  202 (303)
T ss_pred             CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            3899999999999999999999999998754322 233456789999999998765544789999999999999999999


Q ss_pred             CCCCCCh-HHHHHHHhcC--c---------cC------------CC---------CCCChhhhcccccccCCCCCCCCCh
Q 017029           80 PFDDENI-PNLFKKIKGG--I---------YT------------LP---------SHLSPGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        80 Pf~~~~~-~~~~~~i~~~--~---------~~------------~p---------~~~s~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      ||.+... ......+...  .         ..            .|         ...+.++.+|+.+||+.||.+|||+
T Consensus       203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~  282 (303)
T cd07869         203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA  282 (303)
T ss_pred             CCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence            9987432 2222222110  0         00            00         0234678899999999999999999


Q ss_pred             hhhhcCchhhhc
Q 017029          127 PEIRQHPWFQAH  138 (379)
Q Consensus       127 ~ell~hp~f~~~  138 (379)
                      .|+++||||++.
T Consensus       283 ~~~l~h~~f~~~  294 (303)
T cd07869         283 QAALSHEYFSDL  294 (303)
T ss_pred             HHHhcCcccccC
Confidence            999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.93  E-value=2.4e-26  Score=223.31  Aligned_cols=137  Identities=36%  Similarity=0.612  Sum_probs=121.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       116 givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~  194 (325)
T cd05604         116 NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLP  194 (325)
T ss_pred             CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCC
Confidence            389999999999999999999999999875422 233345689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~----~ell~hp~f~~~  138 (379)
                      ||.+.+..+.++++.......++..+..+.++|.+||..||.+||++    .+++.||||...
T Consensus       195 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         195 PFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             CCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence            99999888888888888777788899999999999999999999987    489999999753

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.1e-26  Score=232.46  Aligned_cols=129  Identities=36%  Similarity=0.632  Sum_probs=114.9

Q ss_pred             EEecCCCCCCeEE-cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl-~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      ||||||||+|||+ ++.|+++|+|||.++.....  +.+.|-|..|.|||++....| ++++||||||++||+|++|+.|
T Consensus       436 vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp  512 (612)
T KOG0603|consen  436 VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTL  512 (612)
T ss_pred             eeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCc
Confidence            8999999999999 58999999999999877654  556788899999999998877 8999999999999999999999


Q ss_pred             CCCCChH-HHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           81 FDDENIP-NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        81 f~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |...... ++...|..+.+.  ..+|..+++||++||++||.+|+++.+++.||||
T Consensus       513 ~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  513 FAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             cccCCchHHHHHhhcCCccc--cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            9875444 666777655444  7899999999999999999999999999999999

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.93  E-value=3.2e-26  Score=210.15  Aligned_cols=137  Identities=36%  Similarity=0.584  Sum_probs=116.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccccc-ccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~-~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||.|+|++++|.+||+|||+++.+.......+ .+-|..|+|||.+.|...++..+|+||.|||+.||+-|.+-
T Consensus       122 IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~  201 (318)
T KOG0659|consen  122 ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPF  201 (318)
T ss_pred             hhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCC
Confidence            78999999999999999999999999999876544433 37899999999998877779999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC--------------------CC--------CCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           81 FDDENIPNLFKKIKGGIYT--------------------LP--------SHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~--------------------~p--------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |.|++.-++...|-+...+                    +|        +..+.++.||+.+||.+||.+|+|+.|+++|
T Consensus       202 fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  202 FPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             CCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            9998877776666432111                    11        1346788999999999999999999999999


Q ss_pred             chhhhc
Q 017029          133 PWFQAH  138 (379)
Q Consensus       133 p~f~~~  138 (379)
                      +||+..
T Consensus       282 ~yf~~~  287 (318)
T KOG0659|consen  282 PYFKSL  287 (318)
T ss_pred             hhhhcC
Confidence            999863

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.93  E-value=4.1e-26  Score=222.13  Aligned_cols=137  Identities=34%  Similarity=0.653  Sum_probs=117.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++... ......+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       116 ~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~  194 (327)
T cd05617         116 GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRS  194 (327)
T ss_pred             CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCC
Confidence            38999999999999999999999999987532 2334456789999999999988777 789999999999999999999


Q ss_pred             CCCC-------CChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC------hhhhhcCchhhhc
Q 017029           80 PFDD-------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT------IPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt------~~ell~hp~f~~~  138 (379)
                      ||..       .......+.+......+|..++..+.++|.+||+.||.+|++      +++++.||||+..
T Consensus       195 pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         195 PFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             CCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            9953       223345666677777888899999999999999999999998      4699999999854

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.93  E-value=4.4e-26  Score=221.54  Aligned_cols=137  Identities=39%  Similarity=0.685  Sum_probs=122.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... +......+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       121 ~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~  199 (323)
T cd05615         121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQP  199 (323)
T ss_pred             CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCC
Confidence            489999999999999999999999999876432 223345679999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~  138 (379)
                      ||.+.+...+.+.+......+|..++.++.+++.+||..||.+|++.     +++++||||+..
T Consensus       200 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         200 PFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence            99999888888999888888899999999999999999999999974     789999999854

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=1e-25  Score=221.96  Aligned_cols=138  Identities=32%  Similarity=0.460  Sum_probs=119.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC--cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+|||||..|||||.+|.+||+|||+++++...  ..++..+-|.+|+|||++.|..-++.++|+||+||||.||+.|+
T Consensus       238 gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gk  317 (560)
T KOG0600|consen  238 GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGK  317 (560)
T ss_pred             CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCC
Confidence            3899999999999999999999999999976543  35677788999999999999887799999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc----------CCC-------------------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           79 LPFDDENIPNLFKKIKGGIY----------TLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~----------~~p-------------------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      +.|.|.+..++.++|-+...          .+|                   ..+++.+.+|+..||..||.+|.|+.++
T Consensus       318 PI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~a  397 (560)
T KOG0600|consen  318 PILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSA  397 (560)
T ss_pred             CCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHH
Confidence            99999998888887743211          122                   1367888999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++++||...
T Consensus       398 L~seyF~t~  406 (560)
T KOG0600|consen  398 LQSEYFTTE  406 (560)
T ss_pred             hcCcccccC
Confidence            999999543

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.92  E-value=4.5e-26  Score=221.24  Aligned_cols=137  Identities=32%  Similarity=0.552  Sum_probs=107.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccC--CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.+||+|||+++......    .....+|++.|+|||++.+  ..+ +.++||||+||++|+|
T Consensus       123 ~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el  201 (338)
T cd07859         123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEV  201 (338)
T ss_pred             CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHH
Confidence            48999999999999999999999999997643221    1234579999999999865  344 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhc---------------C-----------ccCC-----CCCCChhhhcccccccCCCCCCC
Q 017029           75 LCGTLPFDDENIPNLFKKIKG---------------G-----------IYTL-----PSHLSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~---------------~-----------~~~~-----p~~~s~~~~~Li~~mL~~dP~~R  123 (379)
                      ++|+.||.+.+.......+..               .           ..+.     -+.+++.+.++|.+||..||.+|
T Consensus       202 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R  281 (338)
T cd07859         202 LTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDR  281 (338)
T ss_pred             HcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccC
Confidence            999999987654332221110               0           0000     02467788999999999999999


Q ss_pred             CChhhhhcCchhhhc
Q 017029          124 ITIPEIRQHPWFQAH  138 (379)
Q Consensus       124 pt~~ell~hp~f~~~  138 (379)
                      ||++|+++||||+..
T Consensus       282 pt~~e~l~hp~f~~~  296 (338)
T cd07859         282 PTAEEALADPYFKGL  296 (338)
T ss_pred             CCHHHHhcCchhhhc
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.92  E-value=1.1e-25  Score=223.28  Aligned_cols=138  Identities=38%  Similarity=0.676  Sum_probs=117.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCC---CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~---~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||++.......  ...+.+||+.|+|||++.+..   +.+.++|+||+||++|+|+
T Consensus       162 ~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyell  241 (370)
T cd05596         162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  241 (370)
T ss_pred             CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHH
Confidence            48999999999999999999999999998764332  224568999999999987542   2478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhhhcccccccCCCCCC--CCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+.+....+.++....  ..+|.  .++.++++||.+||..+|.+  |+|++++++||||+..
T Consensus       242 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         242 VGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             hCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            9999999998888888887643  34454  57999999999999999988  9999999999999864

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.92  E-value=6.1e-26  Score=216.10  Aligned_cols=138  Identities=31%  Similarity=0.505  Sum_probs=116.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +|+||||||.||||+++|.+||+|||+++... ....+...++|..|+|||++.|...++..+||||+|||++||++++.
T Consensus       140 ~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~  219 (323)
T KOG0594|consen  140 GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRP  219 (323)
T ss_pred             CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCC
Confidence            58999999999999999999999999999776 44556777899999999999998667899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc------------------CCC------------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGIY------------------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~------------------~~p------------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      -|.+.+..++...|-.-..                  .++            +..+++..+++.+||+.+|.+|+|++.+
T Consensus       220 LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~a  299 (323)
T KOG0594|consen  220 LFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGA  299 (323)
T ss_pred             CCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHH
Confidence            9999887776666532110                  111            1233588899999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      +.||||...
T Consensus       300 l~h~yf~~~  308 (323)
T KOG0594|consen  300 LTHPYFSEL  308 (323)
T ss_pred             hcChhhccc
Confidence            999999865

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.92  E-value=7.5e-26  Score=223.36  Aligned_cols=136  Identities=38%  Similarity=0.644  Sum_probs=112.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc------------------------------------ccccccCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH------------------------------------FLKTSCGSP   44 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~------------------------------------~~~~~~gt~   44 (379)
                      .|+||||||+|||++.++.+||+|||+++......                                    ...+.+||+
T Consensus       121 givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~  200 (363)
T cd05628         121 GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTP  200 (363)
T ss_pred             CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCc
Confidence            48999999999999999999999999987543210                                    112458999


Q ss_pred             CccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhhhcccccccCCCC
Q 017029           45 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDP  120 (379)
Q Consensus        45 ~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~mL~~dP  120 (379)
                      .|+|||++.+..+ +.++||||+||++|+|++|..||.+.+....+.++...  ...+|+  .++++++++|.+|+. +|
T Consensus       201 ~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~  278 (363)
T cd05628         201 DYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EW  278 (363)
T ss_pred             cccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-Ch
Confidence            9999999988877 78999999999999999999999998888888888753  334453  478999999999775 44


Q ss_pred             C---CCCChhhhhcCchhhhc
Q 017029          121 M---KRITIPEIRQHPWFQAH  138 (379)
Q Consensus       121 ~---~Rpt~~ell~hp~f~~~  138 (379)
                      .   .||+++||++||||+..
T Consensus       279 ~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         279 EHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             hhcCCCCCHHHHhCCCCCCCC
Confidence            4   45899999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=8.2e-26  Score=218.18  Aligned_cols=140  Identities=37%  Similarity=0.647  Sum_probs=121.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc----------------------------------CCc------------
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR----------------------------------DGH------------   35 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~----------------------------------~~~------------   35 (379)
                      ||+||||||||||-++|+|.|+||.+|....                                  ...            
T Consensus       200 ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~  279 (459)
T KOG0610|consen  200 IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRS  279 (459)
T ss_pred             eeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccccccccc
Confidence            8999999999999999999999999863210                                  000            


Q ss_pred             -----------ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC--
Q 017029           36 -----------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--  102 (379)
Q Consensus        36 -----------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--  102 (379)
                                 .....+||-.|.|||++.|... +.++|+|+|||++|||+.|..||.|.+..+.+.+|......+|.  
T Consensus       280 ~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~  358 (459)
T KOG0610|consen  280 LPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP  358 (459)
T ss_pred             chhhhcCCCCccccccccccccccceeeecCCC-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC
Confidence                       0122468899999999999988 89999999999999999999999999999999999998888875  


Q ss_pred             CCChhhhcccccccCCCCCCCCC----hhhhhcCchhhhccCcc
Q 017029          103 HLSPGARDLIPRMLIVDPMKRIT----IPEIRQHPWFQAHLPRY  142 (379)
Q Consensus       103 ~~s~~~~~Li~~mL~~dP~~Rpt----~~ell~hp~f~~~~~~~  142 (379)
                      .++..++|||+++|.+||.+|+.    +.||.+||||+...+..
T Consensus       359 ~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaL  402 (459)
T KOG0610|consen  359 EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWAL  402 (459)
T ss_pred             cchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhh
Confidence            57899999999999999999998    99999999999765443

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.92  E-value=6.8e-26  Score=233.16  Aligned_cols=137  Identities=36%  Similarity=0.641  Sum_probs=121.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||+++.....   ....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       163 ~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG  241 (496)
T PTZ00283        163 HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTL  241 (496)
T ss_pred             CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHC
Confidence            4899999999999999999999999999765432   22345689999999999988777 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+...+..++..+.+ ++|..+++++.+++.+||..||.+|||+.++++|||++..
T Consensus       242 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        242 KRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            999999988888888776654 4678899999999999999999999999999999999864

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=7.3e-26  Score=224.78  Aligned_cols=136  Identities=34%  Similarity=0.557  Sum_probs=106.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCC----------CCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLY----------AGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~----------~~~~~DiWSl   67 (379)
                      .|||.||||.|+|+- .|.+||+|||+++.+....   ...+.+||++||+||.+....+          .+.++|||||
T Consensus       480 gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSL  558 (677)
T KOG0596|consen  480 GIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSL  558 (677)
T ss_pred             ceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhh
Confidence            489999999999985 5889999999999876542   2245699999999998853222          2678999999


Q ss_pred             hhHHHHHhhCCCCCCCCC-hHHHHHHHhcC--ccCCCCCCChh-hhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           68 GVILYALLCGTLPFDDEN-IPNLFKKIKGG--IYTLPSHLSPG-ARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~-~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |||||+|+.|++||..-. ...-+..|...  ..++|..-+.. +.++++.||..||++|||+.|+|+|||++.
T Consensus       559 GCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~  632 (677)
T KOG0596|consen  559 GCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI  632 (677)
T ss_pred             hhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence            999999999999997532 22223333332  23556544444 999999999999999999999999999874

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=8.9e-26  Score=219.84  Aligned_cols=135  Identities=38%  Similarity=0.672  Sum_probs=115.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.....  ...+.+|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       121 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~p  197 (333)
T cd05600         121 GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPP  197 (333)
T ss_pred             CccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCC
Confidence            379999999999999999999999999976543  3346689999999999988876 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc--cCCCC------CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGI--YTLPS------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |.+.+..+.+..+....  ...|.      .+++++.++|.+||..+|.+|||++++++||||...
T Consensus       198 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             CCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            99988877777665432  12222      458999999999999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.92  E-value=4.6e-26  Score=225.16  Aligned_cols=137  Identities=34%  Similarity=0.575  Sum_probs=129.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|||||+.||+++.++.|||+|||+++.+.... ...+..|||.|++||++.+..| +.++|||||||++|||++-+.
T Consensus       126 ~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~  204 (426)
T KOG0589|consen  126 RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKP  204 (426)
T ss_pred             hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhccc
Confidence            48999999999999999999999999999998776 7788899999999999999998 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|.+.+...+..+|..+. .++|..++.+++.+|+.||..+|..||++.+++.+|.+...
T Consensus       205 aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  205 AFKASNMSELILKINRGLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             ccCccchHHHHHHHhhccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            999999999999999888 57889999999999999999999999999999999887744

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.92  E-value=7.9e-26  Score=214.82  Aligned_cols=137  Identities=36%  Similarity=0.645  Sum_probs=115.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++.....+.. .....|++.|+|||++.+..+ +.++|+||+||++|+|++|+.
T Consensus       117 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~  195 (280)
T cd05608         117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARG  195 (280)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCC
Confidence            389999999999999999999999999977654432 234579999999999998877 789999999999999999999


Q ss_pred             CCCCCCh----HHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.....    ......+......+|..+++.+.+++.+||+.||.+||     |++++++||||+..
T Consensus       196 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         196 PFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             CCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            9986532    23344444555566778999999999999999999999     78999999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=1.1e-25  Score=214.43  Aligned_cols=136  Identities=31%  Similarity=0.584  Sum_probs=116.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+||++++++.++|+|||++............+|++.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus       123 ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf  201 (285)
T cd05605         123 IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPF  201 (285)
T ss_pred             cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCC
Confidence            79999999999999999999999999987755554456689999999999987766 78999999999999999999999


Q ss_pred             CCCChHHH----HHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           82 DDENIPNL----FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        82 ~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      .+.+....    ...+......++..++..+.+||.+||..||.+||     +++++++||||...
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         202 RQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             CCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCC
Confidence            88655332    33344455566778999999999999999999999     89999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-25  Score=218.94  Aligned_cols=137  Identities=31%  Similarity=0.478  Sum_probs=111.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-c----cccccCCCCccCccccc-C-CCCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-F----LKTSCGSPNYAAPEVIS-G-KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~----~~~~~gt~~y~APE~l~-~-~~~~~~~~DiWSlGvilyel   74 (379)
                      -||||||+.||||+++|.|||+|||.+..+-+.. .    .++.+|+|+|||||++. . .+| +.|+||||||++..||
T Consensus       147 ~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GY-dfKaDIwSfGITA~EL  225 (516)
T KOG0582|consen  147 HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGY-DFKADIWSFGITACEL  225 (516)
T ss_pred             ceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCc-cchhhhhhhhHHHHHH
Confidence            4899999999999999999999999987764332 1    16679999999999953 2 345 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccCCC----------CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYTLP----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~~p----------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      .+|..||.........-.-.++.++.+          ..++..++++|..||+.||.+|||++++++|+||+...
T Consensus       226 A~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k  300 (516)
T KOG0582|consen  226 AHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK  300 (516)
T ss_pred             hcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence            999999999877665433334433322          23677899999999999999999999999999999764

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.92  E-value=1.5e-25  Score=218.86  Aligned_cols=136  Identities=32%  Similarity=0.557  Sum_probs=109.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++......  ..+.+|++.|+|||++.+....+.++||||+||++|+|++|+.|
T Consensus       138 ~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  215 (343)
T cd07878         138 GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKAL  215 (343)
T ss_pred             CeecccCChhhEEECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCC
Confidence            4899999999999999999999999999875432  34567999999999998754457899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-----------------------CCC--------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-----------------------TLP--------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-----------------------~~p--------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+..+....+.....                       ..+        ...++.+.+||.+||..||.+|||+.|+
T Consensus       216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~el  295 (343)
T cd07878         216 FPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEA  295 (343)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            988665544443321110                       011        1345678899999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++||||...
T Consensus       296 l~hp~~~~~  304 (343)
T cd07878         296 LAHPYFSQY  304 (343)
T ss_pred             hcCcchhcc
Confidence            999999864

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-25  Score=220.22  Aligned_cols=129  Identities=35%  Similarity=0.573  Sum_probs=110.9

Q ss_pred             EEecCCCCCCeEEcCCC-cEEEEecCCcccccCC-cccccccCCCCccCccccc--CCCCCCCccceeeehhHHHHHhhC
Q 017029            2 VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS--GKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~--~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      ||||||||+|||++.++ ++||+|||+++..... ...+...||+.|||||++.  ...| +.++||||||+++|||+||
T Consensus       164 iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~  242 (362)
T KOG0192|consen  164 IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTG  242 (362)
T ss_pred             eeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHC
Confidence            89999999999999998 9999999999887654 2333468999999999999  4466 8999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHh--cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.........+.  .....+|..+++.+..++.+||..||.+||++.+++.
T Consensus       243 ~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  243 EIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999988765555543  3345667789999999999999999999999999875

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.92  E-value=1.5e-25  Score=218.44  Aligned_cols=135  Identities=27%  Similarity=0.542  Sum_probs=109.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+|||++.++.+||+|||++...... ......|++.|+|||++.+..+ +.++||||+||++|+|++|+.||
T Consensus       125 ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~  202 (331)
T cd06649         125 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPI  202 (331)
T ss_pred             EEcCCCChhhEEEcCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCC
Confidence            899999999999999999999999998765432 2345679999999999988776 78999999999999999999999


Q ss_pred             CCCChHHHHHHHhc----------------------------------------------Cc-cCC-CCCCChhhhcccc
Q 017029           82 DDENIPNLFKKIKG----------------------------------------------GI-YTL-PSHLSPGARDLIP  113 (379)
Q Consensus        82 ~~~~~~~~~~~i~~----------------------------------------------~~-~~~-p~~~s~~~~~Li~  113 (379)
                      ...+..++...+..                                              .. ... ...+++++++||.
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  282 (331)
T cd06649         203 PPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVN  282 (331)
T ss_pred             CCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHH
Confidence            77655443322211                                              00 011 1236788999999


Q ss_pred             cccCCCCCCCCChhhhhcCchhhhc
Q 017029          114 RMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       114 ~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +||..||++|||+.++++||||+..
T Consensus       283 ~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         283 KCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             HHccCCcccCCCHHHHhcChHHhhc
Confidence            9999999999999999999999854

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.92  E-value=1e-25  Score=217.31  Aligned_cols=135  Identities=32%  Similarity=0.495  Sum_probs=101.8

Q ss_pred             CEEecCCCCCCeEE----cCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl----~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+|||+    +.++.+||+|||+++......    .....+||+.|+|||++.+...++.++|+||+||++|
T Consensus       128 ~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  207 (317)
T cd07868         128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  207 (317)
T ss_pred             CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHH
Confidence            38999999999999    456789999999998764321    2345678999999999987654588999999999999


Q ss_pred             HHhhCCCCCCCCChH---------HHHHHHhcC----------------------------ccC----------CCCCCC
Q 017029           73 ALLCGTLPFDDENIP---------NLFKKIKGG----------------------------IYT----------LPSHLS  105 (379)
Q Consensus        73 elltG~~Pf~~~~~~---------~~~~~i~~~----------------------------~~~----------~p~~~s  105 (379)
                      +|++|..||.+....         .....+...                            ...          .....+
T Consensus       208 el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (317)
T cd07868         208 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD  287 (317)
T ss_pred             HHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCC
Confidence            999999999753210         111111100                            000          001234


Q ss_pred             hhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029          106 PGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus       106 ~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      .++.+||.+||+.||.+|||++|+++||||
T Consensus       288 ~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         288 SKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            568899999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.92  E-value=2.9e-26  Score=227.89  Aligned_cols=132  Identities=30%  Similarity=0.513  Sum_probs=118.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      +|||||||.-||||..+..|||+|||.++...+......++||..|||||+|..... +.++|||||||+|||||||..|
T Consensus       232 KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiP  310 (904)
T KOG4721|consen  232 KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIP  310 (904)
T ss_pred             hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCC
Confidence            689999999999999999999999999998877766678899999999999999887 7999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           81 FDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |.+-+...+...+....  .+.|..+++.++=||++||.-.|..||++.+|+.|-
T Consensus       311 YkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  311 YKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             ccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            99877666655554433  467889999999999999999999999999999994

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.92  E-value=2.3e-25  Score=221.02  Aligned_cols=138  Identities=36%  Similarity=0.684  Sum_probs=114.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCC---CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~---~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||++........  ..+.+||+.|+|||++.+..   +.+.++|+||+||++|+|+
T Consensus       162 ~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell  241 (370)
T cd05621         162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEML  241 (370)
T ss_pred             CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHH
Confidence            489999999999999999999999999987643322  24668999999999997543   2478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhhhcccccccCCCCCC--CCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+.+....+.++....  ..+|.  .++..+++++.+||..++.+  |+|+.|+++||||+..
T Consensus       242 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         242 VGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             hCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            9999999988888888876543  44454  46899999999999865543  8899999999999864

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.92  E-value=9.6e-26  Score=228.43  Aligned_cols=135  Identities=34%  Similarity=0.463  Sum_probs=111.6

Q ss_pred             CEEecCCCCCCeEEcCC--CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~--~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|||+|||||||||...  ..|||+|||.|.......  .+.+.|..|+|||++.|..| +.+.|+||||||+.||++|.
T Consensus       309 ~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~v--ytYiQSRfYRAPEVILGlpY-~~~IDmWSLGCIlAEL~tG~  385 (586)
T KOG0667|consen  309 GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRV--YTYIQSRFYRAPEVILGLPY-DTAIDMWSLGCILAELFTGE  385 (586)
T ss_pred             CeeeccCChhheeeccCCcCceeEEecccccccCCcc--eeeeeccccccchhhccCCC-CCccceeehhhhHHhHhcCc
Confidence            48999999999999753  479999999998865544  38899999999999999999 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccC----------------------------------------------------CCC----
Q 017029           79 LPFDDENIPNLFKKIKGGIYT----------------------------------------------------LPS----  102 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------------~p~----  102 (379)
                      +-|.|++..+++..|..-...                                                    .|.    
T Consensus       386 PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~  465 (586)
T KOG0667|consen  386 PLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRS  465 (586)
T ss_pred             cccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcc
Confidence            999999888877766321110                                                    110    


Q ss_pred             -------CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          103 -------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       103 -------~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                             .-...+.+||++||.+||.+|+|..++++||||...
T Consensus       466 l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  466 LESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             cchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence                   001245799999999999999999999999999854

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.92  E-value=1.5e-25  Score=215.78  Aligned_cols=139  Identities=27%  Similarity=0.495  Sum_probs=111.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... .......+++.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus       124 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~  203 (309)
T cd07872         124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP  203 (309)
T ss_pred             CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999998765332 223345789999999998765544789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-------------------cCC-----------CCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-------------------YTL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-------------------~~~-----------p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+.+..+....+....                   ...           ...+++++++||.+||..||.+|||++|+
T Consensus       204 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  283 (309)
T cd07872         204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA  283 (309)
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence            998876655443332110                   011           12468889999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      ++||||+...
T Consensus       284 l~h~~~~~~~  293 (309)
T cd07872         284 MKHAYFRSLG  293 (309)
T ss_pred             hcChhhhhcc
Confidence            9999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=8.5e-26  Score=238.80  Aligned_cols=138  Identities=38%  Similarity=0.668  Sum_probs=120.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCccccc----CCCCCCCccceeeehhHHHHHh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~----~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|||||||+|||||..|+|||+|||.|-.+...+..  .+.+|||-|++||++.    ++..+|+.+|+||+||++|||+
T Consensus       196 yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMl  275 (1317)
T KOG0612|consen  196 YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEML  275 (1317)
T ss_pred             ceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHH
Confidence            599999999999999999999999999888744333  4568999999999985    3244599999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcC--ccCCC--CCCChhhhcccccccCCCCCCCCC---hhhhhcCchhhhccC
Q 017029           76 CGTLPFDDENIPNLFKKIKGG--IYTLP--SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAHLP  140 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt---~~ell~hp~f~~~~~  140 (379)
                      +|..||..++..+.+.+|.+.  .+.+|  ..+|+++++||.+++ -+|+.|..   ++++..||||.+..+
T Consensus       276 yG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W  346 (1317)
T KOG0612|consen  276 YGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDW  346 (1317)
T ss_pred             cCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCCh
Confidence            999999999999999999876  57778  568999999999876 47899998   999999999987643

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.92  E-value=1.2e-25  Score=218.45  Aligned_cols=137  Identities=34%  Similarity=0.591  Sum_probs=114.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccC-----CCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilye   73 (379)
                      .|+||||||+|||++.++.+||+|||++........  ....+||+.|+|||++.+     ....+.++||||+||++|+
T Consensus       122 ~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~e  201 (330)
T cd05601         122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYE  201 (330)
T ss_pred             CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeee
Confidence            489999999999999999999999999987654332  234579999999999863     2223689999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           74 LLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        74 lltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |++|..||.+.+....+.++....  ..+|  ..++.++.+||.+||. +|.+|||+++++.||||...
T Consensus       202 l~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~  269 (330)
T cd05601         202 MIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI  269 (330)
T ss_pred             eccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence            999999999888777777776542  2233  3578999999999998 99999999999999999753

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.92  E-value=1.9e-25  Score=228.86  Aligned_cols=136  Identities=32%  Similarity=0.591  Sum_probs=120.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||+++......   ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       189 ~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg  267 (478)
T PTZ00267        189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTL  267 (478)
T ss_pred             CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhC
Confidence            48999999999999999999999999998765432   2345679999999999988777 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ..||.+.+..++...+..+.+ ++|..++.+++++|.+||..||.+|||+++++.|+|++.
T Consensus       268 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        268 HRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999888888888776654 456778999999999999999999999999999999974

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.92  E-value=1.7e-25  Score=221.48  Aligned_cols=138  Identities=33%  Similarity=0.550  Sum_probs=112.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC--cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.++.+||+|||+++.....  .......+++.|+|||++.+....+.++||||+||++|+|++|+
T Consensus       123 ~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~  202 (372)
T cd07853         123 GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR  202 (372)
T ss_pred             CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCC
Confidence            3899999999999999999999999999865432  22334568899999999987654578999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcC-----------------------c---------cCCCCCCChhhhcccccccCCCCCCCCCh
Q 017029           79 LPFDDENIPNLFKKIKGG-----------------------I---------YTLPSHLSPGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~-----------------------~---------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      .||.+.+.......+...                       .         +......++++.+||.+||+.||.+|||+
T Consensus       203 ~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~  282 (372)
T cd07853         203 ILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISA  282 (372)
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCH
Confidence            999887765554443211                       1         11223467889999999999999999999


Q ss_pred             hhhhcCchhhhc
Q 017029          127 PEIRQHPWFQAH  138 (379)
Q Consensus       127 ~ell~hp~f~~~  138 (379)
                      .|+++||||+..
T Consensus       283 ~e~l~hp~~~~~  294 (372)
T cd07853         283 ADALAHPYLDEG  294 (372)
T ss_pred             HHHhcCHhhCCC
Confidence            999999999864

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=2.6e-25  Score=218.97  Aligned_cols=136  Identities=40%  Similarity=0.750  Sum_probs=113.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---------------------------------------cccccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------------------------------------FLKTSC   41 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---------------------------------------~~~~~~   41 (379)
                      .|+||||||+|||++.++.+||+|||++..+....                                       ...+.+
T Consensus       121 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (364)
T cd05599         121 GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTV  200 (364)
T ss_pred             CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccc
Confidence            38999999999999999999999999987543211                                       111347


Q ss_pred             CCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCc--cCCCC--CCChhhhcccccccC
Q 017029           42 GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLPS--HLSPGARDLIPRMLI  117 (379)
Q Consensus        42 gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~Li~~mL~  117 (379)
                      ||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+.......+....  ..+|.  .+++++++||.+||.
T Consensus       201 gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~  279 (364)
T cd05599         201 GTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC  279 (364)
T ss_pred             cCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc
Confidence            9999999999988777 789999999999999999999999988877777776543  23333  478999999999996


Q ss_pred             CCCCCCCC---hhhhhcCchhhhc
Q 017029          118 VDPMKRIT---IPEIRQHPWFQAH  138 (379)
Q Consensus       118 ~dP~~Rpt---~~ell~hp~f~~~  138 (379)
                       +|.+|++   +++++.||||+..
T Consensus       280 -~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         280 -EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             -CHhhcCCCCCHHHHhcCCCcCCC
Confidence             9999998   9999999999753

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.92  E-value=1.5e-25  Score=211.33  Aligned_cols=137  Identities=34%  Similarity=0.462  Sum_probs=117.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+|||||++|+|+++.|.+||+|||+++.+.+. ..++..+-|.+|+|||++.|...++.++|+||+|||+.|++++++-
T Consensus       198 ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl  277 (419)
T KOG0663|consen  198 ILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL  277 (419)
T ss_pred             eEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence            899999999999999999999999999988765 3455667899999999999877778999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc-------------------cCCCC-------------CCChhhhcccccccCCCCCCCCChhh
Q 017029           81 FDDENIPNLFKKIKGGI-------------------YTLPS-------------HLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~-------------------~~~p~-------------~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      |.|....+...+|-...                   ..++.             .+++...+|++.+|.+||.+|+|++|
T Consensus       278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~  357 (419)
T KOG0663|consen  278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED  357 (419)
T ss_pred             CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence            99998887777763321                   11111             15688899999999999999999999


Q ss_pred             hhcCchhhhc
Q 017029          129 IRQHPWFQAH  138 (379)
Q Consensus       129 ll~hp~f~~~  138 (379)
                      .|+|.||.+.
T Consensus       358 ~L~h~~F~e~  367 (419)
T KOG0663|consen  358 GLKHEYFRET  367 (419)
T ss_pred             hhcccccccC
Confidence            9999999874

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.92  E-value=3.2e-25  Score=220.14  Aligned_cols=136  Identities=38%  Similarity=0.635  Sum_probs=111.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----------------------------------------------
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----------------------------------------------   34 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----------------------------------------------   34 (379)
                      .|+||||||+|||++.+|.+||+|||++......                                              
T Consensus       121 ~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (382)
T cd05625         121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQH  200 (382)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcccc
Confidence            3899999999999999999999999997532100                                              


Q ss_pred             --cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhh
Q 017029           35 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGA  108 (379)
Q Consensus        35 --~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~  108 (379)
                        ....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+...++....  ..+|  ..+++++
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  279 (382)
T cd05625         201 QRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEA  279 (382)
T ss_pred             ccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHH
Confidence              00123479999999999988877 789999999999999999999999888776666665432  2333  4689999


Q ss_pred             hcccccccCCCCCCCCC---hhhhhcCchhhhc
Q 017029          109 RDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  138 (379)
Q Consensus       109 ~~Li~~mL~~dP~~Rpt---~~ell~hp~f~~~  138 (379)
                      .++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       280 ~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         280 SDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999986 59999997   9999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.92  E-value=1.6e-25  Score=220.56  Aligned_cols=136  Identities=40%  Similarity=0.711  Sum_probs=113.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc------------------------------------ccccccCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH------------------------------------FLKTSCGSP   44 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~------------------------------------~~~~~~gt~   44 (379)
                      .|+||||||+|||++.+|.+||+|||++.......                                    ...+.+||+
T Consensus       121 givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  200 (360)
T cd05627         121 GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTP  200 (360)
T ss_pred             CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCc
Confidence            48999999999999999999999999986542210                                    012457999


Q ss_pred             CccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhhhcccccccCCCC
Q 017029           45 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGARDLIPRMLIVDP  120 (379)
Q Consensus        45 ~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~Li~~mL~~dP  120 (379)
                      .|+|||++.+..+ +.++|+||+||++|+|++|..||.+.+....+.++...  ...+|.  .+++++++||.+|+ .||
T Consensus       201 ~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p  278 (360)
T cd05627         201 DYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDS  278 (360)
T ss_pred             cccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cCh
Confidence            9999999988877 78999999999999999999999998888888777653  234443  37899999999987 499


Q ss_pred             CCCCC---hhhhhcCchhhhc
Q 017029          121 MKRIT---IPEIRQHPWFQAH  138 (379)
Q Consensus       121 ~~Rpt---~~ell~hp~f~~~  138 (379)
                      .+|++   ++++++||||+..
T Consensus       279 ~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         279 ENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             hhcCCCCCHHHHhcCCCCCCC
Confidence            99994   7999999999864

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.91  E-value=3.1e-25  Score=210.44  Aligned_cols=137  Identities=28%  Similarity=0.546  Sum_probs=113.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.++|+|||++.............|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       115 ~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p  193 (277)
T cd05607         115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTP  193 (277)
T ss_pred             CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCC
Confidence            489999999999999999999999999987765554455679999999999988776 7899999999999999999999


Q ss_pred             CCCCCh----HHHHHHHhcCccCCC-CCCChhhhcccccccCCCCCCCCCh----hhhhcCchhhhc
Q 017029           81 FDDENI----PNLFKKIKGGIYTLP-SHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~----~~~~~~i~~~~~~~p-~~~s~~~~~Li~~mL~~dP~~Rpt~----~ell~hp~f~~~  138 (379)
                      |.+...    ..+...+.......+ ..++++++++|.+||+.||.+|||+    ++++.||||+..
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         194 FKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCC
Confidence            976432    233334433333332 4689999999999999999999999    668899999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=2.2e-25  Score=222.78  Aligned_cols=137  Identities=26%  Similarity=0.399  Sum_probs=104.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC--cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~--~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++.++.+||+|||++......  ......+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       202 ~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~  280 (391)
T PHA03212        202 RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH  280 (391)
T ss_pred             CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCC
Confidence            4899999999999999999999999999754322  22345689999999999988777 78999999999999999999


Q ss_pred             CCCCCCC-------hHHHHHHHhc--------------------------CccCCC---------CCCChhhhccccccc
Q 017029           79 LPFDDEN-------IPNLFKKIKG--------------------------GIYTLP---------SHLSPGARDLIPRML  116 (379)
Q Consensus        79 ~Pf~~~~-------~~~~~~~i~~--------------------------~~~~~p---------~~~s~~~~~Li~~mL  116 (379)
                      .||.+..       .......+..                          .....|         ..++.++.+||.+||
T Consensus       281 ~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL  360 (391)
T PHA03212        281 DSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKML  360 (391)
T ss_pred             CCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHh
Confidence            8864321       1111111110                          000001         124567899999999


Q ss_pred             CCCCCCCCChhhhhcCchhhhc
Q 017029          117 IVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       117 ~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++||.+|||++|+++||||+..
T Consensus       361 ~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        361 AFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             cCChhhCCCHHHHhcChhhccC
Confidence            9999999999999999999865

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.91  E-value=5.2e-25  Score=218.87  Aligned_cols=137  Identities=36%  Similarity=0.612  Sum_probs=109.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----------------------------------------------
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----------------------------------------------   34 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----------------------------------------------   34 (379)
                      .|+||||||+|||++.++.+||+|||++......                                              
T Consensus       121 givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (381)
T cd05626         121 GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQH  200 (381)
T ss_pred             CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccc
Confidence            4899999999999999999999999997532100                                              


Q ss_pred             --cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhc--CccCCCC--CCChhh
Q 017029           35 --HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPS--HLSPGA  108 (379)
Q Consensus        35 --~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~  108 (379)
                        ....+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+......++..  ....+|.  .+++++
T Consensus       201 ~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  279 (381)
T cd05626         201 QRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEA  279 (381)
T ss_pred             cccccccccCCccccCHHHHcCCCC-CCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHH
Confidence              00124579999999999988777 7899999999999999999999998877666666653  2233443  579999


Q ss_pred             hccccccc--CCCCCCCCChhhhhcCchhhhc
Q 017029          109 RDLIPRML--IVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       109 ~~Li~~mL--~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++||.+|+  ..++..|+|+++++.||||+..
T Consensus       280 ~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         280 VDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             HHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence            99999955  4555569999999999999754

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.91  E-value=5.9e-25  Score=218.07  Aligned_cols=138  Identities=36%  Similarity=0.653  Sum_probs=114.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCC---CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~---~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||++.......  ...+.+||+.|+|||++.+..   ..+.++||||+||++|+|+
T Consensus       162 ~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell  241 (371)
T cd05622         162 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  241 (371)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHH
Confidence            48999999999999999999999999998764432  223568999999999987543   2378999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhhhcccccccCCCCCC--CCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+.+....+.++....  ..+|  ..++..++++|.+||..++.+  |++++++++||||+..
T Consensus       242 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         242 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             hCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            9999999998888888887643  3344  368999999999999844433  7899999999999764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=220.55  Aligned_cols=137  Identities=37%  Similarity=0.712  Sum_probs=129.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      ||+|||||||++++.+|-+||.|||+++....+...-|.||||.|.|||++.++.. ..++|.||||+++|||++|.+||
T Consensus       541 iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGH-D~avDyWaLGIli~ELL~G~pPF  619 (732)
T KOG0614|consen  541 IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGH-DRAVDYWALGILIYELLTGSPPF  619 (732)
T ss_pred             ceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCc-chhhHHHHHHHHHHHHHcCCCCC
Confidence            89999999999999999999999999999999998899999999999999999887 68999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhcc
Q 017029           82 DDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAHL  139 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~~  139 (379)
                      .+.+....+..|.+|.  ..+|..++..+.+||+++...+|.+|..     +.+|..|.||....
T Consensus       620 s~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfd  684 (732)
T KOG0614|consen  620 SGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFD  684 (732)
T ss_pred             CCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCC
Confidence            9999999999999886  5789999999999999999999999996     88999999998654

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.91  E-value=5.4e-25  Score=204.89  Aligned_cols=133  Identities=30%  Similarity=0.596  Sum_probs=115.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||+||+++.++.++|+|||++...... ....+..|++.|+|||++.+..+ +.++|+||+||++|++++|..|
T Consensus       123 i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~  201 (257)
T cd08223         123 ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHA  201 (257)
T ss_pred             eeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCC
Confidence            799999999999999999999999999876432 23345578999999999988766 6899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           81 FDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |.+.+.......+..+.. ..+..+++.+.+++.+||+.||.+|||+.+++.||||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         202 FNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            998877776666655544 4566789999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.7e-25  Score=219.33  Aligned_cols=136  Identities=38%  Similarity=0.680  Sum_probs=111.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---------------------------------------------
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------------------------------------------   35 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---------------------------------------------   35 (379)
                      .|+||||||+|||++.++.+||+|||+++......                                             
T Consensus       121 givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (377)
T cd05629         121 GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKN  200 (377)
T ss_pred             CeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhc
Confidence            38999999999999999999999999986321100                                             


Q ss_pred             ---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcC--ccCCCC--CCChhh
Q 017029           36 ---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--IYTLPS--HLSPGA  108 (379)
Q Consensus        36 ---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~  108 (379)
                         .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+.+..+...  ...+|.  .++.++
T Consensus       201 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  279 (377)
T cd05629         201 RRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEA  279 (377)
T ss_pred             ccccccccCCCccccCHHHHccCCC-CCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHH
Confidence               0012479999999999988877 78999999999999999999999998887777777643  234443  578999


Q ss_pred             hcccccccCCCCCCC---CChhhhhcCchhhhc
Q 017029          109 RDLIPRMLIVDPMKR---ITIPEIRQHPWFQAH  138 (379)
Q Consensus       109 ~~Li~~mL~~dP~~R---pt~~ell~hp~f~~~  138 (379)
                      ++||.+||. +|.+|   +|+.+++.||||+..
T Consensus       280 ~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         280 EDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             HHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            999999998 77775   599999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.91  E-value=4.7e-25  Score=216.75  Aligned_cols=139  Identities=35%  Similarity=0.529  Sum_probs=111.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccC----CCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||++...... .......|++.|+|||++..    ..+.+.++|||||||++|+|+
T Consensus       188 ~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~  267 (353)
T PLN00034        188 HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFY  267 (353)
T ss_pred             CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHH
Confidence            3899999999999999999999999999876433 22345679999999998753    234467899999999999999


Q ss_pred             hCCCCCCCCChH---HHHHHHh-cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           76 CGTLPFDDENIP---NLFKKIK-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        76 tG~~Pf~~~~~~---~~~~~i~-~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      +|+.||......   .....+. ......+..++.++++||.+||..||++|||+.|+++||||....
T Consensus       268 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~  335 (353)
T PLN00034        268 LGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ  335 (353)
T ss_pred             hCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence            999999753322   2222222 223345667899999999999999999999999999999998764

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.91  E-value=3.6e-25  Score=210.95  Aligned_cols=137  Identities=34%  Similarity=0.616  Sum_probs=112.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.++|+|||++.....+.......|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       122 ~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~P  200 (285)
T cd05630         122 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSP  200 (285)
T ss_pred             CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCC
Confidence            489999999999999999999999999987655544455689999999999988776 7899999999999999999999


Q ss_pred             CCCCChH----HHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDENIP----NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+....    .....+.......+..+++++++|+.+||+.||.+|||     ++|+++||||++.
T Consensus       201 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         201 FQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             CCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9874321    11111122223456678999999999999999999999     8999999999853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.91  E-value=4.8e-25  Score=212.12  Aligned_cols=135  Identities=30%  Similarity=0.471  Sum_probs=101.0

Q ss_pred             CEEecCCCCCCeEE----cCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl----~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+|||+    +.++.+||+|||+++......    ......||+.|+|||++.+....+.++||||+||++|
T Consensus       128 ~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~  207 (317)
T cd07867         128 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  207 (317)
T ss_pred             CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHH
Confidence            38999999999999    556799999999998764332    2234578999999999987554588999999999999


Q ss_pred             HHhhCCCCCCCCChH---------HHHHHHhc----------------------------CccC----------CCCCCC
Q 017029           73 ALLCGTLPFDDENIP---------NLFKKIKG----------------------------GIYT----------LPSHLS  105 (379)
Q Consensus        73 elltG~~Pf~~~~~~---------~~~~~i~~----------------------------~~~~----------~p~~~s  105 (379)
                      +|++|..||......         .....+..                            ..+.          .....+
T Consensus       208 el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (317)
T cd07867         208 ELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD  287 (317)
T ss_pred             HHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCC
Confidence            999999999753211         00000000                            0000          011234


Q ss_pred             hhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029          106 PGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus       106 ~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ..+.+||.+||+.||.+|||++|+++||||
T Consensus       288 ~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            567889999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.91  E-value=7.8e-25  Score=206.57  Aligned_cols=134  Identities=31%  Similarity=0.537  Sum_probs=109.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||+|+||+++. +.+||+|||++.............+++.|+|||++.+....+.++|+||+||++|+|++|..|
T Consensus       120 ~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p  198 (282)
T cd07831         120 GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPL  198 (282)
T ss_pred             CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcC
Confidence            3799999999999999 999999999998765544444567889999999876555557899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcC------------------ccCCC-----------CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           81 FDDENIPNLFKKIKGG------------------IYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~------------------~~~~p-----------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |.+.+..+....+...                  .+.+|           ..++.++.++|.+||.+||.+|||++++++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         199 FPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            9887765544443211                  11111           246789999999999999999999999999


Q ss_pred             Cchh
Q 017029          132 HPWF  135 (379)
Q Consensus       132 hp~f  135 (379)
                      ||||
T Consensus       279 ~~~~  282 (282)
T cd07831         279 HPYF  282 (282)
T ss_pred             CCCC
Confidence            9997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.2e-24  Score=203.19  Aligned_cols=134  Identities=37%  Similarity=0.596  Sum_probs=112.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||+|+||+++.++.++|+|||++........    .....|+..|+|||++.+..+ +.++|+||+|+++|++++
T Consensus       124 ~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~  202 (263)
T cd06625         124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLT  202 (263)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHh
Confidence            379999999999999999999999999876533211    123468889999999988775 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |+.||.+.+......++...  ...+|..++..+.++|.+||..+|.+|||+.++++||||
T Consensus       203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         203 EKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             CCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            99999876655544444333  345677889999999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.91  E-value=1.3e-24  Score=213.41  Aligned_cols=139  Identities=35%  Similarity=0.602  Sum_probs=112.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++.............|++.|+|||.+.+..+ +.++||||+||++|+|++|+.|
T Consensus       138 gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p  216 (353)
T cd07850         138 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVL  216 (353)
T ss_pred             CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCC
Confidence            489999999999999999999999999987655444445678999999999988777 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC------------------------------------C-------CCCCChhhhcccccccC
Q 017029           81 FDDENIPNLFKKIKGGIYT------------------------------------L-------PSHLSPGARDLIPRMLI  117 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~------------------------------------~-------p~~~s~~~~~Li~~mL~  117 (379)
                      |.+.+....+.++......                                    .       +...++.++++|.+||+
T Consensus       217 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  296 (353)
T cd07850         217 FPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV  296 (353)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcC
Confidence            9877655444443211000                                    0       11235568899999999


Q ss_pred             CCCCCCCChhhhhcCchhhhccC
Q 017029          118 VDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus       118 ~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      .||.+|||+.|++.||||+..+.
T Consensus       297 ~dP~~R~t~~eiL~~~~~~~~~~  319 (353)
T cd07850         297 IDPEKRISVDDALQHPYINVWYD  319 (353)
T ss_pred             CChhhCcCHHHHhcChhHhhccC
Confidence            99999999999999999987654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.91  E-value=2e-24  Score=210.57  Aligned_cols=138  Identities=34%  Similarity=0.664  Sum_probs=112.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccC----CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~----~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.+||+|||++........  ....+||+.|+|||++.+    ....+.++||||+||++|+|
T Consensus       122 ~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~el  201 (332)
T cd05623         122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEM  201 (332)
T ss_pred             CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHH
Confidence            489999999999999999999999999876533222  234579999999999862    22337899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhhhcccccccCCCCCC--CCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~  138 (379)
                      ++|+.||.+.+..+.+.++....  ..+|   ..+++++++||.+||..++.+  |+|++++++||||...
T Consensus       202 l~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         202 LYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             hcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCC
Confidence            99999999988888888876543  2333   357999999999999765544  6899999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.91  E-value=8.6e-25  Score=216.53  Aligned_cols=136  Identities=37%  Similarity=0.612  Sum_probs=110.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC--------------------------------------------cc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--------------------------------------------HF   36 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~--------------------------------------------~~   36 (379)
                      .|+||||||+|||++.++.+||+|||++......                                            ..
T Consensus       121 ~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (376)
T cd05598         121 GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCL  200 (376)
T ss_pred             CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhccccc
Confidence            3899999999999999999999999997432100                                            00


Q ss_pred             cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhhhccc
Q 017029           37 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLI  112 (379)
Q Consensus        37 ~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li  112 (379)
                      ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..||.+.+..+....+....  ..+|  ..+++++.++|
T Consensus       201 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  279 (376)
T cd05598         201 AHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLI  279 (376)
T ss_pred             ccccCCCccccCHHHHcCCCC-CcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHH
Confidence            123479999999999988777 789999999999999999999999988777666665432  2333  36789999999


Q ss_pred             ccccCCCCCCCC---ChhhhhcCchhhhc
Q 017029          113 PRMLIVDPMKRI---TIPEIRQHPWFQAH  138 (379)
Q Consensus       113 ~~mL~~dP~~Rp---t~~ell~hp~f~~~  138 (379)
                      .+|+ .+|.+|+   |+.++++||||+..
T Consensus       280 ~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         280 LRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             HHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            9976 5999999   99999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.91  E-value=9.3e-25  Score=209.22  Aligned_cols=138  Identities=28%  Similarity=0.544  Sum_probs=110.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+....+.++||||+||++|+|++|+.
T Consensus       124 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~  203 (301)
T cd07873         124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP  203 (301)
T ss_pred             CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999998765332 222344678999999998776555789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-------------------cCCC-----------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-------------------YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-------------------~~~p-----------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+.+..+....+....                   ...|           ..+++++++||.+||+.||.+|||++|+
T Consensus       204 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei  283 (301)
T cd07873         204 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA  283 (301)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence            998877655444332110                   0111           2467889999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++||||+..
T Consensus       284 l~h~~f~~~  292 (301)
T cd07873         284 MKHPYFHCL  292 (301)
T ss_pred             hcCcccccc
Confidence            999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.91  E-value=2.2e-25  Score=204.76  Aligned_cols=137  Identities=30%  Similarity=0.520  Sum_probs=113.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC--CCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      +|||||+||+|||++..|.+||||||++..+.+.--.+...|...|||||.+..  .+| ..++|+||||++|||+.||.
T Consensus       188 kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gy-DiRSDvWSLGITL~EvAtG~  266 (361)
T KOG1006|consen  188 KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGY-DIRSDVWSLGITLYEVATGN  266 (361)
T ss_pred             hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCc-chhhhhhhhcceEeeeecCC
Confidence            589999999999999999999999999987766544455689999999999863  335 68999999999999999999


Q ss_pred             CCCCCCC-hHHHHHHHhcCccCC---CC---CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDEN-IPNLFKKIKGGIYTL---PS---HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~-~~~~~~~i~~~~~~~---p~---~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+.+ ..+....+..|.++.   +.   +++..+..+|..||.+|-+.||...+++.+||++..
T Consensus       267 fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y  333 (361)
T KOG1006|consen  267 FPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMY  333 (361)
T ss_pred             CCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhh
Confidence            9998743 333444445554432   22   378899999999999999999999999999999754

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=9.2e-25  Score=218.08  Aligned_cols=139  Identities=24%  Similarity=0.403  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++.+||+|||++........   .....||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       205 givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g  283 (392)
T PHA03207        205 GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVK  283 (392)
T ss_pred             CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHC
Confidence            389999999999999999999999999976544321   224579999999999988777 7899999999999999999


Q ss_pred             CCCCCCCChH---HHHHHHhcC-----------------------------ccCCC-----CCCChhhhcccccccCCCC
Q 017029           78 TLPFDDENIP---NLFKKIKGG-----------------------------IYTLP-----SHLSPGARDLIPRMLIVDP  120 (379)
Q Consensus        78 ~~Pf~~~~~~---~~~~~i~~~-----------------------------~~~~p-----~~~s~~~~~Li~~mL~~dP  120 (379)
                      ..||.+....   .....+...                             .+..|     ..++.++.++|.+||..||
T Consensus       284 ~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp  363 (392)
T PHA03207        284 NVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQ  363 (392)
T ss_pred             CCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccCh
Confidence            9999764321   111111110                             01111     1346678899999999999


Q ss_pred             CCCCChhhhhcCchhhhccC
Q 017029          121 MKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus       121 ~~Rpt~~ell~hp~f~~~~~  140 (379)
                      .+|||+.|++.||||+..-+
T Consensus       364 ~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        364 EFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             hhCCCHHHHhhCchhhccch
Confidence            99999999999999986533

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.90  E-value=1.4e-24  Score=206.65  Aligned_cols=137  Identities=29%  Similarity=0.557  Sum_probs=115.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++.............|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       122 ~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P  200 (285)
T cd05632         122 NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSP  200 (285)
T ss_pred             CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCC
Confidence            389999999999999999999999999977654444456689999999999988776 7899999999999999999999


Q ss_pred             CCCCChHHH----HHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDENIPNL----FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+......    ...+......++..+++++.+|+.+||+.||.+|||     +.+++.|+||+..
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         201 FRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             CCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            987655433    333344445566778999999999999999999999     8899999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA02988 hypothetical protein; Provisional

Probab=99.90  E-value=1e-24  Score=208.07  Aligned_cols=127  Identities=20%  Similarity=0.347  Sum_probs=109.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC--CCCCCCccceeeehhHHHHHhhCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      ++||||||+|||++.++.+||+|||+++......  ....|++.|+|||++.+  ..+ +.++|||||||++|+|++|..
T Consensus       144 ~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~  220 (283)
T PHA02988        144 KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKI  220 (283)
T ss_pred             CCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCC
Confidence            5699999999999999999999999998764432  34578999999999976  445 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+..++...+...  ...+|..+++.+++++.+||+.||.+|||+.|+++
T Consensus       221 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        221 PFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            99998888887777433  44556678999999999999999999999999985

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=8.5e-25  Score=219.46  Aligned_cols=137  Identities=30%  Similarity=0.498  Sum_probs=119.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCccccc-----CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilyel   74 (379)
                      +|||||||..|||++-+|.|+|+|||++...... ....++.|||+|||||+..     ..+| ..++||||||++|.||
T Consensus       150 ~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEM  228 (1187)
T KOG0579|consen  150 NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEM  228 (1187)
T ss_pred             chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHH
Confidence            5899999999999999999999999998765432 3335678999999999874     4555 6899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccC---CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYT---LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..+.+|-...++..+.-+|.+..++   .|.+++.++.||+++||.+||..||++.+|++||||+..
T Consensus       229 AqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  229 AQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             hccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            9999999999988888888766543   478899999999999999999999999999999999843

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.90  E-value=1.8e-24  Score=211.24  Aligned_cols=136  Identities=26%  Similarity=0.539  Sum_probs=107.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       124 ~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p  201 (333)
T cd06650         124 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYP  201 (333)
T ss_pred             CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCC
Confidence            3899999999999999999999999998765332 2244579999999999988766 7899999999999999999999


Q ss_pred             CCCCChHHHHHHH--------------------------------------------hcC-ccCCC-CCCChhhhccccc
Q 017029           81 FDDENIPNLFKKI--------------------------------------------KGG-IYTLP-SHLSPGARDLIPR  114 (379)
Q Consensus        81 f~~~~~~~~~~~i--------------------------------------------~~~-~~~~p-~~~s~~~~~Li~~  114 (379)
                      |.......+...+                                            ... ....+ ..++.++++||.+
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  281 (333)
T cd06650         202 IPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNK  281 (333)
T ss_pred             CCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHH
Confidence            9765443322111                                            110 01111 1356788999999


Q ss_pred             ccCCCCCCCCChhhhhcCchhhhc
Q 017029          115 MLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       115 mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||+.||.+|||+.|++.||||+..
T Consensus       282 ~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         282 CLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hccCCcccCcCHHHHhhCHHHhcC
Confidence            999999999999999999999854

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.90  E-value=1.1e-24  Score=214.82  Aligned_cols=136  Identities=27%  Similarity=0.457  Sum_probs=102.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.++.+||+|||++..........+..||+.|+|||++.+..+ +.++||||+||++|+|+++..|
T Consensus       177 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~  255 (357)
T PHA03209        177 RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPST  255 (357)
T ss_pred             CeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCc
Confidence            489999999999999999999999999976544433445679999999999988777 7899999999999999985444


Q ss_pred             -CCCCChH---------HHHHHHhcCc----cCCC------------------------------CCCChhhhccccccc
Q 017029           81 -FDDENIP---------NLFKKIKGGI----YTLP------------------------------SHLSPGARDLIPRML  116 (379)
Q Consensus        81 -f~~~~~~---------~~~~~i~~~~----~~~p------------------------------~~~s~~~~~Li~~mL  116 (379)
                       |.+....         ....++....    ..+|                              ..++.++.+||.+||
T Consensus       256 ~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL  335 (357)
T PHA03209        256 IFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKML  335 (357)
T ss_pred             cccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHH
Confidence             4432110         0111111100    0011                              134566778999999


Q ss_pred             CCCCCCCCChhhhhcCchhhh
Q 017029          117 IVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus       117 ~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      +.||.+|||+.|+++||||++
T Consensus       336 ~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        336 TFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             cCCcccCcCHHHHhcCchhcc
Confidence            999999999999999999974

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.90  E-value=2.6e-24  Score=201.25  Aligned_cols=137  Identities=41%  Similarity=0.782  Sum_probs=118.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .++|+||+|+||+++.++.++|+|||++............+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..|
T Consensus       113 ~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  191 (262)
T cd05572         113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPP  191 (262)
T ss_pred             CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCC
Confidence            379999999999999999999999999987765443344578999999999887766 6899999999999999999999


Q ss_pred             CCCCC--hHHHHHHHh--cCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDEN--IPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |....  ......++.  .....+|...++++.++|.+||..||.+|||     ++|+++||||++.
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  258 (262)
T cd05572         192 FGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF  258 (262)
T ss_pred             cCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence            98766  666667766  4456677778999999999999999999999     9999999999853

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.90  E-value=1.7e-24  Score=205.63  Aligned_cols=138  Identities=33%  Similarity=0.518  Sum_probs=109.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC--CCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+||+++.++.+||+|||++.............|++.|+|||++.+.  ...+.++||||+||++|+|++|.
T Consensus       128 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~  207 (288)
T cd06616         128 KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK  207 (288)
T ss_pred             CeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCC
Confidence            3899999999999999999999999999766544333455789999999999766  23478999999999999999999


Q ss_pred             CCCCCCCh-HHHHHHHhcCc-cCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENI-PNLFKKIKGGI-YTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~-~~~~~~i~~~~-~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||..... .+...++..+. ..++    ..++.++.+||.+||+.||++|||+++++.||||+..
T Consensus       208 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         208 FPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            99976542 12222222222 1222    2478899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.90  E-value=3.2e-24  Score=204.40  Aligned_cols=135  Identities=46%  Similarity=0.828  Sum_probs=121.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||+|+|||++.++.+||+|||++......  ....+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..|
T Consensus       121 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  197 (290)
T cd05580         121 DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPP  197 (290)
T ss_pred             CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCC
Confidence            4899999999999999999999999999876544  345578999999999987765 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |...+.....+.+..+...+|..++..++++|.+||..||.+|+     +++|+++||||+..
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         198 FFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             CCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccC
Confidence            99888777788888888888989999999999999999999999     89999999999754

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.90  E-value=2.7e-24  Score=204.07  Aligned_cols=137  Identities=33%  Similarity=0.538  Sum_probs=115.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++...... ...+.+|+..|+|||++.+....+.++|+||+||++|+|++|..|
T Consensus       117 ~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p  195 (278)
T cd05606         117 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP  195 (278)
T ss_pred             CEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCC
Confidence            3899999999999999999999999998765432 234567999999999997554347899999999999999999999


Q ss_pred             CCCC---ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDE---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.   ........+.......|..++.++.+++.+||..+|.+|+     ++.++++||||+..
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         196 FRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             CCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            9876   3444444555555677778899999999999999999999     99999999999865

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.90  E-value=3.1e-24  Score=199.62  Aligned_cols=134  Identities=40%  Similarity=0.656  Sum_probs=117.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.+||+|||++........ ..+..|++.|+|||++.+..+ +.++|+||+|+++|+|++|..
T Consensus       130 ~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~  208 (265)
T cd08217         130 TVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSP  208 (265)
T ss_pred             cceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCC
Confidence            389999999999999999999999999988755443 345578999999999987765 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||...+.....+.+..+.. .++..++..+.+++.+||..+|.+|||+.++++|||+
T Consensus       209 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         209 PFTARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             cccCcCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            9998887777777776654 4567889999999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.90  E-value=2e-24  Score=204.39  Aligned_cols=135  Identities=32%  Similarity=0.595  Sum_probs=105.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......+++.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       119 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~  198 (284)
T cd07839         119 NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  198 (284)
T ss_pred             CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence            4899999999999999999999999998765432 222345678999999998776555789999999999999999888


Q ss_pred             CC-CCCChHHHHHHHhcCc-------------------c----------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PF-DDENIPNLFKKIKGGI-------------------Y----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf-~~~~~~~~~~~i~~~~-------------------~----------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      || .+.+..+..+.+....                   +          ...+.++++++++|.+||..||.+|||++++
T Consensus       199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i  278 (284)
T cd07839         199 PLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA  278 (284)
T ss_pred             CCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence            75 4444444333332110                   0          0112467889999999999999999999999


Q ss_pred             hcCchh
Q 017029          130 RQHPWF  135 (379)
Q Consensus       130 l~hp~f  135 (379)
                      +.||||
T Consensus       279 l~h~~f  284 (284)
T cd07839         279 LQHPYF  284 (284)
T ss_pred             hcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.90  E-value=2.2e-24  Score=204.93  Aligned_cols=136  Identities=32%  Similarity=0.505  Sum_probs=110.2

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+|||++.++.++|+|||++....... .....|++.|+|||.+.+....+.++|+||+||++|+|++|..||
T Consensus       118 ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf  196 (279)
T cd05633         118 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF  196 (279)
T ss_pred             cCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence            7999999999999999999999999987654332 234579999999999864333378999999999999999999999


Q ss_pred             CCCC---hHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           82 DDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        82 ~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      .+..   ...+..........+|..++.+++++|.+||..||.+|+     |++|+++||||+..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         197 RQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             CCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            7543   222222222334456778899999999999999999999     69999999999863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.90  E-value=6.1e-24  Score=201.34  Aligned_cols=137  Identities=29%  Similarity=0.456  Sum_probs=112.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCccccc-----CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......|++.|+|||++.     +..+ +.++|+||+||++|+|
T Consensus       123 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el  201 (282)
T cd06643         123 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEM  201 (282)
T ss_pred             CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHH
Confidence            3799999999999999999999999998765332 2223457899999999984     2233 5789999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|..||.+.+.......+....   ...|..++.+++++|.+||..||.+|||+.++++||||+..
T Consensus       202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         202 AQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             ccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence            99999998877666555554432   23456788999999999999999999999999999999854

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.90  E-value=3.1e-24  Score=203.01  Aligned_cols=135  Identities=34%  Similarity=0.516  Sum_probs=105.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......+++.|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       121 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  200 (285)
T cd07861         121 RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP  200 (285)
T ss_pred             CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCC
Confidence            48999999999999999999999999987653322 22334678999999998765544789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC-----------------------------ccCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGG-----------------------------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-----------------------------~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.........+...                             .......+++++.++|.+||+.||.+|||+.+++
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll  280 (285)
T cd07861         201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKAL  280 (285)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHh
Confidence            99876543322211100                             0011234788999999999999999999999999


Q ss_pred             cCchh
Q 017029          131 QHPWF  135 (379)
Q Consensus       131 ~hp~f  135 (379)
                      .||||
T Consensus       281 ~~~~~  285 (285)
T cd07861         281 NHPYF  285 (285)
T ss_pred             cCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.90  E-value=1.3e-24  Score=202.17  Aligned_cols=134  Identities=43%  Similarity=0.755  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCccccc-CCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~-~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+||+++.++.++|+|||.+... ..........+++.|+|||++. +..+ +.++|+||+|+++|+|++|.
T Consensus       118 ~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~~Di~slG~il~~l~~~~  196 (260)
T PF00069_consen  118 GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKY-TRKSDIWSLGIILYELLTGK  196 (260)
T ss_dssp             TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSB-STHHHHHHHHHHHHHHHHSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccc
Confidence            4899999999999999999999999999863 3334455678999999999998 5544 89999999999999999999


Q ss_pred             CCCCCCC---hHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           79 LPFDDEN---IPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        79 ~Pf~~~~---~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      .||....   ......+........+    ...+..+.++|.+||+.||++|||+.++++||||
T Consensus       197 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  197 LPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             SSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             cccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            9999873   2233333332222111    1224899999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.90  E-value=8.4e-24  Score=206.19  Aligned_cols=138  Identities=34%  Similarity=0.670  Sum_probs=111.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccC----CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~----~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.+||+|||++.........  ...+||+.|+|||++.+    ....+.++||||+||++|+|
T Consensus       122 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el  201 (331)
T cd05597         122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEM  201 (331)
T ss_pred             CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHH
Confidence            4899999999999999999999999998765443322  23469999999999863    23347899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhhhcccccccCCCCCC--CCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~  138 (379)
                      ++|+.||.+.+..+.+.++....  ..+|   ..+++.++++|.+||..++.+  |++++++++||||...
T Consensus       202 ~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         202 LYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence            99999999988877777775432  3333   347899999999988764444  7899999999999753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.90  E-value=7.1e-24  Score=196.99  Aligned_cols=134  Identities=35%  Similarity=0.593  Sum_probs=115.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.++|+|||++....... .....+|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       121 ~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~  199 (256)
T cd08529         121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKH  199 (256)
T ss_pred             CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999988765433 2234578999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||...+......++..+.. .++..++.++.+++.+||+.+|++||++.++++|||+
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         200 PFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            9998887777777766654 3455788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.90  E-value=7.9e-24  Score=200.02  Aligned_cols=137  Identities=34%  Similarity=0.604  Sum_probs=109.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC----CCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiWSlGvilyellt   76 (379)
                      .++||||||+||+++.++.+||+|||++.............|+..|+|||++.+    ..+ +.++|+||+||++|+|++
T Consensus       124 ~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~  202 (283)
T cd06617         124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELAT  202 (283)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHh
Confidence            389999999999999999999999999987654333334568899999998865    223 678999999999999999


Q ss_pred             CCCCCCCCC--hHHHHHHHhcCccCCC-CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDEN--IPNLFKKIKGGIYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~--~~~~~~~i~~~~~~~p-~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||....  ...+...+......+| ..++.++.++|.+||..+|.+|||+.+++.||||...
T Consensus       203 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  267 (283)
T cd06617         203 GRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELH  267 (283)
T ss_pred             CCCCCCccccCHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhc
Confidence            999997532  2333333333333343 3578999999999999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.90  E-value=7.7e-24  Score=206.47  Aligned_cols=136  Identities=35%  Similarity=0.701  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccC-----CCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilye   73 (379)
                      .|+||||||+|||++.++.+||+|||++.........  ...+|++.|+|||++.+     ..+ +.++|+||+||++|+
T Consensus       122 ~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwSlGvil~e  200 (331)
T cd05624         122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKY-GPECDWWSLGVCMYE  200 (331)
T ss_pred             CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCC-CCcccEEeeehhhhh
Confidence            4899999999999999999999999999776543322  23579999999999875     234 789999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHHhcCc--cCCCC---CCChhhhcccccccCCCCCC--CCChhhhhcCchhhh
Q 017029           74 LLCGTLPFDDENIPNLFKKIKGGI--YTLPS---HLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQA  137 (379)
Q Consensus        74 lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~  137 (379)
                      |++|+.||.+.+..+.+.++....  .++|.   .++++++++|.+||..++.+  |++++++++||||+.
T Consensus       201 ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         201 MLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             hhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            999999999988877777776543  33443   46899999999999876654  568999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.89  E-value=3.7e-24  Score=205.81  Aligned_cols=138  Identities=32%  Similarity=0.454  Sum_probs=111.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......+++.|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       128 ~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~  207 (309)
T cd07845         128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP  207 (309)
T ss_pred             CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998765432 22333567889999998765444789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-------------------cCCC-----------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-------------------YTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-------------------~~~p-----------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+.+..+....+....                   +..+           ...++.+.++|.+||..||++|||+.++
T Consensus       208 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~i  287 (309)
T cd07845         208 LLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEA  287 (309)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHH
Confidence            999887776666554311                   1111           1257888999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      +.||||+..
T Consensus       288 l~h~~f~~~  296 (309)
T cd07845         288 LESSYFKEK  296 (309)
T ss_pred             hcChhhccC
Confidence            999999854

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.89  E-value=4.8e-24  Score=200.33  Aligned_cols=134  Identities=28%  Similarity=0.419  Sum_probs=107.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccC-----CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+||+++.++.+||+|||++...... ....+..|++.|+|||++.+     ..+ +.++|+||+||++|+|
T Consensus       131 ~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el  209 (272)
T cd06637         131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEM  209 (272)
T ss_pred             CCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHH
Confidence            4799999999999999999999999998765432 22345678999999999863     234 6789999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ++|..||.+.........+....  ...+..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus       210 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         210 AEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            99999998765544443333222  12234578899999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=6.7e-24  Score=210.79  Aligned_cols=129  Identities=29%  Similarity=0.552  Sum_probs=112.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccC--CCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~g--t~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .+|||||.+.||||++++.+||+|||+++...+.......-|  ...|.|||.+....+ +.++|||||||+||||+| |
T Consensus       323 ~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G  401 (468)
T KOG0197|consen  323 NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYG  401 (468)
T ss_pred             CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccC
Confidence            379999999999999999999999999996655543222222  247999999998887 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      +.||.+.+..++.+.+.+|. .+-|+.+++++.+++..||..+|++|||++.+.
T Consensus       402 ~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  402 RVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLR  455 (468)
T ss_pred             CCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence            99999999999999998875 577899999999999999999999999999654

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.89  E-value=8.4e-24  Score=202.78  Aligned_cols=138  Identities=36%  Similarity=0.586  Sum_probs=114.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++........ .....|++.|+|||.+.+..+ +.++|+||+||++|++++|..
T Consensus       135 ~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~  213 (296)
T cd06655         135 QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEP  213 (296)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            379999999999999999999999999876644322 234578899999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC---ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+.+.......+...   ....+..+++.+.++|.+||..||.+|||+.+++.||||+...
T Consensus       214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         214 PYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             CCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence            99887765544444332   2234567889999999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.89  E-value=9.2e-24  Score=200.99  Aligned_cols=136  Identities=30%  Similarity=0.442  Sum_probs=109.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCC----CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~----~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|+..|+|||++....    ..+.++|+||+||++|+|+
T Consensus       148 ~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~  227 (291)
T cd06639         148 RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELG  227 (291)
T ss_pred             CeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHh
Confidence            48999999999999999999999999988654332 223456889999999986432    1268999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      +|+.||...+.......+.....   ..+..++..+.++|.+||+.+|++|||+.|+++||||+
T Consensus       228 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         228 DGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             hCCCCCCCCcHHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            99999987765544444443322   23456778899999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.89  E-value=1.4e-23  Score=199.12  Aligned_cols=137  Identities=34%  Similarity=0.584  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCC-----CCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++.++.+||+|||++...... ...+..|++.|+|||.+.+...     .+.++|+||+||++|+|+
T Consensus       123 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~  201 (286)
T cd06622         123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMA  201 (286)
T ss_pred             CEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHH
Confidence            3899999999999999999999999998765332 2345578899999999864322     267899999999999999


Q ss_pred             hCCCCCCCCChHHHHHH---HhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKK---IKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~---i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|..||...........   +..+ ...+|..+++++.++|.+||..+|.+||++++++.||||...
T Consensus       202 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~  268 (286)
T cd06622         202 LGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY  268 (286)
T ss_pred             hCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhc
Confidence            99999987655444333   3332 245667789999999999999999999999999999999765

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=8.4e-24  Score=203.81  Aligned_cols=137  Identities=42%  Similarity=0.680  Sum_probs=115.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc------------------------------ccccccCCCCccCcc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH------------------------------FLKTSCGSPNYAAPE   50 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~------------------------------~~~~~~gt~~y~APE   50 (379)
                      .|+||||||+||+++.++.++|+|||++.......                              ......|+..|+|||
T Consensus       123 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE  202 (316)
T cd05574         123 GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE  202 (316)
T ss_pred             CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHH
Confidence            37999999999999999999999999986542211                              011236788999999


Q ss_pred             cccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCCC--CChhhhcccccccCCCCCCCCC---
Q 017029           51 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRMLIVDPMKRIT---  125 (379)
Q Consensus        51 ~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~Li~~mL~~dP~~Rpt---  125 (379)
                      ++.+..+ +.++||||+|+++|+|++|..||.+.+....+.++......++..  ++..+.++|.+||..||.+|||   
T Consensus       203 ~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~  281 (316)
T cd05574         203 VISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR  281 (316)
T ss_pred             HHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchh
Confidence            9987766 789999999999999999999999888777777776665555544  6899999999999999999999   


Q ss_pred             -hhhhhcCchhhhc
Q 017029          126 -IPEIRQHPWFQAH  138 (379)
Q Consensus       126 -~~ell~hp~f~~~  138 (379)
                       +++++.||||+..
T Consensus       282 ~~~~ll~~~~~~~~  295 (316)
T cd05574         282 GAAEIKQHPFFRGV  295 (316)
T ss_pred             hHHHHHcCchhhcC
Confidence             9999999999865

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=6.3e-24  Score=216.48  Aligned_cols=136  Identities=28%  Similarity=0.510  Sum_probs=104.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++.+||+|||+++......   .....+||+.|+|||++.+..+ +.++|||||||++|||++|
T Consensus       280 gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g  358 (461)
T PHA03211        280 GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVH  358 (461)
T ss_pred             CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHc
Confidence            48999999999999999999999999997654322   1224579999999999988877 7899999999999999998


Q ss_pred             CCCCCCC--------ChHHHHHHHhcCccC---CC-------------------------------CCCChhhhcccccc
Q 017029           78 TLPFDDE--------NIPNLFKKIKGGIYT---LP-------------------------------SHLSPGARDLIPRM  115 (379)
Q Consensus        78 ~~Pf~~~--------~~~~~~~~i~~~~~~---~p-------------------------------~~~s~~~~~Li~~m  115 (379)
                      ..|+...        ....+.+.+......   ++                               ..++.++.+||.+|
T Consensus       359 ~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  438 (461)
T PHA03211        359 TASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRA  438 (461)
T ss_pred             CCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHH
Confidence            7654221        122233333222111   11                               02456889999999


Q ss_pred             cCCCCCCCCChhhhhcCchhhh
Q 017029          116 LIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus       116 L~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |+.||.+|||+.|+|+||||+.
T Consensus       439 L~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        439 LTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cccChhhCcCHHHHhhCcccCC
Confidence            9999999999999999999974

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.89  E-value=8.4e-24  Score=198.16  Aligned_cols=133  Identities=33%  Similarity=0.559  Sum_probs=111.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-------ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      ++||||+|+||+++.++.+||+|||+++......       ......|++.|+|||.+.+..+ +.++|+||+||++|+|
T Consensus       127 ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l  205 (267)
T cd06628         127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEM  205 (267)
T ss_pred             cccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHH
Confidence            7999999999999999999999999987664211       1123468899999999987766 6899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           75 LCGTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ++|..||.+.+......++... ...+|..++..+.++|.+||+.||.+||++.++++||||
T Consensus       206 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         206 LTGKHPFPDCTQLQAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             hhCCCCCCCccHHHHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999886655544444433 345667789999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=7.6e-24  Score=199.66  Aligned_cols=137  Identities=30%  Similarity=0.458  Sum_probs=114.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.++|+|||++...... .......|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       118 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~  196 (274)
T cd06609         118 GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEP  196 (274)
T ss_pred             CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999999877543 22334578899999999988775 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCC-CChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...+.......+..... ..+.. ++.++.+++.+||..||++|||++++++||||+..
T Consensus       197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         197 PLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             CcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCC
Confidence            9987766555555544432 33344 78899999999999999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.89  E-value=8.6e-24  Score=199.84  Aligned_cols=135  Identities=30%  Similarity=0.581  Sum_probs=107.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......++..|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~  199 (286)
T cd07847         120 NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP  199 (286)
T ss_pred             CceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998765443 23345678899999998765444789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-------------------cCCC------------CCCChhhhcccccccCCCCCCCCChhh
Q 017029           80 PFDDENIPNLFKKIKGGI-------------------YTLP------------SHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-------------------~~~p------------~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ||.+.+..+....+....                   ...|            +.++..+.+||.+||..||++|||+.|
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e  279 (286)
T cd07847         200 LWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEE  279 (286)
T ss_pred             CCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHH
Confidence            998766544333221100                   0001            245788999999999999999999999


Q ss_pred             hhcCchh
Q 017029          129 IRQHPWF  135 (379)
Q Consensus       129 ll~hp~f  135 (379)
                      ++.||||
T Consensus       280 il~~~~f  286 (286)
T cd07847         280 LLEHPYF  286 (286)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.89  E-value=7.5e-24  Score=200.23  Aligned_cols=136  Identities=35%  Similarity=0.588  Sum_probs=109.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+|+||||+||+++.++.++|+|||++.......  ......|+..|+|||++.+....+.++||||+||++|+|++|.
T Consensus       119 ~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~  198 (286)
T cd07832         119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS  198 (286)
T ss_pred             CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCC
Confidence            37999999999999999999999999998765433  2345578999999999876655578999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc-------------------C-----------CCCCCChhhhcccccccCCCCCCCCChhh
Q 017029           79 LPFDDENIPNLFKKIKGGIY-------------------T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~-------------------~-----------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      +||.+.........+.....                   .           ..+..+..+.++|.+||..||.+|||+++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  278 (286)
T cd07832         199 PLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAE  278 (286)
T ss_pred             cCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHH
Confidence            99987765554443322100                   0           11245688899999999999999999999


Q ss_pred             hhcCchhh
Q 017029          129 IRQHPWFQ  136 (379)
Q Consensus       129 ll~hp~f~  136 (379)
                      ++.||||.
T Consensus       279 ~l~h~~~~  286 (286)
T cd07832         279 ALRHPYFT  286 (286)
T ss_pred             HhhCcCcC
Confidence            99999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.89  E-value=1e-23  Score=199.60  Aligned_cols=135  Identities=33%  Similarity=0.529  Sum_probs=106.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++||||+|+||+++.++.+||+|||++....... ......+++.|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       120 ~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~  199 (284)
T cd07860         120 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA  199 (284)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence            47999999999999999999999999987654322 22344678899999998776555788999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-----------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-----------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+......++....                             ......++++++++|.+||+.||.+|||+++++
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l  279 (284)
T cd07860         200 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAAL  279 (284)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHh
Confidence            998766543332221100                             011234678899999999999999999999999


Q ss_pred             cCchh
Q 017029          131 QHPWF  135 (379)
Q Consensus       131 ~hp~f  135 (379)
                      +||||
T Consensus       280 ~~~~f  284 (284)
T cd07860         280 AHPFF  284 (284)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=3.4e-24  Score=217.04  Aligned_cols=138  Identities=31%  Similarity=0.491  Sum_probs=115.1

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCc-ccccccCCCCccCccccc-CCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVIS-GKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~-~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|||||||-+|||++. .|.+||+|||.|+....-. ...|..||..|||||++. |..-+|.++|||||||++.||.||
T Consensus       695 ~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATG  774 (1226)
T KOG4279|consen  695 KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATG  774 (1226)
T ss_pred             ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccC
Confidence            5899999999999975 6999999999998875543 445788999999999995 333349999999999999999999


Q ss_pred             CCCCCCCC-hHHHHHHH--hcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDEN-IPNLFKKI--KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~-~~~~~~~i--~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++||.... ....+-++  -+..+++|..+|.++++||.+|+.+||.+||++.+++.+||++..
T Consensus       775 rPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~  838 (1226)
T KOG4279|consen  775 RPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN  838 (1226)
T ss_pred             CCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence            99997643 33333333  223457889999999999999999999999999999999999865

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.89  E-value=6.9e-24  Score=197.05  Aligned_cols=134  Identities=31%  Similarity=0.522  Sum_probs=110.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.+||+|||++....... ......|+..|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       119 ~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~  197 (256)
T cd06612         119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKP  197 (256)
T ss_pred             CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998765443 2234458899999999988766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC---ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||...........+...   ....+..++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         198 PYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             CCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            99876654443333222   123345678899999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.89  E-value=5.5e-24  Score=199.84  Aligned_cols=137  Identities=36%  Similarity=0.627  Sum_probs=112.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||++..++.+||.|||+++.-...-..+..+.+..|.|||++.|-.| ...+||||+||++.||++|..-
T Consensus       138 ~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vl  216 (369)
T KOG0665|consen  138 GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVL  216 (369)
T ss_pred             ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEE
Confidence            489999999999999999999999999987654434566789999999999999887 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC-------------------------------CCC-----------CCChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGGIYT-------------------------------LPS-----------HLSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~-------------------------------~p~-----------~~s~~~~~Li~~mL~~  118 (379)
                      |.|.+.-+.+.++......                               +|.           .-+..+++++.+||..
T Consensus       217 f~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi  296 (369)
T KOG0665|consen  217 FPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVI  296 (369)
T ss_pred             ecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhcc
Confidence            9998766666665322111                               111           1134578999999999


Q ss_pred             CCCCCCChhhhhcCchhhhc
Q 017029          119 DPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||++|.+++++|+|||++-+
T Consensus       297 ~pe~Risv~daL~HPY~~vw  316 (369)
T KOG0665|consen  297 DPEKRISVDDALRHPYIKVW  316 (369)
T ss_pred             ChhhcccHHHHhcCCeeeee
Confidence            99999999999999999843

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.89  E-value=2e-23  Score=204.46  Aligned_cols=137  Identities=34%  Similarity=0.541  Sum_probs=111.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++......  .....+++.|+|||++.+....+.++||||+||++|++++|+.|
T Consensus       138 gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~p  215 (343)
T cd07851         138 GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTL  215 (343)
T ss_pred             CeecCCCCHHHeEECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCC
Confidence            3899999999999999999999999999876433  34557889999999987654457899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC-------------------------------CCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIYT-------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~-------------------------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+.......+......                               ....+++.+.++|.+||..||.+|||+.++
T Consensus       216 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~el  295 (343)
T cd07851         216 FPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEA  295 (343)
T ss_pred             CCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHH
Confidence            9887665554444322110                               112358899999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      +.||||....
T Consensus       296 l~h~~~~~~~  305 (343)
T cd07851         296 LAHPYLAEYH  305 (343)
T ss_pred             hcCCCccccC
Confidence            9999998654

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.89  E-value=1.7e-23  Score=204.00  Aligned_cols=139  Identities=36%  Similarity=0.584  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++.......    .....+|++.|+|||++.+....+.++||||+||++|+|++
T Consensus       126 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~  205 (336)
T cd07849         126 NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLS  205 (336)
T ss_pred             CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            48999999999999999999999999987654322    12335789999999987654444789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCc--------------------------cC-----CCCCCChhhhcccccccCCCCCCCCC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI--------------------------YT-----LPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~--------------------------~~-----~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      |+.||.+.+.......+....                          ..     ..+..++++.++|.+||+.||++|||
T Consensus       206 G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt  285 (336)
T cd07849         206 NRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT  285 (336)
T ss_pred             CCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC
Confidence            999998765433322221100                          00     11346788999999999999999999


Q ss_pred             hhhhhcCchhhhcc
Q 017029          126 IPEIRQHPWFQAHL  139 (379)
Q Consensus       126 ~~ell~hp~f~~~~  139 (379)
                      +.++++||||+...
T Consensus       286 ~~e~l~hp~~~~~~  299 (336)
T cd07849         286 VEEALAHPYLEQYH  299 (336)
T ss_pred             HHHHhcCccccccC
Confidence            99999999998664

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.89  E-value=2e-23  Score=198.94  Aligned_cols=138  Identities=28%  Similarity=0.408  Sum_probs=111.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCC----CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......|++.|+|||++.+..    ..+.++|+||+||++|+|+
T Consensus       130 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~  209 (292)
T cd06644         130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMA  209 (292)
T ss_pred             CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHh
Confidence            4799999999999999999999999998754322 1223456889999999985321    1267899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|..||...+......++.....   ..+..++.++.++|.+||..||++||+++++++||||...
T Consensus       210 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         210 QIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             cCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            99999988776655555544332   2355678899999999999999999999999999999743

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.89  E-value=2.1e-23  Score=202.30  Aligned_cols=139  Identities=35%  Similarity=0.529  Sum_probs=114.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.++|+|||++.......    ......+++.|+|||++.+....+.++|+||+|+++|+|++
T Consensus       123 gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~  202 (330)
T cd07834         123 NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT  202 (330)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHc
Confidence            37999999999999999999999999998775543    23445688999999999887344789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccC-------------------------------CCCCCChhhhcccccccCCCCCCCCC
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYT-------------------------------LPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      |..||.+.+..+....+......                               ..+.++.++.++|.+||+.+|.+|||
T Consensus       203 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  282 (330)
T cd07834         203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT  282 (330)
T ss_pred             CCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC
Confidence            99999988776655554432111                               11236788999999999999999999


Q ss_pred             hhhhhcCchhhhcc
Q 017029          126 IPEIRQHPWFQAHL  139 (379)
Q Consensus       126 ~~ell~hp~f~~~~  139 (379)
                      +++++.||||+..-
T Consensus       283 ~~~ll~~~~~~~~~  296 (330)
T cd07834         283 ADEALAHPYLAQLH  296 (330)
T ss_pred             HHHHHhCccHHhhc
Confidence            99999999998654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.89  E-value=1.1e-23  Score=201.55  Aligned_cols=137  Identities=32%  Similarity=0.583  Sum_probs=113.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus       138 ~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~  216 (292)
T cd06658         138 GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEP  216 (292)
T ss_pred             CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999998765332 22234578999999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+.....   .....++..+.+++.+||..||.+|||++++++||||...
T Consensus       217 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~  278 (292)
T cd06658         217 PYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLA  278 (292)
T ss_pred             CCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhcc
Confidence            9988776665555543321   2223578889999999999999999999999999999855

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.89  E-value=1.2e-23  Score=196.31  Aligned_cols=135  Identities=33%  Similarity=0.459  Sum_probs=111.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||+|+||+++.++.++|+|||++........     ....+|+..|+|||++......+.++|+||+||++|+|+
T Consensus       122 ~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~  201 (267)
T cd06610         122 GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELA  201 (267)
T ss_pred             CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHH
Confidence            479999999999999999999999999877654322     134468999999999887634478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc-CCC-----CCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY-TLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~-~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      +|..||...+......++..... .++     ..+++.+.+++.+||..||.+|||+++++.||||
T Consensus       202 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         202 TGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             hCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999988776665555544322 111     2567889999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.89  E-value=1.5e-23  Score=204.26  Aligned_cols=130  Identities=29%  Similarity=0.495  Sum_probs=105.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   ..+..+++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       194 ~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~el~~~  272 (338)
T cd05102         194 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSL  272 (338)
T ss_pred             CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCC-CcccCHHHHHHHHHHHHhC
Confidence            489999999999999999999999999986543221   122345678999999988777 789999999999999997 


Q ss_pred             CCCCCCCCChHH-HHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+..... ....+..+ ....|..+++++.+++.+||..||.+|||+.++++
T Consensus       273 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         273 GASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             CCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999998765433 33444433 34556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.89  E-value=7.7e-24  Score=200.29  Aligned_cols=137  Identities=39%  Similarity=0.686  Sum_probs=114.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||+|+||+++.++.+||+|||++.............|+..|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       115 ~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  193 (277)
T cd05577         115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSP  193 (277)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCC
Confidence            379999999999999999999999999887654444445568889999999987775 7899999999999999999999


Q ss_pred             CCCCCh----HHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENI----PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.....    ..+...+.......|..+++.+.++|.+||+.||.+||     ++.+++.||||...
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~  260 (277)
T cd05577         194 FRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL  260 (277)
T ss_pred             CCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcC
Confidence            977543    23333344444566777899999999999999999999     88889999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.89  E-value=1.5e-23  Score=197.07  Aligned_cols=134  Identities=37%  Similarity=0.596  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++......    .......|+..|+|||.+.+..+ +.++|+||+||++|++++
T Consensus       126 ~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~  204 (266)
T cd06651         126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLT  204 (266)
T ss_pred             CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHH
Confidence            4899999999999999999999999998765321    11233468889999999988766 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      |+.||.+........++...  ...+|..+++.+++++ +||..+|++|||++|+++||||+
T Consensus       205 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         205 EKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             CCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            99999876554444333322  2345667889999999 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.89  E-value=1e-23  Score=197.17  Aligned_cols=136  Identities=36%  Similarity=0.632  Sum_probs=111.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .++||||||+||+++.++.++|+|||.+........ ....|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..|
T Consensus       121 ~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p  198 (265)
T cd06605         121 KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA-KTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFP  198 (265)
T ss_pred             CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh-hcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence            379999999999999999999999999876643322 22678899999999988766 7899999999999999999999


Q ss_pred             CCCC-----ChHHHHHHHhcCc-cCCCCC-CChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDE-----NIPNLFKKIKGGI-YTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |...     ...+..+.+.... ...+.. ++.+++++|.+||..||.+|||+.+++.||||+..
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         199 YPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             CCccccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            9764     2334444444332 234444 78899999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.89  E-value=1.5e-23  Score=198.77  Aligned_cols=136  Identities=31%  Similarity=0.529  Sum_probs=109.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       115 ~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~p  192 (279)
T cd06619         115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFP  192 (279)
T ss_pred             CEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCC
Confidence            4899999999999999999999999999765433 2345689999999999988776 7899999999999999999999


Q ss_pred             CCCCC-------hHHHHHHHhcCcc-CC-CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDEN-------IPNLFKKIKGGIY-TL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~-------~~~~~~~i~~~~~-~~-p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |....       .......+..... .. ....++++++++.+||..||.+||+++++++||||...
T Consensus       193 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         193 YPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             chhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            96532       1122233222221 22 23478899999999999999999999999999999754

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.89  E-value=1.2e-23  Score=200.32  Aligned_cols=135  Identities=33%  Similarity=0.509  Sum_probs=109.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+....+.++|+||+|+++|+|++|..
T Consensus       126 ~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  205 (293)
T cd07843         126 WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKP  205 (293)
T ss_pred             CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999999876543 233445678899999998765544789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-------------------------------cCCCCC-CChhhhcccccccCCCCCCCCChh
Q 017029           80 PFDDENIPNLFKKIKGGI-------------------------------YTLPSH-LSPGARDLIPRMLIVDPMKRITIP  127 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-------------------------------~~~p~~-~s~~~~~Li~~mL~~dP~~Rpt~~  127 (379)
                      ||.+........++....                               ..++.. +++.+.++|++||+.||++|||+.
T Consensus       206 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~  285 (293)
T cd07843         206 LFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAE  285 (293)
T ss_pred             CCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHH
Confidence            998876655544432210                               012222 578899999999999999999999


Q ss_pred             hhhcCchh
Q 017029          128 EIRQHPWF  135 (379)
Q Consensus       128 ell~hp~f  135 (379)
                      |++.||||
T Consensus       286 ell~~~~f  293 (293)
T cd07843         286 DALKHPYF  293 (293)
T ss_pred             HHhcCCCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.89  E-value=1.8e-23  Score=194.18  Aligned_cols=134  Identities=39%  Similarity=0.673  Sum_probs=115.1

Q ss_pred             CEEecCCCCCCeEEcCC-CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.+ +.+||+|||++.............|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..
T Consensus       121 ~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~  199 (256)
T cd08220         121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKR  199 (256)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCC
Confidence            48999999999999865 4689999999987765544445678999999999987765 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||.+.+.......+..+. .+++..++.++.+++.+||..||.+|||+.|+++||||
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         200 AFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            999888777766665543 35667789999999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.89  E-value=1.6e-23  Score=195.53  Aligned_cols=134  Identities=34%  Similarity=0.607  Sum_probs=115.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+|+||+|+||+++.++.++|+|||++.............|+..|+|||++.+..+ +.++|+||+|+++|+|++|..|
T Consensus       120 ~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p  198 (258)
T cd05578         120 GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRP  198 (258)
T ss_pred             CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCC
Confidence            379999999999999999999999999987655544455678899999999987765 7899999999999999999999


Q ss_pred             CCCCC---hHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh--hhhhcCchh
Q 017029           81 FDDEN---IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI--PEIRQHPWF  135 (379)
Q Consensus        81 f~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~--~ell~hp~f  135 (379)
                      |...+   ...............|..++..+.++|.+||..||.+||++  +|+++||||
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         199 YRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             CCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            98876   34444444445667788899999999999999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.89  E-value=9e-24  Score=198.31  Aligned_cols=140  Identities=40%  Similarity=0.719  Sum_probs=117.7

Q ss_pred             EEecCCCCCCeEEcCCC---cEEEEecCCccccc--------CCcccccccCCCCccCccccc----CCCCCCCccceee
Q 017029            2 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMR--------DGHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWS   66 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~--------~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiWS   66 (379)
                      |.||||||||||-.+-+   -||||||.+..-+.        ....+.+.||+..|||||++.    ...++..++|.||
T Consensus       197 IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwS  276 (463)
T KOG0607|consen  197 IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWS  276 (463)
T ss_pred             cccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHH
Confidence            78999999999997654   48999998864332        122456779999999999863    2334578999999


Q ss_pred             ehhHHHHHhhCCCCCCCCC---------------hHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChh
Q 017029           67 CGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIP  127 (379)
Q Consensus        67 lGvilyelltG~~Pf~~~~---------------~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~  127 (379)
                      ||||+|-|++|++||.|.-               ...+++.|..|.|.+|.    ++|.+++++|..+|..|+.+|.++.
T Consensus       277 LGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~  356 (463)
T KOG0607|consen  277 LGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAA  356 (463)
T ss_pred             HHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhh
Confidence            9999999999999997631               45689999999999995    5899999999999999999999999


Q ss_pred             hhhcCchhhhccCc
Q 017029          128 EIRQHPWFQAHLPR  141 (379)
Q Consensus       128 ell~hp~f~~~~~~  141 (379)
                      ++++|||++...+.
T Consensus       357 ~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  357 QVLNHPWVQRCAPE  370 (463)
T ss_pred             hccCCccccccchh
Confidence            99999999977654

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.89  E-value=1.9e-23  Score=194.63  Aligned_cols=134  Identities=28%  Similarity=0.591  Sum_probs=115.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++|+||+|+||+++.++.++|+|||++........ .....|++.|+|||++.+..+ +.++|+||+||++|++++|..
T Consensus       121 ~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~  199 (256)
T cd08218         121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKH  199 (256)
T ss_pred             CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCC
Confidence            479999999999999999999999999977644322 223468899999999987766 689999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||...+..+...++..+.. ..+..++.++.++|.+||+.+|.+||++.++++||||
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         200 AFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             CccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            9998888877777766554 4567789999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.89  E-value=1.3e-23  Score=196.82  Aligned_cols=134  Identities=29%  Similarity=0.494  Sum_probs=110.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-------CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-------GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-------~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      .|+|+||+|+||+++.++.++|+|||++.....       ........|+..|+|||++.+..+ +.++|+||+||++|+
T Consensus       122 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~  200 (265)
T cd06631         122 CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFE  200 (265)
T ss_pred             CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHH
Confidence            378999999999999999999999999875421       112234568899999999987766 789999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHHhcC---ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           74 LLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        74 lltG~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |++|..||...+.......+...   ....+..++.++.++|.+||..+|.+|||+.+++.||||
T Consensus       201 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         201 MATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            99999999876554443333322   234667789999999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.89  E-value=1.2e-23  Score=198.53  Aligned_cols=131  Identities=31%  Similarity=0.564  Sum_probs=108.6

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++ .++|+|||++......   ....|+..|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       129 ~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~  204 (267)
T PHA03390        129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKH  204 (267)
T ss_pred             CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCC
Confidence            379999999999999988 9999999998766433   23468899999999988777 789999999999999999999


Q ss_pred             CCCCCChHH-----HHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-hhhhhcCchhh
Q 017029           80 PFDDENIPN-----LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQ  136 (379)
Q Consensus        80 Pf~~~~~~~-----~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-~~ell~hp~f~  136 (379)
                      ||.......     ..... ......+..+++.+.++|.+||+.||.+|++ ++++++||||+
T Consensus       205 p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        205 PFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             CCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCccc
Confidence            997643322     22222 3344556678999999999999999999996 69999999996

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.89  E-value=1.5e-23  Score=198.41  Aligned_cols=134  Identities=28%  Similarity=0.419  Sum_probs=106.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccC-----CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||+|+||+++.++.++|+|||++...... .......|++.|+|||++..     ..+ +.++|+||+||++|+|
T Consensus       141 ~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~-~~~~DvwslG~~l~el  219 (282)
T cd06636         141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DYRSDIWSLGITAIEM  219 (282)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCC-CcccchhHHHHHHHHH
Confidence            3799999999999999999999999998765322 22344578999999998863     334 6789999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCcc-C-CCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ++|..||.+.........+..... . .+..++.++.++|.+||..||.+|||+.||++||||
T Consensus       220 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         220 AEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HhCCCCccccCHHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            999999977654443333332221 1 223578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.89  E-value=3.5e-23  Score=202.04  Aligned_cols=138  Identities=36%  Similarity=0.562  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++||||||+||+++.++.+||+|||++...... ....+..|+..|+|||.+.+....+.++|+||+||++|+|++|..
T Consensus       128 ~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  207 (337)
T cd07858         128 NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKP  207 (337)
T ss_pred             CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCC
Confidence            3799999999999999999999999999876443 333455788999999988754334789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC-----------------------c--------cCCCCCCChhhhcccccccCCCCCCCCChhh
Q 017029           80 PFDDENIPNLFKKIKGG-----------------------I--------YTLPSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-----------------------~--------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ||.+.+.......+...                       .        ....+.+++++.++|.+||+.||.+|||+++
T Consensus       208 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~e  287 (337)
T cd07858         208 LFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEE  287 (337)
T ss_pred             CCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHH
Confidence            99876543322211100                       0        0012357888999999999999999999999


Q ss_pred             hhcCchhhhc
Q 017029          129 IRQHPWFQAH  138 (379)
Q Consensus       129 ll~hp~f~~~  138 (379)
                      +++||||...
T Consensus       288 ll~h~~~~~~  297 (337)
T cd07858         288 ALAHPYLASL  297 (337)
T ss_pred             HHcCcchhhh
Confidence            9999999864

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.89  E-value=1.5e-23  Score=198.33  Aligned_cols=131  Identities=26%  Similarity=0.398  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||++.......   ......+++.|+|||.+.+..+ +.++|+||+||++|+|++ 
T Consensus       144 ~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~  222 (283)
T cd05048         144 HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSY  222 (283)
T ss_pred             CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcC
Confidence            37999999999999999999999999997654332   1233456789999999887766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..++...+..+. ...|..+++++.+|+.+||+.||.+|||+.+++++
T Consensus       223 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         223 GLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999988888888876654 34567899999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.89  E-value=1.9e-23  Score=201.23  Aligned_cols=136  Identities=28%  Similarity=0.568  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++...... ...+.+|++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       120 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p  197 (308)
T cd06615         120 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYP  197 (308)
T ss_pred             CEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCC
Confidence            3899999999999999999999999998765432 2345678999999999887766 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc-------------------------------------cCCC-CCCChhhhcccccccCCCCCC
Q 017029           81 FDDENIPNLFKKIKGGI-------------------------------------YTLP-SHLSPGARDLIPRMLIVDPMK  122 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~-------------------------------------~~~p-~~~s~~~~~Li~~mL~~dP~~  122 (379)
                      |...+.......+....                                     ...| ..++.++++++.+||..||++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~  277 (308)
T cd06615         198 IPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKE  277 (308)
T ss_pred             CCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhh
Confidence            97655433332221110                                     1111 135778999999999999999


Q ss_pred             CCChhhhhcCchhhhc
Q 017029          123 RITIPEIRQHPWFQAH  138 (379)
Q Consensus       123 Rpt~~ell~hp~f~~~  138 (379)
                      |||++++++||||...
T Consensus       278 Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         278 RADLKELTKHPFIKRA  293 (308)
T ss_pred             CcCHHHHhcChhhhhc
Confidence            9999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.89  E-value=1.5e-23  Score=200.46  Aligned_cols=135  Identities=28%  Similarity=0.476  Sum_probs=104.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++.++.+||+|||++.......     ......++..|+|||.+.+....+.++|+||+|+++|+|+
T Consensus       139 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~  218 (310)
T cd07865         139 KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMW  218 (310)
T ss_pred             CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHH
Confidence            48999999999999999999999999997654321     1223467889999998876544478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc-------------------CCCC-------------CCChhhhcccccccCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY-------------------TLPS-------------HLSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~-------------------~~p~-------------~~s~~~~~Li~~mL~~dP~~R  123 (379)
                      +|..||.+.+.......+.....                   .+|.             ..+..+.++|.+||..||.+|
T Consensus       219 t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R  298 (310)
T cd07865         219 TRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKR  298 (310)
T ss_pred             hCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhc
Confidence            99999988765544333222110                   0111             124667899999999999999


Q ss_pred             CChhhhhcCchh
Q 017029          124 ITIPEIRQHPWF  135 (379)
Q Consensus       124 pt~~ell~hp~f  135 (379)
                      ||++++++||||
T Consensus       299 ~t~~e~l~h~~f  310 (310)
T cd07865         299 IDADTALNHDFF  310 (310)
T ss_pred             cCHHHHhcCCCC
Confidence            999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.89  E-value=2.1e-23  Score=194.92  Aligned_cols=134  Identities=40%  Similarity=0.655  Sum_probs=113.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||+|+||+++.++.+||+|||++.....   .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..|
T Consensus       117 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p  192 (260)
T cd05611         117 GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPP  192 (260)
T ss_pred             CeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCC
Confidence            379999999999999999999999999876533   234568899999999988765 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCC----CCCCChhhhcccccccCCCCCCCCC---hhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTL----PSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~mL~~dP~~Rpt---~~ell~hp~f~~~  138 (379)
                      |...+....+..+..+....    +..++.++.++|.+||+.||++|||   ++|++.||||+..
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         193 FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             CCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcC
Confidence            99888877777776554433    2357899999999999999999995   5799999999754

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.89  E-value=2.1e-23  Score=198.52  Aligned_cols=136  Identities=35%  Similarity=0.477  Sum_probs=107.1

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+||+++. ++.+||+|||++...... .......+++.|+|||++.+....+.++|+||+||++|+|++|.
T Consensus       130 ~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~  209 (295)
T cd07837         130 GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQ  209 (295)
T ss_pred             CeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCC
Confidence            4899999999999998 899999999998765322 22233457889999998876544478999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc-----------------CC-----------CCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           79 LPFDDENIPNLFKKIKGGIY-----------------TL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~-----------------~~-----------p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      .||.+.+......++.....                 ..           .+.++..+.++|.+||..||.+|||+.|++
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil  289 (295)
T cd07837         210 PLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL  289 (295)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHh
Confidence            99988765554433322100                 00           134788899999999999999999999999


Q ss_pred             cCchhh
Q 017029          131 QHPWFQ  136 (379)
Q Consensus       131 ~hp~f~  136 (379)
                      .||||+
T Consensus       290 ~~~~~~  295 (295)
T cd07837         290 THPYFD  295 (295)
T ss_pred             cCCCcC
Confidence            999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.88  E-value=2.3e-23  Score=193.81  Aligned_cols=137  Identities=42%  Similarity=0.718  Sum_probs=118.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---------ccccccCCCCccCcccccCCCCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvil   71 (379)
                      .|+||||+|+||+++.++.++|+|||++.......         ......++..|+|||...+..+ +.++|+||+|+++
T Consensus       113 ~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~  191 (265)
T cd05579         113 GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTVDWWSLGCIL  191 (265)
T ss_pred             CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCC-CcchhhHHHHHHH
Confidence            47999999999999999999999999987653321         1223468889999999887765 7899999999999


Q ss_pred             HHHhhCCCCCCCCChHHHHHHHhcCccCCCCCC--ChhhhcccccccCCCCCCCCCh---hhhhcCchhhhc
Q 017029           72 YALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL--SPGARDLIPRMLIVDPMKRITI---PEIRQHPWFQAH  138 (379)
Q Consensus        72 yelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~Li~~mL~~dP~~Rpt~---~ell~hp~f~~~  138 (379)
                      |++++|..||...........+..+....|...  +..+.+++.+||+.+|.+|||+   .++++||||++.
T Consensus       192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~  263 (265)
T cd05579         192 YEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGI  263 (265)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCC
Confidence            999999999999888888888887777777665  8999999999999999999999   999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.88  E-value=1.6e-23  Score=215.85  Aligned_cols=137  Identities=26%  Similarity=0.406  Sum_probs=103.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++.++.+||+|||++..+.....  ..+.+|++.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       287 gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~  365 (501)
T PHA03210        287 KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHD  365 (501)
T ss_pred             CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCC
Confidence            489999999999999999999999999987654322  234579999999999988877 78999999999999999987


Q ss_pred             CC-CCCC--ChHHHHHHHhcCc----cCCC----------------------------CCCChhhhcccccccCCCCCCC
Q 017029           79 LP-FDDE--NIPNLFKKIKGGI----YTLP----------------------------SHLSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        79 ~P-f~~~--~~~~~~~~i~~~~----~~~p----------------------------~~~s~~~~~Li~~mL~~dP~~R  123 (379)
                      .+ |.+.  .......++....    ..+|                            ..++.++.++|.+||.+||.+|
T Consensus       366 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~R  445 (501)
T PHA03210        366 FCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLR  445 (501)
T ss_pred             CCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccC
Confidence            54 4322  1111111111100    0000                            1245677788999999999999


Q ss_pred             CChhhhhcCchhhhc
Q 017029          124 ITIPEIRQHPWFQAH  138 (379)
Q Consensus       124 pt~~ell~hp~f~~~  138 (379)
                      ||+.|++.||||...
T Consensus       446 psa~elL~hp~f~~~  460 (501)
T PHA03210        446 PGAAELLALPLFSAE  460 (501)
T ss_pred             cCHHHHhhChhhhcC
Confidence            999999999999754

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.88  E-value=1.5e-23  Score=200.93  Aligned_cols=137  Identities=35%  Similarity=0.585  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus       136 gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~  214 (296)
T cd06654         136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEP  214 (296)
T ss_pred             CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999987654332 2234578999999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHh-cCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIK-GGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~-~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...+.......+. .+.  ...+..++..+.+++.+||..||.+|||+.++++||||...
T Consensus       215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             CCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            998876544332222 222  22355688899999999999999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.88  E-value=2.9e-23  Score=197.72  Aligned_cols=137  Identities=35%  Similarity=0.622  Sum_probs=114.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.++|+|||++...... .......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus       135 ~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~  213 (285)
T cd06648         135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEP  213 (285)
T ss_pred             CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCC
Confidence            4799999999999999999999999988755332 12234568999999999987776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCC---CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTL---PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+..+....   +..++..+.+++.+||..+|.+|||+.++++||||+..
T Consensus       214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  275 (285)
T cd06648         214 PYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKA  275 (285)
T ss_pred             CCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccC
Confidence            998877766666666553222   23478899999999999999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.88  E-value=2.6e-23  Score=196.38  Aligned_cols=134  Identities=37%  Similarity=0.542  Sum_probs=110.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+|+||+|+||+++.++.+||+|||++.............+++.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       127 ~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~  205 (287)
T cd07838         127 RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPL  205 (287)
T ss_pred             CeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCc
Confidence            379999999999999999999999999987755544445568899999999988776 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-----C-----------C-----------CCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           81 FDDENIPNLFKKIKGGIY-----T-----------L-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-----~-----------~-----------p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |.+....+...++.....     .           +           .+.+++.+.++|.+||+.||.+||++++++.||
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~  285 (287)
T cd07838         206 FRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHP  285 (287)
T ss_pred             ccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCc
Confidence            998877666555532110     0           0           013457788999999999999999999999999


Q ss_pred             hh
Q 017029          134 WF  135 (379)
Q Consensus       134 ~f  135 (379)
                      ||
T Consensus       286 ~~  287 (287)
T cd07838         286 YF  287 (287)
T ss_pred             CC
Confidence            97

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.88  E-value=2.5e-23  Score=198.81  Aligned_cols=138  Identities=35%  Similarity=0.515  Sum_probs=109.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCC---CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~---~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||+|+||+++.++.+||+|||++.............|++.|+|||.+.+..   ..+.++|+||+|+++|+|++|
T Consensus       135 ~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g  214 (296)
T cd06618         135 GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATG  214 (296)
T ss_pred             CEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhC
Confidence            38999999999999999999999999998765544334456888999999987653   126789999999999999999


Q ss_pred             CCCCCCCCh-HHHHHHHhcCc-cCCC--CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENI-PNLFKKIKGGI-YTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~-~~~~~~i~~~~-~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +.||..... .+....+.... ...+  ..++.++.+|+.+||..||.+|||+++++.||||+..
T Consensus       215 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         215 QFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            999976332 23333333332 2222  2468899999999999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.5e-23  Score=197.86  Aligned_cols=136  Identities=35%  Similarity=0.666  Sum_probs=122.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      ||.||||.+|+|+|..|++||+|+|.++.- .+++...|.||||+|.|||++.|..| +..+|+|++||+++||+.|+.|
T Consensus       372 iiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrsp  450 (593)
T KOG0695|consen  372 IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSP  450 (593)
T ss_pred             eeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCC
Confidence            899999999999999999999999999864 66778889999999999999999998 9999999999999999999999


Q ss_pred             CCC-------C-ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC------hhhhhcCchhhhc
Q 017029           81 FDD-------E-NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT------IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~-------~-~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt------~~ell~hp~f~~~  138 (379)
                      |+-       . ...-+++-|......+|..+|-.+..+++..|++||.+|..      +.++..|+||+..
T Consensus       451 fdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i  522 (593)
T KOG0695|consen  451 FDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI  522 (593)
T ss_pred             cceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence            962       2 23346788888889999999999999999999999999984      5789999999854

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=2.4e-23  Score=196.85  Aligned_cols=138  Identities=33%  Similarity=0.452  Sum_probs=113.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCC----CCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGK----LYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~----~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++.++.++|+|||++....... ......|++.|+|||++...    ...+.++|+||+||++|+|+
T Consensus       123 ~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~  202 (280)
T cd06611         123 KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELA  202 (280)
T ss_pred             CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHH
Confidence            37999999999999999999999999987654322 22345689999999998532    12256899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+.+......++..+..   ..|..++.++.++|.+||..+|.+|||+.++++||||...
T Consensus       203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         203 QMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             hCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            99999998877666666665532   3456788999999999999999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.88  E-value=3.1e-23  Score=196.43  Aligned_cols=134  Identities=34%  Similarity=0.477  Sum_probs=108.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccC-----CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||++.+     ..+ +.++|+||+||++|+|
T Consensus       144 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el  222 (286)
T cd06638         144 KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIEL  222 (286)
T ss_pred             CccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHH
Confidence            47999999999999999999999999987664332 2234578999999999853     224 6799999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCc---cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ++|..||.+........++....   ...|..++..+.++|.+||+.||++|||+.|+++|+||
T Consensus       223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         223 GDGDPPLADLHPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             hcCCCCCCCCchhHHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            99999998776544443333222   12345567889999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.88  E-value=1.3e-23  Score=211.86  Aligned_cols=134  Identities=29%  Similarity=0.619  Sum_probs=117.2

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +|||||||.+||+|+. .|.|||+|+|+|..+.... .+...|||.|||||+.. ..| ...+||||||+++.||+|+..
T Consensus       165 PIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eY  241 (632)
T KOG0584|consen  165 PIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEY  241 (632)
T ss_pred             CccccccccceEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccC
Confidence            6999999999999986 4899999999999886544 34578999999999997 456 789999999999999999999


Q ss_pred             CCCC-CChHHHHHHHhcCccCC--CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDD-ENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~-~~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.. .+..++++++..|.-+-  ..--.+++++||.+||.. .+.|+|+.|||.||||...
T Consensus       242 PYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  242 PYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             ChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            9976 67889999999987532  223478999999999999 9999999999999999875

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=2.2e-23  Score=195.16  Aligned_cols=135  Identities=32%  Similarity=0.442  Sum_probs=108.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCC----CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKL----YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~----~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||+|+||+++.++.+||+|||++...... .......|++.|+|||++.+..    ..+.++|+||+||++|+|+
T Consensus       133 ~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~  212 (275)
T cd06608         133 KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELA  212 (275)
T ss_pred             CcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHH
Confidence            3799999999999999999999999998765432 2223456899999999885422    2367899999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      +|..||.+........++.....   ..+..++.+++++|.+||..||++|||+.++++|||+
T Consensus       213 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         213 DGKPPLCDMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hCCCCccccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            99999987665555555544432   2233477899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.88  E-value=1.1e-23  Score=201.96  Aligned_cols=139  Identities=35%  Similarity=0.605  Sum_probs=112.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.++|+|||++........ .....|++.|+|||.+.+..+ +.++|+||+||++|++++|..
T Consensus       135 ~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~  213 (297)
T cd06656         135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEP  213 (297)
T ss_pred             CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCC
Confidence            379999999999999999999999999877644322 234578899999999988766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhc-Cc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           80 PFDDENIPNLFKKIKG-GI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ||.+.+.......+.. +.  ...|..++..+++++.+||..||.+|||++++++||||+...+
T Consensus       214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         214 PYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             CCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            9987654332222221 21  2245567889999999999999999999999999999986543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.88  E-value=3.6e-23  Score=195.76  Aligned_cols=135  Identities=33%  Similarity=0.566  Sum_probs=108.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||+|+||+++.++.+||+|||++.......  ......|+..|+|||++.+....+.++|+||+|+++|+|++|.
T Consensus       120 ~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~  199 (288)
T cd07833         120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGE  199 (288)
T ss_pred             CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCC
Confidence            38999999999999999999999999988765433  3345578899999999988734478999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCc--------------------------------cCCCCCCChhhhcccccccCCCCCCCCCh
Q 017029           79 LPFDDENIPNLFKKIKGGI--------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~--------------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      .||.+.+..+....+....                                ..++..++.++++||++||..+|++|||+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~  279 (288)
T cd07833         200 PLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC  279 (288)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccH
Confidence            9998765544332221100                                01233458889999999999999999999


Q ss_pred             hhhhcCchh
Q 017029          127 PEIRQHPWF  135 (379)
Q Consensus       127 ~ell~hp~f  135 (379)
                      +++++||||
T Consensus       280 ~~il~~~~f  288 (288)
T cd07833         280 DELLQHPYF  288 (288)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.88  E-value=2.8e-23  Score=202.32  Aligned_cols=138  Identities=32%  Similarity=0.514  Sum_probs=108.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++.++.+||+|||++.......     ...+..|+..|+|||.+.+....+.++|+||+||++|+|+
T Consensus       127 ~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~  206 (334)
T cd07855         127 NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEML  206 (334)
T ss_pred             CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHH
Confidence            38999999999999999999999999987654322     1234578999999999876444478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcC--------------------------ccCC-----CCCCChhhhcccccccCCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGG--------------------------IYTL-----PSHLSPGARDLIPRMLIVDPMKRI  124 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~--------------------------~~~~-----p~~~s~~~~~Li~~mL~~dP~~Rp  124 (379)
                      +|+.||.+.+.......+...                          ....     ....++++.++|.+||+.+|.+||
T Consensus       207 ~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp  286 (334)
T cd07855         207 GRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI  286 (334)
T ss_pred             cCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc
Confidence            999999876644332221110                          0001     134688999999999999999999


Q ss_pred             ChhhhhcCchhhhc
Q 017029          125 TIPEIRQHPWFQAH  138 (379)
Q Consensus       125 t~~ell~hp~f~~~  138 (379)
                      |+++++.||||...
T Consensus       287 t~~~~l~~~~~~~~  300 (334)
T cd07855         287 TVEQALQHPFLAQY  300 (334)
T ss_pred             CHHHHHhChhhhhc
Confidence            99999999999865

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.88  E-value=2.6e-23  Score=199.22  Aligned_cols=129  Identities=19%  Similarity=0.216  Sum_probs=103.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--------ccccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+|||++.++.++|+|||+++......        ......||+.|+|||+..+..+ +.++||||+||++|
T Consensus       146 ~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~  224 (294)
T PHA02882        146 GISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCML  224 (294)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHH
Confidence            38999999999999999999999999997653211        1123469999999999988877 79999999999999


Q ss_pred             HHhhCCCCCCCCC-hHH--------HHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           73 ALLCGTLPFDDEN-IPN--------LFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        73 elltG~~Pf~~~~-~~~--------~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      +|++|..||.+.. ...        ....+..+...+ ...+..+.+++..||..+|++||++.++++
T Consensus       225 el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        225 KWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHhCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            9999999998763 221        223344443333 356889999999999999999999999875

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.88  E-value=5.3e-23  Score=190.40  Aligned_cols=134  Identities=46%  Similarity=0.813  Sum_probs=118.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++|+||+|+||+++.++.++|+|||++...... .......|+..|+|||.+.+... +.++|+||+|+++|++++|..
T Consensus       113 ~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~  191 (250)
T cd05123         113 GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKP  191 (250)
T ss_pred             CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCC
Confidence            3799999999999999999999999998776443 23345578899999999987665 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh---hhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI---PEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~---~ell~hp~f  135 (379)
                      ||...+.......+.....++|...+..+.+++.+||..||++|||+   +++++||||
T Consensus       192 p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         192 PFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            99888877777888777788888899999999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.88  E-value=2.4e-23  Score=224.66  Aligned_cols=138  Identities=28%  Similarity=0.407  Sum_probs=110.7

Q ss_pred             EEecCCCCCCeEEcC-----------------CCcEEEEecCCcccccCCcccccccCCCCccCcccccCC-CCCCCccc
Q 017029            2 VVHRDLKPENLLLDS-----------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVD   63 (379)
Q Consensus         2 IiHrDLKpeNILl~~-----------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~D   63 (379)
                      ||||||||+||||+.                 .+.+||+|||++............+||+.|+|||++.+. ...+.++|
T Consensus       146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD  225 (1021)
T PTZ00266        146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD  225 (1021)
T ss_pred             ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence            899999999999964                 235899999999877655545566899999999998643 22378999


Q ss_pred             eeeehhHHHHHhhCCCCCCCCChH-HHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           64 VWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        64 iWSlGvilyelltG~~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |||||||+|+|++|..||...+.. .+...+..+........+.++.+||.+||..+|.+|||+.+++.|+|++...
T Consensus       226 VWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        226 MWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             HHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            999999999999999999865443 4444444433222345789999999999999999999999999999998543

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.88  E-value=2.8e-23  Score=201.81  Aligned_cols=138  Identities=21%  Similarity=0.332  Sum_probs=103.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-c-------ccccccCCCCccCcccccCC-CCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H-------FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~-------~~~~~~gt~~y~APE~l~~~-~~~~~~~DiWSlGvil   71 (379)
                      .|+||||||+|||++.++.++++|||.+...... .       ......++..|+|||++.+. ..++.++||||+||++
T Consensus       121 ~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il  200 (327)
T cd08227         121 GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITA  200 (327)
T ss_pred             CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHH
Confidence            3899999999999999999999999865443211 1       11223567789999999763 2237899999999999


Q ss_pred             HHHhhCCCCCCCCChHHHHHHHhcCccC----------------------------------------------CCCCCC
Q 017029           72 YALLCGTLPFDDENIPNLFKKIKGGIYT----------------------------------------------LPSHLS  105 (379)
Q Consensus        72 yelltG~~Pf~~~~~~~~~~~i~~~~~~----------------------------------------------~p~~~s  105 (379)
                      |+|++|..||.+............+..+                                              ....++
T Consensus       201 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (327)
T cd08227         201 CELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFS  280 (327)
T ss_pred             HHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccC
Confidence            9999999999875544333222221110                                              011246


Q ss_pred             hhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          106 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       106 ~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +.+.+||.+||+.||++|||++|+++||||+..
T Consensus       281 ~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         281 PHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             HHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence            678899999999999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.88  E-value=3.7e-23  Score=195.68  Aligned_cols=135  Identities=33%  Similarity=0.528  Sum_probs=106.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++||||+|+||+++.++.++|+|||++...... .......+++.|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       119 ~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~  198 (283)
T cd07835         119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP  198 (283)
T ss_pred             CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            4799999999999999999999999999765322 122334578899999988765444789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-----------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-----------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-----------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+......++....                             ....+.++..+.++|.+||+.||.+|||++|++
T Consensus       199 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il  278 (283)
T cd07835         199 LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAAL  278 (283)
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHh
Confidence            998765543332221110                             011245678899999999999999999999999


Q ss_pred             cCchh
Q 017029          131 QHPWF  135 (379)
Q Consensus       131 ~hp~f  135 (379)
                      .||||
T Consensus       279 ~~~~~  283 (283)
T cd07835         279 QHPYF  283 (283)
T ss_pred             cCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.88  E-value=3.5e-23  Score=194.18  Aligned_cols=133  Identities=29%  Similarity=0.401  Sum_probs=104.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||++.   +..+ +.++|+||+||++|+|++
T Consensus       126 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~  204 (267)
T cd06645         126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAE  204 (267)
T ss_pred             CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhc
Confidence            37999999999999999999999999987654321 223457899999999974   2334 689999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC-----CCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      |..||...................+     ..++..+.++|.+||..+|++|||++++++|||
T Consensus       205 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         205 LQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            9999876544333223222222221     246788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.88  E-value=3.3e-23  Score=193.10  Aligned_cols=133  Identities=32%  Similarity=0.435  Sum_probs=108.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCC---CCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~---~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||+|+||+++.++.+||+|||++....... ......|+..|+|||.+.+.   .+ +.++|+||+||++|+|++
T Consensus       121 ~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~t  199 (262)
T cd06613         121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAE  199 (262)
T ss_pred             CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHh
Confidence            37999999999999999999999999987654332 23445788999999998765   55 679999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccC-----CCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      |..||.+.+.......+....+.     .+..++.++.+++.+||..+|.+|||+.+++.|+|
T Consensus       200 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         200 LQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            99999887655544444443222     23346788999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.88  E-value=3.4e-23  Score=202.71  Aligned_cols=137  Identities=33%  Similarity=0.500  Sum_probs=109.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++......  .....|++.|+|||++.+....+.++|+||+||++|+|++|+.|
T Consensus       137 ~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~p  214 (342)
T cd07879         137 GIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTL  214 (342)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCC
Confidence            3799999999999999999999999998765322  23446788999999987644447899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc-----------------------cCC--------CCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGI-----------------------YTL--------PSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~-----------------------~~~--------p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+.......+....                       ...        .+..+..+.+||.+||+.||.+|||++++
T Consensus       215 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~  294 (342)
T cd07879         215 FKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEA  294 (342)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHH
Confidence            99876554444332210                       000        12457788999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      +.||||+...
T Consensus       295 l~h~~f~~~~  304 (342)
T cd07879         295 LEHPYFDSFR  304 (342)
T ss_pred             hcCcchhhcc
Confidence            9999998754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.88  E-value=3.6e-23  Score=197.91  Aligned_cols=135  Identities=28%  Similarity=0.480  Sum_probs=106.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc------------cccccCCCCccCcccccCCCCCCCccceeeeh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF------------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCG   68 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~------------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlG   68 (379)
                      .|+||||||+||+++.++.+||+|||++........            .....|++.|+|||.+.+....+.++|+||+|
T Consensus       135 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  214 (311)
T cd07866         135 HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIG  214 (311)
T ss_pred             CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHH
Confidence            379999999999999999999999999976543211            12235678899999887654447899999999


Q ss_pred             hHHHHHhhCCCCCCCCChHHHHHHHhcCccC-----------------------CC-------CCCChhhhcccccccCC
Q 017029           69 VILYALLCGTLPFDDENIPNLFKKIKGGIYT-----------------------LP-------SHLSPGARDLIPRMLIV  118 (379)
Q Consensus        69 vilyelltG~~Pf~~~~~~~~~~~i~~~~~~-----------------------~p-------~~~s~~~~~Li~~mL~~  118 (379)
                      |++|+|++|..||.+.+.......+......                       .+       ..+++.+.++|.+||..
T Consensus       215 ~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  294 (311)
T cd07866         215 CVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSL  294 (311)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHccc
Confidence            9999999999999987766655544321100                       00       13446788999999999


Q ss_pred             CCCCCCChhhhhcCchh
Q 017029          119 DPMKRITIPEIRQHPWF  135 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f  135 (379)
                      ||.+|||+.|++.||||
T Consensus       295 ~p~~R~t~~ell~~~~f  311 (311)
T cd07866         295 DPYKRLTASDALEHPYF  311 (311)
T ss_pred             CcccCcCHHHHhcCCCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.88  E-value=4.2e-23  Score=191.76  Aligned_cols=135  Identities=36%  Similarity=0.536  Sum_probs=112.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+|+||+|+||+++.++.+||+|||++.............|++.|+|||.+......+.++|+||+||++|+|++|..|
T Consensus       122 ~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~p  201 (258)
T cd06632         122 NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPP  201 (258)
T ss_pred             CcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCC
Confidence            37999999999999999999999999988765544345667899999999987665237899999999999999999999


Q ss_pred             CCCCChHHHHHHHhc--CccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           81 FDDENIPNLFKKIKG--GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        81 f~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |..........++..  ....+|..+++.+.+++.+||..+|.+|||+.+++.|||+
T Consensus       202 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         202 WSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             cccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            987665444444433  2335567789999999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.88  E-value=4.5e-23  Score=200.74  Aligned_cols=137  Identities=33%  Similarity=0.554  Sum_probs=107.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      |+||||||+||+++.++.+||+|||++.......     ......|++.|+|||++.+....+.++|+||+||++|++++
T Consensus       126 ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~  205 (332)
T cd07857         126 VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLG  205 (332)
T ss_pred             cccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHh
Confidence            7999999999999999999999999997654322     12345789999999988664334789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCc----------------------------cC---CCCCCChhhhcccccccCCCCCCCCC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI----------------------------YT---LPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~----------------------------~~---~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      |..||.+.+.......+....                            ..   ..+..+..+.+++.+||+.||.+|||
T Consensus       206 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t  285 (332)
T cd07857         206 RKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS  285 (332)
T ss_pred             CCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC
Confidence            999998766444333222110                            00   11235788999999999999999999


Q ss_pred             hhhhhcCchhhhc
Q 017029          126 IPEIRQHPWFQAH  138 (379)
Q Consensus       126 ~~ell~hp~f~~~  138 (379)
                      +.+++.|||++..
T Consensus       286 ~~~ll~~~~~~~~  298 (332)
T cd07857         286 VEEALEHPYLAIW  298 (332)
T ss_pred             HHHHhcChhhhhh
Confidence            9999999999755

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.88  E-value=4.3e-23  Score=197.96  Aligned_cols=137  Identities=33%  Similarity=0.596  Sum_probs=113.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... .....+|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       137 ~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~  215 (297)
T cd06659         137 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEP  215 (297)
T ss_pred             CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999987654322 2234578999999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...+.......+.....   ..+..++..+.++|.+||+.+|.+|||++++++||||.+.
T Consensus       216 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         216 PYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             CCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence            9988776666555544322   2234578899999999999999999999999999999754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.88  E-value=6.7e-23  Score=190.86  Aligned_cols=134  Identities=36%  Similarity=0.565  Sum_probs=115.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.+||+|||++....... ......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..
T Consensus       121 ~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~  199 (256)
T cd08221         121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKR  199 (256)
T ss_pred             CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCC
Confidence            37899999999999999999999999988764433 2345578999999999987765 688999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccC-CCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||...+..+....+..+.+. .+..++.++.++|.+||..+|.+|||+.++++|||+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         200 TFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            99998888877777666543 345678999999999999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.88  E-value=5.6e-23  Score=190.16  Aligned_cols=134  Identities=38%  Similarity=0.664  Sum_probs=116.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++|+||+|+||+++.++.++|+|||++....... ......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..
T Consensus       123 ~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~  201 (258)
T cd08215         123 KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKH  201 (258)
T ss_pred             CEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCC
Confidence            37999999999999999999999999998765443 3345578999999999887776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||...+.......+.... ..+|..++..+.+++.+||..+|++|||+.++++||||
T Consensus       202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         202 PFEGENLLELALKILKGQYPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             CCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            999888777766665543 35566789999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.88  E-value=4.8e-23  Score=201.61  Aligned_cols=138  Identities=28%  Similarity=0.505  Sum_probs=106.7

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+||+++. ++.+||+|||++......    .......|+..|+|||++.+....+.++||||+||++|+|+
T Consensus       134 givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~  213 (342)
T cd07854         134 NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML  213 (342)
T ss_pred             CcccCCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHH
Confidence            3799999999999975 567899999998765322    11223467889999998765444478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCc-------------------------c-----CCCCCCChhhhcccccccCCCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGI-------------------------Y-----TLPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~-------------------------~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      +|+.||.+.+.......+....                         .     ...+.++.++.+||.+||+.||.+|||
T Consensus       214 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  293 (342)
T cd07854         214 TGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT  293 (342)
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC
Confidence            9999998776544443332211                         0     012356788999999999999999999


Q ss_pred             hhhhhcCchhhhc
Q 017029          126 IPEIRQHPWFQAH  138 (379)
Q Consensus       126 ~~ell~hp~f~~~  138 (379)
                      +.+++.||||+..
T Consensus       294 ~~ell~h~~~~~~  306 (342)
T cd07854         294 AEEALMHPYMSCY  306 (342)
T ss_pred             HHHHhCCCccccc
Confidence            9999999999753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.88  E-value=5.8e-23  Score=197.32  Aligned_cols=137  Identities=42%  Similarity=0.720  Sum_probs=112.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----------------ccccccCCCCccCcccccCCCCCCCccce
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----------------FLKTSCGSPNYAAPEVISGKLYAGPEVDV   64 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----------------~~~~~~gt~~y~APE~l~~~~~~~~~~Di   64 (379)
                      .|+||||||+||+++.++.+||+|||+++......                ......|+..|+|||.+.+..+ +.++|+
T Consensus       121 ~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di  199 (305)
T cd05609         121 GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDW  199 (305)
T ss_pred             CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCC-CchhhH
Confidence            37999999999999999999999999986421000                0112457889999999887766 789999


Q ss_pred             eeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCC---CCCChhhhcccccccCCCCCCCCC---hhhhhcCchhhhc
Q 017029           65 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAH  138 (379)
Q Consensus        65 WSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~mL~~dP~~Rpt---~~ell~hp~f~~~  138 (379)
                      ||+||++|++++|..||.+....++...+..+....|   ..++.++.++|.+||+.||.+|||   +.++++||||...
T Consensus       200 ~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~  279 (305)
T cd05609         200 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL  279 (305)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence            9999999999999999998888887777766654433   257889999999999999999998   7899999999643

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.88  E-value=4.1e-23  Score=195.44  Aligned_cols=135  Identities=27%  Similarity=0.457  Sum_probs=107.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||++++++.++|+|||++....... ......|+..|+|||++.+....+.++||||+||++|+|++|..
T Consensus       120 ~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~  199 (286)
T cd07846         120 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP  199 (286)
T ss_pred             CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence            37899999999999999999999999987654332 23345688999999998765545789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-------------------------------CCCCCCChhhhcccccccCCCCCCCCChhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ||.+....+....+.....                               ...+.++..+.+++.+||..+|.+|||+.+
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  279 (286)
T cd07846         200 LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ  279 (286)
T ss_pred             CCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence            9987665443333221000                               012356788999999999999999999999


Q ss_pred             hhcCchh
Q 017029          129 IRQHPWF  135 (379)
Q Consensus       129 ll~hp~f  135 (379)
                      +++||||
T Consensus       280 il~~~~~  286 (286)
T cd07846         280 LLHHEFF  286 (286)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.88  E-value=2.5e-23  Score=199.35  Aligned_cols=135  Identities=37%  Similarity=0.583  Sum_probs=105.6

Q ss_pred             CEEecCCCCCCeEEcC--------------------CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCC
Q 017029            1 MVVHRDLKPENLLLDS--------------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP   60 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~--------------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~   60 (379)
                      +++|-||||||||+.+                    +..|||+|||.++......  .+.+.|.+|+|||++.|-++ +.
T Consensus       212 kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGw-S~  288 (415)
T KOG0671|consen  212 KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGW-SQ  288 (415)
T ss_pred             ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCc-CC
Confidence            5899999999999832                    2358999999998765443  56788999999999999888 68


Q ss_pred             ccceeeehhHHHHHhhCCCCCCCCChHH---HHHHHhcCc------------------cCCCCC----------------
Q 017029           61 EVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGI------------------YTLPSH----------------  103 (379)
Q Consensus        61 ~~DiWSlGvilyelltG~~Pf~~~~~~~---~~~~i~~~~------------------~~~p~~----------------  103 (379)
                      .+||||+||||+|+.+|..-|...+..+   .++.|.+..                  ...|..                
T Consensus       289 pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl  368 (415)
T KOG0671|consen  289 PCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPL  368 (415)
T ss_pred             ccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccH
Confidence            9999999999999999999998765433   444543311                  111110                


Q ss_pred             ---------CChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          104 ---------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       104 ---------~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                               -...+.|||++||.+||.+|+|+.|++.||||+..
T Consensus       369 ~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  369 KKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             HHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence                     01346799999999999999999999999999853

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.88  E-value=5.4e-23  Score=193.21  Aligned_cols=131  Identities=25%  Similarity=0.515  Sum_probs=110.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.+......   ....+++.|+|||++.+..+ +.++|+||+||++|+|++ 
T Consensus       132 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~  210 (272)
T cd05075         132 SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATR  210 (272)
T ss_pred             CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcC
Confidence            4899999999999999999999999999876543321   22346678999999987766 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.........+..+.. ..+..++..+.++|.+||+.||.+|||+.+++++
T Consensus       211 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         211 GQTPYPGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            8999998877777777776543 5567788999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.88  E-value=5.3e-23  Score=194.76  Aligned_cols=131  Identities=25%  Similarity=0.401  Sum_probs=111.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||+++.......   .....+++.|+|||.+.+..+ +.++||||+||++|+|++ 
T Consensus       144 gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~  222 (283)
T cd05091         144 HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSY  222 (283)
T ss_pred             CccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcC
Confidence            379999999999999999999999999886643322   123456789999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....+....+..+.. +.|..++..+.+++.+||+.+|.+||++.+|+..
T Consensus       223 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         223 GLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            8999998888888888776654 4577899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.87  E-value=1.2e-23  Score=225.14  Aligned_cols=137  Identities=32%  Similarity=0.572  Sum_probs=116.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-----cccccccCCCCccCcccccCCCC--CCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~--~~~~~DiWSlGvilyel   74 (379)
                      ||||||||+||||+.+|.+|++|||.+......     ..++...|||.|||||++.+...  .+-++||||+||++.||
T Consensus      1355 IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM 1434 (1509)
T KOG4645|consen 1355 IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEM 1434 (1509)
T ss_pred             ceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEe
Confidence            899999999999999999999999999876543     24556789999999999976432  25689999999999999


Q ss_pred             hhCCCCCCC-CChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDD-ENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~-~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +||+.||.. ++...++-++..| .+++|..+|.+.++||.+||..||++|.++.||++|-|-+..
T Consensus      1435 ~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1435 ATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred             ecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence            999999976 4455666666555 567899999999999999999999999999999999887643

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.87  E-value=4.9e-23  Score=194.16  Aligned_cols=135  Identities=36%  Similarity=0.515  Sum_probs=108.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||||+||+++.++.+||+|||.+....... ......++..|+|||.+.+....+.++|+||+|+++|+|++|+.
T Consensus       118 ~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~  197 (283)
T cd05118         118 GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRP  197 (283)
T ss_pred             CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCC
Confidence            48999999999999999999999999987765433 23344678899999998876344789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-------------------C-----------CCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-------------------T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-------------------~-----------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+.+..+...++.....                   .           ..+.++.++.++|.+||..||.+||++.++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~l  277 (283)
T cd05118         198 LFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQA  277 (283)
T ss_pred             CCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHH
Confidence            9988776554444322100                   0           112467889999999999999999999999


Q ss_pred             hcCchh
Q 017029          130 RQHPWF  135 (379)
Q Consensus       130 l~hp~f  135 (379)
                      +.||||
T Consensus       278 l~~~~~  283 (283)
T cd05118         278 LAHPYF  283 (283)
T ss_pred             hhCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.87  E-value=8.5e-23  Score=192.68  Aligned_cols=129  Identities=29%  Similarity=0.448  Sum_probs=109.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      |+||||||+||+++.++.+||+|||++........   .....+++.|+|||++.+..+ ++++||||+||++|+|++ |
T Consensus       143 i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g  221 (280)
T cd05049         143 FVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYG  221 (280)
T ss_pred             eeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcC
Confidence            79999999999999999999999999875432221   123345788999999988776 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCccC-CCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+.......+..+... .+..++..+++++.+||..||.+|||+.|+++
T Consensus       222 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         222 KQPWYGLSNEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            9999988888888887776653 35678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.87  E-value=8e-23  Score=188.01  Aligned_cols=133  Identities=35%  Similarity=0.560  Sum_probs=109.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .++||||+|+||+++.++.++|+|||.+.............|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..|
T Consensus       118 ~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p  196 (253)
T cd05122         118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPP  196 (253)
T ss_pred             CEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCC
Confidence            379999999999999999999999999987755433345678899999999987765 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhc-CccCCCC--CCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           81 FDDENIPNLFKKIKG-GIYTLPS--HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        81 f~~~~~~~~~~~i~~-~~~~~p~--~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      |...+.......+.. .....+.  .++..+.++|.+||..||++|||+.++++|||
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         197 YSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             CCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            988754443333332 2222332  34889999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.87  E-value=7.8e-23  Score=195.70  Aligned_cols=131  Identities=26%  Similarity=0.401  Sum_probs=108.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.............++..|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus       139 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~  217 (297)
T cd05089         139 QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGT  217 (297)
T ss_pred             CcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCC
Confidence            379999999999999999999999999864322111112233457999999987776 789999999999999997 999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||.+....+...++..+. ...|..++..+.+|+.+||..+|.+|||++++++.
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         218 PYCGMTCAELYEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999988888877776654 34566789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.87  E-value=9.1e-23  Score=190.69  Aligned_cols=130  Identities=25%  Similarity=0.389  Sum_probs=109.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||.||+++.++.+||+|||++........    .....+++.|+|||.+.+..+ +.++|+||+||++|+|++
T Consensus       115 ~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t  193 (257)
T cd05116         115 NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFS  193 (257)
T ss_pred             CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHh
Confidence            379999999999999999999999999987644322    122234578999999877665 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+.+...+...+..+. .+.|..+++++.++|.+||+.||.+|||+.+|..
T Consensus       194 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         194 YGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence             999999888777777777654 4567789999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.87  E-value=1.7e-22  Score=190.90  Aligned_cols=135  Identities=37%  Similarity=0.474  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+|+||+|+||+++.++.++|+|||++.............|+..|+|||++.+....+.++|+||+|+++|+|++|..|
T Consensus       119 ~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~  198 (283)
T cd07830         119 GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPL  198 (283)
T ss_pred             CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCc
Confidence            37999999999999999999999999998776554445567889999999886544447899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-------------------C-----------CCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-------------------T-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-------------------~-----------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      |.+....+...++.....                   .           ..+..+..+.++|.+||..||.+|||++|++
T Consensus       199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~  278 (283)
T cd07830         199 FPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQAL  278 (283)
T ss_pred             cCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHh
Confidence            987765544433321100                   0           0112367899999999999999999999999


Q ss_pred             cCchh
Q 017029          131 QHPWF  135 (379)
Q Consensus       131 ~hp~f  135 (379)
                      .||||
T Consensus       279 ~~~~~  283 (283)
T cd07830         279 QHPYF  283 (283)
T ss_pred             hCCCC
Confidence            99997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.87  E-value=6.8e-23  Score=193.25  Aligned_cols=138  Identities=30%  Similarity=0.546  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.++|+|||++....... ......|+..|+|||.+.+....+.++|+||+||++|+|++|..
T Consensus       121 ~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~  200 (277)
T cd06917         121 GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNP  200 (277)
T ss_pred             CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998765432 22344688999999998765544789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCC-CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~-~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.........+.... ..++. .++.++.+++.+||..||++|||+.+++.|+||++.
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~  261 (277)
T cd06917         201 PYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAH  261 (277)
T ss_pred             CCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcc
Confidence            998876655444333322 22233 377899999999999999999999999999999764

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.87  E-value=2.5e-22  Score=209.57  Aligned_cols=138  Identities=25%  Similarity=0.382  Sum_probs=98.2

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCC--------------------
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLY--------------------   57 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~--------------------   57 (379)
                      .||||||||+|||++. ++.+||+|||+++.+..+.  ...+.+|++.|+|||.+.....                    
T Consensus       275 gIiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~  354 (566)
T PLN03225        275 GIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL  354 (566)
T ss_pred             CEEeCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccc
Confidence            4899999999999986 5899999999998654332  2345689999999997643221                    


Q ss_pred             -CCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCcc---------------------CCCCCCChhhhcccccc
Q 017029           58 -AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY---------------------TLPSHLSPGARDLIPRM  115 (379)
Q Consensus        58 -~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~---------------------~~p~~~s~~~~~Li~~m  115 (379)
                       .+.++||||+||++|||+++..|++.. .......+.....                     ......+...++||.+|
T Consensus       355 ~~~~k~DVwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~m  433 (566)
T PLN03225        355 NLPDRFDIYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSM  433 (566)
T ss_pred             cCCCCcccHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHH
Confidence             124569999999999999987776542 1111111111110                     00011123355899999


Q ss_pred             cCCCCCCCCChhhhhcCchhhhcc
Q 017029          116 LIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       116 L~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |++||.+|||+.++++||||+...
T Consensus       434 L~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        434 MRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             ccCCcccCCCHHHHhCCcCcCCCC
Confidence            999999999999999999998653

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.87  E-value=7.9e-23  Score=191.78  Aligned_cols=134  Identities=34%  Similarity=0.575  Sum_probs=108.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.++|+|||++......    .......|+..|+|||++.+..+ +.++|+||+||++|+|++
T Consensus       126 ~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~  204 (265)
T cd06652         126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLT  204 (265)
T ss_pred             CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhh
Confidence            3899999999999999999999999998765321    11234568899999999987766 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      |..||.+........++...  ....|..++..+.++|.+||. +|.+|||++++++|||+.
T Consensus       205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         205 EKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             CCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            99999876544444444322  233466778889999999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.87  E-value=6.1e-23  Score=194.18  Aligned_cols=137  Identities=31%  Similarity=0.473  Sum_probs=113.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++|+||+|+||+++.++.++|+|||++........ .....++..|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       121 ~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06640         121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCC
Confidence            379999999999999999999999999977644332 223467889999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.........+..+ ...++..++..+.+++.+||..+|.+|||+.+++.|+||...
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06640         200 PNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKN  259 (277)
T ss_pred             CCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhc
Confidence            99887766555444333 233445678899999999999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.87  E-value=1e-22  Score=194.05  Aligned_cols=138  Identities=33%  Similarity=0.500  Sum_probs=107.6

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||+|+||+++. ++.+||+|||++...... .......|++.|+|||++.+....+.++|+||+||++|+|++|.
T Consensus       122 ~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~  201 (294)
T PLN00009        122 RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK  201 (294)
T ss_pred             CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            4899999999999985 567999999999765332 22234467889999999876544478999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCc---------------------c--------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           79 LPFDDENIPNLFKKIKGGI---------------------Y--------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~---------------------~--------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      .||.+....+...++....                     .        ...+.+++++.+++.+||+.+|++||++.++
T Consensus       202 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~  281 (294)
T PLN00009        202 PLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAA  281 (294)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHH
Confidence            9998766554443332100                     0        0123467889999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      +.||||.+.
T Consensus       282 l~~~~~~~~  290 (294)
T PLN00009        282 LEHEYFKDL  290 (294)
T ss_pred             hcCchHhHH
Confidence            999999854

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.87  E-value=5.8e-23  Score=201.37  Aligned_cols=138  Identities=33%  Similarity=0.509  Sum_probs=109.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++......  .....|++.|+|||++.+....+.++|+||+||++|+|++|..|
T Consensus       140 ~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~p  217 (345)
T cd07877         140 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  217 (345)
T ss_pred             CeeecCCChHHEEEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCC
Confidence            3899999999999999999999999998765332  23457889999999987644447899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-----------------------CCC--------CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-----------------------TLP--------SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-----------------------~~p--------~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+.......+.....                       ..|        ...++++.++|.+||+.||.+|||+.++
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~  297 (345)
T cd07877         218 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  297 (345)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHH
Confidence            987665444333321110                       011        1357789999999999999999999999


Q ss_pred             hcCchhhhccC
Q 017029          130 RQHPWFQAHLP  140 (379)
Q Consensus       130 l~hp~f~~~~~  140 (379)
                      +.||||++...
T Consensus       298 l~h~~f~~~~~  308 (345)
T cd07877         298 LAHAYFAQYHD  308 (345)
T ss_pred             hcChhhhhcCC
Confidence            99999987543

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.87  E-value=1.2e-22  Score=198.04  Aligned_cols=138  Identities=37%  Similarity=0.567  Sum_probs=109.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc------ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+||+++.++.+||+|||++.......      ......|++.|+|||++.+....+.++|+||+||++|+|
T Consensus       127 ~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el  206 (337)
T cd07852         127 NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEM  206 (337)
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHH
Confidence            48999999999999999999999999998654322      223446889999999887655457899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCc---------------------------c----CCCCCCChhhhcccccccCCCCCCC
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGI---------------------------Y----TLPSHLSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~---------------------------~----~~p~~~s~~~~~Li~~mL~~dP~~R  123 (379)
                      ++|+.||.+........++....                           .    ...+.++.++.++|.+||+.||.+|
T Consensus       207 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R  286 (337)
T cd07852         207 LLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKR  286 (337)
T ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccc
Confidence            99999998766544433321110                           0    0112368889999999999999999


Q ss_pred             CChhhhhcCchhhhc
Q 017029          124 ITIPEIRQHPWFQAH  138 (379)
Q Consensus       124 pt~~ell~hp~f~~~  138 (379)
                      ||+.++++|||++..
T Consensus       287 ps~~~il~~~~~~~~  301 (337)
T cd07852         287 LTAEEALEHPYVAQF  301 (337)
T ss_pred             cCHHHHhhChhhhhh
Confidence            999999999999865

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.87  E-value=1.4e-22  Score=190.00  Aligned_cols=130  Identities=27%  Similarity=0.498  Sum_probs=109.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.+||+|||++..........  ...+++.|+|||.+.+..+ +.++||||+||++|+|++ |
T Consensus       124 ~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g  202 (263)
T cd05052         124 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYG  202 (263)
T ss_pred             CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCC
Confidence            37999999999999999999999999998765433211  1234567999999987776 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+..+.+..+..+ ....|..++.++.+++.+||..||++|||+.++++
T Consensus       203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         203 MSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            9999998888887777664 34567788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.87  E-value=9.3e-23  Score=190.06  Aligned_cols=136  Identities=39%  Similarity=0.655  Sum_probs=113.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .++||||+|+||+++.++.++|+|||++......... ....|+..|+|||.+.+..+ +.++|+||||+++|+|++|..
T Consensus       120 ~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~  198 (264)
T cd06623         120 HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKF  198 (264)
T ss_pred             CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999999876543322 25568899999999987765 789999999999999999999


Q ss_pred             CCCCC---ChHHHHHHHhcC-ccCCCCC-CChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           80 PFDDE---NIPNLFKKIKGG-IYTLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~---~~~~~~~~i~~~-~~~~p~~-~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ||...   ...+....+... ....+.. ++..+.++|.+||..+|++|||+.++++||||+.
T Consensus       199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         199 PFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             CCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99876   444555555433 2344555 7899999999999999999999999999999974

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.87  E-value=1.2e-22  Score=193.35  Aligned_cols=130  Identities=28%  Similarity=0.430  Sum_probs=109.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   .....+++.|+|||++.+..+ +.++|+||+||++|+|++ 
T Consensus       140 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~  218 (288)
T cd05093         140 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTY  218 (288)
T ss_pred             CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhC
Confidence            379999999999999999999999999976543221   122345778999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.........+..+.. ..+..++.++.+++.+||+.||.+|||+.+++.
T Consensus       219 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         219 GKQPWYQLSNNEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999998887777778877653 456678899999999999999999999999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.87  E-value=9.9e-23  Score=193.88  Aligned_cols=135  Identities=30%  Similarity=0.518  Sum_probs=102.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++..... .......+++.|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       123 ~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  202 (291)
T cd07870         123 HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP  202 (291)
T ss_pred             CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999998764332 222344678999999998765434678999999999999999999


Q ss_pred             CCCCCChH-HHHHHHhcCc---------------------c--CCCC---------CCChhhhcccccccCCCCCCCCCh
Q 017029           80 PFDDENIP-NLFKKIKGGI---------------------Y--TLPS---------HLSPGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        80 Pf~~~~~~-~~~~~i~~~~---------------------~--~~p~---------~~s~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      ||.+.+.. +...++....                     .  ..+.         ..+.++.+++.+||+.||.+|||+
T Consensus       203 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~  282 (291)
T cd07870         203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA  282 (291)
T ss_pred             CCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence            99865432 2111111000                     0  0000         125678899999999999999999


Q ss_pred             hhhhcCchh
Q 017029          127 PEIRQHPWF  135 (379)
Q Consensus       127 ~ell~hp~f  135 (379)
                      .|++.||||
T Consensus       283 ~~~l~h~~~  291 (291)
T cd07870         283 QDALLHPYF  291 (291)
T ss_pred             HHHhcCCCC
Confidence            999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.87  E-value=9.4e-23  Score=198.42  Aligned_cols=139  Identities=32%  Similarity=0.465  Sum_probs=109.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---------------cccccccCCCCccCcccccCCCCCCCcccee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVW   65 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiW   65 (379)
                      .|+||||+|+||+++.++.+||+|||++......               .......+++.|+|||.+.+....+.++|+|
T Consensus       139 ~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~  218 (335)
T PTZ00024        139 YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMW  218 (335)
T ss_pred             CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHH
Confidence            3799999999999999999999999998765411               1122335688999999987755457899999


Q ss_pred             eehhHHHHHhhCCCCCCCCChHHHHHHHhcCcc----------------------------CCCCCCChhhhcccccccC
Q 017029           66 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIY----------------------------TLPSHLSPGARDLIPRMLI  117 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~----------------------------~~p~~~s~~~~~Li~~mL~  117 (379)
                      |+||++|+|++|..||.+.+.......+.....                            ......+.++.++|.+||.
T Consensus       219 slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  298 (335)
T PTZ00024        219 SVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLK  298 (335)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcC
Confidence            999999999999999988776555444322100                            0012457888999999999


Q ss_pred             CCCCCCCChhhhhcCchhhhcc
Q 017029          118 VDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       118 ~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      .+|.+|||+++++.||||+...
T Consensus       299 ~~P~~R~s~~~~l~~~~~~~~~  320 (335)
T PTZ00024        299 LNPLERISAKEALKHEYFKSDP  320 (335)
T ss_pred             CCchhccCHHHHhcCcccCCCC
Confidence            9999999999999999998663

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.87  E-value=8.3e-23  Score=193.04  Aligned_cols=137  Identities=31%  Similarity=0.450  Sum_probs=112.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||+|+||+++.++.++|+|||++........ .....|+..|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus       121 ~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~  199 (277)
T cd06642         121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCC
Confidence            379999999999999999999999999977654321 223468889999999988766 689999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...........+..+. ...+..++.++.++|.+||..+|.+|||+.++++||||...
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         200 PNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             CCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHH
Confidence            998766555444443332 23445678899999999999999999999999999999754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.87  E-value=5.7e-23  Score=197.18  Aligned_cols=135  Identities=33%  Similarity=0.477  Sum_probs=103.3

Q ss_pred             CEEecCCCCCCeEEcC----CCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~----~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+||+++.    ++.+||+|||++........    ....++++.|+|||++.+....+.++|+||+||++|
T Consensus       128 ~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~  207 (316)
T cd07842         128 WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFA  207 (316)
T ss_pred             CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence            3799999999999999    89999999999886543221    233468899999999877554478999999999999


Q ss_pred             HHhhCCCCCCCCChHH---------HHHHHh--------------------------cCccCCC-----------CCCCh
Q 017029           73 ALLCGTLPFDDENIPN---------LFKKIK--------------------------GGIYTLP-----------SHLSP  106 (379)
Q Consensus        73 elltG~~Pf~~~~~~~---------~~~~i~--------------------------~~~~~~p-----------~~~s~  106 (379)
                      +|++|+.||.+.....         ....+.                          .....++           ...+.
T Consensus       208 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  287 (316)
T cd07842         208 ELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS  287 (316)
T ss_pred             HHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCH
Confidence            9999999997644321         000000                          0000111           14567


Q ss_pred             hhhcccccccCCCCCCCCChhhhhcCchh
Q 017029          107 GARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus       107 ~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      .+.+++.+||..||++|||+.|+++||||
T Consensus       288 ~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         288 QGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            88999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.87  E-value=1.4e-22  Score=189.95  Aligned_cols=131  Identities=25%  Similarity=0.475  Sum_probs=110.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||++++++.+||+|||+++........   ....++..|+|||++.+..+ +.++||||+||++|||++ 
T Consensus       133 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~  211 (273)
T cd05035         133 NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATR  211 (273)
T ss_pred             CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhC
Confidence            3899999999999999999999999999876543322   12235678999999887766 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....+....+..+ ....|..++..+.+++.+||+.||.+|||+.|++.+
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         212 GQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999988877777776654 345677889999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.87  E-value=2.3e-22  Score=193.29  Aligned_cols=134  Identities=30%  Similarity=0.418  Sum_probs=109.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||+|+||+++.++.+||+|||++......   .+..|++.|+|||++.   ...+ +.++||||+|+++|+|++|
T Consensus       135 ~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~-~~~sDv~s~G~il~el~tg  210 (307)
T cd06607         135 ERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER  210 (307)
T ss_pred             CceecCCCcccEEECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCC-CcccchHHHHHHHHHHHcC
Confidence            3799999999999999999999999998765432   3456888999999874   2333 6899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCC-CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~-p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+.......+.... ... +..++..+.++|.+||..||.+|||+.+++.||||...
T Consensus       211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         211 KPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             CCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            99998877655544443322 222 23478899999999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.87  E-value=1.3e-22  Score=190.59  Aligned_cols=135  Identities=33%  Similarity=0.521  Sum_probs=106.4

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||+++. ++.+||+|||++....... ......|++.|+|||++.+.. ..+.++|+||+|+++|+|++|
T Consensus       128 ~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g  207 (268)
T cd06624         128 QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATG  207 (268)
T ss_pred             CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhC
Confidence            4899999999999976 6799999999987654322 223346889999999986543 237899999999999999999


Q ss_pred             CCCCCCCChHH--HHHH-HhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           78 TLPFDDENIPN--LFKK-IKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        78 ~~Pf~~~~~~~--~~~~-i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ..||.......  .... .......+|..+++++++++.+||..+|.+|||+.+++.||||
T Consensus       208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         208 KPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            99997643221  1111 1223345677889999999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.87  E-value=7.5e-23  Score=195.17  Aligned_cols=138  Identities=33%  Similarity=0.495  Sum_probs=109.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......+++.|+|||.+.+....+.++|+||+||++|+|++|.+
T Consensus       122 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~  201 (298)
T cd07841         122 WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP  201 (298)
T ss_pred             CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCc
Confidence            3799999999999999999999999999876543 223344578899999998665444789999999999999999998


Q ss_pred             CCCCCChHHHHHHHhcCcc----------------------------CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIY----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~----------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+......++.....                            ......+..+.++|.+||..||.+|||+.|++.
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         202 FLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            8987765554444432110                            011235678899999999999999999999999


Q ss_pred             Cchhhhc
Q 017029          132 HPWFQAH  138 (379)
Q Consensus       132 hp~f~~~  138 (379)
                      ||||++.
T Consensus       282 ~~~~~~~  288 (298)
T cd07841         282 HPYFSND  288 (298)
T ss_pred             CccccCC
Confidence            9999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.87  E-value=9.5e-23  Score=193.82  Aligned_cols=135  Identities=31%  Similarity=0.572  Sum_probs=102.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... .......++..|+|||++.+....+.++||||+||++|+|++|..
T Consensus       123 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~  202 (291)
T cd07844         123 RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRP  202 (291)
T ss_pred             CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999998654321 112233578899999998765444789999999999999999999


Q ss_pred             CCCCCC-hHHHHHHHhcCc-------------------cC-----------CCCCCC--hhhhcccccccCCCCCCCCCh
Q 017029           80 PFDDEN-IPNLFKKIKGGI-------------------YT-----------LPSHLS--PGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        80 Pf~~~~-~~~~~~~i~~~~-------------------~~-----------~p~~~s--~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      ||.+.. ..+....+....                   ..           ....++  .++.+++.+||..+|.+|||+
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~  282 (291)
T cd07844         203 LFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISA  282 (291)
T ss_pred             CCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCH
Confidence            997654 222222221100                   00           001233  778899999999999999999


Q ss_pred             hhhhcCchh
Q 017029          127 PEIRQHPWF  135 (379)
Q Consensus       127 ~ell~hp~f  135 (379)
                      .+++.||||
T Consensus       283 ~e~l~~~~f  291 (291)
T cd07844         283 AEAMKHPYF  291 (291)
T ss_pred             HHHhcCCCC
Confidence            999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.87  E-value=1.7e-22  Score=187.28  Aligned_cols=131  Identities=27%  Similarity=0.454  Sum_probs=112.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||.+.......   ......+++.|+|||.+.+..+ +.++|+||+||++|+|++ 
T Consensus       125 ~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~  203 (262)
T cd00192         125 KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTL  203 (262)
T ss_pred             CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhc
Confidence            37999999999999999999999999998775432   2234467889999999987766 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.......+.+..+. ...|..++.++.+++.+||..||.+|||+.+++++
T Consensus       204 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         204 GATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            699999988888888777543 45677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.87  E-value=1.7e-23  Score=206.70  Aligned_cols=134  Identities=41%  Similarity=0.781  Sum_probs=120.4

Q ss_pred             EEecCCCCCCeEEcCCC---cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            2 VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      |+|.||||||||+.+..   ++||||||++++.....+.++.+|||.|.|||++.++.| ...-|+||.|||+|.-++|.
T Consensus       685 IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGy-NrSLDMWSVGVIiYVsLSGT  763 (888)
T KOG4236|consen  685 IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGY-NRSLDMWSVGVIIYVSLSGT  763 (888)
T ss_pred             eeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccc-cccccceeeeEEEEEEeccc
Confidence            89999999999998753   699999999999999888899999999999999999999 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||..+  +++-.+|.+..+-+|+    .+++++.+||+.+|++.-.+|.|++..+.|||+++.
T Consensus       764 FPFNEd--EdIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  764 FPFNED--EDINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             ccCCCc--cchhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence            999764  3445677777776664    589999999999999999999999999999999854

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.87  E-value=1.2e-22  Score=189.32  Aligned_cols=131  Identities=35%  Similarity=0.592  Sum_probs=112.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||||+||+++.++.++++|||++....... ......|++.|+|||++.+..+ +.++|+||+|+++|+|++|..
T Consensus       120 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~  198 (255)
T cd08219         120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKH  198 (255)
T ss_pred             CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccC
Confidence            37999999999999999999999999998764432 2234578999999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||...+.......+..+.. +.|..++..+.++|.+||+.||.+|||+.+++.-
T Consensus       199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         199 PFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            9999887777777766554 4567789999999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.87  E-value=9.6e-23  Score=192.29  Aligned_cols=135  Identities=33%  Similarity=0.519  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .++|+||+|+||++++++.+||+|||++.......  ......++..|+|||.+.+....+.++||||+|+++|+|++|.
T Consensus       120 ~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~  199 (287)
T cd07840         120 GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGK  199 (287)
T ss_pred             CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCC
Confidence            37899999999999999999999999998765432  2233467889999998876544478999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccC-------------------------------CCCCCChhhhcccccccCCCCCCCCChh
Q 017029           79 LPFDDENIPNLFKKIKGGIYT-------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIP  127 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~-------------------------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~  127 (379)
                      .||.+.+.......+......                               +...++..+.+++.+||..+|.+|||++
T Consensus       200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~  279 (287)
T cd07840         200 PIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISAD  279 (287)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHH
Confidence            999887766555544321100                               0011378889999999999999999999


Q ss_pred             hhhcCchh
Q 017029          128 EIRQHPWF  135 (379)
Q Consensus       128 ell~hp~f  135 (379)
                      +++.||||
T Consensus       280 ~~l~~~~~  287 (287)
T cd07840         280 QALQHEYF  287 (287)
T ss_pred             HHhhCcCC
Confidence            99999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.87  E-value=1.1e-22  Score=191.24  Aligned_cols=134  Identities=37%  Similarity=0.767  Sum_probs=117.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---------------------ccccccCCCCccCcccccCCCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------------------FLKTSCGSPNYAAPEVISGKLYAG   59 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---------------------~~~~~~gt~~y~APE~l~~~~~~~   59 (379)
                      .++|+||+|+||+++.++.++|+|||++.......                     ......|+..|+|||++.+..+ +
T Consensus       122 ~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~  200 (280)
T cd05581         122 GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-G  200 (280)
T ss_pred             CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCC-C
Confidence            37999999999999999999999999987654322                     1123357889999999887665 7


Q ss_pred             CccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh----hhhhcCchh
Q 017029           60 PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWF  135 (379)
Q Consensus        60 ~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~----~ell~hp~f  135 (379)
                      .++|+||+|++++++++|..||........++.+......+|..+++.+.++|.+||+.||.+|||+    +++++||||
T Consensus       201 ~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         201 KSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             hhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            8999999999999999999999988777777788777888899999999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.87  E-value=1.1e-22  Score=192.41  Aligned_cols=135  Identities=35%  Similarity=0.567  Sum_probs=108.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||++++++.++|+|||++....... ......+++.|+|||++.+....+.++|+||+||++|+|++|..
T Consensus       120 ~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~  199 (284)
T cd07836         120 RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRP  199 (284)
T ss_pred             CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999997654321 22344678899999998765545789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc------------------cC-----------CCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI------------------YT-----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~------------------~~-----------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+...++....                  ..           +.+.++..+++++.+||+.||.+|||+.+++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l  279 (284)
T cd07836         200 LFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDAL  279 (284)
T ss_pred             CCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHh
Confidence            998877665544432110                  00           1124578889999999999999999999999


Q ss_pred             cCchh
Q 017029          131 QHPWF  135 (379)
Q Consensus       131 ~hp~f  135 (379)
                      +||||
T Consensus       280 ~~~~f  284 (284)
T cd07836         280 QHPWF  284 (284)
T ss_pred             cCCCC
Confidence            99998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.87  E-value=1.8e-22  Score=188.31  Aligned_cols=134  Identities=34%  Similarity=0.658  Sum_probs=106.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCC--CCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~--~~~~~~DiWSlGvilyel   74 (379)
                      |+||||+|+||+++.++.+||+|||++........     .....+++.|+|||++.+..  ..+.++|+||+|+++|++
T Consensus       120 i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l  199 (264)
T cd06626         120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEM  199 (264)
T ss_pred             cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHH
Confidence            79999999999999999999999999887644322     12356889999999998655  137899999999999999


Q ss_pred             hhCCCCCCCCC-hHHHHHHHhcC-ccCCCCCC--ChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           75 LCGTLPFDDEN-IPNLFKKIKGG-IYTLPSHL--SPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        75 ltG~~Pf~~~~-~~~~~~~i~~~-~~~~p~~~--s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ++|..||.+.. .......+..+ ...+|...  +..+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       200 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         200 ATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999997653 22222233322 33445444  8899999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.87  E-value=1.3e-22  Score=198.69  Aligned_cols=136  Identities=32%  Similarity=0.503  Sum_probs=109.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++......  .....+++.|+|||++.+....+.++|+||+||++|++++|..|
T Consensus       138 gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~p  215 (343)
T cd07880         138 GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPL  215 (343)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            3899999999999999999999999999765432  23446789999999987644447899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-------------------------------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+......++.....                               .....+++.+.++|.+||+.||.+|||+.++
T Consensus       216 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~  295 (343)
T cd07880         216 FKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEA  295 (343)
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHH
Confidence            988765444443322111                               1123567889999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      +.||||+..
T Consensus       296 l~~~~~~~~  304 (343)
T cd07880         296 LAHPYFEEF  304 (343)
T ss_pred             hcCccHhhh
Confidence            999999865

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.87  E-value=1.5e-22  Score=186.88  Aligned_cols=134  Identities=38%  Similarity=0.608  Sum_probs=113.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .++|+||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+..+ +.++|+||+|+++|+|++|
T Consensus       121 ~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g  199 (260)
T cd06606         121 GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATG  199 (260)
T ss_pred             CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhC
Confidence            379999999999999999999999999987765442   345678899999999987765 7899999999999999999


Q ss_pred             CCCCCCCC-hHHHHHHHh--cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           78 TLPFDDEN-IPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        78 ~~Pf~~~~-~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ..||.... .......+.  .....+|..++..+.++|.+||..||.+|||+.+++.||||
T Consensus       200 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         200 KPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             CCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            99998765 333333333  23445677889999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.87  E-value=1.2e-22  Score=195.70  Aligned_cols=134  Identities=30%  Similarity=0.400  Sum_probs=109.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC---CCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||+|+||+++.++.+||+|||++......   ....|++.|+|||.+.+   ..+ +.++||||+||++|+|++|
T Consensus       135 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g  210 (308)
T cd06634         135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER  210 (308)
T ss_pred             CcccCCCCHHhEEECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCC-CcccchHHHHHHHHHHHcC
Confidence            3799999999999999999999999998765432   24568899999999752   233 6799999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-C-CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||...+.......+..+.. . .+..++..+.++|.+||..+|.+|||+.+++.|||+...
T Consensus       211 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             CCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            999987665554444443332 2 234678899999999999999999999999999999764

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.87  E-value=1.4e-22  Score=192.42  Aligned_cols=135  Identities=34%  Similarity=0.599  Sum_probs=108.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+||+++.++.++|+|||++...... .....+|+..|+|||++.+..+ +.++|+||+||++|++++|..||
T Consensus       125 i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~  202 (284)
T cd06620         125 IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPF  202 (284)
T ss_pred             eeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCC
Confidence            799999999999999999999999998755332 2234578999999999887765 78999999999999999999999


Q ss_pred             CCCChH-----------HHHHHHhcCc-cCCCC-CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           82 DDENIP-----------NLFKKIKGGI-YTLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        82 ~~~~~~-----------~~~~~i~~~~-~~~p~-~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ......           +....+.... ..++. .++.++.+|+.+||..||.+|||+.|+++|+||.+.
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~  272 (284)
T cd06620         203 AFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA  272 (284)
T ss_pred             cccchhhhhhhhhhHHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            865431           2233333222 22333 377889999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.87  E-value=1.4e-22  Score=188.39  Aligned_cols=134  Identities=31%  Similarity=0.619  Sum_probs=111.5

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+||+++.++ .+||+|||.+....... ......|++.|+|||++.+..+ +.++|+||+||++|++++|.
T Consensus       121 ~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~  199 (257)
T cd08225         121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLK  199 (257)
T ss_pred             CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence            379999999999999886 46999999998765432 2234468999999999887666 68999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      .||...+.......+..+. ...++.++.++.++|.+||..+|++|||+.++++||||
T Consensus       200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         200 HPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             CCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            9998877666665555443 33456678999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.86  E-value=1.5e-22  Score=191.38  Aligned_cols=131  Identities=22%  Similarity=0.402  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .++||||||+||+++.++.+||+|||++.........   ....+++.|+|||++.+..+ +.++|+||+||++|+|++ 
T Consensus       139 ~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~  217 (277)
T cd05062         139 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATL  217 (277)
T ss_pred             CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcC
Confidence            3799999999999999999999999998765433221   12345778999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+.....+.+..+. ...+..++..+.+++.+||+.||++|||+.|++++
T Consensus       218 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         218 AEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            799999888777766655443 45677788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.86  E-value=2.2e-22  Score=189.54  Aligned_cols=135  Identities=33%  Similarity=0.530  Sum_probs=107.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.+||+|||++....... ......++..|+|||.+.+....+.++|+||+||++|++++|..
T Consensus       118 ~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~  197 (282)
T cd07829         118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKP  197 (282)
T ss_pred             CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998764432 22344567889999998776344789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc------------------cCC-----------CCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI------------------YTL-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~------------------~~~-----------p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+......++....                  ..+           .+.++..+.++|.+||..||++||++.+++
T Consensus       198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l  277 (282)
T cd07829         198 LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEAL  277 (282)
T ss_pred             CCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHh
Confidence            998876555444332210                  000           113477899999999999999999999999


Q ss_pred             cCchh
Q 017029          131 QHPWF  135 (379)
Q Consensus       131 ~hp~f  135 (379)
                      .||||
T Consensus       278 ~~p~~  282 (282)
T cd07829         278 KHPYF  282 (282)
T ss_pred             hCcCC
Confidence            99997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.86  E-value=2.6e-22  Score=186.20  Aligned_cols=132  Identities=36%  Similarity=0.628  Sum_probs=115.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      ++||||+|+||+++.++.+||+|||++...... ......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||
T Consensus       124 i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~  201 (256)
T cd08530         124 ILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPF  201 (256)
T ss_pred             cccCCCCcceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence            789999999999999999999999999877554 3345678999999999988776 68999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           82 DDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ...+.......+..+.+ ..+..++.++++++.+||..+|.+|||+.++++||++
T Consensus       202 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         202 EARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            99888777666665554 4556788999999999999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.86  E-value=4.1e-23  Score=215.09  Aligned_cols=129  Identities=33%  Similarity=0.582  Sum_probs=106.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-------ccc---cccCCCCccCccccc---CCCCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------FLK---TSCGSPNYAAPEVIS---GKLYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-------~~~---~~~gt~~y~APE~l~---~~~~~~~~~DiWSl   67 (379)
                      +|||||||-|||||+.+|+.||||||.+.......       .+.   ...-|+.|+|||++.   +... +.|+|||+|
T Consensus       166 PiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI-~eKsDIWAL  244 (738)
T KOG1989|consen  166 PIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPI-GEKSDIWAL  244 (738)
T ss_pred             ccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCC-cchhHHHHH
Confidence            59999999999999999999999999875432111       000   123689999999873   4444 899999999


Q ss_pred             hhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC--CCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           68 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      ||+||-|+....||++...    -.|.++.|.+|+  .++..+++||..||+.||.+||++.+++.+-+
T Consensus       245 GclLYkLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~  309 (738)
T KOG1989|consen  245 GCLLYKLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIF  309 (738)
T ss_pred             HHHHHHHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHH
Confidence            9999999999999987643    357788888886  68999999999999999999999999887644

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.86  E-value=1.6e-22  Score=189.36  Aligned_cols=135  Identities=36%  Similarity=0.636  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .++||||+|+||+++.++ .+||+|||.+.......     ......|+..|+|||++.+..+ +.++|+||+|+++|++
T Consensus       123 ~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l  201 (268)
T cd06630         123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEM  201 (268)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHH
Confidence            379999999999998776 59999999987664321     1123468889999999987766 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHH---HHh--cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           75 LCGTLPFDDENIPNLFK---KIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~---~i~--~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      ++|..||..........   .+.  ......|..+++++.+++.+||..+|++|||+.++++||||+
T Consensus       202 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         202 ATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999997654322222   221  223456667889999999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.86  E-value=3.1e-22  Score=188.28  Aligned_cols=135  Identities=34%  Similarity=0.517  Sum_probs=107.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyellt   76 (379)
                      .++||||+|+||+++.++.++|+|||++.......   ......|+..|+|||++.+.. ..+.++|+||+|+++|++++
T Consensus       128 ~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~  207 (272)
T cd06629         128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFA  207 (272)
T ss_pred             CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHh
Confidence            37999999999999999999999999987654321   123456889999999987654 23789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |..||...........+...  ...++.    .++.++.++|.+||..+|.+|||++++++||||
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         208 GRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            99999766554433333222  222332    458899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.86  E-value=2.4e-22  Score=191.58  Aligned_cols=130  Identities=28%  Similarity=0.432  Sum_probs=109.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       143 ~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  221 (291)
T cd05094         143 HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTY  221 (291)
T ss_pred             CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhC
Confidence            389999999999999999999999999976543321   123456789999999988776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||...+..+..+.+..+.. ..+..++..+.+++.+||+.||++|||+.++++
T Consensus       222 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         222 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            9999988887777777766554 345567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.86  E-value=2.4e-22  Score=189.35  Aligned_cols=130  Identities=25%  Similarity=0.430  Sum_probs=110.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||+++.......   .....++..|+|||.+.+..+ +.++|+|||||++|++++ 
T Consensus       139 ~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  217 (277)
T cd05032         139 KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATL  217 (277)
T ss_pred             CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhcc
Confidence            379999999999999999999999999876544321   234456789999999987666 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.+.....+.+..+ ....|..++..+.+++.+||+.+|++|||+.++++
T Consensus       218 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         218 AEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             CCCCCccCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99999988877777766644 34667788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.86  E-value=2.2e-22  Score=199.88  Aligned_cols=130  Identities=28%  Similarity=0.479  Sum_probs=103.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   .+..+++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       232 giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~  310 (374)
T cd05106         232 NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSL  310 (374)
T ss_pred             CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhC
Confidence            3899999999999999999999999999765433211   12235567999999987766 789999999999999997 


Q ss_pred             CCCCCCCCChHHHHHH-HhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKK-IKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~-i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||..........+ +..+ ....|..+++++.+++.+||+.||.+|||+.++.+
T Consensus       311 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         311 GKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             CCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999987654433333 3322 23456677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.86  E-value=1e-22  Score=191.01  Aligned_cols=133  Identities=26%  Similarity=0.348  Sum_probs=103.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccC---CCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~---~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||.+.+   ..+ +.++|+||+||++|+|++
T Consensus       126 ~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~  204 (267)
T cd06646         126 GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAE  204 (267)
T ss_pred             CccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHh
Confidence            47999999999999999999999999998664322 2234568899999998853   223 678999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCC-----CCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      |..||...........+....+..     +..++..+.++|.+||..+|++|||++++++|+|
T Consensus       205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         205 LQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999997654333222222222221     2346789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.86  E-value=2.6e-22  Score=192.19  Aligned_cols=138  Identities=33%  Similarity=0.597  Sum_probs=113.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.++|+|||++....... ......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus       136 givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~  214 (292)
T cd06657         136 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEP  214 (292)
T ss_pred             CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            47999999999999999999999999987654322 2233568899999999877666 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+.........+.....   .....++..+.+++.+||..||.+||++.+++.||||....
T Consensus       215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         215 PYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             CCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence            9988776655554443322   22345788999999999999999999999999999998764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.86  E-value=1e-22  Score=188.80  Aligned_cols=128  Identities=29%  Similarity=0.459  Sum_probs=104.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.++++|||.+......  .....++..|+|||.+.+..+ +.++|+||+||++|+|++|..|
T Consensus       105 ~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~~  181 (237)
T cd05576         105 GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEE-TEACDWWSLGAILFELLTGKTL  181 (237)
T ss_pred             CeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCC-CchhhHHHHHHHHHHHHHCcch
Confidence            4899999999999999999999999988765432  234456788999999877666 7899999999999999999998


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchh
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWF  135 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f  135 (379)
                      |....... .   ......+|..+++.++++|.+||+.||++|+|+     +++++||||
T Consensus       182 ~~~~~~~~-~---~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         182 VECHPSGI-N---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             hhcCchhc-c---cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence            86532211 0   112235677889999999999999999999986     899999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.86  E-value=2.4e-22  Score=194.10  Aligned_cols=131  Identities=25%  Similarity=0.413  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc---cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~---~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.........   ...++..|+|||++.+..+ +.++|||||||++|+|++ 
T Consensus       129 ~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~  207 (316)
T cd05108         129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTF  207 (316)
T ss_pred             CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcC
Confidence            38999999999999999999999999998765433221   2234568999999988777 789999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....++...+..+. .+.|..++.++.+++.+||..||.+|||+.+++.+
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         208 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999877766655444432 34566788999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.86  E-value=2.2e-22  Score=192.12  Aligned_cols=135  Identities=33%  Similarity=0.511  Sum_probs=106.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+||+++.++.+||+|||++.......  ......++..|+|||.+.+....+.++||||+||++|+|++|+
T Consensus       136 ~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~  215 (302)
T cd07864         136 NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK  215 (302)
T ss_pred             CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCC
Confidence            48999999999999999999999999998764332  1222356788999998876544478999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc------------------------------CCCCCCChhhhcccccccCCCCCCCCChhh
Q 017029           79 LPFDDENIPNLFKKIKGGIY------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      .||...+..+....+.....                              .....++..+.+++.+||..||.+|||+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~  295 (302)
T cd07864         216 PIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEE  295 (302)
T ss_pred             CCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence            99987665544443322110                              011246789999999999999999999999


Q ss_pred             hhcCchh
Q 017029          129 IRQHPWF  135 (379)
Q Consensus       129 ll~hp~f  135 (379)
                      ++.||||
T Consensus       296 il~~~~~  302 (302)
T cd07864         296 ALNSPWL  302 (302)
T ss_pred             HhcCCCC
Confidence            9999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.86  E-value=2.3e-22  Score=193.47  Aligned_cols=137  Identities=23%  Similarity=0.411  Sum_probs=104.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--------ccccccCCCCccCcccccCC--CCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~~--~~~~~~~DiWSlGvi   70 (379)
                      .|+||||||+||+++.++.+||+|||.+.......        ......++..|+|||++.+.  .+ +.++|+||+||+
T Consensus       121 ~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~i  199 (314)
T cd08216         121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGIT  199 (314)
T ss_pred             CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHH
Confidence            48999999999999999999999999886543221        11234577889999998763  34 689999999999


Q ss_pred             HHHHhhCCCCCCCCChHHH-HHHHhcCcc---------------------------------CCCCCCChhhhccccccc
Q 017029           71 LYALLCGTLPFDDENIPNL-FKKIKGGIY---------------------------------TLPSHLSPGARDLIPRML  116 (379)
Q Consensus        71 lyelltG~~Pf~~~~~~~~-~~~i~~~~~---------------------------------~~p~~~s~~~~~Li~~mL  116 (379)
                      +|+|++|..||........ ..++.....                                 ..+..++.++.+|+.+||
T Consensus       200 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  279 (314)
T cd08216         200 ACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCL  279 (314)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHh
Confidence            9999999999987543332 222221100                                 001123467889999999


Q ss_pred             CCCCCCCCChhhhhcCchhhhc
Q 017029          117 IVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       117 ~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||++|||++++++||||+..
T Consensus       280 ~~~P~~Rpt~~~ll~~p~~~~~  301 (314)
T cd08216         280 QRDPESRPSASQLLNHSFFKQC  301 (314)
T ss_pred             hcCCCcCcCHHHHhcCchHhhh
Confidence            9999999999999999999854

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.86  E-value=2.8e-22  Score=187.04  Aligned_cols=128  Identities=25%  Similarity=0.503  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++.......  .+..++..|+|||++.+..+ +.++|+||+||++|+|++ |..
T Consensus       122 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~  198 (256)
T cd05082         122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRV  198 (256)
T ss_pred             CEeccccchheEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCC
Confidence            48999999999999999999999999987654322  23345678999999987766 789999999999999997 999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||...+...+...+..+. ...+..+++.+.+++.+||..+|.+|||+.++++
T Consensus       199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         199 PYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999888877777776553 3456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.86  E-value=2.6e-22  Score=189.20  Aligned_cols=130  Identities=27%  Similarity=0.420  Sum_probs=106.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..............+..|+|||++.+..+ +.++|+|||||++|+|++ |..
T Consensus       132 ~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~  210 (270)
T cd05047         132 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGT  210 (270)
T ss_pred             CEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCC
Confidence            389999999999999999999999999864322111112234567999999877666 789999999999999997 999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+..+....+..+. ...+..++.++.+++.+||..||.+|||+.+++.
T Consensus       211 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         211 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             CccccCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            999888777777776543 3456678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.86  E-value=2.4e-22  Score=196.69  Aligned_cols=131  Identities=29%  Similarity=0.484  Sum_probs=105.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   ..+..++..|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       193 ~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~SlGv~l~el~t~  271 (337)
T cd05054         193 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVY-TTQSDVWSFGVLLWEIFSL  271 (337)
T ss_pred             CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCC-CccccHHHHHHHHHHHHHc
Confidence            389999999999999999999999999987533221   122345678999999988777 789999999999999998 


Q ss_pred             CCCCCCCCChHH-HHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPN-LFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~-~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....+ ....+..+. ...|...++++.+++.+||+.+|++|||+.|+++|
T Consensus       272 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         272 GASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             CCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999998754333 333333332 34456788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.86  E-value=3.9e-22  Score=189.78  Aligned_cols=131  Identities=27%  Similarity=0.490  Sum_probs=109.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   ....++..|+|||++.+..+ +.++||||+||++|++++ 
T Consensus       152 ~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~  230 (293)
T cd05053         152 KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTL  230 (293)
T ss_pred             CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcC
Confidence            3799999999999999999999999999876543221   12234568999999887766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....+.++.+..+. ...|...+.++.+|+.+||..||.+|||+.+++++
T Consensus       231 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         231 GGSPYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            999999988888777776654 34566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.86  E-value=2.9e-22  Score=185.41  Aligned_cols=134  Identities=33%  Similarity=0.528  Sum_probs=112.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.++|+|||++........ .....|+..|+|||...+..+ +.++|+||+|+++|+|++|..
T Consensus       119 ~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~  197 (254)
T cd06627         119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNP  197 (254)
T ss_pred             CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCC
Confidence            479999999999999999999999999987654332 234568899999999887765 789999999999999999999


Q ss_pred             CCCCCChHHHHHHH-hcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||..........++ ......++..++..+.+++.+||..+|++|||+.+++.||||
T Consensus       198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         198 PYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            99876554443333 344456677889999999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.86  E-value=3.5e-22  Score=188.94  Aligned_cols=137  Identities=29%  Similarity=0.456  Sum_probs=114.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||+|+||+++.++.++|+|||++........ .....|+..|+|||.+.+... +.++|+||+||++|+|++|..
T Consensus       121 ~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~  199 (277)
T cd06641         121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEP  199 (277)
T ss_pred             CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCC
Confidence            379999999999999999999999999876644321 233468889999999987665 689999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...........+..+. ..++..++.++.+++.+||..+|.+||++.++++||||...
T Consensus       200 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         200 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             CCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            998877665555554432 33556788999999999999999999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.86  E-value=2.1e-22  Score=193.59  Aligned_cols=131  Identities=27%  Similarity=0.417  Sum_probs=107.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.............++..|+|||++.+..+ +.++||||+||++|+|++ |..
T Consensus       144 gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~  222 (303)
T cd05088         144 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGT  222 (303)
T ss_pred             CccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCC
Confidence            379999999999999999999999999864322111112234567999999877765 789999999999999998 999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||.+.+..+..+.+..+. ...+..+++++.+++.+||..+|.+|||+++++.+
T Consensus       223 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         223 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CcccCChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999888777777765542 33556678999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.86  E-value=2.5e-22  Score=191.15  Aligned_cols=136  Identities=26%  Similarity=0.477  Sum_probs=112.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   ....++..|+|||.+.+..+ +.++|+||+||++|+|++ 
T Consensus       139 ~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~  217 (288)
T cd05061         139 KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSL  217 (288)
T ss_pred             CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhC
Confidence            3799999999999999999999999998765332211   12345678999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc------Cchhhh
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ------HPWFQA  137 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~------hp~f~~  137 (379)
                      |..||.+....+....+..+ ....+..+++.+.+++.+||+.||.+|||+.++++      ||||..
T Consensus       218 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         218 AEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            89999988877777666544 34556778899999999999999999999999876      788764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.86  E-value=1.5e-22  Score=209.21  Aligned_cols=135  Identities=37%  Similarity=0.586  Sum_probs=110.0

Q ss_pred             CEEecCCCCCCeEEcC---C--CcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDS---K--WNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~--~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvil   71 (379)
                      .||||||||.||||+.   +  ..++|+|||+|+.+..+.    ...+..||-.|+|||++.+... ..++||+|+||++
T Consensus       626 ~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvf  704 (903)
T KOG1027|consen  626 KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVF  704 (903)
T ss_pred             ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceE
Confidence            5899999999999976   3  468999999999886553    2345679999999999987766 6799999999999


Q ss_pred             HHHhh-CCCCCCCCChHHHHHHHhcCccCCCC---CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           72 YALLC-GTLPFDDENIPNLFKKIKGGIYTLPS---HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        72 yellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |+.++ |..||.+.-..  ..+|..+.+.+-.   ....++.+||.+|++++|..|||+.+++.||+|...
T Consensus       705 yYvltgG~HpFGd~~~R--~~NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~  773 (903)
T KOG1027|consen  705 YYVLTGGSHPFGDSLER--QANILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDS  773 (903)
T ss_pred             EEEecCCccCCCchHHh--hhhhhcCccceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCCh
Confidence            99998 59999864333  3567777665432   122289999999999999999999999999999754

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.86  E-value=3.4e-22  Score=189.41  Aligned_cols=131  Identities=23%  Similarity=0.437  Sum_probs=109.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   .....++..|+|||++.+..+ +.++|+||+||++|+|++ 
T Consensus       144 ~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~  222 (283)
T cd05090         144 FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSF  222 (283)
T ss_pred             CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcC
Confidence            379999999999999999999999999987643321   223446678999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.....+.+.+.... .+.+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       223 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         223 GLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            999998877766666665443 45667789999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.86  E-value=2.6e-22  Score=191.98  Aligned_cols=138  Identities=36%  Similarity=0.591  Sum_probs=111.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||.+.+..+ +.++|+||+||++|++++|..
T Consensus       135 gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~  213 (293)
T cd06647         135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEP  213 (293)
T ss_pred             CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            47999999999999999999999999987654432 2234468899999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhc-Cc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKG-GI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||...+.......+.. +.  ...+..++..++++|.+||..+|.+||++.+++.|+||+...
T Consensus       214 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         214 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             CCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            9987665433222221 11  223345678899999999999999999999999999998664

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.6e-22  Score=183.40  Aligned_cols=138  Identities=26%  Similarity=0.440  Sum_probs=112.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      +|+|||+||+|+||+.+|.+||+|||+++.+...+     ..+..+-|..|++||.+.|..-++++.|+|..|||+.||+
T Consensus       144 kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMw  223 (376)
T KOG0669|consen  144 KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMW  223 (376)
T ss_pred             hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHH
Confidence            48999999999999999999999999997664322     2334466899999999998777799999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc----------------------CCCC-------------CCChhhhcccccccCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY----------------------TLPS-------------HLSPGARDLIPRMLIVDP  120 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~----------------------~~p~-------------~~s~~~~~Li~~mL~~dP  120 (379)
                      +|.+-|.+.+......-|..-..                      ++|.             .-++++.+|+.+||..||
T Consensus       224 trspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP  303 (376)
T KOG0669|consen  224 TRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDP  303 (376)
T ss_pred             ccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCc
Confidence            99999998877666555532111                      1111             124578899999999999


Q ss_pred             CCCCChhhhhcCchhhhc
Q 017029          121 MKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       121 ~~Rpt~~ell~hp~f~~~  138 (379)
                      .+|+++.++++|.||...
T Consensus       304 ~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  304 TKRIDADQALNHDFFWKD  321 (376)
T ss_pred             ccCcchHhhhchhhhhcC
Confidence            999999999999999855

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.86  E-value=3.9e-22  Score=188.68  Aligned_cols=130  Identities=25%  Similarity=0.391  Sum_probs=107.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   ....+++.|+|||.+.+..+ +.++||||+||++|||++ 
T Consensus       129 ~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~  207 (279)
T cd05109         129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTF  207 (279)
T ss_pred             CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcC
Confidence            4899999999999999999999999999876433221   12234678999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.......+...+..+. .+.+..++.++.+++.+||..||++|||+.+++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         208 GAKPYDGIPAREIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999998877766666665543 3456678999999999999999999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.86  E-value=3.5e-22  Score=191.66  Aligned_cols=129  Identities=25%  Similarity=0.370  Sum_probs=102.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++....+..   .....++..|+|||++.+..+ +.++|||||||++|+|++ 
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILML  236 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHc
Confidence            379999999999999999999999999986644332   123356788999999887766 789999999999999986 


Q ss_pred             -CCCCCCCCChHHHHHHHhc--------CccCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           77 -GTLPFDDENIPNLFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                       +..||.+.+..+....+..        .....|+.++..+.+++.+||..||.+|||+.+|.
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence             6788887665555443321        11234567889999999999999999999999984

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.86  E-value=3.9e-22  Score=189.09  Aligned_cols=130  Identities=26%  Similarity=0.440  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||+++++.+||+|||++........   .....+++.|+|||++.+..+ +.++|+|||||++|+|++ 
T Consensus       142 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~  220 (280)
T cd05092         142 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTY  220 (280)
T ss_pred             CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcC
Confidence            379999999999999999999999999876543221   122345678999999988776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||...........+..+. ...|..+++.+.++|.+||..||.+||++++++.
T Consensus       221 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         221 GKQPWYQLSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CCCCCccCCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            999998877777666665553 4556778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.86  E-value=4e-22  Score=188.57  Aligned_cols=131  Identities=23%  Similarity=0.436  Sum_probs=107.0

Q ss_pred             CEEecCCCCCCeEEcCCC---cEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+||+++.++   .+||+|||+++........   ....++..|+|||++.+..+ +.++||||+||++|+|
T Consensus       136 ~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el  214 (277)
T cd05036         136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEI  214 (277)
T ss_pred             CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHH
Confidence            389999999999998765   5999999999876332211   12233567999999987776 7899999999999999


Q ss_pred             hh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           75 LC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        75 lt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ++ |..||.+.+.......+... ....|..++..+.+++.+||+.+|++|||+.++++|
T Consensus       215 ~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         215 FSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            97 99999988877776665443 345567889999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.86  E-value=9.4e-24  Score=196.80  Aligned_cols=135  Identities=30%  Similarity=0.477  Sum_probs=113.4

Q ss_pred             EecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            3 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         3 iHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      ||||||.-|||++.+|..||+|||++..+++. ...+|..|||.|||||++..-.| ..++||||||++..||.-|++||
T Consensus       151 IHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY-~~~ADIWSLGITaIEMAEG~PPY  229 (502)
T KOG0574|consen  151 IHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGY-DTKADIWSLGITAIEMAEGRPPY  229 (502)
T ss_pred             HHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhcc-chhhhHhhhcchhhhhhcCCCCc
Confidence            79999999999999999999999999877654 34467899999999999998888 67999999999999999999999


Q ss_pred             CCCChHHHHHHHhcC---ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           82 DDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .+-++....--|-..   .+.-|..+|.++.+|+++||.++|++|.|+-++++|||++..
T Consensus       230 sDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  230 SDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             ccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence            886654322222111   122345688999999999999999999999999999999864

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.86  E-value=4.1e-22  Score=189.52  Aligned_cols=138  Identities=37%  Similarity=0.649  Sum_probs=112.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||+|+|||++.++.+||+|||++.......  ......|+..|+|||.+.+.. ..+.++|+||+|+++|+|++|
T Consensus       125 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g  204 (290)
T cd05613         125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG  204 (290)
T ss_pred             CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcC
Confidence            37999999999999999999999999998764432  223456899999999987532 236789999999999999999


Q ss_pred             CCCCCCC----ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           78 TLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ..||...    ....+...+.....++|..+++.+.+++.+||..||++|+     ++++++.||||+..
T Consensus       205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         205 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             CCCCCcCCccccHHHHHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            9999743    2334445555556667778899999999999999999997     88999999999864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.86  E-value=5.8e-22  Score=185.07  Aligned_cols=130  Identities=26%  Similarity=0.444  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-c---cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-K---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-~---~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........ .   ...++..|+|||.+.+..+ +.++|+||+||++|++++
T Consensus       115 ~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~  193 (257)
T cd05060         115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFS  193 (257)
T ss_pred             CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHc
Confidence            4899999999999999999999999999876443321 1   1123467999999987776 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||...+..+....+..+. ...|..++..++++|.+||..+|.+|||+.++++
T Consensus       194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         194 YGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             CCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             999999888777777766553 3556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.86  E-value=7.4e-22  Score=190.57  Aligned_cols=130  Identities=27%  Similarity=0.483  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   .....+++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       154 gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~  232 (314)
T cd05099         154 RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTL  232 (314)
T ss_pred             CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhC
Confidence            379999999999999999999999999986643221   122234568999999987766 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+......+..+..+. ...|..++.++++++.+||..||.+|||+.++++
T Consensus       233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         233 GGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            899999888888777776654 3456778899999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.86  E-value=6.5e-22  Score=184.93  Aligned_cols=130  Identities=24%  Similarity=0.448  Sum_probs=107.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .++||||||+||+++.++.+||+|||++.........  ....++..|+|||++.+..+ +.++|+||+||++|+|++ |
T Consensus       123 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g  201 (261)
T cd05072         123 NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYG  201 (261)
T ss_pred             CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccC
Confidence            3799999999999999999999999999876543221  12345668999999987766 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.........+..+. .+.+..++.++.+++.+||..+|++|||++++.+
T Consensus       202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         202 KIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            99999887777777766542 3344568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.85  E-value=8.4e-22  Score=186.88  Aligned_cols=131  Identities=25%  Similarity=0.397  Sum_probs=108.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .++||||||+|||++.++.+||+|||+++......   ......|+..|+|||.+.+..+ +.++||||+||++||+++ 
T Consensus       129 ~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~  207 (279)
T cd05111         129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSY  207 (279)
T ss_pred             CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcC
Confidence            37999999999999999999999999998654332   1223456778999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.......+.+..+.. ..+..++.++.+++.+||..||.+|||+.|+++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999998877666555655443 3455677889999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.85  E-value=8.8e-22  Score=190.24  Aligned_cols=135  Identities=27%  Similarity=0.372  Sum_probs=109.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC--CCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||+|+||+++.++.+||+|||++.....   .....|+..|+|||++.+  ....+.++|+||+||++|+|++|.
T Consensus       141 gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~  217 (313)
T cd06633         141 NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK  217 (313)
T ss_pred             CeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCC
Confidence            379999999999999999999999999865432   235578999999999842  222367999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc-C-CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIY-T-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~-~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+.+......++..... . ....++..+++|+.+||+.+|.+|||+.+++.||||+..
T Consensus       218 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         218 PPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             CCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            99988766555555443322 1 123567889999999999999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.85  E-value=6.8e-22  Score=187.65  Aligned_cols=137  Identities=35%  Similarity=0.598  Sum_probs=112.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||+|+||+++.++.++|+|||++....... ......|++.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       136 gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~  214 (286)
T cd06614         136 NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEP  214 (286)
T ss_pred             CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999987654322 2234457889999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCC--CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~--p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...+.......+.... ...  +..++.+++++|.+||+.+|.+|||+.+++.|+||+..
T Consensus       215 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  276 (286)
T cd06614         215 PYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA  276 (286)
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence            998877655544443332 222  23478899999999999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.85  E-value=1.4e-22  Score=178.87  Aligned_cols=128  Identities=25%  Similarity=0.326  Sum_probs=101.5

Q ss_pred             EecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCC
Q 017029            3 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD   82 (379)
Q Consensus         3 iHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~   82 (379)
                      +|..-||+|||++.++.+|+  ||++......    ...|++.|+|||++.+..| +.++||||+||++|+|++|..||.
T Consensus        33 lH~~~kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~  105 (176)
T smart00750       33 LHRQAKSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYN  105 (176)
T ss_pred             HHhcCCcccEeEcCccceee--ccceEeeccc----cCCCcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCcc
Confidence            46666999999999999999  9999876442    2368999999999998887 789999999999999999999997


Q ss_pred             CCCh-HHHHHHHhcCccCC-------CCCCCh--hhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           83 DENI-PNLFKKIKGGIYTL-------PSHLSP--GARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        83 ~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      .... ......+.......       +..++.  +++++|.+||..||.+|||+.++++|+|+..
T Consensus       106 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      106 EERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             ccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence            6532 23333333322221       122333  6899999999999999999999999999863

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.85  E-value=7e-22  Score=185.01  Aligned_cols=130  Identities=26%  Similarity=0.454  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.++|+|||++.........  ....++..|+|||.+.+..+ +.++|+||+||++|+|++ |
T Consensus       122 ~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g  200 (260)
T cd05069         122 NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKG  200 (260)
T ss_pred             CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCC
Confidence            3799999999999999999999999999776443211  12245678999999887766 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+....+....+..+ ....+...+..+.+++.+||..||.+|||++++++
T Consensus       201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         201 RVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            9999988777777776654 23456678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.85  E-value=6.4e-22  Score=185.08  Aligned_cols=129  Identities=26%  Similarity=0.478  Sum_probs=107.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||+++.++.++|+|||++.........  ....++..|+|||++.+..+ +.++|+||||+++|+|++ |.
T Consensus       123 i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~  201 (260)
T cd05070         123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGR  201 (260)
T ss_pred             cccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCC
Confidence            799999999999999999999999999876443221  12234567999999887666 789999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           79 LPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .||.+.+..+....+..+ ..+.+...+..+.+++.+||..+|.+|||+.++.+
T Consensus       202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         202 VPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             CCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            999988877777777654 34556778899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.85  E-value=1.1e-21  Score=189.63  Aligned_cols=135  Identities=31%  Similarity=0.420  Sum_probs=110.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||+|+||+++.++.+||+|||++......   ....|++.|+|||.+.   +..+ +.++|+||+||++|+|++|
T Consensus       145 ~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~-~~~~Dv~slGvil~el~~g  220 (317)
T cd06635         145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER  220 (317)
T ss_pred             CcccCCCCcccEEECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCC-CccccHHHHHHHHHHHHhC
Confidence            3799999999999999999999999998765432   3457889999999974   2334 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CC-CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TL-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+.+.......+..... .. +..+++.+++++.+||+.+|.+|||+.++++|+|+....
T Consensus       221 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  284 (317)
T cd06635         221 KPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRER  284 (317)
T ss_pred             CCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccC
Confidence            999988766555555544332 22 345788899999999999999999999999999997653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.85  E-value=5.6e-22  Score=185.24  Aligned_cols=130  Identities=22%  Similarity=0.441  Sum_probs=107.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||+++.++.+||+|||+++...+.....  ...++..|+|||.+.+..+ +.++|+||+|+++|++++ |.
T Consensus       121 i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~  199 (256)
T cd05059         121 FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             cccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCC
Confidence            7999999999999999999999999987664432211  1123457999999987776 789999999999999998 89


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .||...+..+....+..+. ...|..++..+.+++.+||..+|++|||+.++++.
T Consensus       200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         200 MPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9998877777777776553 45566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.85  E-value=9.9e-22  Score=183.89  Aligned_cols=129  Identities=24%  Similarity=0.473  Sum_probs=107.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccC---CCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG---SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~g---t~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||++........ ....|   +..|+|||++.+..+ +.++|+||+|+++|+|++ 
T Consensus       123 ~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~  200 (261)
T cd05068         123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTY  200 (261)
T ss_pred             CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc-cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhc
Confidence            379999999999999999999999999987653321 12222   357999999987766 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |+.||.+.........+.... ...+..++..+.+++.+||+.+|.+||++.++.+
T Consensus       201 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         201 GRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999988777777775542 3456678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.85  E-value=8.4e-22  Score=183.88  Aligned_cols=130  Identities=26%  Similarity=0.454  Sum_probs=108.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.+||+|||+++.........  ...++..|+|||++.+..+ +.++|+||+|+++|+|++ |
T Consensus       120 ~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g  198 (256)
T cd05114         120 SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEG  198 (256)
T ss_pred             CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCC
Confidence            37999999999999999999999999988654333222  1234568999999987766 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      +.||...+..+....+..+.. ..|...+..+.+++.+||..+|.+|||++++++
T Consensus       199 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         199 KMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             CCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            999999888888888876543 345667889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.85  E-value=7.1e-22  Score=187.72  Aligned_cols=139  Identities=38%  Similarity=0.605  Sum_probs=112.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyelltG   77 (379)
                      .++||||+|+||+++.++.++|+|||++........  ....+|++.|+|||.+.+.. ..+.++|+||+|+++|+|++|
T Consensus       125 ~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg  204 (288)
T cd05583         125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG  204 (288)
T ss_pred             CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhC
Confidence            379999999999999999999999999876543321  12346899999999987654 236799999999999999999


Q ss_pred             CCCCCCCC----hHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC---hhhhhcCchhhhcc
Q 017029           78 TLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT---IPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt---~~ell~hp~f~~~~  139 (379)
                      ..||....    .....+.+.......|..++.+++++|.+||+.||++|||   +.++++||||+...
T Consensus       205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~  273 (288)
T cd05583         205 ASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID  273 (288)
T ss_pred             CCCcccCcccchHHHHHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence            99996432    3344455556666778889999999999999999999998   46789999998653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.85  E-value=8.9e-22  Score=184.51  Aligned_cols=130  Identities=26%  Similarity=0.439  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-c---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-L---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........ .   ....+++.|+|||.+.+..+ +.++|+|||||++|++++
T Consensus       115 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~  193 (257)
T cd05115         115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFS  193 (257)
T ss_pred             CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhc
Confidence            379999999999999999999999999976543321 1   11223578999999887766 789999999999999996


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+....+....+..+. ...|...++++.++|.+||..||++||++.++.+
T Consensus       194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         194 YGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             CCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             999999888777777776543 4567788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.85  E-value=2.7e-22  Score=187.88  Aligned_cols=137  Identities=34%  Similarity=0.538  Sum_probs=105.9

Q ss_pred             EEecCCCCCCeEEcCC----CcEEEEecCCcccccCCc-c---cccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            2 VVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGH-F---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         2 IiHrDLKpeNILl~~~----~~vKL~DFGls~~~~~~~-~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      |+||||||.|||+..+    |.|||+|||+++.+.+.- .   ....+-|..|+|||.+.|...+++++|+||.|||+.|
T Consensus       153 vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaE  232 (438)
T KOG0666|consen  153 VLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAE  232 (438)
T ss_pred             eeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHH
Confidence            7999999999999887    999999999999876531 1   1233567899999999988877999999999999999


Q ss_pred             HhhCCCCCCCCChH---------HHHHHHhcCc-----------cCCCC--------------------------CCChh
Q 017029           74 LLCGTLPFDDENIP---------NLFKKIKGGI-----------YTLPS--------------------------HLSPG  107 (379)
Q Consensus        74 lltG~~Pf~~~~~~---------~~~~~i~~~~-----------~~~p~--------------------------~~s~~  107 (379)
                      |++-++-|.+....         +...+|..-.           -..|+                          .-++.
T Consensus       233 lLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~  312 (438)
T KOG0666|consen  233 LLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPS  312 (438)
T ss_pred             HHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCch
Confidence            99998888664211         1222221110           01111                          12455


Q ss_pred             hhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          108 ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       108 ~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..+|+.+||++||.+|+|++++++|+||...
T Consensus       313 a~~LL~klL~yDP~kRIta~qAleh~yF~~d  343 (438)
T KOG0666|consen  313 ALDLLQKLLTYDPIKRITAEQALEHPYFTED  343 (438)
T ss_pred             HHHHHHHHhccCchhhccHHHHhcccccccC
Confidence            8899999999999999999999999999876

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.85  E-value=5.6e-22  Score=192.72  Aligned_cols=138  Identities=20%  Similarity=0.319  Sum_probs=102.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-ccc-------ccccCCCCccCcccccCCC-CCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFL-------KTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~-------~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvil   71 (379)
                      .|+||||||+|||++.++.+|++|||.+...... ...       ....++..|+|||++.+.. ..+.++|+||+||++
T Consensus       121 ~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l  200 (328)
T cd08226         121 GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITA  200 (328)
T ss_pred             CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHH
Confidence            3899999999999999999999999865433211 110       1123456799999997642 237899999999999


Q ss_pred             HHHhhCCCCCCCCChHHHHHHHhcCcc-----------------------------------------------CCCCCC
Q 017029           72 YALLCGTLPFDDENIPNLFKKIKGGIY-----------------------------------------------TLPSHL  104 (379)
Q Consensus        72 yelltG~~Pf~~~~~~~~~~~i~~~~~-----------------------------------------------~~p~~~  104 (379)
                      |+|++|..||.+.........+.....                                               +.+..+
T Consensus       201 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  280 (328)
T cd08226         201 CELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTF  280 (328)
T ss_pred             HHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhh
Confidence            999999999987654443322221111                                               011235


Q ss_pred             ChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          105 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       105 s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +..+.+||.+||..||.+|||+.|+++||||+..
T Consensus       281 ~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~  314 (328)
T cd08226         281 SPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQV  314 (328)
T ss_pred             hHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHH
Confidence            6778999999999999999999999999999865

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.85  E-value=7.8e-22  Score=184.30  Aligned_cols=131  Identities=27%  Similarity=0.421  Sum_probs=106.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||+++.......     .....+++.|+|||.+.+..+ +.++||||+||++|+|+
T Consensus       118 ~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~  196 (262)
T cd05058         118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELM  196 (262)
T ss_pred             CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHH
Confidence            379999999999999999999999999976543221     112345678999999887766 78999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           76 C-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        76 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      + |.+||...+..+....+..+. ...+..++..+.+++.+||..+|++||++.+++..
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         197 TRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             cCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9 577888777777766666554 33456678999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.85  E-value=7.9e-22  Score=185.64  Aligned_cols=130  Identities=21%  Similarity=0.353  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+|++|||.+..........  ...++..|+|||++.+..+ +.++||||+||++|++++ |
T Consensus       127 ~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g  205 (266)
T cd05064         127 GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYG  205 (266)
T ss_pred             CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCC
Confidence            37999999999999999999999999876543322222  2335678999999988776 789999999999999775 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+..+..+.+..+. .+.|..++..+.+++.+||..+|.+|||+++|++
T Consensus       206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         206 ERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             CCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            99999888877777776653 3567788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.85  E-value=9.3e-22  Score=179.36  Aligned_cols=134  Identities=52%  Similarity=0.881  Sum_probs=116.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+|+||+|.||+++.++.++|+|||.+.............|+..|+|||.+.+..+ +.++|+||+|+++|++++|..|
T Consensus       107 ~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~-~~~~Di~slG~~l~~l~~~~~p  185 (244)
T smart00220      107 GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGY-GKAVDVWSLGVILYELLTGKPP  185 (244)
T ss_pred             CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence            479999999999999999999999999988766544556778999999999987666 6799999999999999999999


Q ss_pred             CCC-CChHHHHHHHhcCccCCCCC---CChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           81 FDD-ENIPNLFKKIKGGIYTLPSH---LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        81 f~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |.. .+.....+.+..+.......   ++.++.+++.+||..+|++||++.++++||||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      186 FPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            988 66666666666665554433   78999999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.85  E-value=1.2e-21  Score=181.82  Aligned_cols=130  Identities=25%  Similarity=0.452  Sum_probs=107.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .++||||||+||+++.++.+||+|||++.....+....  ...+++.|+|||++.+..+ +.++|+||+|+++|++++ |
T Consensus       113 ~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g  191 (250)
T cd05085         113 NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLG  191 (250)
T ss_pred             CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCC
Confidence            37999999999999999999999999987654332211  2234567999999987766 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.........+..+. ...+..++..+.+++.+||..+|++|||+.++.+
T Consensus       192 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         192 VCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999887777666666553 3456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.85  E-value=9.3e-22  Score=187.19  Aligned_cols=136  Identities=36%  Similarity=0.553  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .++||||+|+||+++.++.++|+|||++....... .....++..|+|||.+.+..+ +.++|+||+||++|+|++|..|
T Consensus       125 ~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p  202 (287)
T cd06621         125 KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL-AGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFP  202 (287)
T ss_pred             CcccCCCCHHHEEEecCCeEEEeeccccccccccc-cccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCC
Confidence            37999999999999999999999999987654322 224467889999999987776 7899999999999999999999


Q ss_pred             CCCC-----ChHHHHHHHhcCc-cCCC------CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDE-----NIPNLFKKIKGGI-YTLP------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~-----~~~~~~~~i~~~~-~~~p------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |...     ...+....+.... ..++      ..+++.+.++|.+||..+|.+|||+.|++.||||+..
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         203 FPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence            9865     2233334433321 1111      1345789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.85  E-value=2.2e-22  Score=183.42  Aligned_cols=131  Identities=31%  Similarity=0.458  Sum_probs=101.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-----c-----ccccccCCCCccCcccccCCCC--CCCccceeeehh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----H-----FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGV   69 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-----~-----~~~~~~gt~~y~APE~l~~~~~--~~~~~DiWSlGv   69 (379)
                      .+||||||.|||+.+.+.++|.|||.++...-.     +     .......|..|+|||.+.-+.+  .+.++|||||||
T Consensus       150 yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGC  229 (302)
T KOG2345|consen  150 YAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGC  229 (302)
T ss_pred             ccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhH
Confidence            589999999999999999999999998754211     0     0112246899999999864433  368999999999


Q ss_pred             HHHHHhhCCCCCCCCCh--HHHHHHHhcCccCCC--CCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           70 ILYALLCGTLPFDDENI--PNLFKKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        70 ilyelltG~~Pf~~~~~--~~~~~~i~~~~~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +||+|+.|..||+..-.  ..+.-.+.++.+.+|  ..+|+.+.++|+.||++||.+||++.+++.+
T Consensus       230 tLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  230 TLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            99999999999964211  111223445556666  3589999999999999999999999999864

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.85  E-value=1e-21  Score=184.23  Aligned_cols=133  Identities=34%  Similarity=0.559  Sum_probs=110.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.++|+|||+++.....    .......|+..|+|||++.+... +.++|+||+||++|++++
T Consensus       126 ~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  204 (264)
T cd06653         126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLT  204 (264)
T ss_pred             CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHh
Confidence            3799999999999999999999999999765321    12234568899999999988765 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |..||.+........++...  ...+|..+++.+.++|.+||. +|..|||+.+++.|||.
T Consensus       205 g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         205 EKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             CCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            99999877655554454432  234678899999999999999 57999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.85  E-value=1e-21  Score=183.36  Aligned_cols=129  Identities=26%  Similarity=0.546  Sum_probs=108.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      |+||||||+||+++.++.+||+|||++......... ....++..|+|||++.+..+ +.++|+||+|+++|+|++ |..
T Consensus       125 i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~  203 (261)
T cd05148         125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQV  203 (261)
T ss_pred             eeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCC
Confidence            799999999999999999999999999876543222 22345678999999987766 789999999999999998 899


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+..+.+..+..+ ..+.+..+++.+.+++.+||..||.+|||+.++++
T Consensus       204 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         204 PYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             CCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99988877777777654 34556788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.85  E-value=2.6e-22  Score=201.91  Aligned_cols=135  Identities=35%  Similarity=0.631  Sum_probs=107.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc---------CCc----------------------------------ccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR---------DGH----------------------------------FLK   38 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~---------~~~----------------------------------~~~   38 (379)
                      +|||||||+|||||.+|+|||+|||||.-+.         .+.                                  ...
T Consensus       750 FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ah  829 (1034)
T KOG0608|consen  750 FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAH  829 (1034)
T ss_pred             ceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhh
Confidence            6999999999999999999999999985321         000                                  012


Q ss_pred             cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcC----ccCCCCCCChhhhccccc
Q 017029           39 TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG----IYTLPSHLSPGARDLIPR  114 (379)
Q Consensus        39 ~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~----~~~~p~~~s~~~~~Li~~  114 (379)
                      ..+||++|+|||++....| +..+|+||.|||||||+.|+.||.+....+...+|.+=    .++.-..+|.++.++|.+
T Consensus       830 slvgt~nyiapevl~r~g~-~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~k  908 (1034)
T KOG0608|consen  830 SLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQK  908 (1034)
T ss_pred             hhcCCCcccChHHhcccCc-cccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHH
Confidence            3469999999999998888 78999999999999999999999887665544444321    233345799999999988


Q ss_pred             ccCCCCCCCCC---hhhhhcCchhhhc
Q 017029          115 MLIVDPMKRIT---IPEIRQHPWFQAH  138 (379)
Q Consensus       115 mL~~dP~~Rpt---~~ell~hp~f~~~  138 (379)
                      ++ -+++.|..   ++++..||||+..
T Consensus       909 Lc-~sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  909 LC-CSADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             Hh-cChhhhhcccchhhhhcCcccccc
Confidence            54 57889984   6789999999865

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.85  E-value=1.2e-21  Score=194.71  Aligned_cols=131  Identities=31%  Similarity=0.506  Sum_probs=104.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   .+..++..|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       234 ~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~  312 (375)
T cd05104         234 NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSL  312 (375)
T ss_pred             CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhc
Confidence            3899999999999999999999999999866443221   12334567999999988776 789999999999999998 


Q ss_pred             CCCCCCCCChH-HHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIP-NLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.... ...+.+..+. ...|...+.++++||.+||+.||++|||+.++++.
T Consensus       313 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         313 GSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             CCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            89999876543 3344444432 23455678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.85  E-value=9.8e-22  Score=187.13  Aligned_cols=130  Identities=29%  Similarity=0.453  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||+++++.+||+|||++........   .....++..|+|||.+.+..+ +.++||||+|+++|+|++ 
T Consensus       147 ~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~  225 (290)
T cd05045         147 KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTL  225 (290)
T ss_pred             CeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhc
Confidence            489999999999999999999999999876533221   122345678999999887766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.....+...+..+ ....|..++.++.+++.+||+.+|.+|||+.++++
T Consensus       226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         226 GGNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999988887777766554 23456778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.85  E-value=1.1e-21  Score=184.06  Aligned_cols=131  Identities=27%  Similarity=0.442  Sum_probs=109.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++...... ....  ...+++.|+|||.+.+..+ +.++|+||||+++|+|++ 
T Consensus       126 ~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~  204 (266)
T cd05033         126 NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSY  204 (266)
T ss_pred             CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHcc
Confidence            3799999999999999999999999999877421 1112  2234578999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||...........+..+ ..+.+..+++.+.+++.+||+.+|++||++.+++++
T Consensus       205 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         205 GERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            99999888777777777655 334566789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.85  E-value=1.2e-21  Score=184.01  Aligned_cols=130  Identities=33%  Similarity=0.560  Sum_probs=111.4

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||+|+||+++.++.+||+|||++.............|+..|+|||.+.+..+ +.++|+||+|+++|+|++|..||
T Consensus       135 i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~  213 (269)
T cd08528         135 IVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPF  213 (269)
T ss_pred             eeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcc
Confidence            79999999999999999999999999987665544456678999999999987766 78999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCccCC-CC-CCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           82 DDENIPNLFKKIKGGIYTL-PS-HLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~~~~-p~-~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ...........+..+.+.. +. .+++.+.++|.+||..||++|||+.|+..+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         214 YSTNMLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cccCHHHHHHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8887777766766555432 22 578999999999999999999999998653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.85  E-value=1.2e-21  Score=183.41  Aligned_cols=131  Identities=25%  Similarity=0.434  Sum_probs=108.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.+||+|||.++.........  ...++..|+|||.+.+..+ +.++|+||+||++|+|++ |
T Consensus       120 ~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g  198 (256)
T cd05113         120 QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLG  198 (256)
T ss_pred             CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCC
Confidence            48999999999999999999999999988664433221  1234567999999987766 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||...+.......+..+.. ..+...+..+++++.+||..||.+|||+.+++.+
T Consensus       199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         199 KMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            999998887777777766543 3455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.85  E-value=1.2e-21  Score=183.88  Aligned_cols=130  Identities=25%  Similarity=0.453  Sum_probs=108.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.+||+|||.+.........  ....++..|+|||+..+..+ +.++|+||+||++|+|++ |
T Consensus       122 ~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g  200 (262)
T cd05071         122 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKG  200 (262)
T ss_pred             CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCC
Confidence            3799999999999999999999999999766443321  12345678999999887766 789999999999999999 8


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.........+..+. ...+..++..+.+++.+||+.||.+|||+.++++
T Consensus       201 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         201 RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             CCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            99999887777777665543 3445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.85  E-value=1.3e-21  Score=181.57  Aligned_cols=130  Identities=27%  Similarity=0.433  Sum_probs=107.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||++.....+...   ....++..|+|||.+.+..+ +.++|+||+||++|+|++ 
T Consensus       113 ~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~  191 (251)
T cd05041         113 NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY-TSESDVWSYGILLWETFSL  191 (251)
T ss_pred             CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC-CcchhHHHHHHHHHHHHhc
Confidence            3799999999999999999999999999765432211   11233567999999887766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.........+... ....|..++..+.+++.+||..+|.+|||+.|+++
T Consensus       192 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         192 GDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             cCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            89999888777766666554 24456678899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.85  E-value=1e-21  Score=182.70  Aligned_cols=130  Identities=29%  Similarity=0.484  Sum_probs=105.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccccc---ccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~---~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||++....++.....   ..++..|+|||.+.+..+ +.++|+||+||++|+|++ 
T Consensus       114 ~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~  192 (252)
T cd05084         114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSL  192 (252)
T ss_pred             CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhC
Confidence            379999999999999999999999999876543321111   122356999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||...........+... ....+..++..+.+++.+||+.||++|||+.++++
T Consensus       193 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         193 GAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             CCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99999877766665555443 34566778999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.85  E-value=1.2e-21  Score=183.02  Aligned_cols=133  Identities=32%  Similarity=0.594  Sum_probs=111.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||+|+||+++. +.+||+|||++....... ......|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..
T Consensus       126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~  203 (260)
T cd08222         126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAH  203 (260)
T ss_pred             CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            3799999999999975 679999999987764432 2234568899999999877666 678999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      ||.+........++..+. ...+..++.++.++|.+||..||.+||++.++++||||
T Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         204 AFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             CCCCccHHHHHHHHHcCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            998877766666665443 34566788999999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.85  E-value=2.8e-22  Score=198.01  Aligned_cols=134  Identities=33%  Similarity=0.590  Sum_probs=106.8

Q ss_pred             EEecCCCCCCeEEcCC-CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+|.||||+|||+++. ..+||||||.+....+.. ++...-+..|.|||++.|..| ....|+||.||+||||.||+.-
T Consensus       557 vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene-itPYLVSRFYRaPEIiLG~~y-d~~iD~WSvgctLYElYtGkIl  634 (752)
T KOG0670|consen  557 VLHADIKPDNILVNESKNILKLCDFGSASFASENE-ITPYLVSRFYRAPEIILGLPY-DYPIDTWSVGCTLYELYTGKIL  634 (752)
T ss_pred             eeecccCccceEeccCcceeeeccCcccccccccc-ccHHHHHHhccCcceeecCcc-cCCccceeeceeeEEeecccee
Confidence            8999999999999875 678999999987765544 455566789999999999998 6889999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCC-----------------------------------------------------CC---
Q 017029           81 FDDENIPNLFKKIKGGIYTLPS-----------------------------------------------------HL---  104 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~-----------------------------------------------------~~---  104 (379)
                      |+|.+.....+-......++|.                                                     .+   
T Consensus       635 FpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~de  714 (752)
T KOG0670|consen  635 FPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDE  714 (752)
T ss_pred             cCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCch
Confidence            9997655444332221111210                                                     01   


Q ss_pred             ----ChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029          105 ----SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus       105 ----s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                          -..+++|+.+||..||.+|+|+.++|.||||+.
T Consensus       715 q~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  715 QPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             hHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence                135779999999999999999999999999974

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.84  E-value=1.3e-21  Score=190.67  Aligned_cols=136  Identities=36%  Similarity=0.581  Sum_probs=106.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||+|.||+++.++.+||+|||++.....  ...+..+++.|+|||++.+....+.++|+||+||++|+|++|..|
T Consensus       128 ~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~  205 (328)
T cd07856         128 GVVHRDLKPSNILINENCDLKICDFGLARIQDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPL  205 (328)
T ss_pred             CcccCCCCHHHEeECCCCCEEeCccccccccCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCC
Confidence            379999999999999999999999999876532  223456788999999987644347899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcC--------------------------ccCCC-----CCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGG--------------------------IYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~--------------------------~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.........+...                          ....|     +.++..++++|.+||+.+|.+|||++++
T Consensus       206 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~el  285 (328)
T cd07856         206 FPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEA  285 (328)
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHH
Confidence            9876543222111100                          00111     3467889999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      +.||||...
T Consensus       286 l~~~~~~~~  294 (328)
T cd07856         286 LAHPYLAPY  294 (328)
T ss_pred             hcCCccccc
Confidence            999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.84  E-value=1.6e-21  Score=182.65  Aligned_cols=128  Identities=20%  Similarity=0.277  Sum_probs=102.5

Q ss_pred             CEEecCCCCCCeEEcCCCc--------EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~--------vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+||+++.++.        ++++|||++......   ....+++.|+|||++.+....+.++|+||+||++|
T Consensus       120 ~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~  196 (258)
T cd05078         120 GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLW  196 (258)
T ss_pred             CeecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHH
Confidence            4899999999999987765        699999998765432   23568889999999987544478999999999999


Q ss_pred             HHhhC-CCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           73 ALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        73 elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +|++| ..||...+..... .+......+|...+.++.+++.+||+.||++|||++++++.
T Consensus       197 ~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         197 EIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHcCCCCChhhccHHHHH-HHHHccccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99998 5677665554433 23344556777778899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.84  E-value=1.6e-21  Score=185.60  Aligned_cols=129  Identities=24%  Similarity=0.351  Sum_probs=104.4

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh--
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt--   76 (379)
                      |+||||||+||+++.++.++|+|||+++.......   .....+++.|+|||++.+..+ +.++||||+||++|+|++  
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcC
Confidence            79999999999999999999999999976543321   123356778999999887666 789999999999999998  


Q ss_pred             CCCCCCCCChHHHHHHHhcC--------ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGG--------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||...+.......+...        ....+..++.++.+++.+||+.||.+|||+.|+++
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         230 REQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             CCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            78899877666665555432        12334567889999999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.84  E-value=6.8e-22  Score=214.27  Aligned_cols=135  Identities=17%  Similarity=0.232  Sum_probs=96.6

Q ss_pred             CEEecCCCCCCeEEcC-------------------CCcEEEEecCCcccccCC-----------------cccccccCCC
Q 017029            1 MVVHRDLKPENLLLDS-------------------KWNVKIADFGLSNIMRDG-----------------HFLKTSCGSP   44 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-------------------~~~vKL~DFGls~~~~~~-----------------~~~~~~~gt~   44 (379)
                      .||||||||+||||+.                   ++.+|++|||+++.....                 ......+||+
T Consensus       100 gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        100 GIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             CeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence            4899999999999964                   345666666666532110                 0001246889


Q ss_pred             CccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhhhcccccccCCCCCCC
Q 017029           45 NYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        45 ~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~mL~~dP~~R  123 (379)
                      .|+|||++.+..| +.++|||||||++|||++|..|+....  .....+.....+ .+....+...+++.+||.+||.+|
T Consensus       180 ~Y~APE~~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~R  256 (793)
T PLN00181        180 WYTSPEEDNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCR  256 (793)
T ss_pred             ceEChhhhccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhC
Confidence            9999999988887 789999999999999999999876432  122222222111 111124566789999999999999


Q ss_pred             CChhhhhcCchhhhc
Q 017029          124 ITIPEIRQHPWFQAH  138 (379)
Q Consensus       124 pt~~ell~hp~f~~~  138 (379)
                      ||+.|+++||||...
T Consensus       257 ps~~eil~h~~~~~~  271 (793)
T PLN00181        257 PSMSELLQSEFINEP  271 (793)
T ss_pred             cChHHHhhchhhhhh
Confidence            999999999999753

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.84  E-value=1.7e-21  Score=183.28  Aligned_cols=128  Identities=21%  Similarity=0.337  Sum_probs=101.0

Q ss_pred             CEEecCCCCCCeEEcCCCc-------EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWN-------VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~-------vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      .|+||||||+|||++.++.       +|++|||++......   ....|+..|+|||++.+....+.++||||+||++|+
T Consensus       125 ~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e  201 (262)
T cd05077         125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE  201 (262)
T ss_pred             CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence            4899999999999987664       899999998765322   234678899999998754444789999999999999


Q ss_pred             Hh-hCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           74 LL-CGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        74 ll-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |+ +|..||.+....+.. ....+........+.++.+||.+||+.||.+||++.+|+++
T Consensus       202 l~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         202 ICYNGEIPLKDKTLAEKE-RFYEGQCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHhCCCCCCCCcchhHHH-HHHhcCccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            98 589999876654433 33334444444557889999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.84  E-value=1.9e-21  Score=186.52  Aligned_cols=131  Identities=26%  Similarity=0.465  Sum_probs=110.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   .....+++.|+|||++.+..+ +.++||||||+++|++++ 
T Consensus       157 givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~  235 (304)
T cd05101         157 KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTL  235 (304)
T ss_pred             CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcC
Confidence            389999999999999999999999999987643221   122345678999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..++...+..+. ...+..++..+++++.+||..+|.+|||+.++++.
T Consensus       236 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         236 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            899999988888888776554 34566788999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.84  E-value=2e-21  Score=181.04  Aligned_cols=130  Identities=26%  Similarity=0.421  Sum_probs=107.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .++||||||+||+++.++.+||+|||++........    .....++..|+|||.+.+..+ +.++|+||+||++|+|++
T Consensus       117 ~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t  195 (257)
T cd05040         117 RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFT  195 (257)
T ss_pred             CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHh
Confidence            379999999999999999999999999987644211    112356788999999987776 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||...+..+..+.+...  ....+..++..+.+++.+||..+|++|||+.++++
T Consensus       196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         196 YGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             CCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence             99999888777776666532  23345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.84  E-value=1.8e-21  Score=181.45  Aligned_cols=128  Identities=27%  Similarity=0.528  Sum_probs=107.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+||+++.++.+||+|||.+........  ...++..|+|||.+.+..+ +.++|+||+|+++|++++ |..
T Consensus       122 ~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~  198 (256)
T cd05039         122 NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRV  198 (256)
T ss_pred             CccchhcccceEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCC
Confidence            379999999999999999999999999987643322  3344567999999887666 789999999999999997 999


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.......+...+..+ ....|..+++.+.++|.+||..+|.+|||+.++++
T Consensus       199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         199 PYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            99988877777766554 33456678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.84  E-value=2.1e-21  Score=181.55  Aligned_cols=129  Identities=26%  Similarity=0.505  Sum_probs=107.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      ++||||||+||+++.++.++|+|||++.........  ....++..|+|||++.+..+ +.++|+||+|+++|++++ |.
T Consensus       123 i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~  201 (260)
T cd05067         123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGR  201 (260)
T ss_pred             eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCC
Confidence            799999999999999999999999999776533221  12345678999999987766 789999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .||.+.+..+....+..+. .+.+...+.++.+++.+||..+|++|||+++++.
T Consensus       202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         202 IPYPGMTNPEVIQNLERGYRMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             CCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999888777777665543 3456678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.84  E-value=1.9e-21  Score=183.83  Aligned_cols=130  Identities=25%  Similarity=0.402  Sum_probs=107.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .++||||||+||+++.++.+||+|||+++.+......   ....++..|+|||++.+..+ +.++||||+||++|++++ 
T Consensus       137 ~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~  215 (280)
T cd05043         137 GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTL  215 (280)
T ss_pred             CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcC
Confidence            3799999999999999999999999999866433221   12345678999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.+..++...+..+. ...+..+++++.+++.+||..||++|||+.++++
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         216 GQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCCcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999888777776666543 2345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.84  E-value=2.7e-21  Score=179.30  Aligned_cols=130  Identities=29%  Similarity=0.500  Sum_probs=109.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccccc--ccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~--~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.++|+|||++...........  ..+++.|+|||.+.+..+ +.++|+||+|+++|+|++ |
T Consensus       123 ~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g  201 (258)
T smart00219      123 NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLG  201 (258)
T ss_pred             CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCC
Confidence            379999999999999999999999999987655432222  236789999999976655 789999999999999998 8


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+.....+.+..+.. ..+..++.++.+++.+||..||.+|||+.++++
T Consensus       202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      202 ESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             CCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            999998888887777765543 456678999999999999999999999999875

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.84  E-value=1.4e-21  Score=187.98  Aligned_cols=131  Identities=27%  Similarity=0.481  Sum_probs=109.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .++||||||+||+++.++.+||+|||++.........   ....+++.|+|||++.+..+ +.++|+||+||++|+|++ 
T Consensus       160 gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~  238 (307)
T cd05098         160 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTL  238 (307)
T ss_pred             CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcC
Confidence            3799999999999999999999999998765432211   12234568999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....+....+..+. ...|..++.++.+++.+||..+|.+|||+.+++++
T Consensus       239 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         239 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             CCCCCCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            899999888877777776654 35677889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.84  E-value=2.9e-21  Score=181.61  Aligned_cols=131  Identities=30%  Similarity=0.533  Sum_probs=109.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccccc--ccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~--~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .++||||||+||+++.++.+||+|||+++..........  ..+++.|+|||.+.+..+ +.++|+|||||++|++++ |
T Consensus       127 ~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g  205 (270)
T cd05056         127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLG  205 (270)
T ss_pred             CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcC
Confidence            379999999999999999999999999987654432222  234568999999887766 789999999999999986 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+....+....+..+. ...|..++..+.+++.+||..+|.+|||+.+++..
T Consensus       206 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         206 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             CCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999887777766766553 45677889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.84  E-value=1.4e-21  Score=195.32  Aligned_cols=133  Identities=32%  Similarity=0.431  Sum_probs=113.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHHhhCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||.-|||+++.|.|||+|||.+.++..   .++++|||+|||||||.   .+.| +-++||||||++..||.-.+
T Consensus       147 ~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqY-dgkvDvWSLGITCIELAERk  222 (948)
T KOG0577|consen  147 RIHRDIKAGNILLSEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERK  222 (948)
T ss_pred             HHhhhccccceEecCCCeeeeccccchhhcCc---hhcccCCccccchhHheecccccc-CCccceeeccchhhhhhhcC
Confidence            48999999999999999999999999987754   45889999999999985   3456 45899999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcC-ccCCC-CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGG-IYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~-~~~~p-~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|+-..+.....-.|... .++++ ..+|..+++|+..||++-|.+|||.++++.|+|+...
T Consensus       223 PPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~  284 (948)
T KOG0577|consen  223 PPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE  284 (948)
T ss_pred             CCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence            998777776655555443 34444 4689999999999999999999999999999998754

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.84  E-value=2.5e-21  Score=188.62  Aligned_cols=131  Identities=27%  Similarity=0.477  Sum_probs=110.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   ....++..|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       154 givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~  232 (334)
T cd05100         154 KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTL  232 (334)
T ss_pred             CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhc
Confidence            3799999999999999999999999999766443211   12234567999999988776 689999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..+....+..+. ...|..++.++.+++.+||+.+|.+|||+.|++.+
T Consensus       233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         233 GGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            899999988888887776653 35567788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.84  E-value=2.2e-21  Score=180.62  Aligned_cols=130  Identities=25%  Similarity=0.494  Sum_probs=107.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      ++||||||+||+++.++.+||+|||++.........  ....++..|+|||.+.+..+ +.++|+||+|+++|+|++ |.
T Consensus       121 i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~  199 (256)
T cd05112         121 VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGK  199 (256)
T ss_pred             ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCC
Confidence            799999999999999999999999998765433211  12234568999999987766 789999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           79 LPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .||.........+.+..+.. ..|...+..+.+++.+||..+|++|||+.+++++
T Consensus       200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         200 TPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             CCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            99998887777777765533 3455678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.84  E-value=3e-21  Score=181.04  Aligned_cols=129  Identities=27%  Similarity=0.483  Sum_probs=107.2

Q ss_pred             EEecCCCCCCeEEcCCC-----cEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            2 VVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~-----~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      |+||||||+||+++.++     .+||+|||++.........   ....++..|+|||++.+..+ +.++|||||||++|+
T Consensus       127 i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e  205 (269)
T cd05044         127 FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWE  205 (269)
T ss_pred             cccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHH
Confidence            79999999999999877     8999999998765433211   22345678999999987776 789999999999999


Q ss_pred             Hhh-CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           74 LLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        74 llt-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |++ |..||...+..+....+..+ ....+..++..+.++|.+||..+|.+|||+.++++
T Consensus       206 llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         206 ILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHcCCCCCcccCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            998 99999887777776666543 34566778999999999999999999999999864

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.84  E-value=3.9e-21  Score=179.15  Aligned_cols=128  Identities=27%  Similarity=0.497  Sum_probs=106.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .++||||||+||+++.++.+||+|||++......  ......+..|+|||.+.+..+ +.++|+||+||++|+|++ |..
T Consensus       120 ~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~  196 (254)
T cd05083         120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRA  196 (254)
T ss_pred             CeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCC
Confidence            3799999999999999999999999998764332  122334568999999987766 789999999999999997 999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+..+....+..+. ...+..++..+.+++.+||..+|.+|||+++++.
T Consensus       197 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         197 PYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            999888877777776553 3345668899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.83  E-value=7.8e-22  Score=198.17  Aligned_cols=131  Identities=29%  Similarity=0.477  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc---CCcccccccCCCCccCcccccCC--CCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~---~~~~~~~~~gt~~y~APE~l~~~--~~~~~~~DiWSlGvilyell   75 (379)
                      .|||||||..||++.+++.|||+|||++..-+   ....+....|+..|||||++..+  ..+++.+|||||||++|||+
T Consensus       508 ~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELl  587 (678)
T KOG0193|consen  508 NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELL  587 (678)
T ss_pred             hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHH
Confidence            48999999999999999999999999986543   23345566789999999999642  22478999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCccC-----CCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+||...+...+.-.+.+|...     ....++.++++|+..||.+++++||++.+|+.
T Consensus       588 tg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  588 TGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             hCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            999999977776666666666332     22456779999999999999999999999887

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.83  E-value=3e-21  Score=180.82  Aligned_cols=131  Identities=32%  Similarity=0.548  Sum_probs=105.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.++|+|||++........ .....|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..
T Consensus       126 ~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~  204 (267)
T cd08228         126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQS  204 (267)
T ss_pred             CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCC
Confidence            479999999999999999999999999887654322 234578899999999987766 689999999999999999999


Q ss_pred             CCCCCC--hHHHHHHHhcCcc-CCC-CCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDEN--IPNLFKKIKGGIY-TLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~--~~~~~~~i~~~~~-~~p-~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||....  .......+....+ +.+ ..++..+.+++.+||..+|++|||+.++++.
T Consensus       205 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         205 PFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             CCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            996643  3445555544332 222 3577889999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.83  E-value=3.3e-21  Score=181.14  Aligned_cols=131  Identities=24%  Similarity=0.457  Sum_probs=108.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||+++....+...   ....+++.|++||.+.+..+ +.++|||||||++|+|++ 
T Consensus       133 ~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~  211 (273)
T cd05074         133 NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTR  211 (273)
T ss_pred             CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhC
Confidence            3899999999999999999999999998866433221   22345678999999987766 689999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..+....+..+. ...+...+..+.+++.+||..+|++|||+.+++.+
T Consensus       212 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         212 GQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999888777776665543 34456788999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.83  E-value=4.5e-21  Score=183.28  Aligned_cols=130  Identities=23%  Similarity=0.352  Sum_probs=102.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.++|+|||++..+.....   ..+..+++.|+|||+..+..+ +.++|+||+||++|+|++ 
T Consensus       150 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~  228 (296)
T cd05095         150 NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTL  228 (296)
T ss_pred             CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHh
Confidence            379999999999999999999999999976543321   112334678999998877766 789999999999999998 


Q ss_pred             -CCCCCCCCChHHHHHHHh--------cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIK--------GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~--------~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||...+..+......        ....+.|..+++.+.+|+.+||+.||.+|||+.++.+
T Consensus       229 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         229 CKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             CCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence             789998766555444331        1122445678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.83  E-value=1.6e-21  Score=202.69  Aligned_cols=130  Identities=28%  Similarity=0.461  Sum_probs=115.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccccccc---CCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~---gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      ++|||||...|+||.++..|||+|||+++..-..+..+...   -..+|||||.|....| +.++||||+||+|||+++ 
T Consensus       623 ~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsy  701 (774)
T KOG1026|consen  623 HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSY  701 (774)
T ss_pred             cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhcc
Confidence            47999999999999999999999999998776555544332   2358999999998888 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+....+..+.|..+. .+.|..++.++++|+..||+.+|.+||++.||-.
T Consensus       702 G~QPy~glSn~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~  757 (774)
T KOG1026|consen  702 GKQPYYGLSNQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS  757 (774)
T ss_pred             ccCcccccchHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999998776 5778999999999999999999999999999753

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.83  E-value=3.9e-21  Score=180.40  Aligned_cols=130  Identities=28%  Similarity=0.477  Sum_probs=106.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--cc--ccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KT--SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~--~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++.........  .+  ...++.|+|||++.+..+ +.++|+||+||++|++++
T Consensus       127 ~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~  205 (268)
T cd05063         127 NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMS  205 (268)
T ss_pred             CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHh
Confidence            3799999999999999999999999999766432211  11  123457999999987766 789999999999999997


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||...+.......+..+. .+.+..++..+.+++.+||..+|.+||++.++++
T Consensus       206 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         206 FGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             CCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence             999998887777777776543 2344567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.83  E-value=3.7e-21  Score=182.83  Aligned_cols=130  Identities=27%  Similarity=0.432  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .++||||||+||+++.++.+||+|||++.........   ....++..|+|||++.+..+ +.++|+||+||++|+|++ 
T Consensus       150 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~  228 (288)
T cd05050         150 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSY  228 (288)
T ss_pred             CeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhC
Confidence            3799999999999999999999999998765332211   22334667999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.+..+....+..+.. ..|..++.++.++|.+||+.||.+|||+.|+++
T Consensus       229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         229 GMQPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            8899988877777777765543 456678899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.83  E-value=3.7e-21  Score=180.22  Aligned_cols=130  Identities=32%  Similarity=0.533  Sum_probs=105.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+|+||||+||+++.++.++|+|||++....... .....+|++.|+|||.+.+..+ +.++|+||+|+++|+|++|..
T Consensus       126 ~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~  204 (267)
T cd08229         126 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQS  204 (267)
T ss_pred             CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999987764432 2234578999999999987766 689999999999999999999


Q ss_pred             CCCCCCh--HHHHHHHhcCccC-C-CCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENI--PNLFKKIKGGIYT-L-PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~--~~~~~~i~~~~~~-~-p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+...  ....+.+....++ . +..+++.+++++.+||..||.+|||+.++++
T Consensus       205 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         205 PFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             CcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence            9976543  3444455443332 2 2457889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.83  E-value=4.9e-21  Score=181.52  Aligned_cols=130  Identities=27%  Similarity=0.361  Sum_probs=100.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||+++....+..    .....++..|+|||.+.+..+ +.++||||+||++|+|++
T Consensus       127 ~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~t  205 (283)
T cd05080         127 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLT  205 (283)
T ss_pred             CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHh
Confidence            489999999999999999999999999987654322    122345667999999987766 789999999999999999


Q ss_pred             CCCCCCCCChH---------------HHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIP---------------NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~---------------~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||......               .....+..+ ..+.|..++..+.+++.+||..||++|||+++++.
T Consensus       206 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         206 HCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             CCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99998643210               011111111 12345677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.83  E-value=6.3e-21  Score=178.56  Aligned_cols=129  Identities=26%  Similarity=0.508  Sum_probs=106.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      ++||||||+||+++.++.+||+|||++.........  ....++..|+|||++.+..+ +.++|+||+||++|++++ |.
T Consensus       123 i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~  201 (260)
T cd05073         123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGR  201 (260)
T ss_pred             ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCC
Confidence            799999999999999999999999998766443221  12235567999999987665 789999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .||.+.+.......+..+. .+.+...+.++.+++.+||+.+|.+||++.+++.
T Consensus       202 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         202 IPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             CCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            9999888777777666553 2445678899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.83  E-value=4.7e-21  Score=184.08  Aligned_cols=131  Identities=25%  Similarity=0.406  Sum_probs=106.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   .....++..|+|||++.+..+ +.++||||+||++|++++ 
T Consensus       129 ~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~  207 (303)
T cd05110         129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTF  207 (303)
T ss_pred             CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhC
Confidence            489999999999999999999999999987643322   122345678999999987766 789999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.........+..+. ...+..++..+.+++.+||..+|.+||+++++++.
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         208 GGKPYDGIPTREIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             CCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999998876666555554433 34456678899999999999999999999998774

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.83  E-value=4.4e-21  Score=179.11  Aligned_cols=130  Identities=25%  Similarity=0.463  Sum_probs=107.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+||+++.++.+||+|||++.........  ....++..|+|||.+.+..+ +.++|+||+||++|++++ |
T Consensus       123 ~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g  201 (261)
T cd05034         123 NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYG  201 (261)
T ss_pred             CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCC
Confidence            3799999999999999999999999998776432211  12234568999999987766 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      +.||.+.+......++..+. ...|...+.++.+++.+||..+|.+|||++++.+
T Consensus       202 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         202 RVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            99999888777777776553 3456677899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.83  E-value=4.6e-21  Score=184.34  Aligned_cols=130  Identities=32%  Similarity=0.506  Sum_probs=104.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+|++|||++........   .....+++.|+|||.+.+..+ +.++||||+||++|+|++ 
T Consensus       161 ~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~  239 (302)
T cd05055         161 NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSL  239 (302)
T ss_pred             CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhC
Confidence            389999999999999999999999999976543221   112345678999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHH-hcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKI-KGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i-~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+......+.+. ..+. ...+...++.+.+++.+||..+|++|||+.++++
T Consensus       240 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         240 GSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999887655444333 3332 2345567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.83  E-value=9.4e-21  Score=179.18  Aligned_cols=130  Identities=25%  Similarity=0.408  Sum_probs=108.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc---cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~---~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+||+++.++.+||+|||+++.........   ...++..|+|||.+.+..+ +.++|+||+||++|++++ 
T Consensus       129 ~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~  207 (279)
T cd05057         129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTF  207 (279)
T ss_pred             CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcC
Confidence            48999999999999999999999999998765332211   1223567999999877666 689999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+....++...+..+. .+.|...+..+.+++.+||..||.+|||+.++++
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         208 GAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             CCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999988888777776653 4556678899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.83  E-value=9.3e-21  Score=177.09  Aligned_cols=130  Identities=35%  Similarity=0.586  Sum_probs=105.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||+|+||+++.++.++|+|||++....... ......|++.|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus       126 ~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~  204 (267)
T cd08224         126 RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQS  204 (267)
T ss_pred             CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCC
Confidence            38999999999999999999999999987654332 2234568899999999987776 689999999999999999999


Q ss_pred             CCCCCC--hHHHHHHHhcCcc-CCCC-CCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDEN--IPNLFKKIKGGIY-TLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~--~~~~~~~i~~~~~-~~p~-~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||....  .......+..+.. +.|. .++..+.++|.+||..+|.+|||+.+|++
T Consensus       205 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         205 PFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             CcccCCccHHHHHhhhhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            996543  3344555544433 3343 67889999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.82  E-value=9e-21  Score=181.10  Aligned_cols=129  Identities=25%  Similarity=0.368  Sum_probs=102.4

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh--
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC--   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt--   76 (379)
                      ++||||||+||+++.++.+||+|||++.........   ....+++.|+|||++.+..+ +.++|+|||||++|+|++  
T Consensus       150 i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~  228 (295)
T cd05097         150 FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLC  228 (295)
T ss_pred             eeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcC
Confidence            799999999999999999999999999765433221   12245678999999887766 789999999999999987  


Q ss_pred             CCCCCCCCChHHHHHHHhc-----C---ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKG-----G---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~-----~---~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||...+..+....+..     +   ....++.+++.+.+++.+||..||.+|||++++++
T Consensus       229 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         229 KEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             CCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            7789988766555444321     1   12235567899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.82  E-value=1.1e-20  Score=177.61  Aligned_cols=130  Identities=26%  Similarity=0.430  Sum_probs=105.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---cccc---CCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSC---GSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~---gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .++||||||+||+++.++.+||+|||++.........   ....   ++..|+|||.+.+..+ +.++||||+||++||+
T Consensus       126 g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~  204 (269)
T cd05065         126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEV  204 (269)
T ss_pred             CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHH
Confidence            3799999999999999999999999998765433211   1111   2357999999987776 7899999999999998


Q ss_pred             hh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           75 LC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        75 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++ |..||.+.+..+....+.... .+.+..++..+.+++.+||..+|.+||++++++.
T Consensus       205 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         205 MSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            86 999999888777777765442 3445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.82  E-value=4.6e-21  Score=205.52  Aligned_cols=130  Identities=29%  Similarity=0.509  Sum_probs=113.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccc-cC--CCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~-~g--t~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      ++|||||...|+||+....+||+|||+|+.+-+.+..+.. .+  ...|||||.+....+ +.++|||||||++||+++ 
T Consensus       822 ~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifsl  900 (1025)
T KOG1095|consen  822 HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSL  900 (1025)
T ss_pred             CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhC
Confidence            4799999999999999999999999999965544433322 12  247999999998777 889999999999999999 


Q ss_pred             CCCCCCCCChHHHHH-HHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFK-KIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~-~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.+..+++. -...|..+.|.++++.+.+++.+||..+|++||++..|++
T Consensus       901 G~~PY~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  901 GATPYPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999999998888877 5567788899999999999999999999999999999987

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.82  E-value=9.5e-21  Score=178.01  Aligned_cols=130  Identities=26%  Similarity=0.443  Sum_probs=106.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cc---cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~---~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.++|+|||++........ ..   ...++..|+|||.+.+..+ +.++|+||+||++|++++
T Consensus       126 ~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~  204 (267)
T cd05066         126 GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMS  204 (267)
T ss_pred             CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhc
Confidence            379999999999999999999999999987654321 11   1223568999999987766 789999999999999886


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+....+....+..+. .+.+..+++.+.+++.+||+.+|.+|||+.++++
T Consensus       205 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         205 YGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             CCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence             999998877777767666553 3344567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.82  E-value=2.4e-21  Score=182.10  Aligned_cols=130  Identities=35%  Similarity=0.566  Sum_probs=105.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||+++|||+++++.+||+|||++.........   ....+...|+|||.+.+..+ +.++||||||+++||+++ 
T Consensus       123 ~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~  201 (259)
T PF07714_consen  123 NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTL  201 (259)
T ss_dssp             TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccccccccccccccccc
Confidence            4899999999999999999999999999876322211   23346678999999987776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.+..++..++..+.. ..|..++..+.++|.+||..||.+|||+.++++
T Consensus       202 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  202 GKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             SSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccccccccccccccccccccccceeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            7899999888888788766543 456779999999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.82  E-value=9.8e-21  Score=165.56  Aligned_cols=137  Identities=32%  Similarity=0.566  Sum_probs=113.4

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      |+||||||.|+||+.+|.+|++|||+++.++-.. .....+-|..|.+|.++.|...++...|+||.|||+.|+.. |++
T Consensus       122 vlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrp  201 (292)
T KOG0662|consen  122 VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP  201 (292)
T ss_pred             hhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCC
Confidence            6899999999999999999999999999875443 33445678999999999887777899999999999999996 888


Q ss_pred             CCCCCChHHHHHHHhcCcc-----------CC---------C---------CCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-----------TL---------P---------SHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-----------~~---------p---------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      -|.+.+..+...+|-....           .+         |         +.++..-+++++++|.-+|.+|+++++.+
T Consensus       202 lfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaal  281 (292)
T KOG0662|consen  202 LFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAAL  281 (292)
T ss_pred             CCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHh
Confidence            8999888887777633211           01         1         23455678999999999999999999999


Q ss_pred             cCchhhhc
Q 017029          131 QHPWFQAH  138 (379)
Q Consensus       131 ~hp~f~~~  138 (379)
                      +||||.+.
T Consensus       282 qhpyf~d~  289 (292)
T KOG0662|consen  282 QHPYFSDF  289 (292)
T ss_pred             cCcccccc
Confidence            99999864

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.82  E-value=1.2e-20  Score=177.39  Aligned_cols=130  Identities=22%  Similarity=0.358  Sum_probs=98.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCC------CCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~------~~~~~~~DiWSlGvil   71 (379)
                      .|+||||||+|||++.++.+||+|||++.........   ....+++.|+|||++...      ...+.++||||+||++
T Consensus       120 ~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05042         120 DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTM  199 (269)
T ss_pred             CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHH
Confidence            4899999999999999999999999998754332211   223456789999987532      2236799999999999


Q ss_pred             HHHhh-CCCCCCCCChHHHHHHH-hcCccCC-----CCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           72 YALLC-GTLPFDDENIPNLFKKI-KGGIYTL-----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        72 yellt-G~~Pf~~~~~~~~~~~i-~~~~~~~-----p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |+|++ |..||......+...++ ..+...+     +..++..+.+++..|| .||++|||++++++
T Consensus       200 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         200 WELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence            99999 88999877665554443 3332222     3457788889999998 59999999999875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.82  E-value=2.1e-20  Score=175.90  Aligned_cols=130  Identities=25%  Similarity=0.391  Sum_probs=98.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCC------CCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~------~~~~~~DiWSlGvil   71 (379)
                      .|+||||||+||+++.++.+||+|||++.........   ....|++.|+|||++.+..      ..+.++|+||+||++
T Consensus       120 ~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  199 (269)
T cd05087         120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTI  199 (269)
T ss_pred             CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHH
Confidence            3899999999999999999999999998765433221   2345778899999986432      126799999999999


Q ss_pred             HHHhh-CCCCCCCCChHHHHHH-HhcCccCCC-----CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           72 YALLC-GTLPFDDENIPNLFKK-IKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        72 yellt-G~~Pf~~~~~~~~~~~-i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |+|++ |..||......+.... +......++     ...+..+.+++.+|| .+|++|||++||+.
T Consensus       200 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         200 WELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            99996 9999987665554333 222222222     246778899999998 68999999999874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.82  E-value=1.4e-20  Score=188.72  Aligned_cols=130  Identities=30%  Similarity=0.502  Sum_probs=104.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....+++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       257 ~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~  335 (400)
T cd05105         257 NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSL  335 (400)
T ss_pred             CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHC
Confidence            389999999999999999999999999986543221   123356788999999987766 789999999999999997 


Q ss_pred             CCCCCCCCChHH-HHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+..... ....+..+ ....+..++.++.+++.+||+.||++|||+.++.+
T Consensus       336 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         336 GGTPYPGMIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             CCCCCcccchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            999998754433 34444443 23456678999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.82  E-value=1.7e-20  Score=183.73  Aligned_cols=131  Identities=29%  Similarity=0.489  Sum_probs=104.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   ..+..+++.|+|||++.+..+ +.++|+||+|+++|+|++ 
T Consensus       199 ~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~  277 (343)
T cd05103         199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSL  277 (343)
T ss_pred             CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHC
Confidence            389999999999999999999999999976533221   112335678999999987776 789999999999999997 


Q ss_pred             CCCCCCCCChH-HHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIP-NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.... .....+..+ ....|...++++.+++.+||+.||.+|||+.++++|
T Consensus       278 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         278 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             CCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999875433 233333333 344566678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.81  E-value=2.8e-20  Score=175.27  Aligned_cols=130  Identities=22%  Similarity=0.337  Sum_probs=99.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCC------CCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKL------YAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~------~~~~~~DiWSlGvil   71 (379)
                      .|+||||||+|||++.++.+||+|||++.......   .....+|++.|+|||++.+..      ..+.++||||+||++
T Consensus       119 ~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l  198 (268)
T cd05086         119 NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTL  198 (268)
T ss_pred             CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHH
Confidence            48999999999999999999999999986432221   112457889999999975321      125789999999999


Q ss_pred             HHHhh-CCCCCCCCChHHHHHHHhcCc-c-----CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           72 YALLC-GTLPFDDENIPNLFKKIKGGI-Y-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        72 yellt-G~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |+|++ |..||...+..+...++..+. .     .++..+++.+.+++..|| .+|.+|||++++++
T Consensus       199 ~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         199 WELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            99996 678998877766666543332 1     233457888999999999 68999999999864

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.81  E-value=2.6e-20  Score=176.83  Aligned_cols=131  Identities=27%  Similarity=0.402  Sum_probs=100.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++........    .....|+..|+|||++.+..+ +.++||||+||++|+|++
T Consensus       129 gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt  207 (284)
T cd05079         129 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLT  207 (284)
T ss_pred             CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCC-Cccccchhhhhhhhhhhc
Confidence            389999999999999999999999999986643321    123456778999999887766 789999999999999999


Q ss_pred             CCCCCCCC---------------ChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDE---------------NIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~---------------~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +..|+...               ........+..+ ..+.+..++..+.+|+.+||+.||.+|||+.+++++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         208 YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             CCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            87664321               111111222222 234456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.81  E-value=3.2e-20  Score=190.39  Aligned_cols=137  Identities=28%  Similarity=0.425  Sum_probs=102.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccc--cCCCCccCcccccCCC--------------------CC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKL--------------------YA   58 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~--~gt~~y~APE~l~~~~--------------------~~   58 (379)
                      .|+||||||+|||++.++.+||+|||++..+..+......  .+++.|+|||.+....                    |.
T Consensus       329 ~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg  408 (507)
T PLN03224        329 GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYG  408 (507)
T ss_pred             CeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcC
Confidence            3899999999999999999999999999766544333333  3478999999875322                    10


Q ss_pred             -CCccceeeehhHHHHHhhCCC-CCCCCC-----------hHHHHHHHhcCccCCC--CCCChhhhcccccccCCCC---
Q 017029           59 -GPEVDVWSCGVILYALLCGTL-PFDDEN-----------IPNLFKKIKGGIYTLP--SHLSPGARDLIPRMLIVDP---  120 (379)
Q Consensus        59 -~~~~DiWSlGvilyelltG~~-Pf~~~~-----------~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~mL~~dP---  120 (379)
                       ...+|+||+||++|+|++|.. ||.+..           ....++.+....+.++  ...++.+++|+.+||..+|   
T Consensus       409 ~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~  488 (507)
T PLN03224        409 RPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLLDRNKEAGWDLACKLITKRDQAN  488 (507)
T ss_pred             CCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccccccChHHHHHHHHHhccCCCCc
Confidence             124799999999999999876 775421           1122233333444443  4678999999999999876   


Q ss_pred             CCCCChhhhhcCchhhh
Q 017029          121 MKRITIPEIRQHPWFQA  137 (379)
Q Consensus       121 ~~Rpt~~ell~hp~f~~  137 (379)
                      .+|+|++|+|+||||..
T Consensus       489 ~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        489 RGRLSVGQALSHRFFLP  505 (507)
T ss_pred             ccCCCHHHHhCCCCcCC
Confidence            68999999999999964

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.81  E-value=2.2e-20  Score=175.98  Aligned_cols=130  Identities=26%  Similarity=0.471  Sum_probs=107.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||+++.++.++++|||++.......  ......+++.|+|||.+.+..+ +.++||||+|+++|++++ |.
T Consensus       138 i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~  216 (275)
T cd05046         138 FVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGE  216 (275)
T ss_pred             cccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            7999999999999999999999999987543222  1223456778999999887665 789999999999999998 88


Q ss_pred             CCCCCCChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           79 LPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .||.+.........+..+..  ..+..++..+.+++.+||..||.+|||+.+++..
T Consensus       217 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         217 LPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCccccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            99988777777777765553  3456788999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.81  E-value=2.4e-20  Score=176.76  Aligned_cols=128  Identities=22%  Similarity=0.311  Sum_probs=100.2

Q ss_pred             CEEecCCCCCCeEEcCCC-------cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKW-------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-------~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      .|+||||||+|||++..+       .+|++|||++......   ....++..|+|||.+.+....+.++|+||+||++|+
T Consensus       137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~e  213 (274)
T cd05076         137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLE  213 (274)
T ss_pred             CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHH
Confidence            479999999999997644       3899999988654322   234578889999998764444789999999999999


Q ss_pred             Hh-hCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           74 LL-CGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        74 ll-tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ++ +|..||.+........ ........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus       214 l~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         214 ICFDGEVPLKERTPSEKER-FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHhCCCCCccccChHHHHH-HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            95 6999998766554433 2233345566667889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.81  E-value=2.6e-20  Score=173.23  Aligned_cols=127  Identities=21%  Similarity=0.263  Sum_probs=99.0

Q ss_pred             CEEecCCCCCCeEEcCCC-------cEEEEecCCcccccCCcccccccCCCCccCcccccCC-CCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLLDSKW-------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-------~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+|||++.++       .+||+|||++.....   .....++..|+|||++.+. ...+.++|+||+||++|
T Consensus       121 ~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~  197 (259)
T cd05037         121 KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLL  197 (259)
T ss_pred             CeecccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHH
Confidence            389999999999999887       899999999887543   2234577889999998876 23378999999999999


Q ss_pred             HHhh-CCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           73 ALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        73 ellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      +|++ |..||...+......... .....+......+.+++.+||..+|.+|||+.++++
T Consensus       198 ~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         198 EICSNGEEPLSTLSSSEKERFYQ-DQHRLPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHhCCCCCcccCCchhHHHHHh-cCCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            9999 688887765443333322 222233333488999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=2.1e-20  Score=199.57  Aligned_cols=133  Identities=32%  Similarity=0.588  Sum_probs=106.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-------------------CCcccccccCCCCccCcccccCCC--CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-------------------DGHFLKTSCGSPNYAAPEVISGKL--YAG   59 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-------------------~~~~~~~~~gt~~y~APE~l~~~~--~~~   59 (379)
                      .||||||||.||+++++++|||+|||+++...                   +....+..+||..|+|||++.+..  .++
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            48999999999999999999999999997611                   011335568999999999998766  348


Q ss_pred             CccceeeehhHHHHHhhCCCCCCCC-ChHHHHHHHhcCccCCCCC----CChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           60 PEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        60 ~~~DiWSlGvilyelltG~~Pf~~~-~~~~~~~~i~~~~~~~p~~----~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      .|+|+||||||++||+.   ||... ....+..++..+..+.|+.    --+..+.+|+.||+.||.+|||+.|+|++.|
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~l  873 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSEL  873 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccC
Confidence            89999999999999984   56543 3344566777777666632    2345678999999999999999999999998


Q ss_pred             hh
Q 017029          135 FQ  136 (379)
Q Consensus       135 f~  136 (379)
                      |.
T Consensus       874 lp  875 (1351)
T KOG1035|consen  874 LP  875 (1351)
T ss_pred             CC
Confidence            75

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.80  E-value=3.6e-20  Score=185.94  Aligned_cols=131  Identities=27%  Similarity=0.415  Sum_probs=106.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......   ..+..+++.|+|||.+.+..+ +.++|+||+||++|||++ 
T Consensus       259 ~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~  337 (401)
T cd05107         259 NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTL  337 (401)
T ss_pred             CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHc
Confidence            379999999999999999999999999986533221   123457789999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHH-HHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNL-FKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~-~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||......+. ...+..+ ....|..++.++.+++.+||..+|.+||++++|++.
T Consensus       338 g~~P~~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         338 GGTPYPELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCCCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8999987554443 3334443 234567789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.80  E-value=3.5e-20  Score=199.46  Aligned_cols=131  Identities=27%  Similarity=0.384  Sum_probs=100.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-------------------ccccccCCCCccCcccccCCCCCCCc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------------FLKTSCGSPNYAAPEVISGKLYAGPE   61 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-------------------~~~~~~gt~~y~APE~l~~~~~~~~~   61 (379)
                      .|+||||||+|||++.++.+||+|||++.......                   .....+||+.|+|||++.+..+ +.+
T Consensus       133 GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~k  211 (932)
T PRK13184        133 GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SES  211 (932)
T ss_pred             CccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcH
Confidence            48999999999999999999999999997652100                   0112469999999999988776 789


Q ss_pred             cceeeehhHHHHHhhCCCCCCCCChHHHHHHH-hcCccC--CCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           62 VDVWSCGVILYALLCGTLPFDDENIPNLFKKI-KGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        62 ~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i-~~~~~~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +||||+||++|+|++|..||............ ......  ....+++.+.+++.+||..||.+|++..+.+.+
T Consensus       212 SDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        212 TDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999875544332221 111111  113578889999999999999999876655544

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.79  E-value=1.2e-20  Score=189.64  Aligned_cols=130  Identities=32%  Similarity=0.574  Sum_probs=116.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCC--CCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt--~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      +.|||||...|||+.+...|||+|||+|+.+.+....+.+.|.  .-|||||.+.-..+ +.++|||-|||++||++. |
T Consensus       511 rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lG  589 (974)
T KOG4257|consen  511 RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLG  589 (974)
T ss_pred             chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhc
Confidence            4799999999999999999999999999999988877776665  46999999988777 789999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+-...+..-.|.+| ..+.|+.+++.+..|+.+||.+||.+||++.||..
T Consensus       590 vkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  590 VKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             CCccccccccceEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            9999998777776677666 46889999999999999999999999999988754

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.79  E-value=7.2e-20  Score=173.39  Aligned_cols=130  Identities=26%  Similarity=0.401  Sum_probs=98.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc----ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~----~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++.........    ....++..|+|||++.+..+ +.++|+||+||++|+|++
T Consensus       128 ~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~  206 (284)
T cd05081         128 RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFT  206 (284)
T ss_pred             CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhh
Confidence            3799999999999999999999999999876443221    11223456999999987766 789999999999999999


Q ss_pred             CCCCCCCCChH----------------HHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIP----------------NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~----------------~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..|+......                .+...+..+ ..+.+..++.++.+++.+||..+|++|||+.++++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         207 YSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             cCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            87765432111                011111111 23445678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.79  E-value=1e-19  Score=191.47  Aligned_cols=130  Identities=31%  Similarity=0.542  Sum_probs=110.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc--cccCC--CCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~--~~~gt--~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      ++|||||.+.|||+..+..+||+|||+++...+.....  ...|+  ..|||||.+....| +.++||||+||+|||+.+
T Consensus       438 ~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~Eifs  516 (609)
T KOG0200|consen  438 PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFT  516 (609)
T ss_pred             CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhh
Confidence            47999999999999999999999999999765544443  22332  35999999998766 789999999999999999


Q ss_pred             -CCCCCCCCC-hHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDEN-IPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~-~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+-. ..++++.+..|. ...|.+++.++.++++.||+.+|++||++.++.+
T Consensus       517 LG~~PYp~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  517 LGGTPYPGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence             999999855 667777777775 4788999999999999999999999999998874

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.79  E-value=4.5e-20  Score=191.77  Aligned_cols=137  Identities=30%  Similarity=0.442  Sum_probs=114.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccC-----CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilyel   74 (379)
                      +|||||+|-.|||++.+|.||++|||++...+.. ....|+.|||.|||||++.-     ..| +..+|+||||++..||
T Consensus       143 kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~ty-d~R~D~WsLGITaIEl  221 (953)
T KOG0587|consen  143 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATY-DYRSDLWSLGITAIEM  221 (953)
T ss_pred             ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCc-ccccchhhccceeehh
Confidence            5899999999999999999999999999887654 34568899999999999953     223 5789999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCcc-C--CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIY-T--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .-|.+|+-+.......-+|-+... +  -|..++.++.++|..||.+|-.+||+..++++|||+++.
T Consensus       222 adG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  222 AEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             cCCCCCccCcchhhhhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence            999999988877655444433322 1  245688999999999999999999999999999999843

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.78  E-value=1.4e-19  Score=161.45  Aligned_cols=93  Identities=33%  Similarity=0.561  Sum_probs=77.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC----CCCCCCccceeeehhHHHHHhhC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiWSlGvilyelltG   77 (379)
                      |||||+||.|||++.+|++|+||||+|..+.+.--.+...|...|+|||.+..    +.| +-++||||||+++.||.++
T Consensus       170 vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~l  248 (282)
T KOG0984|consen  170 VIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAIL  248 (282)
T ss_pred             hhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhc
Confidence            79999999999999999999999999998877654444678899999998853    345 6899999999999999999


Q ss_pred             CCCCCCC-ChHHHHHHHhc
Q 017029           78 TLPFDDE-NIPNLFKKIKG   95 (379)
Q Consensus        78 ~~Pf~~~-~~~~~~~~i~~   95 (379)
                      +.||+.. ++.++.+++..
T Consensus       249 r~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  249 RFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             cccccccCCHHHHHHHHhc
Confidence            9999763 44455555543

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.77  E-value=2.2e-19  Score=169.33  Aligned_cols=130  Identities=27%  Similarity=0.425  Sum_probs=100.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc----ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~----~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.++|+|||++.........    ....++..|+|||.+.+..+ +.++|+||+|+++|+|++
T Consensus       129 ~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~t  207 (284)
T cd05038         129 RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFT  207 (284)
T ss_pred             CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeec
Confidence            3799999999999999999999999999876533211    12234567999999887766 789999999999999999


Q ss_pred             CCCCCCCCChH---------------HHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIP---------------NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~---------------~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||......               .....+..+ ..+.+..++.++.+++.+||..+|.+|||+.|+++
T Consensus       208 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         208 YGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             cCCCcccccchhccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99998653221               112222222 23445567889999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=1e-19  Score=168.15  Aligned_cols=138  Identities=31%  Similarity=0.493  Sum_probs=110.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||.|+|+++|..+||||||+++.....+  .++..+-|.+|+|||++.|...++.++||||.|||+.|++..+
T Consensus       176 ~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRr  255 (449)
T KOG0664|consen  176 NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRK  255 (449)
T ss_pred             chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhh
Confidence            48999999999999999999999999998765433  2334466789999999998777789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhc-----------------------CccCCC-----------CCCChhhhcccccccCCCCCCCC
Q 017029           79 LPFDDENIPNLFKKIKG-----------------------GIYTLP-----------SHLSPGARDLIPRMLIVDPMKRI  124 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~-----------------------~~~~~p-----------~~~s~~~~~Li~~mL~~dP~~Rp  124 (379)
                      .-|...+..+..+-|..                       +....|           ..-..+..+++.++|.+||.+|+
T Consensus       256 ILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri  335 (449)
T KOG0664|consen  256 ILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI  335 (449)
T ss_pred             hhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc
Confidence            99988776555544421                       111112           12334667899999999999999


Q ss_pred             ChhhhhcCchhhhc
Q 017029          125 TIPEIRQHPWFQAH  138 (379)
Q Consensus       125 t~~ell~hp~f~~~  138 (379)
                      +.++.+.|++..+.
T Consensus       336 s~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  336 SVEEALQHRYLEEG  349 (449)
T ss_pred             cHhhhccccccccc
Confidence            99999999998765

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.77  E-value=2.9e-19  Score=176.72  Aligned_cols=130  Identities=30%  Similarity=0.491  Sum_probs=96.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-Ccccccc-cCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~-~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      +||||||||+|||||++.+.||+|||+++.... .....+. .||..|+|||++..+.. +.++|||||||++.|+++|+
T Consensus       197 ~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr  275 (361)
T KOG1187|consen  197 PIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGR  275 (361)
T ss_pred             CEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCC
Confidence            599999999999999999999999999976654 4333444 89999999999987555 78999999999999999999


Q ss_pred             CCCCCCC------hHHHH-HHHhcCcc------CCC-CCCC--hh---hhcccccccCCCCCCCCChhhhhc
Q 017029           79 LPFDDEN------IPNLF-KKIKGGIY------TLP-SHLS--PG---ARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~------~~~~~-~~i~~~~~------~~p-~~~s--~~---~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .|.+...      ..+.. ..+..+..      .+. ...+  ..   +..+..+|++.+|.+||++.|+.+
T Consensus       276 ~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  276 KAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            8887432      12211 12222211      111 1222  12   446778899999999999999743

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.77  E-value=3e-19  Score=179.60  Aligned_cols=128  Identities=28%  Similarity=0.534  Sum_probs=112.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCC---CCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS---PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt---~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      +|||||...|+|+.++..||++|||+++.|+... ++...|.   .-|.|||-+.-..+ +.++|||+|||+|||+.| |
T Consensus       386 FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT-YTAHAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYG  463 (1157)
T KOG4278|consen  386 FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYG  463 (1157)
T ss_pred             hhhhhhhhhhccccccceEEeeccchhhhhcCCc-eecccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcC
Confidence            6899999999999999999999999999997543 3444443   47999999887766 689999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      -.||.+-+..+++.-+.++. ..-|+.|++.+.+|+..||+++|.+||+++|+-+
T Consensus       464 MsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  464 MSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             CCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            99999999999888887764 4668999999999999999999999999999854

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.76  E-value=3e-19  Score=181.70  Aligned_cols=136  Identities=27%  Similarity=0.432  Sum_probs=117.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccC----CCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG----SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~g----t~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      ++|||||...|||+.....|||||||+.+.+..++-.....+    ...|.|||.+....+ +.++|+|++||++|||++
T Consensus       232 rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFt  310 (1039)
T KOG0199|consen  232 RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFT  310 (1039)
T ss_pred             hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhc
Confidence            469999999999999999999999999998876554333322    347999999998888 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                       |+.||.|.....+.++|..+. .+-|..+++++.+++..||..+|.+|||+..|.+.-+..+
T Consensus       311 yGEePW~G~~g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l~e  373 (1039)
T KOG0199|consen  311 YGEEPWVGCRGIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE  373 (1039)
T ss_pred             cCCCCCCCCCHHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence             999999999999999997554 5678899999999999999999999999999976655543

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.76  E-value=4.2e-19  Score=172.88  Aligned_cols=140  Identities=34%  Similarity=0.573  Sum_probs=109.6

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccCC---CCCCCccceee
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGK---LYAGPEVDVWS   66 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~---~~~~~~~DiWS   66 (379)
                      +|||-||||.|||+-.   .|.+||+|||++++|.+...        .....||-+|++||.+.-.   .-.+.++||||
T Consensus       590 PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWS  669 (775)
T KOG1151|consen  590 PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWS  669 (775)
T ss_pred             CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEe
Confidence            6999999999999954   48899999999999865432        2345799999999987532   22367999999


Q ss_pred             ehhHHHHHhhCCCCCCCCChH-HHHH--HH-hcCccCCC--CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           67 CGVILYALLCGTLPFDDENIP-NLFK--KI-KGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        67 lGvilyelltG~~Pf~~~~~~-~~~~--~i-~~~~~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      .|||+|.++.|+.||...... ++.+  -| ......+|  +.++.++++||++||++--++|..+.++-.||+|..+..
T Consensus       670 vGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~r  749 (775)
T KOG1151|consen  670 VGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHIR  749 (775)
T ss_pred             eehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchhh
Confidence            999999999999999764322 2221  12 22233444  578999999999999999999999999999999976543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.76  E-value=1.2e-19  Score=186.49  Aligned_cols=130  Identities=28%  Similarity=0.498  Sum_probs=114.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCC--CCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGS--PNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt--~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|||||...|||++++..+|++|||+|+...++.  ..++..|.  ..|.|||.|.-..+ +.++||||+|+++||.++ 
T Consensus       752 YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSy  830 (996)
T KOG0196|consen  752 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSY  830 (996)
T ss_pred             chhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc-CchhhccccceEEEEeccc
Confidence            4899999999999999999999999999886653  22333343  58999999998887 789999999999999987 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..+..+.|..+. .+.|..++..+.+|+..||++|-..||++.+|+.+
T Consensus       831 GERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  831 GERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             CCCcccccchHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            999999999999999998774 46667899999999999999999999999998874

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.74  E-value=4.3e-19  Score=178.61  Aligned_cols=130  Identities=28%  Similarity=0.396  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccccccc-CCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~-gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      .+|||||-.+|+|++.++.+||+|||+|+.-..-......+ -...|+|||.+....| ++++||||+||++||+.+ |.
T Consensus       282 ~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~  360 (474)
T KOG0194|consen  282 NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGA  360 (474)
T ss_pred             CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCC
Confidence            37999999999999999999999999987654222222222 3458999999998877 899999999999999998 89


Q ss_pred             CCCCCCChHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .||.+....++..+|....  .+.|...+..+..++.+||..||++|||+.++.+
T Consensus       361 ~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  361 EPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             CCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            9999999999999994433  3556778899999999999999999999998864

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.72  E-value=2.8e-18  Score=155.20  Aligned_cols=137  Identities=27%  Similarity=0.503  Sum_probs=112.7

Q ss_pred             EEecCCCCCCeEEcCC-CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+|||+||.|++||.. ..++|+|+|++.+...+...+..+.+..|--||.+..-..+...-|+||+||++..|+..+-|
T Consensus       153 ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkep  232 (338)
T KOG0668|consen  153 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP  232 (338)
T ss_pred             cccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCc
Confidence            7899999999999974 679999999999998888888889999999999998777678899999999999999998877


Q ss_pred             C-CCCChHHHHHHHhcC-------------ccCCC------------------------CCCChhhhcccccccCCCCCC
Q 017029           81 F-DDENIPNLFKKIKGG-------------IYTLP------------------------SHLSPGARDLIPRMLIVDPMK  122 (379)
Q Consensus        81 f-~~~~~~~~~~~i~~~-------------~~~~p------------------------~~~s~~~~~Li~~mL~~dP~~  122 (379)
                      | .|.+..++.-+|.+-             ...++                        .-.++++.+|+.++|..|-.+
T Consensus       233 FFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqe  312 (338)
T KOG0668|consen  233 FFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQE  312 (338)
T ss_pred             ccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccc
Confidence            5 555544444443211             01111                        124689999999999999999


Q ss_pred             CCChhhhhcCchhhhc
Q 017029          123 RITIPEIRQHPWFQAH  138 (379)
Q Consensus       123 Rpt~~ell~hp~f~~~  138 (379)
                      |+|+.|++.||||...
T Consensus       313 RlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  313 RLTAKEAMAHPYFAPV  328 (338)
T ss_pred             ccchHHHhcCchHHHH
Confidence            9999999999999754

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.72  E-value=1e-18  Score=182.74  Aligned_cols=137  Identities=40%  Similarity=0.628  Sum_probs=113.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      |.|||||++|++++.+|.+||+|||.+..+...     ......+|+..|+|||++.+..|....+||||+|+++..|.+
T Consensus       441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~  520 (601)
T KOG0590|consen  441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMIL  520 (601)
T ss_pred             ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEec
Confidence            689999999999999999999999999876432     233566899999999999999999999999999999999999


Q ss_pred             CCCCCCCCChHHH---------HHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNL---------FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~---------~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |+.||......+.         ..++..+...+-..++...+.+|.+||++||.+|+|+++|++.+||+..
T Consensus       521 ~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  521 GRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSI  591 (601)
T ss_pred             CCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhc
Confidence            9999965332211         1122233333445678889999999999999999999999999999865

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.72  E-value=2e-18  Score=182.72  Aligned_cols=138  Identities=43%  Similarity=0.746  Sum_probs=119.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc--------CC-------ccc-ccccCCCCccCcccccCCCCCCCccce
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR--------DG-------HFL-KTSCGSPNYAAPEVISGKLYAGPEVDV   64 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~--------~~-------~~~-~~~~gt~~y~APE~l~~~~~~~~~~Di   64 (379)
                      .|+|||+||+|+||+.-|++|++|||+++...        .+       ++. +..||||.|.|||++..+.| |..+|+
T Consensus       163 givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdw  241 (1205)
T KOG0606|consen  163 GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDW  241 (1205)
T ss_pred             CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccH
Confidence            38999999999999999999999999987421        01       111 34599999999999999988 899999


Q ss_pred             eeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC---CCChhhhcccccccCCCCCCCC---ChhhhhcCchhhhc
Q 017029           65 WSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQAH  138 (379)
Q Consensus        65 WSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~Li~~mL~~dP~~Rp---t~~ell~hp~f~~~  138 (379)
                      |++|+|+|+.+.|..||.++..++++..+.......|+   .++++++++|.++|+.+|..|.   .+-++.+|+||+..
T Consensus       242 wamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  242 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             HHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            99999999999999999999999999999888877774   4788999999999999999997   45689999999864


Q ss_pred             c
Q 017029          139 L  139 (379)
Q Consensus       139 ~  139 (379)
                      .
T Consensus       322 D  322 (1205)
T KOG0606|consen  322 D  322 (1205)
T ss_pred             c
Confidence            3

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.70  E-value=4.8e-18  Score=173.74  Aligned_cols=124  Identities=35%  Similarity=0.557  Sum_probs=95.0

Q ss_pred             CEEecCCCCCCeEEcC--CC--cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDS--KW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~--~~--~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||.||++-.  +|  ..||+|||.|+...++....+.+||+.|.+||+.....+++..+|.||+||++|+++|
T Consensus       140 ~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caT  219 (732)
T KOG4250|consen  140 GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECAT  219 (732)
T ss_pred             CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhc
Confidence            5899999999999842  33  4799999999999999988999999999999999864555899999999999999999


Q ss_pred             CCCCCCCCChH-----HHHHHHh--------------cC------ccCCCCCCChhh----hcccccccCCCCCCCC
Q 017029           77 GTLPFDDENIP-----NLFKKIK--------------GG------IYTLPSHLSPGA----RDLIPRMLIVDPMKRI  124 (379)
Q Consensus        77 G~~Pf~~~~~~-----~~~~~i~--------------~~------~~~~p~~~s~~~----~~Li~~mL~~dP~~Rp  124 (379)
                      |..||......     ..+..+.              +|      .+++|.+++..+    -.++..+|..+|.+|-
T Consensus       220 G~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  220 GELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             cCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence            99999643221     2222221              11      123444555444    3567778999999998

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.70  E-value=1.1e-17  Score=178.12  Aligned_cols=134  Identities=34%  Similarity=0.566  Sum_probs=110.8

Q ss_pred             ecCCCCC-CeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            4 HRDLKPE-NLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         4 HrDLKpe-NILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      |++..|. |++++..+.+++.|||.++....+..   ..+.+||+.|+|||++.+..+ +.++||||+||++|||++|..
T Consensus       500 ~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~-~~~~DiwSlG~il~ElltG~~  578 (669)
T cd05610         500 TQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPH-GPAVDWWALGVCLFEFLTGIP  578 (669)
T ss_pred             CCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCC-CcHHHHHHHHHHHHHHHHCCC
Confidence            3455555 66777777789999999887654422   234589999999999998876 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCC---CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+......+..+....+..|   ..++..+.+++.+||..||.+|||+.++++||||...
T Consensus       579 pf~~~~~~~~~~~il~~~~~~p~~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~~~  640 (669)
T cd05610         579 PFNDETPQQVFQNILNRDIPWPEGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGV  640 (669)
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHhhcCC
Confidence            9999998888888876655544   3567889999999999999999999999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.67  E-value=1.7e-17  Score=166.31  Aligned_cols=130  Identities=25%  Similarity=0.438  Sum_probs=107.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccc---cCCCCccCcccccCCCCCCCccceeeehhHHHHHh--
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL--   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~---~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell--   75 (379)
                      .+|||||.+.|+|++.++++||+|||.++.+-.++..+..   +-...|||+|.+.-..+ +.++|+|++|+++||++  
T Consensus       657 nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~  735 (807)
T KOG1094|consen  657 NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFML  735 (807)
T ss_pred             chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHH
Confidence            3799999999999999999999999999977666654432   34568999998887777 78999999999999986  


Q ss_pred             hCCCCCCCCChHHHHHHHhc--------CccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKG--------GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |...||...+.++..++...        .....|.-++.++.+++.+||..|.++|||++++..
T Consensus       736 C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  736 CREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            58999998777766655422        123456789999999999999999999999999854

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.67  E-value=4.4e-17  Score=158.21  Aligned_cols=136  Identities=33%  Similarity=0.580  Sum_probs=98.0

Q ss_pred             EEecCCCCCCeEEcC-CCcEEEEecCCcccc-----------------cC--Cc---------------cc---------
Q 017029            2 VVHRDLKPENLLLDS-KWNVKIADFGLSNIM-----------------RD--GH---------------FL---------   37 (379)
Q Consensus         2 IiHrDLKpeNILl~~-~~~vKL~DFGls~~~-----------------~~--~~---------------~~---------   37 (379)
                      ||||||||.|+|.+. .+.-.|+|||++...                 ..  +.               ..         
T Consensus       153 IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~  232 (418)
T KOG1167|consen  153 IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPS  232 (418)
T ss_pred             ccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccc
Confidence            899999999999985 477899999998610                 00  00               00         


Q ss_pred             --ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCC--ChHHHHH-----------HH--hcCc---
Q 017029           38 --KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE--NIPNLFK-----------KI--KGGI---   97 (379)
Q Consensus        38 --~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~--~~~~~~~-----------~i--~~~~---   97 (379)
                        ....||++|+|||++....-.++++||||.|||+..++++..||-..  +...+.+           +.  ..|.   
T Consensus       233 ~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l  312 (418)
T KOG1167|consen  233 ERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILL  312 (418)
T ss_pred             eecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceee
Confidence              11259999999999988777788999999999999999999998321  1000000           00  0000   


Q ss_pred             ------------------------cC----------CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           98 ------------------------YT----------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        98 ------------------------~~----------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                                              +.          ..+..+..+.+|+.+||..||.+|+|++++|+||||.+
T Consensus       313 ~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  313 WQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             eccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence                                    00          00123457889999999999999999999999999973

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.66  E-value=4.2e-17  Score=180.33  Aligned_cols=127  Identities=23%  Similarity=0.303  Sum_probs=91.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++..++. ||........   .+..|++.|+|||++.+..+ +.++||||+||++|||++|+.|
T Consensus       803 ~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p  877 (968)
T PLN00113        803 AVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSP  877 (968)
T ss_pred             CeecCCCCHHhEEECCCCceEEE-eccccccccC---CCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCC
Confidence            48999999999999998888876 6655433221   23468899999999988777 7899999999999999999999


Q ss_pred             CCCCC-----hHHHHHHHhcC---------cc----CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           81 FDDEN-----IPNLFKKIKGG---------IY----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        81 f~~~~-----~~~~~~~i~~~---------~~----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |+...     ..+..+.....         ..    ..+.....++.+++.+||+.||.+|||++|+++.
T Consensus       878 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        878 ADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            96431     11111111000         00    0111112356789999999999999999999865

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.64  E-value=2.8e-17  Score=166.64  Aligned_cols=128  Identities=38%  Similarity=0.644  Sum_probs=115.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+|||+|++||+++.+|++++.|||+++..-+.+..   |||..|||||++.+.   ..++|.||+|++.++|++|..||
T Consensus       118 iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~gh---~~a~D~ws~gvl~felltg~~pf  191 (612)
T KOG0603|consen  118 IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIINGH---LSAADWWSFGVLAFELLTGTLPF  191 (612)
T ss_pred             HHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhhcc---CCcccchhhhhhHHHHhhCCCCC
Confidence            689999999999999999999999999987655432   999999999999832   57899999999999999999999


Q ss_pred             CCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhcc
Q 017029           82 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAHL  139 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~~  139 (379)
                      .+    ++...|.+.....|..++..+++++..++..+|.+|...     .|+++|+||+...
T Consensus       192 ~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~  250 (612)
T KOG0603|consen  192 GG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSID  250 (612)
T ss_pred             ch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeee
Confidence            98    677888888899999999999999999999999999864     6899999998764

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.61  E-value=3e-16  Score=151.24  Aligned_cols=130  Identities=22%  Similarity=0.404  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccc-cCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTS-CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~-~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|||.||...|.+||+...+||+|=.+|+-.-.++..  ... -....||+||.+....| +.++|+|||||++|||+| 
T Consensus       416 ~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtl  494 (563)
T KOG1024|consen  416 GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTL  494 (563)
T ss_pred             CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhc
Confidence            4899999999999999999999999999876544321  111 12457999999999988 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |+.|+..-++.+...-++.|. ...|-++++++..++..||..+|++||+++++..
T Consensus       495 g~~PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  495 GKLPYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             CCCCccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            999999999999888887774 4568899999999999999999999999999764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.61  E-value=4.9e-16  Score=160.81  Aligned_cols=130  Identities=28%  Similarity=0.459  Sum_probs=112.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccC--CCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCG--SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~g--t~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      ++|||||-..|||+.+-..+||.|||+++..... ..+.+..|  .+.|||=|.+....| +.++||||+||++||++| 
T Consensus       818 rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTF  896 (1177)
T KOG1025|consen  818 RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTF  896 (1177)
T ss_pred             chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhc
Confidence            4799999999999999999999999999987543 33333333  357999999988887 899999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..|+++....++-.-+..+. .+.|+.++-++.-++.+||..|++.||+++++-.
T Consensus       897 Ga~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  897 GAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             CCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            999999988888777766554 6778899999999999999999999999998764

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.61  E-value=1.6e-16  Score=156.30  Aligned_cols=130  Identities=25%  Similarity=0.418  Sum_probs=95.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCC-----CccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAG-----PEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~-----~~~DiWSlGvily   72 (379)
                      .|+|||||..|||+.+++++-|+|||++..+..+..   ....+||.+|||||++.|.....     .+.||||+|.+||
T Consensus       336 ~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLW  415 (534)
T KOG3653|consen  336 PIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLW  415 (534)
T ss_pred             ccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHH
Confidence            489999999999999999999999999988765432   23468999999999997643321     4689999999999


Q ss_pred             HHhhCCC------------CCCC-----CChHHHHHHH--hcCccCCCCC-----CChhhhcccccccCCCCCCCCChhh
Q 017029           73 ALLCGTL------------PFDD-----ENIPNLFKKI--KGGIYTLPSH-----LSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        73 elltG~~------------Pf~~-----~~~~~~~~~i--~~~~~~~p~~-----~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ||++...            ||..     ....++...+  .+..+.+|..     --..+++.+..||..||+.|+|+.-
T Consensus       416 Ei~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  416 EIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             HHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            9997532            3331     1222333333  2344555543     2345778999999999999999865


Q ss_pred             hh
Q 017029          129 IR  130 (379)
Q Consensus       129 ll  130 (379)
                      +.
T Consensus       496 v~  497 (534)
T KOG3653|consen  496 VE  497 (534)
T ss_pred             HH
Confidence            43

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.59  E-value=8.9e-16  Score=156.07  Aligned_cols=136  Identities=29%  Similarity=0.410  Sum_probs=108.8

Q ss_pred             EecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHHhhCC
Q 017029            3 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         3 iHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      +|||||-.|||+++.|.+|++|||.+..++.. ...+...|||.|||||+-.   ...| ...+|||++|+...|+.--+
T Consensus       134 ~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggy-nqlcdiwa~gitAiel~eLq  212 (829)
T KOG0576|consen  134 IHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWALGITAIELGELQ  212 (829)
T ss_pred             ccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccc-cccccccccccchhhhhhcC
Confidence            79999999999999999999999998776543 2335678999999999863   3344 78999999999999998888


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC-----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      +|-.+........-..+..+..|     ..+++.+.+|++.+|..+|++|||++.++.|||....+
T Consensus       213 pplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  213 PPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             CcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccch
Confidence            88555444443333333333333     46889999999999999999999999999999998654

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.55  E-value=1.9e-15  Score=147.74  Aligned_cols=129  Identities=24%  Similarity=0.410  Sum_probs=93.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-c----ccccccCCCCccCcccccCCCC----C-CCccceeeehhHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-H----FLKTSCGSPNYAAPEVISGKLY----A-GPEVDVWSCGVIL   71 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~----~~~~~~gt~~y~APE~l~~~~~----~-~~~~DiWSlGvil   71 (379)
                      |.|||||+.|||+.++|.+-|+|+|++-..... +    ..+..+||..|||||++...-.    . -..+||||||.++
T Consensus       337 IAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVl  416 (513)
T KOG2052|consen  337 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVL  416 (513)
T ss_pred             hhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHH
Confidence            789999999999999999999999999765433 1    2356799999999999864321    1 1468999999999


Q ss_pred             HHHhhC----------CCCCCCC-----ChHHHHHHH--hcCccCCCCCCC-----hhhhcccccccCCCCCCCCChhhh
Q 017029           72 YALLCG----------TLPFDDE-----NIPNLFKKI--KGGIYTLPSHLS-----PGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        72 yelltG----------~~Pf~~~-----~~~~~~~~i--~~~~~~~p~~~s-----~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||++..          ++||.+.     +.++..+-+  .+..+.+|..+.     ..+..+++.||..||.-|.|+-.+
T Consensus       417 WEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  417 WEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             HHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHH
Confidence            999852          5788652     233333222  233345554432     234578999999999999998665


Q ss_pred             h
Q 017029          130 R  130 (379)
Q Consensus       130 l  130 (379)
                      .
T Consensus       497 K  497 (513)
T KOG2052|consen  497 K  497 (513)
T ss_pred             H
Confidence            4

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.53  E-value=1.7e-15  Score=149.51  Aligned_cols=119  Identities=30%  Similarity=0.541  Sum_probs=88.6

Q ss_pred             CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCC----------h
Q 017029           17 KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN----------I   86 (379)
Q Consensus        17 ~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~----------~   86 (379)
                      +..|||+|||-+.....  ..+....|..|+||||+.|..| ++.+||||++|++|||+||..-|+..+          +
T Consensus       390 di~vKIaDlGNACW~~k--hFT~DIQTRQYRapEVllGsgY-~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHi  466 (590)
T KOG1290|consen  390 DIRVKIADLGNACWVHK--HFTEDIQTRQYRAPEVLLGSGY-STSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHI  466 (590)
T ss_pred             ceeEEEeeccchhhhhh--hhchhhhhhhccCcceeecCCC-CCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHH
Confidence            45799999999876422  2345577899999999999999 789999999999999999999885421          1


Q ss_pred             HHHHH---HH-----hcCc------------------------------cCCCCCCChhhhcccccccCCCCCCCCChhh
Q 017029           87 PNLFK---KI-----KGGI------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        87 ~~~~~---~i-----~~~~------------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ..+.+   ++     ..|.                              |.++..-..++.+|+.-||+++|++|||+.+
T Consensus       467 A~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~  546 (590)
T KOG1290|consen  467 ALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQ  546 (590)
T ss_pred             HHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHH
Confidence            11111   10     1111                              1222223456779999999999999999999


Q ss_pred             hhcCchhhhc
Q 017029          129 IRQHPWFQAH  138 (379)
Q Consensus       129 ll~hp~f~~~  138 (379)
                      +++|||+...
T Consensus       547 cl~hPwLn~~  556 (590)
T KOG1290|consen  547 CLKHPWLNPV  556 (590)
T ss_pred             HhcCccccCC
Confidence            9999999865

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.51  E-value=9.2e-15  Score=129.30  Aligned_cols=102  Identities=54%  Similarity=0.872  Sum_probs=86.9

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .++|+||+|.||+++. ++.++|+|||.+....... ......+...|++||.+.+....+.+.|+|++|++++++    
T Consensus       112 ~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----  187 (215)
T cd00180         112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----  187 (215)
T ss_pred             CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----
Confidence            4799999999999999 8999999999998765432 123355788999999987762337899999999999998    


Q ss_pred             CCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                                                 ..+.+++.+|+..||.+||++.++++|+
T Consensus       188 ---------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                       6788999999999999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.48  E-value=5.4e-15  Score=147.63  Aligned_cols=130  Identities=29%  Similarity=0.488  Sum_probs=101.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-------ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .+|||+||.||+...+..+||+|||+...+....       ..+...||..||+||.+.+..| +.++||||||+||+|+
T Consensus       377 ~ihrdlkp~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL  455 (516)
T KOG1033|consen  377 LIHRDLKPSNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAEL  455 (516)
T ss_pred             chhhhccccccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHH
Confidence            5799999999999999999999999988775544       3456689999999999999988 8999999999999999


Q ss_pred             hh-CCCCCCCCChHHHHHHHhcCccCCCC-CCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           75 LC-GTLPFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        75 lt-G~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      +. -..+|.   ....+..+..+.++.-. .-.+.-..|+.+||...|.+||++.+.-.|+|.
T Consensus       456 ~~~f~T~~e---r~~t~~d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  456 LIQFSTQFE---RIATLTDIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             HHHhccHHH---HHHhhhhhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            97 333332   22334455555544111 113455699999999999999988877777764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.47  E-value=1.5e-14  Score=145.28  Aligned_cols=80  Identities=39%  Similarity=0.774  Sum_probs=74.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |||||||-||+.++.+|-+||+|||.+....++. ..+..||..|+|||++.|..|-|..-|||++|++||-++....||
T Consensus       691 ivhrdikdenvivd~~g~~klidfgsaa~~ksgp-fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  691 IVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGP-FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             ceecccccccEEEecCCeEEEeeccchhhhcCCC-cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            8999999999999999999999999998876665 468899999999999999999999999999999999999999988


Q ss_pred             C
Q 017029           82 D   82 (379)
Q Consensus        82 ~   82 (379)
                      .
T Consensus       770 y  770 (772)
T KOG1152|consen  770 Y  770 (772)
T ss_pred             c
Confidence            5

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.47  E-value=5.9e-14  Score=130.75  Aligned_cols=136  Identities=40%  Similarity=0.661  Sum_probs=108.5

Q ss_pred             EEecCCCCCCeEEcCCC-cEEEEecCCcccccCCc-------ccccccCCCCccCcccccCC--CCCCCccceeeehhHH
Q 017029            2 VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGH-------FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGVIL   71 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~-------~~~~~~gt~~y~APE~l~~~--~~~~~~~DiWSlGvil   71 (379)
                      ++|||+||+||+++..+ .++++|||.+.......       .....+|+..|+|||.+.+.  .+.+...|+||+|+++
T Consensus       122 ~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~  201 (384)
T COG0515         122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITL  201 (384)
T ss_pred             eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHH
Confidence            79999999999999988 79999999998654432       34677899999999999874  3457899999999999


Q ss_pred             HHHhhCCCCCCCCCh----HHHHHHHhcCccC-CCCCCC--------hhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           72 YALLCGTLPFDDENI----PNLFKKIKGGIYT-LPSHLS--------PGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        72 yelltG~~Pf~~~~~----~~~~~~i~~~~~~-~p~~~s--------~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      +++++|..||.....    ......+.....+ ......        ..+.+++.+++..+|..|.+..+...+++...
T Consensus       202 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         202 YELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             HHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            999999999887763    4555555444433 222222        46889999999999999999999998866654

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.45  E-value=3.1e-14  Score=131.91  Aligned_cols=133  Identities=32%  Similarity=0.494  Sum_probs=93.6

Q ss_pred             EEecCCCCCCeEEcC--CCcEEEEecCCcccccCCcccccccCCCCccCcccccC----CCCCCCccceeeehhHHHHHh
Q 017029            2 VVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG----KLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         2 IiHrDLKpeNILl~~--~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~----~~~~~~~~DiWSlGvilyell   75 (379)
                      +||||||.+||||-.  ...|||||||++...+.  .....--+..|.|||+...    +....+.+|+|.||+++|.++
T Consensus       142 lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cl  219 (378)
T KOG1345|consen  142 LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCL  219 (378)
T ss_pred             hhhcccccceEEEecCCccEEEeeecccccccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeee
Confidence            799999999999943  34899999999876532  2222334568999997642    222467899999999999999


Q ss_pred             hCCCCCCCCChH----HHHHHHhc-CccCCCC---CCChhhhcccccccCCCCCCCC---ChhhhhcCchhh
Q 017029           76 CGTLPFDDENIP----NLFKKIKG-GIYTLPS---HLSPGARDLIPRMLIVDPMKRI---TIPEIRQHPWFQ  136 (379)
Q Consensus        76 tG~~Pf~~~~~~----~~~~~i~~-~~~~~p~---~~s~~~~~Li~~mL~~dP~~Rp---t~~ell~hp~f~  136 (379)
                      +|.+||......    .-+.+..+ .....|.   .+++.+..+.++-|..+|++|-   +++..+...|..
T Consensus       220 tG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E  291 (378)
T KOG1345|consen  220 TGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKE  291 (378)
T ss_pred             cCCCcchhhhccCchHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHH
Confidence            999999753322    11223322 2334453   4788999999999999999994   444455555654

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.45  E-value=8.1e-14  Score=126.02  Aligned_cols=99  Identities=51%  Similarity=0.759  Sum_probs=81.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccc-cCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVI-SGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l-~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .++|+||+|.||+++.++.++|+|||.+.......  ......++..|++||.+ ....+ +.++|+|++|+++|+|++|
T Consensus       118 ~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g  196 (225)
T smart00221      118 GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWG  196 (225)
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHC
Confidence            47999999999999999999999999998775542  33456788899999998 44444 5699999999999999999


Q ss_pred             CCCCCC--CChHHHHHHHhcCccCC
Q 017029           78 TLPFDD--ENIPNLFKKIKGGIYTL  100 (379)
Q Consensus        78 ~~Pf~~--~~~~~~~~~i~~~~~~~  100 (379)
                      +.||..  .+...+.+.+..+....
T Consensus       197 ~~pf~~~~~~~~~~~~~~~~~~~~~  221 (225)
T smart00221      197 PEPFSGEGEFTSLLSDVWSFGVPLL  221 (225)
T ss_pred             CCCccccchhHHHHHHHHhcCCccc
Confidence            999987  44557777887776443

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.39  E-value=2.4e-14  Score=136.46  Aligned_cols=116  Identities=29%  Similarity=0.393  Sum_probs=75.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC-------CCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-------LYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~-------~~~~~~~DiWSlGvilyel   74 (379)
                      |||+||+|+|++++.+|.+.|+||+.....  +........+..|.+||.....       ...+.+.|.|++|+++|.|
T Consensus       166 lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~--g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~l  243 (288)
T PF14531_consen  166 LVHGDIKPENFLLDQDGGVFLGDFSSLVRA--GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSL  243 (288)
T ss_dssp             EEEST-SGGGEEE-TTS-EEE--GGGEEET--TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHH
T ss_pred             eEecccceeeEEEcCCCCEEEcChHHHeec--CceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHH
Confidence            899999999999999999999999866543  3322223445789999976432       1236789999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCC
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~R  123 (379)
                      +||..||...........   .--... .+++.++.||.++|+.||.+|
T Consensus       244 WC~~lPf~~~~~~~~~~~---~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  244 WCGRLPFGLSSPEADPEW---DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHSS-STCCCGGGSTSGG---GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             HHccCCCCCCCccccccc---cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            999999986543221110   011223 778999999999999999988

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.31  E-value=6.6e-13  Score=141.71  Aligned_cols=122  Identities=31%  Similarity=0.447  Sum_probs=91.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc---cCC--c---ccccccCCCCccCcccccCCC----------CCCCcc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDG--H---FLKTSCGSPNYAAPEVISGKL----------YAGPEV   62 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~---~~~--~---~~~~~~gt~~y~APE~l~~~~----------~~~~~~   62 (379)
                      .|+|+|||.|||||++=+.+.|+||..-+..   .+.  +   +..|+.....|.|||.+....          .-+++-
T Consensus       140 gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paM  219 (1431)
T KOG1240|consen  140 GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAM  219 (1431)
T ss_pred             CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhh
Confidence            3899999999999999999999999765432   111  1   123334445899999886422          125789


Q ss_pred             ceeeehhHHHHHhh-CCCCCCC-----------CChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           63 DVWSCGVILYALLC-GTLPFDD-----------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        63 DiWSlGvilyellt-G~~Pf~~-----------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||||+||++.|+++ |++||.-           .+.+...++|          -+..+++||..|++.||++|.++++.|
T Consensus       220 DIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL  289 (1431)
T KOG1240|consen  220 DIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYL  289 (1431)
T ss_pred             hhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHH
Confidence            99999999999998 8999952           1222223332          245889999999999999999999998


Q ss_pred             cC
Q 017029          131 QH  132 (379)
Q Consensus       131 ~h  132 (379)
                      +.
T Consensus       290 ~~  291 (1431)
T KOG1240|consen  290 QK  291 (1431)
T ss_pred             Hh
Confidence            86

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=6.3e-13  Score=139.42  Aligned_cols=136  Identities=43%  Similarity=0.739  Sum_probs=111.9

Q ss_pred             EEecCCCCCCeEEcCCC-cEEEEecCCcccccC--C--cccccccC-CCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            2 VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRD--G--HFLKTSCG-SPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~--~--~~~~~~~g-t~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      +.|||+||+|.+++..+ .+|++|||++.....  +  ..+...|| ++.|+|||...+..|.++..|+||+|+++..++
T Consensus       145 ~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~  224 (601)
T KOG0590|consen  145 VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAML  224 (601)
T ss_pred             cccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccc
Confidence            67999999999999999 999999999987765  2  23455689 999999999999888899999999999999999


Q ss_pred             hCCCCCCCCChHHH--HHHHhc-C--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           76 CGTLPFDDENIPNL--FKKIKG-G--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        76 tG~~Pf~~~~~~~~--~~~i~~-~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      +|..|+........  ...+.. +  .......++....+++.+++..+|..|.+.+++..+||+..
T Consensus       225 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  225 TGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cCCCCccccccccccceeecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence            99999875433221  111111 1  23344678899999999999999999999999999999987

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.22  E-value=9.5e-12  Score=120.83  Aligned_cols=127  Identities=28%  Similarity=0.396  Sum_probs=92.6

Q ss_pred             CEEecCCCCCCeEEc--CCC--cEEEEecCCcccccCCc-------ccccccCCCCccCcccccCCCC-----CCCccce
Q 017029            1 MVVHRDLKPENLLLD--SKW--NVKIADFGLSNIMRDGH-------FLKTSCGSPNYAAPEVISGKLY-----AGPEVDV   64 (379)
Q Consensus         1 ~IiHrDLKpeNILl~--~~~--~vKL~DFGls~~~~~~~-------~~~~~~gt~~y~APE~l~~~~~-----~~~~~Di   64 (379)
                      .|.|||||.+|||+.  .++  .+.|+|||.+-.-....       ..-...|...-||||+.....-     .-.++|.
T Consensus       361 gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~  440 (598)
T KOG4158|consen  361 GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADT  440 (598)
T ss_pred             cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhh
Confidence            378999999999984  333  58999999874322211       0112347778899999864221     1248999


Q ss_pred             eeehhHHHHHhhCCCCCCCCChHHH--HHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChh
Q 017029           65 WSCGVILYALLCGTLPFDDENIPNL--FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP  127 (379)
Q Consensus        65 WSlGvilyelltG~~Pf~~~~~~~~--~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~  127 (379)
                      |++|.+.||+++...||.+.....+  ..--......+|+.+++.+++++..+|+.||++|++..
T Consensus       441 WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  441 WAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             hhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence            9999999999999999987443322  11112345678899999999999999999999999854

>PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.11  E-value=9.4e-11  Score=81.21  Aligned_cols=44  Identities=36%  Similarity=0.697  Sum_probs=39.5

Q ss_pred             ceEEEEEEEEeec-CCceeeeeccccCCceehHHHHHHHHHHHhc
Q 017029          335 NVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV  378 (379)
Q Consensus       335 ~~~~~~lQLYk~~-~~~YLlDf~~~~g~~~~f~~~c~~~i~~L~~  378 (379)
                      ..|+|+||+||++ .+.|.|||||++|+++.|.++|++++++|++
T Consensus         3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~il~~l~L   47 (47)
T PF02149_consen    3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSKILNELRL   47 (47)
T ss_dssp             C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHHHHHHTT-
T ss_pred             cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHHHHHHccC
Confidence            3599999999998 8899999999999999999999999999974

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.08  E-value=9.7e-11  Score=125.20  Aligned_cols=140  Identities=34%  Similarity=0.570  Sum_probs=118.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc------CC--------------------------cccccccCCCCccCc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR------DG--------------------------HFLKTSCGSPNYAAP   49 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~------~~--------------------------~~~~~~~gt~~y~AP   49 (379)
                      ++|||++|.|+|...+|+.+++|||+.....      +.                          ..-....||+.|.+|
T Consensus       925 r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen  925 RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred             hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence            6899999999999999999999998422110      00                          001223689999999


Q ss_pred             ccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCC---CCCChhhhcccccccCCCCCCCCCh
Q 017029           50 EVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITI  126 (379)
Q Consensus        50 E~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~mL~~dP~~Rpt~  126 (379)
                      |...+... +..+|+|+.|+++++.++|.+||.+.....+++.|.++..+.|   ...+.++++++.+.|..+|.+|.++
T Consensus      1005 e~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a 1083 (1205)
T KOG0606|consen 1005 EILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGA 1083 (1205)
T ss_pred             cccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCc
Confidence            99998876 7899999999999999999999999999999999998887766   4578999999999999999999998


Q ss_pred             h---hhhcCchhhhccCcc
Q 017029          127 P---EIRQHPWFQAHLPRY  142 (379)
Q Consensus       127 ~---ell~hp~f~~~~~~~  142 (379)
                      .   ++..|+||+...+..
T Consensus      1084 ~~~~e~k~~~~~~~~~~~~ 1102 (1205)
T KOG0606|consen 1084 KGAAEVKGHPFFQDVDWEN 1102 (1205)
T ss_pred             ccccccccCCccCCCCccc
Confidence            7   999999999765443

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=98.96  E-value=5e-10  Score=113.63  Aligned_cols=129  Identities=32%  Similarity=0.538  Sum_probs=96.7

Q ss_pred             EecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCCC------CCCccceeeehhHHHH
Q 017029            3 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY------AGPEVDVWSCGVILYA   73 (379)
Q Consensus         3 iHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~------~~~~~DiWSlGvilye   73 (379)
                      .|+.|++.|.++|..-.+||+|||+.......   .......-...|.|||.+.+...      .+.+.|+||+|+++||
T Consensus        71 ~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   71 YHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            79999999999999999999999998876421   11112223457999999987422      2567999999999999


Q ss_pred             HhhCCCCCCCC----ChHHHHHHHhc-CccCC-CC-----CCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           74 LLCGTLPFDDE----NIPNLFKKIKG-GIYTL-PS-----HLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        74 lltG~~Pf~~~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      +++...||+..    ...++...+.+ +...+ |.     ...+++..++.+||.-+|.+||+++++..
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            99999999762    23355555655 33222 11     34557889999999999999999998765

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.92  E-value=1.1e-09  Score=106.70  Aligned_cols=129  Identities=23%  Similarity=0.310  Sum_probs=88.1

Q ss_pred             EEecCCCCCCeEEcCC-----CcEEEEecCCcc--ccc-CCc----c----cccccCCCCccCcccccCCCCCCCcccee
Q 017029            2 VVHRDLKPENLLLDSK-----WNVKIADFGLSN--IMR-DGH----F----LKTSCGSPNYAAPEVISGKLYAGPEVDVW   65 (379)
Q Consensus         2 IiHrDLKpeNILl~~~-----~~vKL~DFGls~--~~~-~~~----~----~~~~~gt~~y~APE~l~~~~~~~~~~DiW   65 (379)
                      +|||||||+|+++...     ..+.|.|||+++  ... ...    .    .....||..|+++.+..+... +.+.|+|
T Consensus       143 ~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDle  221 (322)
T KOG1164|consen  143 FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLE  221 (322)
T ss_pred             cccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhh
Confidence            6899999999999865     469999999998  321 111    0    112349999999999988877 8999999


Q ss_pred             eehhHHHHHhhCCCCCCCCChHHHHHHHh---cCccC--CCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           66 SCGVILYALLCGTLPFDDENIPNLFKKIK---GGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~~~~~~~~~~i~---~~~~~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |++-++.++..|.+||.+........++.   .....  .....+.++..+...+-..+...+|....+..
T Consensus       222 s~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~  292 (322)
T KOG1164|consen  222 SLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE  292 (322)
T ss_pred             hHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence            99999999999999997654322222221   11111  12233455556655555567777776665543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=98.84  E-value=1.8e-09  Score=100.62  Aligned_cols=119  Identities=24%  Similarity=0.333  Sum_probs=91.9

Q ss_pred             CCCCCCeEEcCCCcEEEE--ecCCcccccCCcccccccCCCCccCcccccCCCCC--CCccceeeehhHHHHHhhCCCCC
Q 017029            6 DLKPENLLLDSKWNVKIA--DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--GPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         6 DLKpeNILl~~~~~vKL~--DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~--~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      -|....+++|++.+.+|+  |--+|-.  .    ....-+|.|++||.++.+.-+  -.++|+|||++++||+.|...||
T Consensus       316 ~lns~hvmidedltarismad~kfsfq--e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpf  389 (448)
T KOG0195|consen  316 YLNSKHVMIDEDLTARISMADTKFSFQ--E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPF  389 (448)
T ss_pred             hcccceEEecchhhhheecccceeeee--c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhcccccc
Confidence            467778889888776654  3222211  1    122347899999999876542  35899999999999999999999


Q ss_pred             CCCChHHHHHHH--hcCccCCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           82 DDENIPNLFKKI--KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        82 ~~~~~~~~~~~i--~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      .+-+..+.--+|  ..-...+|+.++.....|++-|++-||.+||.+..+.
T Consensus       390 adlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  390 ADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             ccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            998888775555  3445688999999999999999999999999987654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.72  E-value=1.4e-08  Score=97.04  Aligned_cols=95  Identities=25%  Similarity=0.421  Sum_probs=77.1

Q ss_pred             EEecCCCCCCeEEcCC-----CcEEEEecCCcccccCCccc--------ccccCCCCccCcccccCCCCCCCccceeeeh
Q 017029            2 VVHRDLKPENLLLDSK-----WNVKIADFGLSNIMRDGHFL--------KTSCGSPNYAAPEVISGKLYAGPEVDVWSCG   68 (379)
Q Consensus         2 IiHrDLKpeNILl~~~-----~~vKL~DFGls~~~~~~~~~--------~~~~gt~~y~APE~l~~~~~~~~~~DiWSlG   68 (379)
                      +|.|||||+|+||..-     +.|.|+|||+++...+....        +...||..||+-....|+.. +...|+=|||
T Consensus       145 LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLG  223 (449)
T KOG1165|consen  145 LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALG  223 (449)
T ss_pred             eeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhh
Confidence            6899999999999653     46999999999988765432        34579999999988888777 6889999999


Q ss_pred             hHHHHHhhCCCCCCCC---ChHHHHHHHhcCc
Q 017029           69 VILYALLCGTLPFDDE---NIPNLFKKIKGGI   97 (379)
Q Consensus        69 vilyelltG~~Pf~~~---~~~~~~~~i~~~~   97 (379)
                      -++.+.|-|.+||.|-   +..+-+++|....
T Consensus       224 HvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  224 HVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            9999999999999884   4555667775443

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.71  E-value=7.1e-09  Score=107.30  Aligned_cols=137  Identities=22%  Similarity=0.354  Sum_probs=104.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-----c-----cccCCCCccCcccccCCCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----K-----TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-----~-----~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvi   70 (379)
                      ++||++|.|++|.++.+|.+||+.|+++.....+...     .     -..-...|.|||++.+... ++++|++|+||+
T Consensus       120 k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~-~~~sd~fSlG~l  198 (700)
T KOG2137|consen  120 KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN-TPASDVFSLGVL  198 (700)
T ss_pred             ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc-cccccceeeeeE
Confidence            5899999999999999999999999988665432111     0     0123468999999988554 899999999999


Q ss_pred             HHHHh-hCCCCCCCCChHHHHHH----HhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           71 LYALL-CGTLPFDDENIPNLFKK----IKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        71 lyell-tG~~Pf~~~~~~~~~~~----i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|.+. .|+.-+.+.+....+..    ...+.......++.++++-+.+++..++..||++.++...|||.+.
T Consensus       199 i~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  199 IYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             EEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            99999 56666655432222111    1122344557789999999999999999999999999999999865

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=98.69  E-value=9.3e-09  Score=94.49  Aligned_cols=122  Identities=22%  Similarity=0.296  Sum_probs=85.6

Q ss_pred             EEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeeehhH
Q 017029            2 VVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         2 IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvi   70 (379)
                      .|||||||+|+|..-   ...+.++|||+|+...+...        -+...||..|++-....+... +...|+=|+|-+
T Consensus       132 fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYv  210 (341)
T KOG1163|consen  132 FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYV  210 (341)
T ss_pred             cccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcce
Confidence            589999999999864   46799999999998755432        123469999998877666554 678999999999


Q ss_pred             HHHHhhCCCCCCCCChH---HHHHHHhcCccCCC-----CCCChhhhcccccccCCCCCCCC
Q 017029           71 LYALLCGTLPFDDENIP---NLFKKIKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRI  124 (379)
Q Consensus        71 lyelltG~~Pf~~~~~~---~~~~~i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rp  124 (379)
                      |.+..-|.+||.+-...   +-+++|.......|     ..++.++.-.+.-|-..--++-|
T Consensus       211 LmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P  272 (341)
T KOG1163|consen  211 LMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP  272 (341)
T ss_pred             eeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence            99999999999985433   34556655444443     34556665555555443333333

>PRK12274 serine/threonine protein kinase; Provisional

Probab=98.59  E-value=1.9e-08  Score=92.10  Aligned_cols=84  Identities=19%  Similarity=0.134  Sum_probs=61.7

Q ss_pred             EEecCC-CCCCeEEcCCCcEEEEecCCcccccCCcc----cc----------cccCCCCccCcccccCC-CCCCCcccee
Q 017029            2 VVHRDL-KPENLLLDSKWNVKIADFGLSNIMRDGHF----LK----------TSCGSPNYAAPEVISGK-LYAGPEVDVW   65 (379)
Q Consensus         2 IiHrDL-KpeNILl~~~~~vKL~DFGls~~~~~~~~----~~----------~~~gt~~y~APE~l~~~-~~~~~~~DiW   65 (379)
                      |+|||| ||+|||++.+|.++|+|||++........    +.          -...++.|++|+...-- ..+-...+++
T Consensus       112 IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~  191 (218)
T PRK12274        112 VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF  191 (218)
T ss_pred             CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence            799999 79999999999999999999985543321    11          01257788888743321 1112567888


Q ss_pred             eehhHHHHHhhCCCCCCCCC
Q 017029           66 SCGVILYALLCGTLPFDDEN   85 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~~~   85 (379)
                      +.|.-+|.++|+..++.+++
T Consensus       192 ~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        192 ATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HhcchHHHHHhccCCccccC
Confidence            99999999999999876654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=98.58  E-value=4e-08  Score=105.16  Aligned_cols=71  Identities=27%  Similarity=0.395  Sum_probs=56.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvil   71 (379)
                      .||||||||+|||++.++.+||+|||+++...... .....+|++.|++||...........+++|++|.-.
T Consensus       124 gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~s~~~s~g~~~  195 (669)
T cd05610         124 GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKNDYSRTPGQVLSLISSLGFNT  195 (669)
T ss_pred             CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccccccccCccccCccccccCCCCceeeeeeecCcCC
Confidence            48999999999999999999999999998765432 334567999999999776555545678889998543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PRK09188 serine/threonine protein kinase; Provisional

Probab=98.54  E-value=5.4e-08  Score=96.49  Aligned_cols=54  Identities=26%  Similarity=0.423  Sum_probs=44.3

Q ss_pred             CEEecCC-CCCCeEEcCCCcEEEEecCCcccccCCc---------ccccccCCCCccCcccccC
Q 017029            1 MVVHRDL-KPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKTSCGSPNYAAPEVISG   54 (379)
Q Consensus         1 ~IiHrDL-KpeNILl~~~~~vKL~DFGls~~~~~~~---------~~~~~~gt~~y~APE~l~~   54 (379)
                      .|+|||| ||+|||++.++.+||+|||+++......         .+++.++++.|+|||.+..
T Consensus       131 gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        131 GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            3899999 9999999999999999999998664432         1245578899999999863

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=98.40  E-value=8.1e-08  Score=89.25  Aligned_cols=60  Identities=15%  Similarity=0.195  Sum_probs=44.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      |+|||+||.||+++.+| ++|+|||.+.........           ..++....| +.++|+||+|+++...
T Consensus       156 i~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~a~-----------d~~vler~y-~~~~di~~lg~~~~~~  215 (232)
T PRK10359        156 MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRKAK-----------DRIDLERHY-GIKNEIKDLGYYLLIY  215 (232)
T ss_pred             CccCCCChHHEEEeCCC-EEEEECCCcccccchhhH-----------HHHHHHhHh-cccccccceeEeehHH
Confidence            79999999999999988 999999988665322111           113344456 4799999999987654

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.27  E-value=3.4e-07  Score=93.48  Aligned_cols=134  Identities=26%  Similarity=0.392  Sum_probs=100.9

Q ss_pred             EEecCCCCCCeEEcCC-CcEEEEecCCcccccCCccccc------ccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKT------SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~------~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      ++|-|+||+||++..+ ..++++|||+...+.++.+...      .-|...|++||+..+. + +...|++++|.+..+.
T Consensus       243 ~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~-~~~~di~sl~ev~l~~  320 (524)
T KOG0601|consen  243 IVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-A-TFASDIFSLGEVILEA  320 (524)
T ss_pred             ccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccc-c-chHhhhcchhhhhHhh
Confidence            6899999999999999 8999999999988877653322      2477889999998764 3 7899999999999998


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .+|..++...-... +..+.++..  .+-...+.++...+..|+..+|-.|++.+.++.|+++...
T Consensus       321 ~l~~~~~~~g~~~~-W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~  385 (524)
T KOG0601|consen  321 ILGSHLPSVGKNSS-WSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK  385 (524)
T ss_pred             HhhcccccCCCCCC-ccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence            88876654431111 122222221  1123446667779999999999999999999999998743

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=98.14  E-value=1.4e-06  Score=94.78  Aligned_cols=78  Identities=26%  Similarity=0.427  Sum_probs=66.6

Q ss_pred             CEEecCCCCCCeEEcC-------CCcEEEEecCCcccc---cCCcccccccCCCCccCcccccCCCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDS-------KWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-------~~~vKL~DFGls~~~---~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvi   70 (379)
                      .|||+||||+|+||..       .-.++|+|||.+--|   .++...+..++|-.+-++|+..|+.. +..+|.|.++.+
T Consensus       814 ~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~  892 (974)
T KOG1166|consen  814 GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAAT  892 (974)
T ss_pred             ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHH
Confidence            5999999999999942       345999999998655   45556677789999999999999988 799999999999


Q ss_pred             HHHHhhCCC
Q 017029           71 LYALLCGTL   79 (379)
Q Consensus        71 lyelltG~~   79 (379)
                      ++.||.|+.
T Consensus       893 ~h~mLFG~y  901 (974)
T KOG1166|consen  893 VHVMLFGKY  901 (974)
T ss_pred             HHHHHHHHH
Confidence            999999854

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.03  E-value=6.3e-06  Score=79.20  Aligned_cols=133  Identities=16%  Similarity=0.184  Sum_probs=89.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc---CCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~---~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      +|+|+++..+.|++..+|-+|+.--.......   ...  ......|-++|.|||.=..... +-++|||++|+...+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHH
Confidence            58999999999999999999986432221110   001  1112245688999987543333 45899999999999999


Q ss_pred             hCCCC-CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           76 CGTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        76 tG~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      .|..- -.+++.......|.+..+...   ..--++++.+||+-.|..||++.+++.||..-+
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            88654 344333333333333222221   233478999999999999999999999997654

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.59  E-value=0.00012  Score=72.78  Aligned_cols=124  Identities=20%  Similarity=0.314  Sum_probs=84.6

Q ss_pred             ecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCC----CCCccceeeehhHHHHHhhC-C
Q 017029            4 HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY----AGPEVDVWSCGVILYALLCG-T   78 (379)
Q Consensus         4 HrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~----~~~~~DiWSlGvilyelltG-~   78 (379)
                      -+|+.++|+|+++++.|.|.|-..-....++......+|.+.|.+||.-.-+.+    .+...|.|.|||++++++.| +
T Consensus       140 vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggr  219 (637)
T COG4248         140 VGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGR  219 (637)
T ss_pred             ccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCC
Confidence            379999999999999999998544333344544556689999999997652222    25689999999999999985 9


Q ss_pred             CCCCCCC-----hHHHHHHHhcCccC-----------CC-----CCCChhhhcccccccCC--CCCCCCChh
Q 017029           79 LPFDDEN-----IPNLFKKIKGGIYT-----------LP-----SHLSPGARDLIPRMLIV--DPMKRITIP  127 (379)
Q Consensus        79 ~Pf~~~~-----~~~~~~~i~~~~~~-----------~p-----~~~s~~~~~Li~~mL~~--dP~~Rpt~~  127 (379)
                      .||.|-.     ..-....|..+.+.           .|     .-+++++..|..+|+..  ++.-|||++
T Consensus       220 HPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         220 HPYSGIPLISDAPNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             CCCCcccccCCCCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            9997631     11111234333321           12     13567778888888764  356788865

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=97.41  E-value=8.7e-05  Score=69.48  Aligned_cols=31  Identities=32%  Similarity=0.453  Sum_probs=28.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .|+||||||+|||++.++.++|+|||.+...
T Consensus       162 GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~  192 (239)
T PRK01723        162 GVYHADLNAHNILLDPDGKFWLIDFDRGELR  192 (239)
T ss_pred             CCCCCCCCchhEEEcCCCCEEEEECCCcccC
Confidence            3799999999999999899999999988764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=97.38  E-value=0.0001  Score=75.60  Aligned_cols=131  Identities=20%  Similarity=0.211  Sum_probs=91.9

Q ss_pred             EEecCCCCCCeEEcCC-CcEEEEecCCcccccCCcccccccCCCCcc-CcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            2 VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYA-APEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         2 IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~~~gt~~y~-APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      ++|+|+||+||++..+ +..+++|||....+.-..  ....+.-.+. ..|++........++|++|||..+++.++|..
T Consensus       387 ~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~--~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  387 FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS--GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             hhcccccccceeeccchhhhhccccccccccceec--ccccccccccccchhhccccccccccccccccccccccccCcc
Confidence            5899999999999886 888999999886432111  1122223333 35555444444789999999999999998865


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      --...   .....|..+..+........+..+.+.++..++..|+.+.++..|.-|..
T Consensus       465 ls~~~---~~~~~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  465 LSESG---VQSLTIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             cCccc---ccceeeecccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence            32211   12344555655555555688889999999999999999999988876543

>smart00090 RIO RIO-like kinase

Probab=97.33  E-value=0.00014  Score=68.11  Aligned_cols=30  Identities=33%  Similarity=0.362  Sum_probs=27.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .|+||||||+||+++ ++.++|+|||.+...
T Consensus       169 ~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      169 ELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             CEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence            389999999999999 889999999988654

>PRK10345 hypothetical protein; Provisional

Probab=97.16  E-value=0.00024  Score=65.29  Aligned_cols=29  Identities=24%  Similarity=0.211  Sum_probs=23.3

Q ss_pred             CEEecCCCCCCeEEcCC----CcEEEEecCCcc
Q 017029            1 MVVHRDLKPENLLLDSK----WNVKIADFGLSN   29 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~----~~vKL~DFGls~   29 (379)
                      .||||||||+|||++..    +.++|+||+.++
T Consensus       125 ~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~  157 (210)
T PRK10345        125 RIVTMELKPQNILCQRISESEVIPVVCDNIGES  157 (210)
T ss_pred             CEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence            48999999999999743    479999955443

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=96.82  E-value=0.00091  Score=59.92  Aligned_cols=30  Identities=30%  Similarity=0.525  Sum_probs=27.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .++|||++|+||+++ ++.++++|||++...
T Consensus       110 gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724       110 GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            379999999999999 899999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK14879 serine/threonine protein kinase; Provisional

Probab=96.77  E-value=0.0009  Score=60.47  Aligned_cols=28  Identities=32%  Similarity=0.693  Sum_probs=26.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|||++|.|||++ ++.++|+|||.+..
T Consensus       116 i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        116 IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            78999999999999 78999999999865

>cd05151 ChoK Choline Kinase (ChoK)

Probab=96.65  E-value=0.0015  Score=56.70  Aligned_cols=28  Identities=32%  Similarity=0.536  Sum_probs=25.2

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|++|.||+++ ++.++++|||.+..
T Consensus       109 ~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151         109 PCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             eecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            69999999999999 67899999998754

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=96.64  E-value=0.00085  Score=70.13  Aligned_cols=30  Identities=30%  Similarity=0.512  Sum_probs=26.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .|+||||||+|||+ .++.++|+|||+++..
T Consensus       448 giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        448 GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            37999999999999 6789999999999764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=96.53  E-value=0.0018  Score=66.14  Aligned_cols=31  Identities=26%  Similarity=0.487  Sum_probs=28.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR   32 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~   32 (379)
                      ++|+|++|.||+++.+|.++++|||++..+.
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            7999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=96.07  E-value=0.003  Score=46.46  Aligned_cols=54  Identities=19%  Similarity=0.177  Sum_probs=42.0

Q ss_pred             CCCCCccccccCCCCCCCCCccc----eeeceeccCCHHHHHHHHHHHHHhcCcEEEE
Q 017029          233 HRAPGFMDYQGMGLRGQLPYERK----WALGLQSRAHPREIMTEVLKALQELNVGWKK  286 (379)
Q Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~----w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~  286 (379)
                      ++|..+..++|.+|.++|..+..    -+..+.|+.+|.+||..|..+.+.+||..+|
T Consensus         6 NAFdiIS~S~G~DLSgLFe~~~~~~~~~~~RF~S~~~~~~Ii~klEe~a~~~~~~V~K   63 (63)
T PF03822_consen    6 NAFDIISLSSGFDLSGLFEEKDKSSVKRETRFTSKEPASEIIEKLEEIAKKLGFRVKK   63 (63)
T ss_dssp             -HHHHHCTSTTTSCGGGGGCG-S-SS---EEEEESS-HHHHHHHHHHHHHHTTEEEEE
T ss_pred             cHHHHHHhccCCChHHhcCccccccccccceEecCCCHHHHHHHHHHHHHhcCceeeC
Confidence            45555677889999999865443    4789999999999999999999999998875

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=95.83  E-value=0.0075  Score=54.20  Aligned_cols=29  Identities=34%  Similarity=0.651  Sum_probs=25.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      |||+||.++||++...+ +.++|||++...
T Consensus       113 ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642         113 IVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             eecCCCccceEEEeCCc-EEEEECCccccc
Confidence            89999999999997654 999999998754

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=95.79  E-value=0.0052  Score=64.14  Aligned_cols=32  Identities=22%  Similarity=0.443  Sum_probs=28.8

Q ss_pred             EEecCCCCCCeEEcCCC----cEEEEecCCcccccC
Q 017029            2 VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRD   33 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~----~vKL~DFGls~~~~~   33 (379)
                      ++|+|+||.||+++.+|    .++++|||++.....
T Consensus       281 ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        281 FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            79999999999999888    999999999877643

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=95.28  E-value=0.00065  Score=76.68  Aligned_cols=134  Identities=19%  Similarity=0.124  Sum_probs=97.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .+|++||+-|.+|..+.++|++++|+.++.. .........+++.|++|++...-.+ +.++|+|+.|+-+|+...|..+
T Consensus      1361 ~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~ly~rs~~n~~ 1439 (2724)
T KOG1826|consen 1361 NVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSLYLRSDGNAY 1439 (2724)
T ss_pred             chhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHHHHHhcccHH
Confidence            4799999999999999999999999998432 3344456678899999998876666 5569999999999999888887


Q ss_pred             CCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           81 FDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      |-......+...+.++. ..++.-.+.++-.....+|-+.-..||.-...+.-+.|.
T Consensus      1440 fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1440 FIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             HHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            75433333333333332 234444566666666677777778888888877766654

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=94.82  E-value=0.029  Score=50.63  Aligned_cols=30  Identities=40%  Similarity=0.510  Sum_probs=23.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .|||+||.+.|||++.+ .+.|+|||.+...
T Consensus       127 givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  127 GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             CceecCCChhhEEeecc-eEEEEecCcceec
Confidence            38999999999999877 8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=94.25  E-value=0.032  Score=58.54  Aligned_cols=128  Identities=27%  Similarity=0.234  Sum_probs=89.4

Q ss_pred             EecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCC
Q 017029            3 VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFD   82 (379)
Q Consensus         3 iHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~   82 (379)
                      +|||    ||+..+ +..|..||+....+......++..+++.++|||+.....+ ..+.|.|++|+-..++.-|.+|-.
T Consensus       358 ~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~-~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  358 VHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTI-DGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             cCcc----cccccc-cccccccccCCcccCcccccccCCCCCCCCCchhhccccc-ccCCCccCCCcchhhcCCCCCCCC
Confidence            4566    777654 7799999999887776656678899999999999988877 568999999987777777777754


Q ss_pred             CCChHHHHHHHhcCc--cCCC--CCCChhh-hcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           83 DENIPNLFKKIKGGI--YTLP--SHLSPGA-RDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        83 ~~~~~~~~~~i~~~~--~~~p--~~~s~~~-~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .  +......+..+.  +.+-  ...++.. +++...|+...|..|++.-+++.|.+|...
T Consensus       432 ~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  432 S--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             C--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccC
Confidence            3  111111111111  0000  0112222 258889999999999999999999999765

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=94.05  E-value=0.042  Score=49.55  Aligned_cols=30  Identities=40%  Similarity=0.656  Sum_probs=25.1

Q ss_pred             EEecCCCCCCeEEcCCC---cEEEEecCCcccc
Q 017029            2 VVHRDLKPENLLLDSKW---NVKIADFGLSNIM   31 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~---~vKL~DFGls~~~   31 (379)
                      |||+||..+||++..+|   .+.++|||++...
T Consensus       134 iiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  134 IIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             eecccccccceEEecCCCcCceEEEeecchhcc
Confidence            79999999999997654   3589999998653

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=92.78  E-value=0.11  Score=54.80  Aligned_cols=74  Identities=18%  Similarity=0.279  Sum_probs=52.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .++|++|.-..|+++..|..||++|.++........ .+...---.|..|+.+....   -..|.|-|||++++++.|
T Consensus       125 ~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  125 NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCc
Confidence            379999999999999999999999988765432221 11111112355665543222   357999999999999999

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=92.76  E-value=0.063  Score=48.87  Aligned_cols=30  Identities=27%  Similarity=0.448  Sum_probs=26.7

Q ss_pred             EEecCCCCCCeEEcCCC---cEEEEecCCcccc
Q 017029            2 VVHRDLKPENLLLDSKW---NVKIADFGLSNIM   31 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~---~vKL~DFGls~~~   31 (379)
                      |+|+|+++.|||++.++   .+.++||+.+...
T Consensus       139 i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  139 IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            78999999999999887   8999999987653

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=92.60  E-value=0.074  Score=50.70  Aligned_cols=29  Identities=24%  Similarity=0.350  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcC-------CCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDS-------KWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~-------~~~vKL~DFGls~~   30 (379)
                      |+|+||++.|||++.       +..+.++||+.+..
T Consensus       159 i~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        159 INHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             CccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            789999999999975       46899999998854

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=92.57  E-value=0.078  Score=47.78  Aligned_cols=29  Identities=38%  Similarity=0.620  Sum_probs=20.4

Q ss_pred             EEecCCCCCCeEEc-CCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLD-SKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~-~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       168 ~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  168 LIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             EE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             EEEeccccccceeeeccceeEEEecccceE
Confidence            79999999999999 667778999987643

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=92.27  E-value=0.069  Score=55.03  Aligned_cols=79  Identities=23%  Similarity=0.310  Sum_probs=59.7

Q ss_pred             CCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC-------------CCChhhhcccccccCCCCCCCCC
Q 017029           59 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-------------HLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        59 ~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~-------------~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      ++++||||+|.++.++.-|..-+......+..+.+.+ .+..+.             .++.....+..+|+-..|..||.
T Consensus       109 ~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k-~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l  187 (725)
T KOG1093|consen  109 GPKSDVWSLGFIILELYLGISLEAELTESEYLEILLK-YYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL  187 (725)
T ss_pred             CcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHH-hccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc
Confidence            5799999999999999998776665444444443332 222221             24566778999999999999999


Q ss_pred             hhhhhcCchhhhc
Q 017029          126 IPEIRQHPWFQAH  138 (379)
Q Consensus       126 ~~ell~hp~f~~~  138 (379)
                      ..++++++-|.+.
T Consensus       188 ~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  188 PMELSKRCSFTEV  200 (725)
T ss_pred             hhHHhcCccHHHH
Confidence            9999999999876

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=92.27  E-value=0.13  Score=47.44  Aligned_cols=29  Identities=34%  Similarity=0.530  Sum_probs=24.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.+.||+++.++..-|.||+.+..
T Consensus       166 l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         166 WFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             EEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            79999999999998766567999998754

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=92.07  E-value=0.14  Score=49.02  Aligned_cols=28  Identities=29%  Similarity=0.459  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCC----CcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSK----WNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~----~~vKL~DFGls~   29 (379)
                      ++|+|+.+.|||++.+    +.+.++||..+.
T Consensus       181 lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         181 FCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             EEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            6999999999999975    889999998874

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=91.70  E-value=0.17  Score=46.40  Aligned_cols=28  Identities=29%  Similarity=0.503  Sum_probs=25.0

Q ss_pred             EEecCCCCCCeEEcC-CCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDS-KWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~-~~~vKL~DFGls~   29 (379)
                      ++|+|+.+.|||++. ++.+.++||..+.
T Consensus       172 l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         172 FCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            699999999999998 5789999998764

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF08587 UBA_2: Ubiquitin associated domain (UBA) ; InterPro: IPR013896 This is a UBA (ubiquitin associated) protein []

Probab=91.60  E-value=0.031  Score=38.19  Aligned_cols=40  Identities=33%  Similarity=0.644  Sum_probs=26.7

Q ss_pred             CHHHHHHH-HHcCCCHHHHHHHHHhccc----ChHHHHHHHHhhc
Q 017029          158 DEEILKEV-VKMGFDQNQLVESLRNRLQ----NEATVAYYLLLDN  197 (379)
Q Consensus       158 ~~~~~~~~-~~~~~~~~~~~~~l~~~~~----~~~~~~y~ll~~~  197 (379)
                      +++++..+ ..|||+++++.++|.....    ++...||.|+.+|
T Consensus         2 de~vv~~Ls~tMGY~kdeI~eaL~~~~~~~~~neIkDAY~L~kEN   46 (46)
T PF08587_consen    2 DEDVVSKLSKTMGYDKDEIYEALESSEPSPQSNEIKDAYLLMKEN   46 (46)
T ss_dssp             -HCCHHHHHCTT---HHHHHHHCCSSS------SSCCHHHHHHHH
T ss_pred             cHHHHHHHHHHhCCCHHHHHHHHHcCCCcchHHHHHHHHHHHhcC
Confidence            44555556 3699999999999988766    8888999988764

Ubiquitin is involved in intracellular proteolysis. ; GO: 0004674 protein serine/threonine kinase activity; PDB: 3H4J_B.

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=91.31  E-value=0.17  Score=46.81  Aligned_cols=27  Identities=26%  Similarity=0.288  Sum_probs=24.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+.|.||+++.++ +.|+||+.+.
T Consensus       155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       155 CLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             eEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            58999999999999888 9999999774

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=91.31  E-value=0.19  Score=46.52  Aligned_cols=28  Identities=25%  Similarity=0.268  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       165 l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         165 VTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EECCCCCCccEEEeCCcEEEEEEccccc
Confidence            6999999999999998778899998764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PRK10271 thiK thiamine kinase; Provisional

Probab=91.22  E-value=0.19  Score=45.32  Aligned_cols=28  Identities=18%  Similarity=0.335  Sum_probs=24.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      .+|+|+.|.||+++.+| ++++||+.+..
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            48999999999998777 99999998753

>TIGR02721 ycfN_thiK thiamine kinase

Probab=91.01  E-value=0.18  Score=47.24  Aligned_cols=28  Identities=21%  Similarity=0.370  Sum_probs=24.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.|.||+++.++ +.++||..+..
T Consensus       148 l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       148 PLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             eecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            68999999999999877 78999987743

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK05231 homoserine kinase; Provisional

Probab=90.73  E-value=0.18  Score=48.81  Aligned_cols=28  Identities=29%  Similarity=0.439  Sum_probs=24.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      +||+|+.|.|||++.+...-|+||+.+.
T Consensus       189 liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        189 VIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             cCCCCCCCCcEEEECCceEEEEeccccc
Confidence            7999999999999866556899999774

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=90.52  E-value=0.18  Score=48.11  Aligned_cols=29  Identities=24%  Similarity=0.373  Sum_probs=26.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      |||+|+.+-||+++.+|.+.++||--+..
T Consensus       223 iVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         223 IVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccccCCchheEEEecCCCEEEEeCccccc
Confidence            79999999999999999999999965533

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=89.86  E-value=0.22  Score=45.14  Aligned_cols=29  Identities=34%  Similarity=0.645  Sum_probs=20.6

Q ss_pred             EEecCCCCCCeEE-cCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLL-DSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl-~~~~~vKL~DFGls~~   30 (379)
                      ++|.||.|.|||+ +.++.++++||..|..
T Consensus       145 ~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  145 FCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             EeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            5899999999999 8889999999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=89.71  E-value=0.24  Score=47.73  Aligned_cols=28  Identities=36%  Similarity=0.570  Sum_probs=25.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      +||+|+.+.||+++.++.+.|+||+.+.
T Consensus       189 l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       189 VIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             cCCCCCCcCcEEEECCceEEEeeccccc
Confidence            7999999999999988877899999774

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=89.36  E-value=0.23  Score=47.29  Aligned_cols=28  Identities=32%  Similarity=0.456  Sum_probs=25.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      +||+|+.|.|||++.++.+.|.||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            6899999999999988777899998764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=89.06  E-value=0.37  Score=45.96  Aligned_cols=28  Identities=36%  Similarity=0.551  Sum_probs=25.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|.|+.|+|+|.+..|.++|+||..|.
T Consensus       155 ~cH~Dl~~~N~l~t~~~~l~LIDWEyAg  182 (269)
T COG0510         155 PCHNDLNPGNLLLTDKGGLFLIDWEYAG  182 (269)
T ss_pred             eecCCCCccceEEcCCCcEEEEecccCC
Confidence            7999999999999998999999998764

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=89.00  E-value=0.39  Score=43.32  Aligned_cols=29  Identities=31%  Similarity=0.471  Sum_probs=24.4

Q ss_pred             EEecCCCCCCeEEcCCC-----cEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKW-----NVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~-----~vKL~DFGls~~   30 (379)
                      ++|||+.+.||++..++     .+.+.||..+..
T Consensus       122 l~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      122 LNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             EeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            68999999999998643     689999988753

subfamily of choline kinases

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=87.83  E-value=0.47  Score=46.67  Aligned_cols=28  Identities=32%  Similarity=0.646  Sum_probs=25.2

Q ss_pred             EEecCCCCCCeEEcCCCc-EEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWN-VKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~-vKL~DFGls~   29 (379)
                      |||+|+.|.|||++.+.. +.+.|||-+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            899999999999998875 8999999764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=87.77  E-value=0.46  Score=45.50  Aligned_cols=27  Identities=30%  Similarity=0.471  Sum_probs=23.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      +||+|+.+.||+++. +.+.|+||+.+.
T Consensus       189 liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       189 FCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             eEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            699999999999987 678999998653

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=87.49  E-value=0.47  Score=45.30  Aligned_cols=29  Identities=28%  Similarity=0.570  Sum_probs=24.5

Q ss_pred             EEecCCCCCCeEEcCCCc-EEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWN-VKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~-vKL~DFGls~~   30 (379)
                      ++|+|+.|.|||++.++. .-|.||+.+..
T Consensus       187 lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         187 LVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            799999999999997555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PLN02236 choline kinase

Probab=87.11  E-value=0.54  Score=46.40  Aligned_cols=28  Identities=25%  Similarity=0.541  Sum_probs=24.7

Q ss_pred             EEecCCCCCCeEEcC-CCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDS-KWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~-~~~vKL~DFGls~   29 (379)
                      ++|+|+++.|||++. ++.+.++||..+.
T Consensus       202 ~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        202 FCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             EEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence            689999999999986 4789999998774

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=84.19  E-value=0.75  Score=45.85  Aligned_cols=29  Identities=41%  Similarity=0.675  Sum_probs=26.2

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .=||||...||||+ +|+|.|+||-+++..
T Consensus       343 fehrnlt~~niLId-~GnvtLIDfklsRl~  371 (488)
T COG5072         343 FEHRNLTLDNILID-EGNVTLIDFKLSRLS  371 (488)
T ss_pred             cccccccccceeee-cCceEEEEeeeeecc
Confidence            34999999999999 999999999999854

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=84.04  E-value=0.72  Score=44.54  Aligned_cols=29  Identities=21%  Similarity=0.321  Sum_probs=26.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      +||+|+.+.|+|++.++.+.++||..+..
T Consensus       198 lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       198 LVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            79999999999999999999999987643

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=83.36  E-value=0.68  Score=52.07  Aligned_cols=113  Identities=20%  Similarity=0.232  Sum_probs=75.2

Q ss_pred             CCCcEEEE--ecCCcccccCCcccccccCCCCccCcccccCCCCC-CCccceeeehhHHHHHhhCCCCCCCCChHHHHHH
Q 017029           16 SKWNVKIA--DFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK   92 (379)
Q Consensus        16 ~~~~vKL~--DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~   92 (379)
                      ..+.+.++  ||+.+....+...-.....+..+.|+|......+. ....|+|.+|..+..+..|..+-.-.   .....
T Consensus       324 ~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~---~~~~~  400 (1351)
T KOG1035|consen  324 GEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKS---AVPVS  400 (1351)
T ss_pred             ccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccc---cchhh
Confidence            34556666  88888776555444444456677888887655542 22369999999999988875542111   11111


Q ss_pred             HhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           93 IKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        93 i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      +      .+........+++.+|+.-++++|+++.+++.|+|.+.
T Consensus       401 ~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~  439 (1351)
T KOG1035|consen  401 L------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRF  439 (1351)
T ss_pred             h------hccccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence            1      11111226788999999999999999999999999874

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=82.55  E-value=0.84  Score=45.08  Aligned_cols=30  Identities=33%  Similarity=0.592  Sum_probs=21.6

Q ss_pred             EEecCCCCCCeEEcCCC------------------cEEEEecCCcccc
Q 017029            2 VVHRDLKPENLLLDSKW------------------NVKIADFGLSNIM   31 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~------------------~vKL~DFGls~~~   31 (379)
                      .+|-||||+|||+-...                  .++|.||.+|...
T Consensus       300 F~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  300 FLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             eeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            58999999999983321                  3467777777653

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=82.50  E-value=1.2  Score=43.72  Aligned_cols=28  Identities=29%  Similarity=0.475  Sum_probs=24.5

Q ss_pred             EEecCCCCCCeEEcC-CCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDS-KWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~-~~~vKL~DFGls~   29 (379)
                      ++|.||.+.|||++. ++.++++||..|.
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            589999999999975 5789999998774

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=81.96  E-value=1.4  Score=43.19  Aligned_cols=30  Identities=30%  Similarity=0.640  Sum_probs=27.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      .++|+|+.+.|++++..+-+-|.||+++..
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            379999999999999998899999999865

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=81.13  E-value=1.2  Score=41.27  Aligned_cols=28  Identities=25%  Similarity=0.441  Sum_probs=23.4

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      +.|+|..|.|++++.+ .+++.||+..+.
T Consensus       156 ~~HGD~hpgNFlv~~~-~i~iID~~~k~~  183 (229)
T PF06176_consen  156 FYHGDPHPGNFLVSNN-GIRIIDTQGKRM  183 (229)
T ss_pred             CccCCCCcCcEEEECC-cEEEEECccccc
Confidence            5799999999999855 499999986643

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=81.03  E-value=1.3  Score=41.94  Aligned_cols=31  Identities=26%  Similarity=0.280  Sum_probs=27.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR   32 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~   32 (379)
                      .+||+||..-|||+. ++.+.|+|||-+....
T Consensus       187 ~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         187 GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            379999999999999 8899999999886654

>PRK06148 hypothetical protein; Provisional

Probab=80.71  E-value=1.3  Score=50.00  Aligned_cols=29  Identities=31%  Similarity=0.503  Sum_probs=24.6

Q ss_pred             EEecCCCCCCeEEcCCC--cEE-EEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKW--NVK-IADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~--~vK-L~DFGls~~   30 (379)
                      |||.|+.+.|||++.++  .+. |+|||-+..
T Consensus       205 vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        205 VIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             eECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            79999999999999875  555 999998754

>PHA03111 Ser/Thr kinase; Provisional

Probab=80.48  E-value=0.81  Score=45.00  Aligned_cols=15  Identities=47%  Similarity=0.833  Sum_probs=13.0

Q ss_pred             EEecCCCCCCeEEcC
Q 017029            2 VVHRDLKPENLLLDS   16 (379)
Q Consensus         2 IiHrDLKpeNILl~~   16 (379)
                      .+|-||||+|||+-.
T Consensus       304 F~H~DLKPdNILiFd  318 (444)
T PHA03111        304 FLHVDLKPDNILIFD  318 (444)
T ss_pred             eeeccCCCCcEEEec
Confidence            589999999999843

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	379
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		3e-73
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		2e-67
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-61
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-61
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		6e-61
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-61
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-60
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		5e-59
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-41
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-40
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-39
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-39
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-39
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-38
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-38
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-38
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-36
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-36
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-34
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-30
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-29
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-29
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-29
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		6e-29
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		9e-29
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		9e-29
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-29
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		1e-28
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-28
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-28
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-28
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		4e-28
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		7e-28
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-28
3soa_A	444	Full-Length Human Camkii Length = 444		1e-27
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-27
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-27
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-27
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-27
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-27
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-27
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-27
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		7e-27
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		1e-26
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-26
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-26
3kk9_A	282	Camkii Substrate Complex B Length = 282		1e-26
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-26
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-26
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-26
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-26
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		4e-26
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-26
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		6e-26
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-26
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		6e-26
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		6e-26
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-26
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		1e-25
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		1e-25
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-25
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-25
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-25
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-25
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-25
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		3e-25
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		3e-25
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-25
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-25
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-25
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		4e-25
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-25
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		5e-25
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		5e-25
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		6e-25
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-25
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		6e-25
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-25
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-25
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-25
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		8e-25
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		9e-25
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		9e-25
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		1e-24
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-24
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-24
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-24
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-24
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-24
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-24
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-24
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-24
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-24
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-24
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-24
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-24
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-24
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-24
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-24
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		3e-24
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-24
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		3e-24
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		4e-24
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		7e-24
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		7e-24
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		7e-24
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-24
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-24
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-23
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-23
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-23
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		2e-23
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-23
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-23
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		9e-23
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		9e-23
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-22
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-22
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-22
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-22
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-22
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-22
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-22
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		5e-22
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		6e-22
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		6e-22
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		6e-22
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		1e-21
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-21
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-21
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-21
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-21
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-21
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		1e-21
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-21
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-21
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-21
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-21
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		1e-21
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		1e-21
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		1e-21
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		1e-21
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		1e-21
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		2e-21
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		2e-21
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		2e-21
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-21
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-21
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-21
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		5e-21
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		5e-21
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		5e-21
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-21
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		6e-21
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-21
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		9e-21
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-20
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		1e-20
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		1e-20
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-20
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-20
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-20
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-20
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-20
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-20
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-20
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		2e-20
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-20
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-20
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-20
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-20
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-20
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-20
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-20
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		2e-20
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-20
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-20
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-20
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-20
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-20
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-20
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-20
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-20
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-20
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-20
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-20
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		3e-20
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-20
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-20
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-20
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-20
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-20
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		3e-20
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		3e-20
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-20
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-20
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-20
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		3e-20
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-20
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-20
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-20
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-20
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		3e-20
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-20
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-20
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-20
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-20
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-20
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-20
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-20
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		4e-20
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-20
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-20
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-20
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-20
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-20
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		4e-20
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		4e-20
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		4e-20
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-20
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-20
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-20
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-20
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		5e-20
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-20
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-20
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		7e-20
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		8e-20
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		8e-20
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-19
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-19
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-19
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		1e-19
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-19
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-19
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-19
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-19
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-19
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		2e-19
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-19
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-19
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-19
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-19
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-19
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-19
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-19
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-19
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-19
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-19
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-19
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-19
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		2e-19
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-19
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-19
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-19
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-19
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-19
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-19
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-19
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		3e-19
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-19
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		3e-19
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-19
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-19
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-19
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		3e-19
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-19
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-19
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-19
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		8e-19
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-18
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-18
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		2e-18
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-18
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-18
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-18
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-18
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-18
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-17
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-17
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-17
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		2e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-17
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-17
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-17
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		6e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-17
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-17
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		2e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-16
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-16
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-16
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-16
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		4e-16
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		4e-16
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-16
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		5e-16
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-16
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-16
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-16
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		6e-16
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		7e-16
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		7e-16
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		7e-16
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-16
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-16
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-16
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-16
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		9e-16
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-16
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		9e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		9e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		9e-16
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		9e-16
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-15
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-15
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		1e-15
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-15
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-15
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		1e-15
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		1e-15
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-15
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-15
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-15
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-15
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-15
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-15
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-15
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-15
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-15
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-15
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-15
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-15
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-15
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-15
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-15
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		7e-15
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-14
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-14
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		1e-14
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-14
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-14
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-14
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-14
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-14
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-14
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-14
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-14
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-14
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-14
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-14
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-14
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-14
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-14
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-14
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-14
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-14
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-14
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-14
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-14
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-14
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-14
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-14
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-13
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-13
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-13
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		6e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-13
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-13
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		8e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-13
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		9e-13
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		1e-12
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-12
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		2e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		2e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-12
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-12
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-12
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		2e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		2e-12
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-12
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-12
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-12
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-12
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-12
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-12
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-12
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-12
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-12
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-12
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		3e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-12
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		5e-12
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		7e-12
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-12
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		7e-12
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-12
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-12
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		8e-12
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		8e-12
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-12
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-12
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-12
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-12
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		9e-12
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		9e-12
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		9e-12
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		9e-12
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-12
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		9e-12
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		9e-12
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-12
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-11
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-11
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		1e-11
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		1e-11
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-11
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-11
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-11
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-11
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-11
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-11
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-11
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-11
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		3e-11
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		3e-11
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-11
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		3e-11
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-11
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-11
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		3e-11
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-11
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		4e-11
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		4e-11
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		4e-11
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		4e-11
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		4e-11
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		5e-11
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-11
2oza_B	366	Structure Of P38alpha Complex Length = 366		5e-11
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-11
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-11
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		6e-11
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		6e-11
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		6e-11
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		6e-11
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		6e-11
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-11
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-11
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-11
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-11
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-11
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-11
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		7e-11
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-11
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-11
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-11
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-11
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-11
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-11
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-11
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-11
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-11
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-11
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		8e-11
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		8e-11
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		8e-11
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		8e-11
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-11
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		8e-11
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		8e-11
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		8e-11
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		8e-11
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		8e-11
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		8e-11
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-11
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-11
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-11
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		8e-11
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-11
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		9e-11
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		9e-11
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		9e-11
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-11
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-11
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		9e-11
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-11
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-10
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		1e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-10
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		1e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-10
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-10
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-10
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-10
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-10
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-10
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		3e-10
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		3e-10
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		4e-10
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-10
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-10
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-10
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-10
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-10
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		6e-10
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		7e-10
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		7e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		7e-10
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		8e-10
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		8e-10
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		8e-10
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		8e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		9e-10
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-09
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-09
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-09
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-09
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-09
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		3e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-09
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		3e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-09
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-09
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-09
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		4e-09
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		5e-09
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-09
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		6e-09
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-09
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-09
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		7e-09
4h58_A	275	Braf In Complex With Compound 3 Length = 275		8e-09
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		8e-09
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		8e-09
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-09
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-09
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		8e-09
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-09
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		9e-09
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		9e-09
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		9e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		1e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-08
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-08
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-08
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-08
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-08
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-08
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		3e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-08
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-08
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		4e-08
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		5e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-08
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		6e-08
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-08
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		6e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-08
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		6e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		6e-08
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-08
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-08
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		6e-08
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		7e-08
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-08
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		7e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		7e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		8e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		8e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		8e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		8e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		8e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		8e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		8e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		8e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		8e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		8e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		8e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		9e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		9e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		9e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		9e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		9e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-07
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-07
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-07
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-07
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-07
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-07
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		1e-07
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-07
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-07
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-07
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-07
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-07
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-07
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-07
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-07
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-07
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-07
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-07
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-07
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-07
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-07
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-07
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-07
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-07
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-07
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-07
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		3e-07
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-07
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-07
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		4e-07
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-07
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		4e-07
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-07
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-07
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-07
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-07
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		5e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		6e-07
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-07
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		6e-07
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		6e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		6e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		6e-07
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		7e-07
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		7e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		7e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		7e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		7e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		7e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		8e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		8e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		8e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		8e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		8e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		8e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		8e-07
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		9e-07
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		1e-06
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-06
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		1e-06
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		1e-06
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		1e-06
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		1e-06
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		1e-06
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		1e-06
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		1e-06
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-06
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		1e-06
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		1e-06
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-06
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		1e-06
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		1e-06
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-06
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		1e-06
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-06
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-06
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-06
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-06
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-06
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-06
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-06
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-06
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-06
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-06
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-06
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-06
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-06
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-06
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-06
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-06
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-06
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		3e-06
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		4e-06
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		5e-06
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-06
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-06
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-06
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-06
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-06
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-06
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		5e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		5e-06
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-06
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		5e-06
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-06
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-06
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-06
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-06
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-06
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-06
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-06
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		6e-06
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-06
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		6e-06
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		7e-06
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-06
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		8e-06
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		1e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-05
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-05
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-05
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-05
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-05
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		1e-05
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-05
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-05
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		1e-05
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-05
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-05
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-05
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-05
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		1e-05
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-05
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-05
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-05
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		1e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-05
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-05
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-05
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-05
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-05
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-05
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		2e-05
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		3e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		3e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-05
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		3e-05
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-05
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-05
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-05
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		3e-05
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-05
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-05
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-05
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-05
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-05
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-05
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-05
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-05
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-05
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-05
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-05
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-05
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		5e-05
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		5e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		5e-05
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-05
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		5e-05
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		5e-05
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		5e-05
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-05
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		6e-05
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-05
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		6e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		6e-05
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		6e-05
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		6e-05
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		6e-05
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-05
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		6e-05
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-05
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-05
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-05
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		6e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-05
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		7e-05
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		7e-05
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		7e-05
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		7e-05
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		7e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		8e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		8e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		8e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		9e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-05
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		9e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		9e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-04
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		1e-04
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-04
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-04
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-04
4eai_A	106	Co-Crystal Structure Of An Ampk Core With Amp Lengt		2e-04
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		2e-04
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-04
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-04
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-04
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-04
2y8l_A	173	Structure Of The Regulatory Fragment Of Mammalian A		2e-04
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-04
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-04
2v8q_A	157	Crystal Structure Of The Regulatory Fragment Of Mam		2e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-04
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-04
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-04

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  272 bits (695), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 159/367 (43%), Positives = 213/367 (58%), Gaps = 43/367 (11%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+ SCGSPNYAAPEVISG+LYAGP
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS GVILYALLCGTLPFDD+++P LFKKI  GI+  P +L+P    L+  ML VDP
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDP 255
Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           MKR TI +IR+H WF+  LP+YL   P D    +  ID+E LKEV  K    + +++  L
Sbjct: 256 MKRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCL 313
Query: 180 RNR-LQNEATVAYYLLLDNRFRVSSG---YLGAEFQETM--ESGFNRLHPIE-PAVSPVA 232
            NR  Q+   VAY+L++DNR  ++     YL     ++   +    R HP   P +    
Sbjct: 314 YNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAET 373
Query: 233 HRAPGFMD-YQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYN 291
            RA   +D       + Q   + KW LG++S++ P +IM EV +A+++L+  WK +  Y 
Sbjct: 374 PRARHXLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYY 433
Query: 292 MKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKY 351
           ++ R              NP+ S                       K  +QLY+     Y
Sbjct: 434 LRVRR------------KNPVTS--------------------TFSKMSLQLYQVDSRTY 461
Query: 352 LLDLQRV 358
           LLD + +
Sbjct: 462 LLDFRSI 468

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  252 bits (644), Expect = 2e-67,   Method: Compositional matrix adjust.
 Identities = 123/198 (62%), Positives = 149/198 (75%), Gaps = 4/198 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVI+GKLYAGPE
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWSCG++LY +L G LPFDDE IPNLFKK+   +Y +P  LSPGA+ LI RM++ DPM
Sbjct: 189 VDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPM 248
Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK-MGFDQNQLVESLR 180
           +RITI EIR+ PWF  +LP YL    P    Q    D  I+ ++ + MGF ++ +VE+LR
Sbjct: 249 QRITIQEIRRDPWFNVNLPDYLR---PMEEVQGSYADSRIVSKLGEAMGFSEDYIVEALR 305
Query: 181 NRLQNEATVAYYLLLDNR 198
           +   NE   AY LL +N+
Sbjct: 306 SDENNEVKEAYNLLHENQ 323

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  233 bits (593), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 112/148 (75%), Positives = 121/148 (81%), Gaps = 2/148 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 124 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 183
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  LI RMLIV+P+
Sbjct: 184 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 243
Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPD 149
            RI+I EI Q  WF+  LP YL   PPD
Sbjct: 244 NRISIHEIMQDDWFKVDLPEYLL--PPD 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  233 bits (593), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 112/148 (75%), Positives = 121/148 (81%), Gaps = 2/148 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 128 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 187
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  LI RMLIV+P+
Sbjct: 188 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 247
Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPD 149
            RI+I EI Q  WF+  LP YL   PPD
Sbjct: 248 NRISIHEIMQDDWFKVDLPEYLL--PPD 273

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  231 bits (589), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 109/142 (76%), Positives = 118/142 (83%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 134 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 193
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  LI RMLIV+P+
Sbjct: 194 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 253
Query: 122 KRITIPEIRQHPWFQAHLPRYL 143
            RI+I EI Q  WF+  LP YL
Sbjct: 254 NRISIHEIMQDDWFKVDLPEYL 275

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  231 bits (588), Expect = 6e-61,   Method: Compositional matrix adjust.
 Identities = 109/142 (76%), Positives = 118/142 (83%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVISGKLYAGPE
Sbjct: 133 IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPE 192
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWSCGVILY +LC  LPFDDE+IP LFK I  G+YTLP  LSPGA  LI RMLIV+P+
Sbjct: 193 VDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPL 252
Query: 122 KRITIPEIRQHPWFQAHLPRYL 143
            RI+I EI Q  WF+  LP YL
Sbjct: 253 NRISIHEIMQDDWFKVDLPEYL 274

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  227 bits (579), Expect = 8e-60,   Method: Compositional matrix adjust.
 Identities = 102/143 (71%), Positives = 121/143 (84%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 250
Query: 121 MKRITIPEIRQHPWFQAHLPRYL 143
           +KR TI +IR+H WF+  LP YL
Sbjct: 251 LKRATIKDIREHEWFKQDLPSYL 273

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  224 bits (572), Expect = 5e-59,   Method: Compositional matrix adjust.
 Identities = 101/143 (70%), Positives = 120/143 (83%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+ SCGSPNYAAPEVISG+LYAGP
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGP 190
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 250
Query: 121 MKRITIPEIRQHPWFQAHLPRYL 143
           +KR TI +IR+H WF+  LP YL
Sbjct: 251 LKRATIKDIREHEWFKQDLPSYL 273

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 90/196 (45%), Positives = 120/196 (61%), Gaps = 8/196 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLK ENLLLD+  N+KIADFG SN    G  L T CGSP YAAPE+  GK Y GPE
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ R L+++P+
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 251
Query: 122 KRITIPEIRQHPWFQA-HLPRYLA--VPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVES 178
           KR T+ +I +  W  A H    L   V P   +   K+ID      +V MG+ Q ++ ES
Sbjct: 252 KRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRID-----IMVGMGYSQEEIQES 306
Query: 179 LRNRLQNEATVAYYLL 194
           L     +E T  Y LL
Sbjct: 307 LSKMKYDEITATYLLL 322

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  162 bits (411), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 88/196 (44%), Positives = 119/196 (60%), Gaps = 8/196 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLK ENLLLD+  N+KIADFG SN    G  L   CG+P YAAPE+  GK Y GPE
Sbjct: 135 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPE 194
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ R L+++P+
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPI 254
Query: 122 KRITIPEIRQHPWFQA-HLPRYLA--VPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVES 178
           KR T+ +I +  W  A H    L   V P   +   K+ID      +V MG+ Q ++ ES
Sbjct: 255 KRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQKRID-----IMVGMGYSQEEIQES 309
Query: 179 LRNRLQNEATVAYYLL 194
           L     +E T  Y LL
Sbjct: 310 LSKMKYDEITATYLLL 325

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/199 (43%), Positives = 119/199 (59%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GP
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNP 252
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+A P PD        D    + +V MG+ + ++
Sbjct: 253 SKRGTLEQIMKDRWMNVGHEDDELKPYVA-PLPDYK------DPRRTELMVSMGYTREEI 305
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 306 QDSLVGQRYNEVMATYLLL 324

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 86/199 (43%), Positives = 118/199 (59%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GP
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNP 252
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+  P PD        D    + +V MG+ + ++
Sbjct: 253 SKRGTLEQIMKDRWMNVGHEDDELKPYVE-PLPDYK------DPRRTELMVSMGYTREEI 305
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 306 QDSLVGQRYNEVMATYLLL 324

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  157 bits (397), Expect = 8e-39,   Method: Compositional matrix adjust.
 Identities = 86/199 (43%), Positives = 118/199 (59%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GP
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 192
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNP 252
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+  P PD        D    + +V MG+ + ++
Sbjct: 253 SKRGTLEQIMKDRWMNVGHEDDELKPYVE-PLPDYK------DPRRTELMVSMGYTREEI 305
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 306 QDSLVGQRYNEVMATYLLL 324

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 86/199 (43%), Positives = 118/199 (59%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GP
Sbjct: 126 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP 185
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P
Sbjct: 186 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNP 245
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+  P PD        D    + +V MG+ + ++
Sbjct: 246 SKRGTLEQIMKDRWMNVGHEDDELKPYVE-PLPDYK------DPRRTELMVSMGYTREEI 298
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 299 QDSLVGQRYNEVMATYLLL 317

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 85/199 (42%), Positives = 117/199 (58%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L   CGSP YAAPE+  GK Y GP
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGP 192
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNP 252
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+  P PD        D    + +V MG+ + ++
Sbjct: 253 SKRGTLEQIMKDRWMNVGHEDDELKPYVE-PLPDYK------DPRRTELMVSMGYTREEI 305
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 306 QDSLVGQRYNEVMATYLLL 324

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 84/199 (42%), Positives = 117/199 (58%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L   CG+P YAAPE+  GK Y GP
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ + LI++P
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKFLILNP 252
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+  P PD        D    + +V MG+ + ++
Sbjct: 253 SKRGTLEQIMKDRWMNVGHEDDELKPYVE-PLPDYK------DPRRTELMVSMGYTREEI 305
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 306 QDSLVGQRYNEVMATYLLL 324

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 83/199 (41%), Positives = 114/199 (57%), Gaps = 12/199 (6%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G+ L   CG+P YAAPE+  GK Y GP
Sbjct: 133 FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP 192
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P + S    +L+ + LI++P
Sbjct: 193 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTDCENLLKKFLILNP 252
Query: 121 MKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
            KR T+ +I +  W         L  Y+  P PD        D    +  V  G+ + ++
Sbjct: 253 SKRGTLEQIXKDRWXNVGHEDDELKPYVE-PLPDYK------DPRRTELXVSXGYTREEI 305
Query: 176 VESLRNRLQNEATVAYYLL 194
            +SL  +  NE    Y LL
Sbjct: 306 QDSLVGQRYNEVXATYLLL 324

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  149 bits (376), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 86/198 (43%), Positives = 123/198 (62%), Gaps = 12/198 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLK ENLLLD   N+KIADFG SN    G+ L T CGSP YAAPE+  GK Y GPE
Sbjct: 135 IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPE 194
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ ++L+++P+
Sbjct: 195 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKKLLVLNPI 254
Query: 122 KRITIPEIRQHPWF-----QAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLV 176
           KR ++ +I +  W      +  L  Y   P PD     K+ID      +V MGF ++++ 
Sbjct: 255 KRGSLEQIMKDRWMNVGHEEEELKPYTE-PDPD-FNDTKRID-----IMVTMGFARDEIN 307
Query: 177 ESLRNRLQNEATVAYYLL 194
           ++L N+  +E    Y LL
Sbjct: 308 DALINQKYDEVMATYILL 325

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  127 bits (320), Expect = 7e-30,   Method: Compositional matrix adjust.
 Identities = 71/147 (48%), Positives = 85/147 (57%), Gaps = 8/147 (5%)
Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           V HRDLK EN LLD      +KIADFG S         K++ G+P Y APEV+  K Y G
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIP 113
              DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+ + DP KRI+IPEIR H WF  +LP
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 70/147 (47%), Positives = 84/147 (57%), Gaps = 8/147 (5%)
Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           V HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  K Y G
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIP 113
              DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI 
Sbjct: 195 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 254
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+ + DP KRI+IPEIR H WF  +LP
Sbjct: 255 RIFVADPAKRISIPEIRNHEWFLKNLP 281

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 70/147 (47%), Positives = 84/147 (57%), Gaps = 8/147 (5%)
Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           V HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  K Y G
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIP 113
              DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+ + DP KRI+IPEIR H WF  +LP
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 72/166 (43%), Positives = 99/166 (59%), Gaps = 14/166 (8%)
Query: 2   VVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL  +      +KIADFGLS I+     +KT CG+P Y APE++ G  Y 
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY- 227
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIYTLPS----HLSPGARDLIP 113
           GPEVD+WS G+I Y LLCG  PF DE     +F++I    Y   S     +S  A+DL+ 
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
           +++++DP KR+T  +  QHPW       ++ +   DT Q  KK+ E
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKAANFVHM---DTAQ--KKLQE 328

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  124 bits (312), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 69/141 (48%), Positives = 90/141 (63%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           VVHRDLKPENLLL SK     VK+ADFGL+  +  D        G+P Y +PEV+  + Y
Sbjct: 124 VVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAY 183
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A++LI 
Sbjct: 184 GKP-VDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 242
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           +ML ++P KRIT  E  +HPW
Sbjct: 243 QMLTINPAKRITAHEALKHPW 263

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 69/142 (48%), Positives = 89/142 (62%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           +VHRDLKPENLLL SK     VK+ADFGL+  +  D        G+P Y +PEV+    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 184 GKP-VDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 114 RMLIVDPMKRITIPEIRQHPWF 135
           +ML ++P KRIT  E  +HPW 
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/187 (39%), Positives = 98/187 (52%), Gaps = 12/187 (6%)
Query: 2   VVHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  
Sbjct: 197 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 174
           ++  DP KR T  +  QHPW         A+        +++I +   K   K  F+   
Sbjct: 256 LMEKDPEKRFTCEQALQHPWIAGD----TALDKNIHQSVSEQIKKNFAKSKWKQAFNATA 311
Query: 175 LVESLRN 181
           +V  +R 
Sbjct: 312 VVRHMRK 318

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 74/187 (39%), Positives = 98/187 (52%), Gaps = 12/187 (6%)
Query: 2   VVHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  
Sbjct: 197 -KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 174
           ++  DP KR T  +  QHPW         A+        +++I +   K   K  F+   
Sbjct: 256 LMEKDPEKRFTCEQALQHPWIAGD----TALDKNIHQSVSEQIKKNFAKSKWKQAFNATA 311
Query: 175 LVESLRN 181
           +V  +R 
Sbjct: 312 VVRHMRK 318

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 69/142 (48%), Positives = 89/142 (62%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           +VHRDLKPENLLL SK     VK+ADFGL+  +  D        G+P Y +PEV+    Y
Sbjct: 124 IVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKDPY 183
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 184 GKP-VDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 114 RMLIVDPMKRITIPEIRQHPWF 135
           +ML ++P KRIT  E  +HPW 
Sbjct: 243 KMLTINPAKRITASEALKHPWI 264

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  123 bits (309), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 67/140 (47%), Positives = 83/140 (59%), Gaps = 8/140 (5%)
Query: 2   VVHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  
Sbjct: 197 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 115 MLIVDPMKRITIPEIRQHPW 134
           ++  DP KR T  +  QHPW
Sbjct: 256 LMEKDPEKRFTCEQALQHPW 275

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 67/141 (47%), Positives = 83/141 (58%), Gaps = 8/141 (5%)
Query: 2   VVHRDLKPENLL---LDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL   LD    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y+
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 196
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  
Sbjct: 197 KA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 255
Query: 115 MLIVDPMKRITIPEIRQHPWF 135
           ++  DP KR T  +  QHPW 
Sbjct: 256 LMEKDPEKRFTCEQALQHPWI 276

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 69/142 (48%), Positives = 89/142 (62%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           VVHRDLKPENLLL SK     VK+ADFGL+  +  +        G+P Y +PEV+    Y
Sbjct: 142 VVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 201
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 202 GKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 260
Query: 114 RMLIVDPMKRITIPEIRQHPWF 135
           +ML ++P KRIT  E  +HPW 
Sbjct: 261 KMLTINPSKRITAAEALKHPWI 282

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  122 bits (305), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 69/147 (46%), Positives = 83/147 (56%), Gaps = 8/147 (5%)
Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           V HRDLK EN LLD      +KI  FG S         K++ G+P Y APEV+  K Y G
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIP 113
              DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+ + DP KRI+IPEIR H WF  +LP
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 64/140 (45%), Positives = 83/140 (59%), Gaps = 8/140 (5%)
Query: 2   VVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL    D +  + I+DFGLS +   G  + T+CG+P Y APEV++ K Y+
Sbjct: 141 IVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYS 200
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I  
Sbjct: 201 KA-VDCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRN 259
Query: 115 MLIVDPMKRITIPEIRQHPW 134
           ++  DP KR T  +  +HPW
Sbjct: 260 LMEKDPNKRYTCEQAARHPW 279

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 69/147 (46%), Positives = 82/147 (55%), Gaps = 8/147 (5%)
Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           V HRDLK EN LLD      +KI  FG S         K + G+P Y APEV+  K Y G
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIP 113
              DVWSCGV LY +L G  PF+D   P  F+K    I    Y +P   H+SP  R LI 
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+ + DP KRI+IPEIR H WF  +LP
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFLKNLP 282

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 68/142 (47%), Positives = 89/142 (62%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           VVHR+LKPENLLL SK     VK+ADFGL+  +  +        G+P Y +PEV+    Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 191 GKP-VDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249
Query: 114 RMLIVDPMKRITIPEIRQHPWF 135
           +ML ++P KRIT  E  +HPW 
Sbjct: 250 KMLTINPSKRITAAEALKHPWI 271

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 67/161 (41%), Positives = 91/161 (56%), Gaps = 9/161 (5%)
Query: 2   VVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL    +    + I DFGLS + ++G  + T+CG+P Y APEV++ K Y+
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYS 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF +E    LF+KIK G Y   S     +S  A+D I  
Sbjct: 186 KA-VDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 155
           +L  DP +R T  +   HPW   +   +  + P  ++Q  K
Sbjct: 245 LLEKDPNERYTCEKALSHPWIDGNTALHRDIYPSVSLQIQK 285

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 66/141 (46%), Positives = 89/141 (63%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           +VHRDLKPENLLL SK     VK+ADFGL+  +  +        G+P Y +PEV+    Y
Sbjct: 151 IVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLSPEVLRKDPY 210
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
             P VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A++LI 
Sbjct: 211 GKP-VDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLIN 269
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           +ML ++P KRIT  +  +HPW
Sbjct: 270 QMLTINPAKRITADQALKHPW 290

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 71/164 (43%), Positives = 94/164 (57%), Gaps = 8/164 (4%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y+
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 208
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
            P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 209 KP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID 158
           ML V+P KRIT  +  + PW         A+   DT+   KK +
Sbjct: 268 MLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKKFN 311

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 69/153 (45%), Positives = 90/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+    VKI DFGL+  +  DG   KT CG+PNY APEV+S K ++  
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF- 196
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 256
Query: 121 MKRITIPEIRQHPWFQ-----AHLP-RYLAVPP 147
             R TI E+    +F      A LP   L +PP
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPITCLTIPP 289

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 68/165 (41%), Positives = 98/165 (59%), Gaps = 10/165 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KPEN+LL SK N   VK+ DFG++  +   G       G+P++ APEV+  + Y
Sbjct: 151 IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY 210
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
             P VDVW CGVIL+ LL G LPF       LF+ I  G Y +     SH+S  A+DL+ 
Sbjct: 211 GKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID 158
           RML++DP +RIT+ E   HPW +        +  P+T++Q +K +
Sbjct: 269 RMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 69/153 (45%), Positives = 90/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+    VKI DFGL+  +  DG   KT CG+PNY APEV+S K ++  
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF- 196
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 256
Query: 121 MKRITIPEIRQHPWFQ-----AHLP-RYLAVPP 147
             R TI E+    +F      A LP   L +PP
Sbjct: 257 TARPTINELLNDEFFTSGYIPARLPITCLTIPP 289

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  119 bits (297), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 69/153 (45%), Positives = 90/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+    VKI DFGL+  +  DG   KT CG+PNY APEV+S K ++  
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSF- 200
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 260
Query: 121 MKRITIPEIRQHPWFQ-----AHLP-RYLAVPP 147
             R TI E+    +F      A LP   L +PP
Sbjct: 261 TARPTINELLNDEFFTSGYIPARLPITCLTIPP 293

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 62/147 (42%), Positives = 84/147 (57%), Gaps = 9/147 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L++ CG+P+Y APE+I   +     
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIECSMNDNHP 204
Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLI 112
             G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S      S   +DL+
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAHL 139
            R L+V P KR T  E   HP+FQ ++
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQYV 291

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/153 (44%), Positives = 89/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K ++  
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF- 194
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 254
Query: 121 MKRITIPEIRQHPWFQ-----AHLP-RYLAVPP 147
             R TI E+    +F      A LP   L +PP
Sbjct: 255 TARPTINELLNDEFFTSGYIPARLPITCLTIPP 287

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 68/153 (44%), Positives = 89/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K ++  
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF- 218
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 278
Query: 121 MKRITIPEIRQHPWFQ-----AHLP-RYLAVPP 147
             R TI E+    +F      A LP   L +PP
Sbjct: 279 TARPTINELLNDEFFTSGYIPARLPITCLTIPP 311

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 62/147 (42%), Positives = 83/147 (56%), Gaps = 9/147 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+I   +     
Sbjct: 145 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 204
Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLI 112
             G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S      S   +DL+
Sbjct: 205 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 264
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAHL 139
            R L+V P KR T  E   HP+FQ ++
Sbjct: 265 SRFLVVQPQKRYTAEEALAHPFFQQYV 291

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 66/141 (46%), Positives = 86/141 (60%), Gaps = 8/141 (5%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y+
Sbjct: 125 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
            P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 185 KP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 243
Query: 115 MLIVDPMKRITIPEIRQHPWF 135
           ML V+P KRIT  +  + PW 
Sbjct: 244 MLTVNPKKRITADQALKVPWI 264

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 66/140 (47%), Positives = 86/140 (61%), Gaps = 8/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
            P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 186 KP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 115 MLIVDPMKRITIPEIRQHPW 134
           ML V+P KRIT  +  + PW
Sbjct: 245 MLTVNPKKRITADQALKVPW 264

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 66/141 (46%), Positives = 86/141 (60%), Gaps = 8/141 (5%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y+
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYS 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
            P VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 186 KP-VDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244
Query: 115 MLIVDPMKRITIPEIRQHPWF 135
           ML V+P KRIT  +  + PW 
Sbjct: 245 MLTVNPKKRITADQALKVPWI 265

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 62/146 (42%), Positives = 82/146 (56%), Gaps = 9/146 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+I   +     
Sbjct: 132 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 191
Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLI 112
             G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S      S   +DL+
Sbjct: 192 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 251
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAH 138
            R L+V P KR T  E   HP+FQ +
Sbjct: 252 SRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 68/153 (44%), Positives = 89/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K ++  
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF- 220
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  DP
Sbjct: 221 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDP 280
Query: 121 MKRITIPEIRQHPWFQ-----AHLP-RYLAVPP 147
             R TI E+    +F      A LP   L +PP
Sbjct: 281 TARPTINELLNDEFFTSGYIPARLPITCLTIPP 313

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 68/153 (44%), Positives = 90/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+   +VKI DFGL+  I  DG   KT CG+PNY APEV+  K ++  
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSF- 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADP 281
Query: 121 MKRITIPEIRQHPWFQA-----HLP-RYLAVPP 147
             R ++ E+    +F +      LP   L VPP
Sbjct: 282 TLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 314

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 64/154 (41%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G    
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY-- 204
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
           ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 59/144 (40%), Positives = 83/144 (57%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           +VHRDLKPEN+LLD    ++++DFG S  +  G  L+  CG+P Y APE++   +     
Sbjct: 221 IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHP 280
Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLI 112
             G EVD+W+CGVIL+ LL G+ PF       + + I  G Y   S      S   +DLI
Sbjct: 281 GYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLI 340
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQ 136
            R+L VDP  R+T  +  QHP+F+
Sbjct: 341 SRLLQVDPEARLTAEQALQHPFFE 364

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 64/144 (44%), Positives = 86/144 (59%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G    
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY-- 199
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARDLIPR 114
             + DVWS GVILY LL GT PF  +N  ++ K+++ G Y   LP    +S  A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           ML   P  RIT  +  +HPW Q +
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 64/154 (41%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G    
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY-- 227
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 228 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 287
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
           ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 288 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 321

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 64/154 (41%), Positives = 85/154 (55%), Gaps = 9/154 (5%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G    
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY-- 228
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 229 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 288
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
           ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 289 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 322

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 61/142 (42%), Positives = 85/142 (59%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK     +KI DFGLS +  +   +K   G+  Y APEV+  K   
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKKY-- 214
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
             + DVWS GVIL+ LL G  PF  +    + +K++ G YT  S    ++S GA+DLI +
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274
Query: 115 MLIVDPMKRITIPEIRQHPWFQ 136
           ML  D  +RI+  +  +HPW +
Sbjct: 275 MLQFDSQRRISAQQALEHPWIK 296

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/144 (44%), Positives = 86/144 (59%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G    
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY-- 199
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARDLIPR 114
             + DVWS GVILY LL GT PF  +N  ++ K+++ G Y   LP    +S  A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           ML   P  RIT  +  +HPW Q +
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 64/144 (44%), Positives = 86/144 (59%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G    
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTY-- 199
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--LPS--HLSPGARDLIPR 114
             + DVWS GVILY LL GT PF  +N  ++ K+++ G Y   LP    +S  A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259
Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           ML   P  RIT  +  +HPW Q +
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKY 283

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 85/137 (62%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 190
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +++I    +T P  ++ GARDLI R+L  +  
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHNAS 250
Query: 122 KRITIPEIRQHPWFQAH 138
           +R+T+ E+ +HPW +A+
Sbjct: 251 QRLTLAEVLEHPWIKAN 267

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/153 (43%), Positives = 89/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+   +VKI DFGL+  I  DG   K  CG+PNY APEV+  K ++  
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSF- 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADP 281
Query: 121 MKRITIPEIRQHPWFQA-----HLP-RYLAVPP 147
             R ++ E+    +F +      LP   L VPP
Sbjct: 282 TLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 314

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/153 (43%), Positives = 89/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+   +VKI DFGL+  I  DG   K  CG+PNY APEV+  K ++  
Sbjct: 163 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF- 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP
Sbjct: 222 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADP 281
Query: 121 MKRITIPEIRQHPWFQA-----HLP-RYLAVPP 147
             R ++ E+    +F +      LP   L VPP
Sbjct: 282 TLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 314

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 58/141 (41%), Positives = 87/141 (61%), Gaps = 10/141 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS----NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           V+HRD+KPENLLL S   +KIADFG S    +  RD     T CG+ +Y  PE+I G+++
Sbjct: 133 VIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD-----TLCGTLDYLPPEMIEGRMH 187
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
              +VD+WS GV+ Y  L G  PF+       +++I    +T P  ++ GARDLI R+L 
Sbjct: 188 -DEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLK 246
Query: 118 VDPMKRITIPEIRQHPWFQAH 138
            +  +R+T+ E+ +HPW +A+
Sbjct: 247 HNASQRLTLAEVLEHPWIKAN 267

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 58/138 (42%), Positives = 82/138 (59%), Gaps = 5/138 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG--KLYA 58
           ++HRD+KP NLL+    ++KIADFG+SN  +     L  + G+P + APE +S   K+++
Sbjct: 158 IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFS 217
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRML 116
           G  +DVW+ GV LY  + G  PF DE I  L  KIK      P    ++   +DLI RML
Sbjct: 218 GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRML 277
Query: 117 IVDPMKRITIPEIRQHPW 134
             +P  RI +PEI+ HPW
Sbjct: 278 DKNPESRIVVPEIKLHPW 295

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 67/153 (43%), Positives = 89/153 (58%), Gaps = 8/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLK  NL L+   +VKI DFGL+  I  DG   K  CG+PNY APEV+  K ++  
Sbjct: 147 VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSF- 205
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS G ILY LL G  PF+   +   + +IK   Y++P H++P A  LI RML  DP
Sbjct: 206 EVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRMLHADP 265
Query: 121 MKRITIPEIRQHPWFQA-----HLP-RYLAVPP 147
             R ++ E+    +F +      LP   L VPP
Sbjct: 266 TLRPSVAELLTDEFFTSGYAPMRLPTSCLTVPP 298

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 146 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 203
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 204 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 263
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 264 QRPMLREVLEHPWITAN 280

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 63/147 (42%), Positives = 82/147 (55%), Gaps = 8/147 (5%)
Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           + HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  + Y G
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDG 196
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI----YTLPS--HLSPGARDLIP 113
              DVWSCGV LY +L G  PF+D   P  ++K    I    Y++P    +SP    LI 
Sbjct: 197 KIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLIS 256
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+ + DP  RI+IPEI+ H WF  +LP
Sbjct: 257 RIFVADPATRISIPEIKTHSWFLKNLP 283

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 61/140 (43%), Positives = 81/140 (57%), Gaps = 9/140 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK     +KI DFGLS     G  +K   G+  Y APEV+  K   
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY-- 182
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWSCGVILY LLCG  PF  +    + K+++ G ++      + +S  A+ L+  
Sbjct: 183 DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKL 242
Query: 115 MLIVDPMKRITIPEIRQHPW 134
           ML  +P KRI+  E   HPW
Sbjct: 243 MLTYEPSKRISAEEALNHPW 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 191
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 252 QRPMLREVLEHPWITAN 268

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 212
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 273 QRPMLREVLEHPWITAN 289

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 191
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 252 QRPMLREVLEHPWITAN 268

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 189
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 250 QRPMLREVLEHPWITAN 266

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 189
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 250 QRPMLREVLEHPWITAN 266

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGRMH-DEK 187
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 248 QRPMLREVLEHPWITAN 264

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 128 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 185
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 245
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 246 QRPMLREVLEHPWITAN 262

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 63/154 (40%), Positives = 83/154 (53%), Gaps = 9/154 (5%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK    N++I DFGLS         K   G+  Y APEV+ G    
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTY-- 204
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
            L   P  RI+  +   H W Q +    ++V  P
Sbjct: 265 XLTYVPSXRISARDALDHEWIQTYTKEQISVDVP 298

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 133 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 190
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 250
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 251 QRPMLREVLEHPWITAN 267

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 126 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 183
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 184 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 243
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 244 QRPMLREVLEHPWITAN 260

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  111 bits (278), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 61/140 (43%), Positives = 81/140 (57%), Gaps = 9/140 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK     +KI DFGLS     G  +K   G+  Y APEV+  K   
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRKKY-- 199
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWSCGVILY LLCG  PF  +    + K+++ G ++      + +S  A+ L+  
Sbjct: 200 DEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLVKL 259
Query: 115 MLIVDPMKRITIPEIRQHPW 134
           ML  +P KRI+  E   HPW
Sbjct: 260 MLTYEPSKRISAEEALNHPW 279

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 65/165 (39%), Positives = 95/165 (57%), Gaps = 10/165 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP  +LL SK N   VK+  FG++  +   G       G+P++ APEV+  + Y
Sbjct: 153 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY 212
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
             P VDVW CGVIL+ LL G LPF       LF+ I  G Y +     SH+S  A+DL+ 
Sbjct: 213 GKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVR 270
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID 158
           RML++DP +RIT+ E   HPW +        +  P+T++Q +K +
Sbjct: 271 RMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 315

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 62/157 (39%), Positives = 90/157 (57%), Gaps = 8/157 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISG-KLY 57
           +VH+D+KP NLLL +   +KI+  G++  +         +TS GSP +  PE+ +G   +
Sbjct: 130 IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTF 189
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
           +G +VD+WS GV LY +  G  PF+ +NI  LF+ I  G Y +P    P   DL+  ML 
Sbjct: 190 SGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLE 249
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLA---VPP-PDT 150
            +P KR +I +IRQH WF+   P   A   +PP PDT
Sbjct: 250 YEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDT 286

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 65/165 (39%), Positives = 95/165 (57%), Gaps = 10/165 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP  +LL SK N   VK+  FG++  +   G       G+P++ APEV+  + Y
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY 210
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
             P VDVW CGVIL+ LL G LPF       LF+ I  G Y +     SH+S  A+DL+ 
Sbjct: 211 GKP-VDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKID 158
           RML++DP +RIT+ E   HPW +        +  P+T++Q +K +
Sbjct: 269 RMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFN 313

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 62/145 (42%), Positives = 85/145 (58%), Gaps = 9/145 (6%)
Query: 2   VVHRDLKPENLLL--DSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           V HRDLKPEN L   DS  + +K+ DFGL+   + G  ++T  G+P Y +P+V+ G LY 
Sbjct: 144 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LY- 201
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
           GPE D WS GV++Y LLCG  PF       +  KI+ G +T P     ++SP A  LI R
Sbjct: 202 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 261
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHL 139
           +L   P +RIT  +  +H WF+  L
Sbjct: 262 LLTKSPKQRITSLQALEHEWFEKQL 286

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 59/144 (40%), Positives = 83/144 (57%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRD+KPEN+LL++K    N+KI DFGLS+     + L+   G+  Y APEV+  K   
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKY-- 224
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWSCGVI+Y LLCG  PF  +N  ++ KK++ G Y        ++S  A++LI  
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL 284
Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           ML  D  KR T  E     W + +
Sbjct: 285 MLTYDYNKRCTAEEALNSRWIKKY 308

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/145 (42%), Positives = 85/145 (58%), Gaps = 9/145 (6%)
Query: 2   VVHRDLKPENLLL--DSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           V HRDLKPEN L   DS  + +K+ DFGL+   + G  ++T  G+P Y +P+V+ G LY 
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LY- 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
           GPE D WS GV++Y LLCG  PF       +  KI+ G +T P     ++SP A  LI R
Sbjct: 185 GPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLIRR 244
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHL 139
           +L   P +RIT  +  +H WF+  L
Sbjct: 245 LLTKSPKQRITSLQALEHEWFEKQL 269

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 62/144 (43%), Positives = 81/144 (56%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G    
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY-- 210
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 270
Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           ML   P  RI+  +   H W Q +
Sbjct: 271 MLTYVPSMRISARDALDHEWIQTY 294

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIA+FG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 131 VIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 188
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 248
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 249 QRPMLREVLEHPWITAN 265

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 57/137 (41%), Positives = 81/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +        T CG+ +Y  PE I G+ +   +
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGRXH-DEK 191
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 252 QRPXLREVLEHPWITAN 268

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIA+FG S +        T CG+ +Y  PE+I G+++   +
Sbjct: 132 VIHRDIKPENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGRMH-DEK 189
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 250 QRPMLREVLEHPWITAN 266

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMH-DEK 189
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 250 QRPMLREVLEHPWITAN 266

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 83/137 (60%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+     + +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 131 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMH-DEK 188
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 248
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 249 QRPMLREVLEHPWITAN 265

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 155 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMH-DEK 212
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 272
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 273 QRPMLREVLEHPWITAN 289

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMH-DEK 189
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 250 QRPMLREVLEHPWITAN 266

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 55/138 (39%), Positives = 82/138 (59%), Gaps = 6/138 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDL   NLLL    N+KIADFGL+  ++   + H+  T CG+PNY +PE+ +   + 
Sbjct: 133 ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRSAH- 189
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
           G E DVWS G + Y LL G  PFD + + N   K+    Y +PS LS  A+DLI ++L  
Sbjct: 190 GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRR 249
Query: 119 DPMKRITIPEIRQHPWFQ 136
           +P  R+++  +  HP+  
Sbjct: 250 NPADRLSLSSVLDHPFMS 267

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEK 187
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 248 QRPMLREVLEHPWITAN 264

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEK 191
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 252 QRPMLREVLEHPWITAN 268

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 129 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGRMH-DEK 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 246
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 247 QRPMLREVLEHPWITAN 263

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 82/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   +
Sbjct: 132 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGRMH-DEK 189
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 249
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 250 QRPMLREVLEHPWITAN 266

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 254
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 255 VKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 254
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 255 VKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 134 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 193
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 194 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 253
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 254 VKKLLVVDPKARFTTEEALRHPWLQ 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 135 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 194
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 195 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 254
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 255 VKKLLVVDPKARFTTEEALRHPWLQ 279

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 141 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 200
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 201 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 260
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 261 VKKLLVVDPKARFTTEEALRHPWLQ 285

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/172 (37%), Positives = 93/172 (54%), Gaps = 10/172 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G 
Sbjct: 273 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GR 331
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP
Sbjct: 332 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 391
Query: 121 MKRI-----TIPEIRQHPWFQAHLPRYL---AVPPPDTMQQAKKIDEEILKE 164
            +R+        EI QH +F   + +++    + PP   Q   + D     E
Sbjct: 392 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 443

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 56/137 (40%), Positives = 81/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S          T  G+ +Y  PE+I G+++   +
Sbjct: 130 VIHRDIKPENLLLGSAGELKIADFGWSCHAPSSR-RTTLSGTLDYLPPEMIEGRMH-DEK 187
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 247
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 248 QRPMLREVLEHPWITAN 264

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 274 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 333
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 334 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 393
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 394 VKKLLVVDPKARFTTEEALRHPWLQ 418

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 64/172 (37%), Positives = 93/172 (54%), Gaps = 10/172 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G 
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GR 328
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 388
Query: 121 MKRI-----TIPEIRQHPWFQAHLPRYL---AVPPPDTMQQAKKIDEEILKE 164
            +R+        EI QH +F   + +++    + PP   Q   + D     E
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 440

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 60/145 (41%), Positives = 82/145 (56%), Gaps = 10/145 (6%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     A
Sbjct: 260 IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTA 319
Query: 59  G--PEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDL 111
           G    VD WS GVIL+  L G  PF +     +L  +I  G Y       + +S  A DL
Sbjct: 320 GYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDL 379
Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           + ++L+VDP  R T  E  +HPW Q
Sbjct: 380 VKKLLVVDPKARFTTEEALRHPWLQ 404

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 55/137 (40%), Positives = 81/137 (59%), Gaps = 2/137 (1%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S +           G+ +Y  PE+I G+++   +
Sbjct: 134 VIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGRMH-DEK 191
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 251
Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 252 QRPMLREVLEHPWITAN 268

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/172 (36%), Positives = 92/172 (53%), Gaps = 10/172 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +K  CG+P Y APEV+    Y G 
Sbjct: 131 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-GR 189
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 249
Query: 121 MKRI-----TIPEIRQHPWFQAHLPRYL---AVPPPDTMQQAKKIDEEILKE 164
            +R+        EI QH +F   + +++    + PP   Q   + D     E
Sbjct: 250 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 301

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 63/172 (36%), Positives = 92/172 (53%), Gaps = 10/172 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +K  CG+P Y APEV+    Y G 
Sbjct: 130 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-GR 188
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP
Sbjct: 189 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 248
Query: 121 MKRI-----TIPEIRQHPWFQAHLPRYL---AVPPPDTMQQAKKIDEEILKE 164
            +R+        EI QH +F   + +++    + PP   Q   + D     E
Sbjct: 249 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 300

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/172 (36%), Positives = 92/172 (53%), Gaps = 10/172 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +K  CG+P Y APEV+    Y G 
Sbjct: 132 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDY-GR 190
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP
Sbjct: 191 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 250
Query: 121 MKRI-----TIPEIRQHPWFQAHLPRYL---AVPPPDTMQQAKKIDEEILKE 164
            +R+        EI QH +F   + +++    + PP   Q   + D     E
Sbjct: 251 KQRLGGGSEDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSETDTRYFDE 302

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/140 (40%), Positives = 82/140 (58%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 129 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 187
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 188 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 247
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 248 KQRLGGGPSDAKEVMEHRFF 267

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 61/178 (34%), Positives = 94/178 (52%), Gaps = 21/178 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPEN+LLD   ++KI DFG +  + D  +    CG+P+Y APEV+S K Y    
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--XLCGTPDYIAPEVVSTKPY-NKS 183
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           +D WS G+++Y +L G  PF D N    ++KI       P   +   +DL+ R++  D  
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 243
Query: 122 KRI-----TIPEIRQHPWF-----QAHLPRYLAVP--PP------DTMQQAKKIDEEI 161
           +R+        +++ HPWF     +  L R +  P  PP      DT Q  K  +E+I
Sbjct: 244 QRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTSQFDKYPEEDI 301

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/140 (40%), Positives = 82/140 (58%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 57/140 (40%), Positives = 82/140 (58%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTS--CGSPNYAAPEVISGKLY 57
           +V+RDLK +N+LLD   ++KIADFG+   N++ D    KT+  CG+P+Y APE++ G+ Y
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNXFCGTPDYIAPEILLGQKY 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
               VD WS GV+LY +L G  PF  ++   LF  I+      P  L   A+DL+ ++ +
Sbjct: 196 -NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 254
Query: 118 VDPMKRITIP-EIRQHPWFQ----AHLPRYLAVPP--PDTMQ--QAKKIDEEILKEVVKM 168
            +P KR+ +  +IRQHP F+      L R    PP  P           D+E L E  ++
Sbjct: 255 REPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 314
Query: 169 GFDQNQLVESL-RNRLQN 185
            F    L+ S+ +N  +N
Sbjct: 315 SFADRALINSMDQNMFRN 332

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/198 (35%), Positives = 108/198 (54%), Gaps = 18/198 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTS--CGSPNYAAPEVISGKLY 57
           +V+RDLK +N+LLD   ++KIADFG+   N++ D    KT+  CG+P+Y APE++ G+ Y
Sbjct: 140 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA---KTNEFCGTPDYIAPEILLGQKY 196
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
               VD WS GV+LY +L G  PF  ++   LF  I+      P  L   A+DL+ ++ +
Sbjct: 197 -NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 255
Query: 118 VDPMKRITIP-EIRQHPWFQ----AHLPRYLAVPP--PDTMQ--QAKKIDEEILKEVVKM 168
            +P KR+ +  +IRQHP F+      L R    PP  P           D+E L E  ++
Sbjct: 256 REPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRL 315
Query: 169 GFDQNQLVESL-RNRLQN 185
            F    L+ S+ +N  +N
Sbjct: 316 XFADRALINSMDQNMFRN 333

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 56/140 (40%), Positives = 81/140 (57%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GR 184
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 56/140 (40%), Positives = 81/140 (57%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GR 184
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 56/140 (40%), Positives = 81/140 (57%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GR 184
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 245 KQRLGGGPSDAKEVMEHRFF 264

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 56/140 (40%), Positives = 81/140 (57%), Gaps = 7/140 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +K  CG+P Y APEV+    Y G 
Sbjct: 131 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDY-GR 189
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 190 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 249
Query: 121 MKRI-----TIPEIRQHPWF 135
            +R+        E+ +H +F
Sbjct: 250 KQRLGGGPSDAKEVMEHRFF 269

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 86/154 (55%), Gaps = 4/154 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLL+  K  +KIADFG S +       +  CG+ +Y  PE+I GK +   +
Sbjct: 136 VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH-DEK 193
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+W  GV+ Y  L G  PFD  +     ++I       P  LS G++DLI ++L   P 
Sbjct: 194 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPP 253
Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 155
           +R+ +  + +HPW +A+  R L  PP     Q+K
Sbjct: 254 QRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 285

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 243
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 244 LVENPSARITIPDIKKDRWYNKPLKK 269

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 58/154 (37%), Positives = 86/154 (55%), Gaps = 4/154 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLL+  K  +KIADFG S +       +  CG+ +Y  PE+I GK +   +
Sbjct: 135 VIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGKTH-DEK 192
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+W  GV+ Y  L G  PFD  +     ++I       P  LS G++DLI ++L   P 
Sbjct: 193 VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPP 252
Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 155
           +R+ +  + +HPW +A+  R L  PP     Q+K
Sbjct: 253 QRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 284

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 53/146 (36%), Positives = 84/146 (57%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/144 (36%), Positives = 83/144 (57%), Gaps = 6/144 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHL 139
           L+ +P  RITIP+I++  W+   L
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPL 268

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/144 (36%), Positives = 83/144 (57%), Gaps = 6/144 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHL 139
           L+ +P  RITIP+I++  W+   L
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPL 268

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 53/144 (36%), Positives = 83/144 (57%), Gaps = 6/144 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L   CG+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHL 139
           L+ +P  RITIP+I++  W+   L
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPL 269

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P Y APE+I  K Y    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATW--TLCGTPEYLAPEIILSKGY-NKA 239
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 299
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 300 KRFGNLKNGVNDIKNHKWF 318

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 52/139 (37%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 52/139 (37%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 52/139 (37%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 52/139 (37%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +K+ADFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L+T C +P Y APEV+  + Y 
Sbjct: 130 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKY- 187
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF         P + ++I+ G Y  P    S +S  A+ 
Sbjct: 188 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQ 247
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQAHL-----PRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  DP +R+TI +   HPW    +     P + A    +      ++ EE+   +
Sbjct: 248 LIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSAL 307
Query: 166 VKMGFDQNQL 175
             M  D +Q+
Sbjct: 308 ATMRVDYDQV 317

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 64/190 (33%), Positives = 95/190 (50%), Gaps = 18/190 (9%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L+T C +P Y APEV+  + Y 
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ-NALQTPCYTPYYVAPEVLGPEKY- 206
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF         P + ++I+ G Y  P    S +S  A+ 
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQ 266
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQAHL-----PRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  DP +R+TI +   HPW    +     P + A    +      ++ EE+   +
Sbjct: 267 LIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSAL 326
Query: 166 VKMGFDQNQL 175
             M  D +Q+
Sbjct: 327 ATMRVDYDQV 336

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P Y APE+I  K Y    
Sbjct: 148 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEYLAPEIILSKGY-NKA 204
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 205 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 264
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 265 KRFGNLKDGVNDIKNHKWF 283

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFGL+  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 58/151 (38%), Positives = 90/151 (59%), Gaps = 5/151 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL  K  +KIADFG S +       KT CG+ +Y  PE+I G+++   +
Sbjct: 144 VIHRDIKPENLLLGLKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEGRMH-NEK 201
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+W  GV+ Y LL G  PF+  +    +++I       P+ +  GA+DLI ++L  +P 
Sbjct: 202 VDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHNPS 261
Query: 122 KRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           +R+ + ++  HPW +A+  R L   PP  +Q
Sbjct: 262 ERLPLAQVSAHPWVRANSRRVL---PPSALQ 289

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 188 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 246
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 247 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 306
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  +P +R+TI E   HPW          P + +    +  ++ + + EE+   +
Sbjct: 307 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 366
Query: 166 VKMGFDQNQL 175
             M  D  Q+
Sbjct: 367 ATMRVDYEQI 376

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 240
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  +P +R+TI E   HPW          P + +    +  ++ + + EE+   +
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 360
Query: 166 VKMGFDQNQL 175
             M  D  Q+
Sbjct: 361 ATMRVDYEQI 370

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 53/149 (35%), Positives = 86/149 (57%), Gaps = 12/149 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLI 112
              VDVWSCG++L A+L G LP+D    P+   +         ++L+P  +       L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQ---PSDSXQEYSDWKEKKTYLNPWKKIDSAPLALL 241
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAHLPR 141
            ++L+ +P  RITIP+I++  W+   L +
Sbjct: 242 HKILVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/141 (39%), Positives = 85/141 (60%), Gaps = 7/141 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N++LDS+ ++KIADFG+    M DG   +  CG+P+Y APE+I+ + Y G 
Sbjct: 141 IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPY-GK 199
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PFD E+   LF+ I     + P  LS  A  +   ++   P
Sbjct: 200 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHP 259
Query: 121 MKRITI-PE----IRQHPWFQ 136
            KR+   PE    +R+H +F+
Sbjct: 260 AKRLGCGPEGERDVREHAFFR 280

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 58/155 (37%), Positives = 87/155 (56%), Gaps = 15/155 (9%)
Query: 2   VVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKL 56
           VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV+  + 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLP----SHLSPGAR 109
           Y     D+WS GV+LY +L G  PF    D+    +  +I  G ++L     + +S  A+
Sbjct: 197 YDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQ--AHLPRY 142
           DL+ +ML VDP +R+T   + +HPW      LP+Y
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 196
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 256
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  +P +R+TI E   HPW          P + +    +  ++ + + EE+   +
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 316
Query: 166 VKMGFDQNQL 175
             M  D  Q+
Sbjct: 317 ATMRVDYEQI 326

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 17/190 (8%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 196
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 197 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 256
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  +P +R+TI E   HPW          P + +    +  ++ + + EE+   +
Sbjct: 257 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 316
Query: 166 VKMGFDQNQL 175
             M  D  Q+
Sbjct: 317 ATMRVDYEQI 326

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +K+ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 55/145 (37%), Positives = 84/145 (57%), Gaps = 13/145 (8%)
Query: 2   VVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKL 56
           VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV+  + 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDD---ENIPNLFKKIKGGIYTLP----SHLSPGAR 109
           Y     D+WS G++LY +L G  PF +   +    +  +I  G +TL     + +S  A+
Sbjct: 202 Y-DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAK 260
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           DL+ +ML VDP +R+T  ++ QHPW
Sbjct: 261 DLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 83/146 (56%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 79/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +++ DFGL+  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 83/146 (56%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  + + 
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 245
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 246 LVENPSARITIPDIKKDRWYNKPLKK 271

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 85/145 (58%), Gaps = 13/145 (8%)
Query: 2   VVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKL 56
           VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV+  + 
Sbjct: 142 VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDD--ENIPN-LFKKIKGGIYTLP----SHLSPGAR 109
           Y     D+WS G++LY +L G  PF +   + P  +  +I  G +TL     + +S  A+
Sbjct: 202 Y-DEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAK 260
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           DL+ +ML VDP +R+T  ++ QHPW
Sbjct: 261 DLVSKMLHVDPHQRLTAKQVLQHPW 285

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 52/146 (35%), Positives = 83/146 (56%), Gaps = 6/146 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +P  RITIP+I++  W+   L +
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPLKK 270

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 157 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 213
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 214 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 273
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 274 KRFGNLKNGVNDIKNHKWF 292

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 239
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 299
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 300 KRFGNLKNGVNDIKNHKWF 318

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLPNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 59/150 (39%), Positives = 83/150 (55%), Gaps = 16/150 (10%)
Query: 2   VVHRDLKPENLLL---DSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 57
           VVHRDLKPENLL    +    +KI DFG + +   D   LKT C + +YAAPE+++   Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLP----SHLSP 106
                D+WS GVILY +L G +PF   +          + KKIK G ++       ++S 
Sbjct: 187 -DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245
Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
            A+DLI  +L VDP KR+ +  +R + W Q
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 280 KRFGNLKNGVNDIKNHKWF 298

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 149 LIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 205
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 206 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 265
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 266 KRFGNLKNGVNDIKNHKWF 284

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKDGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 183 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 239
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 240 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 299
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 300 KRFGNLKNGVNDIKNHKWF 318

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 194 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 253 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 281

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 52/144 (36%), Positives = 82/144 (56%), Gaps = 6/144 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLLLD + N+KI+DFGL+ + R  +    L    G+  Y APE++  + + 
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 59  GPEVDVWSCGVILYALLCGTLPFD--DENIPNLFKKIKGGIYTLP-SHLSPGARDLIPRM 115
              VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ ++
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKI 244
Query: 116 LIVDPMKRITIPEIRQHPWFQAHL 139
           L+ +P  RITIP+I++  W+   L
Sbjct: 245 LVENPSARITIPDIKKDRWYNKPL 268

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 211
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 271
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 272 KRFGNLKNGVNDIKNHKWF 290

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 155 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 211
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 212 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 271
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 272 KRFGNLKNGVNDIKNHKWF 290

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 194 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 252
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 253 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 281

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 60/159 (37%), Positives = 83/159 (52%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           R+L+ DP KR+TI +  QHPW          + P DT Q
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPW----------IKPKDTQQ 282

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 143 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 201
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 202 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 261
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 262 LIRNLLKTEPTQRMTITEFMNHPWI 286

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 142 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 200
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 201 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 260
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 261 LIRNLLKTEPTQRMTITEFMNHPWI 285

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 144 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 202
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 203 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 262
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 263 LIRNLLKTEPTQRMTITEFMNHPWI 287

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIIISKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 152 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 210
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 211 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 270
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 271 LIRNLLKTEPTQRMTITEFMNHPWI 295

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 194
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 254
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 56/145 (38%), Positives = 77/145 (53%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 137 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 195
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 196 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 255
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 256 LIRNLLKTEPTQRMTITEFMNHPWI 280

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 69/187 (36%), Positives = 92/187 (49%), Gaps = 37/187 (19%)
Query: 2   VVHRDLKPENLLLDSKWNV---KIADFGL-SNIMRDGHF-------LKTSCGSPNYAAPE 50
           + HRDLKPEN+L +    V   KI DFGL S I  +G         L T CGS  Y APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 51  VISG-----KLYAGPEVDVWSCGVILYALLCGTLPF-----------DDENIPN----LF 90
           V+        +Y     D+WS GVILY LL G  PF             E  P     LF
Sbjct: 192 VVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 91  KKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           + I+ G Y  P    +H+S  A+DLI ++L+ D  +R++  ++ QHPW Q   P    +P
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN-TLP 309
Query: 147 PPDTMQQ 153
            P  +Q+
Sbjct: 310 TPMVLQR 316

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 78/139 (56%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENL++D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 52/142 (36%), Positives = 85/142 (59%), Gaps = 8/142 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLD + + K+ADFG+    + +G    T CG+P+Y APE++   LY GP
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GP 203
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +LCG  PF+ EN  +LF+ I       P+ L   A  ++   +  +P
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNP 263
Query: 121 MKRI-TIPE-----IRQHPWFQ 136
             R+ ++ +     I +HP+F+
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFK 285

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 50/139 (35%), Positives = 77/139 (55%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 163 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 219
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 279
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I  H WF
Sbjct: 280 KRFGNLKNGVNDIXNHKWF 298

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 79/143 (55%), Gaps = 9/143 (6%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQ 136
           R+L+ DP KR+TI +  QHPW +
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 94.4 bits (233), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/143 (39%), Positives = 79/143 (55%), Gaps = 9/143 (6%)
Query: 2   VVHRDLKPEN-LLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN +LLD    K  +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253
Query: 114 RMLIVDPMKRITIPEIRQHPWFQ 136
           R+L+ DP KR+TI +  QHPW +
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/141 (37%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y       SH S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           ++L+ +  KR+TI E  +HPW
Sbjct: 255 KLLVKETRKRLTIQEALRHPW 275

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 77/139 (55%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y AP +I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPAIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTE 205
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 206 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFES 293

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 60/173 (34%), Positives = 85/173 (49%), Gaps = 34/173 (19%)
Query: 2   VVHRDLKPENLLLDSKWNV---KIADFGLSNIMRDGHF--------LKTSCGSPNYAAPE 50
           + HRDLKPEN+L +S   V   KI DF L + M+  +         L T CGS  Y APE
Sbjct: 132 IAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
Query: 51  VI----SGKLYAGPEVDVWSCGVILYALLCGTLPF----------DDENIP-----NLFK 91
           V+        +     D+WS GV+LY +L G  PF          D   +       LF+
Sbjct: 192 VVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE 251
Query: 92  KIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
            I+ G Y  P    +H+S  A+DLI ++L+ D  +R++  ++ QHPW Q   P
Sbjct: 252 SIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQGQAP 304

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/141 (37%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y       SH S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           ++L+ +  KR+TI E  +HPW
Sbjct: 255 KLLVKETRKRLTIQEALRHPW 275

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 53/141 (37%), Positives = 77/141 (54%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y       SH S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           ++L+ +  KR+TI E  +HPW
Sbjct: 255 KLLVKETRKRLTIQEALRHPW 275

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 205
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 206 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 264
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 265 LLVLDATKRLGCEEMEGYGPLKAHPFFES 293

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTE 208
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 77/139 (55%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           K        + +I+ H WF
Sbjct: 279 KAFGNLKNGVNDIKNHKWF 297

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 62/190 (32%), Positives = 88/190 (46%), Gaps = 17/190 (8%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 240
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D WS GVI Y LLCG  PF   +     P    +I+ G Y  P    S +S   + 
Sbjct: 241 DKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKX 300
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQA-----HLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  +P +R TI E   HPW          P + +    +  ++ + + EE    +
Sbjct: 301 LIRNLLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTSRVLKEDKERWEDVKEEXTSAL 360
Query: 166 VKMGFDQNQL 175
             M  D  Q+
Sbjct: 361 ATMRVDYEQI 370

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 135 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 190
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 191 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 249
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 250 LLVLDATKRLGCEEMEGYGPLKAHPFFES 278

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 184
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 185 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKAHPFFES 272

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/155 (36%), Positives = 85/155 (54%), Gaps = 15/155 (9%)
Query: 2   VVHRDLKPENLL-LDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKL 56
           VVHRDLKP N+L +D   N   ++I DFG +  +R +   L T C + N+ APEV+  + 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVAPEVLERQG 196
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLP----SHLSPGAR 109
           Y     D+WS GV+LY  L G  PF    D+    +  +I  G ++L     + +S  A+
Sbjct: 197 YDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQ--AHLPRY 142
           DL+ + L VDP +R+T   + +HPW      LP+Y
Sbjct: 256 DLVSKXLHVDPHQRLTAALVLRHPWIVHWDQLPQY 290

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 206
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 206
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 183
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 184 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 242
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 243 LLVLDATKRLGCEEMEGYGPLKAHPFFES 271

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 206
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 130 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 185
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 186 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 244
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 245 LLVLDATKRLGCEEMEGYGPLKAHPFFES 273

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 84/149 (56%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 156 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 211
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P+   P ARDL+ +
Sbjct: 212 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEK 270
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 271 LLVLDATKRLGCEEMEGYGPLKAHPFFES 299

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFV----GTAQYVSPELLTE 206
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 207 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 265
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 266 LLVLDATKRLGCEEMEGYGPLKAHPFFES 294

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFV----GTAQYVSPELLTE 209
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 210 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 55/145 (37%), Positives = 76/145 (52%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L   C +P Y APEV+  + Y 
Sbjct: 136 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPEVLGPEKY- 194
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 195 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 254
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 255 LIRNLLKTEPTQRMTITEFMNHPWI 279

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 186
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 187 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 245
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 246 LLVLDATKRLGCEEMEGYGPLKAHPFFES 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 154 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 209
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 210 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 268
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 269 LLVLDATKRLGCEEMEGYGPLKAHPFFES 297

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 158 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 213
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 214 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 272
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 273 LLVLDATKRLGCEEMEGYGPLKAHPFFES 301

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 83/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 267
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 7/139 (5%)
Query: 3   VHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VH DLKPEN++  +K +  +K+ DFGL+  +     +K + G+  +AAPEV  GK   G 
Sbjct: 171 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGY 229
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRML 116
             D+WS GV+ Y LL G  PF  EN     + +K   + +     S +S   +D I ++L
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 289
Query: 117 IVDPMKRITIPEIRQHPWF 135
           + DP  R+TI +  +HPW 
Sbjct: 290 LADPNTRMTIHQALEHPWL 308

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 77/139 (55%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +    CG+P   APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLCGTPEALAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 82/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F KI    Y  P    P ARDL+ +
Sbjct: 209 K-SAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 50/149 (33%), Positives = 82/149 (55%), Gaps = 18/149 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-------RDGHFLKTSCGSPNYAAPEVISG 54
           ++HRDLKPEN+LL+   +++I DFG + ++       R   F+    G+  Y +PE+++ 
Sbjct: 153 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFV----GTAQYVSPELLTE 208
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
           K  A    D+W+ G I+Y L+ G  PF   N   +F KI    Y  P    P ARDL+ +
Sbjct: 209 K-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEK 267
Query: 115 MLIVDPMKRITIPE------IRQHPWFQA 137
           +L++D  KR+   E      ++ HP+F++
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFES 296

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 52/144 (36%), Positives = 78/144 (54%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE+++ +  
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  E        I    Y       S+ S  A+D I 
Sbjct: 189 -GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247
Query: 114 RMLIVDPMKRITIPEIRQHPWFQA 137
           R+L+ DP +R+TI +  +H W +A
Sbjct: 248 RLLVKDPKRRMTIAQSLEHSWIKA 271

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 68/187 (36%), Positives = 91/187 (48%), Gaps = 37/187 (19%)
Query: 2   VVHRDLKPENLLLDSKWNV---KIADFGL-SNIMRDGHF-------LKTSCGSPNYAAPE 50
           + HRDLKPEN+L +    V   KI DF L S I  +G         L T CGS  Y APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191
Query: 51  VISG-----KLYAGPEVDVWSCGVILYALLCGTLPF-----------DDENIPN----LF 90
           V+        +Y     D+WS GVILY LL G  PF             E  P     LF
Sbjct: 192 VVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF 250
Query: 91  KKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           + I+ G Y  P    +H+S  A+DLI ++L+ D  +R++  ++ QHPW Q   P    +P
Sbjct: 251 ESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPEN-TLP 309
Query: 147 PPDTMQQ 153
            P  +Q+
Sbjct: 310 TPMVLQR 316

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 77/139 (55%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +     G+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLAGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/159 (35%), Positives = 81/159 (50%), Gaps = 19/159 (11%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y       S  S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQ 152
           ++L+ +  KR+TI E  +HPW          + P DT Q
Sbjct: 255 KLLVKETRKRLTIQEALRHPW----------ITPVDTQQ 283

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 51/139 (36%), Positives = 77/139 (55%), Gaps = 7/139 (5%)
Query: 3   VHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VH DLKPEN++  +K +  +K+ DFGL+  +     +K + G+  +AAPEV  GK   G 
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKP-VGY 335
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRML 116
             D+WS GV+ Y LL G  PF  EN     + +K   + +     S +S   +D I ++L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 117 IVDPMKRITIPEIRQHPWF 135
           + DP  R+TI +  +HPW 
Sbjct: 396 LADPNTRMTIHQALEHPWL 414

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/142 (38%), Positives = 85/142 (59%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RDLK +N++LDS+ ++KIADFG+   NI  DG   K  CG+P+Y APE+I+ + Y G
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKXFCGTPDYIAPEIIAYQPY-G 199
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++   
Sbjct: 200 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 259
Query: 120 PMKRITI-PE----IRQHPWFQ 136
           P KR+   PE    I++H +F+
Sbjct: 260 PGKRLGCGPEGERDIKEHAFFR 281

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/142 (38%), Positives = 85/142 (59%), Gaps = 9/142 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RDLK +N++LDS+ ++KIADFG+   NI  DG   K  CG+P+Y APE+I+ + Y G
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-DGVTTKXFCGTPDYIAPEIIAYQPY-G 520
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++   
Sbjct: 521 KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKH 580
Query: 120 PMKRITI-PE----IRQHPWFQ 136
           P KR+   PE    I++H +F+
Sbjct: 581 PGKRLGCGPEGERDIKEHAFFR 602

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 49/139 (35%), Positives = 77/139 (55%), Gaps = 8/139 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +     G+P Y APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--XLXGTPEYLAPEIILSKGY-NKA 218
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278
Query: 122 KRI-----TIPEIRQHPWF 135
           KR       + +I+ H WF
Sbjct: 279 KRFGNLKNGVNDIKNHKWF 297

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 76/141 (53%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y       S  S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           ++L+ +  KR+TI E  +HPW
Sbjct: 255 KLLVKETRKRLTIQEALRHPW 275

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 76/141 (53%), Gaps = 9/141 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y       S  S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPW 134
           ++L+ +  KR+TI E  +HPW
Sbjct: 255 KLLVKETRKRLTIQEALRHPW 275

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 53/143 (37%), Positives = 80/143 (55%), Gaps = 11/143 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVI--SGKLYA 58
           +++RDLKPEN++L+ + +VK+ DFGL    + DG    T CG+  Y APE++  SG   A
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRA 201
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
              VD WS G ++Y +L G  PF  EN      KI      LP +L+  ARDL+ ++L  
Sbjct: 202 ---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258
Query: 119 DPMKRI-----TIPEIRQHPWFQ 136
           +   R+        E++ HP+F+
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFR 281

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 77/144 (53%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE+++ +  
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 209
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  E        I    Y       S+ S  A+D I 
Sbjct: 210 -GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 268
Query: 114 RMLIVDPMKRITIPEIRQHPWFQA 137
           R+L+ DP +R+ I +  +H W +A
Sbjct: 269 RLLVKDPKRRMXIAQSLEHSWIKA 292

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 77/144 (53%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  E        I    Y       S+ S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 254
Query: 114 RMLIVDPMKRITIPEIRQHPWFQA 137
           R+L+ DP +R+ I +  +H W +A
Sbjct: 255 RLLVKDPKRRMXIAQSLEHSWIKA 278

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 51/144 (35%), Positives = 77/144 (53%), Gaps = 14/144 (9%)
Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           VVH+DLKPEN+L         +KI DFGL+ + +       + G+  Y APEV   K   
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF--KRDV 202
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH------LSPGARDLI 112
             + D+WS GV++Y LL G LPF   ++  + +K     Y  P++      L+P A DL+
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK---ATYKEPNYAVECRPLTPQAVDLL 259
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQ 136
            +ML  DP +R +  ++  H WF+
Sbjct: 260 KQMLTKDPERRPSAAQVLHHEWFK 283

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 52/151 (34%), Positives = 86/151 (56%), Gaps = 17/151 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G 
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GF 232
Query: 61  EVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 292
Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQ 136
           +   L  DP +R+         +I+ HP+F+
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ + +   
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 206
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  +   +P
Sbjct: 207 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 266
Query: 121 MKRI-----TIPEIRQHPWFQA 137
             R+      + EI++H +F  
Sbjct: 267 ANRLGAGPDGVEEIKRHSFFST 288

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ + +   
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 205
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  +   +P
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 121 MKRI-----TIPEIRQHPWFQA 137
             R+      + EI++H +F  
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFST 287

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 52/143 (36%), Positives = 79/143 (55%), Gaps = 11/143 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVI--SGKLYA 58
           +++RDLKPEN++L+ + +VK+ DFGL    + DG      CG+  Y APE++  SG   A
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHNRA 201
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
              VD WS G ++Y +L G  PF  EN      KI      LP +L+  ARDL+ ++L  
Sbjct: 202 ---VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKR 258
Query: 119 DPMKRI-----TIPEIRQHPWFQ 136
           +   R+        E++ HP+F+
Sbjct: 259 NAASRLGAGPGDAGEVQAHPFFR 281

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 49/142 (34%), Positives = 78/142 (54%), Gaps = 7/142 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ + +   
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT-Q 205
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  +   +P
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 121 MKRI-----TIPEIRQHPWFQA 137
             R+      + EI++H +F  
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFST 287

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 79/142 (55%), Gaps = 7/142 (4%)
Query: 2   VVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +VH D+KPEN++ ++K   +VKI DFGL+  +     +K +  +  +AAPE++  +   G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP-VG 228
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRM 115
              D+W+ GV+ Y LL G  PF  E+     + +K   +       S +SP A+D I  +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288
Query: 116 LIVDPMKRITIPEIRQHPWFQA 137
           L  +P KR+T+ +  +HPW + 
Sbjct: 289 LQKEPRKRLTVHDALEHPWLKG 310

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 51/134 (38%), Positives = 76/134 (56%), Gaps = 3/134 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F KT  G+P Y +PE ++ ++    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMN-RMSYNE 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
           + D+WS G +LY L     PF   +   L  KI+ G +  +P   S    ++I RML + 
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 120 PMKRITIPEIRQHP 133
              R ++ EI ++P
Sbjct: 256 DYHRPSVEEILENP 269

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 56/152 (36%), Positives = 85/152 (55%), Gaps = 14/152 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + I +D    K   G+P + APEVIS  LYA  
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYA-T 220
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP------SH-LSPGARDLIP 113
           EVD+WS G+++  ++ G  P+  ++     K+++      P      SH +SP  RD + 
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS----PPPKLKNSHKVSPVLRDFLE 276
Query: 114 RMLIVDPMKRITIPEIRQHPW-FQAHLPRYLA 144
           RML+ DP +R T  E+  HP+  Q  LP  L 
Sbjct: 277 RMLVRDPQERATAQELLDHPFLLQTGLPECLV 308

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 85/151 (56%), Gaps = 17/151 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G      CG+PNY APE++ G+ Y G 
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY-GF 185
Query: 61  EVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  +
Sbjct: 186 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 245
Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQ 136
           +   L  DP +R+         +I+ HP+F+
Sbjct: 246 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 276

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 50/151 (33%), Positives = 85/151 (56%), Gaps = 17/151 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G      CG+PNY APE++ G+ Y G 
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY-GF 200
Query: 61  EVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  +S  A  +
Sbjct: 201 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSMSVKAASV 260
Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQ 136
           +   L  DP +R+         +I+ HP+F+
Sbjct: 261 LKSFLNKDPKERLGCLPQTGFADIQGHPFFR 291

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/151 (33%), Positives = 85/151 (56%), Gaps = 17/151 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G      CG+PNY APE++ G+ Y G 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDY-GF 189
Query: 61  EVDVWSCGVILYALLCGTLPFD--------DENIPN-LFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PFD        D+N  + LF+ I      +P  LS  A  +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 249
Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQ 136
           +   L  DP +R+         +I+ HP+F+
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 52/144 (36%), Positives = 76/144 (52%), Gaps = 9/144 (6%)
Query: 2   VVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++H DLKPEN+L    D+K  +KI DFGL+   +    LK + G+P + APEV++    +
Sbjct: 208 ILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS 266
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPR 114
            P  D+WS GVI Y LL G  PF  +N       I    + L       +S  A++ I +
Sbjct: 267 FP-TDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISK 325
Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           +LI +   RI+  E  +HPW   H
Sbjct: 326 LLIKEKSWRISASEALKHPWLSDH 349

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 73/133 (54%), Gaps = 6/133 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+K EN+++   + +K+ DFG +  +  G    T CG+  Y APEV+ G  Y GPE
Sbjct: 151 IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPE 210
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           +++WS GV LY     TL F++     L + ++  I+  P  +S     L+  +L   P 
Sbjct: 211 LEMWSLGVTLY-----TLVFEENPFCELEETVEAAIHP-PYLVSKELMSLVSGLLQPVPE 264
Query: 122 KRITIPEIRQHPW 134
           +R T+ ++   PW
Sbjct: 265 RRTTLEKLVTDPW 277

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 84/149 (56%), Gaps = 15/149 (10%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SGKL 56
           VHRD+KP+N+LLD   ++++ADFG    M D   +++S   G+P+Y +PE++     G  
Sbjct: 213 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 272
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGARDL 111
             GPE D WS GV +Y +L G  PF  E++   + KI      +  PSH   +S  A+DL
Sbjct: 273 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 332
Query: 112 IPRMLIVDPMKRI---TIPEIRQHPWFQA 137
           I R LI    +R+    I + ++H +F+ 
Sbjct: 333 IQR-LICSRERRLGQNGIEDFKKHAFFEG 360

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 54/149 (36%), Positives = 84/149 (56%), Gaps = 15/149 (10%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVI----SGKL 56
           VHRD+KP+N+LLD   ++++ADFG    M D   +++S   G+P+Y +PE++     G  
Sbjct: 197 VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMG 256
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLPSH---LSPGARDL 111
             GPE D WS GV +Y +L G  PF  E++   + KI      +  PSH   +S  A+DL
Sbjct: 257 KYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHVTDVSEEAKDL 316
Query: 112 IPRMLIVDPMKRI---TIPEIRQHPWFQA 137
           I R LI    +R+    I + ++H +F+ 
Sbjct: 317 IQR-LICSRERRLGQNGIEDFKKHAFFEG 344

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 51/146 (34%), Positives = 83/146 (56%), Gaps = 11/146 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVI---SGKL 56
           ++HRD+KP+N+LLD   ++K+ADFG    M +   +   T+ G+P+Y +PEV+    G  
Sbjct: 195 LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDG 254
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGARDLI 112
           Y G E D WS GV L+ +L G  PF  +++   + KI     +L     + +S  A++LI
Sbjct: 255 YYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKNLI 314
Query: 113 PRMLIVDPMK--RITIPEIRQHPWFQ 136
              L    ++  R  + EI+QHP+F+
Sbjct: 315 CAFLTDREVRLGRNGVEEIKQHPFFK 340

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 50/134 (37%), Positives = 75/134 (55%), Gaps = 3/134 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F K   G+P Y +PE ++ ++    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMN-RMSYNE 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
           + D+WS G +LY L     PF   +   L  KI+ G +  +P   S    ++I RML + 
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 120 PMKRITIPEIRQHP 133
              R ++ EI ++P
Sbjct: 256 DYHRPSVEEILENP 269

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 53/147 (36%), Positives = 79/147 (53%), Gaps = 12/147 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN--IMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +++RD+K EN+LLDS  +V + DFGLS   +  +       CG+  Y AP+++ G     
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239
Query: 60  PE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPR 114
            + VD WS GV++Y LL G  PF  +   N   +I   I       P  +S  A+DLI R
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299
Query: 115 MLIVDPMKRI-----TIPEIRQHPWFQ 136
           +L+ DP KR+        EI++H +FQ
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 50/134 (37%), Positives = 75/134 (55%), Gaps = 3/134 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F K   G+P Y +PE ++ ++    
Sbjct: 137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMN-RMSYNE 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
           + D+WS G +LY L     PF   +   L  KI+ G +  +P   S    ++I RML + 
Sbjct: 196 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 255
Query: 120 PMKRITIPEIRQHP 133
              R ++ EI ++P
Sbjct: 256 DYHRPSVEEILENP 269

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 53/149 (35%), Positives = 83/149 (55%), Gaps = 15/149 (10%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKT-SCGSPNYAAPEVIS----GKL 56
           VHRD+KP+N+L+D   ++++ADFG    +M DG    + + G+P+Y +PE++     GK 
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI-----KGGIYTLPSHLSPGARDL 111
             GPE D WS GV +Y +L G  PF  E++   + KI     +    T  + +S  A+DL
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDL 316
Query: 112 IPRMLIVDPMKRI---TIPEIRQHPWFQA 137
           I R LI     R+    I + ++HP+F  
Sbjct: 317 I-RRLICSREHRLGQNGIEDFKKHPFFSG 344

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 80/145 (55%), Gaps = 12/145 (8%)
Query: 2   VVHRDLKPENLLLDS--KWNVKIADFGLSN---IMRDGHF--LKTSCGSPNYAAPEVISG 54
           + HRD+KPEN L  +   + +K+ DFGLS     + +G +  + T  G+P + APEV++ 
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248
Query: 55  KLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSH--LSPGAR 109
              + GP+ D WS GV+L+ LL G +PF   N  +   ++  K   +  P++  LSP AR
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           DL+  +L  +  +R       QHPW
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPW 333

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 79/144 (54%), Gaps = 10/144 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y    
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 366
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 117
            D W+ G +LY ++ G  PF         ++++  +  +P       SP AR L  ++L 
Sbjct: 367 -DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 118 VDPMKRI-----TIPEIRQHPWFQ 136
            DP +R+     +  E+++HP F+
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFK 449

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 79/144 (54%), Gaps = 10/144 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y    
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF-S 365
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 117
            D W+ G +LY ++ G  PF         ++++  +  +P       SP AR L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 118 VDPMKRI-----TIPEIRQHPWFQ 136
            DP +R+     +  E+++HP F+
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFK 449

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/141 (36%), Positives = 75/141 (53%), Gaps = 8/141 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +V+RDLKPEN+LLDS+ ++ + DFGL   NI  +     T CG+P Y APEV+  + Y  
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST-TSTFCGTPEYLAPEVLHKQPY-D 217
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
             VD W  G +LY +L G  PF   N   ++  I      L  +++  AR L+  +L  D
Sbjct: 218 RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKD 277
Query: 120 PMKRI----TIPEIRQHPWFQ 136
             KR+       EI+ H +F 
Sbjct: 278 RTKRLGAKDDFMEIKSHVFFS 298

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 11/145 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKLY 57
           +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  Y
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 254
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLIP 113
            G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI 
Sbjct: 255 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 314
Query: 114 RMLIVDPMK--RITIPEIRQHPWFQ 136
             L    ++  R  + EI++H +F+
Sbjct: 315 AFLTDREVRLGRNGVEEIKRHLFFK 339

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GP
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGP 249
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 306
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 307 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP 338

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 11/145 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKLY 57
           +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  Y
Sbjct: 190 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 249
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLIP 113
            G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI 
Sbjct: 250 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 309
Query: 114 RMLIVDPMK--RITIPEIRQHPWFQ 136
             L    ++  R  + EI++H +F+
Sbjct: 310 AFLTDREVRLGRNGVEEIKRHLFFK 334

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 51/145 (35%), Positives = 81/145 (55%), Gaps = 11/145 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEVIS---GKLY 57
           +HRD+KP+N+LLD   ++K+ADFG    M     ++  T+ G+P+Y +PEV+    G  Y
Sbjct: 195 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGY 254
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG--GIYTLP--SHLSPGARDLIP 113
            G E D WS GV LY +L G  PF  +++   + KI       T P  + +S  A++LI 
Sbjct: 255 YGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLIC 314
Query: 114 RMLIVDPMK--RITIPEIRQHPWFQ 136
             L    ++  R  + EI++H +F+
Sbjct: 315 AFLTDREVRLGRNGVEEIKRHLFFK 339

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GP
Sbjct: 268 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGP 326
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 327 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 383
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 384 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP 415

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 84/159 (52%), Gaps = 5/159 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 79/145 (54%), Gaps = 11/145 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + APE++ G+ Y   
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DF 368
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRML 116
            VD ++ GV LY ++    PF    E + N  L +++     T P   SP ++D    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 117 IVDPMKRITIPE-----IRQHPWFQ 136
             DP KR+   +     +R HP F+
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 79/145 (54%), Gaps = 11/145 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + APE++ G+ Y   
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DF 368
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRML 116
            VD ++ GV LY ++    PF    E + N  L +++     T P   SP ++D    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 117 IVDPMKRITIPE-----IRQHPWFQ 136
             DP KR+   +     +R HP F+
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GP
Sbjct: 148 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGP 206
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 207 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 263
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 264 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP 295

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 79/145 (54%), Gaps = 11/145 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + APE++ G+ Y   
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DF 368
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRML 116
            VD ++ GV LY ++    PF    E + N  L +++     T P   SP ++D    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 117 IVDPMKRITIPE-----IRQHPWFQ 136
             DP KR+   +     +R HP F+
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GP
Sbjct: 146 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGP 204
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 205 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 261
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 262 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP 293

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 189
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRWCLALRP 243
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 244 SDRPTFEEIQNHPWMQ 259

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GP
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGP 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 252
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 253 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP 284

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 222 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRWCLALRP 275
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 276 SDRPTFEEIQNHPWMQ 291

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 222
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 223 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRWCLALRP 276
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 277 SDRPTFEEIQNHPWMQ 292

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 50/145 (34%), Positives = 79/145 (54%), Gaps = 11/145 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD   NV+I+D GL+  ++ G    K   G+P + APE++ G+ Y   
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DF 368
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRML 116
            VD ++ GV LY ++    PF    E + N  L +++     T P   SP ++D    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428
Query: 117 IVDPMKRITIPE-----IRQHPWFQ 136
             DP KR+   +     +R HP F+
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 222
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 223 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRWCLALRP 276
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 277 SDRPTFEEIQNHPWMQ 292

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 51/152 (33%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG  + + ++    K   G+P + APE+IS +L  GP
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELIS-RLPYGP 199
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------SPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      K I+     LP  L      SP  +  + R
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD---NLPPRLKNLHKVSPSLKGFLDR 256
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ DP +R T  E+ +HP+     P    VP
Sbjct: 257 LLVRDPAQRATAAELLKHPFLAKAGPPASIVP 288

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 222 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSSECQHLIRWCLALRP 275
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 276 SDRPTFEEIQNHPWMQ 291

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 222
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 223 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSXECQHLIRWCLALRP 276
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 277 SDRPTFEEIQNHPWMQ 292

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 222 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSXECQHLIRWCLALRP 275
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 276 SDRPTFEEIQNHPWMQ 291

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 134 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 192
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 193 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 245
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 246 PSDRPTFEEIQNHPWMQ 262

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 74/136 (54%), Gaps = 8/136 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 164 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 222
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I GG       +S   + LI   L + P
Sbjct: 223 SAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFRQRVSXECQHLIRWCLALRP 276
Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 277 SDRPTFEEIQNHPWMQ 292

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 236
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 237 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 289
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 290 PSDRPTFEEIQNHPWMQ 306

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 236
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 237 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 289
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 290 PSDRPTFEEIQNHPWMQ 306

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 189
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 242
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 243 PSDRPTFEEIQNHPWMQ 259

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 194
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 195 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 247
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 248 PSDRPTFEEIQNHPWMQ 264

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 193
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 194 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 246
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 247 PSDRPTFEEIQNHPWMQ 263

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 135 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 193
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 194 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 246
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 247 PSDRPTFEEIQNHPWMQ 263

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 194
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 195 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 247
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 248 PSDRPTFEEIQNHPWMQ 264

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 136 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 194
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 195 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 247
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 248 PSDRPTFEEIQNHPWMQ 264

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 189
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 242
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 243 PSDRPTFEEIQNHPWMQ 259

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 163 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 221
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 222 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 274
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 275 PSDRPTFEEIQNHPWMQ 291

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 209
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 210 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 262
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 263 PSDRPTFEEIQNHPWMQ 279

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 208
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 209 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 261
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 262 PSDRPTFEEIQNHPWMQ 278

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 158 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 216
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 217 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 269
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 270 PSDRPTFEEIQNHPWMQ 286

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 209
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 210 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 262
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 263 PXDRPTFEEIQNHPWMQ 279

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 170 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 228
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 229 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSSECQHLIRWCLALR 281
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 282 PSDRPTFEEIQNHPWMQ 298

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 178 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 236
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 237 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 289
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 290 PSDRPTFEEIQNHPWMQ 306

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 151 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 209
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 210 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 262
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 263 PSDRPTFEEIQNHPWMQ 279

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 150 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 208
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 209 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 261
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 262 PSDRPTFEEIQNHPWMQ 278

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 49/137 (35%), Positives = 76/137 (55%), Gaps = 10/137 (7%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 183 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFD-GTRVYSPPEWIRYHRYHGR 241
Query: 61  EVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
              VWS G++LY ++CG +PF+ DE I      I+G ++     +S   + LI   L + 
Sbjct: 242 SAAVWSLGILLYDMVCGDIPFEHDEEI------IRGQVF-FRQRVSXECQHLIRWCLALR 294
Query: 120 PMKRITIPEIRQHPWFQ 136
           P  R T  EI+ HPW Q
Sbjct: 295 PSDRPTFEEIQNHPWMQ 311

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 5/159 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HR++K +N+LL    +VK+ DFG  + I  +     T  G+P + APEV++ K Y GP
Sbjct: 138 VIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 196
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATK 295

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 5/159 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +        G+P + APEV++ K Y GP
Sbjct: 138 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY-GP 196
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 197 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 256
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 257 MDVEKRGSAKELIQHQFLKIAKPLSSLTPLIAAAKEATK 295

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 5/159 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +        G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAY-GP 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        ++    +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++C  + F   +                P   KK++  + T       
Sbjct: 206 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/159 (33%), Positives = 83/159 (52%), Gaps = 5/159 (3%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG  + I  +        G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAY-GP 195
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +D  KR +  E+ QH + +   P     P     ++A K
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEATK 294

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 77/142 (54%), Gaps = 7/142 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD + ++K+ DFGLS    D      S CG+  Y APEV++ + ++  
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHS-H 209
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             D WS GV+++ +L G+LPF  ++       I      +P  LS  A+ L+  +   +P
Sbjct: 210 SADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRALFKRNP 269
Query: 121 MKRI-----TIPEIRQHPWFQA 137
             R+        EI++H ++  
Sbjct: 270 ANRLGSGPDGAEEIKRHVFYST 291

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 83/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS GVI+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 83/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS GVI+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 152 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 210
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++C  + F   +                P   KK++  + T       
Sbjct: 211 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 270
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 271 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 330
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 331 DPSEAEAPPP 340

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 199
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++C  + F      D  N          P   KK++  + T       
Sbjct: 200 VDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 259
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 260 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 319
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 320 DPSEAEAPPP 329

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 7/144 (4%)
Query: 4   HRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           H D++PEN++  ++ +  +KI +FG +  ++ G   +    +P Y APEV    + +   
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA- 183
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLIPRMLI 117
            D+WS G ++Y LL G  PF  E    + + I    YT        +S  A D + R+L+
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLV 243
Query: 118 VDPMKRITIPEIRQHPWFQAHLPR 141
            +   R+T  E  QHPW +  + R
Sbjct: 244 KERKSRMTASEALQHPWLKQKIER 267

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/137 (35%), Positives = 71/137 (51%), Gaps = 8/137 (5%)
Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VVHRD+K EN+L+D  +   K+ DFG   ++ D  +     G+  Y+ PE IS   Y   
Sbjct: 160 VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFD-GTRVYSPPEWISRHQYHAL 218
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +      ++I       P+H+SP    LI R L   P
Sbjct: 219 PATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKP 272
Query: 121 MKRITIPEIRQHPWFQA 137
             R ++ EI   PW Q 
Sbjct: 273 SSRPSLEEILLDPWMQT 289

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 81/190 (42%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        ++    +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++C  + F   +                P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 206
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 327 DPSEAEAPPP 336

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 45/181 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          E ++ + Y  PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATRWYRAPE 192
Query: 62  V-----------DVWSCGVILYAL---------------------LCGTLPFDDENIPNL 89
           V           DVWSCG IL  L                     + GT P  D ++  +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PHSDNDLRCI 251
Query: 90  FK-KIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
              + +  I +LP +           ++P   DL+ RML+ DP KRIT  E  +HP+ Q 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 138 H 138
           +
Sbjct: 312 Y 312

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 45/181 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          E ++ + Y  PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAPE 192
Query: 62  V-----------DVWSCGVILYAL---------------------LCGTLPFDDENIPNL 89
           V           DVWSCG IL  L                     + GT P  D ++  +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PHSDNDLRCI 251
Query: 90  FK-KIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
              + +  I +LP +           ++P   DL+ RML+ DP KRIT  E  +HP+ Q 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 138 H 138
           +
Sbjct: 312 Y 312

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 82/181 (45%), Gaps = 45/181 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +          E ++ + Y  PE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192
Query: 62  V-----------DVWSCGVILYAL---------------------LCGTLPFDDENIPNL 89
           V           DVWSCG IL  L                     + GT P  D ++  +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PHSDNDLRCI 251
Query: 90  FK-KIKGGIYTLPSH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
              + +  I +LP +           ++P   DL+ RML+ DP KRIT  E  +HP+ Q 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
Query: 138 H 138
           +
Sbjct: 312 Y 312

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 149 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVILGMGYK-EN 207
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 208 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 267
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 268 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 327
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 328 DPSEAEAPPP 337

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 243
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 364 DPAEVEAPPPQIYD--KQLDE 382

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 326 DPAEVEAPPPQIYD--KQLDE 344

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 206
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 266
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 267 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 326
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 327 DPAEVEAPPPQIYD--KQLDE 345

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/190 (30%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++ G + F      D  N          P   KK++  + T       
Sbjct: 206 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTVRTYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 266 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPSEAEAPPP 335

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 326 DPAEVEAPPPQIYD--KQLDE 344

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 206
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 207 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 266
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 267 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 326
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 327 DPAEVEAPPPQIYD--KQLDE 345

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 326 DPAEVEAPPPQIYD--KQLDE 344

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 325
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 326 DPAEVEAPPPQIYD--KQLDE 344

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 140 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 198
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 319 DPAEVEAPPPQIYD--KQLDE 337

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 146 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 204
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 205 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 264
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 265 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 324
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 325 DPAEVEAPPPQIYD--KQLDE 343

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 140 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 198
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 199 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 258
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 259 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 319 DPAEVEAPPPQIYD--KQLDE 337

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 199
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 259
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 260 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 319
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 320 DPAEVEAPPPQIYD--KQLDE 338

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 86/201 (42%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 243
Query: 62  VDVWSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F   +                P   KK++  +         
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 364 DPAEVEAPPPQIYD--KQLDE 382

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 87/201 (43%), Gaps = 46/201 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 141 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 199
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 200 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 259
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 260 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 319
Query: 139 LPRYLAVPPPDTMQQAKKIDE 159
            P  +  PPP      K++DE
Sbjct: 320 DPAEVEAPPPQIYD--KQLDE 338

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  YA   
Sbjct: 147 IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYAA-N 205
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------------------- 99
           VD+WS G I+  L+ G + F   +  + + K+   + T                      
Sbjct: 206 VDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  + P            ARDL+ +ML++DP KRI++ E  +HP+    +
Sbjct: 266 YPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 325
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 326 DPAEAEAPPP 335

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 83/152 (54%), Gaps = 11/152 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL-SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL S   +K++DFG  + + ++    K   G+P + APEVIS +L  G 
Sbjct: 162 VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVIS-RLPYGT 220
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH------LSPGARDLIPR 114
           EVD+WS G+++  ++ G  P+ +E      ++I+    +LP        +S   R  +  
Sbjct: 221 EVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD---SLPPRVKDLHKVSSVLRGFLDL 277
Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           ML+ +P +R T  E+  HP+ +   P    VP
Sbjct: 278 MLVREPSQRATAQELLGHPFLKLAGPPSCIVP 309

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/190 (27%), Positives = 82/190 (43%), Gaps = 44/190 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 145 IIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMGYK-EN 203
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------------------- 99
           VD+WS G I+  L+ G++ F   +  + + K+   + T                      
Sbjct: 204 VDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVENRPA 263
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                     P  + P            ARDL+ +ML++DP KRI++ E  +HP+    +
Sbjct: 264 YPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 323
Query: 139 LPRYLAVPPP 148
            P     PPP
Sbjct: 324 DPAEAEAPPP 333

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/142 (33%), Positives = 70/142 (49%), Gaps = 8/142 (5%)
Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VH DLKP+N+LL S +   ++KI DFG+S  +     L+   G+P Y APE+++     
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPIT 211
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPR 114
               D+W+ G+I Y LL  T PF  E+    +  I            S +S  A D I  
Sbjct: 212 TA-TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270
Query: 115 MLIVDPMKRITIPEIRQHPWFQ 136
           +L+ +P KR T      H W Q
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQ 292

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 77/171 (45%), Gaps = 34/171 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 175 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNMT 232
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------KGGIYTLPSH---------- 103
           VD+WS G I+  LL G   F   +  N  ++I           I  +PSH          
Sbjct: 233 VDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYINSLP 292
Query: 104 -------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLP 140
                         +P A DL+ +ML++D  KRIT  E   HP+F Q H P
Sbjct: 293 QMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDP 343

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 75/172 (43%), Gaps = 35/172 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLL+++  ++KI DFGL+ I    H    FL     +  Y APE++     
Sbjct: 165 VLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKG 224
Query: 58  AGPEVDVWSCGVILYALLC------------------GTLPFDDENIPNLFKKIKGGIY- 98
               +D+WS G IL  +L                   G L    +   N    +K   Y 
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINMKARNYL 284
Query: 99  -TLPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            +LPS                A DL+ RML  +P KRIT+ E   HP+ + +
Sbjct: 285 QSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 75/145 (51%), Gaps = 3/145 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGP 60
           ++HRD+K +N+ L     V++ DFG++ ++     L  +C G+P Y +PE+   K Y   
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNN- 204
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS-HLSPGARDLIPRMLIVD 119
           + D+W+ G +LY L      F+  ++ NL  KI  G +   S H S   R L+ ++   +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRN 264
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLA 144
           P  R ++  I +  +    + ++L+
Sbjct: 265 PRDRPSVNSILEKGFIAKRIEKFLS 289

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 43/176 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+ 
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 51/176 (28%), Positives = 76/176 (43%), Gaps = 43/176 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 147 IIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK-EN 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDEN---------IPNLFKKIKGGIYT------- 99
           VD+WS G I+  ++   + F      D  N          P   KK++  +         
Sbjct: 206 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 265
Query: 100 ---------LPSHLSPG-----------ARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                     P  L P            ARDL+ +ML++DP KRI++ +  QHP+ 
Sbjct: 266 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 22/154 (14%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGP 60
           + HRD+KP N+L+D    VK++DFG S  M D   +K S G+  +  PE  S +  Y G 
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGA 231
Query: 61  EVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLP------------------ 101
           +VD+WS G+ LY +    +PF  + ++  LF  I+      P                  
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291
Query: 102 -SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 134
            + LS    D +   L  +P +RIT  +  +H W
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEW 325

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 125 VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 126 VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKPENLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 127 VLHRDLKPENLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGXKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 49/145 (33%), Positives = 66/145 (45%), Gaps = 33/145 (22%)
Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +     G     SC                 
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGFAK-ETTGEKYDKSC----------------- 179
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 180 ----DMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF 135
           LI  +L  +P +R+TI E   HPW 
Sbjct: 236 LIRNLLKTEPTQRMTITEFMNHPWI 260

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           V+HRD+KP N+L+++   VK+ DFG+S  + D        G   Y APE I+ +L     
Sbjct: 175 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGY 234
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLI 112
             + D+WS G+ +  L     P+D    P  F+++K  +   PS   P  +      D  
Sbjct: 235 SVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLK-QVVEEPSPQLPADKFSAEFVDFT 291
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAH 138
            + L  +  +R T PE+ QHP+F  H
Sbjct: 292 SQCLKKNSKERPTYPELMQHPFFTLH 317

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGXKYY 188
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 248
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 9/153 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS-GKLYAGP 60
           ++HRD+KP N+LLD   N+K+ DFG+S  + D        G   Y APE I       G 
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206
Query: 61  EV--DVWSCGVILYALLCGTLPFDDEN--IPNLFKKIKGGIYTLPS----HLSPGARDLI 112
           +V  DVWS G+ LY L  G  P+   N     L + +KG    L +      SP   + +
Sbjct: 207 DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFV 266
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAV 145
              L  D  KR    E+ +HP+   +  R + V
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMYEERAVEV 299

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 182
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 124 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 181
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 182 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 125 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 182
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 183 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 185
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 245
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 123 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 180
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 126 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 183
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 184 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 243
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 244 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 128 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 185
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 186 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 245
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 292

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 72/146 (49%), Gaps = 12/146 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           V+HRD+KP N+L+++   VK+ DFG+S  + D        G   Y APE I+ +L     
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLI 112
             + D+WS G+ +  L     P+D    P  F+++K  +   PS   P  +      D  
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTP--FQQLK-QVVEEPSPQLPADKFSAEFVDFT 247
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAH 138
            + L  +  +R T PE+ QHP+F  H
Sbjct: 248 SQCLKKNSKERPTYPELMQHPFFTLH 273

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 127 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCKYY 184
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 185 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 244
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 245 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 291

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 78/167 (46%), Gaps = 34/167 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT---SCGSPNYAAPEVISGKLYA 58
           V+HRDLKP+NLL++++  +K+ADFGL+     G  ++T      +  Y APE++ G  Y 
Sbjct: 131 VLHRDLKPQNLLINTEGAIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGCKYY 188
Query: 59  GPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKG----------GIYTLPSH---- 103
              VD+WS G I   ++     F  D  I  LF+  +           G+ ++P +    
Sbjct: 189 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 248
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 249 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 295

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 14/154 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAG 59
           +VHRDLK  NLL+D K+ VK+ DFGLS  ++   FL  K + G+P + APEV+  +  + 
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDE-PSN 217
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLSPGARDLIPRMLI 117
            + DV+S GVIL+ L     P+ + N   +   +  K     +P +L+P    +I     
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 118 VDPMKRITIPEIRQ--HPWFQAHLPRYLAVPPPD 149
            +P KR +   I     P  ++      AVPPP+
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKS------AVPPPN 305

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 72/139 (51%), Gaps = 6/139 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP+N+LLD   +V I DF ++ ++     + T  G+  Y APE+ S +  AG  
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYS 195
Query: 62  --VDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
             VD WS GV  Y LL G  P+      +   +    +  + T PS  S     L+ ++L
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLL 255
Query: 117 IVDPMKRIT-IPEIRQHPW 134
             +P +R + + +++  P+
Sbjct: 256 EPNPDQRFSQLSDVQNFPY 274

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 39/177 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLKP+NLL++S   +K+ADFGL+      +    H + T      Y AP+V+ G  
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW----YRAPDVLMGSK 195
Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG-------GIYTLP---- 101
                VD+WS G I   ++ G   F    DD+ +P +F  +          +  LP    
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 102 -----------SHLSPG----ARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 143
                      S + PG      DL+  ML  DP KRI+  +   HP+F+   P+ +
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQIM 312

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 52/170 (30%), Positives = 78/170 (45%), Gaps = 39/170 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLKP+NLL++S   +K+ADFGL+      +    H + T      Y AP+V+ G  
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW----YRAPDVLMGSK 195
Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG-------GIYTLP---- 101
                VD+WS G I   ++ G   F    DD+ +P +F  +          +  LP    
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 102 -----------SHLSPG----ARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                      S + PG      DL+  ML  DP KRI+  +   HP+F+
Sbjct: 256 RTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 81/154 (52%), Gaps = 14/154 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAG 59
           +VHR+LK  NLL+D K+ VK+ DFGLS  ++   FL  K++ G+P + APEV+  +  + 
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDE-PSN 217
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--KGGIYTLPSHLSPGARDLIPRMLI 117
            + DV+S GVIL+ L     P+ + N   +   +  K     +P +L+P    +I     
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 118 VDPMKRITIPEIRQ--HPWFQAHLPRYLAVPPPD 149
            +P KR +   I     P  ++      AVPPP+
Sbjct: 278 NEPWKRPSFATIMDLLRPLIKS------AVPPPN 305

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 12/146 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           V+HRD+KP N+L+++   VK  DFG+S  + D        G   Y APE I+ +L     
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGY 217
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGAR------DLI 112
             + D+WS G+    L     P+D    P  F+++K  +   PS   P  +      D  
Sbjct: 218 SVKSDIWSLGITXIELAILRFPYDSWGTP--FQQLK-QVVEEPSPQLPADKFSAEFVDFT 274
Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAH 138
            + L  +  +R T PE+ QHP+F  H
Sbjct: 275 SQCLKKNSKERPTYPELXQHPFFTLH 300

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 35/172 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 58  AGPEVDVWSCGVILYALLC------------------GTLPFDDENIPNLFKKIKGGIYT 99
               +D+WS G IL  +L                   G L   ++   N    +K   Y 
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKARNYL 262
Query: 100 LP---------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
           L          + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 314

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL--KARN 262
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 208
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 266
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKG 209
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 267
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 268 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 321

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 266
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 73/152 (48%), Gaps = 23/152 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT--SCGSPNYAAPEVISG------ 54
           VHRD+KP+N+LLD   ++++ADFG    +R    +++  + G+P+Y +PE++        
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLS--------- 105
               GPE D W+ GV  Y +  G  PF  ++    + K    I     HLS         
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGK----IVHYKEHLSLPLVDEGVP 299
Query: 106 PGARDLIPRMLI--VDPMKRITIPEIRQHPWF 135
             ARD I R+L      + R    + R HP+F
Sbjct: 300 EEARDFIQRLLCPPETRLGRGGAGDFRTHPFF 331

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 150 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 209
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 210 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 267
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 268 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 321

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 151 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 210
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 211 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 268
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 269 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 322

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 142 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 201
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 202 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 259
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 260 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 313

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 266
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 264
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 318

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 143 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 202
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 203 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 260
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 261 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 314

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 153 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 212
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 213 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 270
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 271 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 324

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 262
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL--KARN 262
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 145 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 262
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 266
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 266
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 266
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP NL ++    +KI DFGL+    D   +     +  Y APEVI   ++    
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAE-MTGYVVTRWYRAPEVILSWMHYNQT 204
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTLP 101
           VD+WS G I+  +L G   F  ++  +   +I                    K  I +LP
Sbjct: 205 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 264
Query: 102 S-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         SP A DL+ +ML +D  KR+T  +   HP+F+
Sbjct: 265 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 310

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 145 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 204
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 205 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 262
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 263 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 316

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 165 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 282
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 283 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 77/174 (44%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 165 VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 224
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 225 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 282
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+ + +
Sbjct: 283 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 74/166 (44%), Gaps = 33/166 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP NL ++    +KI DFGL+    D   +     +  Y APEVI   ++    
Sbjct: 165 VVHRDLKPGNLAVNEDCELKILDFGLAR-HADAE-MTGYVVTRWYRAPEVILSWMHYNQT 222
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTLP 101
           VD+WS G I+  +L G   F  ++  +   +I                    K  I +LP
Sbjct: 223 VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLP 282
Query: 102 S-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         SP A DL+ +ML +D  KR+T  +   HP+F+
Sbjct: 283 QTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFE 328

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 28/162 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y APEV+    YA P 
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP- 199
Query: 62  VDVWSCGVILYA------LLCGTLPFD-------------DENIPN--------LFKKIK 94
           VD+WS G I         L  G+   D             +E+ P            K  
Sbjct: 200 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 259
Query: 95  GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             I    + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 260 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 28/162 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y APEV+    YA P 
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP- 199
Query: 62  VDVWSCGVILYA------LLCGTLPFD-------------DENIPN--------LFKKIK 94
           VD+WS G I         L  G+   D             +E+ P            K  
Sbjct: 200 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 259
Query: 95  GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             I    + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 260 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 51/162 (31%), Positives = 72/162 (44%), Gaps = 28/162 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y APEV+    YA P 
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP- 199
Query: 62  VDVWSCGVILYA------LLCGTLPFD-------------DENIPN--------LFKKIK 94
           VD+WS G I         L  G+   D             +E+ P            K  
Sbjct: 200 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 259
Query: 95  GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             I    + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 260 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 301

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFAFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/174 (29%), Positives = 76/174 (43%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 147 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 58  AGPEVDVWSCGVILYALLCGTLPF----------------------DDENIPNLFKKIKG 95
               +D+WS G IL  +L     F                      D   I NL  K + 
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL--KARN 264
Query: 96  GIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            + +LP       + L P A     DL+ +ML  +P KRI + +   HP+   +
Sbjct: 265 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQY 318

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 68/119 (57%), Gaps = 10/119 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAG 59
           +VHRD+KP+N+L+DS   +KI DFG++  + +    +T+   G+  Y +PE   G+  A 
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE--AT 189
Query: 60  PE-VDVWSCGVILYALLCGTLPFDDENIPNL-FKKIKGGIYTLPSHLSPGARDLIPRML 116
            E  D++S G++LY +L G  PF+ E   ++  K I+  +     +++   R  IP+ L
Sbjct: 190 DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSV----PNVTTDVRKDIPQSL 244

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 214
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 215 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 265
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 266 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 300

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 147 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 206
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 207 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 257
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 258 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 292

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFAFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 162 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 221
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 222 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 272
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 273 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 307

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 236
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 287
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 288 -YTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSRLLE 322

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 155 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 214
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 215 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 265
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 266 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 300

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 144 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 203
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 204 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 254
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 255 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 289

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 151 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTS 210
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 211 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 261
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 262 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 296

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 328
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 329 PYDQSSESRDLLIDEWKSLTYDE 351

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 222 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 281
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 282 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 332
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 333 -YTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSRLLE 367

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 73/149 (48%), Gaps = 29/149 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---------------TSCGSPNY 46
           ++HRDLK ENLLL ++  +K+ DFG +  +   H+                 T   +P Y
Sbjct: 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTI--SHYPDYSWSAQRRALVEEEITRNTTPMY 216
Query: 47  AAPEVISGKLYA----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 102
             PE+I   LY+    G + D+W+ G ILY L     PF+D        +I  G Y++P 
Sbjct: 217 RTPEIID--LYSNFPIGEKQDIWALGCILYLLCFRQHPFED----GAKLRIVNGKYSIPP 270
Query: 103 HLSPGA--RDLIPRMLIVDPMKRITIPEI 129
           H +       LI  ML V+P +R++I E+
Sbjct: 271 HDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNAMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 148 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 207
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 208 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 258
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 259 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 293

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 253
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 254 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 288

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 156 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 215
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 216 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 266
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 267 -YTEFKFPQIKAHPWTKVFRPR----TPPEAIALCSRLLE 301

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 171 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 230
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 231 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 281
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 282 -YTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSRLLE 316

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 287
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 288 -YTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSRLLE 322

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 179 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 238
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 239 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 289
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 290 -YTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSRLLE 324

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/160 (31%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 181 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 240
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            +DVWS G +L  LL G   F  D  +  L + IK     L +      R++ P      
Sbjct: 241 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK----VLGTPTREQIREMNPN----- 291
Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDE 159
                  P+I+ HPW +   PR     PP+ +    ++ E
Sbjct: 292 -YTEFKFPQIKAHPWTKVFRPRT----PPEAIALCSRLLE 326

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 82/182 (45%), Gaps = 36/182 (19%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD    V K+ DFG + I+  G    +   S  Y APE+I G      
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGATNYTT 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIK-------GGIYTL-PSHLS------ 105
            +D+WS G ++  L+ G   F  E+ I  L + IK         I T+ P+++       
Sbjct: 222 NIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI 281
Query: 106 --------------PGARDLIPRMLIVDPMKRITIPEIRQHPWF------QAHLPRYLAV 145
                         P A DLI R+L   P  R+T  E   HP+F      +A +P    +
Sbjct: 282 RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGREL 341
Query: 146 PP 147
           PP
Sbjct: 342 PP 343

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 327
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 328 PYDQSFESRDLLIDEWKSLTYDE 350

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 75/167 (44%), Gaps = 33/167 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+   +    +     +  Y APEVI   +     
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLAR--QADSEMXGXVVTRWYRAPEVILNWMRYTQT 206
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI---------------------------- 93
           VD+WS G I+  ++ G   F   +  +  K+I                            
Sbjct: 207 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 266
Query: 94  ---KGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
              K    ++ ++ SP A +L+ +ML++D  +R+T  E   HP+F++
Sbjct: 267 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 313

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 269
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 327
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 328 PYDQSFESRDLLIDEWKSLTYDE 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PFDQSFESRDLLIDEWKSLTYDE 344

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 51/172 (29%), Positives = 76/172 (44%), Gaps = 35/172 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 147 VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 206
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG------------GI-------- 97
               +D+WS G IL  +L     F  ++  +    I G            GI        
Sbjct: 207 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKARNYL 266
Query: 98  YTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
            +LP       + L P A     DL+ +ML  +P KRI + +   HP+   +
Sbjct: 267 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQY 318

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 328
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 329 PYDQSLESRDLLIDEWKSLTYDE 351

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 152 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 327
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 328 PYDQSFESRDLLIDEWKSLTYDE 350

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 328
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 329 PYDQSFESRDLLIDEWKSLTYDE 351

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PTDQSFESRDLLIDEWKSLTYDE 344

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGXVATRWYRAPEIMLNWMHYNQT 223
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 283
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 341
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 342 PYDQSFESRDLLIDEWKSLTYDE 364

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 333
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 334 PYDQSFESRDLLIDEWKSLTYDE 356

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 333
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 334 PYDQSFESRDLLIDEWKSLTYDE 356

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 158 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 215
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 216 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 275
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 276 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 333
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 334 PYDQSFESRDLLIDEWKSLTYDE 356

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PQDQSFESRDLLIDEWKSLTYDE 344

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGXVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 210
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 270
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 271 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 328
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 329 PYDQSFESRDLLIDEWKSLTYDE 351

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 157 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 332
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 333 PYDQSFESRDLLIDEWKSLTYDE 355

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 44/145 (30%), Positives = 68/145 (46%), Gaps = 8/145 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KP N+LLD +  +K+ DFG+S  + D      S G   Y APE I       P+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205
Query: 62  ----VDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHL--SPGARDLIP 113
                DVWS G+ L  L  G  P+ +   +   L K ++     LP H+  S   +  + 
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAH 138
             L  D  KR    ++ +H + + +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRY 290

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 152 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 210 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 269
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 270 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 327
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 328 PYDQSFESRDLLIDEWKSLTYDE 350

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 326
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 327 PYDQSFESRDLLIDEWKSLTYDE 349

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 323
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 324 PYDQSFESRDLLIDEWKSLTYDE 346

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 151 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 326
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 327 PYDQSFESRDLLIDEWKSLTYDE 349

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 145 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 202
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 203 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 262
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 263 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 320
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 321 PYDQSFESRDLLIDEWKSLTYDE 343

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 156 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 213
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 214 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 273
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 274 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 331
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 332 PYDQSFESRDLLIDEWKSLTYDE 354

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 226
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 344
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 345 PYDQSFESRDLLIDEWKSLTYDE 367

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 323
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 324 PYDQSFESRDLLIDEWKSLTYDE 346

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 169 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MXGYVATRWYRAPEIMLNWMHYNQT 226
Query: 62  VDVWSCGVILYALLCGTLPF-DDENI--------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   ++I                L KKI           + 
Sbjct: 227 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 286
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 287 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 344
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 345 PYDQSFESRDLLIDEWKSLTYDE 367

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 157 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 214
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 215 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 274
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 275 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 332
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 333 PYDQSFESRDLLIDEWKSLTYDE 355

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 282
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 340
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 341 PYDQSFESRDLLIDEWKSLTYDE 363

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 283
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 341
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 342 PYDQSFESRDLLIDEWKSLTYDE 364

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 67/134 (50%), Gaps = 3/134 (2%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL  + +VK+ADFG++  + D    + T  G+P + APEVI    Y   +
Sbjct: 142 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAY-DSK 200
Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  D + +  LF   K    TL    +   ++ I   L  DP
Sbjct: 201 ADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDFTKSFKEFIDACLNKDP 260
Query: 121 MKRITIPEIRQHPW 134
             R T  E+ +H +
Sbjct: 261 SFRPTAKELLKHKF 274

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 165 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 222
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 223 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 282
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 283 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 340
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 341 PYDQSFESRDLLIDEWKSLTYDE 363

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 326
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 327 PYDQSFESRDLLIDEWKSLTYDE 349

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 260
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 318
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 319 PYDQSFESRDLLIDEWKSLTYDE 341

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 166 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 223
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 224 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 283
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 284 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 341
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 342 PYDQSFESRDLLIDEWKSLTYDE 364

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 148 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 323
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 324 PYDQSFESRDLLIDEWKSLTYDE 346

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 40/205 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++HRDLKP NL ++    +KI DFGL+    D    F+ T      Y APE++   ++  
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW----YRAPEIMLNWMHYN 201
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------G 96
             VD+WS G I+  LL G   F   +                  L KKI           
Sbjct: 202 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 261
Query: 97  IYTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPP 147
           +  +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P 
Sbjct: 262 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPV 319
Query: 148 PDTMQQAKKIDEEILKEVVKMGFDQ 172
            D   Q+ +  + ++ E   + +D+
Sbjct: 320 ADPYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 148 IIHRDLKPSNLAVNEDSELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 205
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 206 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 265
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 266 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 323
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 324 PYDQSFESRDLLIDEWKSLTYDE 346

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 317
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 318 PYDQSFESRDLLIDEWKSLTYDE 340

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PRDQSFESRDLLIDEWKSLTYDE 344

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 259
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 317
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 318 PYDQSFESRDLLIDEWKSLTYDE 340

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 151 IIHRDLKPSNLAVNEDXELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 208
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 209 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 268
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 269 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 326
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 327 PYDQSFESRDLLIDEWKSLTYDE 349

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 143 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 200
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 201 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 260
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 261 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 318
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 319 PYDQSFESRDLLIDEWKSLTYDE 341

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 144 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 202 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 261
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 262 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 319
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 320 PYDQSFESRDLLIDEWKSLTYDE 342

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 40/205 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++HRDLKP NL ++    +KI DFGL+    D    F+ T      Y APE++   ++  
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW----YRAPEIMLNWMHYN 201
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------G 96
             VD+WS G I+  LL G   F   +                  L KKI           
Sbjct: 202 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 261
Query: 97  IYTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPP 147
           +  +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P 
Sbjct: 262 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPV 319
Query: 148 PDTMQQAKKIDEEILKEVVKMGFDQ 172
            D   Q+ +  + ++ E   + +D+
Sbjct: 320 ADPYDQSFESRDLLIDEWKSLTYDE 344

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 199
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLA 259
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 317
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 318 PYDQSFESRDLLIDEWKSLTYDE 340

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKL 56
            VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+   +
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIP 113
                 D +S G +L+ LL G  PF      +  +  +  +     LP   SP  R L+ 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 114 RMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 148
            +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 469

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 129 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 245
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 278

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 88/205 (42%), Gaps = 40/205 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--GHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++HRDLKP NL ++    +KI DFGL+    D    F+ T      Y APE++   ++  
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRW----YRAPEIMLNWMHYN 197
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------G 96
             VD+WS G I+  LL G   F   +                  L KKI           
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 97  IYTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPP 147
           +  +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P 
Sbjct: 258 LAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPV 315
Query: 148 PDTMQQAKKIDEEILKEVVKMGFDQ 172
            D   Q+ +  + ++ E   + +D+
Sbjct: 316 ADPYDQSFESRDLLIDEWKSLTYDE 340

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 292
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 148 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 264
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKL 56
            VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+   +
Sbjct: 311 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGV 365
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIP 113
                 D +S G +L+ LL G  PF      +  +  +  +     LP   SP  R L+ 
Sbjct: 366 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 425
Query: 114 RMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 148
            +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 426 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 468

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 234
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 292
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 38/169 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKL 56
           V+HRDLKP+NLL++ +  +KIADFGL+      + +  H + T      Y AP+V+ G  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLW----YRAPDVLMGSK 176
Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG-------GIYTLPSH-- 103
                +D+WS G I   ++ GT  F    + + +  +F+ +          +  LP +  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 104 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                           L     DL+ +ML +DP +RIT  +  +H +F+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKL 56
            VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+   +
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIP 113
                 D +S G +L+ LL G  PF      +  +  +  +     LP   SP  R L+ 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 114 RMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 148
            +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 469

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 78/166 (46%), Gaps = 26/166 (15%)
Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK----TSCGSPNYAAPEVISGKL 56
            VV+RDLKP N+LLD   +V+I+D GL+       F K     S G+  Y APEV+   +
Sbjct: 312 FVVYRDLKPANILLDEHGHVRISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGV 366
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIP 113
                 D +S G +L+ LL G  PF      +  +  +  +     LP   SP  R L+ 
Sbjct: 367 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 426
Query: 114 RMLIVDPMKRITI-----PEIRQHPWFQA------HLPRYLAVPPP 148
            +L  D  +R+        E+++ P+F++       L +Y   PPP
Sbjct: 427 GLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKY---PPP 469

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 128 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 186
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 187 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 244
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 245 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 277

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 132 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 190
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 191 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 248
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 249 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 281

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/153 (33%), Positives = 72/153 (47%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTS-CGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+      +K S  G+ NY  PE I      
Sbjct: 176 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 292
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 325

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL     D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDSELKILDFGLCRHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSLESRDLLIDEWKSLTYDE 344

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/169 (27%), Positives = 79/169 (46%), Gaps = 38/169 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKL 56
           V+HRDLKP+NLL++ +  +KIADFGL+      + +  H + T      Y AP+V+ G  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW----YRAPDVLMGSK 176
Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG-------GIYTLPSH-- 103
                +D+WS G I   ++ GT  F    + + +  +F+ +          +  LP +  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 104 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                           L     DL+ +ML +DP +RIT  +  +H +F+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/153 (32%), Positives = 70/153 (45%), Gaps = 21/153 (13%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+         +  G+ NY  PE I      
Sbjct: 148 IVHSDLKPANFLIVDGM-LKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSS 206
Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-----YTLPSH 103
                 K    P+ DVWS G ILY +  G  PF  + I N   K+   I        P  
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIEFPDI 264
Query: 104 LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                +D++   L  DP +RI+IPE+  HP+ Q
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQ 297

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           V+HRDLKP+NLL++    +K+ADFGL+        +   C S       Y  P+V+ G  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLADFGLARAFG----IPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 57  YAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-----------LPSH- 103
                +D+WS G I   L     P F   ++ +  K+I   + T           LP + 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 104 -----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
                            L+   RDL+  +L  +P++RI+  E  QHP+F    P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/130 (33%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+ L     VKI DFGL   +++      S G+  Y +PE IS + Y G E
Sbjct: 157 LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKE 215
Query: 62  VDVWSCGVILYALL--CGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
           VD+++ G+IL  LL  C T  F+       F  ++ GI  +        + L+ ++L   
Sbjct: 216 VDLYALGLILAELLHVCDT-AFE---TSKFFTDLRDGI--ISDIFDKKEKTLLQKLLSKK 269
Query: 120 PMKRITIPEI 129
           P  R    EI
Sbjct: 270 PEDRPNTSEI 279

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI D+GL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDYGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 42/147 (28%), Positives = 70/147 (47%), Gaps = 21/147 (14%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL+++ + K+ADFG++  + D    +    G+P + APEVI    Y    
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGY-NCV 205
Query: 62  VDVWSCGVILYALLCGTLPFDD-----------ENIPNLFKKIKGGIYTLPSHLSPGARD 110
            D+WS G+    +  G  P+ D            N P  F+K        P   S    D
Sbjct: 206 ADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRK--------PELWSDNFTD 257
Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQA 137
            + + L+  P +R T  ++ QHP+ ++
Sbjct: 258 FVKQCLVKSPEQRATATQLLQHPFVRS 284

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------HFLKTSCGSPNYAAPEVISGKL 56
           +HRD+K  N+LL    +V+IADFG+S  +  G         KT  G+P + APEV+    
Sbjct: 143 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 202
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARD--- 110
               + D+WS G+    L  G  P+      + +  +K  + TL   P  L  G +D   
Sbjct: 203 GYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTLQNDPPSLETGVQDKEM 256
Query: 111 ----------LIPRMLIVDPMKRITIPEIRQHPWFQ 136
                     +I   L  DP KR T  E+ +H +FQ
Sbjct: 257 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 292

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/172 (26%), Positives = 75/172 (43%), Gaps = 35/172 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLKP+NLL++ +  +K+ DFGL+       +   +   +  Y AP+V+ G      
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYST 188
Query: 61  EVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKG--------GIYTLPSH------ 103
            +D+WSCG IL  ++ G   F   +DE    L   I G         +  LP +      
Sbjct: 189 SIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQ 248
Query: 104 ---------LSPGAR--------DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
                    L P  +        D +  +L ++P  R++  +   HPWF  +
Sbjct: 249 RPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 71/156 (45%), Gaps = 28/156 (17%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG------HFLKTSCGSPNYAAPEVISGKL 56
           +HRD+K  N+LL    +V+IADFG+S  +  G         KT  G+P + APEV+    
Sbjct: 138 IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVR 197
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARD--- 110
               + D+WS G+    L  G  P+      + +  +K  + TL   P  L  G +D   
Sbjct: 198 GYDFKADIWSFGITAIELATGAAPY------HKYPPMKVLMLTLQNDPPSLETGVQDKEM 251
Query: 111 ----------LIPRMLIVDPMKRITIPEIRQHPWFQ 136
                     +I   L  DP KR T  E+ +H +FQ
Sbjct: 252 LKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQ 287

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 69/167 (41%), Gaps = 32/167 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KPEN+L+     VK+ DFG +  +   G        +  Y APE++ G +  G 
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGK 204
Query: 61  EVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSH---------------- 103
            VDVW+ G ++  +  G   F  D +I  L+  +      +P H                
Sbjct: 205 AVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLP 264
Query: 104 --------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                         LS    DL  + L +DP KR    E+  H +FQ
Sbjct: 265 EIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 46/142 (32%), Positives = 68/142 (47%), Gaps = 29/142 (20%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS----NIMR------------------DGHFLKT 39
           ++HRD+KP N+LL+++ +VK+ADFGLS    NI R                  D   L  
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 40  SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT 99
              +  Y APE++ G       +D+WS G IL  +LCG   F   +  N  ++I G I  
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVI-D 248
Query: 100 LPSH------LSPGARDLIPRM 115
            PS+       SP A+ +I  +
Sbjct: 249 FPSNEDVESIQSPFAKTMIESL 270

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+ ++    ++I DFGL+   +    +     +  Y APE++   ++    
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTLP 101
           VD+WS G I+  LL G   F   +  +  K+I                    +  I +LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 102 -----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
                         +P A DL+ RML++D  +R++  E   H +F Q H P     P  +
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE--DEPEAE 327
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              ++ +  E  L+E  ++ + +
Sbjct: 328 PYDESVEAKERTLEEWKELTYQE 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+ ++    ++I DFGL+   +    +     +  Y APE++   ++    
Sbjct: 144 IIHRDLKPSNVAVNEDCELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHYNQT 201
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTLP 101
           VD+WS G I+  LL G   F   +  +  K+I                    +  I +LP
Sbjct: 202 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 261
Query: 102 -----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
                         +P A DL+ RML++D  +R++  E   H +F Q H P     P  +
Sbjct: 262 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE--DEPEAE 319
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              ++ +  E  L+E  ++ + +
Sbjct: 320 PYDESVEAKERTLEEWKELTYQE 342

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+ ++    ++I DFGL+   +    +     +  Y APE++   ++    
Sbjct: 152 IIHRDLKPSNVAVNEDSELRILDFGLAR--QADEEMTGYVATRWYRAPEIMLNWMHYNQT 209
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYTLP 101
           VD+WS G I+  LL G   F   +  +  K+I                    +  I +LP
Sbjct: 210 VDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLP 269
Query: 102 -----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
                         +P A DL+ RML++D  +R++  E   H +F Q H P     P  +
Sbjct: 270 PMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDPE--DEPEAE 327
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              ++ +  E  L+E  ++ + +
Sbjct: 328 PYDESVEAKERTLEEWKELTYQE 350

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 70/163 (42%), Gaps = 30/163 (18%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  Y APEV+    YA P 
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVLLQSTYATP- 191
Query: 62  VDVWSCGVILYA------LLCGTLPFD-------------DENIPNLFKKIKGGI----- 97
           VD+WS G I         L CG    D             +++ P      +G       
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 251
Query: 98  ----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                 +P     GA+ L+  ML  +P KRI+     QH +  
Sbjct: 252 RPVQSVVPEMEESGAQLLL-EMLTFNPHKRISAFRALQHSYLH 293

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 37/82 (45%), Positives = 45/82 (54%), Gaps = 7/82 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  Y APEV+    YA P 
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATP- 199
Query: 62  VDVWSCGVILYA------LLCG 77
           VD+WS G I         L CG
Sbjct: 200 VDMWSVGCIFAEMFRRKPLFCG 221

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 70/163 (42%), Gaps = 30/163 (18%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  Y APEV+    YA P 
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVLLQSTYATP- 191
Query: 62  VDVWSCGVILYA------LLCGTLPFD-------------DENIPNLFKKIKGGI----- 97
           VD+WS G I         L CG    D             +++ P      +G       
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 251
Query: 98  ----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                 +P     GA+ L+  ML  +P KRI+     QH +  
Sbjct: 252 RPVQSVVPEMEESGAQLLL-EMLTFNPHKRISAFRALQHSYLH 293

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 38/169 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEVISGKL 56
           V+HRDLKP+NLL++ +  +KIADFGL+      + +  H + T      Y AP+V+ G  
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLW----YRAPDVLMGSK 176
Query: 57  YAGPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKG-------GIYTLPSH-- 103
                +D+WS G I   ++ G   F    + + +  +F+ +          +  LP +  
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 104 ----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                           L     DL+ +ML +DP +RIT  +  +H +F+
Sbjct: 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 25/143 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK--------------TSCGSPNY 46
           ++HRDLKP N+ +D   NVKI DFGL+ N+ R    LK              ++ G+  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHL 104
            A EV+ G  +   ++D++S G+I + ++    PF    E + N+ KK++      P   
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-NILKKLRSVSIEFPPDF 252
Query: 105 SPGARDL---IPRMLIV-DPMKR 123
                 +   I R+LI  DP KR
Sbjct: 253 DDNKMKVEKKIIRLLIDHDPNKR 275

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 25/143 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK--------------TSCGSPNY 46
           ++HRDLKP N+ +D   NVKI DFGL+ N+ R    LK              ++ G+  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196
Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHL 104
            A EV+ G  +   ++D++S G+I + ++    PF    E + N+ KK++      P   
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV-NILKKLRSVSIEFPPDF 252
Query: 105 SPGARDL---IPRMLIV-DPMKR 123
                 +   I R+LI  DP KR
Sbjct: 253 DDNKMKVEKKIIRLLIDHDPNKR 275

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI  FGL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILGFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/127 (36%), Positives = 63/127 (49%), Gaps = 6/127 (4%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           V+HRD+KP N+ + +   VK+ D GL            S  G+P Y +PE I    Y   
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NF 215
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIY-TLPS-HLSPGARDLIPRML 116
           + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LPS H S   R L+   +
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 275
Query: 117 IVDPMKR 123
             DP KR
Sbjct: 276 NPDPEKR 282

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DF L+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDFYLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 48/151 (31%), Positives = 70/151 (46%), Gaps = 19/151 (12%)
Query: 2   VVHRDLKPENLLLD-----SKWNVKIADFGLSNIMRDG-HFLKTSCGSPN---YAAPEVI 52
           +VHRDLKP N+L+       K    I+DFGL   +  G H      G P    + APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 53  SGKLYAGPE--VDVWSCGVILYALLC-GTLPFDDE-----NIPNLFKKIKGGIYTLPSHL 104
           S      P   VD++S G + Y ++  G+ PF        NI  L             H 
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI--LLGACSLDCLHPEKHE 256
Query: 105 SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
              AR+LI +M+ +DP KR +   + +HP+F
Sbjct: 257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 2   VVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF-----LKTSCGS 43
           ++HRDLKP+N+L+ +                + I+DFGL   +  G       L    G+
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 44  PNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL 100
             + APE++  S K      +D++S G + Y +L  G  PF D+        I  GI++L
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL 271
Query: 101 PS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                     L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 272 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 75/162 (46%), Gaps = 30/162 (18%)
Query: 2   VVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF-----LKTSCGS 43
           ++HRDLKP+N+L+ +                + I+DFGL   +  G       L    G+
Sbjct: 154 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 213
Query: 44  PNYAAPEVI--SGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL 100
             + APE++  S K      +D++S G + Y +L  G  PF D+        I  GI++L
Sbjct: 214 SGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSL 271
Query: 101 PS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                     L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 272 DEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 313

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 37/141 (26%), Positives = 72/141 (51%), Gaps = 8/141 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 145 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 202
Query: 62  VDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSPGA-----RDLIPRM 115
            D+WS G+ L  +  G  P         +F+ +   +   P  L  G      +D + + 
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKC 262
Query: 116 LIVDPMKRITIPEIRQHPWFQ 136
           LI +P +R  + ++  H + +
Sbjct: 263 LIKNPAERADLKQLMVHAFIK 283

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI D GL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDAGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 70/163 (42%), Gaps = 30/163 (18%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VHRDLKPEN+L+ S   VK+ADFGL+ I      L     +  Y APEV+    YA P 
Sbjct: 133 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVLLQSTYATP- 191
Query: 62  VDVWSCGVILYA------LLCGTLPFD-------------DENIPNLFKKIKGGI----- 97
           VD+WS G I         L CG    D             +++ P      +G       
Sbjct: 192 VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGP 251
Query: 98  ----YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                 +P     GA+ L+  ML  +P KRI+     QH +  
Sbjct: 252 RPVQSVVPEMEESGAQLLL-EMLTFNPHKRISAFRALQHSYLH 293

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           V+HRDLKP+NLL++    +K+A+FGL+        +   C S       Y  P+V+ G  
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFG----IPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 57  YAGPEVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-----------LPSH- 103
                +D+WS G I   L     P F   ++ +  K+I   + T           LP + 
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237
Query: 104 -----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
                            L+   RDL+  +L  +P++RI+  E  QHP+F    P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI D GL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDRGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPF------DDENI---------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F      D   +           L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 38/170 (22%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +HRD+KPEN+L+     +K+ DFG + ++     +      +  Y +PE++ G    GP
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGP 182
Query: 61  EVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSH------------- 103
            VDVW+ G +   LL G +P      D +   L +K  G +  +P H             
Sbjct: 183 PVDVWAIGCVFAELLSG-VPLWPGKSDVDQLYLIRKTLGDL--IPRHQQVFSTNQYFSGV 239
Query: 104 -----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                            +S  A  L+   L +DP +R+T  ++  HP+F+
Sbjct: 240 KIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFE 289

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/203 (26%), Positives = 86/203 (42%), Gaps = 36/203 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI D GL+    D   +     +  Y APE++   ++    
Sbjct: 146 IIHRDLKPSNLAVNEDCELKILDGGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQT 203
Query: 62  VDVWSCGVILYALLCGTLPFDDENI---------------PNLFKKIKG--------GIY 98
           VD+WS G I+  LL G   F   +                  L KKI           + 
Sbjct: 204 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 263
Query: 99  TLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPD 149
            +P           +P A DL+ +ML++D  KRIT  +   H +F Q H P     P  D
Sbjct: 264 QMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD--DEPVAD 321
Query: 150 TMQQAKKIDEEILKEVVKMGFDQ 172
              Q+ +  + ++ E   + +D+
Sbjct: 322 PYDQSFESRDLLIDEWKSLTYDE 344

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 573 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 631
Query: 119 DPMKRITIPEIR 130
           DP +R    E++
Sbjct: 632 DPSRRPRFTELK 643

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 136 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 195
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 196 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 254
Query: 119 DPMKRITIPEIR 130
           DP +R    E++
Sbjct: 255 DPSRRPRFTELK 266

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/130 (33%), Positives = 65/130 (50%), Gaps = 9/130 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKP N+ L     VKI DFGL   +++      S G+  Y +PE IS + Y G E
Sbjct: 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDY-GKE 201
Query: 62  VDVWSCGVILYALL--CGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
           VD+++ G+IL  LL  C T  F+       F  ++ GI  +        + L+ ++L   
Sbjct: 202 VDLYALGLILAELLHVCDT-AFE---TSKFFTDLRDGI--ISDIFDKKEKTLLQKLLSKK 255
Query: 120 PMKRITIPEI 129
           P  R    EI
Sbjct: 256 PEDRPNTSEI 265

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 135 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 194
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 195 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 253
Query: 119 DPMKRITIPEIR 130
           DP +R    E++
Sbjct: 254 DPSRRPRFTELK 265

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 51/175 (29%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLKP NLLLD    +K+ADFGL+           S GSPN           Y APE
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLAK----------SFGSPNRAYXHQVVTRWYRAPE 182
Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGTLPF-----DDENIPNLFKKIKG-------GIY 98
           ++ G    G  VD+W+ G IL  LL   +PF     D + +  +F+ +          + 
Sbjct: 183 LLFGARMYGVGVDMWAVGCILAELLL-RVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC 241
Query: 99  TLPSHLS----PGA-------------RDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           +LP +++    PG               DLI  + + +P  RIT  +  +  +F 
Sbjct: 242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 68/141 (48%), Gaps = 3/141 (2%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL  + +VK+ADFG++  + D    +    G+P + APEVI    Y   +
Sbjct: 138 IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF-K 196
Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  D + +  LF   K    TL    S   ++ +   L  DP
Sbjct: 197 ADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQHSKPFKEFVEACLNKDP 256
Query: 121 MKRITIPEIRQHPWFQAHLPR 141
             R T  E+ +H +   +  +
Sbjct: 257 RFRPTAKELLKHKFITRYTKK 277

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 130 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 190 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 248
Query: 119 DPMKRITIPEIR 130
           DP +R    E++
Sbjct: 249 DPSRRPRFTELK 260

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 161 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 220
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 221 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 279
Query: 119 DPMKRITIPEIRQH 132
           DP +R    E++  
Sbjct: 280 DPSRRPRFTELKAQ 293

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 193 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 251
Query: 119 DPMKRITIPEIR 130
           DP +R    E++
Sbjct: 252 DPSRRPRFTELK 263

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 193 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 251
Query: 119 DPMKRITIPEIRQH 132
           DP +R    E++  
Sbjct: 252 DPSRRPRFTELKAQ 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 197
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 198 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 256
Query: 119 DPMKRITIPEIRQH 132
           DP +R    E++  
Sbjct: 257 DPSRRPRFTELKAQ 270

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 75/147 (51%), Gaps = 14/147 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 183
Query: 62  VDVWSCGVILYALLCGTLPF------DDENIP-NLFKKIKGGIYTLPSHLSPGA-----R 109
            D+WS G+ L  +  G  P       +D   P  +F+ +   +   P  L  G      +
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 243
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           D + + LI +P +R  + ++  H + +
Sbjct: 244 DFVNKCLIKNPAERADLKQLMVHAFIK 270

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 3/135 (2%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL     VK+ADFG++  + D    + T  G+P + APEVI    Y   +
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-K 184
Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  + + +  LF   K    TL  + S   ++ +   L  +P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 121 MKRITIPEIRQHPWF 135
             R T  E+ +H + 
Sbjct: 245 SFRPTAKELLKHKFI 259

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 66/135 (48%), Gaps = 3/135 (2%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL     VK+ADFG++  + D    + T  G+P + APEVI    Y   +
Sbjct: 146 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS-K 204
Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  + + +  LF   K    TL  + S   ++ +   L  +P
Sbjct: 205 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 264
Query: 121 MKRITIPEIRQHPWF 135
             R T  E+ +H + 
Sbjct: 265 SFRPTAKELLKHKFI 279

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 64/132 (48%), Gaps = 5/132 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ +   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 513 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 572
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 573 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 631
Query: 119 DPMKRITIPEIR 130
           DP +R    E++
Sbjct: 632 DPSRRPRFTELK 643

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 25/143 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLK--------------TSCGSPNY 46
           ++HR+LKP N+ +D   NVKI DFGL+ N+ R    LK              ++ G+  Y
Sbjct: 137 IIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXY 196
Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLPSHL 104
            A EV+ G  +   ++D +S G+I +  +    PF    E + N+ KK++      P   
Sbjct: 197 VATEVLDGTGHYNEKIDXYSLGIIFFEXIY---PFSTGXERV-NILKKLRSVSIEFPPDF 252
Query: 105 SPGARDL---IPRMLIV-DPMKR 123
                 +   I R+LI  DP KR
Sbjct: 253 DDNKXKVEKKIIRLLIDHDPNKR 275

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 37/143 (25%), Positives = 71/143 (49%), Gaps = 16/143 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D        G+ +Y +PE + G  Y+  +
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPERLQGTHYS-VQ 186
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFK--------KIKGGIYTLPSHLSPGARDLIP 113
            D+WS G+ L  +  G  P     I  L          K+   +++L        +D + 
Sbjct: 187 SDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLE------FQDFVN 240
Query: 114 RMLIVDPMKRITIPEIRQHPWFQ 136
           + LI +P +R  + ++  H + +
Sbjct: 241 KCLIKNPAERADLKQLMVHAFIK 263

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 5/134 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ +   VK+ DFGLS  M D  + K S G     + APE I+ + +   
Sbjct: 133 VHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 192
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 193 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 251
Query: 119 DPMKRITIPEIRQH 132
           DP +R    E++  
Sbjct: 252 DPSRRPRFTELKAQ 265

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 29/80 (36%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y APE + G  Y+  +
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPERLQGTHYS-VQ 193
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  L  G  P 
Sbjct: 194 SDIWSMGLSLVELAVGRYPI 213

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 3/135 (2%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL     VK+ADFG++  + D    +    G+P + APEVI    Y   +
Sbjct: 141 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS-K 199
Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  + + +  LF   K    TL  + S   ++ +   L  +P
Sbjct: 200 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 259
Query: 121 MKRITIPEIRQHPWF 135
             R T  E+ +H + 
Sbjct: 260 SFRPTAKELLKHKFI 274

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVIS-GKLYA 58
           ++HRD+K  N+LLD ++   + DFGL+ +M  +D H      G+  + APE +S GK  +
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGK--S 220
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPN 88
             + DV+  GV+L  L+ G   FD   + N
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAFDLARLAN 250

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/135 (30%), Positives = 65/135 (48%), Gaps = 3/135 (2%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGPE 61
           +HRD+K  N+LL     VK+ADFG++  + D    +    G+P + APEVI    Y   +
Sbjct: 126 IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS-K 184
Query: 62  VDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            D+WS G+    L  G  P  + + +  LF   K    TL  + S   ++ +   L  +P
Sbjct: 185 ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEP 244
Query: 121 MKRITIPEIRQHPWF 135
             R T  E+ +H + 
Sbjct: 245 SFRPTAKELLKHKFI 259

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 63/134 (47%), Gaps = 5/134 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D    K S G     + APE I+ + +   
Sbjct: 133 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSA 192
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIV 118
             DVW  GV ++ +L  G  PF      ++  +I+ G    +P +  P    L+ +    
Sbjct: 193 S-DVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAY 251
Query: 119 DPMKRITIPEIRQH 132
           DP +R    E++  
Sbjct: 252 DPSRRPRFTELKAQ 265

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLKP NLLL +   V KI DFG +  ++    +  + GS  + APEV  G  Y+  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS-E 182
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
           + DV+S G+IL+ ++    PFD+   P    ++    G    L  +L      L+ R   
Sbjct: 183 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWS 242
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYL 143
            DP +R ++ EI +      HL RY 
Sbjct: 243 KDPSQRPSMEEIVK---IMTHLMRYF 265

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 73/146 (50%), Gaps = 10/146 (6%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLKP NLLL +   V KI DFG +  ++    +  + GS  + APEV  G  Y+  
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT--HMTNNKGSAAWMAPEVFEGSNYS-E 183
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
           + DV+S G+IL+ ++    PFD+   P    ++    G    L  +L      L+ R   
Sbjct: 184 KCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWS 243
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYL 143
            DP +R ++ EI +      HL RY 
Sbjct: 244 KDPSQRPSMEEIVK---IMTHLMRYF 266

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 212 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 187 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+ +I  D ++ +K +   P  + APE I   +Y 
Sbjct: 189 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 248
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGGIYTL-PSHLSPGARDLIPRM 115
             E DVWS G+ L+ L   G+ P+    + +  +K IK G   L P H      D++   
Sbjct: 249 F-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 307
Query: 116 LIVDPMKRITIPEIRQ 131
              DP+KR T  +I Q
Sbjct: 308 WDADPLKRPTFKQIVQ 323

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/136 (35%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+ +I  D ++ +K +   P  + APE I   +Y 
Sbjct: 184 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 243
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRM 115
             E DVWS G+ L+ L   G+ P+    + + F K IK G   L P H      D++   
Sbjct: 244 F-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 302
Query: 116 LIVDPMKRITIPEIRQ 131
              DP+KR T  +I Q
Sbjct: 303 WDADPLKRPTFKQIVQ 318

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI    K 
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 190 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 48/136 (35%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+ +I  D ++ +K +   P  + APE I   +Y 
Sbjct: 182 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 241
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRM 115
             E DVWS G+ L+ L   G+ P+    + + F K IK G   L P H      D++   
Sbjct: 242 F-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 300
Query: 116 LIVDPMKRITIPEIRQ 131
              DP+KR T  +I Q
Sbjct: 301 WDADPLKRPTFKQIVQ 316

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 32/90 (35%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVIS-GKLYA 58
           ++HRD+K  N+LLD ++   + DFGL+ +M  +D H      G   + APE +S GK  +
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGK--S 212
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPN 88
             + DV+  GV+L  L+ G   FD   + N
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-----CGSPNYAAPEVISGKLY 57
           +HRD+K  N+LLD  +  KI+DFGL+       F +T       G+  Y APE + G++ 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASE--KFAQTVMXSRIVGTTAYMAPEALRGEI- 211
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 90
             P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/136 (34%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+ +I  D ++ +K +   P  + APE I   +Y 
Sbjct: 189 CIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 248
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPN-LFKKIKGGIYTL-PSHLSPGARDLIPRM 115
             E DVWS G+ L+ L   G+ P+    + +  +K IK G   L P H      D++   
Sbjct: 249 F-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 307
Query: 116 LIVDPMKRITIPEIRQ 131
              DP+KR T  +I Q
Sbjct: 308 WDADPLKRPTFKQIVQ 323

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 50/93 (53%), Gaps = 9/93 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-----CGSPNYAAPEVISGKLY 57
           +HRD+K  N+LLD  +  KI+DFGL+       F +T       G+  Y APE + G++ 
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASE--KFAQTVMXXRIVGTTAYMAPEALRGEI- 211
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLF 90
             P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 212 -TPKSDIYSFGVVLLEIITGLPAVDEHREPQLL 243

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 34/166 (20%)
Query: 2   VVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF-----LKTSCGS 43
           ++HRDLKP+N+L+ +                + I+DFGL   +  G       L    G+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGT 195
Query: 44  PNYAAPEVIS------GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + APE++        K      +D++S G + Y +L  G  PF D+        I  G
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRG 253
Query: 97  IYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           I++L          L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 7/105 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSP-NYAAPEVISGKLYA 58
           VHRDL   N+L+DS    K++DFGLS ++    D  +  T    P  + APE I+ + ++
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
               DVWS GV+++ +L  G  P+ +    ++   ++ G Y LP+
Sbjct: 233 SAS-DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 34/166 (20%)
Query: 2   VVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF-----LKTSCGS 43
           ++HRDLKP+N+L+ +                + I+DFGL   +  G       L    G+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195
Query: 44  PNYAAPEVIS------GKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + APE++        K      +D++S G + Y +L  G  PF D+        I  G
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRG 253
Query: 97  IYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
           I++L          L   A DLI +M+  DP+KR T  ++ +HP F
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 48/136 (35%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+ +I  D ++ +K +   P  + APE I   +Y 
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGIYTL-PSHLSPGARDLIPRM 115
             E DVWS G+ L+ L   G+ P+    + + F K IK G   L P H      D++   
Sbjct: 226 F-ESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 284
Query: 116 LIVDPMKRITIPEIRQ 131
              DP+KR T  +I Q
Sbjct: 285 WDADPLKRPTFKQIVQ 300

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/139 (25%), Positives = 67/139 (48%), Gaps = 7/139 (5%)
Query: 2   VVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLK +N+ +     +VKI D GL+ + R   F K   G+P + APE    K     
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFXAPEXYEEKY--DE 208
Query: 61  EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLI 117
            VDV++ G           P+ + +N   +++++  G+   +      P  +++I   + 
Sbjct: 209 SVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268
Query: 118 VDPMKRITIPEIRQHPWFQ 136
            +  +R +I ++  H +FQ
Sbjct: 269 QNKDERYSIKDLLNHAFFQ 287

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 58/105 (55%), Gaps = 7/105 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L+DS    K++DFGLS ++ D      T+ G      + APE I+ + ++
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
               DVWS GV+++ +L  G  P+ +    ++   ++ G Y LP+
Sbjct: 233 SAS-DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 76/187 (40%), Gaps = 31/187 (16%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP+NLL++ +  +K+ADFGL+               +  Y  P+++ G      
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYST 180
Query: 61  EVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGIYTLP 101
           ++D+W  G I Y +  G   F                    +E  P +    +   Y  P
Sbjct: 181 QIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYP 240
Query: 102 SH-----------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDT 150
            +           L     DL+ ++L  +   RI+  +  +HP+F +   R   +P   +
Sbjct: 241 KYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTS 300
Query: 151 MQQAKKI 157
           +   K+I
Sbjct: 301 IFALKEI 307

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/78 (41%), Positives = 51/78 (65%), Gaps = 5/78 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLY 57
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D + ++    SP +  APE +S  ++
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 58  AGPEVDVWSCGVILYALL 75
           +  + DVWS GV+LY L 
Sbjct: 195 SR-QSDVWSFGVVLYELF 211

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/78 (41%), Positives = 51/78 (65%), Gaps = 5/78 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLY 57
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D + ++    SP +  APE +S  ++
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 58  AGPEVDVWSCGVILYALL 75
           +  + DVWS GV+LY L 
Sbjct: 208 SR-QSDVWSFGVVLYELF 224

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/87 (43%), Positives = 49/87 (56%), Gaps = 7/87 (8%)
Query: 2   VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL    +  +K+ DFG S    +   + T   S  Y APEVI G  Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGARYGM 278
Query: 60  PEVDVWSCGVILYALLCG--TLPFDDE 84
           P +D+WS G IL  LL G   LP +DE
Sbjct: 279 P-IDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 38/87 (43%), Positives = 49/87 (56%), Gaps = 7/87 (8%)
Query: 2   VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL    +  +K+ DFG S    +   + T   S  Y APEVI G  Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGARYGM 278
Query: 60  PEVDVWSCGVILYALLCG--TLPFDDE 84
           P +D+WS G IL  LL G   LP +DE
Sbjct: 279 P-IDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/78 (41%), Positives = 51/78 (65%), Gaps = 5/78 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLY 57
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D + ++    SP +  APE +S  ++
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 58  AGPEVDVWSCGVILYALL 75
           +  + DVWS GV+LY L 
Sbjct: 196 SR-QSDVWSFGVVLYELF 212

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 210
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  +  G  P 
Sbjct: 211 SDIWSMGLSLVEMAVGRYPI 230

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI  +  +
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DS 187
Query: 59  GP---EVDVWSCGVILYALLCGTLPFDDEN 85
            P   + DV++ G++LY L+ G LP+ + N
Sbjct: 188 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 245
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  +  G  P 
Sbjct: 246 SDIWSMGLSLVEMAVGRYPI 265

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 59/105 (56%), Gaps = 7/105 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D    + T+ G      + APE I  + + 
Sbjct: 167 VHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYRKFT 226
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
               DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP+
Sbjct: 227 SAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLPA 269

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTS--CGSPNYAAPEVISGKLYAG 59
           +HRD+K  N+LLD  +  KI+DFGL+         +  S   G+  Y APE + G++   
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEI--T 203
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLF 90
           P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 204 PKSDIYSFGVVLLEIITGLPAVDEHREPQLL 234

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/78 (41%), Positives = 50/78 (64%), Gaps = 5/78 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLY 57
            VHRDL   N+L++S+ +VKIADFGL+ ++   +D   ++    SP +  APE +S  ++
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 58  AGPEVDVWSCGVILYALL 75
           +  + DVWS GV+LY L 
Sbjct: 192 SR-QSDVWSFGVVLYELF 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 183
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  +  G  P 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 183
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  +  G  P 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGL---SNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +HRD+K  N+LLD  +  KI+DFGL   S             G+  Y APE + G++   
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEI--T 206
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLF 90
           P+ D++S GV+L  ++ G    D+   P L 
Sbjct: 207 PKSDIYSFGVVLLEIITGLPAVDEHREPQLL 237

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 183
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  +  G  P 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 27/80 (33%), Positives = 48/80 (60%), Gaps = 2/80 (2%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y+  +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYS-VQ 183
Query: 62  VDVWSCGVILYALLCGTLPF 81
            D+WS G+ L  +  G  P 
Sbjct: 184 SDIWSMGLSLVEMAVGRYPI 203

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI    K 
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 213 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI    K 
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 205 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/89 (37%), Positives = 48/89 (53%), Gaps = 5/89 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVI--SGKL 56
           ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI    K 
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDEN 85
               + DV++ G++LY L+ G LP+ + N
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISGKLY 57
           ++HRD+KP N+L+ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G   
Sbjct: 137 IIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD-S 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPF 81
                DV+S G +LY +L G  PF
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 51/210 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRDLKP NLL++    +KI DFG++        L TS     Y   E ++ + Y  PE
Sbjct: 179 VIHRDLKPSNLLVNENCELKIGDFGMAR------GLCTSPAEHQYFMTEYVATRWYRAPE 232
Query: 62  -----------VDVWSCGVILYALLCGTLPFDDENIPNLFK------------------- 91
                      +D+WS G I   +L     F  +N  +  +                   
Sbjct: 233 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292
Query: 92  -KIKGGIYTLP-------SHLSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF-QAH 138
            +++  I +LP         + PGA      L+ RML  +P  RI+     +HP+  + H
Sbjct: 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352
Query: 139 LP--RYLAVPPPDTMQQAKKIDEEILKEVV 166
            P       PP D     + +  E +KE +
Sbjct: 353 DPDDEPDCAPPFDFAFDREALTRERIKEAI 382

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 16/145 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLK  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+  + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI----GTPYWMAPEVVMCET 211
Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGAR 109
                   + DVWS G+ L  +     P  + N   +  KI          PS  S   +
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D + + L  +   R T  ++ QHP+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS 183
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 184 SKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 222

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS 182
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 183 SKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 221

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 216 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 262
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 263 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVIS-GKLYA 58
           +VHRD+K +N+L+++   V KI+DFG S  +   +   +T  G+  Y APE+I  G    
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPR 114
           G   D+WS G  +  +  G  PF +   P      K G++     +P  +S  A+  I +
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILK 261
Query: 115 MLIVDPMKR 123
               DP KR
Sbjct: 262 CFEPDPDKR 270

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS 180
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 181 SKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 219

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 216 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 262
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 263 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 295

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS 185
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 186 SKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 224

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 41/129 (31%), Positives = 64/129 (49%), Gaps = 8/129 (6%)
Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVIS-GKLYA 58
           +VHRD+K +N+L+++   V KI+DFG S  +   +   +T  G+  Y APE+I  G    
Sbjct: 129 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 188
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPR 114
           G   D+WS G  +  +  G  PF +   P      K G++     +P  +S  A+  I +
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYELGEPQA-AMFKVGMFKVHPEIPESMSAEAKAFILK 247
Query: 115 MLIVDPMKR 123
               DP KR
Sbjct: 248 CFEPDPDKR 256

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS 182
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 183 SKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 221

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 215 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 261
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 262 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 37/87 (42%), Positives = 47/87 (54%), Gaps = 7/87 (8%)
Query: 2   VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL    +  +K+ DFG S       +      S  Y APEVI G  Y  
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYXXIQ--SRFYRAPEVILGARYGM 278
Query: 60  PEVDVWSCGVILYALLCG--TLPFDDE 84
           P +D+WS G IL  LL G   LP +DE
Sbjct: 279 P-IDMWSLGCILAELLTGYPLLPGEDE 304

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 215 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 261
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 262 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 220 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 266
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 267 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 299

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 213 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 259
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 260 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 48/153 (31%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F     KT    P  + A E +  + +
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 274 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 320
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 321 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 353

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 30/100 (30%), Positives = 55/100 (55%), Gaps = 6/100 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           V+HRDL   N L+     +K++DFG++  + D  +  +S G+     +A+PEV S   Y+
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYS 202
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+++ +   G +P+++ +   + + I  G 
Sbjct: 203 SKS-DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF 241

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 47/176 (26%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           ++HRD+K  N+L+     +K+ADFGL+   R     K S   PN          Y  PE+
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLA---RAFSLAKNS--QPNRYXNRVVTLWYRPPEL 200
Query: 52  ISGKLYAGPEVDVWSCGVI---------------------LYALLCGTLP------FDDE 84
           + G+   GP +D+W  G I                     L + LCG++        D+ 
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 260
Query: 85  NIPNLFKKIKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            +    + +KG    +   L      P A DLI ++L++DP +RI   +   H +F
Sbjct: 261 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 206
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 207 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 253
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 254 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 214 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 260
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 261 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 16/145 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLK  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+  + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFI----GTPYWMAPEVVMCET 211
Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGAR 109
                   + DVWS G+ L  +     P  + N   +  KI          PS  S   +
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D + + L  +   R T  ++ QHP+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G   
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-S 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPF 81
                DV+S G +LY +L G  PF
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 215 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 261
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 262 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 213 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 259
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 260 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 292

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 212 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 258
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 259 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 291

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 215 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 261
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 262 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 294

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G   
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-S 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDEN 85
                DV+S G +LY +L G  PF  ++
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G   
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-S 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPF 81
                DV+S G +LY +L G  PF
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI  +  +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DS 199
Query: 59  GP---EVDVWSCGVILYALLCGTLPFDDEN 85
            P   + DV++ G++LY L+ G LP+ + N
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 30/84 (35%), Positives = 45/84 (53%), Gaps = 1/84 (1%)
Query: 2   VVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLL++SK N +K+ DFG +  +           S  Y APE++ G     P
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYTP 221
Query: 61  EVDVWSCGVILYALLCGTLPFDDE 84
            +D+WS G +   L+ G   F  E
Sbjct: 222 SIDLWSIGCVFGELILGKPLFSGE 245

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 84/210 (40%), Gaps = 51/210 (24%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRDLKP NLL++    +KI DFG++        L TS     Y   E ++ + Y  PE
Sbjct: 180 VIHRDLKPSNLLVNENCELKIGDFGMAR------GLCTSPAEHQYFMTEYVATRWYRAPE 233
Query: 62  -----------VDVWSCGVILYALLCGTLPFDDENIPNLFK------------------- 91
                      +D+WS G I   +L     F  +N  +  +                   
Sbjct: 234 LMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 293
Query: 92  -KIKGGIYTLPSH-------LSPGAR----DLIPRMLIVDPMKRITIPEIRQHPWF-QAH 138
            +++  I +LP         + PGA      L+ RML  +P  RI+     +HP+  + H
Sbjct: 294 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 353
Query: 139 LP--RYLAVPPPDTMQQAKKIDEEILKEVV 166
            P       PP D     + +  E +KE +
Sbjct: 354 DPDDEPDCAPPFDFAFDREALTRERIKEAI 383

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 233
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 234 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 280
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 281 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 313

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 7/90 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLK  N+ L     VKI DFGL+   +     H  +   GS  + APEVI  +  +
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ-DS 199
Query: 59  GP---EVDVWSCGVILYALLCGTLPFDDEN 85
            P   + DV++ G++LY L+ G LP+ + N
Sbjct: 200 NPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 28/84 (33%), Positives = 47/84 (55%), Gaps = 5/84 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G   
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-S 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPF 81
                DV+S G +LY +L G  PF
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPF 219

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 66/145 (45%), Gaps = 16/145 (11%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLK  N+L     ++K+ADFG+S      I R   F+    G+P + APEV+  + 
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFI----GTPYWMAPEVVMCET 211
Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGAR 109
                   + DVWS G+ L  +     P  + N   +  KI          PS  S   +
Sbjct: 212 SKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK 271
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPW 134
           D + + L  +   R T  ++ QHP+
Sbjct: 272 DFLKKCLEKNVDARWTTSQLLQHPF 296

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 232
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 233 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 279
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 280 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 312

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 221 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 280
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 281 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 339
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 340 WHGEPSQRPTFSELVEH 356

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 47/176 (26%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           ++HRD+K  N+L+     +K+ADFGL+   R     K S   PN          Y  PE+
Sbjct: 145 ILHRDMKAANVLITRDGVLKLADFGLA---RAFSLAKNS--QPNRYXNRVVTLWYRPPEL 199
Query: 52  ISGKLYAGPEVDVWSCGVI---------------------LYALLCGTLP------FDDE 84
           + G+   GP +D+W  G I                     L + LCG++        D+ 
Sbjct: 200 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 259
Query: 85  NIPNLFKKIKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            +    + +KG    +   L      P A DLI ++L++DP +RI   +   H +F
Sbjct: 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 315

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 47/176 (26%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           ++HRD+K  N+L+     +K+ADFGL+   R     K S   PN          Y  PE+
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLA---RAFSLAKNS--QPNRYXNRVVTLWYRPPEL 200
Query: 52  ISGKLYAGPEVDVWSCGVI---------------------LYALLCGTLP------FDDE 84
           + G+   GP +D+W  G I                     L + LCG++        D+ 
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 260
Query: 85  NIPNLFKKIKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            +    + +KG    +   L      P A DLI ++L++DP +RI   +   H +F
Sbjct: 261 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 219 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 278
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 279 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 337
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 338 WHGEPSQRPTFSELVEH 354

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 212 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 271
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 272 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 330
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 331 WHGEPSQRPTFSELVEH 347

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +     KT    P  + A E +  + +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 210 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 256
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 257 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 49/88 (55%), Gaps = 5/88 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSC---GSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D G+ +  +    G+  Y +PE   G   
Sbjct: 154 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-S 212
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDEN 85
                DV+S G +LY +L G  PF  ++
Sbjct: 213 VDARSDVYSLGCVLYEVLTGEPPFTGDS 240

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 219
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 220 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 273
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 274 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 332
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 333 WHGEPSQRPTFSELVEH 349

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 47/176 (26%), Positives = 75/176 (42%), Gaps = 47/176 (26%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           ++HRD+K  N+L+     +K+ADFGL+   R     K S   PN          Y  PE+
Sbjct: 146 ILHRDMKAANVLITRDGVLKLADFGLA---RAFSLAKNS--QPNRYXNRVVTLWYRPPEL 200
Query: 52  ISGKLYAGPEVDVWSCGVI---------------------LYALLCGTLP------FDDE 84
           + G+   GP +D+W  G I                     L + LCG++        D+ 
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 260
Query: 85  NIPNLFKKIKGGIYTLPSHL-----SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            +    + +KG    +   L      P A DLI ++L++DP +RI   +   H +F
Sbjct: 261 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 316

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 219
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 220 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/130 (30%), Positives = 63/130 (48%), Gaps = 8/130 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRD+K  N+ L     VKI DFGL+ +         ++   GS  + APEVI  +   
Sbjct: 153 IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNN 212
Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP--SHLSPGARDLIPR 114
               + DV+S G++LY L+ G LP+   N  +    + G  Y  P  S L       + R
Sbjct: 213 PFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKR 272
Query: 115 MLIVDPMKRI 124
            L+ D +K++
Sbjct: 273 -LVADCVKKV 281

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 171 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 231 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 289
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 290 WHGEPSQRPTFSELVEH 306

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-------HFLK--------TSCGSPNY 46
           ++HRDL   N L+    NV +ADFGL+ +M D          LK        T  G+P +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188
Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFK---KIKGGI-YTLPS 102
            APE+I+G+ Y   +VDV+S G++L  ++ G +  D + +P        ++G +    P 
Sbjct: 189 MAPEMINGRSY-DEKVDVFSFGIVLCEII-GRVNADPDYLPRTMDFGLNVRGFLDRYCPP 246
Query: 103 HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA---HLPRYLAVPP 147
           +  P    +  R   +DP KR +   ++   W +    HL  +L + P
Sbjct: 247 NCPPSFFPITVRCCDLDPEKRPSF--VKLEHWLETLRMHLAGHLPLGP 292

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 229 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
           +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y  
Sbjct: 166 IHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT- 224
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +    
Sbjct: 225 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTMLDCW 284
Query: 117 IVDPMKRITIPEIRQH 132
             +P +R T  E+ +H
Sbjct: 285 HGEPSQRPTFSELVEH 300

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 68/137 (49%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y 
Sbjct: 206 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 265
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 266 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 324
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 325 WHGEPSQRPTFSELVEH 341

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 51/90 (56%), Gaps = 14/90 (15%)
Query: 2   VVHRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLK--TSCGSPNYAAPEV 51
           ++HRDLK  N+L+  K          +KI DFGL+   R+ H     ++ G+  + APEV
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA---REWHRTTKMSAAGAYAWMAPEV 185
Query: 52  ISGKLYAGPEVDVWSCGVILYALLCGTLPF 81
           I   +++    DVWS GV+L+ LL G +PF
Sbjct: 186 IRASMFSKGS-DVWSYGVLLWELLTGEVPF 214

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 68/136 (50%), Gaps = 7/136 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
           +HRDL   N+LL  K  VKI DFGL+ +I +D  +++         + APE I  ++Y  
Sbjct: 166 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT- 224
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +    
Sbjct: 225 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 284
Query: 117 IVDPMKRITIPEIRQH 132
             +P +R T  E+ +H
Sbjct: 285 HGEPSQRPTFSELVEH 300

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 7/105 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + APE I+ + + 
Sbjct: 146 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFT 205
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
               DVWS G++++ ++  G  P+ +    ++ K ++ G Y LPS
Sbjct: 206 SAS-DVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEG-YRLPS 248

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 58/104 (55%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFG+S ++ D      T+ G      + APE I+ + + 
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP
Sbjct: 198 SAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 239

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/136 (33%), Positives = 64/136 (47%), Gaps = 20/136 (14%)
Query: 2   VVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           +VHRDL+  N+ L S         K+ADFGLS   +  H +    G+  + APE I  + 
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQWMAPETIGAEE 202
Query: 57  YAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTLPSHLSPG 107
            +  E  D +S  +ILY +L G  PFD+ +    + KIK        G   T+P    P 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYS----YGKIKFINMIREEGLRPTIPEDCPPR 258
Query: 108 ARDLIPRMLIVDPMKR 123
            R++I      DP KR
Sbjct: 259 LRNVIELCWSGDPKKR 274

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 7/105 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLY 57
            VHRDL   N+L++S    K++DFG+S ++ D      T+ G      + APE I+ + +
Sbjct: 152 AVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
                DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP
Sbjct: 212 TSAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 254

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 2   VVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN++L     +   KI D G +  +  G       G+  Y APE++  K Y 
Sbjct: 143 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT 202
Query: 59  GPEVDVWSCGVILYALLCGTLPF 81
              VD WS G + +  + G  PF
Sbjct: 203 -VTVDYWSFGTLAFECITGFRPF 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + APE IS + + 
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS 102
               DVWS G++++ ++  G  P+ + +   + K I  G + LP+
Sbjct: 229 SAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/83 (34%), Positives = 42/83 (50%), Gaps = 4/83 (4%)
Query: 2   VVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN++L     +   KI D G +  +  G       G+  Y APE++  K Y 
Sbjct: 142 IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYT 201
Query: 59  GPEVDVWSCGVILYALLCGTLPF 81
              VD WS G + +  + G  PF
Sbjct: 202 -VTVDYWSFGTLAFECITGFRPF 223

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 58/104 (55%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFG+S ++ D      T+ G      + APE I+ + + 
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 191
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++++ ++  G  P+ D +  ++ K I+ G Y LP
Sbjct: 192 SAS-DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 233

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/173 (26%), Positives = 76/173 (43%), Gaps = 37/173 (21%)
Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGK 55
           V+HRDLKP NL ++++   +KI DFGL+ IM D H+     L     +  Y +P ++   
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKGHLSEGLVTKWYRSPRLLLSP 199
Query: 56  LYAGPEVDVWSCGVILYALLCGTLPFDD-----------ENIPNLFKKIKGGIYTLP--- 101
                 +D+W+ G I   +L G   F             E+IP + ++ +  + ++    
Sbjct: 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259
Query: 102 ------------SHLSPG----ARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
                       + L PG    A D + ++L   PM R+T  E   HP+   +
Sbjct: 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIY 312

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 164 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 223
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 224 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 261

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 23/153 (15%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSP-NYAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D        KT    P  + A E +  + +
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              + DVWS GV+L+ L+  G  P+ D N            + +  +L  G R L P   
Sbjct: 214 T-TKSDVWSFGVLLWELMTRGAPPYPDVN-----------TFDITVYLLQGRRLLQPEY- 260
Query: 117 IVDPMKRITI----PEIRQHPWFQAHLPRYLAV 145
             DP+  + +    P+    P F   + R  A+
Sbjct: 261 CPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 293

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 231 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 160 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 219
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 220 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 257

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 231 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 163 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 222
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 223 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 260

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 62/137 (45%), Gaps = 11/137 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VH D+KP N+ L  +   K+ DFGL   +      +   G P Y APE++ G    G  
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY--GTA 235
Query: 62  VDVWSCGVILYALLCGT-LPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            DV+S G+ +  + C   LP   E    L +      +T  + LS   R ++  ML  DP
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPDP 293
Query: 121 MKRIT------IPEIRQ 131
             R T      +P +RQ
Sbjct: 294 KLRATAEALLALPVLRQ 310

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 212 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 271
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 272 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D   ++         + APE I  ++Y 
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 219
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 220 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D   ++         + APE I  ++Y 
Sbjct: 160 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 219
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 220 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 278
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 279 WHGEPSQRPTFSELVEH 295

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/136 (30%), Positives = 67/136 (49%), Gaps = 7/136 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
           +HRDL   N+LL  K  VKI DFGL+ +I +D   ++         + APE I  ++Y  
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT- 228
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +    
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCW 288
Query: 117 IVDPMKRITIPEIRQH 132
             +P +R T  E+ +H
Sbjct: 289 HGEPSQRPTFSELVEH 304

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 215
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 216 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 253

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 79/205 (38%), Gaps = 72/205 (35%)
Query: 2   VVHRDLKPENLL-----LDSKWN--------------VKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L      ++ +N              +++ADFG +    + H   T   
Sbjct: 176 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVA 233
Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNL--FKKIKGGIYT 99
           + +Y  PEVI    +A P  DVWS G IL+    G TL    EN  +L   +KI G I  
Sbjct: 234 TRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI-- 290
Query: 100 LPSHLSPGAR--------------------------------------------DLIPRM 115
            PSH+    R                                            DL+ RM
Sbjct: 291 -PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 349
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLP 140
           L  DP +RIT+ E   HP+F    P
Sbjct: 350 LEFDPAQRITLAEALLHPFFAGLTP 374

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 231 H-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 79/205 (38%), Gaps = 72/205 (35%)
Query: 2   VVHRDLKPENLL-----LDSKWN--------------VKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L      ++ +N              +++ADFG +    + H   T   
Sbjct: 153 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVA 210
Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNL--FKKIKGGIYT 99
           + +Y  PEVI    +A P  DVWS G IL+    G TL    EN  +L   +KI G I  
Sbjct: 211 TRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI-- 267
Query: 100 LPSHLSPGAR--------------------------------------------DLIPRM 115
            PSH+    R                                            DL+ RM
Sbjct: 268 -PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 326
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLP 140
           L  DP +RIT+ E   HP+F    P
Sbjct: 327 LEFDPAQRITLAEALLHPFFAGLTP 351

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 31/102 (30%), Positives = 57/102 (55%), Gaps = 5/102 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+ +    KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-I 191
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 192 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 232

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D   ++         + APE I  ++Y 
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 229 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+      KIADFGL+ ++ D  +           + APE I+   +   
Sbjct: 132 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT-I 190
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++LY ++  G +P+      ++   +  G Y +P
Sbjct: 191 KSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG-YRMP 231

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 79/205 (38%), Gaps = 72/205 (35%)
Query: 2   VVHRDLKPENLL-----LDSKWN--------------VKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L      ++ +N              +++ADFG +    + H   T   
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHH--TTIVA 201
Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TLPFDDENIPNL--FKKIKGGIYT 99
           + +Y  PEVI    +A P  DVWS G IL+    G TL    EN  +L   +KI G I  
Sbjct: 202 TRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPI-- 258
Query: 100 LPSHLSPGAR--------------------------------------------DLIPRM 115
            PSH+    R                                            DL+ RM
Sbjct: 259 -PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRM 317
Query: 116 LIVDPMKRITIPEIRQHPWFQAHLP 140
           L  DP +RIT+ E   HP+F    P
Sbjct: 318 LEFDPAQRITLAEALLHPFFAGLTP 342

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D   ++         + APE I  ++Y 
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 229 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 30/102 (29%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+ +    KIADFGL+ ++ D  +           + APE I+   +   
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-I 364
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/137 (30%), Positives = 67/137 (48%), Gaps = 7/137 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D   ++         + APE I  ++Y 
Sbjct: 169 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLF-KKIKGGI-YTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +   G  P+    I   F +++K G     P + +P     +   
Sbjct: 229 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 287
Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 288 WHGEPSQRPTFSELVEH 304

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 141 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 199
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 200 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 236

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLK  N+L+  + ++++ADFG+S      + +   F+    G+P + APEV+  + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVVMCET 193
Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGAR 109
                   + D+WS G+ L  +     P  + N +  L K  K    TL  PS  S   R
Sbjct: 194 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 253
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQA 137
           D +   L  +P  R +  ++ +HP+  +
Sbjct: 254 DFLKIALDKNPETRPSAAQLLEHPFVSS 281

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 195
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 53/97 (54%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D  +  +     P  + APE I+   +   
Sbjct: 136 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 194
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 195 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 231

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/118 (28%), Positives = 61/118 (51%), Gaps = 9/118 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+D    VK++DFG++  + D  ++ +S G+     ++APEV     Y+ 
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSS 184
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
              DVW+ G++++ +   G +P+D      +  K+  G      HL   A D I +++
Sbjct: 185 KS-DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHL---ASDTIYQIM 238

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 53/102 (51%), Gaps = 11/102 (10%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN------YAAPEVISGK 55
            +HRDL   N+L+     +KIADFGL+   RD H +     + N      + APE +  +
Sbjct: 171 CIHRDLAARNVLVTEDNVMKIADFGLA---RDIHHIDXXKKTTNGRLPVKWMAPEALFDR 227
Query: 56  LYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           +Y   + DVWS GV+L+ +   G  P+    +  LFK +K G
Sbjct: 228 IYTH-QSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 268

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 32/107 (29%), Positives = 53/107 (49%), Gaps = 4/107 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGP 60
            HRD+KPEN+L+ +     + DFG+++   D     L  + G+  Y APE  S + +A  
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFS-ESHATY 214
Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG 107
             D+++   +LY  L G+ P+  + +      I   I   PS + PG
Sbjct: 215 RADIYALTCVLYECLTGSPPYQGDQLSVXGAHINQAI-PRPSTVRPG 260

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 20/136 (14%)
Query: 2   VVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           +VHRDL+  N+ L S         K+ADFG S   +  H +    G+  + APE I  + 
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSGLLGNFQWMAPETIGAEE 202
Query: 57  YAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTLPSHLSPG 107
            +  E  D +S  +ILY +L G  PFD+ +    + KIK        G   T+P    P 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYS----YGKIKFINMIREEGLRPTIPEDCPPR 258
Query: 108 ARDLIPRMLIVDPMKR 123
            R++I      DP KR
Sbjct: 259 LRNVIELCWSGDPKKR 274

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D  +           + APE I+   +   
Sbjct: 126 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 184
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 221

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-----NIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           ++HRDLK  N+L+  + ++++ADFG+S      + +   F+    G+P + APEV+  + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI----GTPYWMAPEVVMCET 185
Query: 57  YAGP----EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGAR 109
                   + D+WS G+ L  +     P  + N +  L K  K    TL  PS  S   R
Sbjct: 186 MKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFR 245
Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQA 137
           D +   L  +P  R +  ++ +HP+  +
Sbjct: 246 DFLKIALDKNPETRPSAAQLLEHPFVSS 273

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D  +           + APE I+   +   
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 189
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 224 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 283
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 284 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+              S  +  PE++        
Sbjct: 158 IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY 217
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLF---------------------------- 90
            +D+WS G +L +++    PF    +N   L                             
Sbjct: 218 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFND 277
Query: 91  -------KKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                  K+ +  I++   HL SP A DL+ ++L  D  +R+T  E  +HP+F
Sbjct: 278 ILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 330

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 165 CIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 224
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 225 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 262

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 40/173 (23%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+L+D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+              S  +  PE++        
Sbjct: 153 IMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDY 212
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLF---------------------------- 90
            +D+WS G +L +++    PF    +N   L                             
Sbjct: 213 SLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYLKKYHIDLDPHFND 272
Query: 91  -------KKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
                  K+ +  I++   HL SP A DL+ ++L  D  +R+T  E  +HP+F
Sbjct: 273 ILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEHPYF 325

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 63/136 (46%), Gaps = 20/136 (14%)
Query: 2   VVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
           +VHRDL+  N+ L S         K+ADF LS   +  H +    G+  + APE I  + 
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSGLLGNFQWMAPETIGAEE 202
Query: 57  YAGPE-VDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTLPSHLSPG 107
            +  E  D +S  +ILY +L G  PFD+ +    + KIK        G   T+P    P 
Sbjct: 203 ESYTEKADTYSFAMILYTILTGEGPFDEYS----YGKIKFINMIREEGLRPTIPEDCPPR 258
Query: 108 ARDLIPRMLIVDPMKR 123
            R++I      DP KR
Sbjct: 259 LRNVIELCWSGDPKKR 274

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 216
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 217 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 258

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 200 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 241

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 200 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 241

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 226
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 227 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 268

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 8/119 (6%)
Query: 2   VVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL +  +  +KI DFG S  +  G  +     S  Y +PEV+ G  Y  
Sbjct: 180 IIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVLLGMPY-D 236
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL---SPGARDLIPRM 115
             +D+WS G IL  +  G   F   N  +   KI   +   P+H+   +P AR    ++
Sbjct: 237 LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 295

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 170 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 229
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 230 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 267

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 167 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 226
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 227 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 264

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 7/105 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLY 57
            VHRDL   N+L++S    K++DFGLS ++ D      T+ G      + +PE I+ + +
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF 227
Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
                DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 228 TSAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 8/119 (6%)
Query: 2   VVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL +  +  +KI DFG S  +  G  +     S  Y +PEV+ G  Y  
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVLLGMPY-D 236
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL---SPGARDLIPRM 115
             +D+WS G IL  +  G   F   N  +   KI   +   P+H+   +P AR    ++
Sbjct: 237 LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 295

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/119 (32%), Positives = 59/119 (49%), Gaps = 8/119 (6%)
Query: 2   VVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL +  +  +KI DFG S  +  G  +     S  Y +PEV+ G  Y  
Sbjct: 161 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVLLGMPY-D 217
Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL---SPGARDLIPRM 115
             +D+WS G IL  +  G   F   N  +   KI   +   P+H+   +P AR    ++
Sbjct: 218 LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKL 276

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTS--CGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++ +D  F K      SP +  APE ++   ++
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 196 VAS-DVWSFGVVLYELF 211

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 52/102 (50%), Gaps = 5/102 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+      KIADFGL+ ++ D  +           + APE I+   +   
Sbjct: 131 IHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFT-I 189
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           + +VWS G++LY ++  G +P+      ++   +  G Y +P
Sbjct: 190 KSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQG-YRMP 230

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 55/99 (55%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     ++IADFGL+ +I    ++ KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D              + APE I+   +   
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFT-I 189
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 32/168 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDL P N+LL    ++ I DF L+                 Y APE++         
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL 214
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------------KGGI 97
           VD+WS G ++  +      F      N   KI                        +  +
Sbjct: 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274
Query: 98  YTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
             +P+           P A DLI +ML  +P +RI+  +  +HP+F++
Sbjct: 275 SNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/168 (24%), Positives = 64/168 (38%), Gaps = 32/168 (19%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDL P N+LL    ++ I DF L+                 Y APE++         
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL 214
Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKI------------------------KGGI 97
           VD+WS G ++  +      F      N   KI                        +  +
Sbjct: 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274
Query: 98  YTLPSH--------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
             +P+           P A DLI +ML  +P +RI+  +  +HP+F++
Sbjct: 275 SNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFES 322

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 157 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 216
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 217 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 276
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 277 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 329

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/133 (27%), Positives = 59/133 (44%), Gaps = 6/133 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N +L     V +ADFGLS  +  G + +  C S     + A E ++  LY  
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT- 217
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLI 117
              DVW+ GV ++ ++  G  P+       ++  + GG     P        DL+ +   
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWS 277
Query: 118 VDPMKRITIPEIR 130
            DP +R +   +R
Sbjct: 278 ADPKQRPSFTCLR 290

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 34/78 (43%), Positives = 44/78 (56%), Gaps = 7/78 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVISG-KLY 57
           +HRDL   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K Y
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFY 215
Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 216 YAS--DVWSFGVTLYELL 231

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 6/80 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYAAPE-VISGKLY 57
           ++HRD+K  N+LLD  +  KI DFG+S     +   H      G+  Y  PE  I G+L 
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRL- 218
Query: 58  AGPEVDVWSCGVILYALLCG 77
              + DV+S GV+L+ +LC 
Sbjct: 219 -TEKSDVYSFGVVLFEVLCA 237

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 31/99 (31%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+  + +  + K +        + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   +   
Sbjct: 137 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 195
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 71/197 (36%), Gaps = 66/197 (33%)
Query: 2   VVHRDLKPENLLL---------------DSKW----NVKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L                D +     ++K+ DFG +    + H   T   
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH--STLVS 196
Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 102
           + +Y APEVI    ++ P  DVWS G IL     G   F   +       ++  +  LP 
Sbjct: 197 TRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK 255
Query: 103 HLSPGAR--------------------------------------------DLIPRMLIV 118
           H+    R                                            DLI +ML  
Sbjct: 256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315
Query: 119 DPMKRITIPEIRQHPWF 135
           DP KRIT+ E  +HP+F
Sbjct: 316 DPAKRITLREALKHPFF 332

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/173 (22%), Positives = 72/173 (41%), Gaps = 39/173 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 152 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 61  EVDVWSCGVILYALLCGTLPF--------------------------DDENIP------- 87
            +D+WS G +L +++    PF                          D  NI        
Sbjct: 212 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 271
Query: 88  ----NLFKKIKGGIYTLPSHL-SPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
               +  K+ +  +++   HL SP A D + ++L  D   R+T  E  +HP+F
Sbjct: 272 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 324

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   +   
Sbjct: 139 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 197
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 198 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 234

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGS--PNYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +   D ++   S G     + APE I+ + ++
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 59  GPEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 96
               DVWS GV ++ AL  G  P+     P +   I+ G
Sbjct: 192 S-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 229

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   +   
Sbjct: 140 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 198
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 199 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 235

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 57/104 (54%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGL+ ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 27/97 (27%), Positives = 51/97 (52%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HR+L+  N+L+    + KIADFGL+ ++ D  +           + APE I+   +   
Sbjct: 127 IHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 185
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 186 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 222

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D     +     P  + APE I+   +   
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 189
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/80 (37%), Positives = 44/80 (55%), Gaps = 6/80 (7%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI---MRDGHFLKTSCGSPNYAAPE-VISGKLY 57
           ++HRD+K  N+LLD  +  KI DFG+S     +   H      G+  Y  PE  I G+L 
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRL- 218
Query: 58  AGPEVDVWSCGVILYALLCG 77
              + DV+S GV+L+ +LC 
Sbjct: 219 -TEKSDVYSFGVVLFEVLCA 237

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/85 (32%), Positives = 43/85 (50%), Gaps = 1/85 (1%)
Query: 2   VVHRDLKPENLLL-DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V HRD+KP N+L+ ++   +K+ DFG +  +           S  Y APE+I G  +   
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTT 211
Query: 61  EVDVWSCGVILYALLCGTLPFDDEN 85
            VD+WS G I   ++ G   F  +N
Sbjct: 212 AVDIWSVGCIFAEMMLGEPIFRGDN 236

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D              + APE I+   +   
Sbjct: 132 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 190
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 191 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 227

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D              + APE I+   +   
Sbjct: 133 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 191
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 192 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 228

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 28/97 (28%), Positives = 50/97 (51%), Gaps = 4/97 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D              + APE I+   +   
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFT-I 189
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
           + DVWS G++L  ++  G +P+     P + + ++ G
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 74/172 (43%), Gaps = 28/172 (16%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSN---IMRDGH--------FLKTSCGSPNYAAPEV 51
            HRDLKP N+LL  +    + D G  N   I  +G         +    C + +Y APE+
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC-TISYRAPEL 214
Query: 52  ISGKLYA--GPEVDVWSCGVILYALLCGTLPFD----DENIPNLFKKIKGGIYTLPSHLS 105
            S + +       DVWS G +LYA++ G  P+D      +   L  + +  I   P H S
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH-S 273
Query: 106 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKI 157
                L+  M+ VDP +R  IP +         L +  A+ PP   Q   +I
Sbjct: 274 SALWQLLNSMMTVDPHQRPHIPLL---------LSQLEALQPPAPGQHTTQI 316

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 74/177 (41%), Gaps = 48/177 (27%)
Query: 2   VVHRDLKPENLLL---DSKWN--VKIADFGLSN-----IMRDGHFLKTSCGSPNYAAPEV 51
            +HRDLKP+NLLL   D+     +KI DFGL+      I +  H + T      Y  PE+
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW----YRPPEI 208
Query: 52  ISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLS-PGAR 109
           + G  +    VD+WS   I   +L  T  F  D  I  LFK  +  +  LP   + PG  
Sbjct: 209 LLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFE--VLGLPDDTTWPGVT 266
Query: 110 DL------IPR------------------------MLIVDPMKRITIPEIRQHPWFQ 136
            L       P+                        ML +DP+KRI+     +HP+F 
Sbjct: 267 ALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS 323

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 56/104 (53%), Gaps = 7/104 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGL  ++ D      T+ G      + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 SAS-DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 81/209 (38%), Gaps = 70/209 (33%)
Query: 2   VVHRDLKPENLL-----------LDSKWN--------VKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L           L+ K +        V++ DFG +    + H   T   
Sbjct: 158 LTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATFDHEHH--STIVS 215
Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDEN--------------IPN 88
           + +Y APEVI    ++ P  DVWS G I++    G   F   +              IP+
Sbjct: 216 TRHYRAPEVILELGWSQP-CDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPS 274
Query: 89  -LFKKIKGGIYT-----------------------LPSHLSPGAR------DLIPRMLIV 118
            + +K +   Y                        L  +L+  A       DLI  ML  
Sbjct: 275 RMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESMLEY 334
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPP 147
           +P KR+T+ E  QHP+F     R  A PP
Sbjct: 335 EPAKRLTLGEALQHPFF----ARLRAEPP 359

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 64/158 (40%), Gaps = 34/158 (21%)
Query: 2   VVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGH-----FLKTSC-------------- 41
           +VHRD+KP N L + +     + DFGL+    D       F+++                
Sbjct: 138 IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICL 197
Query: 42  ----------GSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF----DDENIP 87
                     G+P + APEV++        +D+WS GVI  +LL G  PF    DD    
Sbjct: 198 SRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTAL 257
Query: 88  NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT 125
                I+G   T+ +  + G   L  + +    ++++ 
Sbjct: 258 AQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLC 295

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 70/197 (35%), Gaps = 66/197 (33%)
Query: 2   VVHRDLKPENLLL---------------DSKW----NVKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L                D +     ++K+ DFG +    + H   T   
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHH--STLVX 196
Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS 102
             +Y APEVI    ++ P  DVWS G IL     G   F   +       ++  +  LP 
Sbjct: 197 XRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK 255
Query: 103 HLSPGAR--------------------------------------------DLIPRMLIV 118
           H+    R                                            DLI +ML  
Sbjct: 256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315
Query: 119 DPMKRITIPEIRQHPWF 135
           DP KRIT+ E  +HP+F
Sbjct: 316 DPAKRITLREALKHPFF 332

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I       KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 199 VAS-DVWSFGVVLYELF 214

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 226
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 227 VAS-DVWSFGVVLYELF 242

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 140 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 199
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 200 VAS-DVWSFGVVLYELF 215

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+ +I       KT+ G     + APE +  ++Y 
Sbjct: 178 CIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYT 237
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+++ +   G  P+    +  LFK +K G
Sbjct: 238 H-QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 135 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 194
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 195 VAS-DVWSFGVVLYELF 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 141 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 200
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 201 VAS-DVWSFGVVLYELF 216

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 134 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 193
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 194 VAS-DVWSFGVVLYELF 209

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 57/192 (29%)
Query: 2   VVHRDLKPENLLL---DSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 55
           ++H D+KPEN+L+   DS  N   +KIAD G +    D H+   S  +  Y +PEV+ G 
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEHY-TNSIQTREYRSPEVLLGA 210
Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF----------DDENIPNLFK--------KIKGGI 97
            + G   D+WS   +++ L+ G   F          DD++I  + +         ++ G 
Sbjct: 211 PW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269
Query: 98  YTLPSHLSPG------------------------------ARDLIPRMLIVDPMKRITIP 127
           YT     S G                                D +  ML +DP KR    
Sbjct: 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329
Query: 128 EIRQHPWFQAHL 139
            +  HPW +  L
Sbjct: 330 GLVNHPWLKDTL 341

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 49/192 (25%), Positives = 76/192 (39%), Gaps = 57/192 (29%)
Query: 2   VVHRDLKPENLLL---DSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 55
           ++H D+KPEN+L+   DS  N   +KIAD G +    D H+   S  +  Y +PEV+ G 
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLG-NACWYDEHY-TNSIQTREYRSPEVLLGA 210
Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF----------DDENIPNLFK--------KIKGGI 97
            + G   D+WS   +++ L+ G   F          DD++I  + +         ++ G 
Sbjct: 211 PW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269
Query: 98  YTLPSHLSPG------------------------------ARDLIPRMLIVDPMKRITIP 127
           YT     S G                                D +  ML +DP KR    
Sbjct: 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329
Query: 128 EIRQHPWFQAHL 139
            +  HPW +  L
Sbjct: 330 GLVNHPWLKDTL 341

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 199 VAS-DVWSFGVVLYELF 214

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 139 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 198
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 199 VAS-DVWSFGVVLYELF 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/78 (42%), Positives = 44/78 (56%), Gaps = 7/78 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVISG-KLY 57
           +HR+L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K Y
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 199 YAS--DVWSFGVTLYELL 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 196 VAS-DVWSFGVVLYELF 211

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 142 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 201
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 202 VAS-DVWSFGVVLYELF 217

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 33/78 (42%), Positives = 44/78 (56%), Gaps = 7/78 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVISG-KLY 57
           +HR+L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K Y
Sbjct: 139 IHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 198
Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 199 YAS--DVWSFGVTLYELL 214

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 214 VAS-DVWSFGVVLYELF 229

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 195
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 196 VAS-DVWSFGVVLYELF 211

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 154 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 213
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 214 VAS-DVWSFGVVLYELF 229

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/77 (36%), Positives = 46/77 (59%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++   ++   +K    SP +  APE ++   ++
Sbjct: 143 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFS 202
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 203 VAS-DVWSFGVVLYELF 218

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 55/106 (51%), Gaps = 14/106 (13%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVI-SGKLY 57
           VHRDL   N+L++S+  VKI DFGL+  +   ++   +K    SP +  APE +   K Y
Sbjct: 136 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFY 195
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 103
                DVWS GV L+ LL  T    D +   LF K+ G     P+H
Sbjct: 196 IAS--DVWSFGVTLHELL--TYCDSDSSPMALFLKMIG-----PTH 232

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGS--PNYAAPEVISGKLYA 58
           VHR+L   N+LL ++   KI+DFGLS  +   D ++   S G     + APE I+ + ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 59  GPEVDVWSCGVILY-ALLCGTLPFDDENIPNLFKKIKGG 96
               DVWS GV ++ AL  G  P+     P +   I+ G
Sbjct: 518 S-RSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG 555

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 55/106 (51%), Gaps = 14/106 (13%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVI-SGKLY 57
           VHRDL   N+L++S+  VKI DFGL+  +   ++   +K    SP +  APE +   K Y
Sbjct: 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFY 207
Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH 103
                DVWS GV L+ LL  T    D +   LF K+ G     P+H
Sbjct: 208 IAS--DVWSFGVTLHELL--TYCDSDSSPMALFLKMIG-----PTH 244

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 14/87 (16%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-------------SCGSPNYAA 48
           ++HRDLKP N+       VK+ DFGL   M      +T               G+  Y +
Sbjct: 139 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198
Query: 49  PEVISGKLYAGPEVDVWSCGVILYALL 75
           PE I G  Y+  +VD++S G+IL+ LL
Sbjct: 199 PEQIHGNSYSH-KVDIFSLGLILFELL 224

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 9/89 (10%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL     VK+ DFG+S  + R      T  G+P + APEVI+      P
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACD--ENP 207
Query: 61  EV------DVWSCGVILYALLCGTLPFDD 83
           +       D+WS G+    +  G  P  D
Sbjct: 208 DATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 33/78 (42%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVI-SGKLY 57
           +HR L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K Y
Sbjct: 133 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 192
Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 193 YAS--DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 33/78 (42%), Positives = 43/78 (55%), Gaps = 7/78 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNY-AAPEVI-SGKLY 57
           +HR L   N+LLD+   VKI DFGL+  + +GH    ++    SP +  APE +   K Y
Sbjct: 134 IHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKECKFY 193
Query: 58  AGPEVDVWSCGVILYALL 75
                DVWS GV LY LL
Sbjct: 194 YAS--DVWSFGVTLYELL 209

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 9/106 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS------PNYAAPEVISGKL 56
           VHRDL   N+L++S    K++DFGLS  + +     T   S        + APE I+ + 
Sbjct: 140 VHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRK 199
Query: 57  YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
           +     D WS G++++ ++  G  P+ D +  ++   I+   Y LP
Sbjct: 200 FTSAS-DAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQD-YRLP 243

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK---LYA 58
           ++HRD+K  N+LL     VK+ DFG ++IM   +      G+P + APEVI       Y 
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 231
Query: 59  GPEVDVWSCGVILYAL 74
           G +VDVWS G+    L
Sbjct: 232 G-KVDVWSLGITCIEL 246

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 54/112 (48%), Gaps = 21/112 (18%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY------------AAPE 50
           VHRDL   N+L++S    K++DFGLS       FL+ +   P Y             APE
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGLS------RFLEENSSDPTYTSSLGGKIPIRWTAPE 191
Query: 51  VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
            I+ + +     D WS G++++ ++  G  P+ D +  ++   I+   Y LP
Sbjct: 192 AIAFRKFTSAS-DAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQD-YRLP 241

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/112 (30%), Positives = 52/112 (46%), Gaps = 21/112 (18%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY------------AAPE 50
           VHRDL   N+L++S    K++DFGLS       FL+     P Y             APE
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLS------RFLEDDTSDPTYTSALGGKIPIRWTAPE 210
Query: 51  VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
            I  + +     DVWS G++++ ++  G  P+ D    ++   I+   Y LP
Sbjct: 211 AIQYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLP 260

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 20/171 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 196
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 257 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKQG 292

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 180
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 106
              D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 181 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 227

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 126 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 184
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 106
              D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 185 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 231

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 185
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 106
              D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 186 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 43/87 (49%), Gaps = 14/87 (16%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-------------SCGSPNYAA 48
           ++HRDLKP N+       VK+ DFGL   M      +T               G+  Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 49  PEVISGKLYAGPEVDVWSCGVILYALL 75
           PE I G  Y+  +VD++S G+IL+ LL
Sbjct: 245 PEQIHGNNYSH-KVDIFSLGLILFELL 270

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 20/171 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 252 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKRG 287

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/76 (39%), Positives = 42/76 (55%), Gaps = 7/76 (9%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK---LYA 58
           ++HRD+K  N+LL     VK+ DFG ++IM   +      G+P + APEVI       Y 
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYD 192
Query: 59  GPEVDVWSCGVILYAL 74
           G +VDVWS G+    L
Sbjct: 193 G-KVDVWSLGITCIEL 207

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 20/171 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 252 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKRG 287

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 133 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 106
              D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 192 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 238

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 47/77 (61%), Gaps = 5/77 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNY-AAPEVISGKLYA 58
           +HR+L   N+L++++  VKI DFGL+ ++   ++ + +K    SP +  APE ++   ++
Sbjct: 137 IHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS 196
Query: 59  GPEVDVWSCGVILYALL 75
               DVWS GV+LY L 
Sbjct: 197 VAS-DVWSFGVVLYELF 212

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 5/133 (3%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFS-I 210
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  ++  + KG     P    P   +L+      
Sbjct: 211 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGCPPKVYELMRACWKW 270
Query: 119 DPMKRITIPEIRQ 131
            P  R +  E  Q
Sbjct: 271 SPADRPSFAETHQ 283

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 43/91 (47%), Gaps = 11/91 (12%)
Query: 2   VVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           +VHR++KP N++     D +   K+ DFG +  + D     +  G+  Y  P++    + 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVL 192
Query: 58  A-------GPEVDVWSCGVILYALLCGTLPF 81
                   G  VD+WS GV  Y    G+LPF
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 20/171 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 196
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 256
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 257 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKRG 292

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 56/107 (52%), Gaps = 6/107 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 105
              D+W+ GV+++ +   G +P++        + I  G+     HL+
Sbjct: 201 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 70/147 (47%), Gaps = 9/147 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           +HRDL+  N+L+ +    KIADFGL+ ++ D     +     P  + APE  + G+    
Sbjct: 127 IHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI- 185
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 117
            + DVWS G++L  L+  G +P+   N   + ++++ G     P        +L+     
Sbjct: 186 -KSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHELMIHCWK 244
Query: 118 VDPMKRITIPEIRQ--HPWFQAHLPRY 142
            DP +R T   ++     +F A  P+Y
Sbjct: 245 KDPEERPTFEYLQSFLEDYFTATEPQY 271

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 185
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 186 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 243
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 244 RKDPEERPTF------EYLQAFLEDYFTSTEP 269

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL  ++ D  +  +     P  + APE  + G+    
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 361
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 362 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 419
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 420 RKDPEERPTF------EYLQAFLEDYFTSTEP 445

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 491 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 550
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
             + DVWS GV+++ A   G  P+
Sbjct: 551 S-KSDVWSFGVLMWEAFSYGQKPY 573

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 59/139 (42%), Gaps = 14/139 (10%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
            +HRDL   N L+  K  +KI+DFG+S    DG +  +         + APE ++   Y+
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYS 293
Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------KGGIYTLPSHLSPGARDLI 112
             E DVWS G++L+     T        PNL  +       KGG    P         L+
Sbjct: 294 S-ESDVWSFGILLWE----TFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLM 348
Query: 113 PRMLIVDPMKRITIPEIRQ 131
            +    +P +R +   I Q
Sbjct: 349 EQCWAYEPGQRPSFSTIYQ 367

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 183
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 184 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 241
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 242 RKDPEERPTF------EYLQAFLEDYFTSTEP 267

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 492 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 551
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
             + DVWS GV+++ A   G  P+
Sbjct: 552 S-KSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
             + DVWS GV+++ A   G  P+
Sbjct: 209 S-KSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 149 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 208
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
             + DVWS GV+++ A   G  P+
Sbjct: 209 S-KSDVWSFGVLMWEAFSYGQKPY 231

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/97 (31%), Positives = 44/97 (45%), Gaps = 23/97 (23%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGL---------SNIMRD--------------GHFLK 38
           ++HRDLKP N LL+   +VK+ DFGL         +NI+ D                 L 
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209
Query: 39  TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 75
           +   +  Y APE+I  +      +D+WS G I   LL
Sbjct: 210 SHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELL 246

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
               DVWS GV+++ A   G  P+
Sbjct: 199 SKS-DVWSFGVLMWEAFSYGQKPY 221

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 47/84 (55%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 147 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 206
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
             + DVWS GV+++ A   G  P+
Sbjct: 207 S-KSDVWSFGVLMWEAFSYGQKPY 229

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   P  + APE I   +Y 
Sbjct: 187 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 246
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    + + F K+    Y +  P+        ++   
Sbjct: 247 -VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 305
Query: 116 LIVDPMKRITIPEI 129
             ++P  R T  +I
Sbjct: 306 WALEPTHRPTFQQI 319

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 188
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
               DVWS GV+++ A   G  P+
Sbjct: 189 SKS-DVWSFGVLMWEAFSYGQKPY 211

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
               DVWS GV+++ A   G  P+
Sbjct: 193 SKS-DVWSFGVLMWEAFSYGQKPY 215

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/171 (25%), Positives = 75/171 (43%), Gaps = 20/171 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HR+L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 398
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 458
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 459 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKRG 494

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D ++ K          + APE I+   ++
Sbjct: 127 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 186
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
               DVWS GV+++ A   G  P+
Sbjct: 187 SKS-DVWSFGVLMWEAFSYGQKPY 209

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 69/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 167 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 226
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L ++L             
Sbjct: 227 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYRIELDPQLEA 286
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 287 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 340

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 34/133 (25%), Positives = 65/133 (48%), Gaps = 7/133 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++  +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-TK 366
Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVD 119
            DVWS G++L+ +   G +P+    + ++  ++ KG     P    P   D++     +D
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLD 426
Query: 120 PMKRITIPEIRQH 132
              R T  ++R+ 
Sbjct: 427 AATRPTFLQLREQ 439

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 32/100 (32%), Positives = 44/100 (44%), Gaps = 26/100 (26%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---NIMRDGHF---------------------- 36
           ++HRDLKP N LL+   +VKI DFGL+   N  +D H                       
Sbjct: 152 IIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKNLKK 211
Query: 37  -LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL 75
            L +   +  Y APE+I  +      +D+WS G I   LL
Sbjct: 212 QLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELL 251

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/108 (27%), Positives = 56/108 (51%), Gaps = 6/108 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D  +  +S GS     ++ PEV+    ++ 
Sbjct: 127 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLSP 106
              D+W+ GV+++ +   G +P++        + I  G+     HL+ 
Sbjct: 186 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLAS 232

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   P  + APE I   +Y 
Sbjct: 181 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 240
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    + + F K+    Y +  P+        ++   
Sbjct: 241 -VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 299
Query: 116 LIVDPMKRITIPEI 129
             ++P  R T  +I
Sbjct: 300 WALEPTHRPTFQQI 313

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   P  + APE I   +Y 
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    + + F K+    Y +  P+        ++   
Sbjct: 245 -VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 303
Query: 116 LIVDPMKRITIPEI 129
             ++P  R T  +I
Sbjct: 304 WALEPTHRPTFQQI 317

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL   N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   P  + APE I   +Y 
Sbjct: 185 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 244
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    + + F K+    Y +  P+        ++   
Sbjct: 245 -VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 303
Query: 116 LIVDPMKRITIPEI 129
             ++P  R T  +I
Sbjct: 304 WALEPTHRPTFQQI 317

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 60/141 (42%), Gaps = 18/141 (12%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-----PNYAAPEVISGKL 56
            +HRDL   N L+  K  +KI+DFG+S    DG  +  + G        + APE ++   
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADG--VXAASGGLRQVPVKWTAPEALNYGR 291
Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI------KGGIYTLPSHLSPGARD 110
           Y+  E DVWS G++L+     T        PNL  +       KGG    P         
Sbjct: 292 YSS-ESDVWSFGILLWE----TFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFR 346
Query: 111 LIPRMLIVDPMKRITIPEIRQ 131
           L+ +    +P +R +   I Q
Sbjct: 347 LMEQCWAYEPGQRPSFSTIYQ 367

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 30/77 (38%), Positives = 45/77 (58%), Gaps = 4/77 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRDL   N+LL     VKI DFGL+ +I ++  ++ K     P  + APE I  K+Y+
Sbjct: 220 CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPLKWMAPESIFDKIYS 279
Query: 59  GPEVDVWSCGVILYALL 75
             + DVWS GV+L+ + 
Sbjct: 280 -TKSDVWSYGVLLWEIF 295

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           +HRDL   N+L+   +  KIADFGLS   ++ +  KT    P  + A E ++  +Y    
Sbjct: 154 IHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TN 211
Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 118
            DVWS GV+L+ ++  G  P+       L++K+  G Y L  P +      DL+ +    
Sbjct: 212 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWRE 270
Query: 119 DPMKRITIPEI 129
            P +R +  +I
Sbjct: 271 KPYERPSFAQI 281

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   P  + APE I   +Y 
Sbjct: 173 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 232
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    + + F K+    Y +  P+        ++   
Sbjct: 233 -VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 291
Query: 116 LIVDPMKRITIPEI 129
             ++P  R T  +I
Sbjct: 292 WALEPTHRPTFQQI 305

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
           +VHRDL   N+L+     +KI+DFGLS ++  +  ++K S G     + A E +   +Y 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ ++  G  P+       LF  +K G
Sbjct: 231 -TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           +HRDL   N+L+   +  KIADFGLS   ++ +  KT    P  + A E ++  +Y    
Sbjct: 164 IHRDLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TN 221
Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 118
            DVWS GV+L+ ++  G  P+       L++K+  G Y L  P +      DL+ +    
Sbjct: 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWRE 280
Query: 119 DPMKRITIPEI 129
            P +R +  +I
Sbjct: 281 KPYERPSFAQI 291

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 66/134 (49%), Gaps = 7/134 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFL-KTSCGSP-NYAAPEVISGKLYA 58
            +HRD+   N+LL +    KI DFGL+ +IM D +++ K +   P  + APE I   +Y 
Sbjct: 179 CIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT 238
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    + + F K+    Y +  P+        ++   
Sbjct: 239 -VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQAC 297
Query: 116 LIVDPMKRITIPEI 129
             ++P  R T  +I
Sbjct: 298 WALEPTHRPTFQQI 311

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 11/136 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHF-LKTSCGSP-NYAAPEVISGKLYA 58
            VHRDL   N+L+     VKI DFGL+ +IM D ++ ++ +   P  + APE +   +Y 
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIP---NLFKKIKGGI-YTLPSHLSPGARDLIP 113
             + DVWS G++L+ +   G  P+    IP   N +K I+ G     P + +     ++ 
Sbjct: 253 -IKSDVWSYGILLWEIFSLGVNPYP--GIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQ 309
Query: 114 RMLIVDPMKRITIPEI 129
                D  KR + P +
Sbjct: 310 SCWAFDSRKRPSFPNL 325

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 360
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 361 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 418
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 419 RKEPEERPTF------EYLQAFLEDYFTSTEP 444

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 30/176 (17%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTFTAHAGAKFPIKWTAPESLAYNKFS- 188
Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 113
            + DVW+ GV+L+ +   G  P+   D   +  L +K     Y +  P        +L+ 
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK----DYRMERPEGCPEKVYELMR 244
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
                +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 245 ACWQWNPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKRG 285

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKK 92
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 221 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 257

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 360
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 361 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 418
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 419 RKEPEERPTF------EYLQAFLEDYFTSTEP 444

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 360
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 361 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 418
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 419 RKEPEERPTF------EYLQAFLEDYFTSTEP 444

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD---DENIPNLFKK 92
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 198 H-QSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEK 234

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 204
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 264
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 265 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 298

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 191
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 192 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 249
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 250 RKEPEERPTF------EYLQAFLEDYFTSTEP 275

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 27/91 (29%), Positives = 42/91 (46%), Gaps = 11/91 (12%)
Query: 2   VVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           +VHR++KP N++     D +   K+ DFG +  + D        G+  Y  P++    + 
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVL 192
Query: 58  A-------GPEVDVWSCGVILYALLCGTLPF 81
                   G  VD+WS GV  Y    G+LPF
Sbjct: 193 RKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 28/83 (33%), Positives = 40/83 (48%), Gaps = 6/83 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-----PNYAAPEVISGKLY 57
           VHRDL   N +LD  + VK+ADFGL+  + D  +              + A E +    +
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205
Query: 58  AGPEVDVWSCGVILYALLCGTLP 80
              + DVWS GV+L+ LL    P
Sbjct: 206 TT-KSDVWSFGVLLWELLTRGAP 227

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 193
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 254 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 287

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/152 (27%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D     +     P  + APE  + G+    
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI- 194
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 195 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 252
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             DP +R T        + QA L  Y     P
Sbjct: 253 RKDPEERPTF------EYLQAFLEDYFTSTEP 278

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 193
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 254 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 287

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHR+L   N+LL S   V++ADFG+++++   D   L +   +P  + A E I    Y 
Sbjct: 154 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 213
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 92
             + DVWS GV ++ L+  G  P+       +P+L +K
Sbjct: 214 H-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 250

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/151 (26%), Positives = 66/151 (43%), Gaps = 13/151 (8%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 443
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 117
            + DVWS G++L  L   G +P+       +  +++ G     P        DL+ +   
Sbjct: 444 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 502
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
            +P +R T        + QA L  Y     P
Sbjct: 503 KEPEERPTF------EYLQAFLEDYFTSTEP 527

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 32/98 (32%), Positives = 53/98 (54%), Gaps = 8/98 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHR+L   N+LL S   V++ADFG+++++   D   L +   +P  + A E I    Y 
Sbjct: 136 MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT 195
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 92
             + DVWS GV ++ L+  G  P+       +P+L +K
Sbjct: 196 H-QSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEK 232

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI- 187
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 188 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 245
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 246 RKEPEERPTF------EYLQAFLEDYFTSTEP 271

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 53/101 (52%), Gaps = 13/101 (12%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           +HRDL+  N+L+ +    KIADFGL+ +             P  + APE I+   +   +
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARV---------GAKFPIKWTAPEAINFGSFT-IK 349
Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
            DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 350 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 389

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 147 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 206
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 207 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 266
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 267 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 320

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 205
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 206 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 265
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 266 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 319

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/189 (23%), Positives = 76/189 (40%), Gaps = 55/189 (29%)
Query: 2   VVHRDLKPENLLL----DSKWNVKIADFGLSNI----MRDGHFLKTSCGSPNYAAPEVIS 53
           V+HRDLKP N+L+      +  VKIAD G + +    ++    L     +  Y APE++ 
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 208
Query: 54  GKLYAGPEVDVWSCGVILYALLCG-------------TLPFDDENIPNLFK-------KI 93
           G  +    +D+W+ G I   LL               + P+  + +  +F        K 
Sbjct: 209 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKD 268
Query: 94  KGGIYTLPSH-------------------------LSPGAR--DLIPRMLIVDPMKRITI 126
              I  +P H                         + P ++   L+ ++L +DP+KRIT 
Sbjct: 269 WEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITS 328
Query: 127 PEIRQHPWF 135
            +  Q P+F
Sbjct: 329 EQAMQDPYF 337

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS-I 193
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 253
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 254 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 287

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           +P  R +  EI Q                 +TM Q   I +E+ KE+
Sbjct: 252 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKEL 283

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
            VHRD+   N+L+ S   VK+ DFGLS  + D  + K S       + +PE I+ + +  
Sbjct: 130 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 189
Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 115
              DVW   V ++ +L  G  PF   +++++  + +  KG     P    P    L+ R 
Sbjct: 190 AS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGDRLPKPDLCPPVLYTLMTRC 246
Query: 116 LIVDPMKRITIPEI 129
              DP  R    E+
Sbjct: 247 WDYDPSDRPRFTEL 260

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAG 59
           VHRDL   N ++   + VKI DFG++ +I    ++ K   G     + APE +   ++  
Sbjct: 152 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTT 211
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 117
              D+WS GV+L+ +      P+   +   + K +  GG    P +      DL+     
Sbjct: 212 SS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQ 270
Query: 118 VDPMKRITIPEI 129
            +P  R T  EI
Sbjct: 271 FNPKMRPTFLEI 282

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 172 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 232 H-QSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 22/170 (12%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++ 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS- 191
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 117
            + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+     
Sbjct: 192 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 251
Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
            +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 252 WNPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 286

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 148 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 207
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 208 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 267
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 268 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 321

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 205
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 206 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 265
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 266 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 319

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 205
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 206 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 265
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 266 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 319

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 205
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 206 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 265
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 266 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 319

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 73/167 (43%), Gaps = 20/167 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 251
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           +P  R +  EI Q                 +TM Q   I +E+ KE+
Sbjct: 252 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKEL 283

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 75/176 (42%), Gaps = 30/176 (17%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS- 188
Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 113
            + DVW+ GV+L+ +   G  P+   D   +  L +K     Y +  P        +L+ 
Sbjct: 189 IKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEK----DYRMERPEGCPEKVYELMR 244
Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
                +P  R +  EI Q                 +TM Q   I +E+ KE+ K G
Sbjct: 245 ACWQWNPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGKRG 285

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 147 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 206
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 207 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 266
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 267 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 320

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
            VHRD+   N+L+ S   VK+ DFGLS  + D  + K S       + +PE I+ + +  
Sbjct: 146 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 205
Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 115
              DVW   V ++ +L  G  PF   +++++  + +  KG     P    P    L+ R 
Sbjct: 206 AS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGDRLPKPDLCPPVLYTLMTRC 262
Query: 116 LIVDPMKRITIPEI 129
              DP  R    E+
Sbjct: 263 WDYDPSDRPRFTEL 276

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 45.1 bits (105), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/169 (26%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFS-I 192
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 252
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 253 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 286

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 199 H-QSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 68/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D  +  +     P  + APE  + G+    
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTI- 191
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 192 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 249
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 250 RKEPEERPTF------EYLQAFLEDYFTSTEP 275

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 198 H-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 33/112 (29%), Positives = 51/112 (45%), Gaps = 21/112 (18%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY------------AAPE 50
           VHR L   N+L++S    K++DFGLS       FL+     P Y             APE
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLS------RFLEDDTSDPTYTSALGGKIPIRWTAPE 184
Query: 51  VISGKLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
            I  + +     DVWS G++++ ++  G  P+ D    ++   I+   Y LP
Sbjct: 185 AIQYRKFTSAS-DVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQD-YRLP 234

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 74/169 (43%), Gaps = 20/169 (11%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HR+L   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 437
Query: 61  EVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIV 118
           + DVW+ GV+L+ +   G  P+   ++  +++ + K      P        +L+      
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQW 497
Query: 119 DPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
           +P  R +  EI Q                 +TM Q   I +E+ KE+ K
Sbjct: 498 NPSDRPSFAEIHQ---------------AFETMFQESSISDEVEKELGK 531

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/134 (28%), Positives = 61/134 (45%), Gaps = 9/134 (6%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--PNYAAPEVISGKLYAG 59
            VHRD+   N+L+ S   VK+ DFGLS  + D  + K S       + +PE I+ + +  
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTT 193
Query: 60  PEVDVWSCGVILYALLC-GTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRM 115
              DVW   V ++ +L  G  PF   +++++  + +  KG     P    P    L+ R 
Sbjct: 194 AS-DVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE--KGDRLPKPDLCPPVLYTLMTRC 250
Query: 116 LIVDPMKRITIPEI 129
              DP  R    E+
Sbjct: 251 WDYDPSDRPRFTEL 264

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 30/107 (28%), Positives = 55/107 (51%), Gaps = 6/107 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L++ +  VK++DFGLS  + D     +S GS     ++ PEV+    ++ 
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-ETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPSHLS 105
              D+W+ GV+++ +   G +P++        + I  G+     HL+
Sbjct: 201 KS-DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 205
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 206 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 265
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 266 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 319

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 40/174 (22%), Positives = 68/174 (39%), Gaps = 39/174 (22%)
Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 146 IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDLQDYDY 205
Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKG-GIYTLPSHL------------- 104
            +D+WS G +   ++    PF    +N   L K  K  G   L  +L             
Sbjct: 206 SLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYRIELDPQLEA 265
Query: 105 ----------------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                 SP A D + ++L  D  +R+T  E   HP+FQ
Sbjct: 266 LVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHPYFQ 319

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 207
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 208 H-QSDVWSYGVTVWELMTFGSKPYD 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 205 H-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 198
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 199 H-QSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 38/132 (28%), Positives = 58/132 (43%), Gaps = 6/132 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           VHRDL   N L+ +   VKI DFG+S  +    + +    +     +  PE I  + +  
Sbjct: 155 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT- 213
Query: 60  PEVDVWSCGVILYALLC-GTLP-FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
            E DVWS GVIL+ +   G  P F   N   +    +G +   P        D++     
Sbjct: 214 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVYDVMLGCWQ 273
Query: 118 VDPMKRITIPEI 129
            +P +R+ I EI
Sbjct: 274 REPQQRLNIKEI 285

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 222
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 223 H-QSDVWSYGVTVWELMTFGSKPYD 246

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 201 H-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 198 H-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 203
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 204 H-QSDVWSYGVTVWELMTFGSKPYD 227

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 200 H-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 198 H-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 201 H-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 31/84 (36%), Positives = 45/84 (53%), Gaps = 6/84 (7%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP---NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +R D +  K          + APE I+   ++
Sbjct: 133 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKFS 192
Query: 59  GPEVDVWSCGVILY-ALLCGTLPF 81
               DVWS GV+++ A   G  P+
Sbjct: 193 SKS-DVWSFGVLMWEAFSYGQKPY 215

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 201
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 202 H-QSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 205 H-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 198 H-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 201 H-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 204
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 205 H-QSDVWSYGVTVWELMTFGSKPYD 228

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 200
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 201 H-QSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 199
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 200 H-QSDVWSYGVTVWELMTFGSKPYD 223

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAG 59
           VHRDL   N ++   + VKI DFG++ +I    ++ K   G     + APE +   ++  
Sbjct: 152 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 211
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 117
              D+WS GV+L+ +      P+   +   + K +  GG    P +      DL+     
Sbjct: 212 SS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQ 270
Query: 118 VDPMKRITIPEI 129
            +P  R T  EI
Sbjct: 271 FNPKMRPTFLEI 282

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 194
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 195 H-QSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 197
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 198 H-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/85 (34%), Positives = 48/85 (56%), Gaps = 5/85 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSP-NYAAPEVISGKLYA 58
           +VHRDL   N+L+ +  +VKI DFGL+ ++   +  +       P  + A E I  ++Y 
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT 191
Query: 59  GPEVDVWSCGVILYALLC-GTLPFD 82
             + DVWS GV ++ L+  G+ P+D
Sbjct: 192 H-QSDVWSYGVTVWELMTFGSKPYD 215

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 6/132 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCG--SPNYAAPEVISGKLYAG 59
           VHRDL   N ++   + VKI DFG++ +I    ++ K   G     + APE +   ++  
Sbjct: 151 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTT 210
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 117
              D+WS GV+L+ +      P+   +   + K +  GG    P +      DL+     
Sbjct: 211 SS-DMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERVTDLMRMCWQ 269
Query: 118 VDPMKRITIPEI 129
            +P  R T  EI
Sbjct: 270 FNPKMRPTFLEI 281

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 65/131 (49%), Gaps = 7/131 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           +HR+L   N+L+   +  KIADFGLS   ++ +  KT    P  + A E ++  +Y    
Sbjct: 161 IHRNLAARNILVGENYVAKIADFGLSR-GQEVYVKKTMGRLPVRWMAIESLNYSVYT-TN 218
Query: 62  VDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIV 118
            DVWS GV+L+ ++  G  P+       L++K+  G Y L  P +      DL+ +    
Sbjct: 219 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDLMRQCWRE 277
Query: 119 DPMKRITIPEI 129
            P +R +  +I
Sbjct: 278 KPYERPSFAQI 288

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
           +VHRDL   N+L+     +KI+DFGLS ++  +   +K S G     + A E +   +Y 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ ++  G  P+       LF  +K G
Sbjct: 231 -TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 5/99 (5%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--PNYAAPEVISGKLYA 58
           +VHRDL   N+L+     +KI+DFGLS ++  +   +K S G     + A E +   +Y 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + DVWS GV+L+ ++  G  P+       LF  +K G
Sbjct: 231 -TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG 268

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 28/76 (36%), Positives = 36/76 (47%), Gaps = 4/76 (5%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           VHRDL   N L+     VKIADFGLS  +    + K          +  PE I    Y  
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTT 255
Query: 60  PEVDVWSCGVILYALL 75
            E DVW+ GV+L+ + 
Sbjct: 256 -ESDVWAYGVVLWEIF 270

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 18/101 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLY- 57
           + HRD+K +N+LL +     IADFGL+     G     +    G+  Y APEV+ G +  
Sbjct: 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211
Query: 58  ---AGPEVDVWSCGVILYALL--CGT---------LPFDDE 84
              A   +D+++ G++L+ L   C           LPF++E
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE 252

>pdb|4EAI|A Chain A, Co-Crystal Structure Of An Ampk Core With Amp Length = 106

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 27/104 (25%), Positives = 45/104 (43%), Gaps = 32/104 (30%)
Query: 255 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 314
           KW LG++S++ P +IM EV +A+++L+  WK +  Y ++ R              NP+ S
Sbjct: 7   KWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVR------------RKNPVTS 54
Query: 315 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV 358
                                  K  +QLY+     YLLD + +
Sbjct: 55  --------------------TFSKMSLQLYQVDSRTYLLDFRSI 78

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 196
Query: 61  EVDVWSCGVILYAL 74
           + DVW+ GV+L+ +
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 195
Query: 61  EVDVWSCGVILYAL 74
           + DVW+ GV+L+ +
Sbjct: 196 KSDVWAFGVLLWEI 209

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 196
Query: 61  EVDVWSCGVILYAL 74
           + DVW+ GV+L+ +
Sbjct: 197 KSDVWAFGVLLWEI 210

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191
Query: 61  EVDVWSCGVILYAL 74
           + DVW+ GV+L+ +
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 67/152 (44%), Gaps = 15/152 (9%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGSP-NYAAPE-VISGKLYAG 59
           VHRDL+  N+L+      K+ADFGL+ ++ D     +     P  + APE  + G+    
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI- 184
Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS--HLSPGARDLIPRML 116
            + DVWS G++L  L   G +P+       +  +++ G Y +P          DL+ +  
Sbjct: 185 -KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCW 242
Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
             +P +R T        + QA L  Y     P
Sbjct: 243 RKEPEERPTF------EYLQAFLEDYFTSTEP 268

>pdb|2Y8L|A Chain A, Structure Of The Regulatory Fragment Of Mammalian Ampk In Complex With Two Adp Length = 173

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 29/116 (25%), Positives = 49/116 (42%), Gaps = 36/116 (31%)
Query: 243 GMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISG 302
           G+  RG +     W LG++S++ P +IM EV +A+++L+  WK +  Y ++ R       
Sbjct: 10  GLVPRGSM----AWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRR------ 59
Query: 303 HHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV 358
                  NP+ S                       K  +QLY+     YLLD + +
Sbjct: 60  ------KNPVTS--------------------TFSKMSLQLYQVDSRTYLLDFRSI 89

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/74 (35%), Positives = 41/74 (55%), Gaps = 3/74 (4%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M  D +        P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191
Query: 61  EVDVWSCGVILYAL 74
           + DVW+ GV+L+ +
Sbjct: 192 KSDVWAFGVLLWEI 205

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/98 (33%), Positives = 51/98 (52%), Gaps = 8/98 (8%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           +VHRDL   N+L+ S  +VKI DFGL+ ++        + G      + A E I  + + 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 59  GPEVDVWSCGVILYALLC-GTLPFDD---ENIPNLFKK 92
             + DVWS GV ++ L+  G  P+D      IP+L +K
Sbjct: 200 H-QSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEK 236

>pdb|2V8Q|A Chain A, Crystal Structure Of The Regulatory Fragment Of Mammalian Ampk In Complexes With Amp Length = 157

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/103 (25%), Positives = 44/103 (42%), Gaps = 32/103 (31%)
Query: 256 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSN 315
           W LG++S++ P +IM EV +A+++L+  WK +  Y ++ R              NP+ S 
Sbjct: 5   WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRR------------KNPVTS- 51
Query: 316 HYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV 358
                                 K  +QLY+     YLLD + +
Sbjct: 52  -------------------TFSKMSLQLYQVDSRTYLLDFRSI 75

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 31/101 (30%), Positives = 49/101 (48%), Gaps = 18/101 (17%)
Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLY- 57
           + HRD K +N+LL S     +ADFGL+     G          G+  Y APEV+ G +  
Sbjct: 144 IAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLEGAINF 203
Query: 58  ---AGPEVDVWSCGVILYALL--CGT---------LPFDDE 84
              A   +D+++ G++L+ L+  C           LPF++E
Sbjct: 204 QRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEE 244

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 46/107 (42%), Gaps = 32/107 (29%)
Query: 2   VVHRDLKPENLLLDSKW-------------------------NVKIADFGLSNIMRDGHF 36
           + H DLKPEN+LLD  +                          +K+ DFG +    D H 
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYH- 216
Query: 37  LKTSCGSPNYAAPEVISGKLYAGPEV--DVWSCGVILYALLCGTLPF 81
             +   +  Y APEVI   L  G +V  D+WS G +L  L  G+L F
Sbjct: 217 -GSIINTRQYRAPEVI---LNLGWDVSSDMWSFGCVLAELYTGSLLF 259

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 26/75 (34%), Positives = 41/75 (54%), Gaps = 5/75 (6%)
Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP---NYAAPEVISGKLYAG 59
           +HRDL   N L+     VK+ADFGLS +M  G       G+     + APE ++   ++ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTXTAHAGAKFPIKWTAPESLAYNKFS- 188
Query: 60  PEVDVWSCGVILYAL 74
            + DVW+ GV+L+ +
Sbjct: 189 IKSDVWAFGVLLWEI 203
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	379
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-158
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-125
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-117
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-110
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-106
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-105
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-99
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	8e-97
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	8e-93
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-90
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	3e-90
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-88
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-88
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	5e-85
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-84
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-84
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-82
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-79
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-78
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	9e-77
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	8e-76
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-75
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-74
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	7e-74
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-72
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-71
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-67
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-66
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-66
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-66
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-63
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	9e-63
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-62
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	5e-62
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-61
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-61
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-60
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-60
3bhy_A	283	Death-associated protein kinase 3; death associate	2e-60
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	2e-60
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-60
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-60
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	5e-60
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-59
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-59
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-59
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-59
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-58
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-58
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	4e-58
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-58
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-57
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-57
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-57
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-56
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-56
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-55
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-55
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	1e-54
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-53
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-53
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-51
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-49
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-49
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	8e-49
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	7e-48
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-48
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-47
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	7e-46
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-45
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-44
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-44
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-44
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-44
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	6e-44
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-43
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-43
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-43
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-42
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	8e-42
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-41
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-41
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-41
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	7e-41
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	1e-39
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-39
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-39
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-39
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-39
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-39
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-39
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	8e-39
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	2e-38
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-38
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	2e-36
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	2e-34
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	8e-32
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	5e-30
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	5e-30
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-29
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	1e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-29
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-29
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-29
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-28
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	1e-27
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	6e-27
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	2e-26
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-26
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-26
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-26
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-26
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-25
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-25
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-25
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-25
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-25
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	4e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-25
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	6e-25
3an0_A	340	Dual specificity mitogen-activated protein kinase;	9e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-24
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-24
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-24
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-24
2dyl_A	318	Dual specificity mitogen-activated protein kinase	6e-24
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	7e-24
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-23
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-23
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-23
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	6e-23
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-23
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-22
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-22
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	2e-22
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-22
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-22
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-22
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-22
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-21
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-21
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-21
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-21
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-21
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	6e-21
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	8e-21
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-20
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-20
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-20
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-20
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-20
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-20
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	3e-20
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	1e-19
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-19
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-19
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-19
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-19
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-18
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-18
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	1e-17
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	7e-16
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-15
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-14
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	9e-14
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-13
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-04
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	7e-12
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-07
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-11
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-11
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	2e-11
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-10
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-10
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-10
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-10
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	6e-10
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-10
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-09
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-09
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-09
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-09
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-09
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-09
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-09
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-09
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	6e-09
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	7e-09
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-09
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	9e-09
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-08
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-08
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-08
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-08
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-08
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-08
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	3e-08
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-08
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	3e-08
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-08
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-08
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	5e-08
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	5e-08
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-08
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-08
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	6e-08
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	6e-08
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	6e-08
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-07
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-07
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-07
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-07
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-07
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-07
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-07
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-07
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-07
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	7e-07
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-07
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-07
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-06
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	9e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-04
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-04

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  453 bits (1167), Expect = e-158
 Identities = 153/375 (40%), Positives = 207/375 (55%), Gaps = 43/375 (11%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 195

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WS GVILYALLCGTLPFDD+++P LFKKI  GI+  P +L+P    L+  ML VDP
Sbjct: 196 EVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDP 255

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV-KMGFDQNQLVESL 179
           MKR TI +IR+H WF+  LP+YL   P D    +  ID+E LKEV  K    + +++  L
Sbjct: 256 MKRATIKDIREHEWFKQDLPKYLF--PEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCL 313

Query: 180 RNR-LQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEP-------AVSPV 231
            NR  Q+   VAY+L++DNR  ++            +S  +  H   P        V+  
Sbjct: 314 YNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAET 373

Query: 232 AHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYN 291
                   +      + Q   + KW LG++S++ P +IM EV +A+++L+  WK +  Y 
Sbjct: 374 PRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYY 433

Query: 292 MKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKY 351
           ++ R    +                                +    K  +QLY+     Y
Sbjct: 434 LRVRRKNPV--------------------------------TSTFSKMSLQLYQVDSRTY 461

Query: 352 LLDLQRVQGPQFLFL 366
           LLD + +       L
Sbjct: 462 LLDFRSIDDEILEVL 476

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  362 bits (932), Expect = e-125
 Identities = 123/204 (60%), Positives = 149/204 (73%), Gaps = 4/204 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLKPENLLLD   NVKIADFGLSNIM DG+FLKTSCGSPNYAAPEVI+GKLYAGP
Sbjct: 128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGP 187

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWSCG++LY +L G LPFDDE IPNLFKK+   +Y +P  LSPGA+ LI RM++ DP
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADP 247

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK-MGFDQNQLVESL 179
           M+RITI EIR+ PWF  +LP YL    P    Q    D  I+ ++ + MGF ++ +VE+L
Sbjct: 248 MQRITIQEIRRDPWFNVNLPDYL---RPMEEVQGSYADSRIVSKLGEAMGFSEDYIVEAL 304

Query: 180 RNRLQNEATVAYYLLLDNRFRVSS 203
           R+   NE   AY LL +N+     
Sbjct: 305 RSDENNEVKEAYNLLHENQVIQEK 328

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  343 bits (882), Expect = e-117
 Identities = 83/196 (42%), Positives = 116/196 (59%), Gaps = 2/196 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            +VHRDLK ENLLLD+  N+KIADFG SN    G  L   CG+P YAAPE+  GK Y GP
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVDVWS GVILY L+ G+LPFD +N+  L +++  G Y +P ++S    +L+ R L+++P
Sbjct: 194 EVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNP 253

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQLVESLR 180
           +KR T+ +I +  W  A          P    +    D++ +  +V MG+ Q ++ ESL 
Sbjct: 254 IKRGTLEQIMKDRWINAGHEEDE--LKPFVEPELDISDQKRIDIMVGMGYSQEEIQESLS 311

Query: 181 NRLQNEATVAYYLLLD 196
               +E T  Y LL  
Sbjct: 312 KMKYDEITATYLLLGR 327

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  327 bits (839), Expect = e-110
 Identities = 73/211 (34%), Positives = 105/211 (49%), Gaps = 9/211 (4%)

Query: 1   MVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
            + HRDLK EN LLD      +KI DFG S         K++ G+P Y APEV+  + Y 
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKK----IKGGIYTLPS--HLSPGARDLI 112
           G   DVWSCGV LY +L G  PF+D   P  ++K    I    Y++P    +SP    LI
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255

Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQ 172
            R+ + DP  RI+IPEI+ H WF  +LP  L +   +T  Q ++ ++ +      M    
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFLKNLPADL-MNESNTGSQFQEPEQPMQSLDTIMQIIS 314

Query: 173 NQLVESLRNRLQNEATVAYYLLLDNRFRVSS 203
              + ++RNR  ++       L D+     S
Sbjct: 315 EATIPAVRNRCLDDFMTDNLDLDDDMDDFDS 345

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  311 bits (798), Expect = e-105
 Identities = 102/143 (71%), Positives = 121/143 (84%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           MVVHRDLKPEN+LLD+  N KIADFGLSN+M DG FL+TSCGSPNYAAPEVISG+LYAGP
Sbjct: 131 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGP 190

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           EVD+WSCGVILYALLCGTLPFDDE++P LFKKI+GG++ +P +L+     L+  ML VDP
Sbjct: 191 EVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDP 250

Query: 121 MKRITIPEIRQHPWFQAHLPRYL 143
           +KR TI +IR+H WF+  LP YL
Sbjct: 251 LKRATIKDIREHEWFKQDLPSYL 273

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  296 bits (759), Expect = 2e-99
 Identities = 61/165 (36%), Positives = 91/165 (55%), Gaps = 8/165 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIM---RDGHFLKTSCGSPNYAAPEVISG-KL 56
            +VH+D+KP NLLL +   +KI+  G++  +         +TS GSP +  PE+ +G   
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
           ++G +VD+WS GV LY +  G  PF+ +NI  LF+ I  G Y +P    P   DL+  ML
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGML 248

Query: 117 IVDPMKRITIPEIRQHPWFQAHLPRYLAVPP----PDTMQQAKKI 157
             +P KR +I +IRQH WF+   P   A  P    PDT  + + +
Sbjct: 249 EYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRWRSM 293

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  290 bits (744), Expect = 8e-97
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 8/187 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 57
            + HRD+KPENLLLD + N+KI+DFGL+ + R       L   CG+  Y APE++  + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLP-SHLSPGARDLIPR 114
               VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 174
           +L+ +P  RITIP+I++  W+   L +      P               + ++   D + 
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGA--KRPRVTSGGVSESPSGFSKHIQSNLDFSP 302

Query: 175 LVESLRN 181
           +  + R 
Sbjct: 303 VNSASRT 309

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  286 bits (735), Expect = 4e-96
 Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 6/152 (3%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 57
            + HRD+KPENLLLD + N+KI+DFGL+ + R       L   CG+  Y APE++  + +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIYTLP-SHLSPGARDLIPR 114
               VDVWSCG++L A+L G LP+D   ++        +   Y  P   +      L+ +
Sbjct: 185 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 244

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           +L+ +P  RITIP+I++  W+   L +    P
Sbjct: 245 ILVENPSARITIPDIKKDRWYNKPLKKGAKRP 276

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  279 bits (715), Expect = 8e-93
 Identities = 65/161 (40%), Positives = 89/161 (55%), Gaps = 8/161 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K +  
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-S 193

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  D
Sbjct: 194 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 253

Query: 120 PMKRITIPEIRQHPWFQAHL------PRYLAVPPPDTMQQA 154
           P  R TI E+    +F +           L +PP  ++  +
Sbjct: 254 PTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS 294

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  273 bits (700), Expect = 2e-90
 Identities = 58/141 (41%), Positives = 82/141 (58%), Gaps = 5/141 (3%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISG--KLY 57
            ++HRD+KP NLL+    ++KIADFG+SN  +     L  + G+P + APE +S   K++
Sbjct: 157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIF 216

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH--LSPGARDLIPRM 115
           +G  +DVW+ GV LY  + G  PF DE I  L  KIK      P    ++   +DLI RM
Sbjct: 217 SGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRM 276

Query: 116 LIVDPMKRITIPEIRQHPWFQ 136
           L  +P  RI +PEI+ HPW  
Sbjct: 277 LDKNPESRIVVPEIKLHPWVT 297

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  274 bits (702), Expect = 3e-90
 Identities = 68/174 (39%), Positives = 91/174 (52%), Gaps = 7/174 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            V+HRDLK  NL L+    VKI DFGL+  +  DG   K  CG+PNY APEV+S K +  
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-S 219

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            EVDVWS G I+Y LL G  PF+   +   + +IK   Y++P H++P A  LI +ML  D
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTD 279

Query: 120 PMKRITIPEIRQHPWFQAH-----LPRYLAVPPPDTMQQAKKIDEEILKEVVKM 168
           P  R TI E+    +F +      LP      PP        +D    K +  +
Sbjct: 280 PTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPSSLDPSNRKPLTVL 333

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  268 bits (688), Expect = 3e-88
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 8/166 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            ++HRD+K EN+++   + +K+ DFG +  +  G    T CG+  Y APEV+ G  Y GP
Sbjct: 150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGP 209

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           E+++WS GV LY L+    PF +       ++        P  +S     L+  +L   P
Sbjct: 210 ELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSKELMSLVSGLLQPVP 263

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 166
            +R T+ ++   PW    +   LA    + + +  K +  +L    
Sbjct: 264 ERRTTLEKLVTDPWVTQPVN--LADYTWEEVFRVNKPESGVLSAAS 307

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  265 bits (681), Expect = 7e-88
 Identities = 54/141 (38%), Positives = 79/141 (56%), Gaps = 2/141 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            ++HRDL   NLLL    N+KIADFGL+  +        T CG+PNY +PE+ +   + G
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-G 190

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
            E DVWS G + Y LL G  PFD + + N   K+    Y +PS LS  A+DLI ++L  +
Sbjct: 191 LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRN 250

Query: 120 PMKRITIPEIRQHPWFQAHLP 140
           P  R+++  +  HP+   +  
Sbjct: 251 PADRLSLSSVLDHPFMSRNSS 271

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  259 bits (665), Expect = 5e-85
 Identities = 49/154 (31%), Positives = 77/154 (50%), Gaps = 9/154 (5%)

Query: 1   MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            V+HRD+K EN+L+D  +  +K+ DFG   +++D        G+  Y+ PE I    Y G
Sbjct: 169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHG 227

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
               VWS G++LY ++CG +PF+ +      ++I  G       +S   + LI   L + 
Sbjct: 228 RSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALR 281

Query: 120 PMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQ 152
           P  R T  EI+ HPW Q   LP+  A     ++ 
Sbjct: 282 PSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLS 315

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  257 bits (659), Expect = 3e-84
 Identities = 49/149 (32%), Positives = 72/149 (48%), Gaps = 8/149 (5%)

Query: 1   MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            VVHRD+K EN+L+D +    K+ DFG   ++ D  +     G+  Y+ PE IS   Y  
Sbjct: 159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY-TDFDGTRVYSPPEWISRHQYHA 217

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVD 119
               VWS G++LY ++CG +PF+ +      ++I       P+H+SP    LI R L   
Sbjct: 218 LPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDCCALIRRCLAPK 271

Query: 120 PMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
           P  R ++ EI   PW Q         P  
Sbjct: 272 PSSRPSLEEILLDPWMQTPAEDVPLNPSK 300

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  258 bits (660), Expect = 8e-84
 Identities = 50/177 (28%), Positives = 79/177 (44%), Gaps = 22/177 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL-YAGP 60
           + HRD+KP N+L+D    VK++DFG S  M D   +K S G+  +  PE  S +  Y G 
Sbjct: 173 ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESSYNGA 231

Query: 61  EVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLP------------------ 101
           +VD+WS G+ LY +    +PF  + ++  LF  I+      P                  
Sbjct: 232 KVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291

Query: 102 -SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKI 157
            + LS    D +   L  +P +RIT  +  +H W        L     +  ++ KK+
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  252 bits (645), Expect = 2e-82
 Identities = 59/155 (38%), Positives = 87/155 (56%), Gaps = 4/155 (2%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            V+HRD+KPENLL+  K  +KIADFG S +       +T CG+ +Y  PE+I GK +   
Sbjct: 134 KVIHRDIKPENLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTH-DE 191

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           +VD+W  GV+ Y  L G  PFD  +     ++I       P  LS G++DLI ++L   P
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHP 251

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 155
            +R+ +  + +HPW +A+  R L  PP     Q+K
Sbjct: 252 PQRLPLKGVMEHPWVKANSRRVL--PPVYQSTQSK 284

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  246 bits (629), Expect = 2e-79
 Identities = 59/146 (40%), Positives = 80/146 (54%), Gaps = 10/146 (6%)

Query: 1   MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
            ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     
Sbjct: 134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 193

Query: 58  A--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPS----HLSPGARD 110
           A     VD WS GVIL+  L G  PF +     +L  +I  G Y         +S  A D
Sbjct: 194 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 253

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ 136
           L+ ++L+VDP  R T  E  +HPW Q
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWLQ 279

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  240 bits (614), Expect = 7e-78
 Identities = 56/153 (36%), Positives = 86/153 (56%), Gaps = 2/153 (1%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            V+HRD+KPENLLL S   +KIADFG S +          CG+ +Y  PE+I G+++   
Sbjct: 129 RVIHRDIKPENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMH-DE 186

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
           +VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 246

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 153
            +R  + E+ +HPW  A+  +       ++  +
Sbjct: 247 SQRPMLREVLEHPWITANSSKPSNCQNKESASK 279

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  237 bits (608), Expect = 9e-77
 Identities = 68/159 (42%), Positives = 89/159 (55%), Gaps = 8/159 (5%)

Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y 
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 184

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 185 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 153
           ML V+P KRIT  +  + PW         A+   DT+  
Sbjct: 245 MLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDC 283

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  238 bits (608), Expect = 8e-76
 Identities = 59/145 (40%), Positives = 83/145 (57%), Gaps = 9/145 (6%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-- 58
            +VHRDLKPEN+LLD    ++++DFG S  +  G  L+  CG+P Y APE++   +    
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279

Query: 59  ---GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 111
              G EVD+W+CGVIL+ LL G+ PF       + + I  G Y   S      S   +DL
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339

Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           I R+L VDP  R+T  +  QHP+F+
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFFE 364

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  234 bits (600), Expect = 2e-75
 Identities = 62/152 (40%), Positives = 84/152 (55%), Gaps = 9/152 (5%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA-- 58
            +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+I   +    
Sbjct: 144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 203

Query: 59  ---GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDL 111
              G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S      S   +DL
Sbjct: 204 PGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDL 263

Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 143
           + R L+V P KR T  E   HP+FQ ++   +
Sbjct: 264 VSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  232 bits (593), Expect = 1e-74
 Identities = 59/147 (40%), Positives = 82/147 (55%), Gaps = 9/147 (6%)

Query: 1   MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
            V HRDLKPEN L  +      +K+ DFGL+   + G  ++T  G+P Y +P+V+ G  Y
Sbjct: 126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y 184

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            GPE D WS GV++Y LLCG  PF       +  KI+ G +T P     ++SP A  LI 
Sbjct: 185 -GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR 243

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           R+L   P +RIT  +  +H WF+  L 
Sbjct: 244 RLLTKSPKQRITSLQALEHEWFEKQLS 270

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  234 bits (600), Expect = 7e-74
 Identities = 59/146 (40%), Positives = 80/146 (54%), Gaps = 10/146 (6%)

Query: 1   MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
            ++HRDLKPEN+LL S+     +KI DFG S I+ +   ++T CG+P Y APEV+     
Sbjct: 259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGT 318

Query: 58  A--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLPS----HLSPGARD 110
           A     VD WS GVIL+  L G  PF +     +L  +I  G Y         +S  A D
Sbjct: 319 AGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALD 378

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ 136
           L+ ++L+VDP  R T  E  +HPW Q
Sbjct: 379 LVKKLLVVDPKARFTTEEALRHPWLQ 404

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  229 bits (586), Expect = 1e-72
 Identities = 70/162 (43%), Positives = 91/162 (56%), Gaps = 8/162 (4%)

Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHR+LKPENLLL SK     VK+ADFGL+  + D        G+P Y +PEV+    Y 
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY- 207

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD+W+CGVILY LL G  PF DE+   L+ +IK G Y  PS     ++P A+ LI  
Sbjct: 208 SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           ML V+P KRIT  +  + PW         A+   DT+   KK
Sbjct: 268 MLTVNPKKRITADQALKVPWICNRERVASAIHRQDTVDCLKK 309

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  224 bits (572), Expect = 2e-71
 Identities = 48/141 (34%), Positives = 73/141 (51%), Gaps = 8/141 (5%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           VVH+DLKPEN+L         +KI DFGL+ + +       + G+  Y APEV    +  
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKRDV-- 202

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---HLSPGARDLIPRM 115
             + D+WS GV++Y LL G LPF   ++  + +K              L+P A DL+ +M
Sbjct: 203 TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQM 262

Query: 116 LIVDPMKRITIPEIRQHPWFQ 136
           L  DP +R +  ++  H WF+
Sbjct: 263 LTKDPERRPSAAQVLHHEWFK 283

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  215 bits (549), Expect = 8e-67
 Identities = 55/219 (25%), Positives = 84/219 (38%), Gaps = 22/219 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+         +  G+ NY  PE I      
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGG-IYTLPSHLS 105
                 K    P+ DVWS G ILY +  G  PF      I  L   I        P    
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 294

Query: 106 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
              +D++   L  DP +RI+IPE+  HP+ Q         P     +   +  + +L ++
Sbjct: 295 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH-----PVNQMAKGTTEEMKYVLGQL 349

Query: 166 VKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSG 204
           V +    + L  +           ++       F    G
Sbjct: 350 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  211 bits (540), Expect = 5e-66
 Identities = 54/219 (24%), Positives = 84/219 (38%), Gaps = 22/219 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYA 58
           +VH DLKP N L+     +K+ DFG++N M+         +  G+ NY  PE I     +
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 59  ----------GPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI-YTLPSHLS 105
                      P+ DVWS G ILY +  G  PF      I  L   I        P    
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 247

Query: 106 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
              +D++   L  DP +RI+IPE+  HP+ Q         P     +   +  + +L ++
Sbjct: 248 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH-----PVNQMAKGTTEEMKYVLGQL 302

Query: 166 VKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFRVSSG 204
           V +    + L  +           ++       F    G
Sbjct: 303 VGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  210 bits (537), Expect = 6e-66
 Identities = 54/175 (30%), Positives = 73/175 (41%), Gaps = 25/175 (14%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISG---- 54
           +VH DLKP N L+     +K+ DFG++N M+         +  G+ NY  PE I      
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 55  ------KLYAGPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGI-YTLPSHLS 105
                 K    P+ DVWS G ILY +  G  PF      I  L   I        P    
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPE 266

Query: 106 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEE 160
              +D++   L  DP +RI+IPE+  HP+ Q        +      Q AK   EE
Sbjct: 267 KDLQDVLKCCLKRDPKQRISIPELLAHPYVQ--------IQTHPVNQMAKGTTEE 313

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  209 bits (535), Expect = 7e-66
 Identities = 63/144 (43%), Positives = 85/144 (59%), Gaps = 9/144 (6%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y- 199

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
             + DVWS GVILY LL GT PF  +N  ++ K+++ G Y         +S  A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 115 MLIVDPMKRITIPEIRQHPWFQAH 138
           ML   P  RIT  +  +HPW Q +
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKY 283

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  204 bits (520), Expect = 5e-63
 Identities = 48/149 (32%), Positives = 74/149 (49%), Gaps = 12/149 (8%)

Query: 2   VVHRDLKPENLLLDSK--WNVKIADFGLSNIMR-----DGHFLKTSCGSPNYAAPEVISG 54
           + HRD+KPEN L  +   + +K+ DFGLS         + + + T  G+P + APEV++ 
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248

Query: 55  KLYA-GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGAR 109
              + GP+ D WS GV+L+ LL G +PF   N  +   ++        +     LSP AR
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR 308

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
           DL+  +L  +  +R       QHPW    
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWISQF 337

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  202 bits (516), Expect = 9e-63
 Identities = 43/186 (23%), Positives = 74/186 (39%), Gaps = 39/186 (20%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS---------------NIMRDGHFLKTSCGSPNY 46
           ++HRDLKP N+ +D   NVKI DFGL+               N+      L ++ G+  Y
Sbjct: 137 IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMY 196

Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL-- 104
            A EV+ G  +   ++D++S G+I + ++            N+ KK++      P     
Sbjct: 197 VATEVLDGTGHYNEKIDMYSLGIIFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDD 254

Query: 105 --SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEIL 162
                 + +I  ++  DP KR     +    W                     K  +E++
Sbjct: 255 NKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLP------------------VKHQDEVI 296

Query: 163 KEVVKM 168
           KE +K 
Sbjct: 297 KEALKS 302

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  201 bits (514), Expect = 2e-62
 Identities = 64/142 (45%), Positives = 82/142 (57%), Gaps = 9/142 (6%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL  +      + I DFGLS + ++G  + T+CG+P Y APEV++ K Y 
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPY- 184

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
              VD WS GVI Y LLCG  PF +E    LF+KIK G Y   S     +S  A+D I  
Sbjct: 185 SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244

Query: 115 MLIVDPMKRITIPEIRQHPWFQ 136
           +L  DP +R T  +   HPW  
Sbjct: 245 LLEKDPNERYTCEKALSHPWID 266

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  204 bits (521), Expect = 5e-62
 Identities = 68/145 (46%), Positives = 89/145 (61%), Gaps = 9/145 (6%)

Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 57
           VVHR+LKPENLLL SK     VK+ADFGL+  +  +        G+P Y +PEV+    Y
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY 190

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            G  VD+W+CGVILY LL G  PF DE+   L+++IK G Y  PS     ++P A+DLI 
Sbjct: 191 -GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 249

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAH 138
           +ML ++P KRIT  E  +HPW    
Sbjct: 250 KMLTINPSKRITAAEALKHPWISHR 274

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  200 bits (511), Expect = 1e-61
 Identities = 64/163 (39%), Positives = 93/163 (57%), Gaps = 10/163 (6%)

Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP  +LL SK N   VK+  FG++  +   G       G+P++ APEV+  + Y
Sbjct: 151 IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY 210

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            G  VDVW CGVIL+ LL G LPF       LF+ I  G Y +      H+S  A+DL+ 
Sbjct: 211 -GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHISESAKDLVR 268

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           RML++DP +RIT+ E   HPW +        +  P+T++Q +K
Sbjct: 269 RMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRK 311

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  200 bits (510), Expect = 2e-61
 Identities = 59/198 (29%), Positives = 93/198 (46%), Gaps = 27/198 (13%)

Query: 2   VVHRDLKPENLLLDSK----WNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKL 56
           VVHRDLKP N+L   +     +++I DFG +  +R +   L T C + N+ APEV+  + 
Sbjct: 137 VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQG 196

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFD---DENIPNLFKKIKGGIYTLPS----HLSPGAR 109
           Y     D+WS GV+LY +L G  PF    D+    +  +I  G ++L       +S  A+
Sbjct: 197 Y-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG 169
           DL+ +ML VDP +R+T   + +HPW                     +++ +    +VK  
Sbjct: 256 DLVSKMLHVDPHQRLTAALVLRHPWIV-----------HWDQLPQYQLNRQDAPHLVKGA 304

Query: 170 FDQNQLVESLRNRLQNEA 187
                   S  NR Q+  
Sbjct: 305 MAATY---SALNRNQSPV 319

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  206 bits (525), Expect = 1e-60
 Identities = 54/257 (21%), Positives = 92/257 (35%), Gaps = 41/257 (15%)

Query: 1   MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
            ++HRDLKPEN++L         KI D G +  +  G       G+  Y APE++  K Y
Sbjct: 141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY 200

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLF-KKIKGGIY------------------ 98
               VD WS G + +  + G  PF     P  +  K++                      
Sbjct: 201 -TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSV 259

Query: 99  -TLPSHLSPGARDLIPR----MLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPPDTMQ 152
              P+HLS      + R    ML+    +R T P+      FQA      L +     M 
Sbjct: 260 LPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMV 319

Query: 153 QAKKIDEEILKEVVKMGFDQNQLVESLRNRLQNEATVAY---YLLLDNRFRVSSGYLGAE 209
             +     +          +N+ +++L++ LQ +  +      LL  +   ++S     +
Sbjct: 320 SGRVHTYPV---------TENENLQNLKSWLQQDTGIPEEEQELLQASGLALNSAQPLTQ 370

Query: 210 FQETMESGFNRLHPIEP 226
           +         R    + 
Sbjct: 371 YVIDCTVIDGRQGEGDL 387

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  198 bits (505), Expect = 1e-60
 Identities = 66/147 (44%), Positives = 89/147 (60%), Gaps = 9/147 (6%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLL  +      +KIADFGLS I+     +KT CG+P Y APE++ G  Y 
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY- 227

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
           GPEVD+WS G+I Y LLCG  PF DE     +F++I    Y   S     +S  A+DL+ 
Sbjct: 228 GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLP 140
           +++++DP KR+T  +  QHPW      
Sbjct: 288 KLIVLDPKKRLTTFQALQHPWVTGKAA 314

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  195 bits (499), Expect = 2e-60
 Identities = 51/145 (35%), Positives = 77/145 (53%), Gaps = 9/145 (6%)

Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K      +K+ DFG+++ +  G+  K   G+P + APE+++ +  
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL 188

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  E        I    Y        + S  A+D I 
Sbjct: 189 -GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIR 247

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAH 138
           R+L+ DP +R+TI +  +H W +A 
Sbjct: 248 RLLVKDPKRRMTIAQSLEHSWIKAI 272

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  197 bits (502), Expect = 2e-60
 Identities = 49/162 (30%), Positives = 72/162 (44%), Gaps = 8/162 (4%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VH DLKP+N+LL S     ++KI DFG+S  +     L+   G+P Y APE+++     
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI- 210

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
               D+W+ G+I Y LL  T PF  E+    +  I              +S  A D I  
Sbjct: 211 TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQS 270

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           +L+ +P KR T      H W Q      L  P   +     +
Sbjct: 271 LLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQ 312

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  196 bits (501), Expect = 2e-60
 Identities = 65/201 (32%), Positives = 92/201 (45%), Gaps = 26/201 (12%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLY 57
           VVHRDLKPENLL   +     +KI DFG + +   D   LKT C + +YAAPE+++   Y
Sbjct: 127 VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY 186

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDEN-------IPNLFKKIKGGIYTLPS----HLSP 106
                D+WS GVILY +L G +PF   +          + KKIK G ++       ++S 
Sbjct: 187 -DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ 245

Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 166
            A+DLI  +L VDP KR+ +  +R + W Q           P             +   V
Sbjct: 246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ---LSSNPLMTPDILGSSGAAVHTCV 302

Query: 167 KMGFDQNQLVESLRNRLQNEA 187
           K  F          N+ + E 
Sbjct: 303 KATF-------HAFNKYKREG 316

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  196 bits (500), Expect = 3e-60
 Identities = 38/182 (20%), Positives = 62/182 (34%), Gaps = 40/182 (21%)

Query: 1   MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
            +VHR++KP N++     D +   K+ DFG +  + D     +  G+  Y  P++    +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 57  YA-------GPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYT------ 99
                    G  VD+WS GV  Y    G+LPF     P     +  KI  G  +      
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251

Query: 100 ---------------LPSHLSPGARD----LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
                          +   LS G +     ++  +L  D  K     +         H  
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG 311

Query: 141 RY 142
             
Sbjct: 312 NS 313

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  197 bits (502), Expect = 5e-60
 Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 18/235 (7%)

Query: 2   VVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y          S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIR 254

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMG-FDQ 172
           ++L+ +  KR+TI E  +HPW                +++   ++ E  K+      +  
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPV------DTQQAMVRRESVVNLENFKKQYVRRRWKL 308

Query: 173 NQLVESLRNRLQNEATVAYYLLLDNRFRVSSGYLGAEFQETMESGFNRLHPIEPA 227
           +  + SL N L        +L      R        E         +       +
Sbjct: 309 SFSIVSLCNHLTRSLMKKVHLRTSEDLRNCES--DTEENIARRKALHPRRRSSTS 361

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  194 bits (495), Expect = 2e-59
 Identities = 53/162 (32%), Positives = 79/162 (48%), Gaps = 9/162 (5%)

Query: 2   VVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  K     ++K+ DFGL++ + DG   K   G+P + APE+++ +  
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL 195

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        I    Y        H S  A+D I 
Sbjct: 196 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIR 254

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 155
           ++L+ +  KR+TI E  +HPW      +   V     +    
Sbjct: 255 KLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  194 bits (495), Expect = 2e-59
 Identities = 55/186 (29%), Positives = 88/186 (47%), Gaps = 20/186 (10%)

Query: 2   VVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           + H DLKPEN++L  +      +KI DFGL++ +  G+  K   G+P + APE+++ +  
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 194

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
            G E D+WS GVI Y LL G  PF  +        +    Y        + S  A+D I 
Sbjct: 195 -GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIR 253

Query: 114 RMLIVDPMKRITIPEIRQHPWFQ-----AHLPRYLAVPPPDTMQQ------AKKIDEEIL 162
           R+L+ DP KR+TI +  QHPW +       L R  +    +  ++      +       L
Sbjct: 254 RLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGSGGGL 313

Query: 163 KEVVKM 168
            ++ + 
Sbjct: 314 NDIFEA 319

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  196 bits (500), Expect = 2e-59
 Identities = 55/146 (37%), Positives = 77/146 (52%), Gaps = 12/146 (8%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 182 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 240

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPS----HLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P+     +S   + 
Sbjct: 241 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 300

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ 136
           LI  +L  +P +R+TI E   HPW  
Sbjct: 301 LIRNLLKTEPTQRMTITEFMNHPWIM 326

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  197 bits (502), Expect = 7e-59
 Identities = 65/154 (42%), Positives = 86/154 (55%), Gaps = 9/154 (5%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK    N++I DFGLS        +K   G+  Y APEV+ G  Y 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-Y- 204

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
             + DVWS GVILY LL G  PF+  N  ++ KK++ G YT        +S  A+DLI +
Sbjct: 205 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
           ML   P  RI+  +   H W Q +    ++V  P
Sbjct: 265 MLTYVPSMRISARDALDHEWIQTYTKEQISVDVP 298

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  196 bits (501), Expect = 1e-58
 Identities = 64/169 (37%), Positives = 88/169 (52%), Gaps = 16/169 (9%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPEN+LL+SK    ++KI DFGLS   +    +K   G+  Y APEV+ G  Y 
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y- 199

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
             + DVWS GVILY LL GT PF  +N  ++ K+++ G Y         +S  A+DLI +
Sbjct: 200 DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRK 259

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILK 163
           ML   P  RIT  +  +HPW Q +      +             E  + 
Sbjct: 260 MLTFHPSLRITATQCLEHPWIQKYSSETPTISD-------LPSLESAMT 301

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  191 bits (488), Expect = 2e-58
 Identities = 43/146 (29%), Positives = 72/146 (49%), Gaps = 7/146 (4%)

Query: 2   VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           + H D++PEN++  ++ +  +KI +FG +  ++ G   +    +P Y APEV    +   
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-S 181

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 115
              D+WS G ++Y LL G  PF  E    + + I    YT        +S  A D + R+
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPR 141
           L+ +   R+T  E  QHPW +  + R
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIER 267

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  191 bits (487), Expect = 4e-58
 Identities = 63/190 (33%), Positives = 93/190 (48%), Gaps = 18/190 (9%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +        L+T C +P Y APEV+  + Y 
Sbjct: 149 IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLGPEKY- 206

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPS----HLSPGARD 110
               D+WS GVI+Y LLCG  PF         P + ++I+ G Y  P+     +S  A+ 
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQ 266

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ-----AHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  DP +R+TI +   HPW          P + A    +      ++ EE+   +
Sbjct: 267 LIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSAL 326

Query: 166 VKMGFDQNQL 175
             M  D +Q+
Sbjct: 327 ATMRVDYDQV 336

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  191 bits (488), Expect = 9e-58
 Identities = 47/161 (29%), Positives = 82/161 (50%), Gaps = 7/161 (4%)

Query: 2   VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +VH D+KPEN++ ++K    VKI DFGL+  +     +K +  +  +AAPE++  +   G
Sbjct: 170 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 228

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 115
              D+W+ GV+ Y LL G  PF  E+     + +K   +         +SP A+D I  +
Sbjct: 229 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
           L  +P KR+T+ +  +HPW +       +  P     + ++
Sbjct: 289 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQ 329

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  191 bits (486), Expect = 1e-57
 Identities = 30/156 (19%), Positives = 58/156 (37%), Gaps = 17/156 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS-------- 53
           +VH  L+P +++LD +  V +  F     +RDG     S  S  +  PE+ +        
Sbjct: 227 LVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGAR-VVSSVSRGFEPPELEARRATISYH 283

Query: 54  --GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDL 111
              +       D W+ G+++Y + C  LP   +      +     I+    ++    R L
Sbjct: 284 RDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEW----IFRSCKNIPQPVRAL 339

Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 147
           +   L      R+   +  + P ++       A  P
Sbjct: 340 LEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAALP 375

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  194 bits (495), Expect = 1e-57
 Identities = 60/154 (38%), Positives = 84/154 (54%), Gaps = 9/154 (5%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRD+KPEN+LL++K    N+KI DFGLS+     + L+   G+  Y APEV+  K Y 
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKK-Y- 224

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
             + DVWSCGVI+Y LLCG  PF  +N  ++ KK++ G Y        ++S  A++LI  
Sbjct: 225 NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKL 284

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
           ML  D  KR T  E     W + +          
Sbjct: 285 MLTYDYNKRCTAEEALNSRWIKKYANNINKSDQK 318

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  189 bits (483), Expect = 3e-57
 Identities = 49/143 (34%), Positives = 74/143 (51%), Gaps = 7/143 (4%)

Query: 2   VVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+L  ++    +KI DFGL+   +    LK + G+P + APEV++   +  
Sbjct: 208 ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYD-FVS 266

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 115
              D+WS GVI Y LL G  PF  +N       I    + L       +S  A++ I ++
Sbjct: 267 FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326

Query: 116 LIVDPMKRITIPEIRQHPWFQAH 138
           LI +   RI+  E  +HPW   H
Sbjct: 327 LIKEKSWRISASEALKHPWLSDH 349

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  185 bits (473), Expect = 3e-56
 Identities = 59/173 (34%), Positives = 80/173 (46%), Gaps = 34/173 (19%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPE 50
           + HRDLKPEN+L +       VKI DF L + ++            L T CGS  Y APE
Sbjct: 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPE 191

Query: 51  VISGKLYA----GPEVDVWSCGVILYALLCGTLPFDDENIPN---------------LFK 91
           V+              D+WS GVILY LL G  PF      +               LF+
Sbjct: 192 VVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFE 251

Query: 92  KIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
            I+ G Y  P     H+S  A+DLI ++L+ D  +R++  ++ QHPW Q   P
Sbjct: 252 SIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  190 bits (485), Expect = 3e-56
 Identities = 63/160 (39%), Positives = 91/160 (56%), Gaps = 9/160 (5%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           +VHRDLKPENLLL+SK     +KI DFGLS +  +   +K   G+  Y APEV+  K Y 
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRKK-Y- 214

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPR 114
             + DVWS GVIL+ LL G  PF  +    + +K++ G YT  S    ++S GA+DLI +
Sbjct: 215 DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQ 274

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 154
           ML  D  +RI+  +  +HPW +    +  +     ++  A
Sbjct: 275 MLQFDSQRRISAQQALEHPWIKEMCSKKESGIELPSLANA 314

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  190 bits (484), Expect = 2e-55
 Identities = 51/173 (29%), Positives = 81/173 (46%), Gaps = 17/173 (9%)

Query: 2   VVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            VH DLKPEN++  +K    +K+ DFGL+  +     +K + G+  +AAPEV  GK   G
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 334

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 115
              D+WS GV+ Y LL G  PF  EN     + +K   + +       +S   +D I ++
Sbjct: 335 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKM 168
           L+ DP  R+TI +  +HPW              +   +  +I      ++   
Sbjct: 395 LLADPNTRMTIHQALEHPWLTPG----------NAPGRDSQIPSSRYTKIRDS 437

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  185 bits (471), Expect = 3e-55
 Identities = 38/181 (20%), Positives = 62/181 (34%), Gaps = 40/181 (22%)

Query: 1   MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
            +VHR++KP N++     D +   K+ DFG +  + D     +  G+  Y  P++    +
Sbjct: 132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAV 191

Query: 57  YA-------GPEVDVWSCGVILYALLCGTLPFDDENIP----NLFKKIKGGIYT------ 99
                    G  VD+WS GV  Y    G+LPF     P     +  KI  G  +      
Sbjct: 192 LRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGV 251

Query: 100 ---------------LPSHLSPGARD----LIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
                          +   LS G +     ++  +L  D  K     +         H  
Sbjct: 252 QKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM 311

Query: 141 R 141
            
Sbjct: 312 V 312

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  180 bits (459), Expect = 1e-54
 Identities = 53/144 (36%), Positives = 77/144 (53%), Gaps = 3/144 (2%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F KT  G+P Y +PE ++   Y  
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-N 194

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIV 118
            + D+WS G +LY L     PF   +   L  KI+ G +  +P   S    ++I RML +
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNL 254

Query: 119 DPMKRITIPEIRQHPWFQAHLPRY 142
               R ++ EI ++P    H   +
Sbjct: 255 KDYHRPSVEEILENPLILEHHHHH 278

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  182 bits (464), Expect = 1e-53
 Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 34/167 (20%)

Query: 2   VVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGHF-----LKTSCGS 43
           ++HRDLKP+N+L+ +                + I+DFGL   +  G       L    G+
Sbjct: 136 IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGT 195

Query: 44  PNYAAPEVISG------KLYAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGG 96
             + APE++        K      +D++S G + Y +L  G  PF D+        I  G
Sbjct: 196 SGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRG 253

Query: 97  IYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           I++L          L   A DLI +M+  DP+KR T  ++ +HP F 
Sbjct: 254 IFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFW 300

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  178 bits (453), Expect = 3e-53
 Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 22/173 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-------------TSCGSPNYAA 48
           ++HRDLK ENLLL ++  +K+ DFG +  +                    T   +P Y  
Sbjct: 159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRT 218

Query: 49  PEVIS--GKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL-- 104
           PE+I        G + D+W+ G ILY L     PF+D        +I  G Y++P H   
Sbjct: 219 PEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRIVNGKYSIPPHDTQ 274

Query: 105 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRY-LAVPPPDTMQQAKK 156
                 LI  ML V+P +R++I E+       A         P  + ++Q   
Sbjct: 275 YTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLEQNGG 327

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  174 bits (444), Expect = 8e-51
 Identities = 49/216 (22%), Positives = 87/216 (40%), Gaps = 21/216 (9%)

Query: 2   VVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVI 52
           +VHRDLKP N+L+            I+DFGL   +  G           G+  + APE++
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198

Query: 53  SGKLYA--GPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS---HLSP 106
           S          VD++S G + Y ++  G+ PF           +            H   
Sbjct: 199 SEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDV 258

Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVV 166
            AR+LI +M+ +DP KR +   + +HP+F +   +           + + +D  I+K++ 
Sbjct: 259 IARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQFFQDVSDRIEKESLDGPIVKQLE 318

Query: 167 KMGFD------QNQLVESLRNRLQNEATVAYYLLLD 196
           + G        +  +   L+  L+   T     + D
Sbjct: 319 RGGRAVVKMDWRENITVPLQTDLRKFRTYKGGSVRD 354

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  168 bits (427), Expect = 4e-49
 Identities = 37/145 (25%), Positives = 73/145 (50%), Gaps = 3/145 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+K +N+ L     V++ DFG++ ++       +   G+P Y +PE+   K Y   
Sbjct: 146 ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY-NN 204

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVD 119
           + D+W+ G +LY L      F+  ++ NL  KI  G +  +  H S   R L+ ++   +
Sbjct: 205 KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRN 264

Query: 120 PMKRITIPEIRQHPWFQAHLPRYLA 144
           P  R ++  I +  +    + ++L+
Sbjct: 265 PRDRPSVNSILEKGFIAKRIEKFLS 289

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  167 bits (424), Expect = 5e-49
 Identities = 38/152 (25%), Positives = 57/152 (37%), Gaps = 15/152 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----------LKTSCGSPNYAAPEV 51
             HRDLKP N+LL  +    + D G  N                       + +Y APE+
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 52  ISGKLYA--GPEVDVWSCGVILYALLCGTLPFDDENIP-NLFKKIKGGIYTLP--SHLSP 106
            S + +       DVWS G +LYA++ G  P+D      +          ++P     S 
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSS 274

Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAH 138
               L+  M+ VDP +R  IP +         
Sbjct: 275 ALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP 306

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} Length = 130

 Score =  160 bits (406), Expect = 8e-49
 Identities = 32/125 (25%), Positives = 57/125 (45%), Gaps = 4/125 (3%)

Query: 254 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNN--P 311
            KW LG++S++ P +IM EV +A++ L+  WK I  Y+++ R     +G    M      
Sbjct: 6   AKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQ 65

Query: 312 LHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAA 371
           + +  Y  D  ++   +  V+  + V  E           ++ LQ        F ++CAA
Sbjct: 66  VDAKSYLLDFKSL--TNDEVEQGDDVIMESLTPPPLSVSGVMPLQPTGHHTMEFFEMCAA 123

Query: 372 FLAQL 376
            + QL
Sbjct: 124 LIIQL 128

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  165 bits (419), Expect = 7e-48
 Identities = 28/145 (19%), Positives = 47/145 (32%), Gaps = 12/145 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGP 60
           +VH    P+NL +     + + D       + G     S     YA  E ++        
Sbjct: 215 LVHGHFTPDNLFIMPDGRLMLGDVSALW--KVGTRGPASSVPVTYAPREFLNASTATFTH 272

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN---------IPNLFKKIKGGIYTLPSHLSPGARDL 111
            ++ W  G+ +Y + C  LPF                         +   + L    + L
Sbjct: 273 ALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTL 332

Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQ 136
           I R L  D  +R+   E  + P F 
Sbjct: 333 IGRFLNFDRRRRLLPLEAMETPEFL 357

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  163 bits (415), Expect = 8e-48
 Identities = 46/144 (31%), Positives = 78/144 (54%), Gaps = 10/144 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYA 58
           ++HRDLKPEN+LL+   +++I DFG + ++          +  G+  Y +PE+++ K   
Sbjct: 151 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA- 209

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
               D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ ++L++
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 269

Query: 119 DPMKRITIP------EIRQHPWFQ 136
           D  KR+          ++ HP+F+
Sbjct: 270 DATKRLGCEEMEGYGPLKAHPFFE 293

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  161 bits (409), Expect = 4e-47
 Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 5/139 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKP N+ L     VKI DFGL   +++      S G+  Y +PE IS + Y G E
Sbjct: 143 LINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKE 201

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+++ G+IL  LL       + +    F  ++ GI  +        + L+ ++L   P 
Sbjct: 202 VDLYALGLILAELLHVCDTAFETS--KFFTDLRDGI--ISDIFDKKEKTLLQKLLSKKPE 257

Query: 122 KRITIPEIRQHPWFQAHLP 140
            R    EI +        P
Sbjct: 258 DRPNTSEILRTLTVWKKSP 276

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  158 bits (401), Expect = 7e-46
 Identities = 49/146 (33%), Positives = 66/146 (45%), Gaps = 33/146 (22%)

Query: 2   VVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG                     A E    K Y 
Sbjct: 138 IAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKETTGEK-Y- 175

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENI----PNLFKKIKGGIYTLPS----HLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P+     +S   + 
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 235

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ 136
           LI  +L  +P +R+TI E   HPW  
Sbjct: 236 LIRNLLKTEPTQRMTITEFMNHPWIM 261

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  160 bits (406), Expect = 1e-45
 Identities = 42/141 (29%), Positives = 71/141 (50%), Gaps = 6/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG-- 59
           ++HRD+KP+N+LLD   +V I DF ++ ++     + T  G+  Y APE+ S +  AG  
Sbjct: 136 IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYS 195

Query: 60  PEVDVWSCGVILYALLCGTLPF---DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRML 116
             VD WS GV  Y LL G  P+      +   +    +  + T PS  S     L+ ++L
Sbjct: 196 FAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLL 255

Query: 117 IVDPMKRI-TIPEIRQHPWFQ 136
             +P +R   + +++  P+  
Sbjct: 256 EPNPDQRFSQLSDVQNFPYMN 276

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  157 bits (398), Expect = 2e-44
 Identities = 30/161 (18%), Positives = 57/161 (35%), Gaps = 15/161 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPNYAAPEVISG--- 54
           +VH  L+P +++LD +  V +  F     +RDG    +        P   A  ++     
Sbjct: 232 LVHTYLRPVDIVLDQRGGVFLTGFEHL--VRDGASAVSPIGRGFAPPETTAERMLPFGQH 289

Query: 55  -KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIP 113
                    D W+ G+ +Y + C  LP  D+      +     I+    ++    R L+ 
Sbjct: 290 HPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEW----IFRSCKNIPQPVRALLE 345

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 154
             L      R+   +  + P ++  L   L+   P      
Sbjct: 346 GFLRYPKEDRLLPLQAMETPEYE-QLRTELSAALPLYQTDG 385

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  154 bits (392), Expect = 2e-44
 Identities = 40/136 (29%), Positives = 59/136 (43%), Gaps = 5/136 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +VH D+KP N+ L  +   K+ DFGL   +      +   G P Y APE++ G  Y G  
Sbjct: 178 LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS-Y-GTA 235

Query: 62  VDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            DV+S G+ +  + C   LP   E    L +          + LS   R ++  ML  DP
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPP--EFTAGLSSELRSVLVMMLEPDP 293

Query: 121 MKRITIPEIRQHPWFQ 136
             R T   +   P  +
Sbjct: 294 KLRATAEALLALPVLR 309

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  155 bits (394), Expect = 3e-44
 Identities = 51/140 (36%), Positives = 76/140 (54%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +   R      T CG+P   APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILSKGY-NKA 218

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 122 KRI-----TIPEIRQHPWFQ 136
           KR       + +I+ H WF 
Sbjct: 279 KRFGNLKNGVNDIKNHKWFA 298

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  153 bits (390), Expect = 5e-44
 Identities = 51/140 (36%), Positives = 80/140 (57%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPEN+LLD   ++KI DFG +  + D     T CG+P+Y APEV+S K Y    
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPY-NKS 183

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           +D WS G+++Y +L G  PF D N    ++KI       P   +   +DL+ R++  D  
Sbjct: 184 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 243

Query: 122 KRI-----TIPEIRQHPWFQ 136
           +R+        +++ HPWF+
Sbjct: 244 QRLGNLQNGTEDVKNHPWFK 263

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  153 bits (390), Expect = 6e-44
 Identities = 50/141 (35%), Positives = 78/141 (55%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN++L+ + +VK+ DFGL    + DG    T CG+  Y APE++    +   
Sbjct: 142 IIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NR 200

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD WS G ++Y +L G  PF  EN      KI      LP +L+  ARDL+ ++L  + 
Sbjct: 201 AVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNA 260

Query: 121 MKRI-----TIPEIRQHPWFQ 136
             R+        E++ HP+F+
Sbjct: 261 ASRLGAGPGDAGEVQAHPFFR 281

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  153 bits (388), Expect = 1e-43
 Identities = 47/141 (33%), Positives = 78/141 (55%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD + ++K+ DFGLS   +       + CG+  Y APEV++ + +   
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQ 205

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             D WS GV+++ +L GTLPF  ++       I      +P  LSP A+ L+  +   +P
Sbjct: 206 SADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265

Query: 121 MKRI-----TIPEIRQHPWFQ 136
             R+      + EI++H +F 
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFS 286

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  152 bits (387), Expect = 3e-43
 Identities = 55/137 (40%), Positives = 81/137 (59%), Gaps = 3/137 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +V+RDLK +N+LLD   ++KIADFG+    M       T CG+P+Y APE++ G+ Y   
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NH 197

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD WS GV+LY +L G  PF  ++   LF  I+      P  L   A+DL+ ++ + +P
Sbjct: 198 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 257

Query: 121 MKRI-TIPEIRQHPWFQ 136
            KR+    +IRQHP F+
Sbjct: 258 EKRLGVRGDIRQHPLFR 274

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  152 bits (387), Expect = 5e-43
 Identities = 50/140 (35%), Positives = 73/140 (52%), Gaps = 6/140 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +V+RDLKPEN+LLDS+ ++ + DFGL    +       T CG+P Y APEV+  + Y   
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DR 218

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  G +LY +L G  PF   N   ++  I      L  +++  AR L+  +L  D 
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDR 278

Query: 121 MKRITIP----EIRQHPWFQ 136
            KR+       EI+ H +F 
Sbjct: 279 TKRLGAKDDFMEIKSHVFFS 298

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  150 bits (381), Expect = 1e-42
 Identities = 57/141 (40%), Positives = 82/141 (58%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 121 MKRI-----TIPEIRQHPWFQ 136
            +R+        E+ +H +F 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFL 265

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  148 bits (377), Expect = 8e-42
 Identities = 52/142 (36%), Positives = 82/142 (57%), Gaps = 8/142 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLD + + K+ADFG+    + +G    T CG+P+Y APE++   LY GP
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GP 203

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +LCG  PF+ EN  +LF+ I       P+ L   A  ++   +  +P
Sbjct: 204 AVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNP 263

Query: 121 MKRI------TIPEIRQHPWFQ 136
             R+          I +HP+F+
Sbjct: 264 TMRLGSLTQGGEHAILRHPFFK 285

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  148 bits (376), Expect = 1e-41
 Identities = 52/141 (36%), Positives = 84/141 (59%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N++LDS+ ++KIADFG+    + DG   KT CG+P+Y APE+I+ + Y G 
Sbjct: 142 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GK 200

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++   P
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 260

Query: 121 MKRI-----TIPEIRQHPWFQ 136
            KR+        +I++H +F+
Sbjct: 261 GKRLGCGPEGERDIKEHAFFR 281

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  148 bits (375), Expect = 2e-41
 Identities = 51/147 (34%), Positives = 79/147 (53%), Gaps = 12/147 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS--NIMRDGHFLKTSCGSPNYAAPEVISGKLYA- 58
           +++RD+K EN+LLDS  +V + DFGLS   +  +       CG+  Y AP+++ G     
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 239

Query: 59  GPEVDVWSCGVILYALLCGTLPF----DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
              VD WS GV++Y LL G  PF    +  +   + ++I       P  +S  A+DLI R
Sbjct: 240 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 299

Query: 115 MLIVDPMKRI-----TIPEIRQHPWFQ 136
           +L+ DP KR+        EI++H +FQ
Sbjct: 300 LLMKDPKKRLGCGPRDADEIKEHLFFQ 326

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  149 bits (378), Expect = 3e-41
 Identities = 59/141 (41%), Positives = 82/141 (58%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RDLK ENL+LD   ++KI DFGL    ++DG  +KT CG+P Y APEV+    Y G 
Sbjct: 270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GR 328

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  L P A+ L+  +L  DP
Sbjct: 329 AVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDP 388

Query: 121 MKRI-----TIPEIRQHPWFQ 136
            +R+        EI QH +F 
Sbjct: 389 KQRLGGGSEDAKEIMQHRFFA 409

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  145 bits (367), Expect = 7e-41
 Identities = 40/150 (26%), Positives = 63/150 (42%), Gaps = 19/150 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-------------TSCGSPNYAA 48
           ++HRDLKP N+       VK+ DFGL   M      +                G+  Y +
Sbjct: 139 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMS 198

Query: 49  PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN-LFKKIKGGIY-TLPSHLSP 106
           PE I G  Y   +VD++S G+IL+ LL    PF  +         ++   +  L +   P
Sbjct: 199 PEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYP 254

Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
               ++  ML   PM+R     I ++  F+
Sbjct: 255 CEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  142 bits (360), Expect = 1e-39
 Identities = 45/138 (32%), Positives = 65/138 (47%), Gaps = 6/138 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+KP N+ + +   VK+ D GL            +  G+P Y +PE I    Y   
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NF 215

Query: 61  EVDVWSCGVILYALLCGTLPF--DDENIPNLFKKIKGGIYT-LPS-HLSPGARDLIPRML 116
           + D+WS G +LY +     PF  D  N+ +L KKI+   Y  LPS H S   R L+   +
Sbjct: 216 KSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 275

Query: 117 IVDPMKRITIPEIRQHPW 134
             DP KR  +  +     
Sbjct: 276 NPDPEKRPDVTYVYDVAK 293

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  147 bits (373), Expect = 2e-39
 Identities = 52/141 (36%), Positives = 84/141 (59%), Gaps = 7/141 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N++LDS+ ++KIADFG+    + DG   KT CG+P+Y APE+I+ + Y G 
Sbjct: 463 IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GK 521

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W+ GV+LY +L G  PF+ E+   LF+ I       P  +S  A  +   ++   P
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 581

Query: 121 MKRI-----TIPEIRQHPWFQ 136
            KR+        +I++H +F+
Sbjct: 582 GKRLGCGPEGERDIKEHAFFR 602

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  144 bits (364), Expect = 2e-39
 Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 13/147 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA- 58
            +HRD+KP+N+LLD   ++K+ADFG    M     ++     G+P+Y +PEV+  +    
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----LSPGARDLI 112
             G E D WS GV LY +L G  PF  +++   + KI     +L       +S  A++LI
Sbjct: 249 YYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLI 308

Query: 113 PRMLIVDPMKRIT---IPEIRQHPWFQ 136
               + D   R+    + EI++H +F+
Sbjct: 309 -CAFLTDREVRLGRNGVEEIKRHLFFK 334

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  146 bits (370), Expect = 3e-39
 Identities = 46/144 (31%), Positives = 76/144 (52%), Gaps = 10/144 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +V+RDLKPEN+LLD   +++I+D GL+  + +G  +K   G+  Y APEV+  + Y    
Sbjct: 307 IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFS 365

Query: 62  VDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
            D W+ G +LY ++ G  PF           + + +K          SP AR L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425

Query: 118 VDPMKRI-----TIPEIRQHPWFQ 136
            DP +R+     +  E+++HP F+
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFK 449

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  145 bits (368), Expect = 3e-39
 Identities = 47/145 (32%), Positives = 74/145 (51%), Gaps = 11/145 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLKPEN+LLD   NV+I+D GL+  +       K   G+P + APE++ G+ Y   
Sbjct: 310 IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DF 368

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPN----LFKKIKGGIYTLPSHLSPGARDLIPRML 116
            VD ++ GV LY ++    PF           L +++     T P   SP ++D    +L
Sbjct: 369 SVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALL 428

Query: 117 IVDPMKRI-----TIPEIRQHPWFQ 136
             DP KR+     +   +R HP F+
Sbjct: 429 QKDPEKRLGFRDGSCDGLRTHPLFR 453

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  141 bits (357), Expect = 3e-39
 Identities = 39/150 (26%), Positives = 64/150 (42%), Gaps = 19/150 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-------------SCGSPNYAA 48
           ++HRDLKP N+       VK+ DFGL   M      +T               G+  Y +
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 49  PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIYT-LPSHLSP 106
           PE I G  Y   +VD++S G+IL+ LL     F  +     +   ++   +  L +   P
Sbjct: 245 PEQIHGNNY-SHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQKYP 300

Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
               ++  ML   P +R    +I ++  F+
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  141 bits (358), Expect = 5e-39
 Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 17/151 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNI-MRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G 
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GF 189

Query: 61  EVDVWSCGVILYALLCGTLPF---------DDENIPNLFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PF         D      LF+ I      +P  LS  A  +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 249

Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQ 136
           +   L  DP +R+         +I+ HP+F+
Sbjct: 250 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  142 bits (361), Expect = 8e-39
 Identities = 48/149 (32%), Positives = 79/149 (53%), Gaps = 15/149 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA- 58
            VHRD+KP+N+L+D   ++++ADFG    + +   +++S   G+P+Y +PE++       
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGK 255

Query: 59  ---GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGARD 110
              GPE D WS GV +Y +L G  PF  E++   + KI             + +S  A+D
Sbjct: 256 GRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKD 315

Query: 111 LIPRMLIVDPMKRIT---IPEIRQHPWFQ 136
           LI R LI     R+    I + ++HP+F 
Sbjct: 316 LI-RRLICSREHRLGQNGIEDFKKHPFFS 343

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  141 bits (356), Expect = 2e-38
 Identities = 45/151 (29%), Positives = 72/151 (47%), Gaps = 17/151 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA- 58
            VHRD+KP+N+LLD   ++++ADFG    +R    +++    G+P+Y +PE++       
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGP 242

Query: 59  -----GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP-----SHLSPGA 108
                GPE D W+ GV  Y +  G  PF  ++    + KI      L        +   A
Sbjct: 243 GTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEA 302

Query: 109 RDLIPRMLIVDPMKRIT---IPEIRQHPWFQ 136
           RD I + L+  P  R+      + R HP+F 
Sbjct: 303 RDFI-QRLLCPPETRLGRGGAGDFRTHPFFF 332

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  140 bits (356), Expect = 2e-38
 Identities = 50/151 (33%), Positives = 82/151 (54%), Gaps = 17/151 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +++RDLK +N+LLDS+ ++K+ D+G+    +R G    T CG+PNY APE++ G+ Y G 
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GF 232

Query: 61  EVDVWSCGVILYALLCGTLPF---------DDENIPNLFKKIKGGIYTLPSHLSPGARDL 111
            VD W+ GV+++ ++ G  PF         D      LF+ I      +P  LS  A  +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 292

Query: 112 IPRMLIVDPMKRI------TIPEIRQHPWFQ 136
           +   L  DP +R+         +I+ HP+F+
Sbjct: 293 LKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  139 bits (351), Expect = 2e-36
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 9/143 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VV+RDLKP N+LLD   +V+I+D GL+           S G+  Y APEV+   +     
Sbjct: 313 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSS 371

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
            D +S G +L+ LL G  PF      +   + +        LP   SP  R L+  +L  
Sbjct: 372 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 431

Query: 119 DPMKRI-----TIPEIRQHPWFQ 136
           D  +R+        E+++ P+F+
Sbjct: 432 DVNRRLGCLGRGAQEVKESPFFR 454

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* Length = 106

 Score =  122 bits (307), Expect = 2e-34
 Identities = 28/134 (20%), Positives = 50/134 (37%), Gaps = 40/134 (29%)

Query: 251 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNN 310
               KW LG++S++ P +IM EV +A+++L+  WK +  Y ++ R    ++         
Sbjct: 3   HMGAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTF------ 56

Query: 311 PLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ--------GPQ 362
                                      K  +QLY+     YLLD + +            
Sbjct: 57  --------------------------SKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHT 90

Query: 363 FLFLDLCAAFLAQL 376
             F ++CA  +  L
Sbjct: 91  IEFFEMCANLIKIL 104

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  120 bits (303), Expect = 8e-32
 Identities = 28/155 (18%), Positives = 56/155 (36%), Gaps = 26/155 (16%)

Query: 2   VVHRDLKPENLLLD-------------------SKWNVKIADFGLSNIMRDGHFLKTSCG 42
           +VH D+KP N+ +                    +K   KI D G    +      +   G
Sbjct: 136 LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS---PQVEEG 192

Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLP 101
              + A EV+       P+ D+++  + +           + +    + +I+ G    +P
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIP 249

Query: 102 SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             LS    +L+  M+  DP +R +   + +H    
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  116 bits (292), Expect = 5e-30
 Identities = 46/135 (34%), Positives = 67/135 (49%), Gaps = 13/135 (9%)

Query: 2   VVHRDLKPENLLLDSKWNV-KIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAG 59
           ++HRDLKP NLLL +   V KI DFG +    D     T+  GS  + APEV  G  Y  
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTA---CDIQTHMTNNKGSAAWMAPEVFEGSNY-S 181

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGARDLIPR 114
            + DV+S G+IL+ ++    PFD+  I     +I   ++      L  +L      L+ R
Sbjct: 182 EKCDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTR 239

Query: 115 MLIVDPMKRITIPEI 129
               DP +R ++ EI
Sbjct: 240 CWSKDPSQRPSMEEI 254

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} PDB: 3tdh_A* 3te5_A* 2qlv_A Length = 179

 Score =  112 bits (282), Expect = 5e-30
 Identities = 34/195 (17%), Positives = 66/195 (33%), Gaps = 50/195 (25%)

Query: 208 AEFQETMESGFNRLHPIEPAVSPVAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPR 267
            + +++  S      P     + +A  +P       +  +     + +W  G++SR++P 
Sbjct: 6   YKEEDSTVSILPTSLPQIHRANMLAQGSPAASKISPLVTKKS---KTRWHFGIRSRSYPL 62

Query: 268 EIMTEVLKALQELNVGWKKIGH---YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAI 324
           ++M E+  AL+ L   W K      + +K RW   I         N              
Sbjct: 63  DVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTN---TNE------------- 106

Query: 325 IENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ---------------------F 363
                  K P+++K  +QL++     YL+D +                           +
Sbjct: 107 -------KIPDLMKMVIQLFQIETNNYLVDFKFDGWESSYGDDTTVSNISEDEMSTFSAY 159

Query: 364 LFLDLCAAFLAQLRV 378
            FL L    + +L V
Sbjct: 160 PFLHLTTKLIMELAV 174

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  115 bits (290), Expect = 1e-29
 Identities = 42/136 (30%), Positives = 66/136 (48%), Gaps = 12/136 (8%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAG 59
            +VHR+LK  NLL+D K+ VK+ DFGLS +         S  G+P + APEV+  +    
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-N 217

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY------TLPSHLSPGARDLIP 113
            + DV+S GVIL+ L     P+   N+     ++   +        +P +L+P    +I 
Sbjct: 218 EKSDVYSFGVILWELATLQQPW--GNLNPA--QVVAAVGFKCKRLEIPRNLNPQVAAIIE 273

Query: 114 RMLIVDPMKRITIPEI 129
                +P KR +   I
Sbjct: 274 GCWTNEPWKRPSFATI 289

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* Length = 173

 Score =  111 bits (278), Expect = 1e-29
 Identities = 26/125 (20%), Positives = 47/125 (37%), Gaps = 33/125 (26%)

Query: 239 MDYQGMGLRGQLPYER-KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWI 297
           M +      G +P     W LG++S++ P +IM EV +A+++L+  WK +  Y ++ R  
Sbjct: 1   MSHHHHHHSGLVPRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRK 60

Query: 298 PGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQR 357
             ++                                    K  +QLY+     YLLD + 
Sbjct: 61  NPVTSTF--------------------------------SKMSLQLYQVDSRTYLLDFRS 88

Query: 358 VQGPQ 362
           +    
Sbjct: 89  IDDEI 93

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  114 bits (288), Expect = 1e-29
 Identities = 35/139 (25%), Positives = 71/139 (51%), Gaps = 7/139 (5%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLK +N+ +     +VKI D GL+ + R   F K   G+P + APE+   K     
Sbjct: 152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK--YDE 208

Query: 61  EVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLI 117
            VDV++ G+ +  +     P+ + +N   +++++  G+   +      P  +++I   + 
Sbjct: 209 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 268

Query: 118 VDPMKRITIPEIRQHPWFQ 136
            +  +R +I ++  H +FQ
Sbjct: 269 QNKDERYSIKDLLNHAFFQ 287

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  114 bits (288), Expect = 3e-29
 Identities = 38/155 (24%), Positives = 64/155 (41%), Gaps = 11/155 (7%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSC------GSPNYAAPEVISG 54
           ++H D+K +N+LL S      + DFG +  ++     K+        G+  + APEV+ G
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGG--IYTLPSHLSPGARDL 111
           K     +VD+WS   ++  +L G  P+      P   K       I  +P   +P     
Sbjct: 231 KPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQA 289

Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVP 146
           I   L  +P+ R +  E+R+           L  P
Sbjct: 290 IQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSP 324

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  115 bits (289), Expect = 3e-29
 Identities = 27/160 (16%), Positives = 56/160 (35%), Gaps = 24/160 (15%)

Query: 2   VVHRDLKPENLLL-----------DSKWNVKIADFGLS---NIMRDGHFLKTSCGSPNYA 47
           ++H D+KP+N +L           D    + + D G S    +   G      C +  + 
Sbjct: 193 IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQ 252

Query: 48  APEVISGKLYAGPEVDVWSCGVILYALLCGTLPF-DDENIPNLFKKIKGGIYTLPSHLSP 106
             E++S K +   ++D +     +Y +L GT     +E      + +   +  L      
Sbjct: 253 CVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRRLPHLDM---- 307

Query: 107 GARDLIPRMLIVDPMKRITIPEIRQHP---WFQAHLPRYL 143
              +    ML +     +   ++ +      FQ H    +
Sbjct: 308 -WNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (282), Expect = 1e-28
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 6/141 (4%)

Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLY-A 58
           +VHRD+K +N+L+++    +KI+DFG S  +   +    +  G+  Y APE+I       
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGY 202

Query: 59  GPEVDVWSCGVILYALLCGTLPFDD--ENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 115
           G   D+WS G  +  +  G  PF +  E    +FK     ++  +P  +S  A+  I + 
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKC 262

Query: 116 LIVDPMKRITIPEIRQHPWFQ 136
              DP KR    ++    + +
Sbjct: 263 FEPDPDKRACANDLLVDEFLK 283

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* Length = 157

 Score =  105 bits (263), Expect = 1e-27
 Identities = 23/109 (21%), Positives = 42/109 (38%), Gaps = 32/109 (29%)

Query: 254 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLH 313
             W LG++S++ P +IM EV +A+++L+  WK +  Y ++ R    ++            
Sbjct: 3   MAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTF--------- 53

Query: 314 SNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ 362
                                   K  +QLY+     YLLD + +    
Sbjct: 54  -----------------------SKMSLQLYQVDSRTYLLDFRSIDDEI 79

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  106 bits (268), Expect = 6e-27
 Identities = 30/133 (22%), Positives = 54/133 (40%), Gaps = 8/133 (6%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++    L   ++++D     +I+   +    +          +P + APE +  K     
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTN 188

Query: 61  E--VDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 116
               D+WS  V+L+ L+   +PF D  N+    K    G+  T+P  +SP    L+   +
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICM 248

Query: 117 IVDPMKRITIPEI 129
             DP KR     I
Sbjct: 249 NEDPAKRPKFDMI 261

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* Length = 137

 Score =  101 bits (253), Expect = 2e-26
 Identities = 29/142 (20%), Positives = 43/142 (30%), Gaps = 37/142 (26%)

Query: 254 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLH 313
            KW  G++ R    EI+  V +ALQ     +      N K R                  
Sbjct: 11  NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDM--------------- 55

Query: 314 SNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ-------------- 359
              Y       I +            E+QLY+     ++LD++                 
Sbjct: 56  ---YTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYSHPERTADH 112

Query: 360 -----GPQFLFLDLCAAFLAQL 376
                   F FLDLCA  + +L
Sbjct: 113 GMDDLKSSFPFLDLCAMLVCKL 134

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  106 bits (266), Expect = 2e-26
 Identities = 46/173 (26%), Positives = 62/173 (35%), Gaps = 50/173 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           +VHRDLKPEN+L+ S   VK+ADFGL+   R                       Y APEV
Sbjct: 141 IVHRDLKPENILVTSGGTVKLADFGLA---R-------IYSYQMALTPVVVTLWYRAPEV 190

Query: 52  ISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GIYT 99
           +    Y    VD+WS G I   +         + E    L K   + G           +
Sbjct: 191 LLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSE-ADQLGKIFDLIGLPPEDDWPRDVS 248

Query: 100 LP----------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           LP                  +      L+  ML  +P KRI+     QH +  
Sbjct: 249 LPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLH 301

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  105 bits (263), Expect = 4e-26
 Identities = 40/144 (27%), Positives = 62/144 (43%), Gaps = 15/144 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLK  N+ L     VKI DFGL+         H  +   GS  + APEVI  +   
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNL--------FKKIKGGIYTLPSHLSPGA 108
               + DV++ G++LY L+ G LP+   NI N            +   +  + S+     
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 109 RDLIPRMLIVDPMKRITIPEIRQH 132
           + L+   L     +R + P I   
Sbjct: 259 KRLMAECLKKKRDERPSFPRILAE 282

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  105 bits (264), Expect = 4e-26
 Identities = 53/177 (29%), Positives = 78/177 (44%), Gaps = 54/177 (30%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           V+HRDLKP+NLL++ +  +KIADFGL+   R       + G P            Y AP+
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLA---R-------AFGIPVRKYTHEIVTLWYRAPD 170

Query: 51  VISG-KLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GI 97
           V+ G K Y    +D+WS G I   ++ GT   P   E    L +  +I G         +
Sbjct: 171 VLMGSKKY-STTIDIWSVGCIFAEMVNGTPLFPGVSE-ADQLMRIFRILGTPNSKNWPNV 228

Query: 98  YTLP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             LP                    L     DL+ +ML +DP +RIT  +  +H +F+
Sbjct: 229 TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  105 bits (265), Expect = 4e-26
 Identities = 48/187 (25%), Positives = 67/187 (35%), Gaps = 51/187 (27%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN----------YAAPEV 51
           VVHRDLKP+N+L+ S   +K+ADFGL+   R                       Y APEV
Sbjct: 141 VVHRDLKPQNILVTSSGQIKLADFGLA---R-------IYSFQMALTSVVVTLWYRAPEV 190

Query: 52  ISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GIYT 99
           +    Y    VD+WS G I   +           + +  L K   + G            
Sbjct: 191 LLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSD-VDQLGKILDVIGLPGEEDWPRDVA 248

Query: 100 LPSH----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL 143
           LP                  +    +DL+ + L  +P KRI+      HP+FQ  L R  
Sbjct: 249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD-LERCK 307

Query: 144 AVPPPDT 150
                  
Sbjct: 308 ENLDSHL 314

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  104 bits (262), Expect = 1e-25
 Identities = 46/203 (22%), Positives = 76/203 (37%), Gaps = 59/203 (29%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           V+HRDLKP+NLL++ +  +K+ADFGL+   R       +   P            Y  P+
Sbjct: 121 VLHRDLKPQNLLINERGELKLADFGLA---R-------AKSIPTKTYDNEVVTLWYRPPD 170

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GIY 98
           ++ G      ++D+W  G I Y +  G    P        L    +I G        GI 
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTV-EEQLHFIFRILGTPTEETWPGIL 229

Query: 99  TLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF---- 135
           +                       L     DL+ ++L  +   RI+  +  +HP+F    
Sbjct: 230 SNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289

Query: 136 --QAHLPRYLAVPPPDTMQQAKK 156
                LP   ++     +Q  K+
Sbjct: 290 ERIHKLPDTTSIFALKEIQLQKE 312

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  103 bits (260), Expect = 1e-25
 Identities = 45/143 (31%), Positives = 70/143 (48%), Gaps = 6/143 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 60
           V+HRD+KP N+L+++   VK+ DFG+S  + D        G   Y APE I+ +L     
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY 190

Query: 61  --EVDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPS-HLSPGARDLIPRM 115
             + D+WS G+ +  L     P+D    P   L + ++     LP+   S    D   + 
Sbjct: 191 SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQC 250

Query: 116 LIVDPMKRITIPEIRQHPWFQAH 138
           L  +  +R T PE+ QHP+F  H
Sbjct: 251 LKKNSKERPTYPELMQHPFFTLH 273

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  104 bits (261), Expect = 1e-25
 Identities = 51/182 (28%), Positives = 73/182 (40%), Gaps = 53/182 (29%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLKP+NLL++S   +K+ADFGL+   R       + G P            Y AP+
Sbjct: 140 ILHRDLKPQNLLINSDGALKLADFGLA---R-------AFGIPVRSYTHEVVTLWYRAPD 189

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GIY 98
           V+ G       VD+WS G I   ++ G    P   +    L K   I G         + 
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTD-DDQLPKIFSILGTPNPREWPQVQ 248

Query: 99  TLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 139
            LP                           DL+  ML  DP KRI+  +   HP+F+   
Sbjct: 249 ELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

Query: 140 PR 141
           P+
Sbjct: 309 PQ 310

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  104 bits (261), Expect = 1e-25
 Identities = 44/191 (23%), Positives = 72/191 (37%), Gaps = 55/191 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
            +HRD+KPEN+L+     +K+ DFG +   R           P+           Y +PE
Sbjct: 123 CIHRDVKPENILITKHSVIKLCDFGFA---R-------LLTGPSDYYDDEVATRWYRSPE 172

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK----------KIKGGIY 98
           ++ G    GP VDVW+ G +   LL G    P   + +  L+           + +    
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSD-VDQLYLIRKTLGDLIPRHQQVFS 231

Query: 99  TLP--------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA- 137
           T                       ++S  A  L+   L +DP +R+T  ++  HP+F+  
Sbjct: 232 TNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENI 291

Query: 138 HLPRYLAVPPP 148
                LA    
Sbjct: 292 REIEDLAKEHD 302

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  102 bits (258), Expect = 2e-25
 Identities = 49/189 (25%), Positives = 75/189 (39%), Gaps = 60/189 (31%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           V+HRDLKP+NLL++    +K+A+FGL+   R       + G P            Y  P+
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLA---R-------AFGIPVRCYSAEVVTLWYRPPD 171

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGTLPF---DDENIPNLFK--KIKG--------GI 97
           V+ G       +D+WS G I   L     P    +D     L +  ++ G         +
Sbjct: 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDV-DDQLKRIFRLLGTPTEEQWPSM 230

Query: 98  YTLP------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL 139
             LP                    L+   RDL+  +L  +P++RI+  E  QHP+F    
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS--- 287

Query: 140 PRYLAVPPP 148
                  PP
Sbjct: 288 ----DFCPP 292

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  103 bits (259), Expect = 4e-25
 Identities = 46/178 (25%), Positives = 68/178 (38%), Gaps = 54/178 (30%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRD+KPEN+L+     VK+ DFG +   R       +  +P            Y APE
Sbjct: 145 IIHRDIKPENILVSQSGVVKLCDFGFA---R-------TLAAPGEVYDDEVATRWYRAPE 194

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GIY 98
           ++ G +  G  VDVW+ G ++  +  G    P D + I  L+      G           
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD-IDQLYHIMMCLGNLIPRHQELFN 253

Query: 99  TLP--------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
             P                      LS    DL  + L +DP KR    E+  H +FQ
Sbjct: 254 KNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQ 311

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  102 bits (255), Expect = 5e-25
 Identities = 43/143 (30%), Positives = 61/143 (42%), Gaps = 16/143 (11%)

Query: 2   VVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG-- 54
           +VHRDL+  N+ L S         K+ADFGLS        +    G+  + APE I    
Sbjct: 145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEE 202

Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-----TLPSHLSPGAR 109
           + Y   + D +S  +ILY +L G  PFD+ +     K I          T+P    P  R
Sbjct: 203 ESY-TEKADTYSFAMILYTILTGEGPFDEYS-YGKIKFINMIREEGLRPTIPEDCPPRLR 260

Query: 110 DLIPRMLIVDPMKRITIPEIRQH 132
           ++I      DP KR     I + 
Sbjct: 261 NVIELCWSGDPKKRPHFSYIVKE 283

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  103 bits (258), Expect = 6e-25
 Identities = 53/176 (30%), Positives = 76/176 (43%), Gaps = 53/176 (30%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLKP NLLLD    +K+ADFGL+           S GSPN           Y APE
Sbjct: 133 ILHRDLKPNNLLLDENGVLKLADFGLA----------KSFGSPNRAYTHQVVTRWYRAPE 182

Query: 51  VISG-KLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GI 97
           ++ G ++Y G  VD+W+ G IL  LL     LP D + +  L +  +  G         +
Sbjct: 183 LLFGARMY-GVGVDMWAVGCILAELLLRVPFLPGDSD-LDQLTRIFETLGTPTEEQWPDM 240

Query: 98  YTLP-----------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
            +LP                 S       DLI  + + +P  RIT  +  +  +F 
Sbjct: 241 CSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS 296

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  101 bits (254), Expect = 1e-24
 Identities = 33/144 (22%), Positives = 56/144 (38%), Gaps = 17/144 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM------RDGHFLKTSCGSPNYAAPEVISGK 55
           ++H+DLK +N+  D    V I DFGL +I       R    L+   G   + APE+I   
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 56  LYAGPE--------VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLS 105
                E         DV++ G I Y L     PF  +    +  ++  G+        + 
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMG 269

Query: 106 PGARDLIPRMLIVDPMKRITIPEI 129
               D++      +  +R T  ++
Sbjct: 270 KEISDILLFCWAFEQEERPTFTKL 293

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  100 bits (252), Expect = 1e-24
 Identities = 39/141 (27%), Positives = 61/141 (43%), Gaps = 12/141 (8%)

Query: 2   VVHRDLKPENLLLDSK--------WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS 53
           ++HRDLK  N+L+  K          +KI DFGL+          ++ G+  + APEVI 
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIR 187

Query: 54  GKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIY-TLPSHLSPGARDL 111
             ++     DVWS GV+L+ LL G +PF   + +   +      +   +PS        L
Sbjct: 188 ASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKL 246

Query: 112 IPRMLIVDPMKRITIPEIRQH 132
           +      DP  R +   I   
Sbjct: 247 MEDCWNPDPHSRPSFTNILDQ 267

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  101 bits (254), Expect = 3e-24
 Identities = 54/209 (25%), Positives = 84/209 (40%), Gaps = 47/209 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 148 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KEN 206

Query: 62  VDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGIYTLP- 101
           VD+WS G I+  ++ G + F                     E +  L   ++  +   P 
Sbjct: 207 VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPK 266

Query: 102 ----------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                                    +  ARDL+ +ML++D  KRI++ E  QHP+    +
Sbjct: 267 YAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY 326

Query: 139 LPRYLAVPPPDTMQQA---KKIDEEILKE 164
            P     PPP    +    ++   E  KE
Sbjct: 327 DPSEAEAPPPKIPDKQLDEREHTIEEWKE 355

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 99.7 bits (249), Expect = 6e-24
 Identities = 44/145 (30%), Positives = 67/145 (46%), Gaps = 8/145 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KP N+LLD +  +K+ DFG+S  + D      S G   Y APE I       P+
Sbjct: 146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPD 205

Query: 62  ----VDVWSCGVILYALLCGTLPFDDENIP--NLFKKIKGGIYTLPSHL--SPGARDLIP 113
                DVWS G+ L  L  G  P+ +       L K ++     LP H+  S   +  + 
Sbjct: 206 YDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVK 265

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAH 138
             L  D  KR    ++ +H + + +
Sbjct: 266 DCLTKDHRKRPKYNKLLEHSFIKRY 290

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  101 bits (253), Expect = 7e-24
 Identities = 53/209 (25%), Positives = 85/209 (40%), Gaps = 47/209 (22%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G  Y    
Sbjct: 185 IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KEN 243

Query: 62  VDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGGIYTLP- 101
           VD+WS G I+  ++   + F                     E +  L   ++  +   P 
Sbjct: 244 VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPK 303

Query: 102 ----------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-H 138
                                    +  ARDL+ +ML++DP KRI++ +  QHP+    +
Sbjct: 304 YAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363

Query: 139 LPRYLAVPPPDTMQQA---KKIDEEILKE 164
            P  +  PPP    +    ++   E  KE
Sbjct: 364 DPAEVEAPPPQIYDKQLDEREHTIEEWKE 392

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 99.2 bits (248), Expect = 1e-23
 Identities = 45/198 (22%), Positives = 75/198 (37%), Gaps = 58/198 (29%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           ++HRDLKP+NLL++ +  +K+ DFGL+   R       + G P            Y AP+
Sbjct: 129 ILHRDLKPQNLLINKRGQLKLGDFGLA---R-------AFGIPVNTFSSEVVTLWYRAPD 178

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG--------GIY 98
           V+ G       +D+WSCG IL  ++ G    P  ++    L     I G         + 
Sbjct: 179 VLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND-EEQLKLIFDIMGTPNESLWPSVT 237

Query: 99  TLP-----------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF 135
            LP                         L     D +  +L ++P  R++  +   HPWF
Sbjct: 238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWF 297

Query: 136 QAHLPRYLAVPPPDTMQQ 153
                 + ++    +   
Sbjct: 298 A-EYYHHASMGGSRSHHH 314

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 44/208 (21%), Positives = 69/208 (33%), Gaps = 45/208 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDL P N+LL    ++ I DF L+                 Y APE++         
Sbjct: 155 VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKL 214

Query: 62  VDVWSCGVILYALL---------------------CGTLPFDD-ENIPN----------L 89
           VD+WS G ++  +                       GT   +D     +          L
Sbjct: 215 VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSL 274

Query: 90  FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPP 148
                     +     P A DLI +ML  +P +RI+  +  +HP+F++   P  L     
Sbjct: 275 SNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLS 334

Query: 149 ---------DTMQQAKKIDEEILKEVVK 167
                      +       +    EV +
Sbjct: 335 ERFHFDESVTDVYDMH---KIFTAEVER 359

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 97.7 bits (244), Expect = 4e-23
 Identities = 56/194 (28%), Positives = 76/194 (39%), Gaps = 64/194 (32%)

Query: 2   VVHRDLKPENLLLDSKW-----NVKIADFGLSNIMRDGHFLKTSCGSPN----------- 45
            +HRDLKP+NLLL          +KI DFGL+   R       + G P            
Sbjct: 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA---R-------AFGIPIRQFTHEIITLW 202

Query: 46  YAAPEVISGKLYAGPEVDVWSCGVILYALLCGT--LPFDDENIPNLFK--KIKG------ 95
           Y  PE++ G  +    VD+WS   I   +L  T   P D E I  LFK  ++ G      
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE-IDQLFKIFEVLGLPDDTT 261

Query: 96  --GIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW 134
             G+  LP                   + L     DL+  ML +DP+KRI+     +HP+
Sbjct: 262 WPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321

Query: 135 FQAHLPRYLAVPPP 148
           F  H         P
Sbjct: 322 FS-HND-----FDP 329

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 98.6 bits (246), Expect = 5e-23
 Identities = 55/204 (26%), Positives = 87/204 (42%), Gaps = 41/204 (20%)

Query: 2   VVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 58
           + HRD+KP+NLLLD     +K+ DFG + I+  G     S  C S  Y APE+I G    
Sbjct: 162 ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPN-VSYIC-SRYYRAPELIFGATNY 219

Query: 59  GPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL--------FK 91
              +D+WS G ++  L+ G   F                     E I  +        F 
Sbjct: 220 TTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFP 279

Query: 92  KIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF------QAHLPRYL 143
           +I+   ++        P A DLI R+L   P  R+T  E   HP+F      +A +P   
Sbjct: 280 QIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTGEARMPNGR 339

Query: 144 AVPPP-DTMQQAKKIDEEILKEVV 166
            +PP  +  ++   +  +++  +V
Sbjct: 340 ELPPLFNWTKEELSVRPDLISRLV 363

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.6 bits (246), Expect = 6e-23
 Identities = 52/202 (25%), Positives = 73/202 (36%), Gaps = 37/202 (18%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD     +K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 236

Query: 61  EVDVWSCGVILYALLCGTLPF-------------------DDENIPNL--------FKKI 93
            +DVWS G +L  LL G   F                     E I  +        F +I
Sbjct: 237 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 296

Query: 94  KGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ------AHLPRYLAV 145
           K             P A  L  R+L   P  R+T  E   H +F         LP     
Sbjct: 297 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDT 356

Query: 146 PPP-DTMQQAKKIDEEILKEVV 166
           P   +   Q    +  +   ++
Sbjct: 357 PALFNFTTQELSSNPPLATILI 378

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 97.0 bits (242), Expect = 7e-23
 Identities = 46/146 (31%), Positives = 65/146 (44%), Gaps = 9/146 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP- 60
           ++HRD+KP N+LLD   N+K+ DFG+S  + D        G   Y APE I         
Sbjct: 147 IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY 206

Query: 61  --EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHL----SPGARDLI 112
               DVWS G+ LY L  G  P+   N     L + +KG    L +      SP   + +
Sbjct: 207 DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFV 266

Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAH 138
              L  D  KR    E+ +HP+   +
Sbjct: 267 NLCLTKDESKRPKYKELLKHPFILMY 292

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 33/162 (20%), Positives = 60/162 (37%), Gaps = 32/162 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----KTSCGSPNYAAPEVISGKL 56
           + HRDLK +N+L+       IAD GL+ +                G+  Y APEV+   +
Sbjct: 134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETI 193

Query: 57  YAGPE-----VDVWSCGVILYALLCGT----------LPFDDENIPNL-FKKIKGGIY-- 98
                     VD+W+ G++L+ +               PF D    +  F+ ++  +   
Sbjct: 194 QVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVD 253

Query: 99  ----TLPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQ 131
                +P+             L+      +P  R+T   I++
Sbjct: 254 QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 95.5 bits (238), Expect = 2e-22
 Identities = 54/160 (33%), Positives = 85/160 (53%), Gaps = 10/160 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +++LL     VK++DFG    I +D    K+  G+P + APEVIS  LY   
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-AT 220

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           EVD+WS G+++  ++ G  P+  ++ +  + +        L     +SP  RD + RML+
Sbjct: 221 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLV 280

Query: 118 VDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKK 156
            DP +R T  E+  HP+  Q  LP  L       +Q  +K
Sbjct: 281 RDPQERATAQELLDHPFLLQTGLPECLV----PLIQLYRK 316

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 95.1 bits (237), Expect = 2e-22
 Identities = 54/164 (32%), Positives = 84/164 (51%), Gaps = 10/164 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG    I  +     T  G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 255

Query: 118 VDPMKRITIPEIRQHPWFQ-AHLPRYLAVPPPDTMQQAKKIDEE 160
           +D  KR +  E+ QH + + A     L       +  AK+  + 
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLT----PLIAAAKEATKN 295

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 45/199 (22%), Positives = 80/199 (40%), Gaps = 46/199 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKL 56
           ++HRD+K  N+L+     +K+ADFGL+         + +  +       Y  PE++ G+ 
Sbjct: 145 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 204

Query: 57  YAGPEVDVWSCGVILYAL---------------------LCGTLPFDDENIPN-----LF 90
             GP +D+W  G I+  +                     LCG+     E  PN     L+
Sbjct: 205 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGS-I-TPEVWPNVDNYELY 262

Query: 91  KKIKGGIY-------TLPSH-LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-----A 137
           +K++            L ++   P A DLI ++L++DP +RI   +   H +F      +
Sbjct: 263 EKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPS 322

Query: 138 HLPRYLAVPPPDTMQQAKK 156
            L   L+       +    
Sbjct: 323 DLKGMLSTHLTSMFEYLAP 341

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 95.8 bits (239), Expect = 2e-22
 Identities = 62/231 (26%), Positives = 91/231 (39%), Gaps = 59/231 (25%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----------YAAPE 50
           V+HRDLKP NLL++S  ++K+ DFGL+ I+ +     +                 Y APE
Sbjct: 133 VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPE 192

Query: 51  VISGKLYAGPEVDVWSCGVILYALL---------------------CGTLPFDDENIPNL 89
           V+         +DVWSCG IL  L                       GT P  D ++  +
Sbjct: 193 VMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT-PHSDNDLRCI 251

Query: 90  F-KKIKGGIYTLP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
              + +  I +LP             ++P   DL+ RML+ DP KRIT  E  +HP+ Q 
Sbjct: 252 ESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311

Query: 138 -HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 186
            H P       P            I     +    +  L  + L+  + NE
Sbjct: 312 YHDPNDEPEGEP------------IPPSFFEFDHYKEALTTKDLKKLIWNE 350

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 39/146 (26%), Positives = 66/146 (45%), Gaps = 19/146 (13%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---------------KTSCGSPNY 46
           ++HRDL   N L+    NV +ADFGL+ +M D                    T  G+P +
Sbjct: 129 IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYW 188

Query: 47  AAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLF--KKIKGGI-YTLPSH 103
            APE+I+G+ Y   +VDV+S G++L  ++       D     +     ++G +    P +
Sbjct: 189 MAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCPPN 247

Query: 104 LSPGARDLIPRMLIVDPMKRITIPEI 129
             P    +  R   +DP KR +  ++
Sbjct: 248 CPPSFFPITVRCCDLDPEKRPSFVKL 273

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 93.4 bits (233), Expect = 6e-22
 Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 8/129 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAG 59
           +VHRD+KP+N+L+DS   +KI DFG++  + +    +T+   G+  Y +PE   G+    
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATD 190

Query: 60  PEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSHLSPG----ARDLIPR 114
              D++S G++LY +L G  PF+ E  +    K I+  +  + + +         ++I R
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILR 250

Query: 115 MLIVDPMKR 123
               D   R
Sbjct: 251 ATEKDKANR 259

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 94.3 bits (235), Expect = 1e-21
 Identities = 51/220 (23%), Positives = 87/220 (39%), Gaps = 56/220 (25%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRDLKP NL ++    +KI DFGL+    D   +     +  Y APE++   ++    
Sbjct: 153 IIHRDLKPSNLAVNEDCELKILDFGLARHTAD--EMTGYVATRWYRAPEIMLNWMHYNQT 210

Query: 62  VDVWSCGVILYALL---------------------CGTLPFDD-ENIPNLFKKIKGGIYT 99
           VD+WS G I+  LL                      GT   +  + I +  +  +  I +
Sbjct: 211 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS--ESARNYIQS 268

Query: 100 LP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPP 147
           L               +P A DL+ +ML++D  KRIT  +   H +F   H P       
Sbjct: 269 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP------- 321

Query: 148 PDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 186
                     D+E + +      +   L ++  ++   +E
Sbjct: 322 ----------DDEPVADPYDQSLESRDLLIDEWKSLTYDE 351

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 44/171 (25%), Positives = 68/171 (39%), Gaps = 37/171 (21%)

Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGK 55
           V+HRDLKP NL ++++   +KI DFGL+ IM D H+      S       Y +P ++   
Sbjct: 141 VLHRDLKPANLFINTEDLVLKIGDFGLARIM-DPHYSHKGHLSEGLVTKWYRSPRLLLSP 199

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLFKKIKGG 96
                 +D+W+ G I   +L G   F                    +E+   L   I   
Sbjct: 200 NNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVY 259

Query: 97  IYTLPS-----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           I    +            +S  A D + ++L   PM R+T  E   HP+  
Sbjct: 260 IRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMS 310

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 58/220 (26%), Positives = 86/220 (39%), Gaps = 55/220 (25%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAG 59
           VVHRDLKP NL ++    +KI DFGL+         ++ T      Y APEVI   ++  
Sbjct: 147 VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW----YRAPEVILSWMHYN 202

Query: 60  PEVDVWSCGVILYALLCGTLPF-------------------DDENIPNLF-KKIKGGIYT 99
             VD+WS G I+  +L G   F                     E +  L  K  K  I +
Sbjct: 203 QTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQS 262

Query: 100 LP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPP 147
           LP              SP A DL+ +ML +D  KR+T  +   HP+F+    P       
Sbjct: 263 LPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDPE------ 316

Query: 148 PDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 186
                     +E   ++      +  +L V+  +  +  E
Sbjct: 317 ----------EETEAQQPFDDSLEHEKLTVDEWKQHIYKE 346

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 93.1 bits (232), Expect = 2e-21
 Identities = 36/174 (20%), Positives = 68/174 (39%), Gaps = 39/174 (22%)

Query: 2   VVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 151 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 210

Query: 61  EVDVWSCGVILYALLCGTLPF--------------------DDENIPNLF--KKIKGGIY 98
            +D+WS G +L +++    PF                    D  +  + +  +       
Sbjct: 211 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 270

Query: 99  TLPSH----------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
            L  H                +SP A D + ++L  D   R+T  E  +HP+F 
Sbjct: 271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 324

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.7 bits (231), Expect = 3e-21
 Identities = 47/210 (22%), Positives = 76/210 (36%), Gaps = 46/210 (21%)

Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 58
           V HRD+KP N+L++ +   +K+ DFG +  +        +  C S  Y APE+I G  + 
Sbjct: 152 VCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYIC-SRYYRAPELIFGNQHY 209

Query: 59  GPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL--------FK 91
              VD+WS G I   ++ G   F                     E +  L          
Sbjct: 210 TTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLY 269

Query: 92  KIKG-----GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ------AHLP 140
             KG              +  A DL+  +L   P +R+   E   HP+F         LP
Sbjct: 270 NSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPATKLP 329

Query: 141 RYLAVPPPD---TMQQAKKIDEEILKEVVK 167
               +P         + + + E    ++V+
Sbjct: 330 NNKDLPEDLFRFLPNEIEVMSEAQKAKLVR 359

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 92.0 bits (229), Expect = 5e-21
 Identities = 52/220 (23%), Positives = 87/220 (39%), Gaps = 56/220 (25%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAG 59
           ++HRDLKP NL ++    +KI DFGL+         ++ T      Y APEVI   +   
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW----YRAPEVILNWMRYT 204

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKI--------------------KGGIYT 99
             VD+WS G I+  ++ G   F   +  +  K+I                    K  +  
Sbjct: 205 QTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKG 264

Query: 100 LP-----------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPP 147
           LP           ++ SP A +L+ +ML++D  +R+T  E   HP+F++ H         
Sbjct: 265 LPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT------- 317

Query: 148 PDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 186
                     ++E   +     FD     ++  +     E
Sbjct: 318 ----------EDEPQVQKYDDSFDDVDRTLDEWKRVTYKE 347

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 91.3 bits (227), Expect = 8e-21
 Identities = 33/162 (20%), Positives = 60/162 (37%), Gaps = 32/162 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----KTSCGSPNYAAPEVISGKL 56
           + HRDLK +N+L+       IAD GL+               T  G+  Y  PEV+   L
Sbjct: 163 IAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL 222

Query: 57  YAGPE-----VDVWSCGVILYALLCGT----------LPFDDENIPNL-FKKIKGGIY-- 98
                      D++S G+IL+ +              LP+ D    +  ++ ++  +   
Sbjct: 223 NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIK 282

Query: 99  ----TLPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQ 131
               + P+  S          L+      +P  R+T   +++
Sbjct: 283 KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 90.1 bits (224), Expect = 1e-20
 Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 11/164 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYAGP 60
            +HRD+K  N+LL     VK+ADFG++  + D    + T  G+P + APEVI    Y   
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DS 198

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
           + D+WS G+    L  G  P  + + P   LF   K    TL  + S   ++ +   L  
Sbjct: 199 KADIWSLGITAIELARGEPPHSELH-PMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 257

Query: 119 DPMKRITIPEIRQHPWF--QAHLPRYLAVPPPDTMQQAKKIDEE 160
           +P  R T  E+ +H +    A    YL     + + + K+   E
Sbjct: 258 EPSFRPTAKELLKHKFILRNAKKTSYLT----ELIDRYKRWKAE 297

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 90.0 bits (224), Expect = 2e-20
 Identities = 40/155 (25%), Positives = 66/155 (42%), Gaps = 15/155 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAG 59
             HRD+KPEN+L+ +     + DFG+++   D    +     G+  Y APE  S   +A 
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES-HAT 213

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPG----ARDLIPRM 115
              D+++   +LY  L G+ P+  + +  +   I   I   PS + PG       +I R 
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAI-PRPSTVRPGIPVAFDAVIARG 272

Query: 116 LIVDPMKR-ITIPEIRQHPWFQAHLPRYLAVPPPD 149
           +  +P  R +T  +        A     LA    D
Sbjct: 273 MAKNPEDRYVTCGD------LSAAAHAALATADQD 301

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 90.8 bits (226), Expect = 2e-20
 Identities = 58/222 (26%), Positives = 89/222 (40%), Gaps = 53/222 (23%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 149 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 208

Query: 58  AGPEVDVWSCGVILYALLC---------------------GTLPFDDEN----------I 86
               +D+WS G IL  +L                      G+   +D N          +
Sbjct: 209 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 268

Query: 87  PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAV 145
            +L  K K     L  +    A DL+ +ML  +P KRI + +   HP+ +  + P     
Sbjct: 269 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS---- 324

Query: 146 PPPDTMQQAKKIDEEILKEVVKMGFDQNQL-VESLRNRLQNE 186
                       DE I +   K   + + L  E L+  +  E
Sbjct: 325 ------------DEPIAEAPFKFDMELDDLPKEKLKELIFEE 354

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 90.2 bits (224), Expect = 2e-20
 Identities = 34/136 (25%), Positives = 56/136 (41%), Gaps = 19/136 (13%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYA 58
           + HRD+K +N+LL +     IADFGL+     G          G+  Y APEV+ G +  
Sbjct: 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINF 211

Query: 59  GPE----VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPR 114
             +    +D+++ G++L+ L       D               Y LP     G    +  
Sbjct: 212 QRDAFLRIDMYAMGLVLWELASRCTAADGPVDE----------YMLPFEEEIGQHPSLED 261

Query: 115 M--LIVDPMKRITIPE 128
           M  ++V   KR  + +
Sbjct: 262 MQEVVVHKKKRPVLRD 277

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 90.6 bits (225), Expect = 2e-20
 Identities = 46/190 (24%), Positives = 72/190 (37%), Gaps = 35/190 (18%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYA 58
           + HRD+KP+NLL++SK   +K+ DFG +  +        +  C S  Y APE++ G    
Sbjct: 162 ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-VAYIC-SRFYRAPELMLGATEY 219

Query: 59  GPEVDVWSCGVILYALLCGTLPF-------------------DDENIPNL--------FK 91
            P +D+WS G +   L+ G   F                     E +  +        F 
Sbjct: 220 TPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFP 279

Query: 92  KIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPP 148
            +K   +   LP      A DL+ ++L  +P  RI   E   HP+F          V   
Sbjct: 280 TLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNN 339

Query: 149 DTMQQAKKID 158
                    +
Sbjct: 340 SNFPHGVNQN 349

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 89.3 bits (222), Expect = 3e-20
 Identities = 48/170 (28%), Positives = 77/170 (45%), Gaps = 22/170 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFG----LSNIM--RDGHFLKTSCGSPNYAAPEVISGK 55
            +HRD+K  N+LL+++ + K+ADFG    L++ M  R      T  G+P + APEVI   
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR-----NTVIGTPFWMAPEVIQEI 200

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL--PSHLSPGARDL 111
            Y     D+WS G+    +  G  P+ D + P   +F        T   P   S    D 
Sbjct: 201 GY-NCVADIWSLGITAIEMAEGKPPYADIH-PMRAIFMIPTNPPPTFRKPELWSDNFTDF 258

Query: 112 IPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKKIDEE 160
           + + L+  P +R T  ++ QHP+   A     L     D + +A  +  +
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRSAKGVSILR----DLINEAMDVKLK 304

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 89.9 bits (223), Expect = 3e-20
 Identities = 37/185 (20%), Positives = 70/185 (37%), Gaps = 54/185 (29%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFG----LSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP N+L++S+  +K+ DFG    L + M       +  G+ +Y +PE + G  Y
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-----NSFVGTRSYMSPERLQGTHY 207

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKG---------------------- 95
              + D+WS G+ L  +  G  P    +   L                            
Sbjct: 208 -SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNK 266

Query: 96  ---------GIYTLPSHL-------------SPGARDLIPRMLIVDPMKRITIPEIRQHP 133
                     I+ L  ++             S   +D + + LI +P +R  + ++  H 
Sbjct: 267 FGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 326

Query: 134 WFQAH 138
           + +  
Sbjct: 327 FIKRS 331

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 45/157 (28%), Positives = 68/157 (43%), Gaps = 18/157 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL------KTSCGSPNYAAPEVISGK 55
            +HRD+K  N+LL    +V+IADFG+S  +  G  +      KT  G+P + APEV+   
Sbjct: 142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQV 201

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL---------PSHL 104
                + D+WS G+    L  G  P+     P   L   ++    +L             
Sbjct: 202 RGYDFKADIWSFGITAIELATGAAPYHKYP-PMKVLMLTLQNDPPSLETGVQDKEMLKKY 260

Query: 105 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR 141
               R +I   L  DP KR T  E+ +H +FQ    +
Sbjct: 261 GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKNK 297

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 87.3 bits (217), Expect = 1e-19
 Identities = 33/130 (25%), Positives = 61/130 (46%), Gaps = 9/130 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC----GSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D     T      G+  Y +PE   G   
Sbjct: 137 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-S 195

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTLPSH---LSPGARDLIP 113
                DV+S G +LY +L G  PF  ++ +   ++ ++       +    LS     ++ 
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 255

Query: 114 RMLIVDPMKR 123
           + L  +P  R
Sbjct: 256 KALAKNPENR 265

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 50/258 (19%), Positives = 88/258 (34%), Gaps = 90/258 (34%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------------- 45
           ++HRD+KP N+LL+++ +VK+ADFGLS    +   +  +                     
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189

Query: 46  ------YAAPEVI-SGKLYAGPEVDVWSCGVILYALLC---------------------G 77
                 Y APE++     Y    +D+WS G IL  +LC                      
Sbjct: 190 YVATRWYRAPEILLGSTKY-TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVID 248

Query: 78  TLPFDD-------------ENIP--------NLFKKIKGGIYTLPSHL-----SPGARDL 111
               +D             E++         N           L         +  A DL
Sbjct: 249 FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDL 308

Query: 112 IPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGF 170
           + ++L  +P KRI+  +  +HP+    H P                 +E     ++ +  
Sbjct: 309 LDKLLQFNPNKRISANDALKHPFVSIFHNPN----------------EEPNCDHIITIPI 352

Query: 171 DQNQL--VESLRNRLQNE 186
           + N    ++  RN + +E
Sbjct: 353 NDNVKHSIDDYRNLVYSE 370

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 27/162 (16%), Positives = 57/162 (35%), Gaps = 32/162 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKL 56
           + HRDLK +N+L+       IAD GL+                  G+  Y APEV+   +
Sbjct: 168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 227

Query: 57  YAGPE-----VDVWSCGVILYALLCGT----------LPFDDENIPNL-FKKIKGGIY-- 98
                      D+++ G++ + +              LP+ D    +   ++++  +   
Sbjct: 228 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 287

Query: 99  ----TLPSHLS-----PGARDLIPRMLIVDPMKRITIPEIRQ 131
                +P+             ++      +   R+T   I++
Sbjct: 288 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 87.5 bits (217), Expect = 3e-19
 Identities = 49/194 (25%), Positives = 70/194 (36%), Gaps = 63/194 (32%)

Query: 2   VVHRDLKPENLLLDSKWN----VKIADFGLSNIMRDGHFLKTSCGSPN------YAAPEV 51
           V+HRDLKP N+L+  +      VKIAD G + +      LK             Y APE+
Sbjct: 149 VLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYRAPEL 206

Query: 52  ISG-KLYAGPEVDVWSCGVILYALL------------------------------CGTLP 80
           + G + Y    +D+W+ G I   LL                               G  P
Sbjct: 207 LLGARHY-TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF-P 264

Query: 81  FDDE--------NIPNLFKKIKGGIYTLPS----------HLSPGARDLIPRMLIVDPMK 122
            D +            L K  +   YT  S               A  L+ ++L +DP+K
Sbjct: 265 ADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIK 324

Query: 123 RITIPEIRQHPWFQ 136
           RIT  +  Q P+F 
Sbjct: 325 RITSEQAMQDPYFL 338

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 45/165 (27%), Positives = 69/165 (41%), Gaps = 14/165 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG-- 59
           ++HRD+K  N+LL     VK+ DFG ++IM       +  G+P + APEVI         
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYD 231

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLSPGARDLIPRML 116
            +VDVWS G+    L     P  + N     L+   +     L   H S   R+ +   L
Sbjct: 232 GKVDVWSLGITCIELAERKPPLFNMN-AMSALYHIAQNESPALQSGHWSEYFRNFVDSCL 290

Query: 117 IVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKKIDEE 160
              P  R T   + +H +  +   P  +     D +Q+ K    E
Sbjct: 291 QKIPQDRPTSEVLLKHRFVLRERPPTVIM----DLIQRTKDAVRE 331

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 85.1 bits (211), Expect = 1e-18
 Identities = 43/168 (25%), Positives = 73/168 (43%), Gaps = 10/168 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC-GSPNYAAPEVISGKLYA-- 58
           V+HRD+K +N+LL     VK+ DFG+S  +      + +  G+P + APEVI+       
Sbjct: 150 VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDA 209

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLSPGARDLIP 113
               + D+WS G+    +  G  P  D + P   LF   +     L     S   +  I 
Sbjct: 210 TYDFKSDLWSLGITAIEMAEGAPPLCDMH-PMRALFLIPRNPAPRLKSKKWSKKFQSFIE 268

Query: 114 RMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPPDTMQQAKKIDEE 160
             L+ +  +R    ++ +HP+       R + +   D + + KK   E
Sbjct: 269 SCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLKDHIDRTKKKRGE 316

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 42/153 (27%), Positives = 71/153 (46%), Gaps = 11/153 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK-TSCGSPNYAAPEVISGKLYA-- 58
           ++HRDLK  N+L+  + ++++ADFG+S         + +  G+P + APEV+  +     
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL--PSHLSPGARDLI 112
               + D+WS G+ L  +     P  + N P   L K  K    TL  PS  S   RD +
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPPHHELN-PMRVLLKIAKSDPPTLLTPSKWSVEFRDFL 256

Query: 113 PRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLA 144
              L  +P  R +  ++ +HP+       + L 
Sbjct: 257 KIALDKNPETRPSAAQLLEHPFVSSITSNKALR 289

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 83.6 bits (207), Expect = 5e-18
 Identities = 45/201 (22%), Positives = 71/201 (35%), Gaps = 57/201 (28%)

Query: 2   VVHRDLKPENLLLD------SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK 55
           ++H D+KPEN+L++      +   +KIAD G +           S  +  Y +PEV+ G 
Sbjct: 153 IIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGA 210

Query: 56  LYAGPEVDVWSCGVILYAL---------------------------LCGTLP-------- 80
            + G   D+WS   +++ L                           L G LP        
Sbjct: 211 PW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGK 269

Query: 81  -----FDDE----NIPNL-FKKIKGGIYTLPSHLSPGAR---DLIPRMLIVDPMKRITIP 127
                F+      NI  L F  ++  +          A+   D +  ML +DP KR    
Sbjct: 270 YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAG 329

Query: 128 EIRQHPWFQAHLPRYLAVPPP 148
            +  HPW +  L       P 
Sbjct: 330 GLVNHPWLKDTLGMEEIRVPD 350

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 84.5 bits (209), Expect = 6e-18
 Identities = 28/123 (22%), Positives = 51/123 (41%), Gaps = 14/123 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           +V+ DLKPEN++L  +  +K+ D G  + +   G+      G+P + APE++        
Sbjct: 203 LVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLY----GTPGFQAPEIVRTG--PTV 255

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
             D+++ G  L AL       +   +  L +                   L+ R +  DP
Sbjct: 256 ATDIYTVGRTLAALTLDLPTRNGRYVDGLPED------DPVLKTYDSYGRLLRRAIDPDP 309

Query: 121 MKR 123
            +R
Sbjct: 310 RQR 312

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 82.9 bits (205), Expect = 1e-17
 Identities = 54/216 (25%), Positives = 75/216 (34%), Gaps = 69/216 (31%)

Query: 2   VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL    +  +K+ DFG S       +  T   S  Y APEVI G  Y G
Sbjct: 221 IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVY--TYIQSRFYRAPEVILGARY-G 277

Query: 60  PEVDVWSCGVILYAL---------------------LCGTLP-------------FDDEN 85
             +D+WS G IL  L                     L G                   + 
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKG 337

Query: 86  IPN--LFKKIKGGIYTLPSHLS--------PGAR---------------DLIPRMLIVDP 120
            P       +  G   L    S        P +R               D + + L  DP
Sbjct: 338 YPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDP 397

Query: 121 MKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKK 156
             R+T  +  +HPW +  LP+     PP   + + K
Sbjct: 398 AVRMTPGQALRHPWLRRRLPK-----PPTGEKTSVK 428

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 78.3 bits (193), Expect = 2e-16
 Identities = 35/145 (24%), Positives = 58/145 (40%), Gaps = 27/145 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---------CGSPNYAAPEVI 52
           + HRDL   N+L+ +     I+DFGLS  +     ++            G+  Y APEV+
Sbjct: 141 ISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVL 200

Query: 53  SGKL------YAGPEVDVWSCGVILYALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLS 105
            G +       A  +VD+++ G+I + +    T  F  E++P          Y +     
Sbjct: 201 EGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE---------YQMAFQTE 251

Query: 106 PGARDLIPRM--LIVDPMKRITIPE 128
            G       M  L+    +R   PE
Sbjct: 252 VGNHPTFEDMQVLVSREKQRPKFPE 276

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 77.3 bits (190), Expect = 7e-16
 Identities = 38/221 (17%), Positives = 67/221 (30%), Gaps = 71/221 (32%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD--------GHFLKTSCGSPNYAAPEVIS 53
            VHR +K  ++L+     V ++    +  M            F K S     + +PEV+ 
Sbjct: 149 YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQ 208

Query: 54  GKLYA-GPEVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL----------- 100
             L     + D++S G+    L  G +PF D      L +K+ G +  L           
Sbjct: 209 QNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEEL 268

Query: 101 ----------------------------------PSHLSPGARDLIPRMLIVDPMKRITI 126
                                                 SP     + + L  +P  R + 
Sbjct: 269 TMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSA 328

Query: 127 PEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
             +  H +F                +Q K+   E L E+++
Sbjct: 329 STLLNHSFF----------------KQIKRRASEALPELLR 353

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 76.4 bits (189), Expect = 7e-16
 Identities = 28/87 (32%), Positives = 45/87 (51%), Gaps = 11/87 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS------CGSPNYAAPEVISGK 55
            +HRD+K  N+LLD  +  KI+DFGL+   R       +       G+  Y APE + G+
Sbjct: 154 HIHRDIKSANILLDEAFTAKISDFGLA---RASEKFAQTVMTSRIVGTTAYMAPEALRGE 210

Query: 56  LYAGPEVDVWSCGVILYALLCGTLPFD 82
           +    + D++S GV+L  ++ G    D
Sbjct: 211 ITP--KSDIYSFGVVLLEIITGLPAVD 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 47/270 (17%), Positives = 70/270 (25%), Gaps = 101/270 (37%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------------- 45
           ++HRDLKP N LL+   +VK+ DFGL+  +                              
Sbjct: 150 IIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLT 209

Query: 46  -------YAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPN--LFK----- 91
                  Y APE+I  +      +D+WS G I   LL       ++      LF      
Sbjct: 210 SHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCF 269

Query: 92  ----KIKGGIYTLPSHL----------------------SPGARDLIPRM---------- 115
                         S+                        P     I             
Sbjct: 270 PLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQ 329

Query: 116 ----------------LIVDPMKRITIPEIRQHPWFQA-HLPRYLAVPPPDTMQQAKKID 158
                           L  +P KRITI +   HP+ +     +                 
Sbjct: 330 KYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK----------------L 373

Query: 159 EEILKEVVKMGFDQNQL--VESLRNRLQNE 186
           E    + + + FD   +     LR     E
Sbjct: 374 ENFSTKKIILPFDDWMVLSETQLRYIFLKE 403

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 19/129 (14%), Positives = 33/129 (25%), Gaps = 34/129 (26%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V      P  + +    +V +A                                  A P+
Sbjct: 150 VALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPD--------ANPQ 182

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFK---KIKGGIYTLPSHLSPGA----RDLIPR 114
            D+   G  LYALL    P  +  + +      +   G    P+ +          +  R
Sbjct: 183 DDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAAR 242

Query: 115 MLIVDPMKR 123
            +  D   R
Sbjct: 243 SVQGDGGIR 251

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 72.2 bits (178), Expect = 3e-14
 Identities = 33/95 (34%), Positives = 50/95 (52%), Gaps = 12/95 (12%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPE-VISGKLY 57
           ++HRD+K  N+LLD  +  KI DFG+S    +    H      G+  Y  PE  I G+L 
Sbjct: 160 IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLT 219

Query: 58  AGPEVDVWSCGVILYALLCG------TLPFDDENI 86
              + DV+S GV+L+ +LC       +LP +  N+
Sbjct: 220 E--KSDVYSFGVVLFEVLCARSAIVQSLPREMVNL 252

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 70.8 bits (174), Expect = 9e-14
 Identities = 41/206 (19%), Positives = 66/206 (32%), Gaps = 74/206 (35%)

Query: 2   VVHRDLKPENLLLDS-------------------------KWNVKIADFGLSNIMRDGHF 36
           + H DLKPEN+LLD                             +K+ DFG +    D H 
Sbjct: 158 LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHG 217

Query: 37  LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------L 75
              +  +  Y APEVI    +     D+WS G +L  L                     +
Sbjct: 218 SIIN--TRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESI 274

Query: 76  CGTLP--------------FDDENIPNLF--------KKIKGGIYTLPSHLS---PGARD 110
              +P              + +++   L           IK     LP +         D
Sbjct: 275 IQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQ 136
            +  +L +DP  R +  E+ +H + +
Sbjct: 335 FLYSILQIDPTLRPSPAELLKHKFLE 360

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 48/216 (22%), Positives = 71/216 (32%), Gaps = 68/216 (31%)

Query: 2   VVHRDLKPENLLLDS-------------------KWNVKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L  +                     ++++ADFG +    D     T   
Sbjct: 144 LTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVA 201

Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLP- 80
           + +Y  PEVI    +A P  DVWS G IL+                       + G +P 
Sbjct: 202 TRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPS 260

Query: 81  -----------FDDENIPNLFKKIKGGIYTLPSHLSPGAR------------DLIPRMLI 117
                      F    +         G Y   +     +             DL+ RML 
Sbjct: 261 HMIHRTRKQKYFYKGGLVWDENSSD-GRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLE 319

Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 153
            DP +RIT+ E   HP+F    P   +        +
Sbjct: 320 FDPAQRITLAEALLHPFFAGLTPEERSFHTSRNPSR 355

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 66.5 bits (163), Expect = 2e-12
 Identities = 49/197 (24%), Positives = 68/197 (34%), Gaps = 66/197 (33%)

Query: 2   VVHRDLKPENLLLDS-------------------KWNVKIADFGLSNIMRDGHFLKTSCG 42
           + H DLKPEN+L                        ++K+ DFG +    + H    S  
Sbjct: 139 LTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVS-- 196

Query: 43  SPNYAAPEVISGKLYAGPEVDVWSCGVILYAL---------------------LCGTLP- 80
           + +Y APEVI    ++ P  DVWS G IL                        + G LP 
Sbjct: 197 TRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPK 255

Query: 81  -----------FDDENIPNLFKKIKGGIY-----TLPSHLSP------GARDLIPRMLIV 118
                      F  + +        G         L   +           DLI +ML  
Sbjct: 256 HMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315

Query: 119 DPMKRITIPEIRQHPWF 135
           DP KRIT+ E  +HP+F
Sbjct: 316 DPAKRITLREALKHPFF 332

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 35/105 (33%), Positives = 51/105 (48%), Gaps = 5/105 (4%)

Query: 2   VVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           ++H DLKPEN+LL    +  +KI DFG S  +    +      S  Y +PEV+ G  Y  
Sbjct: 180 IIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIY--QYIQSRFYRSPEVLLGMPYDL 237

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL 104
             +D+WS G IL  +  G   F   N  +   KI   +   P+H+
Sbjct: 238 A-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI 281

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 42.0 bits (99), Expect = 2e-04
 Identities = 13/27 (48%), Positives = 15/27 (55%)

Query: 110 DLIPRMLIVDPMKRITIPEIRQHPWFQ 136
           DLI RML  DP  RI      QH +F+
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFFK 377

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 66.1 bits (162), Expect = 3e-12
 Identities = 30/90 (33%), Positives = 48/90 (53%), Gaps = 5/90 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPE-VISGKLYA 58
           ++HRD+K  N+LLD ++   + DFGL+ +M     H      G+  + APE + +GK   
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-- 212

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPN 88
             + DV+  GV+L  L+ G   FD   + N
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLAN 242

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 25/98 (25%), Positives = 37/98 (37%), Gaps = 28/98 (28%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN---------------- 45
           ++HRDLKP N L++   +VK+ DFGL+  +       +                      
Sbjct: 177 ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNL 236

Query: 46  ------------YAAPEVISGKLYAGPEVDVWSCGVIL 71
                       Y APE+I  +      +DVWS G I 
Sbjct: 237 KRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 51.0 bits (122), Expect = 4e-07
 Identities = 25/104 (24%), Positives = 36/104 (34%), Gaps = 19/104 (18%)

Query: 86  IPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA-HLPRYLA 144
           I    K+    +       S  A  L+ RML+ +P KRITI E   HP+F+   +     
Sbjct: 351 IRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE--- 407

Query: 145 VPPPDTMQQAKKIDEEILKEVVKMGFDQNQL--VESLRNRLQNE 186
                         E    E V++ F+         LR     E
Sbjct: 408 -------------VETNATEKVRLPFNDWMNMDEPQLRYAFVKE 438

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           VHRDL+  N+L+      K+ADFGL+ ++ D  +        P  + APE      +   
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-I 360

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  L   G +P+       +  +++ G Y +P
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 401

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 30/102 (29%), Positives = 50/102 (49%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           VHRDL+  N+L+      K+ADFGL+ ++ D  +        P  + APE      +   
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFT-I 443

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  L   G +P+       +  +++ G Y +P
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMP 484

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 26/102 (25%), Positives = 51/102 (50%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY--AAPEVISGKLYAGP 60
           +HR+L   N L+     VK+ADFGLS +M    +   +         APE ++   ++  
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 398

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVW+ GV+L+ +   G  P+   ++  +++ ++   Y + 
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 439

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G  P  + APE I+ + +   
Sbjct: 513 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-S 571

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
             DVW  GV ++ +L  G  PF      ++  +I+ G   LP
Sbjct: 572 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 612

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 59.9 bits (146), Expect = 2e-10
 Identities = 28/102 (27%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     VK+ADFGLS +M    +   +    P  + APE ++   ++  
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS-I 191

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVW+ GV+L+ +   G  P+   ++  +++ ++   Y + 
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRME 232

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 38/137 (27%), Positives = 61/137 (44%), Gaps = 10/137 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNY----AAPEVISGKLY 57
            +HRDL   N L+  K  +KI+DFG+S    DG +   S G         APE ++   Y
Sbjct: 234 CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY-AASGGLRQVPVKWTAPEALNYGRY 292

Query: 58  AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
           +  E DVWS G++L+     G  P+ + +     + ++ G   L  P         L+ +
Sbjct: 293 S-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFRLMEQ 350

Query: 115 MLIVDPMKRITIPEIRQ 131
               +P +R +   I Q
Sbjct: 351 CWAYEPGQRPSFSTIYQ 367

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 59.6 bits (145), Expect = 3e-10
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 6/103 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISGKLYAG 59
           VHRDL   N+L+ +  +VKI DFGL+ ++        + G   P  + A E I  ++Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT- 197

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
            + DVWS GV ++ L+  G+ P+D      +   ++ G   LP
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 58.4 bits (142), Expect = 6e-10
 Identities = 37/102 (36%), Positives = 53/102 (51%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCG-SP-NYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  M D  + K S G  P  + APE I+ + +   
Sbjct: 138 VHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT-S 196

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
             DVW  GV ++ +L  G  PF      ++  +I+ G   LP
Sbjct: 197 ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLP 237

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 59.3 bits (144), Expect = 7e-10
 Identities = 31/102 (30%), Positives = 56/102 (54%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+ +    KIADFGL+ ++ D  +        P  + APE I+   +   
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT-I 364

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  ++  G +P+   + P + + ++ G Y +P
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMP 405

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 33/103 (32%), Positives = 53/103 (51%), Gaps = 6/103 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISGKLYAG 59
           VHRDL   N+L+ +  +VKI DFGL+ ++        + G   P  + A E I  ++Y  
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYT- 197

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
            + DVWS GV ++ L+  G+ P+D      +   ++ G   LP
Sbjct: 198 HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLP 239

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 57.6 bits (140), Expect = 1e-09
 Identities = 30/102 (29%), Positives = 54/102 (52%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL+  N+L+    + KIADFGL+ ++ D  +        P  + APE I+   +   
Sbjct: 131 IHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT-I 189

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L  ++  G +P+     P + + ++ G Y + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMV 230

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 57.7 bits (140), Expect = 2e-09
 Identities = 39/140 (27%), Positives = 64/140 (45%), Gaps = 15/140 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRD+   N+LL +    KI DFGL+ +IM D +++       P  + APE I   +Y  
Sbjct: 186 IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT- 244

Query: 60  PEVDVWSCGVILYALL-CGTLPF-DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
            + DVWS G++L+ +   G  P+         +K +K G Y +  P+        +   M
Sbjct: 245 VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG-YQMAQPAFAPKNIYSI---M 300

Query: 116 LI---VDPMKRITIPEIRQH 132
                ++P  R T  +I   
Sbjct: 301 QACWALEPTHRPTFQQICSF 320

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 29/102 (28%), Positives = 56/102 (54%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL   N L+     +K++DFG++  + D  +  ++    P  +A+PEV S   Y+  
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-S 184

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS GV+++ +   G +P+++ +   + + I  G + L 
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLY 225

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 56.8 bits (138), Expect = 2e-09
 Identities = 29/102 (28%), Positives = 54/102 (52%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL   N L+D    VK++DFG++  + D  ++ +     P  ++APEV     Y+  
Sbjct: 126 IHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS-S 184

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVW+ G++++ +   G +P+D      +  K+  G + L 
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 56.9 bits (138), Expect = 3e-09
 Identities = 29/103 (28%), Positives = 49/103 (47%), Gaps = 6/103 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISGKLYAG 59
           VHR+L   N+LL S   V++ADFG+++++           +  P  + A E I    Y  
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYT- 195

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
            + DVWS GV ++ L+  G  P+    +  +   ++ G   L 
Sbjct: 196 HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLA 237

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 43/141 (30%), Positives = 70/141 (49%), Gaps = 15/141 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+ +I +D  +++      P  + APE I  ++Y 
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT 273

Query: 59  GPEVDVWSCGVILYALLC-GTLPFDD-ENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
             + DVWS GV+L+ +   G  P+   +      +++K G   +  P + +P        
Sbjct: 274 -IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG-TRMRAPDYTTPEMYQT--- 328

Query: 115 MLI---VDPMKRITIPEIRQH 132
           ML     +P +R T  E+ +H
Sbjct: 329 MLDCWHGEPSQRPTFSELVEH 349

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 57.0 bits (138), Expect = 4e-09
 Identities = 27/101 (26%), Positives = 54/101 (53%), Gaps = 7/101 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGPE 61
           VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++  +
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFST-K 366

Query: 62  VDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
            DVWS G++L+ +   G +P+    + ++  +++ G Y + 
Sbjct: 367 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 406

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 55.7 bits (135), Expect = 5e-09
 Identities = 27/102 (26%), Positives = 52/102 (50%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           +HRDL   N L++ +  VK++DFGLS  + D  +  +     P  ++ PEV+    ++  
Sbjct: 142 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS-S 200

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + D+W+ GV+++ +   G +P++        + I  G   L 
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLY 241

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 56.1 bits (136), Expect = 5e-09
 Identities = 46/141 (32%), Positives = 65/141 (46%), Gaps = 15/141 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+ +I  D +++       P  + APE I   +Y 
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT 225

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDD-ENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
             E DVWS G+ L+ L   G+ P+         +K IK G + +  P H      D+   
Sbjct: 226 -FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEG-FRMLSPEHAPAEMYDI--- 280

Query: 115 MLI---VDPMKRITIPEIRQH 132
           M      DP+KR T  +I Q 
Sbjct: 281 MKTCWDADPLKRPTFKQIVQL 301

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 55.8 bits (135), Expect = 6e-09
 Identities = 40/141 (28%), Positives = 65/141 (46%), Gaps = 15/141 (10%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYA 58
            VHRDL   N+L+     VKI DFGL+ +IM D +++       P  + APE +   +Y 
Sbjct: 193 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT 252

Query: 59  GPEVDVWSCGVILYALL-CGTLPF-DDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
             + DVWS G++L+ +   G  P+       N +K I+ G + +  P + +     +   
Sbjct: 253 -IKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNG-FKMDQPFYATEEIYII--- 307

Query: 115 MLI---VDPMKRITIPEIRQH 132
           M      D  KR + P +   
Sbjct: 308 MQSCWAFDSRKRPSFPNLTSF 328

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 55.3 bits (134), Expect = 7e-09
 Identities = 27/102 (26%), Positives = 54/102 (52%), Gaps = 7/102 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVISGKLYAGP 60
            VHRDL   N+L+      K++DFGL+   ++    + +   P  + APE +  K ++  
Sbjct: 138 FVHRDLAARNVLVSEDNVAKVSDFGLT---KEASSTQDTGKLPVKWTAPEALREKKFS-T 193

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
           + DVWS G++L+ +   G +P+    + ++  +++ G Y + 
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMD 234

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 55.8 bits (135), Expect = 8e-09
 Identities = 40/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G  P  + APE +  ++Y  
Sbjct: 225 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT- 283

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS GV+++ +   G  P+    +  LFK +K G + +  P++ +     +   M 
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKPANCTNELYMM---MR 339

Query: 117 I---VDPMKRITIPEIRQH 132
                 P +R T  ++ + 
Sbjct: 340 DCWHAVPSQRPTFKQLVED 358

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 55.4 bits (134), Expect = 9e-09
 Identities = 40/160 (25%), Positives = 62/160 (38%), Gaps = 20/160 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRDL   N +L     V +ADFGLS  I    ++ +      P  + A E ++  LY  
Sbjct: 159 IHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT- 217

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
              DVW+ GV ++ ++  G  P+       ++  + GG   L  P        DL   M 
Sbjct: 218 VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG-NRLKQPPECMEEVYDL---MY 273

Query: 117 ---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQ 153
                DP +R +   +R        L   L      +  Q
Sbjct: 274 QCWSADPKQRPSFTCLRM------ELENILGHLSVLSTSQ 307

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 32/102 (31%), Positives = 50/102 (49%), Gaps = 5/102 (4%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAGP 60
           VHRD+   N+L+ S   VK+ DFGLS  + D  + K S    P  + +PE I+ + +   
Sbjct: 135 VHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT-T 193

Query: 61  EVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
             DVW   V ++ +L  G  PF      ++   ++ G   LP
Sbjct: 194 ASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLP 234

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 54.9 bits (133), Expect = 1e-08
 Identities = 43/139 (30%), Positives = 68/139 (48%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VHRDL   N+L+     +KI+DFGLS ++  +  ++K S G  P  + A E +   +Y  
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT- 230

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS GV+L+ ++  G  P+       LF  +K G + +  P + S     L   ML
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTG-HRMERPDNCSEEMYRL---ML 286

Query: 117 I---VDPMKRITIPEIRQH 132
                +P KR    +I + 
Sbjct: 287 QCWKQEPDKRPVFADISKD 305

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 33/104 (31%), Positives = 57/104 (54%), Gaps = 7/104 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGS--P-NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGL  ++ D      T+ G   P  + +PE I+ + + 
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++L+ ++  G  P+ + +  ++ K +  G Y LP
Sbjct: 229 -SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 32/104 (30%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGKLYA 58
           VHR+L   N+LL ++   KI+DFGLS  +  D  +         P  + APE I+ + ++
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS GV ++  L  G  P+     P +   I+ G   + 
Sbjct: 518 -SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRME 559

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 54.2 bits (131), Expect = 2e-08
 Identities = 35/139 (25%), Positives = 61/139 (43%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VHRDL   N ++   + VKI DFG++ +I    ++ K   G  P  + +PE +   ++  
Sbjct: 160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT- 218

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
              DVWS GV+L+ +      P+   +   + + +  G   L  P +      +L   M 
Sbjct: 219 TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG-GLLDKPDNCPDMLFEL---MR 274

Query: 117 I---VDPMKRITIPEIRQH 132
           +    +P  R +  EI   
Sbjct: 275 MCWQYNPKMRPSFLEIISS 293

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 44/234 (18%), Positives = 63/234 (26%), Gaps = 102/234 (43%)

Query: 2   VVHRDLKPENLLL----------------------------------------------- 14
           ++H D+KPEN+LL                                               
Sbjct: 168 IIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEP 227

Query: 15  --DSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-YAAPEVISGKLYAGPEVDVWSCGVIL 71
               K  VKIAD G +  +       T       Y + EV+ G  Y     D+WS   + 
Sbjct: 228 KNAEKLKVKIADLGNACWVHKHF---TEDIQTRQYRSLEVLIGSGY-NTPADIWSTACMA 283

Query: 72  YAL---------------------------LCGTLP-------------FDDENIPNLFK 91
           + L                           L G +P             F  +       
Sbjct: 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT 343

Query: 92  KIKGG--------IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA 137
           K+K           Y      + G  D +  ML + P KR T  E  +HPW  +
Sbjct: 344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 35/104 (33%), Positives = 57/104 (54%), Gaps = 7/104 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGS--P-NYAAPEVISGKLYA 58
           VHRDL   N+L++S    K++DFGLS ++ D      T+ G   P  + APE IS + + 
Sbjct: 169 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS G++++ ++  G  P+ + +   + K I  G + LP
Sbjct: 229 -SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP 270

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 31/104 (29%), Positives = 51/104 (49%), Gaps = 7/104 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +  D ++ K       P  + APE I+   ++
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS 198

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
             + DVWS GV+++     G  P+       +   ++ G   + 
Sbjct: 199 -SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMG 240

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 36/104 (34%), Positives = 58/104 (55%), Gaps = 7/104 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-KTSCGS--P-NYAAPEVISGKLYA 58
           VHRDL   N+L+DS    K++DFGLS ++ D      T+ G   P  + APE I+ + ++
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS GV+++ +L  G  P+ +    ++   ++ G Y LP
Sbjct: 233 -SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLP 274

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 53.8 bits (130), Expect = 3e-08
 Identities = 34/139 (24%), Positives = 59/139 (42%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRDL   N +L     V +ADFGLS  I    ++ +      P  + A E ++ ++Y  
Sbjct: 169 LHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT- 227

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVW+ GV ++ +   G  P+       ++  +  G + L  P        ++   M 
Sbjct: 228 SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG-HRLKQPEDCLDELYEI---MY 283

Query: 117 ---IVDPMKRITIPEIRQH 132
                DP+ R T   +R  
Sbjct: 284 SCWRTDPLDRPTFSVLRLQ 302

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 53.9 bits (130), Expect = 3e-08
 Identities = 35/171 (20%), Positives = 66/171 (38%), Gaps = 17/171 (9%)

Query: 3   VHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKL 56
           +HRD+   N LL         KI DFG++ +I R  ++ K  C   P  +  PE     +
Sbjct: 162 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI 221

Query: 57  YAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 113
           +   + D WS GV+L+ +   G +P+  ++   + + +  G   +  P +       +  
Sbjct: 222 FT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPGPVYRI-- 277

Query: 114 RML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEI 161
            M       P  R     I +   +    P  +    P       + +E++
Sbjct: 278 -MTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALPIEYGPLVEEEEKV 327

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 53.0 bits (128), Expect = 5e-08
 Identities = 30/73 (41%), Positives = 44/73 (60%), Gaps = 4/73 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRDL   N+LL  K  VKI DFGL+ +I +D  +++      P  + APE I  ++Y  
Sbjct: 170 IHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT- 228

Query: 60  PEVDVWSCGVILY 72
            + DVWS GV+L+
Sbjct: 229 IQSDVWSFGVLLW 241

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 32/99 (32%), Positives = 51/99 (51%), Gaps = 7/99 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSP-NYAAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++         K    SP  + APE ++   ++
Sbjct: 136 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS 195

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+LY L   T     ++ P  F ++ G  
Sbjct: 196 -VASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 231

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 42/139 (30%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G  P  + APE +  ++Y  
Sbjct: 213 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT- 271

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS GV+L+ +   G  P+    +  LFK +K G + +  PS+ +     +   M 
Sbjct: 272 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMM---MR 327

Query: 117 I---VDPMKRITIPEIRQH 132
                 P +R T  ++ + 
Sbjct: 328 DCWHAVPSQRPTFKQLVED 346

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 52.7 bits (127), Expect = 5e-08
 Identities = 28/74 (37%), Positives = 39/74 (52%), Gaps = 5/74 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSP-NYAAPEVISGKLYA 58
           VHRDL   N+L++S+  VKI DFGL+  +        +K    SP  + APE +    + 
Sbjct: 148 VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY 207

Query: 59  GPEVDVWSCGVILY 72
               DVWS GV L+
Sbjct: 208 -IASDVWSFGVTLH 220

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 52.7 bits (127), Expect = 6e-08
 Identities = 40/139 (28%), Positives = 71/139 (51%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           +HRDL   N+L+     +KIADFGL+ +I    ++ KT+ G  P  + APE +  ++Y  
Sbjct: 179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT- 237

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            + DVWS GV+++ +   G  P+    +  LFK +K G + +  P++ +     +   M 
Sbjct: 238 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG-HRMDKPANCTNELYMM---MR 293

Query: 117 I---VDPMKRITIPEIRQH 132
                 P +R T  ++ + 
Sbjct: 294 DCWHAVPSQRPTFKQLVED 312

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 52.6 bits (127), Expect = 6e-08
 Identities = 33/104 (31%), Positives = 50/104 (48%), Gaps = 7/104 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS--P-NYAAPEVISGKLYA 58
           VHRDL   N+LL ++   KI+DFGLS  +  D  +         P  + APE I+ + ++
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
               DVWS GV ++  L  G  P+     P +   I+ G   + 
Sbjct: 192 -SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRME 233

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 52.8 bits (127), Expect = 6e-08
 Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 7/99 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCG-SP-NYAAPEVISGKLYA 58
           +HRDL   N+L++++  VKI DFGL+ ++      +     G SP  + APE ++   ++
Sbjct: 167 IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS 226

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI 97
               DVWS GV+LY L   T     ++ P  F ++ G  
Sbjct: 227 -VASDVWSFGVVLYELF--TYIEKSKSPPAEFMRMIGND 262

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 52.4 bits (126), Expect = 1e-07
 Identities = 35/158 (22%), Positives = 62/158 (39%), Gaps = 17/158 (10%)

Query: 3   VHRDLKPENLLLDSKWN---VKIADFGLS-NIMRDGHFLKTSCG-SP-NYAAPEVISGKL 56
           +HRD+   N LL         KI DFG++ +I R G++ K  C   P  +  PE     +
Sbjct: 203 IHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI 262

Query: 57  YAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIP 113
           +   + D WS GV+L+ +   G +P+  ++   + + +  G   +  P +       +  
Sbjct: 263 FT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG-GRMDPPKNCPGPVYRI-- 318

Query: 114 RML---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPPP 148
            M       P  R     I +   +    P  +    P
Sbjct: 319 -MTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 33/75 (44%), Positives = 42/75 (56%), Gaps = 7/75 (9%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCG-SP-NYAAPEVIS-GKLY 57
           +HRDL   N+LLD+   VKI DFGL+  + +GH  +     G SP  + APE +   K Y
Sbjct: 156 IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFY 215

Query: 58  AGPEVDVWSCGVILY 72
                DVWS GV LY
Sbjct: 216 Y--ASDVWSFGVTLY 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 25/86 (29%), Positives = 39/86 (45%), Gaps = 6/86 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSP---NYAAPEVISGKLYA 58
           +HRDL   NLLL ++  VKI DFGL   + ++               + APE +  + ++
Sbjct: 143 IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS 202

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDD 83
               D W  GV L+ +   G  P+  
Sbjct: 203 -HASDTWMFGVTLWEMFTYGQEPWIG 227

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 31/74 (41%), Positives = 49/74 (66%), Gaps = 5/74 (6%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMR--DGHFLKTSCG-SP-NYAAPEVISGKLYA 58
           VHRDL   N+L++S+ +VKIADFGL+ ++     +++    G SP  + APE +S  +++
Sbjct: 149 VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFS 208

Query: 59  GPEVDVWSCGVILY 72
             + DVWS GV+LY
Sbjct: 209 -RQSDVWSFGVVLY 221

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 51.1 bits (123), Expect = 2e-07
 Identities = 33/105 (31%), Positives = 49/105 (46%), Gaps = 8/105 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKLY 57
           VHRDL   N +LD  + VK+ADFGL+  + D  +              + A E +    +
Sbjct: 146 VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF 205

Query: 58  AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
              + DVWS GV+L+ LL  G  P+   +  +L   +  G   LP
Sbjct: 206 T-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRLP 248

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 50.8 bits (122), Expect = 2e-07
 Identities = 38/139 (27%), Positives = 57/139 (41%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VHRDL   N L+     VKI DFG+S +I    ++        P  +  PE I  + +  
Sbjct: 180 VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT- 238

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            E DVWS GV+L+ +   G  P+   +       I  G   L  P    P    +   M 
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG-RELERPRACPPEVYAI---MR 294

Query: 117 I---VDPMKRITIPEIRQH 132
                +P +R +I ++   
Sbjct: 295 GCWQREPQQRHSIKDVHAR 313

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 50.7 bits (122), Expect = 3e-07
 Identities = 40/139 (28%), Positives = 60/139 (43%), Gaps = 17/139 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGS--P-NYAAPEVISGKLYAG 59
           +HRDL   N+L+   +  KIADFGLS   R             P  + A E ++  +Y  
Sbjct: 164 IHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGRLPVRWMAIESLNYSVYT- 219

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
              DVWS GV+L+ ++  G  P+       L++K+  G Y L  P +      DL   M 
Sbjct: 220 TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVYDL---MR 275

Query: 117 I---VDPMKRITIPEIRQH 132
                 P +R +  +I   
Sbjct: 276 QCWREKPYERPSFAQILVS 294

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 49.9 bits (120), Expect = 5e-07
 Identities = 43/154 (27%), Positives = 63/154 (40%), Gaps = 20/154 (12%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VHRDL   N L+ +   VKI DFG+S ++    ++        P  +  PE I  + +  
Sbjct: 155 VHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT- 213

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            E DVWS GVIL+ +   G  P+   +   + + I  G   L  P        D+   ML
Sbjct: 214 TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQG-RVLERPRVCPKEVYDV---ML 269

Query: 117 ---IVDPMKRITIPEIRQHPWFQAHLPRYLAVPP 147
                +P +R+ I EI         L       P
Sbjct: 270 GCWQREPQQRLNIKEI------YKILHALGKATP 297

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 49.6 bits (119), Expect = 5e-07
 Identities = 34/105 (32%), Positives = 52/105 (49%), Gaps = 8/105 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  +      +       + A E +  + +
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
              + DVWS GV+L+ L+  G  P+ D N  ++   +  G   L 
Sbjct: 210 T-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 252

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} PDB: 1ul7_A Length = 120

 Score = 46.9 bits (111), Expect = 7e-07
 Identities = 18/123 (14%), Positives = 44/123 (35%), Gaps = 33/123 (26%)

Query: 256 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSN 315
           W++   S   P ++M E+ K L   N  +++   + + C                     
Sbjct: 29  WSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVH------------------- 69

Query: 316 HYFGDESAIIENDGVVKSPNVVKFEVQLYK-TRDEKYLLDLQRVQGPQFLFLDLCAAFLA 374
                        G  +  ++V++E+++ K  R     +  +R+ G    F ++ +    
Sbjct: 70  -------------GDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIAN 116

Query: 375 QLR 377
           +L+
Sbjct: 117 ELK 119

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 49.6 bits (119), Expect = 7e-07
 Identities = 40/139 (28%), Positives = 57/139 (41%), Gaps = 14/139 (10%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VHRDL   N L+     VKIADFGLS NI    ++      + P  +  PE I    Y  
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT- 254

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRML 116
            E DVW+ GV+L+ +   G  P+       +   ++ G   L  P +      +L   M 
Sbjct: 255 TESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDG-NILACPENCPLELYNL---MR 310

Query: 117 ---IVDPMKRITIPEIRQH 132
                 P  R +   I + 
Sbjct: 311 LCWSKLPADRPSFCSIHRI 329

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 49.8 bits (119), Expect = 8e-07
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 8/105 (7%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPN-----YAAPEVISGKLY 57
           VHRDL   N +LD K+ VK+ADFGL+  M D  F      +       + A E +  + +
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLP 101
              + DVWS GV+L+ L+  G  P+ D N  ++   +  G   L 
Sbjct: 274 T-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLL 316

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 48.1 bits (115), Expect = 2e-06
 Identities = 22/110 (20%), Positives = 42/110 (38%), Gaps = 17/110 (15%)

Query: 3   VHRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLKTSCGSP-NYAAPEVIS 53
           +H ++  +N+LL  + +        +K++D G+S  +     L+        +  PE I 
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQ----ERIPWVPPECIE 190

Query: 54  -GKLYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
             K       D WS G  L+ +   G  P    +     +  +   + LP
Sbjct: 191 NPKNLN-LATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDR-HQLP 238

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 47.6 bits (114), Expect = 2e-06
 Identities = 30/103 (29%), Positives = 51/103 (49%), Gaps = 6/103 (5%)

Query: 3   VHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGS-P-NYAAPEVISGKLYAG 59
           VH+DL   N+L+  K NVKI+D GL   +    ++        P  + APE I    ++ 
Sbjct: 150 VHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS- 208

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTLP 101
            + D+WS GV+L+ +   G  P+   +  ++ + I+     LP
Sbjct: 209 IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QVLP 250

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 9e-06
 Identities = 64/401 (15%), Positives = 118/401 (29%), Gaps = 125/401 (31%)

Query: 9   PENLL-LDSKWNVKIAD-FGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS 66
              LL L +  N K  + F LS         K    +      + +S        +D  S
Sbjct: 244 ENCLLVLLNVQNAKAWNAFNLS--------CKILLTTRFKQVTDFLSAATTTHISLDHHS 295

Query: 67  CGVILYALLCGTLPFDDENIPNLF-KKIKGGIYTLPS---HLSPGARDLIPRMLIVDPM- 121
                            + + +L  K +      LP      +P    +I   +      
Sbjct: 296 MT------------LTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLAT 343

Query: 122 ----KRITIPEIR---------QHPWFQAHLPRYLAVPPPDTMQQAKKIDEEIL------ 162
               K +   ++            P     +   L+V PP        I   +L      
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSA-----HIPTILLSLIWFD 398

Query: 163 --KEVVKMGFDQNQLVE-SLRNRLQNEATVAYY-LLLDNRFRVSSGYLGAEFQETMESGF 218
             K  V +    N+L + SL  +   E+T++   + L+ + ++ + Y             
Sbjct: 399 VIKSDVMV--VVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY------------- 443

Query: 219 NRLHP--IE----PAVSPVAHRAPGFMD---YQGMG--LRGQLPYERKWALGLQSRAHPR 267
             LH   ++    P         P ++D   Y  +G  L+     ER             
Sbjct: 444 -ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERM------------ 490

Query: 268 EIMTEVLKALQELNVGW--KKIGHYNMKCRWIPGISGHHEGMVNNPLHS-NHYFGDESAI 324
            +   V      L+  +  +KI H           + +  G + N L     Y   +  I
Sbjct: 491 TLFRMVF-----LDFRFLEQKIRH--------DSTAWNASGSILNTLQQLKFY---KPYI 534

Query: 325 IENDG----VVKS--PNVVKFEVQLYKTRDEKYLLDLQRVQ 359
            +ND     +V +    + K E  L  ++      DL  ++
Sbjct: 535 CDNDPKYERLVNAILDFLPKIEENLICSKY----TDL--LR 569

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.0 bits (95), Expect = 6e-04
 Identities = 31/273 (11%), Positives = 69/273 (25%), Gaps = 96/273 (35%)

Query: 155 KKIDEEILKEVVKMGFDQNQLVESLRNRLQNE----------ATVAYYLLLD-------- 196
           K I        V   FD   + +  ++ L  E          A      L          
Sbjct: 19  KDILSVFEDAFVD-NFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEE 77

Query: 197 --NRF-----RVSSGYLGAEFQ----------ETMESGFNRLHPIEPAVSP--VAHRAPG 237
              +F     R++  +L +  +                 +RL+      +   V+ R   
Sbjct: 78  MVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVS-RLQP 136

Query: 238 FMDYQ---------------GMGLRGQLPYERKWALGLQS-RAHPREIMTEVLKALQELN 281
           ++  +               G+   G      K  + L    ++  +          +  
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSG------KTWVALDVCLSYKVQCK-------MDFK 183

Query: 282 VGWKKIGHYN-----MK-----CRWI-PGISGHHEGMVNNPLHSN-------HYFGDE-- 321
           + W  + + N     ++        I P  +   +   N  L  +            +  
Sbjct: 184 IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPY 243

Query: 322 --SAIIENDGVVKSPNVVK-FEVQ---LYKTRD 348
               ++  +  V++      F +    L  TR 
Sbjct: 244 ENCLLVLLN--VQNAKAWNAFNLSCKILLTTRF 274

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 42.1 bits (99), Expect = 2e-04
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 19/93 (20%)

Query: 2   VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDG----HFL----KTSCGSPNYAAPEV 51
            VH D+K  NLLL+ K    V + D+GL+           +     +   G+  +     
Sbjct: 173 YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFT---- 228

Query: 52  ISGKLYAGPEV----DVWSCGVILYALLCGTLP 80
            S   + G       D+   G  +   L G LP
Sbjct: 229 -SIDAHNGVAPSRRGDLEILGYCMIQWLTGHLP 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 41.6 bits (98), Expect = 2e-04
 Identities = 26/93 (27%), Positives = 36/93 (38%), Gaps = 19/93 (20%)

Query: 2   VVHRDLKPENLLLDSKWNVKI--ADFGLSNIMRDG----HFL----KTSCGSPNYAAPEV 51
            VH D+K  NLLL  K   ++  AD+GLS           +     K   G+  +     
Sbjct: 172 YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFT---- 227

Query: 52  ISGKLYAGPEV----DVWSCGVILYALLCGTLP 80
            S   + G  +    DV   G  +   LCG LP
Sbjct: 228 -SLDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	379
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qrd_A	137	SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind	100.0
4eai_A	106	5'-AMP-activated protein kinase catalytic subunit	100.0
3t4n_A	179	Carbon catabolite-derepressing protein kinase; CBS	100.0
2v8q_A	157	5'-AMP-activated protein kinase catalytic subunit;	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4eag_A	130	EG:132E8.2 protein; AMPK, transferase; HET: ATP TA	100.0
2y8l_A	173	5'-AMP-activated protein kinase catalytic subunit;	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	99.98
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.97
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.97
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	99.96
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
4aoj_A	329	High affinity nerve growth factor receptor; transf	99.96
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	99.96
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.95
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.95
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.95
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.95
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
3niz_A	311	Rhodanese family protein; structural genomics, str	99.95
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.95
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.95
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.95
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.95
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.95
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.94
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.94
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.94
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.94
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.94
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.94
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.94
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.94
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.94
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.94
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.94
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.94
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.94
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.94
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.94
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.94
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.94
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.94
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.94
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.94
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.94
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.94
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.94
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.94
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.94
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.94
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.94
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.94
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.94
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.94
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.94
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.94
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.94
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.94
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.94
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.94
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.94
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.94
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.94
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.94
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.93
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.93
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.93
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.93
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.93
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.93
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.93
3bhy_A	283	Death-associated protein kinase 3; death associate	99.93
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.93
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.93
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.93
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.93
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.93
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.93
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.93
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.93
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.93
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.93
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.93
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.93
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.93
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.93
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.93
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.93
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.93
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.93
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.93
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.93
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.93
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.93
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.93
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.92
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.92
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.92
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.92
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.92
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.92
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.92
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.92
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.92
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.92
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.92
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.92
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.92
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.92
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.91
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.91
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.91
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.91
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.91
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.91
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.91
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.91
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.91
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.91
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.91
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.91
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.91
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.9
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.9
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.9
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.9
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.9
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.9
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.9
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.9
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.9
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.9
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.9
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.9
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.9
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.9
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.89
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.89
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.89
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.89
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.89
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.89
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.89
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.89
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.89
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.89
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.89
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.89
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.89
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.89
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.89
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.89
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.89
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.89
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.89
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.89
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.89
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.89
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.89
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.89
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.89
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.89
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.88
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.88
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.88
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.88
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.88
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.88
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.88
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.88
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.88
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.88
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.88
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.88
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.88
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.88
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.88
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.88
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.88
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.88
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.88
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.88
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.88
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.87
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.87
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.87
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.87
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.87
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.87
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.87
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.87
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.87
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.87
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.87
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.86
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.86
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.86
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.86
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.86
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.86
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.86
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.86
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.86
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.86
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.85
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.84
1v5s_A	126	MAP/microtubule affinity-regulating kinase 3; Ka1	99.84
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.83
3ose_A	120	Serine/threonine-protein kinase MARK1; kinase asso	99.81
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.78
3uqc_A	286	Probable conserved transmembrane protein; structur	99.65
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.56
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.0
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	98.44
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	98.42
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	98.24
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	97.76
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	96.46
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	96.13
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	95.66
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	94.56
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	93.95
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	93.19
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	91.88
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	91.29
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	90.74
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	90.09
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	89.85
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	89.27
3ats_A	357	Putative uncharacterized protein; hypothetical pro	89.13
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	89.11
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	86.56
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	86.28
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	85.39
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	85.12
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	84.47
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	83.2
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	82.77
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	82.51
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	81.34

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.3e-63  Score=508.88  Aligned_cols=328  Identities=47%  Similarity=0.812  Sum_probs=228.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||+++....+....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..|
T Consensus       136 givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P  215 (476)
T 2y94_A          136 MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP  215 (476)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence            48999999999999999999999999999887777778889999999999999888778899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCcccCCCCCChhhhhcccCHH
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEE  160 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l~~~~~~~~~~~~~~~~~  160 (379)
                      |.+.+...+..++..+.+..|..+++++.+||.+||..||.+|||++|+++||||+...+.++.+..+.  .....++++
T Consensus       216 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~--~~~~~~~~~  293 (476)
T 2y94_A          216 FDDDHVPTLFKKICDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPS--YSSTMIDDE  293 (476)
T ss_dssp             SCCSSSHHHHHHHHTTCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSC--SSCSHHHHH
T ss_pred             CCCCCHHHHHHHHhcCCcCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcc--cccccCCHH
Confidence            999999999999999999999999999999999999999999999999999999998877665432221  222334555


Q ss_pred             HHHHHH-HcCCCHHHHHHHHHhc-ccChHHHHHHHHhhccccccCCc---chhhHHH-HHHh-ccCCCCCCCCCCCC---
Q 017029          161 ILKEVV-KMGFDQNQLVESLRNR-LQNEATVAYYLLLDNRFRVSSGY---LGAEFQE-TMES-GFNRLHPIEPAVSP---  230 (379)
Q Consensus       161 ~~~~~~-~~~~~~~~~~~~l~~~-~~~~~~~~y~ll~~~~~~~~~~~---~~~~~~~-~~~~-~~~~~~~~~~~~~~---  230 (379)
                      .+.++. .++++.+++.+++.+. ..+..+++|++++++++......   ....... ..+. .....+| +..++.   
T Consensus       294 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  372 (476)
T 2y94_A          294 ALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHP-ERVPFLVAE  372 (476)
T ss_dssp             HHHSCCCC-------------------------------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSS-CTTTTCSCC
T ss_pred             HHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHHHHHHHhchhhhhhhhccccccCCccccccccccccCCc-ccCCccccc
Confidence            555553 5788888888888764 46789999999999987643221   1111111 0000 0011111 110000   


Q ss_pred             ---CCCCCCCccccccCCCCCCCCCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCc
Q 017029          231 ---VAHRAPGFMDYQGMGLRGQLPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGM  307 (379)
Q Consensus       231 ---~~~~~~~~~~~~~~~~~~~~~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~  307 (379)
                         .....+.+   ...+..+..++++|||||||||++|.|||.||||||++|||+||++++|+|+|||+++.       
T Consensus       373 ~~~~~~~~~~~---~~~~~~~~~~~~~~w~lgi~s~~~p~~im~ev~~al~~lg~~Wk~~~~~~i~~r~~~~~-------  442 (476)
T 2y94_A          373 TPRARHTLDEL---NPQKSKHQGVRKAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPV-------  442 (476)
T ss_dssp             CCCCSTTCTTT---SSSTTTCSCCCCCCEEESEEECSCHHHHHHHHHHHHHTTTCBCCEEETTEEEEEEECTT-------
T ss_pred             CCccccccccc---ccccccccccccceeeecCccCCCHHHHHHHHHHHHHHcCCeeccCCCEEEEEEECCCC-------
Confidence               00111111   11233455678999999999999999999999999999999999999999999998531       


Q ss_pred             cCCCCCCCCccCCccceeccCccccCCceEEEEEEEEeecCCceeeeeccccCCceehH
Q 017029          308 VNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFL  366 (379)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g~~~~f~  366 (379)
                           +                    +..|||+|||||+++++||||||+++|++|+||
T Consensus       443 -----~--------------------~~~~k~~lqly~~~~~~~llDf~~~~~~~~~~~  476 (476)
T 2y94_A          443 -----T--------------------STFSKMSLQLYQVDSRTYLLDFRSIDDEILEVL  476 (476)
T ss_dssp             -----T--------------------CCEEEEEEEEEECSSSCEEEEEEEECCC-----
T ss_pred             -----C--------------------CceEEEEEEEEEecCCcEEEEeeecCCCccccC
Confidence                 1                    457999999999999999999999999999996

>2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A*

Probab=100.00  E-value=1.5e-40  Score=279.73  Aligned_cols=103  Identities=27%  Similarity=0.454  Sum_probs=88.1

Q ss_pred             CCCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEe---------cceeeEEEeecCCCCCCCCccCCCCCCCCccCC
Q 017029          250 LPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKI---------GHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGD  320 (379)
Q Consensus       250 ~~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~---------~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~  320 (379)
                      .++++|||||||||++|.|||.|||||||+||++||++         ++|+|||||+++..++                 
T Consensus         7 ~~~~~kWhlGIRSrs~P~eIM~EVyrALk~Lg~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~-----------------   69 (137)
T 2qrd_A            7 KSRRNKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKR-----------------   69 (137)
T ss_dssp             ----CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHH-----------------
T ss_pred             CcccCccccccccCCCHHHHHHHHHHHHHHCCCEEEeccccccccCCCceEEEEEEecCCCcc-----------------
Confidence            45689999999999999999999999999999999999         9999999998532100                 


Q ss_pred             ccceeccCccccCCceEEEEEEEEeecCCceeeeeccccCC---------------c----eehHHHHHHHHHHHhcC
Q 017029          321 ESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGP---------------Q----FLFLDLCAAFLAQLRVL  379 (379)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g~---------------~----~~f~~~c~~~i~~L~~~  379 (379)
                                ...+..|||+||||||++++||||||+++|+               .    |+|||+|++||+|||+.
T Consensus        70 ----------~~~~~~vkm~iQLYqv~~~~YLlDFk~~~~~~~~~~~~~~~~~~~~~~~s~~~Fldlca~Li~eLa~~  137 (137)
T 2qrd_A           70 ----------EGKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLFSA  137 (137)
T ss_dssp             ----------TTCCEEEEEEEEEEEEETTEEEEEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHHHC
T ss_pred             ----------ccCCceEEEEEEEEEecCCcEEEEEEecCCccccccCccccccCCccccccccHHHHHHHHHHHHhcC
Confidence                      0115689999999999999999999999998               6    99999999999999964

>4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A*

Probab=100.00  E-value=9.1e-40  Score=262.35  Aligned_cols=95  Identities=29%  Similarity=0.661  Sum_probs=86.5

Q ss_pred             CCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCcc
Q 017029          251 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGV  330 (379)
Q Consensus       251 ~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (379)
                      .+++||||||+|+++|.|||.||||||++||++||++++|+|||||+++.            +                 
T Consensus         3 ~~~~kW~LGIrS~~~P~eiM~eIyraLk~lg~~Wk~~~~Y~lkcR~~~~~------------~-----------------   53 (106)
T 4eai_A            3 HMGAKWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPV------------T-----------------   53 (106)
T ss_dssp             ---CEEEESEEECSCHHHHHHHHHHHHHHHTCEEEEEETTEEEEEEECTT------------T-----------------
T ss_pred             CcCccceEcceeCCCHHHHHHHHHHHHHHcCCEEeeCCceEEEEEEcCCC------------C-----------------
Confidence            46789999999999999999999999999999999999999999998531            1                 


Q ss_pred             ccCCceEEEEEEEEeecCCceeeeeccccC--------CceehHHHHHHHHHHHh
Q 017029          331 VKSPNVVKFEVQLYKTRDEKYLLDLQRVQG--------PQFLFLDLCAAFLAQLR  377 (379)
Q Consensus       331 ~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g--------~~~~f~~~c~~~i~~L~  377 (379)
                         +..+||+|||||+++++||||||+++|        ++|+|||+||+||++||
T Consensus        54 ---~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~~~~~~F~d~ca~li~~la  105 (106)
T 4eai_A           54 ---STFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGGSHTIEFFEMCANLIKILA  105 (106)
T ss_dssp             ---CCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSSCHHHHHHHHHHHHHHHCC
T ss_pred             ---CceeEEEEEEEEecCCcEEEEEEeccCCCCCCCCcCcEeHHHHHHHHHHHHh
Confidence               457999999999999999999999999        69999999999999997

>3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A

Probab=100.00  E-value=5.1e-39  Score=277.87  Aligned_cols=105  Identities=29%  Similarity=0.618  Sum_probs=88.3

Q ss_pred             CCCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEec---ceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceec
Q 017029          250 LPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIG---HYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIE  326 (379)
Q Consensus       250 ~~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~---~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  326 (379)
                      ..+++|||||||||++|.|||.|||||||.||++||+++   +|+|||||+++.+++...                    
T Consensus        45 ~~~~~kW~LGIrS~~~P~eIM~EVyrALk~Lg~~WKk~~~~~pY~IkcRw~~~~~~~~~~--------------------  104 (179)
T 3t4n_A           45 KKSKTRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTNT--------------------  104 (179)
T ss_dssp             CCCCCCCEESEEECSCHHHHHHHHHHHHHHHTCEEECCCGGGTTEEEEEECC----------------------------
T ss_pred             CcccceeeeccccCCCHHHHHHHHHHHHHHcCCEEeeCCCCCceEEEEEEeCCCCccccc--------------------
Confidence            456789999999999999999999999999999999998   999999999765432110                    


Q ss_pred             cCccccCCceEEEEEEEEeecCCceeeeeccccC----------------------CceehHHHHHHHHHHHhc
Q 017029          327 NDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQG----------------------PQFLFLDLCAAFLAQLRV  378 (379)
Q Consensus       327 ~~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g----------------------~~~~f~~~c~~~i~~L~~  378 (379)
                         ....+++|||+||||||++++|||||| ++|                      ++|+|||||++||++||+
T Consensus       105 ---~~~~p~~vKmeLQLYkv~~~~YLLDfk-~~G~e~~~~~~~~~~~~~~~e~~~~s~~pFLdlca~LI~eLa~  174 (179)
T 3t4n_A          105 ---NEKIPDLMKMVIQLFQIETNNYLVDFK-FDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELAV  174 (179)
T ss_dssp             ------CCCEEEEEEEEEEEETTEEEEEEE-EEEEECC----------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             ---ccCCCceeEEEEEEEEecCCceEEEEE-eccccccccccccccccccccccccCCccHHHHHHHHHHHHHh
Confidence               011266899999999999999999999 777                      789999999999999997

>2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C*

Probab=100.00  E-value=1.7e-38  Score=268.69  Aligned_cols=77  Identities=30%  Similarity=0.669  Sum_probs=70.7

Q ss_pred             ccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCcccc
Q 017029          253 ERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVK  332 (379)
Q Consensus       253 ~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (379)
                      ++|||||||||++|.|||.|||||||+||++||++++|+|||||+++.            +                   
T Consensus         2 ~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~~~pY~IkcRw~~~~------------~-------------------   50 (157)
T 2v8q_A            2 SMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPV------------T-------------------   50 (157)
T ss_dssp             CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTT------------T-------------------
T ss_pred             CccceeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCC------------C-------------------
Confidence            579999999999999999999999999999999999999999998532            1                   


Q ss_pred             CCceEEEEEEEEeecCCceeeeeccccCC
Q 017029          333 SPNVVKFEVQLYKTRDEKYLLDLQRVQGP  361 (379)
Q Consensus       333 ~~~~~~~~lQLYk~~~~~YLlDf~~~~g~  361 (379)
                       +..|||+||||||++++||||||+++|+
T Consensus        51 -~~~vKm~LQLYkv~~~~YLLDFk~l~g~   78 (157)
T 2v8q_A           51 -STFSKMSLQLYQVDSRTYLLDFRSIDDE   78 (157)
T ss_dssp             -CCEEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred             -CceEEEEEEEEEecCCCEEEEEEecCCC
Confidence             3479999999999999999999998775

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.3e-39  Score=305.73  Aligned_cols=143  Identities=76%  Similarity=1.299  Sum_probs=123.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.++++||+|||+|+...+.....+.+||+.|+|||++.+..|++.++||||+||++|+|++|+.|
T Consensus       132 ~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~P  211 (275)
T 3hyh_A          132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP  211 (275)
T ss_dssp             TCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCC
Confidence            38999999999999999999999999999887777777889999999999999998878899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCccc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  143 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l  143 (379)
                      |.+.+...+++.+..+.+++|..+|+++++||.+||++||.+|||++|+++||||+..+|+++
T Consensus       212 F~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~~p~~L  274 (275)
T 3hyh_A          212 FDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVDLPEYL  274 (275)
T ss_dssp             SCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTTCCGGG
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccCCChhh
Confidence            999999999999999999999999999999999999999999999999999999998887764

>4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster}

Probab=100.00  E-value=4.5e-38  Score=258.22  Aligned_cols=96  Identities=32%  Similarity=0.640  Sum_probs=83.9

Q ss_pred             CCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCcc
Q 017029          251 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGV  330 (379)
Q Consensus       251 ~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (379)
                      .+++|||||||||++|.|||.|||||||.||++||++++|+|||||+++.            +                 
T Consensus         3 ~k~~kW~LGIrS~~~P~eIM~EVyrALk~Lg~eWK~~~pY~vkcR~~n~~------------~-----------------   53 (130)
T 4eag_A            3 HMGAKWHLGIRSQSKPNDIMLEVYRAMKALSYEWKIINPYHVRVRRQNVK------------T-----------------   53 (130)
T ss_dssp             ---CCEEESBCCCSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTT------------T-----------------
T ss_pred             ccccceeeeeecCCCHHHHHHHHHHHHHHCCCEEeeCCCEEEEEEecCCC------------C-----------------
Confidence            46889999999999999999999999999999999999999999998431            1                 


Q ss_pred             ccCCceEEEEEEEEeecCCceeeeeccccCCc--------------------------------eehHHHHHHHHHHHhc
Q 017029          331 VKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ--------------------------------FLFLDLCAAFLAQLRV  378 (379)
Q Consensus       331 ~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g~~--------------------------------~~f~~~c~~~i~~L~~  378 (379)
                         +..+||+||||||++++||||||+++|+.                                |+||||||+||++||.
T Consensus        54 ---~~~vKm~LQLYqv~~~~YLLDfk~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~h~tmeffemc~~li~~la~  130 (130)
T 4eag_A           54 ---GKFSKMSLQLYQVDAKSYLLDFKSLTNDEVEQGDDVIMESLTPPPLSVSGVMPLQPTGHHTMEFFEMCAALIIQLAR  130 (130)
T ss_dssp             ---CCEEEEEEEEEESSSSCEEEEEEECC---------------------------CCCSCCHHHHHHHHHHHHHHHHHC
T ss_pred             ---CceeEEEEEEEEecCCcEEEEeccCCcchhhccCCccccccCCCcccccCCCCCCCCCcccChHHHHHHHHHHHHhC
Confidence               45799999999999999999999998762                                9999999999999983

>2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A*

Probab=100.00  E-value=8.2e-38  Score=267.63  Aligned_cols=80  Identities=29%  Similarity=0.614  Sum_probs=71.3

Q ss_pred             CCCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCc
Q 017029          250 LPYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDG  329 (379)
Q Consensus       250 ~~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  329 (379)
                      .++++|||||||||++|.|||.|||||||+||+|||++++|+|||||+++.            +                
T Consensus        13 ~~k~~kWhLGIrSrs~P~eIM~EVyRALk~Lg~eWK~i~pY~IkcRw~~~~------------~----------------   64 (173)
T 2y8l_A           13 PRGSMAWHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPV------------T----------------   64 (173)
T ss_dssp             ---CCEEEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTT------------T----------------
T ss_pred             ccccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeeCCCeEEEEEEcCCC------------C----------------
Confidence            356899999999999999999999999999999999999999999998532            1                


Q ss_pred             cccCCceEEEEEEEEeecCCceeeeeccccCC
Q 017029          330 VVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGP  361 (379)
Q Consensus       330 ~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g~  361 (379)
                          +..|||+||||||++++||||||+++|+
T Consensus        65 ----~~~vKmeLQLYKv~~~~YLLDFk~l~Gd   92 (173)
T 2y8l_A           65 ----STFSKMSLQLYQVDSRTYLLDFRSIDDE   92 (173)
T ss_dssp             ----CCEEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred             ----CeeEEEEEEEEEEcCCCEEEEEEecCCC
Confidence                3479999999999999999999998775

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=6.1e-37  Score=295.46  Aligned_cols=138  Identities=34%  Similarity=0.675  Sum_probs=127.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.+|.+||+|||+|+.+...   ....+.|||+.|+|||++.+..| +.++||||+||++|+|++|
T Consensus       152 ~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G  230 (311)
T 4aw0_A          152 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAG  230 (311)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhC
Confidence            4899999999999999999999999999987432   34567899999999999998888 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhh------hhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPE------IRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e------ll~hp~f~~~~  139 (379)
                      ..||.+.+..+++.+|..+.+.+|..+|+++++||.+||++||.+|||++|      |++||||+...
T Consensus       231 ~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~id  298 (311)
T 4aw0_A          231 LPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT  298 (311)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCC
Confidence            999999999999999999999999999999999999999999999999988      58899998653

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.5e-35  Score=287.52  Aligned_cols=193  Identities=43%  Similarity=0.723  Sum_probs=168.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.....+....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..|
T Consensus       134 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  213 (328)
T 3fe3_A          134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP  213 (328)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCC
Confidence            37999999999999999999999999999887777778889999999999999988877899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCcccCCCCCChhhhhcccCHH
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEE  160 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l~~~~~~~~~~~~~~~~~  160 (379)
                      |.+.+...+...+..+.+.+|..+++++.+||.+||..||.+|||++|+++||||+.........+  .........++.
T Consensus       214 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~~~~~~--~~~~~~~~~~~~  291 (328)
T 3fe3_A          214 FDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP--FVEPELDISDQK  291 (328)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTTCCCCC--CCCCCCCCCCHH
T ss_pred             CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcccccCc--ccCCCcCcccHH
Confidence            999999999999999999999999999999999999999999999999999999986543211111  011112234667


Q ss_pred             HHHHHHHcCCCHHHHHHHHHhcccChHHHHHHHHh
Q 017029          161 ILKEVVKMGFDQNQLVESLRNRLQNEATVAYYLLL  195 (379)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~  195 (379)
                      .+..+..+|++.+++.+.+.+...++.+++|++|.
T Consensus       292 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~  326 (328)
T 3fe3_A          292 RIDIMVGMGYSQEEIQESLSKMKYDEITATYLLLG  326 (328)
T ss_dssp             HHHHHHHTTCCHHHHHHHHHTTCCSHHHHHHHHHT
T ss_pred             HHHHHHHCCCCHHHHHHHHHcCCCCHHHHHHHHhc
Confidence            78888899999999999999999999999998875

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.7e-36  Score=295.50  Aligned_cols=197  Identities=62%  Similarity=1.066  Sum_probs=175.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.....+....+.+||+.|+|||++.+..+.++++||||+||++|+|++|..|
T Consensus       128 givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~P  207 (336)
T 3h4j_B          128 KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP  207 (336)
T ss_dssp             TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCC
Confidence            37999999999999999999999999999888877778889999999999999888778899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCcccCCCCCChhhhhcccCHH
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEE  160 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l~~~~~~~~~~~~~~~~~  160 (379)
                      |.+.....+..++..+.+.+|..+++++.+||.+||..||.+|||++|+++||||+...+.++.+...   ......+..
T Consensus       208 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~---~~~~~~~~~  284 (336)
T 3h4j_B          208 FDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEE---VQGSYADSR  284 (336)
T ss_dssp             SBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCGGGSCCCC---CCCCCCCHH
T ss_pred             CCCccHHHHHHHHHcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCccccCCchh---cccccCCHH
Confidence            99988777777788888889999999999999999999999999999999999999887776543221   223456777


Q ss_pred             HHHHH-HHcCCCHHHHHHHHHhcccChHHHHHHHHhhcccc
Q 017029          161 ILKEV-VKMGFDQNQLVESLRNRLQNEATVAYYLLLDNRFR  200 (379)
Q Consensus       161 ~~~~~-~~~~~~~~~~~~~l~~~~~~~~~~~y~ll~~~~~~  200 (379)
                      ++..+ ..+|++.+.+.++|.++..++.+++|+||.+++..
T Consensus       285 ~~~~~~~~~~~~~~~i~~~l~~~~~~~~~~~y~ll~~~~~~  325 (336)
T 3h4j_B          285 IVSKLGEAMGFSEDYIVEALRSDENNEVKEAYNLLHENQVI  325 (336)
T ss_dssp             HHHHHHHTTCCCHHHHHHHTTSSSCCSSTTHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCHHHHHHHHhcCCCCHHHHHHHHHHhChhh
Confidence            77777 46899999999999999999999999999988764

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=4.1e-36  Score=293.70  Aligned_cols=138  Identities=33%  Similarity=0.599  Sum_probs=124.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+||||+.+|.+||+|||+|+..... ....+.|||+.|+|||++.+..| +.++||||+||++|||++|..
T Consensus       190 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~  268 (346)
T 4fih_A          190 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEP  268 (346)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCC
Confidence            4899999999999999999999999999877543 45567899999999999998888 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+.+..+++..|.....   ..+..+|+++++||.+||++||.+|||++|+++||||++..
T Consensus       269 PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          269 PYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             TTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            9999999998888876643   23356899999999999999999999999999999998764

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3e-36  Score=290.00  Aligned_cols=137  Identities=35%  Similarity=0.639  Sum_probs=124.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.+|.+||+|||+|+...+. ....+.|||+.|+|||++.+..| +.++||||+||++|+|++|+.
T Consensus       146 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~  224 (304)
T 3ubd_A          146 GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTL  224 (304)
T ss_dssp             TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCC
Confidence            3899999999999999999999999999875443 44567899999999999999888 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      ||.+.+..+++.+|.++.+.+|..+|+++++||.+||++||.+|||     ++|+++||||+..
T Consensus       225 PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          225 PFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCC
Confidence            9999999999999999999999999999999999999999999998     4799999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3e-36  Score=295.10  Aligned_cols=140  Identities=26%  Similarity=0.562  Sum_probs=126.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+||||+.+|.+||+|||+|+...... ...+.|||+.|+|||++.+..| +.++|||||||++|+|++|+.
T Consensus       145 ~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~  223 (350)
T 4b9d_A          145 KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKH  223 (350)
T ss_dssp             TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSC
T ss_pred             CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCC
Confidence            48999999999999999999999999998875543 3456789999999999999888 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCc
Q 017029           80 PFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  141 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~  141 (379)
                      ||.+.+..+++.+|..+.+ +++..+|+++++||.+||++||.+|||++|+++||||+.....
T Consensus       224 PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~~~  286 (350)
T 4b9d_A          224 AFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEK  286 (350)
T ss_dssp             SCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTTGGG
T ss_pred             CCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcCCCc
Confidence            9999999999999988775 4677899999999999999999999999999999999876543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.1e-35  Score=292.83  Aligned_cols=138  Identities=33%  Similarity=0.599  Sum_probs=124.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+||||+.+|.+||+|||+|+..... ....+.|||+.|||||++.+..| +.++|||||||++|||++|+.
T Consensus       267 ~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~  345 (423)
T 4fie_A          267 GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEP  345 (423)
T ss_dssp             TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCC
Confidence            4899999999999999999999999999877543 45567899999999999998888 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+.+..+++..|.....   ..+..+|+++++||.+||++||.+|||++|+++||||+...
T Consensus       346 PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          346 PYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             TTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            9999999998888876643   34467899999999999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.7e-35  Score=281.69  Aligned_cols=134  Identities=27%  Similarity=0.594  Sum_probs=115.5

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +||||||||+||||+. +|.+||+|||+|+... .....+.+||+.|||||++.+. | +.++|||||||++|+|+||+.
T Consensus       151 ~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~-~~~~~~~~GTp~YmAPE~~~~~-y-~~~~DiwSlGvilyelltg~~  227 (290)
T 3fpq_A          151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEY  227 (290)
T ss_dssp             CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC-TTSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEecccChhheeEECCCCCEEEEeCcCCEeCC-CCccCCcccCccccCHHHcCCC-C-CcHHHHHHHHHHHHHHHHCCC
Confidence            4899999999999985 7999999999998643 3455678999999999999764 6 789999999999999999999


Q ss_pred             CCCCC-ChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           80 PFDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ||.+. +...++..+..+..  .++..+++++++||.+||+.||.+|||++|+++||||++
T Consensus       228 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          228 PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             TTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             CCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            99764 55666777776654  345678899999999999999999999999999999985

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=279.47  Aligned_cols=138  Identities=29%  Similarity=0.449  Sum_probs=118.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+|||++.+|.+||+|||+|+.+...     ....+.+||+.|+|||++.+..+++.++||||+||++|||+
T Consensus       178 ~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell  257 (398)
T 4b99_A          178 QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEML  257 (398)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHH
T ss_pred             cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHH
Confidence            3899999999999999999999999999876432     34457799999999999988777789999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCccCCC-------------------------------CCCChhhhcccccccCCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIYTLP-------------------------------SHLSPGARDLIPRMLIVDPMKRI  124 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~~~p-------------------------------~~~s~~~~~Li~~mL~~dP~~Rp  124 (379)
                      +|++||.+.+..+.+..|.......+                               +.+++++++||.+||++||.+||
T Consensus       258 ~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~  337 (398)
T 4b99_A          258 ARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI  337 (398)
T ss_dssp             HTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC
T ss_pred             HCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc
Confidence            99999999998888887754332211                               24688999999999999999999


Q ss_pred             ChhhhhcCchhhhc
Q 017029          125 TIPEIRQHPWFQAH  138 (379)
Q Consensus       125 t~~ell~hp~f~~~  138 (379)
                      |++|+|+||||++.
T Consensus       338 ta~e~L~Hp~f~~~  351 (398)
T 4b99_A          338 SAAAALRHPFLAKY  351 (398)
T ss_dssp             CHHHHTTSGGGTTT
T ss_pred             CHHHHhcCHhhCcC
Confidence            99999999999865

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=99.98  E-value=5.7e-34  Score=277.58  Aligned_cols=137  Identities=26%  Similarity=0.410  Sum_probs=116.9

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCcc------cccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHF------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~~------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      .||||||||+||||+.+| .+||+|||+|+.......      ..+.|||+.|||||++.+..| +.++||||+||++||
T Consensus       170 ~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilye  248 (336)
T 4g3f_A          170 RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLH  248 (336)
T ss_dssp             TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHH
T ss_pred             CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHH
Confidence            489999999999999987 699999999987754321      233589999999999999888 789999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhh-------------hcCchhhh
Q 017029           74 LLCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEI-------------RQHPWFQA  137 (379)
Q Consensus        74 lltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el-------------l~hp~f~~  137 (379)
                      |++|+.||.+.+...+..+|..+..   .+|+.+++++++||.+||++||.+|||+.|+             ++|||+.+
T Consensus       249 mltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~  328 (336)
T 4g3f_A          249 MLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGE  328 (336)
T ss_dssp             HHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSS
T ss_pred             HHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCC
Confidence            9999999999887777778877654   4678899999999999999999999999997             57888864


Q ss_pred             c
Q 017029          138 H  138 (379)
Q Consensus       138 ~  138 (379)
                      .
T Consensus       329 ~  329 (336)
T 4g3f_A          329 Y  329 (336)
T ss_dssp             C
T ss_pred             C
Confidence            3

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.97  E-value=6.7e-33  Score=272.88  Aligned_cols=137  Identities=31%  Similarity=0.529  Sum_probs=106.7

Q ss_pred             CEEecCCCCCCeEEcCC-CcEEEEecCCcccccCC-----------------------------cccccccCCCCccCcc
Q 017029            1 MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDG-----------------------------HFLKTSCGSPNYAAPE   50 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~-----------------------------~~~~~~~gt~~y~APE   50 (379)
                      .||||||||+|||++.+ +.+||+|||+|+...+.                             ....+.+||+.|+|||
T Consensus       137 gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE  216 (361)
T 4f9c_A          137 GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPE  216 (361)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHH
T ss_pred             CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHH
Confidence            48999999999999876 89999999999754322                             1234568999999999


Q ss_pred             cccCCCCCCCccceeeehhHHHHHhhCCCCCCC-CChHHHHHHHhc----------------------------------
Q 017029           51 VISGKLYAGPEVDVWSCGVILYALLCGTLPFDD-ENIPNLFKKIKG----------------------------------   95 (379)
Q Consensus        51 ~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~-~~~~~~~~~i~~----------------------------------   95 (379)
                      ++.+..+++.++||||+||++|+|++|+.||.+ .+..+....|..                                  
T Consensus       217 ~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  296 (361)
T 4f9c_A          217 VLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCE  296 (361)
T ss_dssp             HHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHH
T ss_pred             HHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHH
Confidence            998876568999999999999999999999954 333333333211                                  


Q ss_pred             ----Ccc----------------CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           96 ----GIY----------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        96 ----~~~----------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                          ...                .....+|+++++||.+||++||.+|+|++|+++||||++
T Consensus       297 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          297 RLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             hhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence                000                111357889999999999999999999999999999985

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.97  E-value=2.3e-32  Score=286.35  Aligned_cols=137  Identities=32%  Similarity=0.523  Sum_probs=121.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+||||+.+|++||+|||+|+..... ...+.|||+.|+|||++.++..++.++||||+||++|+|++|.+|
T Consensus       312 gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~P  390 (689)
T 3v5w_A          312 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP  390 (689)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred             CccccCCchHHeEEeCCCCEEecccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence            4899999999999999999999999999887554 346789999999999997543348999999999999999999999


Q ss_pred             CCCC---ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDE---NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+.   +...+...+....+.+|..+|+++++||.+||++||.+|++     ++||++||||+..
T Consensus       391 F~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i  456 (689)
T 3v5w_A          391 FRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  456 (689)
T ss_dssp             TCGGGCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred             CCCCChHHHHHHHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence            9764   44567778888888999999999999999999999999998     6999999999864

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=5.6e-32  Score=281.33  Aligned_cols=137  Identities=37%  Similarity=0.679  Sum_probs=127.1

Q ss_pred             CEEecCCCCCCeEEcCC--CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~--~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.+  +.+||+|||+|+.+.......+.|||+.|+|||++.+..| +.++||||+||++|+|++|.
T Consensus       275 ~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~  353 (573)
T 3uto_A          275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGL  353 (573)
T ss_dssp             TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSC
T ss_pred             CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCC
Confidence            48999999999999864  8999999999999888777888999999999999999888 79999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+.+..+++.+|..+.+.++    ..+|+++++||.+||+.||.+|||+.|+++||||+..
T Consensus       354 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~  417 (573)
T 3uto_A          354 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  417 (573)
T ss_dssp             CSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence            99999999999999998877665    4689999999999999999999999999999999865

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=99.96  E-value=5.8e-32  Score=259.65  Aligned_cols=134  Identities=30%  Similarity=0.488  Sum_probs=101.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-------------ccccccCCCCccCcccccCCCCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-------------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSl   67 (379)
                      .||||||||+|||++.+|.+||+|||+|+......             ...+.|||+.|||||++.+..| +.++||||+
T Consensus       138 ~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSl  216 (299)
T 4g31_A          138 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSL  216 (299)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHH
T ss_pred             cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHH
Confidence            38999999999999999999999999998765432             1234589999999999999888 799999999


Q ss_pred             hhHHHHHhhCCCCCCCCCh-HHHHHHHhcCccC-CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           68 GVILYALLCGTLPFDDENI-PNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~~-~~~~~~i~~~~~~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||++|||++   ||.+... ......+....++ .+...++.+.+||.+||+.||.+|||+.|+++||||++.
T Consensus       217 Gvilyell~---Pf~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          217 GLILFELLY---PFSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHHHHHS---CCSSHHHHHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHHHHHcc---CCCCccHHHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            999999996   8875432 2233444443322 123456778899999999999999999999999999853

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=99.96  E-value=1.2e-31  Score=257.58  Aligned_cols=134  Identities=28%  Similarity=0.426  Sum_probs=118.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+|||++.++.+||+|||+|+........   ...+||+.|+|||++.+..| +.++|||||||++|||+| 
T Consensus       148 ~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~  226 (299)
T 4asz_A          148 HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTY  226 (299)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcC
Confidence            4899999999999999999999999999876544322   23469999999999998887 799999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |+.||.+.+..++...+..+. .+.|..+++++.+|+.+||+.||++|||++++  ++|++.
T Consensus       227 G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~  286 (299)
T 4asz_A          227 GKQPWYQLSNNEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQN  286 (299)
T ss_dssp             TCCTTTTSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHH
Confidence            999999999999988888775 46788999999999999999999999999999  567764

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=99.96  E-value=4.8e-31  Score=256.53  Aligned_cols=131  Identities=26%  Similarity=0.423  Sum_probs=109.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+||||+.++.+||+|||+|+.......   ..+.+||+.|||||++.+..| +.++|||||||++|||+| 
T Consensus       178 ~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~  256 (329)
T 4aoj_A          178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTY  256 (329)
T ss_dssp             TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcC
Confidence            489999999999999999999999999987644332   234679999999999999888 799999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |+.||.+.+..++...+..+. .+.|..+++++.+|+.+||+.||++|||++||+++
T Consensus       257 G~~Pf~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          257 GKQPWYQLSNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             SCCTTCSSCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            999999999888888887764 67788999999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=99.96  E-value=6.1e-31  Score=253.39  Aligned_cols=133  Identities=28%  Similarity=0.431  Sum_probs=104.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCC--CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+||||++++.+||+|||+|+.....   ....+.+||+.|||||++.+..  .++.++|||||||++|||+
T Consensus       152 ~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Ell  231 (307)
T 3omv_A          152 NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM  231 (307)
T ss_dssp             TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHH
Confidence            4899999999999999999999999999876432   2345679999999999997532  2378999999999999999


Q ss_pred             hCCCCCCCCChHH-HHHHHhcCcc-----CCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           76 CGTLPFDDENIPN-LFKKIKGGIY-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        76 tG~~Pf~~~~~~~-~~~~i~~~~~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      ||+.||.+.+... +...+..+..     ..+..+++++.+||.+||+.||.+|||+.|++++.
T Consensus       232 tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          232 TGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             HSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             HCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            9999998866544 4444444432     23567899999999999999999999999987653

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=99.96  E-value=3.4e-31  Score=255.33  Aligned_cols=131  Identities=27%  Similarity=0.403  Sum_probs=117.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+||||++++.+||+|||+++......   ...+.+||+.|+|||++.+..| +.++|||||||++|||+| 
T Consensus       165 ~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~  243 (308)
T 4gt4_A          165 HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSY  243 (308)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhC
Confidence            48999999999999999999999999998764432   2345689999999999998887 799999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..++...+..+. .+.|..+++++.+|+.+||+.||.+|||+.||+++
T Consensus       244 g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          244 GLQPYCGYSNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            899999999999988887765 46788999999999999999999999999999865

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=99.96  E-value=6.3e-31  Score=258.01  Aligned_cols=131  Identities=30%  Similarity=0.499  Sum_probs=113.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+|||+++++.+||+|||+|+......   ...+.+||+.|||||++.+..| +.++|||||||++|||+| 
T Consensus       205 ~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~  283 (353)
T 4ase_A          205 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSL  283 (353)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTT
T ss_pred             CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhC
Confidence            48999999999999999999999999998764432   2234589999999999998887 799999999999999998 


Q ss_pred             CCCCCCCCCh-HHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENI-PNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~-~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+. ..+...+..+ ..+.|..+++++.++|.+||+.||.+|||+.||++|
T Consensus       284 G~~Pf~~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          284 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            9999998654 4455555554 457788999999999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=5.9e-30  Score=249.21  Aligned_cols=137  Identities=42%  Similarity=0.746  Sum_probs=126.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|.+||+|||+++.. ..+....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       125 ~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~  203 (337)
T 1o6l_A          125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL  203 (337)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSC
T ss_pred             CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCC
Confidence            3799999999999999999999999999864 33445567799999999999998877 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+...+...+..+...+|..+++++++||.+||..||.+||     +++|+++||||+..
T Consensus       204 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~  267 (337)
T 1o6l_A          204 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999888999999999999999999999999999     89999999999854

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=1.6e-30  Score=254.71  Aligned_cols=137  Identities=38%  Similarity=0.727  Sum_probs=121.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.+|.+||+|||+++... .+....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..
T Consensus       144 givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~  222 (353)
T 3txo_A          144 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHA  222 (353)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCC
Confidence            37999999999999999999999999998643 3344567799999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh------hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~------~ell~hp~f~~~  138 (379)
                      ||.+.+..+++.+|..+...+|..+++++.+||.+||..||.+||++      +|+++||||+..
T Consensus       223 Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          223 PFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence            99999999999999999999999999999999999999999999998      899999999864

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=7.5e-30  Score=249.33  Aligned_cols=137  Identities=39%  Similarity=0.698  Sum_probs=125.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|.+||+|||+++.... .....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       138 ~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~  216 (345)
T 1xjd_A          138 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQS  216 (345)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCC
Confidence            379999999999999999999999999986432 334567799999999999998877 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChh-hhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP-EIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~-ell~hp~f~~~  138 (379)
                      ||.+.+..+++.++..+...+|..+++++++||.+||..||.+|||+. ++++||||+..
T Consensus       217 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          217 PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            999999999999999998889999999999999999999999999998 99999999865

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=1.2e-29  Score=248.69  Aligned_cols=137  Identities=38%  Similarity=0.673  Sum_probs=125.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|.+||+|||+++... .+....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       141 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~  219 (353)
T 2i0e_A          141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA  219 (353)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCC
Confidence            37999999999999999999999999998643 3344567799999999999998887 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      ||.+.+..+++++|..+...+|..+++++++||.+||..||.+||+     ++++++||||+..
T Consensus       220 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~  283 (353)
T 2i0e_A          220 PFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  283 (353)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999999999999999999995     6999999999854

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=2.4e-29  Score=242.77  Aligned_cols=135  Identities=38%  Similarity=0.768  Sum_probs=125.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.+|.+||+|||+++.....  ..+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..|
T Consensus       126 ~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~p  202 (318)
T 1fot_A          126 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTP  202 (318)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CccccCCChheEEEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCC
Confidence            3899999999999999999999999999876442  346789999999999998877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.+....+.++..+...+|..++++++++|.+||..||.+||     +++++++||||+..
T Consensus       203 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~  265 (318)
T 1fot_A          203 FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  265 (318)
T ss_dssp             TCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCC
Confidence            99999999999999998999999999999999999999999999     89999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.95  E-value=2.3e-29  Score=247.39  Aligned_cols=136  Identities=38%  Similarity=0.678  Sum_probs=124.9

Q ss_pred             CEEecCCCCCCeEEcCCC----cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++    .+||+|||++.....+....+.+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       135 givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~  213 (361)
T 2yab_A          135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLS  213 (361)
T ss_dssp             TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHH
T ss_pred             CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHh
Confidence            389999999999998877    799999999998877666677899999999999988777 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |..||.+.+..+.+..+..+.+.++    ..+++.+++||.+||..||.+|||+.|+++||||+.
T Consensus       214 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          214 GASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             SCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            9999999999999999998887765    578999999999999999999999999999999974

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.95  E-value=1.7e-29  Score=251.43  Aligned_cols=137  Identities=36%  Similarity=0.671  Sum_probs=121.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.+|.+||+|||+++.. ..+....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..
T Consensus       173 givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~  251 (396)
T 4dc2_A          173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRS  251 (396)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999999863 34455667899999999999999887 799999999999999999999


Q ss_pred             CCCCC---------ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh------hhhhcCchhhhc
Q 017029           80 PFDDE---------NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~------~ell~hp~f~~~  138 (379)
                      ||.+.         ....+++.+......+|..+++++++||.+||+.||.+||++      +|+++||||+..
T Consensus       252 Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i  325 (396)
T 4dc2_A          252 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  325 (396)
T ss_dssp             SSTTTTC------CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred             CCcccccccccchhhHHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence            99642         344567888888899999999999999999999999999995      799999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=2e-29  Score=248.77  Aligned_cols=138  Identities=33%  Similarity=0.560  Sum_probs=113.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC----------------------CcccccccCCCCccCcccccCCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD----------------------GHFLKTSCGSPNYAAPEVISGKLYA   58 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~----------------------~~~~~~~~gt~~y~APE~l~~~~~~   58 (379)
                      .|+||||||+|||++.++.+||+|||+++....                      .......+||+.|+|||++.+...+
T Consensus       129 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  208 (388)
T 3oz6_A          129 GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKY  208 (388)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCC
T ss_pred             CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCC
Confidence            389999999999999999999999999986532                      1223456899999999999875444


Q ss_pred             CCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccC---------------------------------------
Q 017029           59 GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------------------------------------   99 (379)
Q Consensus        59 ~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~---------------------------------------   99 (379)
                      +.++||||+||++|+|++|..||.+.+.......+......                                       
T Consensus       209 ~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (388)
T 3oz6_A          209 TKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKW  288 (388)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHH
T ss_pred             CChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcch
Confidence            89999999999999999999999998877776666421110                                       


Q ss_pred             --------CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          100 --------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       100 --------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                              .+..+++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       289 ~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          289 KNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             HHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             hhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence                    112678899999999999999999999999999999864

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=4.1e-29  Score=251.38  Aligned_cols=136  Identities=43%  Similarity=0.760  Sum_probs=123.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      ||||||||+|||++.++.+||+|||+++... ......+.+||+.|+|||++.+..| +.++||||+||++|+|++|..|
T Consensus       270 iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~P  348 (446)
T 4ejn_A          270 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLP  348 (446)
T ss_dssp             CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCC
Confidence            8999999999999999999999999998643 3344567799999999999988877 7999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.+...+...+......+|..+++++.+||.+||..||.+||     |++|+++||||+..
T Consensus       349 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          349 FYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            99999999999999999999999999999999999999999999     99999999999864

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=3.5e-29  Score=238.59  Aligned_cols=136  Identities=33%  Similarity=0.474  Sum_probs=116.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus       141 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf  219 (308)
T 3g33_A          141 IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLF  219 (308)
T ss_dssp             CCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSC
T ss_pred             cccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCC
Confidence            79999999999999999999999999988766666667789999999999988877 78999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCccC---------------------------CCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           82 DDENIPNLFKKIKGGIYT---------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~~~---------------------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      .+.+......++......                           ..+.+++.+.+||.+||+.||.+|||+.|+++|||
T Consensus       220 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~  299 (308)
T 3g33_A          220 CGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY  299 (308)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTT
T ss_pred             CCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCcc
Confidence            998888777666432111                           11357788999999999999999999999999999


Q ss_pred             hhhc
Q 017029          135 FQAH  138 (379)
Q Consensus       135 f~~~  138 (379)
                      |+..
T Consensus       300 ~~~~  303 (308)
T 3g33_A          300 LHKD  303 (308)
T ss_dssp             C---
T ss_pred             ccCC
Confidence            9864

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.95  E-value=4.6e-29  Score=244.05  Aligned_cols=135  Identities=37%  Similarity=0.707  Sum_probs=125.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.+|.+||+|||+++.....  ..+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       161 ~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~P  237 (350)
T 1rdq_E          161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPP  237 (350)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccccCccceEEECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCC
Confidence            3899999999999999999999999999876543  346789999999999998877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+.+...++.++..+...+|..+++++.++|.+||+.||.+||+     ++++++||||+..
T Consensus       238 f~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~  300 (350)
T 1rdq_E          238 FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence            999999999999999999999999999999999999999999998     9999999999854

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=2.2e-29  Score=242.91  Aligned_cols=138  Identities=30%  Similarity=0.598  Sum_probs=126.0

Q ss_pred             CEEecCCCCCCeEEcC--CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~--~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.  ++.+||+|||++.....+......+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       122 givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~  200 (321)
T 1tki_A          122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCC
Confidence            3899999999999987  78999999999998877766677889999999999988766 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      .||.+.+.......+..+.+.++    ..+++++.+||.+||..||.+|||+.|+++||||++..
T Consensus       201 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            99999999999999988887766    47899999999999999999999999999999998653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.95  E-value=4.2e-29  Score=243.72  Aligned_cols=137  Identities=36%  Similarity=0.661  Sum_probs=121.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|.+||+|||+++... .+....+.+||+.|+|||++.+..+ +.++|+||+||++|+|++|..
T Consensus       130 ~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~  208 (345)
T 3a8x_A          130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRS  208 (345)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998643 3344567799999999999998877 789999999999999999999


Q ss_pred             CCCC---------CChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh------hhhhcCchhhhc
Q 017029           80 PFDD---------ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI------PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~------~ell~hp~f~~~  138 (379)
                      ||..         .....+++.+......+|..++.++++||.+||..||.+|||+      +|+++||||+..
T Consensus       209 pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~  282 (345)
T 3a8x_A          209 PFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV  282 (345)
T ss_dssp             TTTTTTC-------CHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred             CcCCcccccccccccHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence            9975         3445567788888888999999999999999999999999995      799999999864

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=7.4e-29  Score=262.49  Aligned_cols=137  Identities=38%  Similarity=0.679  Sum_probs=127.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc-cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~-~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+||||+.+|.+||+|||+++.. ..+....+.+||+.|+|||++.+..| +.++||||+||++|||++|..
T Consensus       462 gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~  540 (674)
T 3pfq_A          462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQA  540 (674)
T ss_dssp             SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSC
T ss_pred             CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCC
Confidence            4899999999999999999999999999864 33445567899999999999998888 899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~  138 (379)
                      ||.+.+..+++++|......+|..+++++++||.+||+.||.+|+++     +||++||||+..
T Consensus       541 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i  604 (674)
T 3pfq_A          541 PFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYI  604 (674)
T ss_dssp             SSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence            99999999999999999999999999999999999999999999998     999999999864

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.95  E-value=5.1e-29  Score=245.99  Aligned_cols=137  Identities=36%  Similarity=0.627  Sum_probs=125.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCccccc-CCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|++||+|||+++... ......+.+||+.|+|||++.+..| +.++|+||+||++|+|++|..
T Consensus       159 givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~  237 (373)
T 2r5t_A          159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLP  237 (373)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCC
Confidence            37999999999999999999999999998643 3344567799999999999998877 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh----hhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~----~ell~hp~f~~~  138 (379)
                      ||.+.+..+++.+|......+|..++.++++||.+||+.||.+||++    .++++||||+..
T Consensus       238 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~  300 (373)
T 2r5t_A          238 PFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLI  300 (373)
T ss_dssp             TTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence            99999999999999999888999999999999999999999999997    589999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=3.7e-29  Score=234.02  Aligned_cols=142  Identities=71%  Similarity=1.284  Sum_probs=120.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+||+++.++.+||+|||++............+|++.|+|||++.+..+.+.++|+||+|+++|+|++|..||
T Consensus       132 i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~  211 (276)
T 2h6d_A          132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF  211 (276)
T ss_dssp             SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSS
T ss_pred             CccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCC
Confidence            78999999999999999999999999988766655567789999999999988776568999999999999999999999


Q ss_pred             CCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCccc
Q 017029           82 DDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYL  143 (379)
Q Consensus        82 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~~l  143 (379)
                      .+.+.......+..+...+|..++..+.++|.+||..||.+|||+.++++||||++.++.++
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~~~  273 (276)
T 2h6d_A          212 DDEHVPTLFKKIRGGVFYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYL  273 (276)
T ss_dssp             CCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCCGGG
T ss_pred             CCCcHHHHHHHhhcCcccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCchhcc
Confidence            99999899999998888889999999999999999999999999999999999998877654

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.95  E-value=1e-28  Score=244.92  Aligned_cols=139  Identities=33%  Similarity=0.488  Sum_probs=118.4

Q ss_pred             CEEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++ .++.+||+|||+++....+......+||+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus       161 ~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~  240 (394)
T 4e7w_A          161 GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP  240 (394)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            489999999999999 7999999999999887666666677899999999999876545899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-----------------c------------CCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-----------------Y------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-----------------~------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+....+....                 .            .++..+++++.+||.+||+.||.+|||+.|++
T Consensus       241 pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (394)
T 4e7w_A          241 LFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEAL  320 (394)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHh
Confidence            999988766655553311                 0            12345789999999999999999999999999


Q ss_pred             cCchhhhcc
Q 017029          131 QHPWFQAHL  139 (379)
Q Consensus       131 ~hp~f~~~~  139 (379)
                      +||||++..
T Consensus       321 ~hp~f~~~~  329 (394)
T 4e7w_A          321 CHPFFDELR  329 (394)
T ss_dssp             TSGGGSTTT
T ss_pred             cChhhhhhc
Confidence            999998653

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=3.2e-29  Score=254.20  Aligned_cols=138  Identities=33%  Similarity=0.604  Sum_probs=110.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||+++...........+||+.|+|||++.+..| +.++||||+||++|+|++|+.|
T Consensus       184 ~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~p  262 (464)
T 3ttj_A          184 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKIL  262 (464)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCC
Confidence            379999999999999999999999999998776666677899999999999998877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCC-------------------------------CCC-----------CChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGGIYTL-------------------------------PSH-----------LSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~-------------------------------p~~-----------~s~~~~~Li~~mL~~  118 (379)
                      |.+.+..+...+|.......                               |..           .++++++||.+||.+
T Consensus       263 F~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~  342 (464)
T 3ttj_A          263 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  342 (464)
T ss_dssp             SCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCC
Confidence            99988777766664321111                               000           145789999999999


Q ss_pred             CCCCCCChhhhhcCchhhhcc
Q 017029          119 DPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+|||++|+++||||+...
T Consensus       343 dP~~R~ta~e~L~Hp~~~~~~  363 (464)
T 3ttj_A          343 DPAKRISVDDALQHPYINVWY  363 (464)
T ss_dssp             STTTSCCHHHHHTSTTTGGGC
T ss_pred             ChhhCCCHHHHhcChhhhhcc
Confidence            999999999999999998653

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.95  E-value=1.1e-28  Score=236.60  Aligned_cols=139  Identities=32%  Similarity=0.487  Sum_probs=112.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus       139 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  218 (311)
T 3niz_A          139 RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKP  218 (311)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999999876533 334456899999999999875545889999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccC------------------------------CCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYT------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~------------------------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+....+....+......                              ..+.+++++.+||.+||+.||.+|||++|+
T Consensus       219 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  298 (311)
T 3niz_A          219 LFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDA  298 (311)
T ss_dssp             SCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHH
Confidence            99887665555544321110                              123467889999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      ++||||++..
T Consensus       299 l~hp~f~~~~  308 (311)
T 3niz_A          299 MNHPYFKDLD  308 (311)
T ss_dssp             HTSGGGTTSC
T ss_pred             hcCcccccCC
Confidence            9999998653

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.95  E-value=1.1e-28  Score=238.43  Aligned_cols=137  Identities=36%  Similarity=0.626  Sum_probs=120.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... +......+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       141 ~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~  219 (327)
T 3a62_A          141 GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAP  219 (327)
T ss_dssp             TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCC
Confidence            379999999999999999999999999976433 333456789999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ||.+.+......++......+|..+++++++||.+||..||.+||     ++.|+++||||+..
T Consensus       220 pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~  283 (327)
T 3a62_A          220 PFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI  283 (327)
T ss_dssp             SCCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence            999999999999999888899999999999999999999999999     88899999999854

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.95  E-value=1.6e-28  Score=235.83  Aligned_cols=141  Identities=28%  Similarity=0.513  Sum_probs=116.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus       128 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~  207 (317)
T 2pmi_A          128 KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKP  207 (317)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999999876433 334456899999999999875444889999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc----------------------------------CCCCCCChhhhcccccccCCCCCCCCC
Q 017029           80 PFDDENIPNLFKKIKGGIY----------------------------------TLPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~----------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      ||.+.+..+....+.....                                  ..+..+++++.+||.+||+.||.+|||
T Consensus       208 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  287 (317)
T 2pmi_A          208 LFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS  287 (317)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC
T ss_pred             CCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC
Confidence            9999887776666543111                                  112256789999999999999999999


Q ss_pred             hhhhhcCchhhhccCc
Q 017029          126 IPEIRQHPWFQAHLPR  141 (379)
Q Consensus       126 ~~ell~hp~f~~~~~~  141 (379)
                      ++|+++||||++....
T Consensus       288 ~~e~l~hp~f~~~~~~  303 (317)
T 2pmi_A          288 AKQALHHPWFAEYYHH  303 (317)
T ss_dssp             HHHHTTSGGGGGGCC-
T ss_pred             HHHHhCChhhhcccch
Confidence            9999999999976543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.6e-28  Score=236.57  Aligned_cols=148  Identities=26%  Similarity=0.470  Sum_probs=114.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus       120 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  199 (324)
T 3mtl_A          120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP  199 (324)
T ss_dssp             TEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            3899999999999999999999999999765433 233456889999999999875545889999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccC------------------------------CCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYT------------------------------LPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~------------------------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      ||.+.+..+....+......                              .++.+++++.+||.+||+.||.+|||++|+
T Consensus       200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  279 (324)
T 3mtl_A          200 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDA  279 (324)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHH
Confidence            99998887776665432111                              113467889999999999999999999999


Q ss_pred             hcCchhhhccCcccCCCCC
Q 017029          130 RQHPWFQAHLPRYLAVPPP  148 (379)
Q Consensus       130 l~hp~f~~~~~~~l~~~~~  148 (379)
                      ++||||..........+..
T Consensus       280 l~hp~f~~~~~~~~~~~~~  298 (324)
T 3mtl_A          280 MKHPFFLSLGERIHKLPDT  298 (324)
T ss_dssp             TTSGGGGGGCSTTSSSCTT
T ss_pred             hcChhhhhcccccccCCCC
Confidence            9999999875554444433

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.95  E-value=9.8e-29  Score=242.53  Aligned_cols=137  Identities=47%  Similarity=0.812  Sum_probs=123.2

Q ss_pred             CEEecCCCCCCeEEcCCC---cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++   .+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g  226 (362)
T 2bdw_A          148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVG  226 (362)
T ss_dssp             TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHC
Confidence            379999999999998654   599999999988776666667799999999999988777 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+...+...+..+.+.+|.    .+++++++||.+||..||.+|||+.++++||||...
T Consensus       227 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          227 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            9999999999999999888777663    578999999999999999999999999999999753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.95  E-value=1.7e-28  Score=232.75  Aligned_cols=136  Identities=42%  Similarity=0.787  Sum_probs=119.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCC--CCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~--~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+...  .+.++||||+||++|+|++|
T Consensus       157 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g  236 (298)
T 2zv2_A          157 KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFG  236 (298)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHC
Confidence            38999999999999999999999999998765433 3455689999999999976542  36789999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC--CCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      ..||.+.........+......+|  ..+++++.+||.+||..||.+|||+.|+++||||+
T Consensus       237 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          237 QCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            999999888888888877666554  46899999999999999999999999999999996

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.95  E-value=9.8e-29  Score=245.79  Aligned_cols=137  Identities=39%  Similarity=0.721  Sum_probs=110.9

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.   ++.+||+|||+++.........+.+||+.|+|||++.+..| +.++||||+||++|+|++|
T Consensus       181 ~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g  259 (400)
T 1nxk_A          181 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCG  259 (400)
T ss_dssp             TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHS
T ss_pred             CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhC
Confidence            4899999999999998   78999999999988766666677899999999999988877 7899999999999999999


Q ss_pred             CCCCCCCChH----HHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIP----NLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~----~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+..    .....+..+.+.+|    ..+++++++||.+||..||.+|||+.|+++||||...
T Consensus       260 ~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          260 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             SCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCCccccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            9999875432    24556666666655    4689999999999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=1.7e-28  Score=247.64  Aligned_cols=137  Identities=48%  Similarity=0.844  Sum_probs=122.5

Q ss_pred             CEEecCCCCCCeEEc---CCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~---~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++   .++.+||+|||++....... .....+||+.|+|||++.+..| +.++||||+||++|+|++
T Consensus       130 givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~  208 (444)
T 3soa_A          130 GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLV  208 (444)
T ss_dssp             TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHH
T ss_pred             CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHh
Confidence            379999999999998   45789999999998765433 3456789999999999988877 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.+...+...+..+.+.+|.    .+++++++||.+||+.||.+|||+.|+++||||+..
T Consensus       209 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          209 GYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             SSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             CCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            99999999999999999988876653    689999999999999999999999999999999854

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.95  E-value=1.6e-28  Score=233.99  Aligned_cols=137  Identities=34%  Similarity=0.564  Sum_probs=118.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++....... ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       136 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~  214 (297)
T 3fxz_A          136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEP  214 (297)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCC
Confidence            48999999999999999999999999998765433 3345689999999999998887 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC---ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+...   ....|..+++.+.+||.+||..||.+|||++|+++||||+..
T Consensus       215 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             TTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99988776655544322   234466789999999999999999999999999999999865

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.6e-28  Score=237.14  Aligned_cols=137  Identities=39%  Similarity=0.688  Sum_probs=122.7

Q ss_pred             CEEecCCCCCCeEEcCCC----cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++    .+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       134 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  212 (326)
T 2y0a_A          134 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLS  212 (326)
T ss_dssp             TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHH
T ss_pred             CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHH
Confidence            389999999999999887    899999999988766665667789999999999988777 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.+..+....+....+.++    ..+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus       213 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          213 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             SCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            9999999988888888877766554    5689999999999999999999999999999999743

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.95  E-value=2.5e-28  Score=242.07  Aligned_cols=137  Identities=30%  Similarity=0.571  Sum_probs=122.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC---CCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.+|.+||+|||++..........+.+||+.|+|||++.+   ..| +.++||||+||++|+|++|
T Consensus       135 givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG  213 (384)
T 4fr4_A          135 RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRG  213 (384)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHS
T ss_pred             CceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhC
Confidence            389999999999999999999999999998877666778899999999999974   234 7899999999999999999


Q ss_pred             CCCCCC---CChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-hhhhhcCchhhhc
Q 017029           78 TLPFDD---ENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-IPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-~~ell~hp~f~~~  138 (379)
                      ..||.+   .........+......+|..+++++.+||.+||..||.+||+ ++++++||||+..
T Consensus       214 ~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          214 RRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             SCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             CCCCCCCCCccHHHHHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence            999974   445666777788888899999999999999999999999998 8999999999864

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=1.8e-28  Score=232.01  Aligned_cols=139  Identities=30%  Similarity=0.538  Sum_probs=113.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       121 ~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~  200 (292)
T 3o0g_A          121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCC
Confidence            3899999999999999999999999999876533 334556899999999999877655899999999999999998777


Q ss_pred             C-CCCCChHHHHHHHhcCcc-----------------------------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 P-FDDENIPNLFKKIKGGIY-----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 P-f~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      | |.+.+.......+.....                             ...+.+++++++||.+||+.||.+|||++|+
T Consensus       201 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~  280 (292)
T 3o0g_A          201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHH
Confidence            7 666666666665533111                             1123578889999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      ++||||++..
T Consensus       281 l~hp~f~~~~  290 (292)
T 3o0g_A          281 LQHPYFSDFC  290 (292)
T ss_dssp             HTSGGGTTC-
T ss_pred             hcCcccccCC
Confidence            9999998653

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=1.5e-28  Score=238.80  Aligned_cols=140  Identities=28%  Similarity=0.398  Sum_probs=118.2

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++. ++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       151 ~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~  230 (360)
T 3e3p_A          151 NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP  230 (360)
T ss_dssp             CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            3799999999999997 899999999999987766666677899999999999776655899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc--------------------------------CCCCCCChhhhcccccccCCCCCCCCChh
Q 017029           80 PFDDENIPNLFKKIKGGIY--------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIP  127 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~--------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~  127 (379)
                      ||.+.+.......+.....                                ..+...++++.+||.+||+.||.+|||+.
T Consensus       231 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~  310 (360)
T 3e3p_A          231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPY  310 (360)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHH
Confidence            9999887776666543211                                11122567899999999999999999999


Q ss_pred             hhhcCchhhhccC
Q 017029          128 EIRQHPWFQAHLP  140 (379)
Q Consensus       128 ell~hp~f~~~~~  140 (379)
                      |+++||||++...
T Consensus       311 e~l~hp~f~~~~~  323 (360)
T 3e3p_A          311 EALCHPYFDELHD  323 (360)
T ss_dssp             HHTTSGGGGGGGC
T ss_pred             HHhcCccccccCC
Confidence            9999999997643

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=3.2e-28  Score=243.44  Aligned_cols=139  Identities=32%  Similarity=0.450  Sum_probs=116.0

Q ss_pred             CEEecCCCCCCeEEcCC-CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+ +.+||+|||+++....+......+||+.|+|||++.+...++.++||||+||++|||++|+.
T Consensus       176 ~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~  255 (420)
T 1j1b_A          176 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP  255 (420)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCC
Confidence            48999999999999965 67899999999987666555667899999999999876444899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC-----------------ccC------------CCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGG-----------------IYT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+...++...                 .+.            ++..+++++.+||.+||..||.+|||+.|++
T Consensus       256 pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l  335 (420)
T 1j1b_A          256 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC  335 (420)
T ss_dssp             SSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHh
Confidence            99998766655554321                 111            2345789999999999999999999999999


Q ss_pred             cCchhhhcc
Q 017029          131 QHPWFQAHL  139 (379)
Q Consensus       131 ~hp~f~~~~  139 (379)
                      +||||+...
T Consensus       336 ~hp~f~~~~  344 (420)
T 1j1b_A          336 AHSFFDELR  344 (420)
T ss_dssp             TSGGGGGGG
T ss_pred             CCHhhcccc
Confidence            999998653

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.94  E-value=1.8e-28  Score=245.12  Aligned_cols=138  Identities=36%  Similarity=0.664  Sum_probs=120.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCC---CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKL---YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~---~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+|||++.+|.+||+|||+++.......  ..+.+||+.|+|||++.+..   +++.++||||+||++|+|+
T Consensus       188 givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell  267 (410)
T 3v8s_A          188 GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEML  267 (410)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHH
T ss_pred             CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHH
Confidence            389999999999999999999999999987755432  34678999999999998654   1378999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCc--cCCC--CCCChhhhcccccccCCCCCC--CCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGI--YTLP--SHLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+.+....+.+|..+.  ..+|  ..+++++++||.+||..+|.+  |++++||++||||+..
T Consensus       268 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          268 VGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             hCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            9999999999999999887653  3444  479999999999999999988  9999999999999864

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.94  E-value=2.8e-28  Score=236.75  Aligned_cols=138  Identities=25%  Similarity=0.440  Sum_probs=115.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-----CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-----GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-----~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||++.....     .......+||+.|+|||++.+...++.++||||+||++|+|+
T Consensus       144 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell  223 (351)
T 3mi9_A          144 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  223 (351)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHH
Confidence            389999999999999999999999999987642     223345679999999999987555589999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCccCCCCC--------------------------------CChhhhcccccccCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIYTLPSH--------------------------------LSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~--------------------------------~s~~~~~Li~~mL~~dP~~R  123 (379)
                      +|..||.+.+.......+......++..                                .++.+.+||.+||..||.+|
T Consensus       224 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  303 (351)
T 3mi9_A          224 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR  303 (351)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGS
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhC
Confidence            9999999988887777665443333221                                25678899999999999999


Q ss_pred             CChhhhhcCchhhhc
Q 017029          124 ITIPEIRQHPWFQAH  138 (379)
Q Consensus       124 pt~~ell~hp~f~~~  138 (379)
                      ||++|+++||||+..
T Consensus       304 ~t~~e~l~hp~f~~~  318 (351)
T 3mi9_A          304 IDSDDALNHDFFWSD  318 (351)
T ss_dssp             CCHHHHHTSGGGGSS
T ss_pred             CCHHHHhCCCCcCCC
Confidence            999999999999854

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.94  E-value=1.6e-28  Score=232.07  Aligned_cols=137  Identities=31%  Similarity=0.500  Sum_probs=109.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       120 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~  199 (288)
T 1ob3_A          120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP  199 (288)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999999876432 233456899999999999875545899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-----------------------------CCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+....+.....                             .....+++++.+||.+||..||.+|||++|++
T Consensus       200 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  279 (288)
T 1ob3_A          200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (288)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence            9999877766555532110                             11234788899999999999999999999999


Q ss_pred             cCchhhh
Q 017029          131 QHPWFQA  137 (379)
Q Consensus       131 ~hp~f~~  137 (379)
                      +||||++
T Consensus       280 ~hp~f~~  286 (288)
T 1ob3_A          280 EHAYFKE  286 (288)
T ss_dssp             TSGGGGC
T ss_pred             cCcchhh
Confidence            9999985

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.94  E-value=3.4e-28  Score=239.70  Aligned_cols=137  Identities=36%  Similarity=0.633  Sum_probs=122.8

Q ss_pred             CEEecCCCCCCeEE--cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLL--DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl--~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||+  +.++.+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       207 ~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~  285 (373)
T 2x4f_A          207 YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGL  285 (373)
T ss_dssp             TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSS
T ss_pred             CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCC
Confidence            38999999999999  5678999999999998876666667789999999999987766 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+.+..+....+......++    ..+++++++||.+||..||.+|||+.|+++||||++.
T Consensus       286 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          286 SPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999998888888887766554    4689999999999999999999999999999999854

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.94  E-value=8.1e-28  Score=225.80  Aligned_cols=138  Identities=46%  Similarity=0.798  Sum_probs=123.6

Q ss_pred             CEEecCCCCCCeEEcCCCc---EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~---vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||+++.++.   +||+|||++.............|++.|+|||++.+..+ +.++||||+|+++|+|++|
T Consensus       125 ~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g  203 (284)
T 3kk8_A          125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVG  203 (284)
T ss_dssp             TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHS
T ss_pred             CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHC
Confidence            3899999999999987655   99999999988776666667789999999999998877 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+.+.......+..+....|    ..+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       204 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          204 YPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             CCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            999999999888888888776655    36799999999999999999999999999999998653

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.94  E-value=5.2e-28  Score=226.55  Aligned_cols=138  Identities=43%  Similarity=0.852  Sum_probs=125.1

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||+   +.++.+||+|||++............+||+.|+|||++.+. + +.++||||+|+++|+|++|
T Consensus       126 ~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g  203 (277)
T 3f3z_A          126 NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCG  203 (277)
T ss_dssp             TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHS
T ss_pred             CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHC
Confidence            38999999999999   78899999999999887766666778899999999998765 4 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ..||.+.+.......+..+...+|.    .+++.+.++|.+||..||.+|||+.++++||||++...
T Consensus       204 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~  270 (277)
T 3f3z_A          204 YPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS  270 (277)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence            9999999988888888888877774    68999999999999999999999999999999987643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.94  E-value=4.5e-28  Score=227.46  Aligned_cols=137  Identities=41%  Similarity=0.751  Sum_probs=121.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++...... .....+|++.|+|||++.+..+ +.++||||+|+++|+|++|..|
T Consensus       129 ~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  206 (279)
T 3fdn_A          129 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPP  206 (279)
T ss_dssp             TCEECCCCGGGEEECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CEecccCChHhEEEcCCCCEEEEeccccccCCcc-cccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCC
Confidence            3799999999999999999999999998654433 2345689999999999988766 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |.+.+.......+......+|..+++++.+||.+||..||.+|||+.|+++||||+...
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          207 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             TCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred             CCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence            99999999999999888899999999999999999999999999999999999999764

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.94  E-value=2.9e-28  Score=238.94  Aligned_cols=141  Identities=43%  Similarity=0.789  Sum_probs=108.0

Q ss_pred             CEEecCCCCCCeEEcCCCc--EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~--vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.++.  +||+|||+++...........+||+.|+|||++.+..+.+.++||||+||++|+|++|.
T Consensus       136 ~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~  215 (361)
T 3uc3_A          136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA  215 (361)
T ss_dssp             TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred             CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence            3799999999999987765  99999999986554444556789999999999988887666699999999999999999


Q ss_pred             CCCCCCC----hHHHHHHHhcCccCCCC--CCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCc
Q 017029           79 LPFDDEN----IPNLFKKIKGGIYTLPS--HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  141 (379)
Q Consensus        79 ~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~  141 (379)
                      .||.+..    .......+....+.+|.  .+++++++||.+||..||.+|||+.|+++||||...++.
T Consensus       216 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~~  284 (361)
T 3uc3_A          216 YPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPA  284 (361)
T ss_dssp             CSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCCC
T ss_pred             CCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCch
Confidence            9998743    34556666666666665  589999999999999999999999999999999876544

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.94  E-value=2.1e-28  Score=245.49  Aligned_cols=138  Identities=35%  Similarity=0.509  Sum_probs=111.5

Q ss_pred             CEEecCCCCCCeEEcCCCc--EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~--vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++.++.  +||+|||++.....  ...+.+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       220 ~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~  296 (429)
T 3kvw_A          220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ--RVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGY  296 (429)
T ss_dssp             TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC--CCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSS
T ss_pred             CeecCCCCHHHeEEccCCCcceEEeecccceecCC--cccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCC
Confidence            4899999999999999887  99999999976543  3456789999999999998877 79999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccC-----------------------------------------------------------
Q 017029           79 LPFDDENIPNLFKKIKGGIYT-----------------------------------------------------------   99 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~-----------------------------------------------------------   99 (379)
                      .||.+.+..+....+......                                                           
T Consensus       297 ~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  376 (429)
T 3kvw_A          297 PLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNA  376 (429)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHH
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhh
Confidence            999998877665554321100                                                           


Q ss_pred             CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCc
Q 017029          100 LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  141 (379)
Q Consensus       100 ~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~  141 (379)
                      ++...++.+.+||.+||++||.+|||++|+++||||+...+.
T Consensus       377 l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~~  418 (429)
T 3kvw_A          377 LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPK  418 (429)
T ss_dssp             TTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC-----
T ss_pred             ccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCCC
Confidence            011236778999999999999999999999999999976543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.94  E-value=1e-27  Score=225.64  Aligned_cols=139  Identities=39%  Similarity=0.700  Sum_probs=125.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+||+++.++.+||+|||++...... .....+|++.|+|||++.+..+ +.++||||+|+++|+|++|..|
T Consensus       134 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  211 (284)
T 2vgo_A          134 KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPP  211 (284)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CceecCCCHHHEEEcCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCC
Confidence            3899999999999999999999999998765433 2345689999999999998777 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  141 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~  141 (379)
                      |.+.+.......+......+|..++.+++++|.+||..||.+|||++++++||||+....+
T Consensus       212 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~  272 (284)
T 2vgo_A          212 FDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR  272 (284)
T ss_dssp             TCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred             CCCCCHhHHHHHHhccccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence            9999888888888888888999999999999999999999999999999999999976443

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.94  E-value=4.9e-28  Score=238.53  Aligned_cols=138  Identities=30%  Similarity=0.442  Sum_probs=118.5

Q ss_pred             CEEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++ .++.+||+|||++............+||+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus       161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~  240 (383)
T 3eb0_A          161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP  240 (383)
T ss_dssp             TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence            389999999999998 5899999999999987666666677899999999999876645899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-----------------------------CCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+....+.....                             .+|..+++++.+||.+||..||.+|||+.|++
T Consensus       241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAM  320 (383)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHh
Confidence            9999887776666542110                             13556888999999999999999999999999


Q ss_pred             cCchhhhc
Q 017029          131 QHPWFQAH  138 (379)
Q Consensus       131 ~hp~f~~~  138 (379)
                      +||||+..
T Consensus       321 ~hp~f~~~  328 (383)
T 3eb0_A          321 AHPFFDHL  328 (383)
T ss_dssp             TSGGGHHH
T ss_pred             cCHHHHHH
Confidence            99999865

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.94  E-value=5.2e-28  Score=243.68  Aligned_cols=138  Identities=33%  Similarity=0.673  Sum_probs=118.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCccccc-----CCCCCCCccceeeehhHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilye   73 (379)
                      .||||||||+|||++.+|.+||+|||+++.......  ....+||+.|+|||++.     +..| +.++||||+||++||
T Consensus       195 giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~e  273 (437)
T 4aw2_A          195 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYE  273 (437)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHH
T ss_pred             CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHH
Confidence            389999999999999999999999999977654432  23468999999999987     3445 789999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHHhcC--ccCCCC---CCChhhhcccccccCCCCCC--CCChhhhhcCchhhhcc
Q 017029           74 LLCGTLPFDDENIPNLFKKIKGG--IYTLPS---HLSPGARDLIPRMLIVDPMK--RITIPEIRQHPWFQAHL  139 (379)
Q Consensus        74 lltG~~Pf~~~~~~~~~~~i~~~--~~~~p~---~~s~~~~~Li~~mL~~dP~~--Rpt~~ell~hp~f~~~~  139 (379)
                      |++|+.||.+.+..+.+.+|...  .+.+|.   .+++++++||.+||..+|++  |++++|+++||||+...
T Consensus       274 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~  346 (437)
T 4aw2_A          274 MLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGID  346 (437)
T ss_dssp             HHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCC
T ss_pred             HHhCCCCCCCCChhHHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCC
Confidence            99999999999999888888654  244554   48999999999999999888  99999999999998653

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.94  E-value=7.8e-28  Score=238.62  Aligned_cols=138  Identities=33%  Similarity=0.646  Sum_probs=122.6

Q ss_pred             CEEecCCCCCCeEEcC--CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~--~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.  ++.+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       169 givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~  247 (387)
T 1kob_A          169 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGL  247 (387)
T ss_dssp             TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSC
T ss_pred             CeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCC
Confidence            4899999999999974  47899999999998776666667789999999999988777 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      .||.+.+.......+......++    ..+++++++||.+||..||.+|||+.|+++||||+...
T Consensus       248 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          248 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            99999988888888877765544    46799999999999999999999999999999998653

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.94  E-value=4.2e-28  Score=251.76  Aligned_cols=137  Identities=34%  Similarity=0.630  Sum_probs=124.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+|.+||+|||++.....+....+.+||+.|+|||++.+..| +.++||||+||++|+|++|..|
T Consensus       306 gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~P  384 (576)
T 2acx_A          306 RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSP  384 (576)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCC
Confidence            489999999999999999999999999998876666677899999999999998877 7899999999999999999999


Q ss_pred             CCCC----ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDE----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.    ....+...+......+|..+++++++||.+||..||.+||     |++|+++||||+..
T Consensus       385 F~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          385 FQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             SSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             CcccccchhHHHHHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            9875    3456677777777788899999999999999999999999     78999999999864

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.94  E-value=1.1e-27  Score=229.99  Aligned_cols=137  Identities=39%  Similarity=0.680  Sum_probs=123.4

Q ss_pred             CEEecCCCCCCeEEcCCC----cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++    .+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       135 ~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  213 (321)
T 2a2a_A          135 KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLS  213 (321)
T ss_dssp             TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHH
Confidence            389999999999999887    799999999988776655567789999999999988777 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.+..+....+....+.++    ..+++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus       214 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          214 GASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             SCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             CCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            9999999998888888888776655    5789999999999999999999999999999999743

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.94  E-value=7e-28  Score=248.86  Aligned_cols=137  Identities=35%  Similarity=0.630  Sum_probs=122.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.+|.+||+|||++........ ..+.+||+.|+|||++.+..| +.++||||+||++|+|++|..
T Consensus       309 gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~  387 (543)
T 3c4z_A          309 NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARG  387 (543)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCC
Confidence            389999999999999999999999999988765443 344599999999999998877 789999999999999999999


Q ss_pred             CCCCC----ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCCh-----hhhhcCchhhhc
Q 017029           80 PFDDE----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI-----PEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~-----~ell~hp~f~~~  138 (379)
                      ||.+.    ....+.+.+......+|..+++++++||.+||..||.+||++     +++++||||+..
T Consensus       388 PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          388 PFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             SSCCTTCCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             CCCCCccchhHHHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            99875    456778888888888999999999999999999999999964     889999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.94  E-value=8.4e-28  Score=234.50  Aligned_cols=136  Identities=44%  Similarity=0.830  Sum_probs=117.6

Q ss_pred             CEEecCCCCCCeEEcCCCc---EEEEecCCcccccCCcc-cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHF-LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~---vKL~DFGls~~~~~~~~-~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.   +||+|||++........ ....+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       150 ~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  228 (351)
T 3c0i_A          150 NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLS  228 (351)
T ss_dssp             TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHH
T ss_pred             CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHH
Confidence            3899999999999987655   99999999987765433 345689999999999998877 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+. ...++..+..+.+..+    ..+++++++||.+||..||.+|||+.|+++||||+..
T Consensus       229 g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          229 GCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             SSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            99999885 4566677777766554    5789999999999999999999999999999999854

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.94  E-value=4.1e-28  Score=238.28  Aligned_cols=138  Identities=34%  Similarity=0.594  Sum_probs=104.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       147 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~p  225 (371)
T 2xrw_A          147 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVL  225 (371)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCC
Confidence            379999999999999999999999999987765555566789999999999998777 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCC------------------------------------CC------CCChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGGIYTL------------------------------------PS------HLSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~------------------------------------p~------~~s~~~~~Li~~mL~~  118 (379)
                      |.+.+....+.++.......                                    |.      ..++++++||.+||..
T Consensus       226 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~  305 (371)
T 2xrw_A          226 FPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI  305 (371)
T ss_dssp             SCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcC
Confidence            99988877777665432211                                    00      0146789999999999


Q ss_pred             CCCCCCChhhhhcCchhhhcc
Q 017029          119 DPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+|||++|+++||||+...
T Consensus       306 dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          306 DASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             SGGGSCCHHHHHHSHHHHTTC
T ss_pred             ChhhCCCHHHHhCCcchhhhc
Confidence            999999999999999998653

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.94  E-value=3.2e-28  Score=239.82  Aligned_cols=135  Identities=35%  Similarity=0.466  Sum_probs=110.7

Q ss_pred             CEEecCCCCCCeEEc--CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~--~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++  .++.+||+|||++......  ....+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       179 ~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~  255 (382)
T 2vx3_A          179 SIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGE  255 (382)
T ss_dssp             CEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSS
T ss_pred             CEEcCCCCcccEEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCC
Confidence            389999999999995  4788999999999876432  346789999999999998877 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC------------------C------------------C-------------------
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP------------------S------------------H-------------------  103 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p------------------~------------------~-------------------  103 (379)
                      .||.+.+..+....+.......|                  .                  .                   
T Consensus       256 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  335 (382)
T 2vx3_A          256 PLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRR  335 (382)
T ss_dssp             CSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTT
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccc
Confidence            99999887777666643211111                  0                  0                   


Q ss_pred             ---------CChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          104 ---------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       104 ---------~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                               .++++++||.+||+.||.+|||++|+++||||++.
T Consensus       336 ~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          336 AGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             TTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             cccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence                     00367899999999999999999999999999864

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.94  E-value=1.4e-27  Score=233.60  Aligned_cols=140  Identities=33%  Similarity=0.554  Sum_probs=115.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++.......    .....+||+.|+|||++.+....+.++||||+||++|+|++
T Consensus       148 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~  227 (364)
T 3qyz_A          148 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  227 (364)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHH
Confidence            38999999999999999999999999998764332    23456899999999988765545889999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-------------------------------CCCCCCChhhhcccccccCCCCCCCCC
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-------------------------------TLPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      |..||.+.+..+....+.....                               ...+.+++++.+||.+||..||.+|||
T Consensus       228 g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t  307 (364)
T 3qyz_A          228 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE  307 (364)
T ss_dssp             SSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC
T ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC
Confidence            9999998876666555532111                               012457889999999999999999999


Q ss_pred             hhhhhcCchhhhccC
Q 017029          126 IPEIRQHPWFQAHLP  140 (379)
Q Consensus       126 ~~ell~hp~f~~~~~  140 (379)
                      +.|+++||||++...
T Consensus       308 ~~e~l~hp~~~~~~~  322 (364)
T 3qyz_A          308 VEQALAHPYLEQYYD  322 (364)
T ss_dssp             HHHHHTSGGGTTTCC
T ss_pred             HHHHhcCcchhhccC
Confidence            999999999997643

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=99.94  E-value=2.6e-28  Score=234.48  Aligned_cols=132  Identities=19%  Similarity=0.298  Sum_probs=97.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCC-----CCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~-----~~~~~DiWSlGvi   70 (379)
                      .||||||||+||||+.++++||+|||+|+.......     ..+.+||+.|+|||++.+...     ++.++|||||||+
T Consensus       128 ~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvv  207 (303)
T 3hmm_A          128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  207 (303)
T ss_dssp             CEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred             CEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHH
Confidence            489999999999999999999999999987654321     234589999999999976521     2578999999999


Q ss_pred             HHHHhhCCCCCCCC---------------ChHHHHHHHhcCcc--CCCCC-----CChhhhcccccccCCCCCCCCChhh
Q 017029           71 LYALLCGTLPFDDE---------------NIPNLFKKIKGGIY--TLPSH-----LSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        71 lyelltG~~Pf~~~---------------~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      +|||+||..||...               ....+...+.....  .+|..     .+..+.+|+.+||+.||.+|||+.|
T Consensus       208 l~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~e  287 (303)
T 3hmm_A          208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             HHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence            99999997765321               22344444443332  33332     2246789999999999999999999


Q ss_pred             hhcC
Q 017029          129 IRQH  132 (379)
Q Consensus       129 ll~h  132 (379)
                      +++.
T Consensus       288 i~~~  291 (303)
T 3hmm_A          288 IKKT  291 (303)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9864

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.1e-27  Score=235.31  Aligned_cols=136  Identities=32%  Similarity=0.510  Sum_probs=114.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||+++....  .....+||+.|+|||++.+...++.++||||+||++|+|++|+.|
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  225 (367)
T 1cm8_A          148 GIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  225 (367)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CccccCcCHHHEEEcCCCCEEEEeeeccccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCC
Confidence            389999999999999999999999999987543  235668999999999998744448999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-------------------------------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+..+....|.....                               ......++.+.+||.+||..||.+|||++|+
T Consensus       226 f~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~  305 (367)
T 1cm8_A          226 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  305 (367)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHH
Confidence            999887766665543211                               1224568899999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++||||+..
T Consensus       306 l~hp~f~~~  314 (367)
T 1cm8_A          306 LAHPYFESL  314 (367)
T ss_dssp             HHSGGGTTT
T ss_pred             hcChHHHhh
Confidence            999999865

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.94  E-value=3.6e-28  Score=235.79  Aligned_cols=132  Identities=32%  Similarity=0.646  Sum_probs=117.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++..........+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..|
T Consensus       150 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  229 (335)
T 3dls_A          150 DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP  229 (335)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred             CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCc
Confidence            38999999999999999999999999999887766667788999999999999887767899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |....      .........|..+++++.+||.+||..||.+|||++++++||||++.
T Consensus       230 f~~~~------~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          230 FCELE------ETVEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CSSGG------GGTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             hhhHH------HHHhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            97632      23344556677899999999999999999999999999999999864

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.94  E-value=1.1e-27  Score=239.66  Aligned_cols=138  Identities=35%  Similarity=0.611  Sum_probs=117.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCccccc-------CCCCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVIS-------GKLYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~-------~~~~~~~~~DiWSlGvil   71 (379)
                      .||||||||+|||++.+|++||+|||+++.......  ..+.+||+.|+|||++.       +..| +.++||||+||++
T Consensus       182 giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvil  260 (412)
T 2vd5_A          182 GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFA  260 (412)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHH
T ss_pred             CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHH
Confidence            389999999999999999999999999987755433  23468999999999997       3445 7899999999999


Q ss_pred             HHHhhCCCCCCCCChHHHHHHHhcCc--cCCC---CCCChhhhcccccccCCCCCCC---CChhhhhcCchhhhccC
Q 017029           72 YALLCGTLPFDDENIPNLFKKIKGGI--YTLP---SHLSPGARDLIPRMLIVDPMKR---ITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        72 yelltG~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~~~~Li~~mL~~dP~~R---pt~~ell~hp~f~~~~~  140 (379)
                      |||++|+.||.+.+..+.+.+|....  ..+|   ..+++++++||.+||. +|.+|   ++++|+++||||+....
T Consensus       261 yelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w  336 (412)
T 2vd5_A          261 YEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDW  336 (412)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCS
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCH
Confidence            99999999999999988888887532  3334   5799999999999999 99998   58999999999987543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=9.2e-28  Score=231.49  Aligned_cols=138  Identities=35%  Similarity=0.540  Sum_probs=116.4

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.   ++.+||+|||++............+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       151 givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g  229 (327)
T 3lm5_A          151 NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTH  229 (327)
T ss_dssp             TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhC
Confidence            4899999999999988   78999999999988766655566789999999999988777 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+.+.......+.......+    ..+++.+.+||.+||..||.+|||++++++||||+...
T Consensus       230 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~  295 (327)
T 3lm5_A          230 TSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWD  295 (327)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCC
T ss_pred             CCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccc
Confidence            999999988888777776554443    46889999999999999999999999999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.94  E-value=1.5e-27  Score=234.11  Aligned_cols=135  Identities=44%  Similarity=0.834  Sum_probs=120.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC------CCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK------LYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~------~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.+|.+||+|||++............+||+.|+|||++.+.      .+ +.++||||+||++|+|
T Consensus       220 gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~el  298 (365)
T 2y7j_A          220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTL  298 (365)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHH
Confidence            3899999999999999999999999999887766666778999999999998632      34 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      ++|..||.+.+.......+..+.+.++    ..++..+.+||.+||..||.+|||+.++++||||+
T Consensus       299 l~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          299 LAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            999999999888888888877766554    46889999999999999999999999999999996

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.94  E-value=1.4e-27  Score=226.47  Aligned_cols=141  Identities=40%  Similarity=0.762  Sum_probs=124.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC---CcccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~---~~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++.....   ........|++.|+|||++.+.. +.+.++||||+||++|+|++
T Consensus       129 ~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~  208 (305)
T 2wtk_C          129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT  208 (305)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHH
T ss_pred             CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHh
Confidence            389999999999999999999999999987642   22334567999999999997643 33678999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  141 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~  141 (379)
                      |..||.+.+.......+..+.+.+|..+++.+.++|.+||..||.+|||++|+++||||+...+.
T Consensus       209 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          209 GLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             SSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             CCCCCCCchHHHHHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            99999999999999999999889999999999999999999999999999999999999976543

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.94  E-value=6.2e-28  Score=234.90  Aligned_cols=133  Identities=29%  Similarity=0.459  Sum_probs=111.1

Q ss_pred             CEEecCCCCCCeEEcC-------------------------CCcEEEEecCCcccccCCcccccccCCCCccCcccccCC
Q 017029            1 MVVHRDLKPENLLLDS-------------------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK   55 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-------------------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~   55 (379)
                      .||||||||+|||++.                         ++.+||+|||++......  ....+||+.|+|||++.+.
T Consensus       157 ~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~  234 (360)
T 3llt_A          157 SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNL  234 (360)
T ss_dssp             TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTC
T ss_pred             CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCC
Confidence            3899999999999975                         789999999999865432  3466899999999999988


Q ss_pred             CCCCCccceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC---------------------------------
Q 017029           56 LYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---------------------------------  102 (379)
Q Consensus        56 ~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---------------------------------  102 (379)
                      .+ +.++||||+||++|+|++|..||.+.+..+....+.....++|.                                 
T Consensus       235 ~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~  313 (360)
T 3llt_A          235 GW-DVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINS  313 (360)
T ss_dssp             CC-CTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHH
T ss_pred             CC-CCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhh
Confidence            77 78999999999999999999999988877766665443333221                                 


Q ss_pred             -------------CCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029          103 -------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus       103 -------------~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                                   ..++.+.+||.+||+.||.+|||++|+++||||+
T Consensus       314 ~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          314 IKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             hhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence                         1236677999999999999999999999999995

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.94  E-value=1e-27  Score=233.93  Aligned_cols=138  Identities=47%  Similarity=0.870  Sum_probs=107.4

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.   ++.+||+|||++..........+.+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       168 ~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g  246 (349)
T 2w4o_A          168 GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCG  246 (349)
T ss_dssp             TCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhC
Confidence            3799999999999976   88999999999988766555567789999999999998777 7899999999999999999


Q ss_pred             CCCCCCCChHH-HHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPN-LFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~-~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+..... ....+..+.+..+    ..++.++.+||.+||..||.+|||+.|+++||||+...
T Consensus       247 ~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          247 FEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             SCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             CCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            99998765443 6677776665443    46889999999999999999999999999999998653

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.94  E-value=1.9e-27  Score=242.39  Aligned_cols=136  Identities=44%  Similarity=0.782  Sum_probs=122.4

Q ss_pred             CEEecCCCCCCeEEcCC---CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~---~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++..   +.+||+|||++............+||+.|+|||++.+ .| +.++||||+||++|+|++|
T Consensus       156 ~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g  233 (494)
T 3lij_A          156 NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAG  233 (494)
T ss_dssp             TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHS
T ss_pred             CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhC
Confidence            38999999999999764   4599999999998877666677899999999999875 45 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+..++...+..+.+.++    ..+++.+++||.+||+.||.+|||+.|+++||||+..
T Consensus       234 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          234 YPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            999999999999999988877655    3689999999999999999999999999999999875

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.94  E-value=1.2e-27  Score=241.17  Aligned_cols=139  Identities=33%  Similarity=0.445  Sum_probs=102.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----------------------------cccccccCCCCccCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----------------------------HFLKTSCGSPNYAAPEVI   52 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----------------------------~~~~~~~gt~~y~APE~l   52 (379)
                      .||||||||+|||++.++.+||+|||+++.....                            ......+||+.|+|||++
T Consensus       176 ~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~  255 (458)
T 3rp9_A          176 GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELI  255 (458)
T ss_dssp             TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHH
T ss_pred             CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHh
Confidence            3899999999999999999999999999876422                            123456899999999987


Q ss_pred             cCCCCCCCccceeeehhHHHHHhh-----------CCCCCCCCCh--------------------HHHHHHHhcCc----
Q 017029           53 SGKLYAGPEVDVWSCGVILYALLC-----------GTLPFDDENI--------------------PNLFKKIKGGI----   97 (379)
Q Consensus        53 ~~~~~~~~~~DiWSlGvilyellt-----------G~~Pf~~~~~--------------------~~~~~~i~~~~----   97 (379)
                      .+...++.++||||+||++|||++           |.++|.+.+.                    ......|....    
T Consensus       256 ~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~  335 (458)
T 3rp9_A          256 LLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPS  335 (458)
T ss_dssp             TTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCC
T ss_pred             hCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCC
Confidence            544444899999999999999998           7777766431                    11111111000    


Q ss_pred             ---------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           98 ---------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        98 ---------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                                                 ....+..++++.+||.+||.+||.+|||++|+++||||+...
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          336 EEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             HHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence                                       011235689999999999999999999999999999998753

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=4.9e-28  Score=245.67  Aligned_cols=138  Identities=44%  Similarity=0.752  Sum_probs=123.7

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||+   +.++.+||+|||++............+||+.|+|||++.+. | +.++||||+||++|+|++|
T Consensus       146 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g  223 (484)
T 3nyv_A          146 KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT-Y-DEKCDVWSTGVILYILLSG  223 (484)
T ss_dssp             TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHTC-C-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecCC-C-CCcceeHHHHHHHHHHHHC
Confidence            37999999999999   46789999999999888776666778999999999999873 5 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ..||.+.+..++...+..+.+.++    ..+++++++||.+||+.||.+|||+.|+++||||+....
T Consensus       224 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          224 CPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            999999999999999988876554    468999999999999999999999999999999987643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.94  E-value=7.4e-28  Score=234.64  Aligned_cols=137  Identities=38%  Similarity=0.745  Sum_probs=118.3

Q ss_pred             CEEecCCCCCCeEEcCC----CcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSK----WNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~----~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||+..+    +.+||+|||++...... ....+.+||+.|+|||++.+..| +.++||||+||++|+|+
T Consensus       136 givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell  214 (342)
T 2qr7_A          136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTML  214 (342)
T ss_dssp             TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHH
T ss_pred             CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHh
Confidence            38999999999998543    35999999999876543 34567799999999999987766 78999999999999999


Q ss_pred             hCCCCCCC---CChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           76 CGTLPFDD---ENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~---~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+   .+..++...+..+.+.++    ..+++++++||.+||..||.+|||+.++++||||...
T Consensus       215 ~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          215 TGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             cCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            99999986   466778888888877665    4689999999999999999999999999999999764

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.94  E-value=2.2e-27  Score=228.63  Aligned_cols=137  Identities=34%  Similarity=0.610  Sum_probs=118.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       161 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~  239 (321)
T 2c30_A          161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEP  239 (321)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            4899999999999999999999999999876543 23345689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccC---CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYT---LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+.....+   .+..+++.+.++|.+||..||.+|||+.|+++||||...
T Consensus       240 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          240 PYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             TTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred             CCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence            99998887777777655432   234578899999999999999999999999999999854

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.94  E-value=2.4e-27  Score=242.19  Aligned_cols=137  Identities=43%  Similarity=0.746  Sum_probs=124.5

Q ss_pred             CEEecCCCCCCeEEcCCC---cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++   .+||+|||++............+||+.|+|||++.+ .+ +.++||||+||++|+|++|
T Consensus       166 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g  243 (504)
T 3q5i_A          166 NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCG  243 (504)
T ss_dssp             TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhC
Confidence            489999999999998876   699999999998877666677899999999999875 35 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+.+..++...+..+.+.++    ..+++++++||.+||..||.+|||++|+++||||+...
T Consensus       244 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          244 YPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            999999999999999998887665    57899999999999999999999999999999998764

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.94  E-value=1.5e-27  Score=227.06  Aligned_cols=138  Identities=28%  Similarity=0.567  Sum_probs=107.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       122 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  201 (311)
T 4agu_A          122 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVP  201 (311)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCC
Confidence            3899999999999999999999999999876533 334566899999999999875545899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-------------------CCC------------CCCChhhhcccccccCCCCCCCCChhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-------------------TLP------------SHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-------------------~~p------------~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ||.+.+..+....+.....                   ..|            +.++.++.+||.+||..||.+|||++|
T Consensus       202 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  281 (311)
T 4agu_A          202 LWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQ  281 (311)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHH
T ss_pred             CCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHH
Confidence            9999877665544432110                   011            357888999999999999999999999


Q ss_pred             hhcCchhhhc
Q 017029          129 IRQHPWFQAH  138 (379)
Q Consensus       129 ll~hp~f~~~  138 (379)
                      +++||||++.
T Consensus       282 ll~hp~f~~~  291 (311)
T 4agu_A          282 LLHHPYFENI  291 (311)
T ss_dssp             HHTSGGGTTC
T ss_pred             HhcChHHHhc
Confidence            9999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.94  E-value=1.7e-27  Score=231.38  Aligned_cols=137  Identities=31%  Similarity=0.447  Sum_probs=115.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||+|||++.++.+||+|||++...... ......+||+.|+|||++.+...++.++||||+||++|+|++|..|
T Consensus       133 ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~  212 (346)
T 1ua2_A          133 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF  212 (346)
T ss_dssp             CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCC
Confidence            799999999999999999999999999876443 3345668999999999997755458899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCC----------------------------CCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           81 FDDENIPNLFKKIKGGIYTL----------------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~----------------------------p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |.+.+..+....+.......                            ...+++++++||.+||..||.+|||+.|+++|
T Consensus       213 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          213 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            99988777766664321100                            13457889999999999999999999999999


Q ss_pred             chhhhc
Q 017029          133 PWFQAH  138 (379)
Q Consensus       133 p~f~~~  138 (379)
                      |||+..
T Consensus       293 ~~f~~~  298 (346)
T 1ua2_A          293 KYFSNR  298 (346)
T ss_dssp             GGGTSS
T ss_pred             hhhhcC
Confidence            999865

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.94  E-value=2.8e-27  Score=223.72  Aligned_cols=138  Identities=43%  Similarity=0.726  Sum_probs=124.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.+..+ +.++||||+|+++|+|++|..
T Consensus       135 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~  213 (294)
T 2rku_A          135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP  213 (294)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            3899999999999999999999999999876532 33445679999999999988776 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+....+....+......+|..+++.+.++|.+||..||.+|||++++++||||+...
T Consensus       214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  273 (294)
T 2rku_A          214 PFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  273 (294)
T ss_dssp             TTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCCCCCHHHHHHHHhhccCCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCC
Confidence            999999888888888888889999999999999999999999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.94  E-value=2.8e-28  Score=239.15  Aligned_cols=135  Identities=21%  Similarity=0.272  Sum_probs=108.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC--CCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++.++.+||+|||++......  .....|++.|+|||++.+  ..+ +.++||||+||++|+|++|.
T Consensus       214 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~  290 (371)
T 3q60_A          214 GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLF  290 (371)
T ss_dssp             TEEETTCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSS
T ss_pred             CCccCcCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCC
Confidence            4899999999999999999999999999876432  224567799999999986  555 79999999999999999999


Q ss_pred             CCCCCCChHHH--HHH-----HhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNL--FKK-----IKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~--~~~-----i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+......  +..     .....+  +.+..+++.+.+||.+||..||.+|||+.++++||||++.
T Consensus       291 ~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          291 LPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             CSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            99987643210  100     011122  2235789999999999999999999999999999999865

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.94  E-value=5.9e-28  Score=231.23  Aligned_cols=132  Identities=28%  Similarity=0.469  Sum_probs=107.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++............+||+.|+|||++.+ .+ +.++||||+||++|+|++|..|
T Consensus       177 ~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~  254 (311)
T 3p1a_A          177 GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMEL  254 (311)
T ss_dssp             TEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCC
T ss_pred             CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCC
Confidence            389999999999999999999999999988766555566789999999999987 45 7899999999999999999776


Q ss_pred             CCCCChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           81 FDDENIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      |.+..   ....+..+..  .++..+++++.++|.+||+.||.+|||++|+++||||++
T Consensus       255 ~~~~~---~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          255 PHGGE---GWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CSSHH---HHHHHTTTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CCCcc---HHHHHhccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            65432   2334444332  235678999999999999999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.94  E-value=1.4e-27  Score=242.80  Aligned_cols=137  Identities=45%  Similarity=0.789  Sum_probs=119.4

Q ss_pred             CEEecCCCCCCeEEc---CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~---~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++   .++.+||+|||++............+||+.|+|||++.+. | +.++||||+||++|+|++|
T Consensus       141 ~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~-~~~~DiwslG~il~~ll~g  218 (486)
T 3mwu_A          141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSG  218 (486)
T ss_dssp             TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGSC-C-CHHHHHHHHHHHHHHHHHS
T ss_pred             CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCCC-C-CchhhHHHHHHHHHHHHhC
Confidence            379999999999995   4567999999999887766666778899999999999864 5 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+.+..++...+..+.+.++    ..+++++++||.+||..||.+|||+.++++||||+...
T Consensus       219 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          219 TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             SCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            999999999999999988876554    35799999999999999999999999999999998753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.94  E-value=9.1e-28  Score=225.03  Aligned_cols=137  Identities=39%  Similarity=0.709  Sum_probs=96.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++...... ......+|++.|+|||++.+..+ +.++||||+|+++|+|++|..
T Consensus       132 ~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~  210 (278)
T 3cok_A          132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRP  210 (278)
T ss_dssp             TEECSSCCGGGEEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSC
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            3899999999999999999999999999876432 22345679999999999987766 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||..........++....+..|..++.++.++|.+||..||.+|||++++++||||...
T Consensus       211 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          211 PFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             SSCCCSCC-----CCSSCCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             CCCChhHHHHHHHHhhcccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence            99987777766777666677888899999999999999999999999999999999754

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.94  E-value=2e-27  Score=229.33  Aligned_cols=141  Identities=38%  Similarity=0.746  Sum_probs=115.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||++......   ......+||+.|+|||++.+..+.+.++||||+||++|+|++|
T Consensus       125 givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  204 (323)
T 3tki_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (323)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence            3899999999999999999999999999876432   2234668999999999998877767889999999999999999


Q ss_pred             CCCCCCCChH-HHHHHHhcCccCC--CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccCc
Q 017029           78 TLPFDDENIP-NLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPR  141 (379)
Q Consensus        78 ~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~~  141 (379)
                      ..||.+.... ..+..........  ...+++.+.+||.+||..||.+|||++|+++||||+.....
T Consensus       205 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  271 (323)
T 3tki_A          205 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK  271 (323)
T ss_dssp             SCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCCC
T ss_pred             CCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccccc
Confidence            9999875543 2333333333222  24689999999999999999999999999999999876543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.94  E-value=2.5e-27  Score=227.44  Aligned_cols=138  Identities=25%  Similarity=0.472  Sum_probs=110.9

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++ .+||+|||++............+|++.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       150 ~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  229 (330)
T 3nsz_A          150 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE  229 (330)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCC
Confidence            389999999999999776 8999999999887766666777899999999999874445899999999999999999999


Q ss_pred             CCCCC-ChHHHHHH-------------HhcCccCC------------------------CCCCChhhhcccccccCCCCC
Q 017029           80 PFDDE-NIPNLFKK-------------IKGGIYTL------------------------PSHLSPGARDLIPRMLIVDPM  121 (379)
Q Consensus        80 Pf~~~-~~~~~~~~-------------i~~~~~~~------------------------p~~~s~~~~~Li~~mL~~dP~  121 (379)
                      ||... +.......             +.......                        +..+++++.+||.+||..||.
T Consensus       230 p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~  309 (330)
T 3nsz_A          230 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ  309 (330)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGG
T ss_pred             CcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcc
Confidence            99543 22222221             11111111                        122789999999999999999


Q ss_pred             CCCChhhhhcCchhhhc
Q 017029          122 KRITIPEIRQHPWFQAH  138 (379)
Q Consensus       122 ~Rpt~~ell~hp~f~~~  138 (379)
                      +|||++|+++||||+..
T Consensus       310 ~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          310 SRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             GSCCHHHHHTSGGGTTC
T ss_pred             cCCCHHHHhcCccHhhh
Confidence            99999999999999865

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.94  E-value=2.8e-27  Score=228.83  Aligned_cols=138  Identities=44%  Similarity=0.741  Sum_probs=125.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++..... .......+|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       161 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~  239 (335)
T 2owb_A          161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKP  239 (335)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcC
Confidence            389999999999999999999999999987653 233455689999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||.+....+....+....+.+|..+++.+.+||.+||..||.+|||++|+++||||+...
T Consensus       240 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~  299 (335)
T 2owb_A          240 PFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGY  299 (335)
T ss_dssp             TTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence            999998888888888888889999999999999999999999999999999999998753

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.94  E-value=1.4e-27  Score=235.33  Aligned_cols=137  Identities=22%  Similarity=0.352  Sum_probs=107.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--------ccccccCCCCccCcccccC--CCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvi   70 (379)
                      .|+||||||+|||++.++.+||+|||.+.......        .....+||+.|+|||++.+  ..+ +.++||||+||+
T Consensus       148 ~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~i  226 (389)
T 3gni_B          148 GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGIT  226 (389)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHH
Confidence            48999999999999999999999999886543221        1233478999999999987  445 789999999999


Q ss_pred             HHHHhhCCCCCCCCChHHHHHHHhcCcc----------------------------------------------CCCCCC
Q 017029           71 LYALLCGTLPFDDENIPNLFKKIKGGIY----------------------------------------------TLPSHL  104 (379)
Q Consensus        71 lyelltG~~Pf~~~~~~~~~~~i~~~~~----------------------------------------------~~p~~~  104 (379)
                      +|+|++|..||.+.+.......+..+..                                              +.+..+
T Consensus       227 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (389)
T 3gni_B          227 ACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTF  306 (389)
T ss_dssp             HHHHHHSSCTTTTCCSTTHHHHC--------------------------------------------------------C
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcccccc
Confidence            9999999999988655444333322211                                              234567


Q ss_pred             ChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          105 SPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       105 s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++++.+||.+||+.||.+|||++|+++||||+..
T Consensus       307 s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          307 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence            8899999999999999999999999999999865

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.94  E-value=1.2e-27  Score=231.10  Aligned_cols=138  Identities=42%  Similarity=0.750  Sum_probs=99.6

Q ss_pred             CEEecCCCCCCeEEcCCC---cEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++   .+||+|||++...... ....+.+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       126 ~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~  204 (325)
T 3kn6_A          126 GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLS  204 (325)
T ss_dssp             TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCC-CHHHHHHHHHHHHHHHHH
T ss_pred             CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHh
Confidence            389999999999998765   8999999999866443 34456789999999999988877 789999999999999999


Q ss_pred             CCCCCCCCC-------hHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           77 GTLPFDDEN-------IPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        77 G~~Pf~~~~-------~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |..||.+.+       ..++...+..+.+.++.    .+++++++||.+||..||.+|||++|+++||||+...
T Consensus       205 g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          205 GQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             SSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             CCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence            999998643       45677888888776663    5899999999999999999999999999999998653

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.93  E-value=9.7e-28  Score=225.69  Aligned_cols=137  Identities=33%  Similarity=0.540  Sum_probs=101.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccc----cCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----SGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l----~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++............+||+.|+|||++    .+..+ +.++||||+||++|+|++
T Consensus       130 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~  208 (290)
T 3fme_A          130 SVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAI  208 (290)
T ss_dssp             CCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHH
Confidence            3799999999999999999999999999877665555566899999999997    33344 789999999999999999


Q ss_pred             CCCCCCCC-Ch-HHHHHHHhcCccCCC-CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDE-NI-PNLFKKIKGGIYTLP-SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~-~~-~~~~~~i~~~~~~~p-~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||... .. ......+.......+ ..+++++.++|.+||+.||.+|||+.|+++||||+..
T Consensus       209 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          209 LRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             TSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCccccCchHHHHHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            99999863 33 333334444444333 4689999999999999999999999999999999865

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.93  E-value=1.8e-27  Score=234.08  Aligned_cols=137  Identities=33%  Similarity=0.492  Sum_probs=104.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||+++.....  ....+||+.|+|||++.+...++.++||||+||++|+|++|+.|
T Consensus       152 givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~p  229 (367)
T 2fst_X          152 DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  229 (367)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CeeeCCCCHhhEEECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCC
Confidence            3799999999999999999999999999875432  34568999999999998744448999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC-----------------------C--------CCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIYT-----------------------L--------PSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~-----------------------~--------p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+.......+......                       .        ....++.+.+||.+||..||.+|||+.|+
T Consensus       230 f~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~  309 (367)
T 2fst_X          230 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  309 (367)
T ss_dssp             CCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHH
Confidence            9998877666555431110                       0        12467889999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      ++||||+...
T Consensus       310 L~hp~~~~~~  319 (367)
T 2fst_X          310 LAHAYFAQYH  319 (367)
T ss_dssp             HTSGGGTTTC
T ss_pred             hcChhhhhcc
Confidence            9999998653

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.93  E-value=8.4e-27  Score=233.84  Aligned_cols=139  Identities=32%  Similarity=0.455  Sum_probs=102.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----------------------ccccccCCCCccCcccccCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----------------------FLKTSCGSPNYAAPEVISGKLY   57 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----------------------~~~~~~gt~~y~APE~l~~~~~   57 (379)
                      .|+||||||+|||++.++.+||+|||+++......                       ...+.+||+.|+|||++.+...
T Consensus       149 givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~  228 (432)
T 3n9x_A          149 GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQEN  228 (432)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSC
T ss_pred             CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCC
Confidence            38999999999999999999999999998764331                       2356789999999998755444


Q ss_pred             CCCccceeeehhHHHHHhhC-----------CCCCCCCCh-----------------HHHHHHH----------------
Q 017029           58 AGPEVDVWSCGVILYALLCG-----------TLPFDDENI-----------------PNLFKKI----------------   93 (379)
Q Consensus        58 ~~~~~DiWSlGvilyelltG-----------~~Pf~~~~~-----------------~~~~~~i----------------   93 (379)
                      ++.++||||+||++|+|++|           .++|.+.+.                 ......|                
T Consensus       229 ~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~  308 (432)
T 3n9x_A          229 YTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNIN  308 (432)
T ss_dssp             CCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhcc
Confidence            48999999999999999984           444544321                 1111111                


Q ss_pred             --------hcCccCCC-------CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           94 --------KGGIYTLP-------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        94 --------~~~~~~~p-------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                              .......+       +.+++++.+||.+||+.||.+|||++|+++||||+...
T Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          309 KPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             CHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence                    11111111       35799999999999999999999999999999998753

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.93  E-value=3e-27  Score=223.24  Aligned_cols=135  Identities=36%  Similarity=0.649  Sum_probs=110.0

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||+   +.++.+||+|||++............+|++.|+|||++.+ .+ +.++||||+||++|+|++|
T Consensus       144 ~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g  221 (285)
T 3is5_A          144 HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTG  221 (285)
T ss_dssp             TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHS
T ss_pred             CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhC
Confidence            37999999999999   4568899999999988766655567789999999999865 34 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC---CCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP---SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p---~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ..||.+.+.......+.......+   ..+++++.+||.+||..||.+|||+.|+++||||++
T Consensus       222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          222 CLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            999999988887777765544433   347899999999999999999999999999999974

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.93  E-value=5.7e-27  Score=226.30  Aligned_cols=138  Identities=36%  Similarity=0.626  Sum_probs=115.1

Q ss_pred             CEEecCCCCCCeEEcCCC--cEEEEecCCcccccCCc-----ccccccCCCCccCcccccC--CCCCCCccceeeehhHH
Q 017029            1 MVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVIL   71 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~--~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvil   71 (379)
                      .|+||||||+|||++.++  .+||+|||++.......     .....+||+.|+|||++.+  ..+ +.++||||+||++
T Consensus       188 ~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il  266 (345)
T 3hko_A          188 GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVLL  266 (345)
T ss_dssp             TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC-CTHHHHHHHHHHH
T ss_pred             CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC-CcHHHHHHHHHHH
Confidence            389999999999998776  89999999998653321     2345679999999999975  344 7899999999999


Q ss_pred             HHHhhCCCCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           72 YALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        72 yelltG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |+|++|..||.+.+..+....+......++.    .+++++.+||.+||..||.+|||+.++++||||++..
T Consensus       267 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          267 HLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             HHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            9999999999998888888887766654432    4789999999999999999999999999999998753

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.93  E-value=4.9e-27  Score=224.80  Aligned_cols=137  Identities=34%  Similarity=0.500  Sum_probs=117.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++............+|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       140 gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  218 (326)
T 1blx_A          140 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPL  218 (326)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCC
Confidence            379999999999999999999999999987765555566789999999999988776 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc---------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           81 FDDENIPNLFKKIKGGI---------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~---------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |.+.+.......+....                           ..++..+++.+++||.+||..||.+|||+.|+++||
T Consensus       219 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp  298 (326)
T 1blx_A          219 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  298 (326)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCc
Confidence            99988777666654211                           012346788899999999999999999999999999


Q ss_pred             hhhhc
Q 017029          134 WFQAH  138 (379)
Q Consensus       134 ~f~~~  138 (379)
                      ||++.
T Consensus       299 ~~~~~  303 (326)
T 1blx_A          299 YFQDL  303 (326)
T ss_dssp             GGTTC
T ss_pred             ccccc
Confidence            99865

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.93  E-value=1.8e-27  Score=236.16  Aligned_cols=138  Identities=30%  Similarity=0.451  Sum_probs=102.0

Q ss_pred             CEEecCCCCCCeEE----cCCCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl----~~~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+|||+    +.++.+||+|||++......    ......+||+.|+|||++.+...++.++||||+||++|
T Consensus       148 ~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  227 (405)
T 3rgf_A          148 WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFA  227 (405)
T ss_dssp             TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHH
T ss_pred             CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHH
Confidence            37999999999999    67789999999999876432    23345689999999999988654589999999999999


Q ss_pred             HHhhCCCCCCCCChH---------HHHHHHhcCccCC--------------------------------------CCCCC
Q 017029           73 ALLCGTLPFDDENIP---------NLFKKIKGGIYTL--------------------------------------PSHLS  105 (379)
Q Consensus        73 elltG~~Pf~~~~~~---------~~~~~i~~~~~~~--------------------------------------p~~~s  105 (379)
                      +|++|..||.+....         +....+.......                                      ....+
T Consensus       228 ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (405)
T 3rgf_A          228 ELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD  307 (405)
T ss_dssp             HHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTT
T ss_pred             HHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCC
Confidence            999999999765431         2222222111000                                      01226


Q ss_pred             hhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          106 PGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       106 ~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +.+.+||.+||..||.+|||++|+++||||++.
T Consensus       308 ~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~  340 (405)
T 3rgf_A          308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYFLED  340 (405)
T ss_dssp             SHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSS
T ss_pred             HHHHHHHHHHccCCcccCCCHHHHhcChhhccC
Confidence            788999999999999999999999999999865

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.93  E-value=4.7e-27  Score=220.48  Aligned_cols=138  Identities=38%  Similarity=0.663  Sum_probs=117.8

Q ss_pred             CEEecCCCCCCeEEcCCC----cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++    .+||+|||++.............|++.|+|||++.+..+ +.++||||+|+++|+|++
T Consensus       128 ~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  206 (283)
T 3bhy_A          128 RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLS  206 (283)
T ss_dssp             TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHH
T ss_pred             CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHH
Confidence            389999999999998877    899999999988766555566789999999999988776 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |..||.+.+.......+.......+    ..+++.+.++|.+||..||.+|||+.++++||||+...
T Consensus       207 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  273 (283)
T 3bhy_A          207 GASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR  273 (283)
T ss_dssp             SSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred             CCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence            9999999988888888877766554    56889999999999999999999999999999998653

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.93  E-value=1.5e-27  Score=230.18  Aligned_cols=138  Identities=31%  Similarity=0.436  Sum_probs=106.9

Q ss_pred             CEEecCCCCCCeEEc-----CCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLD-----SKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-----~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++     .++.+||+|||++...... ......+||+.|+|||++.+...++.++||||+||++|+|
T Consensus       152 ~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  231 (329)
T 3gbz_A          152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEM  231 (329)
T ss_dssp             TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHH
T ss_pred             CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHH
Confidence            379999999999994     4556999999999876433 3344567899999999998765458999999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccCC------------------------------CCCCChhhhcccccccCCCCCCCC
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYTL------------------------------PSHLSPGARDLIPRMLIVDPMKRI  124 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~~------------------------------p~~~s~~~~~Li~~mL~~dP~~Rp  124 (379)
                      ++|..||.+.+..+...++.......                              +..+++++.+||.+||..||.+||
T Consensus       232 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~  311 (329)
T 3gbz_A          232 LMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI  311 (329)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC
T ss_pred             HHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC
Confidence            99999999988777666654321110                              011678899999999999999999


Q ss_pred             ChhhhhcCchhhhc
Q 017029          125 TIPEIRQHPWFQAH  138 (379)
Q Consensus       125 t~~ell~hp~f~~~  138 (379)
                      |++|+++||||+..
T Consensus       312 t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          312 SAKNALEHPYFSHN  325 (329)
T ss_dssp             CHHHHHTSGGGSSS
T ss_pred             CHHHHhCCcccCCC
Confidence            99999999999864

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.93  E-value=1.8e-27  Score=227.08  Aligned_cols=138  Identities=43%  Similarity=0.757  Sum_probs=109.2

Q ss_pred             CEEecCCCCCCeEEcCCCc---EEEEecCCcccccCC--------cccccccCCCCccCcccccC-----CCCCCCccce
Q 017029            1 MVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDG--------HFLKTSCGSPNYAAPEVISG-----KLYAGPEVDV   64 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~---vKL~DFGls~~~~~~--------~~~~~~~gt~~y~APE~l~~-----~~~~~~~~Di   64 (379)
                      .|+||||||+|||++.++.   +||+|||++......        ....+.+||+.|+|||++.+     ..+ +.++||
T Consensus       131 ~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~Di  209 (316)
T 2ac3_A          131 GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDL  209 (316)
T ss_dssp             TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHH
T ss_pred             CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCC-Cccccc
Confidence            3799999999999998776   999999998765321        12234579999999999874     334 789999


Q ss_pred             eeehhHHHHHhhCCCCCCCCC---------------hHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCC
Q 017029           65 WSCGVILYALLCGTLPFDDEN---------------IPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        65 WSlGvilyelltG~~Pf~~~~---------------~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      ||+||++|+|++|..||.+..               ...+...+..+.+.+|    ..+++.+++||.+||..||.+|||
T Consensus       210 wslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  289 (316)
T 2ac3_A          210 WSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS  289 (316)
T ss_dssp             HHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             HhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCC
Confidence            999999999999999998754               2446677777777766    468999999999999999999999


Q ss_pred             hhhhhcCchhhhcc
Q 017029          126 IPEIRQHPWFQAHL  139 (379)
Q Consensus       126 ~~ell~hp~f~~~~  139 (379)
                      +.|+++||||+...
T Consensus       290 ~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          290 AAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHSTTCC---
T ss_pred             HHHHhcChhhcCCC
Confidence            99999999998653

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.93  E-value=5.4e-28  Score=237.79  Aligned_cols=130  Identities=19%  Similarity=0.326  Sum_probs=107.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC-----------CCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-----------LYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~-----------~~~~~~~DiWSlGv   69 (379)
                      .|+||||||+|||++.++.+||+|||++....  ....+.+| +.|+|||++.+.           .+ +.++|||||||
T Consensus       226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~  301 (377)
T 3byv_A          226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGL  301 (377)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHH
T ss_pred             CeecCCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHH
Confidence            38999999999999999999999999998643  34456688 999999999876           55 78999999999


Q ss_pred             HHHHHhhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           70 ILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        70 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|+|++|..||.+.+.......+    ...+..+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       302 il~elltg~~Pf~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  366 (377)
T 3byv_A          302 VIYWIWCADLPITKDAALGGSEWI----FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  366 (377)
T ss_dssp             HHHHHHHSSCCC------CCSGGG----GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred             HHHHHHHCCCCCcccccccchhhh----hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence            999999999999876544333332    23346789999999999999999999999999999999854

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.93  E-value=2.5e-27  Score=228.63  Aligned_cols=136  Identities=32%  Similarity=0.490  Sum_probs=111.2

Q ss_pred             CEEecCCCCCCeEE-------------------cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCc
Q 017029            1 MVVHRDLKPENLLL-------------------DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE   61 (379)
Q Consensus         1 ~IiHrDLKpeNILl-------------------~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~   61 (379)
                      .|+||||||+|||+                   +.++.+||+|||++......  ....+||+.|+|||++.+..+ +.+
T Consensus       143 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~  219 (355)
T 2eu9_A          143 QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGW-AQP  219 (355)
T ss_dssp             TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCC-CTH
T ss_pred             CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCC-CCc
Confidence            48999999999999                   56789999999999865433  345689999999999988877 789


Q ss_pred             cceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCC---------------------------------------
Q 017029           62 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS---------------------------------------  102 (379)
Q Consensus        62 ~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~---------------------------------------  102 (379)
                      +||||+||++|+|++|..||.+.+.......+......+|.                                       
T Consensus       220 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (355)
T 2eu9_A          220 CDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSY  299 (355)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred             cchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCccccc
Confidence            99999999999999999999988766655444332222221                                       


Q ss_pred             -----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029          103 -----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       103 -----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                           ..+.++.+||.+||..||.+|||+.|+++||||+...
T Consensus       300 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          300 MLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             ccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence                 1134788999999999999999999999999998653

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=2.8e-27  Score=226.53  Aligned_cols=135  Identities=33%  Similarity=0.493  Sum_probs=110.8

Q ss_pred             CEEecCCCCCCeEEcC-------------------CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCc
Q 017029            1 MVVHRDLKPENLLLDS-------------------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE   61 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-------------------~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~   61 (379)
                      .|+||||||+|||++.                   ++.+||+|||++......  ..+.+||+.|+|||++.+..+ +.+
T Consensus       138 ~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~  214 (339)
T 1z57_A          138 KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGW-SQP  214 (339)
T ss_dssp             TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCC-CTH
T ss_pred             CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCC-Ccc
Confidence            3899999999999987                   668999999999875432  345689999999999998777 789


Q ss_pred             cceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCC----------------------------------------
Q 017029           62 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----------------------------------------  101 (379)
Q Consensus        62 ~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----------------------------------------  101 (379)
                      +||||+||++|+|++|..||.+.+..+....+.....++|                                        
T Consensus       215 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (339)
T 1z57_A          215 CDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEF  294 (339)
T ss_dssp             HHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGG
T ss_pred             hhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhh
Confidence            9999999999999999999998877665544432222221                                        


Q ss_pred             ----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029          102 ----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       102 ----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                          ...++.+.+||.+||..||.+|||+.|+++||||+..
T Consensus       295 ~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          295 MLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLL  335 (339)
T ss_dssp             CSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred             cccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence                1224668899999999999999999999999999854

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.93  E-value=2.9e-27  Score=227.95  Aligned_cols=138  Identities=30%  Similarity=0.487  Sum_probs=108.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.+....+.++||||+||++|+|++|..
T Consensus       144 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  223 (331)
T 4aaa_A          144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEP  223 (331)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCC
Confidence            3799999999999999999999999999876443 334566899999999999876445889999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-------------------CC------------CCCCChhhhcccccccCCCCCCCCChhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-------------------TL------------PSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-------------------~~------------p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ||.+.+..+....+.....                   ..            .+.+++.+.+||.+||..||.+|||+.|
T Consensus       224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e  303 (331)
T 4aaa_A          224 LFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAE  303 (331)
T ss_dssp             SCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGG
T ss_pred             CCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHH
Confidence            9998876665544432110                   01            1357889999999999999999999999


Q ss_pred             hhcCchhhhc
Q 017029          129 IRQHPWFQAH  138 (379)
Q Consensus       129 ll~hp~f~~~  138 (379)
                      +++||||+..
T Consensus       304 ll~hp~f~~~  313 (331)
T 4aaa_A          304 LLHHDFFQMD  313 (331)
T ss_dssp             GGGSHHHHGG
T ss_pred             HhcCchhccC
Confidence            9999999854

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.93  E-value=7e-27  Score=229.48  Aligned_cols=136  Identities=35%  Similarity=0.512  Sum_probs=110.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++......  ....+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus       164 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~p  241 (371)
T 4exu_A          164 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  241 (371)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcCCCcCHHHeEECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCC
Confidence            3799999999999999999999999999865432  34568999999999998744448999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-------------------------------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+..+....+.....                               ..++.+++.+.+||.+||+.||.+|||++|+
T Consensus       242 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  321 (371)
T 4exu_A          242 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  321 (371)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHH
Confidence            999887666655532110                               1124578999999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++||||+..
T Consensus       322 l~hp~f~~~  330 (371)
T 4exu_A          322 LTHPFFEPF  330 (371)
T ss_dssp             HTSGGGTTT
T ss_pred             hcCcccccC
Confidence            999999864

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.93  E-value=5.4e-27  Score=226.75  Aligned_cols=137  Identities=34%  Similarity=0.617  Sum_probs=119.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC-CCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......|++.|+|||++.+. .+.+.++||||+||++|+|++|..
T Consensus       172 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~  250 (348)
T 2pml_X          172 NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVV  250 (348)
T ss_dssp             CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CEeecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCC
Confidence            3899999999999999999999999999876544 34566899999999999877 443339999999999999999999


Q ss_pred             CCCCCCh-HHHHHHHhcCccCCC-------------------CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENI-PNLFKKIKGGIYTLP-------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~-~~~~~~i~~~~~~~p-------------------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+... .+....+..+...+|                   ..+++++.+||.+||..||.+|||+.|+++||||++.
T Consensus       251 pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          251 PFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             SSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             CCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            9998776 778888888877777                   6789999999999999999999999999999999854

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.93  E-value=3.2e-27  Score=230.03  Aligned_cols=139  Identities=29%  Similarity=0.426  Sum_probs=106.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++............+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus       154 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p  233 (362)
T 3pg1_A          154 GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKAL  233 (362)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCC
Confidence            37999999999999999999999999998766555556678999999999998744448999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc--------------------------------CCCCCCChhhhcccccccCCCCCCCCChhh
Q 017029           81 FDDENIPNLFKKIKGGIY--------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~--------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      |.+.+..+....+.....                                ..++..++.+.+||.+||..||.+|||+.|
T Consensus       234 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  313 (362)
T 3pg1_A          234 FRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQ  313 (362)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence            999887666655532110                                112456888999999999999999999999


Q ss_pred             hhcCchhhhcc
Q 017029          129 IRQHPWFQAHL  139 (379)
Q Consensus       129 ll~hp~f~~~~  139 (379)
                      +++||||+...
T Consensus       314 ll~hp~f~~~~  324 (362)
T 3pg1_A          314 ALRHPYFESLF  324 (362)
T ss_dssp             HHTSGGGTTTC
T ss_pred             HHcCchhhhcc
Confidence            99999998764

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.93  E-value=3e-27  Score=231.79  Aligned_cols=134  Identities=29%  Similarity=0.501  Sum_probs=106.0

Q ss_pred             CEEecCCCCCCeEEcCCC-------------------------------------------------cEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKW-------------------------------------------------NVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-------------------------------------------------~vKL~DFGls~~~   31 (379)
                      .|+||||||+|||++.++                                                 .+||+|||++...
T Consensus       167 givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~  246 (397)
T 1wak_A          167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV  246 (397)
T ss_dssp             CEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEET
T ss_pred             CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccc
Confidence            389999999999999775                                                 7999999999876


Q ss_pred             cCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCCh------HHHHHHHhcCc--------
Q 017029           32 RDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENI------PNLFKKIKGGI--------   97 (379)
Q Consensus        32 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~------~~~~~~i~~~~--------   97 (379)
                      ...  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.      ......+....        
T Consensus       247 ~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~  323 (397)
T 1wak_A          247 HKH--FTEDIQTRQYRSLEVLIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI  323 (397)
T ss_dssp             TBC--SCSCCSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHH
T ss_pred             ccc--CccCCCCCcccCChhhcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHh
Confidence            443  345689999999999998877 7899999999999999999999986542      12222221100        


Q ss_pred             ----------------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           98 ----------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        98 ----------------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                                                        +..+...+..+.+||.+||+.||.+|||++|+++||||++
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          324 VAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             hcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                                              0112223456889999999999999999999999999973

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.93  E-value=8.3e-27  Score=220.41  Aligned_cols=138  Identities=45%  Similarity=0.804  Sum_probs=121.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc------CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS------GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~------~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+||+++.++.+||+|||++............+|++.|+|||++.      ...+ +.++||||+|+++|+|
T Consensus       144 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l  222 (298)
T 1phk_A          144 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTL  222 (298)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHH
T ss_pred             CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHH
Confidence            38999999999999999999999999998877666666778999999999985      2334 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ++|..||.+.+.......+..+.+.++    ..++..+.++|.+||..||.+|||+.|+++||||++..
T Consensus       223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          223 LAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             HHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             HHCCCCCcCccHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            999999999888888888877766554    35788999999999999999999999999999998653

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.93  E-value=9.6e-27  Score=225.42  Aligned_cols=139  Identities=37%  Similarity=0.581  Sum_probs=111.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----------ccccccCCCCccCcccccCCCCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGv   69 (379)
                      .|+||||||+|||++.++.+||+|||++.......           .....+||+.|+|||++.+....+.++||||+||
T Consensus       132 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~  211 (353)
T 2b9h_A          132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGC  211 (353)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHH
T ss_pred             CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHH
Confidence            38999999999999999999999999998764321           1223578999999998876444488999999999


Q ss_pred             HHHHHhhCCCCCCCCChHHHHHHHhcCc------------------------c--------CCCCCCChhhhcccccccC
Q 017029           70 ILYALLCGTLPFDDENIPNLFKKIKGGI------------------------Y--------TLPSHLSPGARDLIPRMLI  117 (379)
Q Consensus        70 ilyelltG~~Pf~~~~~~~~~~~i~~~~------------------------~--------~~p~~~s~~~~~Li~~mL~  117 (379)
                      ++|+|++|..||.+.+.......+....                        .        ..++.+++++.+||.+||.
T Consensus       212 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  291 (353)
T 2b9h_A          212 ILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLV  291 (353)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSC
T ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcC
Confidence            9999999999999887665544332110                        0        0124678999999999999


Q ss_pred             CCCCCCCChhhhhcCchhhhcc
Q 017029          118 VDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       118 ~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      .||.+|||++|+++||||+...
T Consensus       292 ~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          292 FDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             SSGGGSCCHHHHHTSGGGTTTC
T ss_pred             cCcccCCCHHHHhcCccccccC
Confidence            9999999999999999998653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.93  E-value=6.1e-27  Score=231.97  Aligned_cols=137  Identities=34%  Similarity=0.553  Sum_probs=109.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCC----------CCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiWSl   67 (379)
                      .|+||||||+|||++ ++.+||+|||+++......   ...+.+||+.|+|||++.+.          ..++.++|||||
T Consensus       175 ~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSl  253 (390)
T 2zmd_A          175 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL  253 (390)
T ss_dssp             TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHH
T ss_pred             CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHH
Confidence            379999999999995 5899999999998765432   23456899999999998752          223789999999


Q ss_pred             hhHHHHHhhCCCCCCCCC-hHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           68 GVILYALLCGTLPFDDEN-IPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~-~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||++|+|++|..||.+.. .......+....  ..+|...+.++.+||.+||..||.+|||+.|+++||||+..
T Consensus       254 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          254 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             HHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            999999999999998753 334445555433  35567778999999999999999999999999999999854

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.93  E-value=1.2e-26  Score=216.61  Aligned_cols=140  Identities=38%  Similarity=0.747  Sum_probs=114.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||+++.++.+||+|||++.......   .....+|++.|+|||++.+..+.+.++||||+||++|+|++|
T Consensus       125 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g  204 (276)
T 2yex_A          125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  204 (276)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhC
Confidence            38999999999999999999999999998664322   234568999999999998877657789999999999999999


Q ss_pred             CCCCCCCChH-HHHHHHhcCccCC--CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           78 TLPFDDENIP-NLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        78 ~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ..||.+.... .....+.......  ...+++.+.++|.+||..||.+|||++|+++||||+....
T Consensus       205 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          205 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             SCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence            9999875543 2333443333222  2468999999999999999999999999999999986643

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.93  E-value=6.8e-27  Score=222.33  Aligned_cols=136  Identities=46%  Similarity=0.858  Sum_probs=119.9

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||++   +.++.+||+|||++...... .....+|++.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       126 ~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g  203 (304)
T 2jam_A          126 GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCG  203 (304)
T ss_dssp             TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHS
T ss_pred             CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHC
Confidence            37999999999999   77899999999999765432 3445679999999999988776 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+...+...+..+.+.++    ..+++++.++|.+||..||.+|||++++++||||+..
T Consensus       204 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          204 YPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             SCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            999999998888888887765543    4688999999999999999999999999999999865

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.93  E-value=6.6e-27  Score=226.97  Aligned_cols=136  Identities=34%  Similarity=0.565  Sum_probs=106.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccC-----------CCCCCCccceee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISG-----------KLYAGPEVDVWS   66 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~-----------~~~~~~~~DiWS   66 (379)
                      .|+||||||+|||++ ++.+||+|||++.......   .....+||+.|+|||++.+           ..+ +.++||||
T Consensus       128 ~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~Diws  205 (343)
T 3dbq_A          128 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWS  205 (343)
T ss_dssp             TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------C-CHHHHHHH
T ss_pred             CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHH
Confidence            379999999999997 6889999999998765432   2345689999999999864           334 78999999


Q ss_pred             ehhHHHHHhhCCCCCCCCCh-HHHHHHHhc--CccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           67 CGVILYALLCGTLPFDDENI-PNLFKKIKG--GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        67 lGvilyelltG~~Pf~~~~~-~~~~~~i~~--~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +||++|+|++|..||.+... ......+..  ....+|...+.++.+||.+||..||.+|||+.|+++||||+..
T Consensus       206 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          206 LGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             HHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             HHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            99999999999999987432 233334433  2345677788899999999999999999999999999999854

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.93  E-value=5.3e-27  Score=228.68  Aligned_cols=136  Identities=28%  Similarity=0.567  Sum_probs=105.8

Q ss_pred             CEEecCCCCCCeEEc------CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLD------SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~------~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++      ..+.+||+|||++......  ....+||+.|+|||++.+..+ +.++||||+||++|+|
T Consensus       152 ~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el  228 (373)
T 1q8y_A          152 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFEL  228 (373)
T ss_dssp             CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHH
T ss_pred             CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHH
Confidence            389999999999994      3448999999999876443  345689999999999998877 7899999999999999


Q ss_pred             hhCCCCCCCCCh------HHHHHHHhc------------------------------------------CccCCCCCCCh
Q 017029           75 LCGTLPFDDENI------PNLFKKIKG------------------------------------------GIYTLPSHLSP  106 (379)
Q Consensus        75 ltG~~Pf~~~~~------~~~~~~i~~------------------------------------------~~~~~p~~~s~  106 (379)
                      ++|..||.+.+.      ......+..                                          ..+.++..++.
T Consensus       229 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (373)
T 1q8y_A          229 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK  308 (373)
T ss_dssp             HHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHH
T ss_pred             HhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHH
Confidence            999999986542      111122111                                          11223344567


Q ss_pred             hhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029          107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       107 ~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ++.+||.+||+.||.+|||++|+++||||++..
T Consensus       309 ~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          309 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             HHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             HHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence            889999999999999999999999999999764

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.93  E-value=1.4e-26  Score=218.44  Aligned_cols=134  Identities=27%  Similarity=0.601  Sum_probs=111.6

Q ss_pred             EEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||+|||++ .++.+||+|||++...... .....+|++.|+|||++.+. + +.++||||+||++|+|++|..|
T Consensus       152 i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p  228 (290)
T 1t4h_A          152 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEYP  228 (290)
T ss_dssp             CCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSCT
T ss_pred             EEECCCCHHHEEEECCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHhcc-C-CCcchHHHHHHHHHHHHhCCCC
Confidence            89999999999998 7899999999999765433 34556899999999998754 4 7899999999999999999999


Q ss_pred             CCCC-ChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |.+. +.......+..+..  .++...++++.++|.+||..||.+|||+.++++||||++.
T Consensus       229 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          229 YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             TTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            9874 44555555555432  3455678899999999999999999999999999999853

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.93  E-value=9.3e-27  Score=227.46  Aligned_cols=138  Identities=37%  Similarity=0.614  Sum_probs=116.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCC-CCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~-~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||+++......  .....+||+.|+|||++.+. ...+.++|||||||++|+|++|
T Consensus       179 ~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g  258 (355)
T 1vzo_A          179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  258 (355)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC
Confidence            37999999999999999999999999998654322  23456899999999999863 2237899999999999999999


Q ss_pred             CCCCCCC----ChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           78 TLPFDDE----NIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      ..||...    ....+...+......+|..++..+.+||.+||..||.+||     |++|+++||||+..
T Consensus       259 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~  328 (355)
T 1vzo_A          259 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  328 (355)
T ss_dssp             SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             CCCCccCCccchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence            9999753    3455666777777788889999999999999999999999     99999999999864

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.93  E-value=1.1e-26  Score=226.63  Aligned_cols=134  Identities=30%  Similarity=0.408  Sum_probs=114.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||++......   ...+||+.|+|||++.   +..+ +.++||||+||++|+|++|
T Consensus       174 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g  249 (348)
T 1u5q_A          174 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER  249 (348)
T ss_dssp             TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhC
Confidence            3799999999999999999999999999876432   3568999999999985   3444 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccC--CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+.......+..+..+  .+..+++.+.+||.+||+.||.+|||++++++||||...
T Consensus       250 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          250 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             SCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            9999988877666666554332  245689999999999999999999999999999999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=1.8e-26  Score=224.36  Aligned_cols=137  Identities=34%  Similarity=0.508  Sum_probs=110.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++......  ....+||+.|+|||++.+....+.++||||+||++|+|++|..|
T Consensus       146 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~p  223 (353)
T 3coi_A          146 GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTL  223 (353)
T ss_dssp             TCCCSSCCGGGEEECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CcccCCCCHHHEeECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence            3799999999999999999999999999865432  34568999999999998744448899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc-------------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGI-------------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~-------------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+..+....+....                               ...+..+++++.+||.+||..||.+|||++++
T Consensus       224 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~  303 (353)
T 3coi_A          224 FKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQA  303 (353)
T ss_dssp             SBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence            99887766555543210                               11234678999999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      ++||||+...
T Consensus       304 l~hp~f~~~~  313 (353)
T 3coi_A          304 LTHPFFEPFR  313 (353)
T ss_dssp             HTSGGGTTTC
T ss_pred             hcCcchhhcc
Confidence            9999998653

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.93  E-value=5.1e-27  Score=219.80  Aligned_cols=137  Identities=38%  Similarity=0.655  Sum_probs=119.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||+|||++.++.+||+|||++....... .....+|++.|+|||++.+..+ +.++||||+|+++|+|++|..|
T Consensus       137 ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p  215 (279)
T 2w5a_A          137 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPP  215 (279)
T ss_dssp             -CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCS
T ss_pred             eEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCC
Confidence            8999999999999999999999999998765432 2345679999999999988776 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           81 FDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      |.+.+...+...+..+.. .+|..+++++.++|.+||..||.+|||+.|+++|+|+.+..
T Consensus       216 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          216 FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             SCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CcccCHHHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            999888888888877665 56778999999999999999999999999999999998764

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.93  E-value=7.4e-27  Score=233.47  Aligned_cols=137  Identities=43%  Similarity=0.775  Sum_probs=106.0

Q ss_pred             CEEecCCCCCCeEEcCCC---cEEEEecCCcccccCCcccccccCCCCccCcccccC---CCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG---KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~---~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++   .+||+|||+++.........+.+||+.|+|||++.+   ..+ +.++||||+||++|+|
T Consensus       259 ~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~l  337 (419)
T 3i6u_A          259 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFIC  337 (419)
T ss_dssp             TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHH
T ss_pred             CccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHH
Confidence            379999999999997654   599999999998876666677899999999999864   333 6799999999999999


Q ss_pred             hhCCCCCCCCCh-HHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENI-PNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~-~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|..||.+... ..+...+..+.+..+    ..+++.+.+||.+||+.||.+|||++|+++||||++.
T Consensus       338 ltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          338 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             HHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            999999986533 344556666665543    4689999999999999999999999999999999753

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.93  E-value=2.5e-27  Score=236.43  Aligned_cols=130  Identities=21%  Similarity=0.301  Sum_probs=109.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccc----------cCCCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVI----------SGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l----------~~~~~~~~~~DiWSlGvi   70 (379)
                      .||||||||+|||++.++.+||+|||+++.....  ..+.+| +.|+|||++          .+..+ +.++|||||||+
T Consensus       231 ~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvi  306 (413)
T 3dzo_A          231 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLA  306 (413)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHH
T ss_pred             CcccCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHH
Confidence            4899999999999999999999999998765433  456788 999999999          44445 789999999999


Q ss_pred             HHHHhhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           71 LYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        71 lyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|+|++|+.||.+.+.......+.    .....+++++.+||.+||..||.+|||+.++++||||+..
T Consensus       307 l~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          307 IYWIWCADLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHHHHSSCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHHHCCCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            999999999998876544433332    2234678999999999999999999999999999999753

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.92  E-value=2e-26  Score=219.47  Aligned_cols=136  Identities=31%  Similarity=0.516  Sum_probs=103.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc-----CCCCCCCccceeeehhHHHHHhh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilyellt   76 (379)
                      |+||||||+|||++.++.+||+|||++............+|++.|+|||++.     +..+ +.++||||+||++|+|++
T Consensus       146 i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~  224 (318)
T 2dyl_A          146 VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELAT  224 (318)
T ss_dssp             CCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHh
Confidence            7999999999999999999999999998776655555678999999999985     3334 789999999999999999


Q ss_pred             CCCCCCC-CChHHHHHHHhcCccC-CC--CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDD-ENIPNLFKKIKGGIYT-LP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.. .........+..+... +|  ..+++++.++|.+||..||.+|||++++++||||+..
T Consensus       225 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          225 GQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             SSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            9999987 3445555555554432 23  3578999999999999999999999999999999854

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.92  E-value=1e-26  Score=223.44  Aligned_cols=132  Identities=36%  Similarity=0.689  Sum_probs=114.1

Q ss_pred             CEEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+|||++ .++.+||+|||++...... ......||+.|+|||++.+..+.+.++||||+||++|+|++|..
T Consensus       169 ~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  247 (320)
T 3a99_A          169 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  247 (320)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCC
Confidence            389999999999999 7899999999999876543 33456799999999999877766788999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||....      .+..+...++..+++++.+||.+||..||.+|||++++++||||++..
T Consensus       248 pf~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          248 PFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             SCCSHH------HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             CCCChh------hhhcccccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            997632      334455667788999999999999999999999999999999998653

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.92  E-value=1.5e-26  Score=225.23  Aligned_cols=135  Identities=27%  Similarity=0.536  Sum_probs=108.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPF   81 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf   81 (379)
                      |+||||||+|||++.++.+||+|||++...... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..||
T Consensus       153 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf  230 (360)
T 3eqc_A          153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPI  230 (360)
T ss_dssp             CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCS
T ss_pred             EEcCCccHHHEEECCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCC
Confidence            799999999999999999999999999765332 2345689999999999988777 78999999999999999999999


Q ss_pred             CCCChHHHHHH------------------------------------------HhcCcc-CC-CCCCChhhhcccccccC
Q 017029           82 DDENIPNLFKK------------------------------------------IKGGIY-TL-PSHLSPGARDLIPRMLI  117 (379)
Q Consensus        82 ~~~~~~~~~~~------------------------------------------i~~~~~-~~-p~~~s~~~~~Li~~mL~  117 (379)
                      ...+.......                                          +..... .. +..++.++.+||.+||.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  310 (360)
T 3eqc_A          231 PPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLI  310 (360)
T ss_dssp             SCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHC
T ss_pred             CCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhh
Confidence            87665443221                                          111111 11 23478899999999999


Q ss_pred             CCCCCCCChhhhhcCchhhhc
Q 017029          118 VDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       118 ~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+|||++|+++||||+..
T Consensus       311 ~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          311 KNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             SSTTTSCCHHHHHTSHHHHHH
T ss_pred             cChhhCCCHHHHhhChHhhcc
Confidence            999999999999999999865

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.92  E-value=2.4e-26  Score=218.61  Aligned_cols=138  Identities=30%  Similarity=0.487  Sum_probs=111.7

Q ss_pred             CEEecCCCCCCeEEc-CCCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++ .++.+||+|||++......    .......|++.|+|||++.+....+.++||||+||++|+|+
T Consensus       140 ~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~  219 (320)
T 2i6l_A          140 NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEML  219 (320)
T ss_dssp             TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHH
T ss_pred             CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHH
Confidence            379999999999997 5679999999999876432    22344578999999999876444488999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc------------------------------CCCCCCChhhhcccccccCCCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY------------------------------TLPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      +|..||.+.+..+....+.....                              ..+..++.++.+||.+||..||.+|||
T Consensus       220 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt  299 (320)
T 2i6l_A          220 TGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT  299 (320)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC
Confidence            99999999887666655543211                              112468999999999999999999999


Q ss_pred             hhhhhcCchhhhc
Q 017029          126 IPEIRQHPWFQAH  138 (379)
Q Consensus       126 ~~ell~hp~f~~~  138 (379)
                      ++|+++||||+..
T Consensus       300 ~~ell~hp~~~~~  312 (320)
T 2i6l_A          300 AEEALSHPYMSIY  312 (320)
T ss_dssp             HHHHHTSHHHHTT
T ss_pred             HHHHhCCcccccc
Confidence            9999999999854

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.92  E-value=5.3e-26  Score=215.85  Aligned_cols=137  Identities=29%  Similarity=0.450  Sum_probs=119.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       139 ~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~  217 (303)
T 3a7i_A          139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEP  217 (303)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCC
Confidence            38999999999999999999999999998765443 2345679999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.........+..+. ..++..++..+.+||.+||..||.+|||+.++++||||...
T Consensus       218 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          218 PHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             TTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             CCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            999888777666665443 34567889999999999999999999999999999999865

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.92  E-value=3e-26  Score=219.81  Aligned_cols=136  Identities=43%  Similarity=0.790  Sum_probs=112.8

Q ss_pred             CEEecCCCCCCeEEcCCCc---EEEEecCCcccccCCcccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~---vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.   +||+|||++............+||+.|+|||++.   +..+ +.++||||+||++|+|
T Consensus       134 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l  212 (322)
T 2ycf_A          134 GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFIC  212 (322)
T ss_dssp             TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHH
T ss_pred             CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHH
Confidence            3899999999999987665   9999999998876655556678999999999974   3334 7899999999999999


Q ss_pred             hhCCCCCCCCChH-HHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           75 LCGTLPFDDENIP-NLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        75 ltG~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ++|..||.+.... .+...+..+.+..+    ..+++.+.+||.+||..||.+|||+.++++||||+.
T Consensus       213 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          213 LSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            9999999765432 34455555554432    468999999999999999999999999999999974

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.92  E-value=7.2e-26  Score=215.77  Aligned_cols=137  Identities=29%  Similarity=0.483  Sum_probs=116.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       145 ~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~  223 (314)
T 3com_A          145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKP  223 (314)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSC
T ss_pred             CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCC
Confidence            38999999999999999999999999998765432 2345679999999999988777 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc---cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGI---YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+....   ...+..++..+.+||.+||..||.+|||+.++++||||+..
T Consensus       224 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          224 PYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             TTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             CCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            999877665554444332   23355678999999999999999999999999999999864

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.92  E-value=2.5e-26  Score=216.70  Aligned_cols=136  Identities=46%  Similarity=0.812  Sum_probs=118.9

Q ss_pred             CEEecCCCCCCeEEcCC---CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~---~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||+++.+   +.+||+|||++.............|++.|+|||++.+. + +.++||||+|+++|+|++|
T Consensus       141 ~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g  218 (287)
T 2wei_A          141 NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSG  218 (287)
T ss_dssp             TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHS
T ss_pred             CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhC
Confidence            37999999999999764   46999999999877665555566789999999999865 4 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+.......+..+.+..+    ..+++++.++|.+||..||.+|||+.|+++||||++.
T Consensus       219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          219 TPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             SCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999988888888887765443    4689999999999999999999999999999999865

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.92  E-value=3.6e-26  Score=219.15  Aligned_cols=136  Identities=32%  Similarity=0.541  Sum_probs=107.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +|+||||||+|||++.++.+||+|||++....... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|..
T Consensus       159 ~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~  237 (309)
T 3p86_A          159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQ  237 (309)
T ss_dssp             CCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCC
T ss_pred             CEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            38999999999999999999999999998654432 2345689999999999998877 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHh--cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc--Cchhhh
Q 017029           80 PFDDENIPNLFKKIK--GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~--~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~--hp~f~~  137 (379)
                      ||.+.+.......+.  .....+|..+++.+.+||.+||..||.+|||++++++  .++++.
T Consensus       238 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          238 PWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             TTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            999988887776663  3456678899999999999999999999999999987  455543

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.92  E-value=1.7e-26  Score=221.87  Aligned_cols=137  Identities=33%  Similarity=0.548  Sum_probs=90.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc----CCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS----GKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~----~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++.............|++.|+|||++.    +..+ +.++||||+||++|+|++
T Consensus       146 ~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~  224 (327)
T 3aln_A          146 KIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELAT  224 (327)
T ss_dssp             SCCCSCCCGGGEEEETTTEEEECCCSSSCC------------------------------C-CSHHHHHHHHHHHHHHHH
T ss_pred             CEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHH
Confidence            37999999999999999999999999998776554445558999999999983    4444 789999999999999999


Q ss_pred             CCCCCCCCChH-HHHHHHhcCcc-CCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIP-NLFKKIKGGIY-TLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~-~~~~~i~~~~~-~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.... +....+..+.. .++    ..+++.+.+||.+||..||.+|||+.++++||||...
T Consensus       225 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          225 GRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             SCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            99999874321 22222222221 222    3578999999999999999999999999999999864

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.92  E-value=2.3e-26  Score=222.85  Aligned_cols=137  Identities=40%  Similarity=0.754  Sum_probs=88.1

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.   ++.+||+|||++...... .....+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       148 ~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g  225 (336)
T 3fhr_A          148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCG  225 (336)
T ss_dssp             TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHH-HHHHHHHHHHHHHHHHHHS
T ss_pred             CeecCCCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHC
Confidence            3899999999999976   455999999999876533 3456689999999999987777 7899999999999999999


Q ss_pred             CCCCCCCChHHH----HHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNL----FKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~----~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+......    ...+..+.+.++    ..+++++.+||.+||..||.+|||++|+++||||++..
T Consensus       226 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  295 (336)
T 3fhr_A          226 FPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM  295 (336)
T ss_dssp             SCCC---------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred             CCCCCCccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence            999987654433    233333333333    46899999999999999999999999999999998753

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.92  E-value=5.8e-26  Score=217.56  Aligned_cols=137  Identities=27%  Similarity=0.418  Sum_probs=107.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCccccc-----CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.     +..+ +.++||||+||++|+|
T Consensus       149 ~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l  227 (326)
T 2x7f_A          149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEM  227 (326)
T ss_dssp             TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHH
T ss_pred             CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHH
Confidence            3799999999999999999999999999876433 2234567999999999986     3344 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCccC--CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|..||.+.+.......+.....+  .+..++..+.+||.+||..||.+|||+.++++||||++.
T Consensus       228 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          228 AEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             HHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             HhCCCCCCCCcHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            9999999988776665555444322  245689999999999999999999999999999999854

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.92  E-value=6.1e-26  Score=212.14  Aligned_cols=132  Identities=20%  Similarity=0.333  Sum_probs=106.9

Q ss_pred             CEEecCCCCCCeEEcCC-------------------CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCc
Q 017029            1 MVVHRDLKPENLLLDSK-------------------WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE   61 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-------------------~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~   61 (379)
                      .|+||||||+|||++.+                   ..+||+|||++.......   ...||+.|+|||++.+....+++
T Consensus       135 ~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~  211 (289)
T 1x8b_A          135 SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPK  211 (289)
T ss_dssp             TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHH
T ss_pred             CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCch
Confidence            38999999999999844                   479999999998765432   45699999999999876554679


Q ss_pred             cceeeehhHHHHHhhCCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           62 VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        62 ~DiWSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +||||+||++|+|++|..|+....   ....+..+. ..+|..+++++.++|.+||..||.+|||+.++++||||+..
T Consensus       212 ~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          212 ADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             hhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            999999999999999998776543   233444443 45677899999999999999999999999999999999854

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.92  E-value=8.8e-27  Score=222.76  Aligned_cols=134  Identities=28%  Similarity=0.458  Sum_probs=106.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-------------ccccccCCCCccCcccccCCCCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-------------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-------------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSl   67 (379)
                      .|+||||||+|||++.++.+||+|||++.......             .....+||+.|+|||++.+..+ +.++||||+
T Consensus       184 ~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~sl  262 (332)
T 3qd2_B          184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY-SHKVDIFSL  262 (332)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCC-CTHHHHHHH
T ss_pred             CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCC-cchhhHHHH
Confidence            38999999999999999999999999998765432             2234579999999999998877 789999999


Q ss_pred             hhHHHHHhhCCCCCCCCChHHHHHHHhcCccC-CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           68 GVILYALLCGTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ||++|+|++|..|+..  .......+.....+ .+...++++.+||.+||..||.+|||++|+++||||++
T Consensus       263 G~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          263 GLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            9999999998777532  22233334333222 12345788899999999999999999999999999974

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.91  E-value=6.4e-26  Score=216.16  Aligned_cols=131  Identities=37%  Similarity=0.684  Sum_probs=113.6

Q ss_pred             CEEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++ .++.+||+|||++....... .....|++.|+|||++.+..+.+.++||||+||++|+|++|..
T Consensus       159 ~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~  237 (312)
T 2iwi_A          159 GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDI  237 (312)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCC
Confidence            389999999999999 78999999999998765543 4566799999999999877765668999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||...      ..+......++..++..+.++|.+||..||.+|||++|+++||||+..
T Consensus       238 pf~~~------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          238 PFERD------QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             SCCSH------HHHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CCCCh------HHHhhhccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            99763      234455667888999999999999999999999999999999999865

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.91  E-value=3.8e-26  Score=216.27  Aligned_cols=137  Identities=28%  Similarity=0.430  Sum_probs=111.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCccccc-----CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.+||+|||++...... ......+|++.|+|||++.     +..+ +.++||||+||++|+|
T Consensus       137 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l  215 (302)
T 2j7t_A          137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEM  215 (302)
T ss_dssp             TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHH
T ss_pred             CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHH
Confidence            3799999999999999999999999987643221 1223457999999999984     4444 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|..||.+.+.......+.....   ..+..++..+.++|.+||..||.+|||+.++++||||+..
T Consensus       216 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          216 AQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             hcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            999999999887777666655543   2345688999999999999999999999999999999854

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.91  E-value=6.8e-26  Score=216.53  Aligned_cols=137  Identities=24%  Similarity=0.405  Sum_probs=109.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++.......    .....+||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       136 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~  214 (311)
T 3ork_A          136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLT  214 (311)
T ss_dssp             TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHH
T ss_pred             CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHh
Confidence            37999999999999999999999999998764432    2234579999999999998876 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCC----CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.+.......+.......    +..+++++.++|.+||..||.+||+..+++.|+|++..
T Consensus       215 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          215 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             SSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            999999988877766555444332    24689999999999999999999999999999999864

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.91  E-value=7.4e-26  Score=216.74  Aligned_cols=138  Identities=26%  Similarity=0.445  Sum_probs=106.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++.........   ....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       157 ~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~  235 (323)
T 3qup_A          157 NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTR  235 (323)
T ss_dssp             TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhC
Confidence            3799999999999999999999999999876544322   23356788999999988776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCC-------hhhhhcCchhhhcc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRIT-------IPEIRQHPWFQAHL  139 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-------~~ell~hp~f~~~~  139 (379)
                      |..||.+.+.......+..+. ...+..+++++.+||.+||..||.+|||       +++++.|||+....
T Consensus       236 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          236 GQTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            999999988888877776654 5667889999999999999999999999       77888999997653

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.91  E-value=4.7e-26  Score=215.23  Aligned_cols=137  Identities=31%  Similarity=0.449  Sum_probs=106.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc------ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      |+||||||+||+++.++.+||+|||++.......      .....+|++.|+|||++.+....+.++||||+||++|+|+
T Consensus       142 i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~  221 (303)
T 2vwi_A          142 QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA  221 (303)
T ss_dssp             CCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHH
T ss_pred             CCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHH
Confidence            7999999999999999999999999987654322      2234579999999999875333378999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCcc----------CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIY----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~----------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|..||.+...............          .....++.++.++|.+||..||.+|||+.++++||||+..
T Consensus       222 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          222 TGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             HSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             hCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            99999998766555444333221          1224678899999999999999999999999999999854

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.91  E-value=1.4e-25  Score=225.22  Aligned_cols=135  Identities=35%  Similarity=0.649  Sum_probs=103.3

Q ss_pred             CEEecCCCCCCeEEcCC-------------CcEEEEecCCcccccCCc-----ccccccCCCCccCcccccC------CC
Q 017029            1 MVVHRDLKPENLLLDSK-------------WNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISG------KL   56 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~-------------~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~------~~   56 (379)
                      .||||||||+|||++.+             +.+||+|||++.......     .....+||+.|+|||++.+      ..
T Consensus       135 ~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  214 (434)
T 2rio_A          135 KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKR  214 (434)
T ss_dssp             TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCC
T ss_pred             CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhcccccccccc
Confidence            48999999999999754             489999999998775432     1234589999999999975      12


Q ss_pred             CCCCccceeeehhHHHHHhh-CCCCCCCCChHHHHHHHhcCccCCCC-------CCChhhhcccccccCCCCCCCCChhh
Q 017029           57 YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTLPS-------HLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        57 ~~~~~~DiWSlGvilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      ..+.++||||+||++|+|++ |..||.+.....  ..+..+.+..+.       .+++++.+||.+||+.||.+|||+.+
T Consensus       215 ~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e  292 (434)
T 2rio_A          215 RLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMK  292 (434)
T ss_dssp             CCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHH
Confidence            34789999999999999999 999998765443  334444443332       23578999999999999999999999


Q ss_pred             hhcCchhhh
Q 017029          129 IRQHPWFQA  137 (379)
Q Consensus       129 ll~hp~f~~  137 (379)
                      +++||||..
T Consensus       293 il~hp~f~~  301 (434)
T 2rio_A          293 VLRHPLFWP  301 (434)
T ss_dssp             HHTSGGGSC
T ss_pred             HHhCCccCC
Confidence            999999964

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.91  E-value=1.3e-25  Score=211.59  Aligned_cols=138  Identities=28%  Similarity=0.460  Sum_probs=110.6

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||+++. ++.+||+|||++....... ......|++.|+|||++.+.. ..+.++||||+|+++|+|++|
T Consensus       142 ~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g  221 (295)
T 2clq_A          142 QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATG  221 (295)
T ss_dssp             TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHT
T ss_pred             CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHC
Confidence            3899999999999987 8999999999998765432 234567999999999987543 237899999999999999999


Q ss_pred             CCCCCCCChHH-H-HH-HHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPN-L-FK-KIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~-~-~~-~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+..... . .. ........+|..+++++.++|.+||..||.+|||+.++++||||+..
T Consensus       222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          222 KPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             SCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             CCCccCCCchhHHHHhhccccccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhc
Confidence            99997643222 1 11 22233456778899999999999999999999999999999999854

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.91  E-value=1.9e-25  Score=214.96  Aligned_cols=131  Identities=24%  Similarity=0.412  Sum_probs=111.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++......   ......|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       135 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~  213 (325)
T 3kex_A          135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTF  213 (325)
T ss_dssp             TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhC
Confidence            37999999999999999999999999998764432   2234568889999999987776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.........+..+ ....|..++.++.++|.+||..||.+|||+.+++++
T Consensus       214 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          214 GAEPYAGLRLAEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             SCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             CCCCccccCHHHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999998888877777765 355677889999999999999999999999999887

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.91  E-value=6.3e-26  Score=217.33  Aligned_cols=133  Identities=28%  Similarity=0.443  Sum_probs=106.9

Q ss_pred             CEEecCCCCCCeEE----cCCCcEEEEecCCcccccCCcccccccCCCCccCccccc--------CCCCCCCccceeeeh
Q 017029            1 MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS--------GKLYAGPEVDVWSCG   68 (379)
Q Consensus         1 ~IiHrDLKpeNILl----~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~--------~~~~~~~~~DiWSlG   68 (379)
                      .|+||||||+|||+    +.++.+||+|||++..........+.+||+.|+|||++.        +..+ +.++||||+|
T Consensus       132 ~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG  210 (319)
T 4euu_A          132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIG  210 (319)
T ss_dssp             TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHH
T ss_pred             CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHH
Confidence            38999999999999    778889999999999887666666778999999999986        3445 7899999999


Q ss_pred             hHHHHHhhCCCCCCCCC----hHHHHHHHhcCcc-------------------C------CCCCCChhhhcccccccCCC
Q 017029           69 VILYALLCGTLPFDDEN----IPNLFKKIKGGIY-------------------T------LPSHLSPGARDLIPRMLIVD  119 (379)
Q Consensus        69 vilyelltG~~Pf~~~~----~~~~~~~i~~~~~-------------------~------~p~~~s~~~~~Li~~mL~~d  119 (379)
                      |++|+|++|..||....    ..+...++..+..                   .      ++..++..+.++|.+||+.|
T Consensus       211 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~d  290 (319)
T 4euu_A          211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD  290 (319)
T ss_dssp             HHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred             HHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCC
Confidence            99999999999997432    2344444443322                   1      11223457889999999999


Q ss_pred             CCCCCChhhhhcCch
Q 017029          120 PMKRITIPEIRQHPW  134 (379)
Q Consensus       120 P~~Rpt~~ell~hp~  134 (379)
                      |.+|||++|+++||-
T Consensus       291 P~~R~s~~ell~h~~  305 (319)
T 4euu_A          291 QEKCWGFDQFFAETS  305 (319)
T ss_dssp             TTTSCCHHHHHHHHH
T ss_pred             hhhhccHHHhhhccH
Confidence            999999999999974

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.91  E-value=2.5e-25  Score=218.78  Aligned_cols=131  Identities=26%  Similarity=0.472  Sum_probs=114.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++|||||||++|+|++ 
T Consensus       223 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~  301 (370)
T 2psq_A          223 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTL  301 (370)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcC
Confidence            489999999999999999999999999987654322   233467889999999988777 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+....++...+..+. ...|..++.++.++|.+||..||.+|||+.|++++
T Consensus       302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          302 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999988888888777664 45677899999999999999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.91  E-value=3.8e-25  Score=211.08  Aligned_cols=137  Identities=34%  Similarity=0.554  Sum_probs=105.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCC----------CCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGK----------LYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~----------~~~~~~~DiWSl   67 (379)
                      .|+||||||+|||++ ++.+||+|||++.......   .....+|++.|+|||++.+.          ...+.++||||+
T Consensus       147 ~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~sl  225 (313)
T 3cek_A          147 GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSL  225 (313)
T ss_dssp             TCCCCCCCGGGEEEE-TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHH
T ss_pred             CceecCCCcccEEEE-CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHH
Confidence            379999999999996 4899999999998764432   22345799999999998751          223789999999


Q ss_pred             hhHHHHHhhCCCCCCCCC-hHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           68 GVILYALLCGTLPFDDEN-IPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||++|+|++|..||.+.. .......+...  ...+|...+.++.++|.+||..||.+|||+.|+++||||+..
T Consensus       226 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          226 GCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             HHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             HHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            999999999999998753 22333344332  235667788999999999999999999999999999999865

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.91  E-value=1.9e-25  Score=210.54  Aligned_cols=135  Identities=29%  Similarity=0.537  Sum_probs=103.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---------------cccccccCCCCccCcccccCCCCCCCcccee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---------------HFLKTSCGSPNYAAPEVISGKLYAGPEVDVW   65 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---------------~~~~~~~gt~~y~APE~l~~~~~~~~~~DiW   65 (379)
                      .|+||||||+|||++.++.+||+|||++......               ......+|++.|+|||++.+....+.++|||
T Consensus       136 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  215 (303)
T 1zy4_A          136 GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMY  215 (303)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHH
T ss_pred             CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHH
Confidence            3799999999999999999999999999765421               2234557999999999998764448899999


Q ss_pred             eehhHHHHHhhCCCCCCC-CChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           66 SCGVILYALLCGTLPFDD-ENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~-~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |+||++|+|++   ||.. .+.......+......+|.    ..+..+.++|.+||..||.+|||+.++++||||+..
T Consensus       216 slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          216 SLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             HHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             HHHHHHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            99999999998   5543 3344556666665555554    455668999999999999999999999999999743

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.91  E-value=1.2e-25  Score=220.61  Aligned_cols=139  Identities=19%  Similarity=0.355  Sum_probs=118.0

Q ss_pred             CEEecCCCCCCeEEcCCC---cEEEEecCCcccccCC---cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKW---NVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~---~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++   .+||+|||+++.....   .......||+.|+|||++.+..+ +.++|||||||++|+|
T Consensus       201 ~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~el  279 (367)
T 3l9p_A          201 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEI  279 (367)
T ss_dssp             TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHH
T ss_pred             CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHH
Confidence            379999999999999655   5999999999765322   22234578999999999987776 7899999999999999


Q ss_pred             hh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           75 LC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        75 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      ++ |..||.+.+..++...+..+. ...+..++..+.+||.+||+.||.+|||+.+++++.++....+
T Consensus       280 lt~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          280 FSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence            98 999999999888888887665 4567789999999999999999999999999999988765543

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.90  E-value=3.5e-25  Score=222.55  Aligned_cols=138  Identities=30%  Similarity=0.491  Sum_probs=101.8

Q ss_pred             CEEecCCCCCCeEEcC-----CCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCC--CCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGK--LYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-----~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~--~~~~~~~DiWSlGv   69 (379)
                      .|+||||||+|||++.     ...+||+|||+++....+.    .....+||+.|+|||++.+.  ...+.++||||+||
T Consensus       138 ~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~  217 (432)
T 3p23_A          138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGC  217 (432)
T ss_dssp             TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHH
T ss_pred             cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHH
Confidence            3799999999999953     2368899999998765432    23456899999999999742  22367999999999


Q ss_pred             HHHHHhh-CCCCCCCCChHHHHHHHhcCccCC---CCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           70 ILYALLC-GTLPFDDENIPNLFKKIKGGIYTL---PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        70 ilyellt-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|+|++ |..||...........+.......   +...+..+++||.+||+.||.+|||++++++||||...
T Consensus       218 il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~  290 (432)
T 3p23_A          218 VFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL  290 (432)
T ss_dssp             HHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred             HHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence            9999999 999997765544433322222111   12235568899999999999999999999999999753

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.90  E-value=3.2e-25  Score=209.06  Aligned_cols=130  Identities=24%  Similarity=0.305  Sum_probs=106.3

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGv   69 (379)
                      .|+||||||+|||+   +.++.+||+|||++........        ....+||+.|+|||++.+..+ +.++||||+||
T Consensus       125 ~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~  203 (296)
T 3uzp_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGY  203 (296)
T ss_dssp             TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHH
T ss_pred             CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHH
Confidence            38999999999999   4789999999999987654322        245579999999999998776 78999999999


Q ss_pred             HHHHHhhCCCCCCCCC---hHHHHHHHhcCccCCC-----CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           70 ILYALLCGTLPFDDEN---IPNLFKKIKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        70 ilyelltG~~Pf~~~~---~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++|+|++|..||.+..   .......+.......|     ..+++++.++|.+||+.||.+|||+.++++
T Consensus       204 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          204 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            9999999999998733   2233344433333333     678999999999999999999999999876

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.90  E-value=6e-25  Score=207.37  Aligned_cols=131  Identities=18%  Similarity=0.244  Sum_probs=106.8

Q ss_pred             CEEecCCCCCCeEEcCCCc-----EEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~-----vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSl   67 (379)
                      .|+||||||+|||++.++.     +||+|||++........        ....+||+.|+|||++.+..+ +.++||||+
T Consensus       126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~sl  204 (298)
T 1csn_A          126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEAL  204 (298)
T ss_dssp             TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHH
T ss_pred             CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHH
Confidence            3899999999999987776     99999999987654321        245579999999999988777 789999999


Q ss_pred             hhHHHHHhhCCCCCCCC---ChHHHHHHHhcCcc-----CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           68 GVILYALLCGTLPFDDE---NIPNLFKKIKGGIY-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        68 GvilyelltG~~Pf~~~---~~~~~~~~i~~~~~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||++|+|++|..||.+.   ........+.....     .....+++++.++|.+||..||.+|||++++++.
T Consensus       205 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          205 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            99999999999999874   34444444433322     2235789999999999999999999999998764

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.90  E-value=4.1e-25  Score=208.05  Aligned_cols=130  Identities=24%  Similarity=0.308  Sum_probs=106.1

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGv   69 (379)
                      .|+||||||+|||+   +.++.+||+|||++........        .....||+.|+|||++.+..+ +.++||||+||
T Consensus       125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~  203 (296)
T 4hgt_A          125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGY  203 (296)
T ss_dssp             TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHH
T ss_pred             CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHH
Confidence            38999999999999   7889999999999987654322        235579999999999998876 78999999999


Q ss_pred             HHHHHhhCCCCCCCCCh---HHHHHHHhcCccCCC-----CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           70 ILYALLCGTLPFDDENI---PNLFKKIKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        70 ilyelltG~~Pf~~~~~---~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++|+|++|..||.+.+.   ......+.......|     ..+++++.++|.+||..||.+|||++++++
T Consensus       204 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          204 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            99999999999987432   223333333333333     678999999999999999999999999886

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.90  E-value=6.1e-25  Score=216.48  Aligned_cols=131  Identities=27%  Similarity=0.456  Sum_probs=114.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++.......   ......|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       211 ~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~  289 (382)
T 3tt0_A          211 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTL  289 (382)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhC
Confidence            37999999999999999999999999998765432   2234467889999999988776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..++...+..+. ...|..+++++.+||.+||..||.+|||+.|++++
T Consensus       290 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          290 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999888888887663 45677899999999999999999999999999986

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.90  E-value=4.8e-25  Score=205.48  Aligned_cols=129  Identities=29%  Similarity=0.478  Sum_probs=103.8

Q ss_pred             EEecCCCCCCeEEcC--------CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHH
Q 017029            2 VVHRDLKPENLLLDS--------KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYA   73 (379)
Q Consensus         2 IiHrDLKpeNILl~~--------~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilye   73 (379)
                      |+||||||+|||++.        ++.+||+|||++....... .....|++.|+|||++.+..+ +.++||||+|+++|+
T Consensus       129 i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~  206 (271)
T 3dtc_A          129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWE  206 (271)
T ss_dssp             CCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHH
T ss_pred             eeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHH
Confidence            789999999999986        7789999999998765433 235579999999999987766 789999999999999


Q ss_pred             HhhCCCCCCCCChHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           74 LLCGTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        74 lltG~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |++|..||.+.+.......+....  ...|..+++.+.++|.+||..||.+|||+.|++++
T Consensus       207 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          207 LLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            999999999988777666665443  45667899999999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.90  E-value=7e-25  Score=211.45  Aligned_cols=131  Identities=27%  Similarity=0.429  Sum_probs=110.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       171 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~  249 (325)
T 3kul_A          171 GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLA  249 (325)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHT
T ss_pred             CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHc
Confidence            389999999999999999999999999987654321    122346778999999987777 789999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 -GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                       |..||.+.........+..+ ..+.|..+++.+.++|.+||..||.+|||+.++++.
T Consensus       250 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          250 YGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             TSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             99999999988888887766 345677899999999999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.90  E-value=2.3e-25  Score=214.68  Aligned_cols=131  Identities=25%  Similarity=0.419  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++........   ....||+.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       137 ~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~  215 (327)
T 3poz_A          137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTF  215 (327)
T ss_dssp             TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhc
Confidence            3799999999999999999999999999876543322   23456889999999988777 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+...+...+..+. ...|..++.++.+++.+||+.||.+|||+.+++++
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          216 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             CCCCccCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999988877777776554 45677899999999999999999999999999876

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.90  E-value=3e-25  Score=208.57  Aligned_cols=131  Identities=29%  Similarity=0.533  Sum_probs=102.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||++.........  ....+++.|+|||++.+..+ +.++||||+||++|+|++ |
T Consensus       136 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g  214 (281)
T 1mp8_A          136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHG  214 (281)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTS
T ss_pred             CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcC
Confidence            3799999999999999999999999999876544322  23456789999999987776 789999999999999996 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+....+....+..+. .+.+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       215 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          215 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999988877777776654 46778899999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.90  E-value=1.1e-24  Score=203.06  Aligned_cols=131  Identities=25%  Similarity=0.436  Sum_probs=112.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||++.........  ....|++.|+|||++.+..+ +.++||||+|+++|+|++ |
T Consensus       124 ~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g  202 (268)
T 3sxs_A          124 QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLG  202 (268)
T ss_dssp             TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTT
T ss_pred             CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCC
Confidence            3899999999999999999999999999876554322  23346678999999988777 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+.........+..+.. ..|...++.+.++|.+||..||.+|||+.+++++
T Consensus       203 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          203 KMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999888888777776653 4566789999999999999999999999999976

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.90  E-value=4.1e-25  Score=206.14  Aligned_cols=130  Identities=25%  Similarity=0.477  Sum_probs=113.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||+++.++.+||+|||++.......  ......|++.|+|||++.+..+ +.++||||+|+++|+|++ |.
T Consensus       127 i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~  205 (269)
T 4hcu_A          127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGK  205 (269)
T ss_dssp             CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred             eecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCC
Confidence            7999999999999999999999999998764432  1233457788999999987776 789999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .||.+.........+..+. ...|..+++.+.+++.+||..||.+|||+.++++|
T Consensus       206 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          206 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            9999999988888887763 45567789999999999999999999999999876

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.90  E-value=4.6e-25  Score=212.02  Aligned_cols=131  Identities=27%  Similarity=0.417  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+|||++.++.+||+|||++.............+++.|+|||++.+..+ +.++||||+||++|+|++ |..
T Consensus       162 ~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~  240 (327)
T 1fvr_A          162 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGT  240 (327)
T ss_dssp             TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCC
Confidence            389999999999999999999999999975443333344567889999999987766 789999999999999998 999


Q ss_pred             CCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||.+.+.......+..+. ...|..+++.+.+||.+||..||.+|||+++++++
T Consensus       241 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          241 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcHHHHHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999888888887663 45667889999999999999999999999999986

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.90  E-value=8.4e-25  Score=207.88  Aligned_cols=131  Identities=28%  Similarity=0.444  Sum_probs=113.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       170 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          170 KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTT
T ss_pred             CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhC
Confidence            389999999999999999999999999987644322   223457889999999988776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.....+...+..+. ...|..+++++.++|.+||..||.+|||+.+++++
T Consensus       249 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          249 GGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999988888877776654 45677899999999999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.89  E-value=6.1e-25  Score=211.60  Aligned_cols=129  Identities=22%  Similarity=0.341  Sum_probs=106.3

Q ss_pred             CEEecCCCCCCeEEcCCCc-----EEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~-----vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSl   67 (379)
                      .|+||||||+|||++.++.     +||+|||++........        ....+||+.|+|||++.+..+ +.++|||||
T Consensus       125 ~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~sl  203 (330)
T 2izr_A          125 NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEAL  203 (330)
T ss_dssp             TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHH
T ss_pred             CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHH
Confidence            3899999999999999887     99999999987644322        245689999999999998877 789999999


Q ss_pred             hhHHHHHhhCCCCCCCC---ChHHHHHHHhcCccCCC-----CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           68 GVILYALLCGTLPFDDE---NIPNLFKKIKGGIYTLP-----SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        68 GvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~p-----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||++|+|++|..||.+.   ...+.+..+.......+     ..++ ++.++|.+||..||.+||++++|.+
T Consensus       204 G~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          204 GHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            99999999999999873   44455566654444333     2344 9999999999999999999998876

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.1e-24  Score=205.34  Aligned_cols=133  Identities=28%  Similarity=0.413  Sum_probs=114.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++........    .....|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       130 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt  208 (287)
T 1u59_A          130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALS  208 (287)
T ss_dssp             TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHT
T ss_pred             CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHc
Confidence            389999999999999999999999999987654322    123356889999999987766 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                       |..||.+....+....+..+. ..+|..+++++.++|.+||..||.+|||+.+++++.+
T Consensus       209 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          209 YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             TSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence             999999988888877777664 4667889999999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.89  E-value=7.2e-25  Score=211.52  Aligned_cols=131  Identities=25%  Similarity=0.425  Sum_probs=106.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       137 ~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~  215 (327)
T 3lzb_A          137 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTF  215 (327)
T ss_dssp             TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHC
Confidence            379999999999999999999999999987644322   223456788999999988777 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.....+...+..+. .+.|..++.++.++|.+||..||.+|||+.|+++.
T Consensus       216 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          216 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             SCCTTTTCCGGGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999988888777776654 56677899999999999999999999999999874

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.89  E-value=4.2e-25  Score=214.36  Aligned_cols=131  Identities=30%  Similarity=0.498  Sum_probs=108.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++.......   ......||+.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       213 ~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~  291 (359)
T 3vhe_A          213 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSL  291 (359)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTT
T ss_pred             CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhc
Confidence            37999999999999999999999999998664332   2234568899999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHH-HHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+..... ....+..+ ....|..+++++.++|.+||..||.+|||+.|+++|
T Consensus       292 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          292 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            999998866433 33444333 456678899999999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.89  E-value=1.1e-24  Score=211.31  Aligned_cols=131  Identities=21%  Similarity=0.260  Sum_probs=103.2

Q ss_pred             CEEecCCCCCCeEEcCCC--cEEEEecCCcccccCCc--------ccccccCCCCccCcccccCCCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~--~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvi   70 (379)
                      .|+||||||+|||++.++  .+||+|||+++......        .....+||+.|+|||++.+..+ +.++||||+||+
T Consensus       171 ~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~i  249 (345)
T 2v62_A          171 EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYC  249 (345)
T ss_dssp             TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHH
T ss_pred             CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHH
Confidence            389999999999999887  99999999997764321        1245579999999999998776 789999999999


Q ss_pred             HHHHhhCCCCCCCC--ChHHHHHHHhcCccCCC---------CCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           71 LYALLCGTLPFDDE--NIPNLFKKIKGGIYTLP---------SHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        71 lyelltG~~Pf~~~--~~~~~~~~i~~~~~~~p---------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +|+|++|..||.+.  +..............+|         ..+++++.++|.+||..||.+|||++++++.
T Consensus       250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            99999999999652  32222222211112222         2788999999999999999999999998863

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.89  E-value=6.8e-25  Score=211.30  Aligned_cols=131  Identities=27%  Similarity=0.378  Sum_probs=112.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++.......   ......|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       194 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  272 (343)
T 1luf_A          194 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSY  272 (343)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhc
Confidence            37999999999999999999999999997654332   2234568899999999987776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..+....+..+.. ..|..+++++.++|.+||..||.+|||+.+++++
T Consensus       273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            9999999988888888776654 5678899999999999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.89  E-value=1.7e-24  Score=205.59  Aligned_cols=135  Identities=26%  Similarity=0.430  Sum_probs=106.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.++.+||+|||++.......  .....+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       131 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~  209 (294)
T 4eqm_A          131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGE  209 (294)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSS
T ss_pred             CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCC
Confidence            37999999999999999999999999998765432  2234579999999999998776 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc-----CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           79 LPFDDENIPNLFKKIKGGIY-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      .||.+.+......+......     ..+..+++.+.++|.+||..||.+||+..+.+.+.|..
T Consensus       210 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          210 PPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             CSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             CCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            99999887766555444332     23467899999999999999999999666666666643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.89  E-value=1.2e-24  Score=204.21  Aligned_cols=131  Identities=23%  Similarity=0.395  Sum_probs=113.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||++........  .....|++.|+|||++.+..+ +.++||||+|+++|+|++ |
T Consensus       140 ~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g  218 (283)
T 3gen_A          140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLG  218 (283)
T ss_dssp             TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTT
T ss_pred             CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCC
Confidence            379999999999999999999999999987644321  223456788999999987776 789999999999999998 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+.+.......+..+. ...|..+++.+.++|.+||..||.+|||+.++++|
T Consensus       219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          219 KMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccChhHHHHHHhcccCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            99999998888888887764 34566789999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.89  E-value=1.1e-24  Score=213.07  Aligned_cols=130  Identities=19%  Similarity=0.260  Sum_probs=102.2

Q ss_pred             CEEecCCCCCCeEEc--CCCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~--~~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvi   70 (379)
                      .|+||||||+|||++  .++.+||+|||+++.......        ....+||+.|+|||++.+..+ +.++|||||||+
T Consensus       172 ~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~  250 (364)
T 3op5_A          172 EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYC  250 (364)
T ss_dssp             TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHH
T ss_pred             CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHH
Confidence            489999999999999  889999999999977643321        133469999999999998877 799999999999


Q ss_pred             HHHHhhCCCCCCCCChH-HHHHHHh----cCcc------CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           71 LYALLCGTLPFDDENIP-NLFKKIK----GGIY------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        71 lyelltG~~Pf~~~~~~-~~~~~i~----~~~~------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      +|+|++|..||.+.... .......    ....      -.+..+++++.+++..||..||.+|||+.+|++
T Consensus       251 l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          251 MIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            99999999999863221 1111111    1100      112567999999999999999999999999876

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.89  E-value=2.7e-24  Score=202.30  Aligned_cols=127  Identities=33%  Similarity=0.505  Sum_probs=104.2

Q ss_pred             EEecCCCCCCeEEcCCCc-----EEEEecCCcccccCCcccccccCCCCccCcccccC--CCCCCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~-----vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvilyel   74 (379)
                      |+||||||+|||++.++.     +||+|||++.....  .....+||+.|+|||++.+  ..+ +.++||||+||++|+|
T Consensus       145 ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l  221 (287)
T 4f0f_A          145 IVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTI  221 (287)
T ss_dssp             CBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHH
T ss_pred             eecCCCCcceEEEeccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHH
Confidence            899999999999988876     99999999975443  3455689999999999843  333 7899999999999999


Q ss_pred             hhCCCCCCCCChHHH--HHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           75 LCGTLPFDDENIPNL--FKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~--~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++|..||.+......  ...+...  ...++..+++.+.++|.+||..||.+|||++++++
T Consensus       222 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          222 LTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCCCccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            999999987654332  3333322  34567789999999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.89  E-value=1.5e-24  Score=206.72  Aligned_cols=131  Identities=24%  Similarity=0.442  Sum_probs=107.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       167 ~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~  245 (313)
T 3brb_A          167 NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATR  245 (313)
T ss_dssp             TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhc
Confidence            379999999999999999999999999987654322   223457889999999988776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.........+..+ ....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus       246 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          246 GMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999998888777777665 345677899999999999999999999999999875

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.89  E-value=1.3e-24  Score=209.90  Aligned_cols=133  Identities=26%  Similarity=0.399  Sum_probs=110.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....||+.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       192 ~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          192 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTT
T ss_pred             CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcC
Confidence            389999999999999999999999999987644322   234467889999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHH-HhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           77 GTLPFDDENIPNLFKK-IKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~-i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      |..||.+......... +..+ ....|..+++++.+||.+||..||.+|||+.++++|..
T Consensus       271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            9999988765444433 3333 34556788999999999999999999999999998743

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.89  E-value=2.9e-24  Score=216.55  Aligned_cols=128  Identities=26%  Similarity=0.502  Sum_probs=110.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+|||++.++.+||+|||+++.....  ..+..+++.|+|||++.+..+ +.++|||||||++|+|++ |..
T Consensus       309 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~  385 (450)
T 1k9a_A          309 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRV  385 (450)
T ss_dssp             TEECSCCCGGGEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCC
T ss_pred             CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCC
Confidence            3899999999999999999999999999865332  234467889999999988877 789999999999999998 999


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+..+....+..+ ....|..+++.+.++|.+||..||.+|||+.++++
T Consensus       386 P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          386 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             SSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            99998877777777766 35677889999999999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.89  E-value=1.6e-24  Score=213.26  Aligned_cols=130  Identities=27%  Similarity=0.437  Sum_probs=110.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc---cccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK---TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~---~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||+++...++....   ...+++.|+|||++.+..+ +.++||||+||++|||++ 
T Consensus       233 ~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~  311 (377)
T 3cbl_A          233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSL  311 (377)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTT
T ss_pred             CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhC
Confidence            38999999999999999999999999998654432211   1234678999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.+.+.......+..+ ..+.|..+++++.+||.+||..||.+|||++++++
T Consensus       312 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          312 GASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             SCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999998888877777655 35667889999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.89  E-value=2e-24  Score=206.47  Aligned_cols=131  Identities=22%  Similarity=0.388  Sum_probs=113.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       158 ~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~  236 (322)
T 1p4o_A          158 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATL  236 (322)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHT
T ss_pred             CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhc
Confidence            379999999999999999999999999986644322   223467889999999987776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+.......+..+. ...+..+++.+.++|.+||..||.+|||+.|++++
T Consensus       237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          237 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            899999988888877776654 45677899999999999999999999999999886

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.89  E-value=1.3e-24  Score=204.01  Aligned_cols=130  Identities=27%  Similarity=0.412  Sum_probs=108.4

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+|||++.++.+||+|||++........  .....|++.|+|||++.+..+ +.++||||+||++|+|++ |.
T Consensus       134 i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~  212 (281)
T 3cc6_A          134 CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGK  212 (281)
T ss_dssp             CCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTC
T ss_pred             cccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCC
Confidence            79999999999999999999999999987654332  233457889999999987766 789999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           79 LPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .||...........+..+ ..+.|..+++.+.++|.+||..||.+|||+.|++++
T Consensus       213 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          213 QPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CTTTTSCGGGHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccCChHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            999887776666666554 345677899999999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.89  E-value=1.5e-24  Score=207.65  Aligned_cols=130  Identities=32%  Similarity=0.463  Sum_probs=87.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-------------ccccCCCCccCcccc---cCCCCCCCcccee
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-------------KTSCGSPNYAAPEVI---SGKLYAGPEVDVW   65 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-------------~~~~gt~~y~APE~l---~~~~~~~~~~DiW   65 (379)
                      |+||||||+|||++.++.+||+|||++.........             .+.+||+.|+|||++   .+..+ +.++|||
T Consensus       159 ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~  237 (337)
T 3ll6_A          159 IIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIW  237 (337)
T ss_dssp             CBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCS-SHHHHHH
T ss_pred             EEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHH
Confidence            899999999999999999999999999876543221             145699999999998   34444 7899999


Q ss_pred             eehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           66 SCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      ||||++|+|++|..||.+..........  .....+...+..+.+||.+||+.||.+|||+.|+++|.+
T Consensus       238 slG~il~el~~g~~p~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          238 ALGCILYLLCFRQHPFEDGAKLRIVNGK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             HHHHHHHHHHHSSCCC--------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCcchhHHHhhcCc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            9999999999999999876544332221  122344567889999999999999999999999998854

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.89  E-value=2.3e-24  Score=201.65  Aligned_cols=133  Identities=29%  Similarity=0.461  Sum_probs=113.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+||+|||++.............|++.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       142 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~  220 (284)
T 2a19_B          142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDT  220 (284)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSS
T ss_pred             CeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCc
Confidence            389999999999999999999999999988766555566789999999999988777 7899999999999999999998


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |...  ......+..+  .++..++..+.++|.+||..||.+|||+.|+++|.+.-..
T Consensus       221 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~  274 (284)
T 2a19_B          221 AFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKK  274 (284)
T ss_dssp             HHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC
T ss_pred             chhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhh
Confidence            7532  2334444443  3466789999999999999999999999999999887543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.89  E-value=2.2e-24  Score=217.57  Aligned_cols=130  Identities=26%  Similarity=0.496  Sum_probs=112.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||+++.......  .....+++.|+|||++.+..+ +.++|||||||++|||++ |
T Consensus       304 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g  382 (454)
T 1qcf_A          304 NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYG  382 (454)
T ss_dssp             TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred             CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCC
Confidence            379999999999999999999999999987644321  123346788999999987776 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+..++...+..+. .+.|..+++++.++|.+||..||.+|||+++|++
T Consensus       383 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          383 RIPYPGMSNPEVIRALERGYRMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             CCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            99999998888888777653 4567789999999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.89  E-value=2.6e-24  Score=203.33  Aligned_cols=130  Identities=25%  Similarity=0.413  Sum_probs=98.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCCC-----CCccceeeehhHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYA-----GPEVDVWSCGVIL   71 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~-----~~~~DiWSlGvil   71 (379)
                      |+||||||+|||++.++.+||+|||++........     ....+||+.|+|||++.+....     +.++||||+||++
T Consensus       134 ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il  213 (301)
T 3q4u_A          134 IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVL  213 (301)
T ss_dssp             EECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHH
T ss_pred             eecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHH
Confidence            89999999999999999999999999977654322     2234899999999999876321     3689999999999


Q ss_pred             HHHhhC----------CCCCCCCC----hHHHHHHHhcC---ccCCCC-----CCChhhhcccccccCCCCCCCCChhhh
Q 017029           72 YALLCG----------TLPFDDEN----IPNLFKKIKGG---IYTLPS-----HLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        72 yelltG----------~~Pf~~~~----~~~~~~~i~~~---~~~~p~-----~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |+|++|          ..||.+..    ...........   ...+|.     ..++.+.+||.+||+.||.+|||+.++
T Consensus       214 ~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i  293 (301)
T 3q4u_A          214 WEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI  293 (301)
T ss_dssp             HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHH
Confidence            999999          88886531    22222222211   122221     244679999999999999999999998


Q ss_pred             hc
Q 017029          130 RQ  131 (379)
Q Consensus       130 l~  131 (379)
                      ++
T Consensus       294 ~~  295 (301)
T 3q4u_A          294 KK  295 (301)
T ss_dssp             HH
T ss_pred             HH
Confidence            75

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.89  E-value=3.8e-24  Score=202.06  Aligned_cols=130  Identities=26%  Similarity=0.392  Sum_probs=111.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc----ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~----~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++.........    ....|++.|+|||++.+..+ +.++||||+|+++|+|++
T Consensus       137 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  215 (291)
T 1xbb_A          137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFS  215 (291)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHh
Confidence            3899999999999999999999999999876543321    22356788999999987776 789999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+.+.......+..+. ...|..+++.+.++|.+||..||.+|||+.++++
T Consensus       216 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          216 YGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             cCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence             999999998888877776654 4567789999999999999999999999999886

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.89  E-value=3.5e-24  Score=206.67  Aligned_cols=131  Identities=26%  Similarity=0.472  Sum_probs=113.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       177 ~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~  255 (334)
T 2pvf_A          177 KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTL  255 (334)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhC
Confidence            389999999999999999999999999987654332   223457789999999987776 789999999999999999 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+..++...+..+. ...+..++..+.++|.+||..||.+|||+.+++++
T Consensus       256 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          256 GGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             SCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            999999998888887776654 45677899999999999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.89  E-value=2.6e-24  Score=202.30  Aligned_cols=130  Identities=25%  Similarity=0.395  Sum_probs=110.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+||+++.++.+||+|||++........    .....|++.|+|||++.+..+ +.++||||+|+++|+|++
T Consensus       141 ~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  219 (291)
T 1u46_A          141 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFT  219 (291)
T ss_dssp             TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHh
Confidence            389999999999999999999999999987654321    123467888999999987776 789999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+.+.......+....  .+.+..++.++.++|.+||..||.+|||+.++++
T Consensus       220 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          220 YGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence             999999998888888876654  3455678999999999999999999999999987

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.89  E-value=5.5e-24  Score=199.32  Aligned_cols=130  Identities=26%  Similarity=0.494  Sum_probs=112.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||++.........  ....|++.|+|||++.+..+ +.++||||+||++|+|++ |
T Consensus       129 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g  207 (279)
T 1qpc_A          129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHG  207 (279)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTT
T ss_pred             CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCC
Confidence            3899999999999999999999999999876544322  23457789999999987766 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+..+....+..+. ...+..+++++.++|.+||..||.+|||+.++++
T Consensus       208 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCcccCHHHHHHHHhcccCCCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            99999988888888777653 3456788999999999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.89  E-value=3e-24  Score=201.27  Aligned_cols=128  Identities=24%  Similarity=0.490  Sum_probs=105.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++......  .....+++.|+|||++.+..+ +.++||||+|+++|+|++ |..
T Consensus       137 ~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~  213 (278)
T 1byg_A          137 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRV  213 (278)
T ss_dssp             TCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CccccCCCcceEEEeCCCcEEEeecccccccccc--ccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCC
Confidence            3799999999999999999999999998765433  234568899999999987766 789999999999999998 999


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||...+..+....+..+ ....+..+++.+.++|.+||..||.+|||+.++++
T Consensus       214 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          214 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             SCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            99998888877777665 34567789999999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.89  E-value=2.2e-24  Score=200.23  Aligned_cols=130  Identities=25%  Similarity=0.477  Sum_probs=112.1

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||+++.++.+||+|||++.......  ......|++.|+|||++.+..+ +.++||||+|+++|+|++ |.
T Consensus       125 i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~  203 (267)
T 3t9t_A          125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGK  203 (267)
T ss_dssp             CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred             cccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCC
Confidence            7999999999999999999999999998764322  1223457788999999987766 789999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .||.+.+.......+..+. ...|..+++.+.+++.+||..||.+|||+.+++++
T Consensus       204 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          204 IPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999998888888887764 34567789999999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.88  E-value=2.9e-24  Score=206.50  Aligned_cols=131  Identities=24%  Similarity=0.343  Sum_probs=98.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCC----CCCccceeeehhHHHHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLY----AGPEVDVWSCGVILYAL   74 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~----~~~~~DiWSlGvilyel   74 (379)
                      |+||||||+|||++.++.+||+|||++........   ....+||+.|+|||++.+...    .+.++||||+||++|+|
T Consensus       152 ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el  231 (322)
T 3soc_A          152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL  231 (322)
T ss_dssp             EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHH
Confidence            89999999999999999999999999987654332   234579999999999986322    25678999999999999


Q ss_pred             hhCCCCCCCCC----------------hHHHHHHHhcCccC--CCCC-----CChhhhcccccccCCCCCCCCChhhhhc
Q 017029           75 LCGTLPFDDEN----------------IPNLFKKIKGGIYT--LPSH-----LSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        75 ltG~~Pf~~~~----------------~~~~~~~i~~~~~~--~p~~-----~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++|..||.+..                .......+......  ++..     .++++.+||.+||+.||.+|||+.|+++
T Consensus       232 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999997642                22222222222211  1111     2344899999999999999999999986


Q ss_pred             C
Q 017029          132 H  132 (379)
Q Consensus       132 h  132 (379)
                      .
T Consensus       312 ~  312 (322)
T 3soc_A          312 R  312 (322)
T ss_dssp             H
T ss_pred             H
Confidence            3

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.88  E-value=1.8e-24  Score=203.49  Aligned_cols=128  Identities=20%  Similarity=0.287  Sum_probs=104.9

Q ss_pred             CEEecCCCCCCeEEcCCCc--------EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHH
Q 017029            1 MVVHRDLKPENLLLDSKWN--------VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILY   72 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~--------vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvily   72 (379)
                      .|+||||||+|||++.++.        +||+|||++......   ....|++.|+|||++.+....+.++||||+||++|
T Consensus       133 ~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  209 (289)
T 4fvq_A          133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLW  209 (289)
T ss_dssp             TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHH
T ss_pred             CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHH
Confidence            3799999999999998887        999999998765332   24468899999999987444489999999999999


Q ss_pred             HHhhC-CCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           73 ALLCG-TLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        73 elltG-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +|++| ..||........ ..+.......|...++++.++|.+||..||.+|||+.++++|
T Consensus       210 el~~g~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          210 EICSGGDKPLSALDSQRK-LQFYEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHTTTCCTTTTSCHHHH-HHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCCCccccchHHH-HHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99995 555655554443 344445666777889999999999999999999999999986

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.88  E-value=3.7e-24  Score=202.20  Aligned_cols=130  Identities=31%  Similarity=0.530  Sum_probs=96.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC---CcccccccCCCCccCccccc---CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD---GHFLKTSCGSPNYAAPEVIS---GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~---~~~~~~~~gt~~y~APE~l~---~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.+||+|||++.....   ........||+.|+|||++.   +..+ +.++||||+||++|+|
T Consensus       140 ~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el  218 (289)
T 3og7_A          140 SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYEL  218 (289)
T ss_dssp             TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHH
T ss_pred             CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHH
Confidence            379999999999999999999999999976543   22334567999999999986   3444 6799999999999999


Q ss_pred             hhCCCCCCCCChH-HHHHHHhcCccC-----CCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           75 LCGTLPFDDENIP-NLFKKIKGGIYT-----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        75 ltG~~Pf~~~~~~-~~~~~i~~~~~~-----~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++|..||.+.... .+...+..+...     .+..+++.+.+||.+||..||.+|||+.++++
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          219 MTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            9999999875443 444444444332     23468899999999999999999999999886

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=6.3e-24  Score=205.26  Aligned_cols=131  Identities=26%  Similarity=0.441  Sum_probs=106.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       167 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt  245 (333)
T 1mqb_A          167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMT  245 (333)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHT
T ss_pred             CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHc
Confidence            379999999999999999999999999987644321    122346788999999988776 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 -GTLPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                       |..||.+.+..++...+..+ ..+.+..+++.+.++|.+||..||.+|||+.+++++
T Consensus       246 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          246 YGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCCCcccCCHHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             99999998888888887766 345677899999999999999999999999999875

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.88  E-value=2.2e-24  Score=207.20  Aligned_cols=138  Identities=19%  Similarity=0.342  Sum_probs=115.4

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.   +..+||+|||++.......   ......|++.|+|||++.+..+ +.++||||+||++|+|
T Consensus       160 ~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el  238 (327)
T 2yfx_A          160 HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEI  238 (327)
T ss_dssp             TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHH
T ss_pred             CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHH
Confidence            3799999999999984   4469999999997654332   1234568899999999987766 7899999999999999


Q ss_pred             hh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           75 LC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        75 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ++ |..||.+.........+..+. ...+..+++.+.++|.+||..||.+|||+.++++|.|+-...
T Consensus       239 lt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          239 FSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcCCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            98 999999988888877776653 456678999999999999999999999999999999876543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.88  E-value=3.1e-24  Score=204.46  Aligned_cols=128  Identities=30%  Similarity=0.453  Sum_probs=102.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc---------------ccccCCCCccCcccccCCCCCCCcccee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL---------------KTSCGSPNYAAPEVISGKLYAGPEVDVW   65 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~---------------~~~~gt~~y~APE~l~~~~~~~~~~DiW   65 (379)
                      .|+||||||+|||++.++.+||+|||++.........               .+.+||+.|+|||++.+..+ +.++|||
T Consensus       128 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~  206 (310)
T 3s95_A          128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVF  206 (310)
T ss_dssp             TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCC-CTHHHHH
T ss_pred             CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHH
Confidence            3899999999999999999999999999876433221               15579999999999998877 7899999


Q ss_pred             eehhHHHHHhhCCCCCCCCChHHH-----HHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           66 SCGVILYALLCGTLPFDDENIPNL-----FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~~~~~~~-----~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |+||++|+|++|..||........     .....  ....|..+++.+.++|.+||..||.+|||+.++++
T Consensus       207 slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          207 SFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            999999999999999875321110     01111  12346788999999999999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.88  E-value=8.3e-24  Score=196.33  Aligned_cols=126  Identities=22%  Similarity=0.346  Sum_probs=107.6

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCC--CccceeeehhHHHHHhhCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG--PEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~--~~~DiWSlGvilyelltG~~   79 (379)
                      |+||||||+|||++.++.++|+|||++.....    ....||+.|+|||++.+..+..  .++||||+||++|+|++|..
T Consensus       134 i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~  209 (271)
T 3kmu_A          134 IPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREV  209 (271)
T ss_dssp             CTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSC
T ss_pred             eecCCCccceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            89999999999999999999999998765332    3457899999999998765532  27999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+.......+...  ....|..+++++.++|.+||..||.+|||++++++
T Consensus       210 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          210 PFADLSNMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             TTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CccccChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            99998887776665543  34567889999999999999999999999999885

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.88  E-value=3.9e-24  Score=201.02  Aligned_cols=129  Identities=26%  Similarity=0.468  Sum_probs=111.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||+++.++.+||+|||++........  .....|++.|+|||++.+..+ +.++||||+|+++|+|++ |.
T Consensus       132 i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~  210 (288)
T 3kfa_A          132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGM  210 (288)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSC
T ss_pred             ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            79999999999999999999999999987654332  233457889999999987776 789999999999999999 99


Q ss_pred             CCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           79 LPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      .||.+.+.......+... ....|..+++.+.+||.+||..||.+|||+.++++
T Consensus       211 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          211 SPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            999998887777777665 34567789999999999999999999999999976

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.88  E-value=2.6e-24  Score=204.34  Aligned_cols=131  Identities=33%  Similarity=0.501  Sum_probs=107.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       165 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~  243 (313)
T 1t46_A          165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSL  243 (313)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhC
Confidence            379999999999999999999999999987654432   223457889999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHH-HhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKK-IKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~-i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+......... +..+ ....+..+++.+.++|.+||..||.+|||+.|++++
T Consensus       244 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            9999988765443333 3332 234467789999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.88  E-value=7.1e-24  Score=202.49  Aligned_cols=128  Identities=32%  Similarity=0.512  Sum_probs=99.5

Q ss_pred             EEecCCCCCCeEEcCCCc-EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWN-VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~-vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      |+||||||+|||++.++. +||+|||++......  .....||+.|+|||++.+..+ +.++||||+||++|+|++|..|
T Consensus       126 ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p  202 (307)
T 2eva_A          126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKP  202 (307)
T ss_dssp             CCCCCCSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCT
T ss_pred             eecCCCChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCC
Confidence            899999999999998886 799999999765432  234579999999999988776 7899999999999999999999


Q ss_pred             CCCCC--hHHHHHHHhc-CccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           81 FDDEN--IPNLFKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        81 f~~~~--~~~~~~~i~~-~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |....  .......+.. .....+..+++.+.++|.+||..||.+|||+++++++
T Consensus       203 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          203 FDEIGGPAFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             TTTTCSSHHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhhCccHHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            98643  2233333333 3345567889999999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.88  E-value=3.8e-24  Score=203.52  Aligned_cols=131  Identities=30%  Similarity=0.495  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....||+.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       168 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~  246 (316)
T 2xir_A          168 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSL  246 (316)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhC
Confidence            379999999999999999999999999987643321   234467899999999988776 789999999999999998 


Q ss_pred             CCCCCCCCChH-HHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIP-NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.... .....+..+ ....|..+++++.++|.+||..||.+|||+.++++|
T Consensus       247 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999886543 334444433 356677899999999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.88  E-value=5.6e-24  Score=214.59  Aligned_cols=130  Identities=25%  Similarity=0.450  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||+++.......  .....+++.|+|||++.+..+ +.++|||||||++|+|++ |
T Consensus       300 ~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g  378 (452)
T 1fmk_A          300 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKG  378 (452)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTT
T ss_pred             CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCC
Confidence            379999999999999999999999999987654322  123356788999999987776 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+....+....+..+. .+.|..+++.+.++|.+||..||.+|||++++++
T Consensus       379 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          379 RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            99999998888888877663 4567889999999999999999999999999886

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=1.1e-23  Score=198.67  Aligned_cols=130  Identities=28%  Similarity=0.421  Sum_probs=109.2

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      |+||||||+|||++.++.+||+|||++.......     ......|++.|+|||.+.+..+ +.++||||+||++|+|++
T Consensus       145 i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  223 (298)
T 3pls_A          145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLT  223 (298)
T ss_dssp             CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHH
T ss_pred             cccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhh
Confidence            7999999999999999999999999997654322     2234467889999999988777 789999999999999999


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                       |.+||...+.......+..+. ...+..+++.+.++|.+||..||.+|||+.++++.
T Consensus       224 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          224 RGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             TSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence             566677777777766666554 45677889999999999999999999999998864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.88  E-value=6.7e-24  Score=200.61  Aligned_cols=131  Identities=27%  Similarity=0.422  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||++........     .....|++.|+|||++.+..+ +.++||||+||++|+|+
T Consensus       148 ~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~  226 (298)
T 3f66_A          148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELM  226 (298)
T ss_dssp             TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHH
T ss_pred             CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHH
Confidence            379999999999999999999999999987644321     233467789999999988776 78999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           76 C-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        76 t-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      + |.+||.+.+..+....+..+.. ..|..+++.+.++|.+||..||.+|||+.++++.
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          227 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             TTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hCCCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9 7778888777766666665554 4467789999999999999999999999999863

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.88  E-value=4.4e-24  Score=210.43  Aligned_cols=131  Identities=28%  Similarity=0.431  Sum_probs=101.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||++.++.+||+|||+++.......     .....|++.|+|||++.+..+ +.++||||+||++|+|+
T Consensus       212 ~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ell  290 (373)
T 3c1x_A          212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELM  290 (373)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHH
T ss_pred             CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHH
Confidence            379999999999999999999999999986643321     123457789999999987777 78999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           76 C-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        76 t-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      + |.+||.+.+..+....+..+. ...|..+++.+.++|.+||..||.+|||+.+++++
T Consensus       291 t~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          291 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             TTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9 788998877666666666554 34567899999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.88  E-value=3.3e-24  Score=206.13  Aligned_cols=131  Identities=24%  Similarity=0.414  Sum_probs=107.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .|+||||||+|||++.++.+||+|||++........   .....|++.|+|||++.+..+ +.++||||+||++|+|++ 
T Consensus       184 ~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~  262 (333)
T 2i1m_A          184 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSL  262 (333)
T ss_dssp             TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTT
T ss_pred             CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcC
Confidence            389999999999999999999999999986643321   223457789999999987776 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.........+...  ....|..+++.+.++|.+||..||.+|||+.+++++
T Consensus       263 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          263 GLNPYPGILVNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             SCCSSTTCCSSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCcccchhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            99999887655444443322  234567789999999999999999999999999873

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.88  E-value=8.5e-24  Score=208.16  Aligned_cols=130  Identities=25%  Similarity=0.439  Sum_probs=100.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....+++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       167 ~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt  245 (373)
T 2qol_A          167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMS  245 (373)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHT
T ss_pred             CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHh
Confidence            379999999999999999999999999987654321    112245678999999987777 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+.+..++...+..+. .+.+..++..+.++|.+||+.||.+|||+.++++
T Consensus       246 ~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          246 YGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             TC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence             999999988888888877663 4456678999999999999999999999999886

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.88  E-value=8.5e-24  Score=205.56  Aligned_cols=131  Identities=15%  Similarity=0.189  Sum_probs=104.0

Q ss_pred             CEEecCCCCCCeEEcCCC--cEEEEecCCcccccCCc--------ccccccCCCCccCcccccCCCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKW--NVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~--~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvi   70 (379)
                      .|+||||||+|||++.++  .+||+|||++.......        ......||+.|+|||++.+..+ +.++|||||||+
T Consensus       179 ~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~i  257 (352)
T 2jii_A          179 EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYC  257 (352)
T ss_dssp             TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHH
T ss_pred             CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHH
Confidence            379999999999999998  99999999997664322        1134479999999999988776 789999999999


Q ss_pred             HHHHhhCCCCCCCCC--hHHHHHHH---hcCccCCC------CCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           71 LYALLCGTLPFDDEN--IPNLFKKI---KGGIYTLP------SHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        71 lyelltG~~Pf~~~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +|+|++|..||.+..  ...+....   ......++      ..+++++.+||.+||..||.+|||++++++.
T Consensus       258 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          258 MLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            999999999998753  33222222   22222222      2468999999999999999999999998863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.88  E-value=5.2e-24  Score=201.29  Aligned_cols=130  Identities=23%  Similarity=0.376  Sum_probs=101.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++.......    ......|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       134 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~  212 (295)
T 3ugc_A          134 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFT  212 (295)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHH
T ss_pred             CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHh
Confidence            37999999999999999999999999998765432    1223457778999999988777 789999999999999999


Q ss_pred             CCCCCCCCChH----------------HHHHHHh-cCccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIP----------------NLFKKIK-GGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~----------------~~~~~i~-~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||......                .....+. ....+.|..+++++.++|.+||..||.+|||+.|+++
T Consensus       213 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            99998653211                1222222 2345667889999999999999999999999999875

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.88  E-value=8.8e-24  Score=215.70  Aligned_cols=130  Identities=25%  Similarity=0.458  Sum_probs=111.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .||||||||+|||++.++.+||+|||+++........  ....+++.|+|||++.+..+ +.++|||||||++|+|++ |
T Consensus       338 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g  416 (495)
T 1opk_A          338 NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYG  416 (495)
T ss_dssp             TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCC
Confidence            3899999999999999999999999999876543321  23346778999999987777 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ..||.+.+...+...+..+. ...|..+++.+.+||.+||+.||.+|||+.++++
T Consensus       417 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          417 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            99999988888777776653 4567889999999999999999999999999975

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.88  E-value=2e-23  Score=199.32  Aligned_cols=130  Identities=25%  Similarity=0.416  Sum_probs=98.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.++.+||+|||++.......  ......|++.|+|||++.+..+ +.++||||+|+++|+|++|.
T Consensus       154 ~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~  232 (309)
T 2h34_A          154 GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGS  232 (309)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSS
T ss_pred             cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCC
Confidence            37999999999999999999999999998765432  2335579999999999988766 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCC-Chhhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRI-TIPEIRQ  131 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rp-t~~ell~  131 (379)
                      .||.+.+.......+.....   ..+..+++.+.++|.+||..||.+|| |++++++
T Consensus       233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          233 PPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             CSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             CCCCCchHHHHHHHhccCCCCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            99998877655555544332   34567899999999999999999999 7887765

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.87  E-value=8.9e-24  Score=202.76  Aligned_cols=132  Identities=24%  Similarity=0.382  Sum_probs=98.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc-----cccccCCCCccCcccccCCCCCCC-----ccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF-----LKTSCGSPNYAAPEVISGKLYAGP-----EVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~-----~~~~~gt~~y~APE~l~~~~~~~~-----~~DiWSlGvi   70 (379)
                      .|+||||||+|||++.++.+||+|||++........     ..+.+||+.|+|||++.+..+...     ++||||+||+
T Consensus       162 ~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i  241 (337)
T 3mdy_A          162 AIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLI  241 (337)
T ss_dssp             CEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHH
T ss_pred             CEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHH
Confidence            389999999999999999999999999976643321     124589999999999987665322     3899999999


Q ss_pred             HHHHhhC----------CCCCCCCC-----hHHHHHHHhcC--ccCCCC-----CCChhhhcccccccCCCCCCCCChhh
Q 017029           71 LYALLCG----------TLPFDDEN-----IPNLFKKIKGG--IYTLPS-----HLSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        71 lyelltG----------~~Pf~~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      +|+|++|          ..||....     .......+...  ...+|.     .+++++.++|.+||..||.+|||+.+
T Consensus       242 l~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~e  321 (337)
T 3mdy_A          242 LWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALR  321 (337)
T ss_dssp             HHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHH
T ss_pred             HHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHH
Confidence            9999999          77775431     22222222211  122232     34566899999999999999999999


Q ss_pred             hhcC
Q 017029          129 IRQH  132 (379)
Q Consensus       129 ll~h  132 (379)
                      +++|
T Consensus       322 ll~~  325 (337)
T 3mdy_A          322 VKKT  325 (337)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9976

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.87  E-value=5.7e-24  Score=204.51  Aligned_cols=131  Identities=23%  Similarity=0.344  Sum_probs=95.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---------ccccccCCCCccCcccccCC------CCCCCcccee
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---------FLKTSCGSPNYAAPEVISGK------LYAGPEVDVW   65 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---------~~~~~~gt~~y~APE~l~~~------~~~~~~~DiW   65 (379)
                      .|+||||||+|||++.++.+||+|||++.......         .....+||+.|+|||++.+.      ...+.++|||
T Consensus       140 ~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Diw  219 (336)
T 3g2f_A          140 AISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMY  219 (336)
T ss_dssp             CEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHH
T ss_pred             ceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchH
Confidence            38999999999999999999999999998764322         22345799999999999863      1225789999


Q ss_pred             eehhHHHHHhhCCCCCCC-CC-----------------hHHHHHHHh--cCccCCCCCC------ChhhhcccccccCCC
Q 017029           66 SCGVILYALLCGTLPFDD-EN-----------------IPNLFKKIK--GGIYTLPSHL------SPGARDLIPRMLIVD  119 (379)
Q Consensus        66 SlGvilyelltG~~Pf~~-~~-----------------~~~~~~~i~--~~~~~~p~~~------s~~~~~Li~~mL~~d  119 (379)
                      |+||++|+|++|..||.. ..                 .......+.  .....+|..+      ++++.+||.+||..|
T Consensus       220 slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  299 (336)
T 3g2f_A          220 ALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQD  299 (336)
T ss_dssp             HHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSS
T ss_pred             HHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCC
Confidence            999999999999766532 21                 111111111  1122334332      347999999999999


Q ss_pred             CCCCCChhhhhc
Q 017029          120 PMKRITIPEIRQ  131 (379)
Q Consensus       120 P~~Rpt~~ell~  131 (379)
                      |.+|||+.|+++
T Consensus       300 P~~Rps~~e~l~  311 (336)
T 3g2f_A          300 AEARLTAQXAEE  311 (336)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcchHHHHH
Confidence            999999999965

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.87  E-value=2.9e-24  Score=205.87  Aligned_cols=133  Identities=23%  Similarity=0.350  Sum_probs=101.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.+||+|||++......   ......+||+.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       159 ~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g  237 (321)
T 2qkw_B          159 AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCA  237 (321)
T ss_dssp             TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHC
T ss_pred             CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhC
Confidence            3899999999999999999999999999865432   12234568999999999987776 7899999999999999999


Q ss_pred             CCCCCCCChHHH-------HHHHhcCcc----------CCCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           78 TLPFDDENIPNL-------FKKIKGGIY----------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        78 ~~Pf~~~~~~~~-------~~~i~~~~~----------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      +.||.+......       ......+..          ..+...+..+.+++.+||..||.+|||+.|++++..
T Consensus       238 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~  311 (321)
T 2qkw_B          238 RSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE  311 (321)
T ss_dssp             CTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence            999976432211       111111111          112234567889999999999999999999998754

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.87  E-value=1.6e-23  Score=219.37  Aligned_cols=130  Identities=28%  Similarity=0.430  Sum_probs=109.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc----ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~----~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++.+||+|||+++........    ....+++.|+|||++.+..+ +.++|||||||++|||++
T Consensus       456 ~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt  534 (613)
T 2ozo_A          456 NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALS  534 (613)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHT
T ss_pred             CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHH
Confidence            3799999999999999999999999999876433211    22345689999999987777 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+.+..++...+..+. ...|..+++++.++|.+||..||.+|||+.++++
T Consensus       535 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          535 YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             TSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             999999988888888887764 4667889999999999999999999999998754

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.87  E-value=1.1e-23  Score=221.30  Aligned_cols=130  Identities=26%  Similarity=0.388  Sum_probs=110.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++.+||+|||+++.......    .....|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       489 ~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt  567 (635)
T 4fl3_A          489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFS  567 (635)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHT
T ss_pred             CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHh
Confidence            379999999999999999999999999987654321    223456788999999988777 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |..||.+.+..++...+..+. ...|..+++++.+||.+||..||.+|||++++++
T Consensus       568 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          568 YGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence             999999999888888887664 4567889999999999999999999999999875

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.87  E-value=2.9e-23  Score=197.87  Aligned_cols=129  Identities=25%  Similarity=0.345  Sum_probs=104.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccC------CcccccccCCCCccCcccccCC--------CCCCCccceeee
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRD------GHFLKTSCGSPNYAAPEVISGK--------LYAGPEVDVWSC   67 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~------~~~~~~~~gt~~y~APE~l~~~--------~~~~~~~DiWSl   67 (379)
                      |+||||||+|||++ ++.+||+|||++.....      ........|++.|+|||++.+.        ...+.++||||+
T Consensus       151 i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~sl  229 (319)
T 2y4i_B          151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL  229 (319)
T ss_dssp             CCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHH
T ss_pred             ccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHH
Confidence            79999999999998 68999999999875431      1223345689999999998752        223789999999


Q ss_pred             hhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCC--CCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           68 GVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP--SHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||++|+|++|..||.+.........+..+..+..  ..++.++.++|.+||..||.+|||+.++++
T Consensus       230 G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          230 GTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999988888877776654332  358899999999999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.87  E-value=2.7e-23  Score=211.80  Aligned_cols=130  Identities=24%  Similarity=0.300  Sum_probs=105.8

Q ss_pred             CEEecCCCCCCeEE---cCCCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccCCCCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl---~~~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGv   69 (379)
                      .||||||||+||||   +.++.+||+|||+++.......        ....+||+.|+|||++.+..+ +.++|||||||
T Consensus       123 gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGv  201 (483)
T 3sv0_A          123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGY  201 (483)
T ss_dssp             TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHH
T ss_pred             CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHH
Confidence            38999999999999   6889999999999987654332        125689999999999998877 78999999999


Q ss_pred             HHHHHhhCCCCCCCCC---hHHHHHHHhcCcc-----CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           70 ILYALLCGTLPFDDEN---IPNLFKKIKGGIY-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        70 ilyelltG~~Pf~~~~---~~~~~~~i~~~~~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ++|+|++|..||.+..   ....+.++.....     .++..++.++.+||.+||..||.+||++.+|++
T Consensus       202 il~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          202 VLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999998743   3333444332222     233678999999999999999999999998765

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.87  E-value=2.1e-23  Score=219.46  Aligned_cols=137  Identities=30%  Similarity=0.442  Sum_probs=107.0

Q ss_pred             CEEecCCCCCCeEEcCCCc---EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~---vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.++.   +||+|||++............+|++.|+|||++.+..+ +.++||||+||++|+|++|
T Consensus       141 gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG  219 (676)
T 3qa8_A          141 RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITG  219 (676)
T ss_dssp             TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSS
T ss_pred             CCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHC
Confidence            3799999999999997765   99999999998877666667789999999999988777 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHH--------------HhcCcc------CCC----CCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           78 TLPFDDENIPNLFKK--------------IKGGIY------TLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~--------------i~~~~~------~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      ..||.+......+..              ...+..      +.|    ..+++.+.+||.+||..||.+|||++++++||
T Consensus       220 ~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp  299 (676)
T 3qa8_A          220 FRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG  299 (676)
T ss_dssp             CSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred             CCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence            999977543321100              011111      111    22567889999999999999999999999999


Q ss_pred             hhhhc
Q 017029          134 WFQAH  138 (379)
Q Consensus       134 ~f~~~  138 (379)
                      ||+..
T Consensus       300 ~F~~l  304 (676)
T 3qa8_A          300 CFQAL  304 (676)
T ss_dssp             THHHH
T ss_pred             HHHHH
Confidence            99853

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.87  E-value=1.1e-23  Score=202.46  Aligned_cols=131  Identities=27%  Similarity=0.427  Sum_probs=106.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       147 ~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~  225 (327)
T 3lxl_A          147 RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFT  225 (327)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHh
Confidence            389999999999999999999999999987654321    233468888999999988776 789999999999999999


Q ss_pred             CCCCCCCCCh---------------HHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENI---------------PNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~---------------~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.....               ......+..+ ....+..+++++.+||.+||..||.+|||+.+++++
T Consensus       226 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          226 YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             TTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999865332               1222333332 345677899999999999999999999999999765

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.87  E-value=1.9e-23  Score=200.24  Aligned_cols=133  Identities=26%  Similarity=0.360  Sum_probs=101.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.++.+||+|||++.......  .....+||+.|+|||++.+..+ +.++||||+||++|+|++|.
T Consensus       154 ~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~  232 (326)
T 3uim_A          154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQ  232 (326)
T ss_dssp             CEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCC
T ss_pred             CeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCC
Confidence            38999999999999999999999999998764332  2344569999999999987776 78999999999999999999


Q ss_pred             CCCCCC-----ChHHHHHHHhc---C-c----------cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCch
Q 017029           79 LPFDDE-----NIPNLFKKIKG---G-I----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPW  134 (379)
Q Consensus        79 ~Pf~~~-----~~~~~~~~i~~---~-~----------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~  134 (379)
                      .||...     ........+..   . .          ...+...+..+.+++.+||..||.+|||+.|+++|-.
T Consensus       233 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          233 RAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             CSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             CcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            999621     11111111111   0 0          0111123467889999999999999999999998865

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.87  E-value=2.4e-23  Score=214.49  Aligned_cols=131  Identities=25%  Similarity=0.447  Sum_probs=112.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .||||||||+|||++.++.+||+|||+++.......  .....++..|+|||++.+..+ +.++|||||||++|+|++ |
T Consensus       383 ~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g  461 (535)
T 2h8h_A          383 NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKG  461 (535)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTT
T ss_pred             CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCC
Confidence            379999999999999999999999999987654321  123356788999999987766 789999999999999999 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+....++...+..+. ...|..+++.+.+||.+||..||.+|||+++|++.
T Consensus       462 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          462 RVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999998888888887663 45678899999999999999999999999998863

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.86  E-value=1.8e-23  Score=197.84  Aligned_cols=130  Identities=26%  Similarity=0.385  Sum_probs=104.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....||+.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       146 ~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~  224 (302)
T 4e5w_A          146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLT  224 (302)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHH
Confidence            389999999999999999999999999987754432    234568888999999988777 689999999999999999


Q ss_pred             CCCCCCCC---------------ChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDE---------------NIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~---------------~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..|+...               ........+..+ ....|..+++++.+||.+||..||.+|||+.++++
T Consensus       225 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          225 YCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             ccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99886431               112223333332 34567889999999999999999999999999875

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.86  E-value=5e-23  Score=195.88  Aligned_cols=131  Identities=31%  Similarity=0.514  Sum_probs=97.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .|+||||||+||+++.++.+||+|||++....... ......|++.|+|||++.+..+ +.++||||+|+++|+|++|..
T Consensus       156 ~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~  234 (310)
T 2wqm_A          156 RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQS  234 (310)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSC
T ss_pred             CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCC
Confidence            37999999999999999999999999998764432 2344579999999999988776 789999999999999999999


Q ss_pred             CCCCC--ChHHHHHHHhcCccCC--CCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDE--NIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~--~~~~~~~~i~~~~~~~--p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||.+.  +.......+..+.++.  +..+++++.++|.+||..||.+|||+.+++++
T Consensus       235 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          235 PFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             TTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            99764  3445556665554332  25689999999999999999999999999864

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.86  E-value=4.7e-23  Score=198.32  Aligned_cols=131  Identities=21%  Similarity=0.377  Sum_probs=101.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCCC-----CCccceeeehhHH
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLYA-----GPEVDVWSCGVIL   71 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~~-----~~~~DiWSlGvil   71 (379)
                      |+||||||+|||++.++.+||+|||++.......     .....+||+.|+|||++.+....     +.++||||+||++
T Consensus       168 ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il  247 (342)
T 1b6c_B          168 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVF  247 (342)
T ss_dssp             EECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHH
T ss_pred             eeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHH
Confidence            8999999999999999999999999998765443     22445799999999999865321     2689999999999


Q ss_pred             HHHhhC----------CCCCCCC-----ChHHHHHHHhcCcc--CCCC-----CCChhhhcccccccCCCCCCCCChhhh
Q 017029           72 YALLCG----------TLPFDDE-----NIPNLFKKIKGGIY--TLPS-----HLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        72 yelltG----------~~Pf~~~-----~~~~~~~~i~~~~~--~~p~-----~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |+|++|          ..||.+.     ....+...+.....  .+|.     ..+..+.+||.+||..||.+|||+.++
T Consensus       248 ~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i  327 (342)
T 1b6c_B          248 WEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRI  327 (342)
T ss_dssp             HHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHH
T ss_pred             HHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHH
Confidence            999999          7898764     23444444433322  2222     223578899999999999999999999


Q ss_pred             hcC
Q 017029          130 RQH  132 (379)
Q Consensus       130 l~h  132 (379)
                      ++|
T Consensus       328 ~~~  330 (342)
T 1b6c_B          328 KKT  330 (342)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            876

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.86  E-value=3.8e-23  Score=218.07  Aligned_cols=131  Identities=29%  Similarity=0.533  Sum_probs=110.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||++.........  ....|++.|+|||++.+..+ +.++||||+||++|+|++ |
T Consensus       511 givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g  589 (656)
T 2j0j_A          511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHG  589 (656)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred             CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcC
Confidence            3799999999999999999999999999876544322  23457789999999987776 789999999999999997 9


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+.+..+....+..+. .+.|..+++.+.++|.+||..||.+|||+.++++.
T Consensus       590 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          590 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             CCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            99999998888887776654 56788899999999999999999999999998863

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.86  E-value=8.7e-24  Score=209.32  Aligned_cols=131  Identities=28%  Similarity=0.487  Sum_probs=104.0

Q ss_pred             CEEecCCCCCCeEE----cCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC--------CCCCCCccceeeeh
Q 017029            1 MVVHRDLKPENLLL----DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--------KLYAGPEVDVWSCG   68 (379)
Q Consensus         1 ~IiHrDLKpeNILl----~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--------~~~~~~~~DiWSlG   68 (379)
                      .|+||||||+|||+    +.++.+||+|||++..........+.+||+.|+|||++.+        ..+ +.++||||+|
T Consensus       132 ~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG  210 (396)
T 4eut_A          132 GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIG  210 (396)
T ss_dssp             TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHH
T ss_pred             CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHH
Confidence            38999999999999    7788899999999988766666667789999999999864        334 6799999999


Q ss_pred             hHHHHHhhCCCCCCC----CChHHHHHHHhcCccC-------------------CC------CCCChhhhcccccccCCC
Q 017029           69 VILYALLCGTLPFDD----ENIPNLFKKIKGGIYT-------------------LP------SHLSPGARDLIPRMLIVD  119 (379)
Q Consensus        69 vilyelltG~~Pf~~----~~~~~~~~~i~~~~~~-------------------~p------~~~s~~~~~Li~~mL~~d  119 (379)
                      |++|+|++|..||.+    ....+...++..+...                   +|      ..++..+.++|.+||..|
T Consensus       211 ~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~d  290 (396)
T 4eut_A          211 VTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD  290 (396)
T ss_dssp             HHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCC
T ss_pred             HHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccC
Confidence            999999999999964    2334455555444321                   11      123456789999999999


Q ss_pred             CCCCCChhhhhcC
Q 017029          120 PMKRITIPEIRQH  132 (379)
Q Consensus       120 P~~Rpt~~ell~h  132 (379)
                      |.+|||+.+++++
T Consensus       291 P~~R~s~~e~l~~  303 (396)
T 4eut_A          291 QEKCWGFDQFFAE  303 (396)
T ss_dssp             TTTSCCHHHHHHH
T ss_pred             hhhhccHHHHHHH
Confidence            9999999998664

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.86  E-value=8.6e-23  Score=193.89  Aligned_cols=117  Identities=38%  Similarity=0.707  Sum_probs=91.9

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.   ++.+||+|||++.....                     ..+ +.++||||+||++|+|++|
T Consensus       137 ~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---------------------~~~-~~~~DiwslG~il~el~tg  194 (299)
T 3m2w_A          137 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---------------------EKY-DKSCDMWSLGVIMYILLCG  194 (299)
T ss_dssp             TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------------CGG-GGHHHHHHHHHHHHHHHHS
T ss_pred             CcccCCCCHHHEEEecCCCCCcEEEecccccccccc---------------------ccC-CchhhHHHHHHHHHHHHHC
Confidence            3899999999999998   78999999999865421                     223 6799999999999999999


Q ss_pred             CCCCCCCChHHHHH----HHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029           78 TLPFDDENIPNLFK----KIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~----~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ..||.+.+......    .+..+...+|    ..+++++.+||.+||..||.+|||+.|+++||||++..
T Consensus       195 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~  264 (299)
T 3m2w_A          195 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  264 (299)
T ss_dssp             SCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred             CCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence            99998765443322    2222333344    56899999999999999999999999999999998763

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.86  E-value=3.8e-23  Score=197.13  Aligned_cols=132  Identities=28%  Similarity=0.361  Sum_probs=101.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----------ccccccCCCCccCcccccCCCC--CCCccceeeeh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----------FLKTSCGSPNYAAPEVISGKLY--AGPEVDVWSCG   68 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----------~~~~~~gt~~y~APE~l~~~~~--~~~~~DiWSlG   68 (379)
                      .|+||||||+|||++.++.+||+|||++.......          ......|++.|+|||++.+...  .+.++||||+|
T Consensus       154 ~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG  233 (317)
T 2buj_A          154 GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLG  233 (317)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHH
T ss_pred             CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHH
Confidence            48999999999999999999999999987653211          1123468999999999876542  37899999999


Q ss_pred             hHHHHHhhCCCCCCCCC--hHHHHHHHhc-CccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           69 VILYALLCGTLPFDDEN--IPNLFKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        69 vilyelltG~~Pf~~~~--~~~~~~~i~~-~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |++|+|++|..||....  .......+.. ...+.+..+++++.++|.+||..||.+|||+.+++++
T Consensus       234 ~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          234 CVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             HHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            99999999999995411  1111222222 2233446789999999999999999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.86  E-value=3e-23  Score=198.91  Aligned_cols=130  Identities=28%  Similarity=0.376  Sum_probs=104.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       154 ~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~  232 (318)
T 3lxp_A          154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLT  232 (318)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHh
Confidence            389999999999999999999999999987755432    234568889999999988777 689999999999999999


Q ss_pred             CCCCCCCCChH---------------HHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIP---------------NLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~---------------~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||......               .....+..+ ....+..+++++.+||.+||..||.+|||+.|+++
T Consensus       233 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          233 HCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             TTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            99999753211               122222222 34567789999999999999999999999999985

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.86  E-value=3.4e-23  Score=196.62  Aligned_cols=130  Identities=28%  Similarity=0.461  Sum_probs=101.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+||+++.++.+||+|||++.......   .....+|++.|+|||++.+. + +.++||||+||++|+|++|
T Consensus       153 ~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g  230 (307)
T 2nru_A          153 HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITG  230 (307)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHC
T ss_pred             CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHC
Confidence            38999999999999999999999999998764422   12345799999999998764 4 7899999999999999999


Q ss_pred             CCCCCCCChH----HHHHHHhcCc-----------cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIP----NLFKKIKGGI-----------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~----~~~~~i~~~~-----------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ..||.+....    .+...+....           ...+...++.+.+++.+||..||.+|||+.+++++
T Consensus       231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          231 LPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999875432    2222222211           11223345678899999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.85  E-value=9.1e-23  Score=199.24  Aligned_cols=127  Identities=19%  Similarity=0.360  Sum_probs=97.8

Q ss_pred             CEEecCCCCCCeEEcC-----------CCcEEEEecCCccccc---CCcccccccCCCCccCcccccCCCCCCCccceee
Q 017029            1 MVVHRDLKPENLLLDS-----------KWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWS   66 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-----------~~~vKL~DFGls~~~~---~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWS   66 (379)
                      .||||||||+|||++.           ++.+||+|||++..+.   ........+||+.|+|||++.+..+ +.++||||
T Consensus       192 ~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Diws  270 (365)
T 3e7e_A          192 EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFG  270 (365)
T ss_dssp             TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHH
T ss_pred             CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHH
Confidence            3899999999999998           8999999999997543   3344566789999999999998887 79999999


Q ss_pred             ehhHHHHHhhCCCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           67 CGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        67 lGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +||++|+|++|+.||........  .+ ...+. ....++.+.+++.+||+.+|.+|++..+.+.+
T Consensus       271 lG~il~elltg~~pf~~~~~~~~--~~-~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          271 VAATVYCMLFGTYMKVKNEGGEC--KP-EGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             HHHHHHHHHHSSCCCEEEETTEE--EE-CSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhCCCccccCCCCce--ee-chhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            99999999999999965322100  00 01111 11246778899999999999999765544443

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.84  E-value=1.4e-22  Score=194.80  Aligned_cols=130  Identities=23%  Similarity=0.358  Sum_probs=104.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||++........    .....|++.|+|||++.+..+ +.++||||+||++|+|++
T Consensus       165 ~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t  243 (326)
T 2w1i_A          165 RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFT  243 (326)
T ss_dssp             TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHH
T ss_pred             CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHh
Confidence            489999999999999999999999999987654432    123457778999999987776 789999999999999999


Q ss_pred             CCCCCCCCCh----------------HHHHHHHhc-CccCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENI----------------PNLFKKIKG-GIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~----------------~~~~~~i~~-~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |..||.....                ..+...+.. ...+.|..+++++.++|.+||..||.+|||+.++++
T Consensus       244 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          244 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999864211                011222222 234567789999999999999999999999999875

>1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1

Probab=99.84  E-value=8.4e-21  Score=157.33  Aligned_cols=88  Identities=18%  Similarity=0.316  Sum_probs=79.9

Q ss_pred             eeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCccccCCceEEE
Q 017029          260 LQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKF  339 (379)
Q Consensus       260 i~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (379)
                      ++|+.+|.+||.||+|||+++|++|++.++|.++|+|.++.         .                       ...|+|
T Consensus        33 tTSsk~P~eIm~EI~rvL~~~~i~~k~~~~y~L~C~~~~~~---------~-----------------------~~~vkf   80 (126)
T 1v5s_A           33 QGSSGSSGDMMREIRKVLGANNCDYEQRERFLLFCVHGDGH---------A-----------------------ENLVQW   80 (126)
T ss_dssp             CCCCSSHHHHHHHHHHHHHHTTEEEEEEETTEEEEEECSSS---------T-----------------------TTCEEE
T ss_pred             eecCCCHHHHHHHHHHHHHHcCCcEEEECCEEEEEEECCCC---------C-----------------------CceEEE
Confidence            89999999999999999999999999999999999986320         0                       335999


Q ss_pred             EEEEEeec-CCceeeeeccccCCceehHHHHHHHHHHHhcC
Q 017029          340 EVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRVL  379 (379)
Q Consensus       340 ~lQLYk~~-~~~YLlDf~~~~g~~~~f~~~c~~~i~~L~~~  379 (379)
                      |||+|||. .+.|.|||||++|+.+.|.++|++|+++|+++
T Consensus        81 EiEVcKvp~l~l~GI~fKRisGd~w~YK~lc~~IL~eLkL~  121 (126)
T 1v5s_A           81 EMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKLS  121 (126)
T ss_dssp             EEECCCCTTTCSCCCEEEEEESCHHHHHHHHHHHHHHTTCC
T ss_pred             EEEEEEecCCCceeEEEeeccCchhHHHHHHHHHHHHHhcc
Confidence            99999995 78999999999999999999999999999864

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.83  E-value=2.7e-22  Score=193.50  Aligned_cols=125  Identities=20%  Similarity=0.236  Sum_probs=98.0

Q ss_pred             CEEecCCCCCCeEEcCCC--------------------cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCC
Q 017029            1 MVVHRDLKPENLLLDSKW--------------------NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP   60 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~--------------------~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~   60 (379)
                      .||||||||+|||++.++                    .+||+|||+++.....    +.+||+.|+|||++.+..  +.
T Consensus       182 ~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~  255 (336)
T 2vuw_A          182 RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DY  255 (336)
T ss_dssp             CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SH
T ss_pred             CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--cc
Confidence            389999999999999887                    8999999999877543    458999999999998765  67


Q ss_pred             ccceeeehhH-HHHHhhCCCCCCCCCh-HHHHHHHhcC-ccC------CCCCCChhhhcccccccCCCCCCCCChhhhh-
Q 017029           61 EVDVWSCGVI-LYALLCGTLPFDDENI-PNLFKKIKGG-IYT------LPSHLSPGARDLIPRMLIVDPMKRITIPEIR-  130 (379)
Q Consensus        61 ~~DiWSlGvi-lyelltG~~Pf~~~~~-~~~~~~i~~~-~~~------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell-  130 (379)
                      ++||||+|++ .+++++|..||.+... ......+... ...      .+..+++++++||.+||++|     |++|++ 
T Consensus       256 ~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~  330 (336)
T 2vuw_A          256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLC  330 (336)
T ss_dssp             HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHH
T ss_pred             ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHHHHHh
Confidence            9999998766 8889999999964221 1223333321 111      11246889999999999987     999999 


Q ss_pred             cCchhh
Q 017029          131 QHPWFQ  136 (379)
Q Consensus       131 ~hp~f~  136 (379)
                      +||||+
T Consensus       331 ~Hp~f~  336 (336)
T 2vuw_A          331 QHSLFK  336 (336)
T ss_dssp             HCGGGC
T ss_pred             cCCCcC
Confidence            999995

>3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A

Probab=99.81  E-value=9.1e-20  Score=151.10  Aligned_cols=94  Identities=17%  Similarity=0.364  Sum_probs=85.3

Q ss_pred             ccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCcccc
Q 017029          253 ERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVK  332 (379)
Q Consensus       253 ~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (379)
                      +..|.+|.+|+.+|.+||.||.+||.++|++|++.++|.++|+|..+.         .                      
T Consensus        26 k~~~~v~tTS~~~P~eIm~eI~rvL~~~gi~~~~~g~y~l~C~~~~~~---------~----------------------   74 (120)
T 3ose_A           26 RFTWSMKTTSSMDPNDMMREIRKVLDANNCDYEQKERFLLFCVHGDAR---------Q----------------------   74 (120)
T ss_dssp             CCCTTCCCEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEESCTT---------T----------------------
T ss_pred             eceeeecCcccCCHHHHHHHHHHHHHHCCCEEEEcCCEEEEEEecCCC---------C----------------------
Confidence            579999999999999999999999999999999999999999986321         0                      


Q ss_pred             CCceEEEEEEEEeec-CCceeeeeccccCCceehHHHHHHHHHHHhc
Q 017029          333 SPNVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV  378 (379)
Q Consensus       333 ~~~~~~~~lQLYk~~-~~~YLlDf~~~~g~~~~f~~~c~~~i~~L~~  378 (379)
                       ...|+|++|+||+. .+.|+||||+++|+++.|.++|++|+.+|++
T Consensus        75 -~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~yk~lc~~il~~L~L  120 (120)
T 3ose_A           75 -DSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL  120 (120)
T ss_dssp             -TCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHHHHHHHHHHHHCCC
T ss_pred             -CccEEEEEEEEEecCCCceeEEEEecCCCHHHHHHHHHHHHHHhcC
Confidence             33599999999996 7899999999999999999999999999974

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.78  E-value=3.8e-21  Score=203.44  Aligned_cols=124  Identities=23%  Similarity=0.286  Sum_probs=99.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+ .+||+|||++......   ...+||+.|+|||++.+. + +.++||||+||++|+|++|..|
T Consensus       202 giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~  275 (681)
T 2pzi_A          202 GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPT  275 (681)
T ss_dssp             TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCE
T ss_pred             CCeecccChHHeEEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCC
Confidence            38999999999999875 8999999999876543   456799999999998765 3 6899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      |.+.....+.    .  .......++.+.++|.+||..||.+||+..+.+.|+|+.
T Consensus       276 ~~~~~~~~~~----~--~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          276 RNGRYVDGLP----E--DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             ETTEECSSCC----T--TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             Cccccccccc----c--cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            8753211000    0  000012357889999999999999999999999999875

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.65  E-value=4.1e-18  Score=161.42  Aligned_cols=104  Identities=16%  Similarity=0.158  Sum_probs=81.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.+|.+||+++|                   |++|       + +.++|||||||++|+|++|+.|
T Consensus       149 givH~Dikp~NIll~~~g~~kl~~~~-------------------~~~~-------~-~~~~Di~slG~il~elltg~~P  201 (286)
T 3uqc_A          149 GVALSIDHPSRVRVSIDGDVVLAYPA-------------------TMPD-------A-NPQDDIRGIGASLYALLVNRWP  201 (286)
T ss_dssp             TCCCCCCSGGGEEEETTSCEEECSCC-------------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEEC
T ss_pred             CCccCCCCcccEEEcCCCCEEEEecc-------------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCC
Confidence            37999999999999999999998543                   3333       3 7899999999999999999999


Q ss_pred             CCCCChHHHHH---HHhcCcc----CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           81 FDDENIPNLFK---KIKGGIY----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        81 f~~~~~~~~~~---~i~~~~~----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |.+.+......   +...+..    ..+..+++++.++|.+||+.||.+| |+.|+++.
T Consensus       202 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          202 LPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             SCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             CCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence            98865432110   1111111    1235789999999999999999999 99999874

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.56  E-value=1e-16  Score=166.38  Aligned_cols=122  Identities=14%  Similarity=0.051  Sum_probs=76.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.+|.+||+|||+++..... ....+.+||+.|+|||++.+..  ..++|+||+|+++|++.++..
T Consensus       359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~  436 (569)
T 4azs_A          359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWS  436 (569)
T ss_dssp             TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTHH
T ss_pred             CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCCC--CCcccccccccchhhhccccc
Confidence            3899999999999999999999999999876543 4456779999999999998763  568999999999998877644


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                      ++.        ..+.    ..|.. ...+..+...+...+|..|+.......++|...
T Consensus       437 ~~~--------~~l~----~~~~~-~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~  481 (569)
T 4azs_A          437 NWL--------YAVW----QEPVE-RWNFVLLLALFEKKAKLPSAEQQRGATEQWIIA  481 (569)
T ss_dssp             HHH--------HHHH----TSCGG-GCSHHHHHHHHHTGGGSCCGGGSSCCHHHHHHH
T ss_pred             hhH--------HHhh----cCCCC-CCcHHHHHHHHhCCCCCCCCChhhhccchhHHH
Confidence            431        1111    11111 112456666777888888888888888888653

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.00  E-value=1.9e-11  Score=125.89  Aligned_cols=79  Identities=23%  Similarity=0.278  Sum_probs=64.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--------cccccCCCCccCcccccC--CCCCCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--------LKTSCGSPNYAAPEVISG--KLYAGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--------~~~~~gt~~y~APE~l~~--~~~~~~~~DiWSlGvi   70 (379)
                      .|+||||||+|||++.  .+||+|||+++.......        ..+.+||+.|+|||++.+  ..| +..+|+||..+-
T Consensus       451 gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~  527 (540)
T 3en9_A          451 DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILE  527 (540)
T ss_dssp             TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHH
T ss_pred             cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHH
Confidence            4899999999999998  999999999988755321        246689999999999986  555 567899998888


Q ss_pred             HHHHhhCCCCCC
Q 017029           71 LYALLCGTLPFD   82 (379)
Q Consensus        71 lyelltG~~Pf~   82 (379)
                      ..+.+.++.+|.
T Consensus       528 ~l~~v~~r~rY~  539 (540)
T 3en9_A          528 LMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHTCSCCC
T ss_pred             HHHHHHhccccC
Confidence            777777666653

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana}

Probab=98.44  E-value=3.8e-07  Score=77.33  Aligned_cols=114  Identities=12%  Similarity=0.238  Sum_probs=89.2

Q ss_pred             CCCCCCCccccccCCCCCCCCCcc---ceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCc
Q 017029          231 VAHRAPGFMDYQGMGLRGQLPYER---KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGM  307 (379)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~---~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~  307 (379)
                      ..++|..+..++|.++.++|..+.   +-...+.|+.+|.+|+..|..+++.+||.+++.+ |.+++--..  .+     
T Consensus         6 ~lNAFdiIs~S~g~dLSgLFe~~~~~~~r~tRF~s~~~a~~ii~klEe~a~~lg~~V~kk~-~~vkl~~~~--~g-----   77 (143)
T 2ehb_D            6 MMNAFEMITLSQGLNLSALFDRRQDFVKRQTRFVSRREPSEIIANIEAVANSMGFKSHTRN-FKTRLEGLS--SI-----   77 (143)
T ss_dssp             ECCHHHHHTTCTTTCGGGGGCSCCCSCCCCCEEEECSCHHHHHHHHHHHHHHTTEEEEESS-SEEEEEECC--SS-----
T ss_pred             ccCHHHHHHHCcCCCchhhhccccccccccceEEeCCCHHHHHHHHHHHHHhcCcEEEEcC-cEEEEEEec--CC-----
Confidence            356677777888999999886542   5578999999999999999999999999999874 566553210  00     


Q ss_pred             cCCCCCCCCccCCccceeccCccccCCceEEEEEEEEeecCCceeeeeccccCCceehHHHHHHHHHHHh
Q 017029          308 VNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCAAFLAQLR  377 (379)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g~~~~f~~~c~~~i~~L~  377 (379)
                                            +   ...+-+.+.+|.|.+.-+||||++-.|+.++|-.+|..|-..|.
T Consensus        78 ----------------------r---kG~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~~Lr~~L~  122 (143)
T 2ehb_D           78 ----------------------K---AGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYKKLCSKLE  122 (143)
T ss_dssp             ----------------------G---GGCCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHHHHHHHST
T ss_pred             ----------------------C---cceEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHhh
Confidence                                  0   11256778889999999999999999999999998877766664

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=98.42  E-value=2.6e-08  Score=93.91  Aligned_cols=40  Identities=28%  Similarity=0.277  Sum_probs=34.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCccccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS   53 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~   53 (379)
                      .|+||||||+|||++ ++.+||+|||++..            +..+.|||++.
T Consensus       213 giiHrDlkp~NILl~-~~~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          213 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TEECSCCSTTSEEEE-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             CCEeCCCCHHHEEEE-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence            389999999999999 99999999999863            34578899875

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana}

Probab=98.24  E-value=1.8e-06  Score=71.26  Aligned_cols=111  Identities=12%  Similarity=0.053  Sum_probs=82.2

Q ss_pred             CCCCCCCccccccCCCCCCCCC--ccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCcc
Q 017029          231 VAHRAPGFMDYQGMGLRGQLPY--ERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMV  308 (379)
Q Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~--~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~  308 (379)
                      ..|+|..+..++|.+|+++|..  +.+-...+.|+.+|.+|+..|..+.+.|||.|++.+. . .+...           
T Consensus         5 ~lNAFdiIs~S~g~dLSgLFe~~~~~~r~tRF~S~~~a~~ii~klEe~a~~lg~~v~kk~~-~-~~~~~-----------   71 (123)
T 2zfd_B            5 RMNAFDIISGSPGFNLSGLFGDARKYDRVERFVSAWTAERVVERLEEIVSAENLTVAKKET-W-GMKIE-----------   71 (123)
T ss_dssp             CCCHHHHHHTSTTSSSGGGGGGGCSSCCCEEEEESSCHHHHHHHHHHHHHHTTCEEEEEET-T-EEEEE-----------
T ss_pred             cccHHHHHHHCcCCCchHhcCcccccccceEEEeCCCHHHHHHHHHHHHHHCCCEEEEcCC-c-ccccc-----------
Confidence            3567777888899999999953  2255789999999999999999999999999997643 3 21100           


Q ss_pred             CCCCCCCCccCCccceeccCccccCCceEEEEEEEEeecCCceeeeeccccCCceehHHHHH-HHHHHHh
Q 017029          309 NNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQFLFLDLCA-AFLAQLR  377 (379)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~g~~~~f~~~c~-~~i~~L~  377 (379)
                                          ++   ...+-+.+.+|.|.+.-|||||++-.|+.++|-.+|. .|-..|.
T Consensus        72 --------------------g~---kG~l~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~  118 (123)
T 2zfd_B           72 --------------------GQ---KGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFV  118 (123)
T ss_dssp             --------------------EG---GGTEEEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHH
T ss_pred             --------------------CC---CccEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHh
Confidence                                00   1126678888999999999999999999999888776 3555543

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=97.76  E-value=1.3e-05  Score=74.05  Aligned_cols=29  Identities=28%  Similarity=0.404  Sum_probs=26.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccc
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIM   31 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~   31 (379)
                      .||||||||+|||++.  .++|+|||+|...
T Consensus       191 givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          191 ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            4899999999999998  8999999999764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=96.46  E-value=0.00028  Score=66.27  Aligned_cols=81  Identities=21%  Similarity=0.324  Sum_probs=48.6

Q ss_pred             EEecCCCCCCeEEcC--CCcEEEEecCCcccccCCcccccccCCCCccCcccccC--CCCCC-----------Cccceee
Q 017029            2 VVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG--KLYAG-----------PEVDVWS   66 (379)
Q Consensus         2 IiHrDLKpeNILl~~--~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~-----------~~~DiWS   66 (379)
                      ++|+|++|.||+++.  .+.+.|+||+.+..-....-+........-..|+....  ..|..           .-.+.|+
T Consensus       193 ~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~  272 (304)
T 3sg8_A          193 LIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWS  272 (304)
T ss_dssp             EECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHH
T ss_pred             eEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHH
Confidence            799999999999998  55688999998865322111111100000022221110  01101           1257899


Q ss_pred             ehhHHHHHhhCCCCCC
Q 017029           67 CGVILYALLCGTLPFD   82 (379)
Q Consensus        67 lGvilyelltG~~Pf~   82 (379)
                      +|.++|.+.+|..+|-
T Consensus       273 l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          273 FEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHHHHHHHHTTCHHHH
T ss_pred             HHHHHHHHHcCCHHHH
Confidence            9999999999988764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=96.13  E-value=0.0019  Score=63.55  Aligned_cols=30  Identities=20%  Similarity=0.215  Sum_probs=25.5

Q ss_pred             CEEecCCCCCCeEEcCCC----------cEEEEecCCccc
Q 017029            1 MVVHRDLKPENLLLDSKW----------NVKIADFGLSNI   30 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----------~vKL~DFGls~~   30 (379)
                      .||||||||.|||++.+|          .+.|+||+-+..
T Consensus       225 gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          225 GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            389999999999998876          389999987644

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=95.66  E-value=0.0035  Score=56.31  Aligned_cols=29  Identities=21%  Similarity=0.267  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       186 l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          186 VTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCCCcEEEECCcEEEEEcchhccc
Confidence            79999999999998776677999998754

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=94.56  E-value=0.015  Score=52.66  Aligned_cols=29  Identities=24%  Similarity=0.291  Sum_probs=24.7

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|++|.||+++.++.+.|+||+.+..
T Consensus       185 l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EECCCCCcCcEEEECCcEEEEEEchhccc
Confidence            79999999999998765667999997743

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=93.95  E-value=0.023  Score=54.25  Aligned_cols=29  Identities=28%  Similarity=0.551  Sum_probs=25.2

Q ss_pred             EEecCCCCCCeEEcCCCc--EEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWN--VKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~--vKL~DFGls~~   30 (379)
                      +||+|++|.|||++.++.  +.|+||+.+..
T Consensus       218 lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          218 IVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             EECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             EEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            799999999999997753  69999998864

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=93.19  E-value=0.038  Score=51.70  Aligned_cols=28  Identities=21%  Similarity=0.329  Sum_probs=25.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      +||+|+++.|||++.++.+.|+||+.+.
T Consensus       224 l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          224 LCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             EECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             eecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            7999999999999888889999999764

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=91.88  E-value=0.066  Score=52.39  Aligned_cols=28  Identities=18%  Similarity=0.329  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|++|.|||++.++ ++++||+.+..
T Consensus       234 liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          234 LIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             EEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            79999999999998776 99999998864

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=91.29  E-value=0.092  Score=47.55  Aligned_cols=29  Identities=31%  Similarity=0.440  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       195 l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          195 VTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEECCeEEEEEECccccc
Confidence            68999999999999877777999998754

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=90.09  E-value=0.1  Score=48.66  Aligned_cols=28  Identities=25%  Similarity=0.334  Sum_probs=24.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      +||+|+.+.|||++.++.+.|+||+.+.
T Consensus       189 liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          189 VIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCCCCCCccCEEEeCCceEEEecchhcc
Confidence            7999999999999877656899998764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=89.27  E-value=0.15  Score=47.93  Aligned_cols=29  Identities=34%  Similarity=0.517  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCC----CcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSK----WNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~----~~vKL~DFGls~~   30 (379)
                      +||||+.+.||+++.+    +.+.|+||+.+..
T Consensus       185 lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          185 FVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            7999999999999874    6899999998754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=89.13  E-value=0.12  Score=48.95  Aligned_cols=29  Identities=17%  Similarity=0.289  Sum_probs=24.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       224 l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          224 LLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             EECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             EEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            79999999999999644578999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=89.11  E-value=0.17  Score=47.29  Aligned_cols=29  Identities=34%  Similarity=0.613  Sum_probs=24.3

Q ss_pred             EEecCCCCCCeEEcC---CCc-EEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDS---KWN-VKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~---~~~-vKL~DFGls~~   30 (379)
                      ++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       192 ~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          192 LIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             EECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             eEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence            699999999999987   455 48999997754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=86.56  E-value=0.25  Score=46.08  Aligned_cols=26  Identities=19%  Similarity=0.267  Sum_probs=23.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+++.|||++ + .+.|+||+.+.
T Consensus       197 l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          197 RLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             ECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             eeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            68999999999998 4 89999998764

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=86.28  E-value=0.3  Score=46.59  Aligned_cols=27  Identities=30%  Similarity=0.575  Sum_probs=23.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+.+.|||++.++ +.|+||..+.
T Consensus       214 l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          214 FCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             EEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            78999999999998654 8999998774

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=85.39  E-value=0.3  Score=46.34  Aligned_cols=29  Identities=21%  Similarity=0.417  Sum_probs=25.8

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       208 ~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          208 LCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            79999999999999888899999987643

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=85.12  E-value=0.38  Score=46.30  Aligned_cols=27  Identities=19%  Similarity=0.382  Sum_probs=23.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+.+.||+++.+ .++++||..+.
T Consensus       229 L~HGDl~~~Nil~~~~-~~~lID~e~a~  255 (397)
T 2olc_A          229 LIHGDLHTGSIFASEH-ETKVIDPEFAF  255 (397)
T ss_dssp             EECSCCSGGGEEECSS-CEEECCCTTCE
T ss_pred             eeeCCCCcCcEEEeCC-CeEEEeCcccc
Confidence            6899999999999865 48999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=84.47  E-value=0.39  Score=44.43  Aligned_cols=27  Identities=33%  Similarity=0.346  Sum_probs=23.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+.+.||+ ..++.+.++||..+.
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            699999999999 566778999998774

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=83.20  E-value=0.5  Score=42.54  Aligned_cols=80  Identities=21%  Similarity=0.162  Sum_probs=46.7

Q ss_pred             CCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCCCCCCChH
Q 017029            8 KPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIP   87 (379)
Q Consensus         8 KpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~Pf~~~~~~   87 (379)
                      .|..|++..+|+|...+ +.+.           .....+.|||....  ..+.+.=|+|||+++|..+--..|=      
T Consensus        77 ~~~~i~l~~dG~V~f~~-~~s~-----------~~~~~~~~pe~~~~--~~te~~~IysLG~tLY~ALDygL~e------  136 (229)
T 2yle_A           77 SAAQIRVWRDGAVTLAP-AADD-----------AGEPPPVAGKLGYS--QCMETEVIESLGIIIYKALDYGLKE------  136 (229)
T ss_dssp             SGGGEEEETTSCEEECC-C-----------------------CCSSS--SSCHHHHHHHHHHHHHHHHTTTCCT------
T ss_pred             CCcceEEecCCceeccc-cccc-----------ccccCCCChhhccc--cchHHHHHHHHHHHHHHHhhcCCCc------
Confidence            35678888888887664 1111           12235668887642  2246778999999999987533321      


Q ss_pred             HHHHHHhcCccCCCCCCChhhhcccccccCC
Q 017029           88 NLFKKIKGGIYTLPSHLSPGARDLIPRMLIV  118 (379)
Q Consensus        88 ~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~  118 (379)
                                 .-+..+|+.+..||..|..-
T Consensus       137 -----------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          137 -----------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             -----------TEEECCCHHHHHHHHHHTTC
T ss_pred             -----------ccchhhCHHHHHHHHHHHhc
Confidence                       12345788888888888755

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=82.77  E-value=0.41  Score=47.16  Aligned_cols=16  Identities=38%  Similarity=0.603  Sum_probs=14.1

Q ss_pred             EEecCCCCCCeEEcCC
Q 017029            2 VVHRDLKPENLLLDSK   17 (379)
Q Consensus         2 IiHrDLKpeNILl~~~   17 (379)
                      ++|+|+.+.|||++.+
T Consensus       251 ~~H~Dl~~gNiL~~~~  266 (429)
T 1nw1_A          251 FCHNDLQEGNILLPKA  266 (429)
T ss_dssp             EECSCCCGGGEEEEC-
T ss_pred             EEeCCCCCCeEEeeCC
Confidence            6899999999999875

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=82.51  E-value=0.59  Score=46.57  Aligned_cols=14  Identities=29%  Similarity=0.458  Sum_probs=13.4

Q ss_pred             EEecCCCCCCeEEc
Q 017029            2 VVHRDLKPENLLLD   15 (379)
Q Consensus         2 IiHrDLKpeNILl~   15 (379)
                      ++|+|+.+.|||++
T Consensus       292 ~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          292 LCHCDLLSSNIINT  305 (458)
T ss_dssp             EECSCCCGGGEEEC
T ss_pred             EEecCCCCCcEEee
Confidence            68999999999998

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=81.34  E-value=0.67  Score=44.96  Aligned_cols=29  Identities=31%  Similarity=0.465  Sum_probs=25.5

Q ss_pred             EEecCCCCCCeEEcCC----CcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSK----WNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~----~~vKL~DFGls~~   30 (379)
                      ++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       222 ~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          222 FCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            7899999999999876    7899999987743

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	379
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-50
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-45
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	9e-45
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-44
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	4e-44
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	9e-44
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-43
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	4e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-42
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	5e-42
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	3e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-40
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	4e-39
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-39
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-37
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-37
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	9e-37
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-36
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-36
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-35
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	7e-35
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	4e-34
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-33
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	3e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-32
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-32
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-32
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-31
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-31
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-31
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-30
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-30
d2qrda1	127	d.129.6.2 (A:450-576) Snf1-like protein kinase ssp	3e-30
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	5e-30
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-29
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-29
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-29
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-29
d2v8qa1	153	d.129.6.2 (A:396-548) 5'-AMP-activated protein kin	2e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-29
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-29
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	3e-29
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	5e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-28
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-28
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	2e-28
d2qlva1	171	d.129.6.2 (A:460-630) Carbon catabolite-derepressi	2e-28
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	4e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	4e-27
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	7e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	1e-25
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-25
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-23
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-23
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-23
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	5e-23
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-21
d1ul7a_	102	d.129.6.1 (A:) Map/microtubule affinity-regulating	3e-20
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-05

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 4e-50
 Identities = 57/137 (41%), Positives = 82/137 (59%), Gaps = 2/137 (1%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           V+HRD+KPENLLL S   +KIADFG S          T CG+ +Y  PE+I G+++   +
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMH-DEK 184

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD+WS GV+ Y  L G  PF+       +K+I    +T P  ++ GARDLI R+L  +P 
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 244

Query: 122 KRITIPEIRQHPWFQAH 138
           +R  + E+ +HPW  A+
Sbjct: 245 QRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 3e-45
 Identities = 53/147 (36%), Positives = 82/147 (55%), Gaps = 6/147 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 57
            + HRD+KPENLLLD + N+KI+DFGL+ + R       L   CG+  Y APE++  + +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 58  AGPEVDVWSCGVILYALLCGTLPFD-DENIPNLFKKIKGGIYTLP--SHLSPGARDLIPR 114
               VDVWSCG++L A+L G LP+D   +    +   K     L     +      L+ +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242

Query: 115 MLIVDPMKRITIPEIRQHPWFQAHLPR 141
           +L+ +P  RITIP+I++  W+   L +
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 9e-45
 Identities = 65/192 (33%), Positives = 100/192 (52%), Gaps = 11/192 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS-CGSPNYAAPEVISGKLYAGP 60
           +V+RDLK +N+LLD   ++KIADFG+      G     + CG+P+Y APE++ G+ Y   
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NH 182

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD WS GV+LY +L G  PF  ++   LF  I+      P  L   A+DL+ ++ + +P
Sbjct: 183 SVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREP 242

Query: 121 MKRITIP-EIRQHPWFQ----AHLPRYLAVPP----PDTMQQAKKIDEEILKEVVKMGFD 171
            KR+ +  +IRQHP F+      L R    PP      +       D+E L E  ++ F 
Sbjct: 243 EKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFA 302

Query: 172 QNQLVESLRNRL 183
              L+ S+   +
Sbjct: 303 DRALINSMDQNM 314

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-44
 Identities = 51/135 (37%), Positives = 74/135 (54%), Gaps = 3/135 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP N+ LD K NVK+ DFGL+ I+  D  F K   G+P Y +PE ++   Y   
Sbjct: 135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NE 193

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVD 119
           + D+WS G +LY L     PF   +   L  KI+ G +  +P   S    ++I RML + 
Sbjct: 194 KSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLK 253

Query: 120 PMKRITIPEIRQHPW 134
              R ++ EI ++P 
Sbjct: 254 DYHRPSVEEILENPL 268

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 2e-44
 Identities = 35/139 (25%), Positives = 70/139 (50%), Gaps = 7/139 (5%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRDLK +N+ +     +VKI D GL+ + R   F K   G+P + APE+   K     
Sbjct: 135 IIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-ASFAKAVIGTPEFMAPEMYEEKY--DE 191

Query: 61  EVDVWSCGVILYALLCGTLPFDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLI 117
            VDV++ G+ +  +     P+ +  N   +++++  G+   +      P  +++I   + 
Sbjct: 192 SVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIR 251

Query: 118 VDPMKRITIPEIRQHPWFQ 136
            +  +R +I ++  H +FQ
Sbjct: 252 QNKDERYSIKDLLNHAFFQ 270

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 4e-44
 Identities = 53/157 (33%), Positives = 82/157 (52%), Gaps = 5/157 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSN-IMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K +N+LL    +VK+ DFG    I  +     T  G+P + APEV++ K Y GP
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GP 195

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN-IPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
           +VD+WS G++   ++ G  P+ +EN +  L+     G   L  P  LS   RD + R L 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLD 255

Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA 154
           +D  KR +  E+ QH + +   P     P     ++A
Sbjct: 256 MDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEA 292

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  150 bits (381), Expect = 9e-44
 Identities = 62/147 (42%), Positives = 83/147 (56%), Gaps = 9/147 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA--- 58
           +VHRDLKPEN+LLD   N+K+ DFG S  +  G  L+  CG+P+Y APE+I   +     
Sbjct: 131 IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHP 190

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLI 112
             G EVD+WS GVI+Y LL G+ PF       + + I  G Y   S      S   +DL+
Sbjct: 191 GYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLV 250

Query: 113 PRMLIVDPMKRITIPEIRQHPWFQAHL 139
            R L+V P KR T  E   HP+FQ ++
Sbjct: 251 SRFLVVQPQKRYTAEEALAHPFFQQYV 277

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (382), Expect = 1e-43
 Identities = 43/162 (26%), Positives = 71/162 (43%), Gaps = 12/162 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYA-- 58
           ++HRDLK  N+L     ++K+ADFG+S    R      +  G+P + APEV+  +     
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG---IYTLPSHLSPGARDLIP 113
               + DVWS G+ L  +     P  + N   +  KI          PS  S   +D + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLK 250

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAK 155
           + L  +   R T  ++ QHP+      +    P  + + +AK
Sbjct: 251 KCLEKNVDARWTTSQLLQHPFVTVDSNK----PIRELIAEAK 288

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 4e-43
 Identities = 46/145 (31%), Positives = 78/145 (53%), Gaps = 10/145 (6%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 57
            ++HRDLKPEN+LL+   +++I DFG + ++          +  G+  Y +PE+++ K  
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLI 117
                D+W+ G I+Y L+ G  PF   N   +F+KI    Y  P    P ARDL+ ++L+
Sbjct: 188 -CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLV 246

Query: 118 VDPMKRITI------PEIRQHPWFQ 136
           +D  KR+          ++ HP+F+
Sbjct: 247 LDATKRLGCEEMEGYGPLKAHPFFE 271

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 46/170 (27%), Positives = 82/170 (48%), Gaps = 8/170 (4%)

Query: 2   VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           + H D++PEN++  ++ +  +KI +FG +  ++ G   +    +P Y APEV    +   
Sbjct: 123 IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-S 181

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRM 115
              D+WS G ++Y LL G  PF  E    + + I    YT        +S  A D + R+
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
           L+ +   R+T  E  QHPW +  + R ++     T++  +     I K++
Sbjct: 242 LVKERKSRMTASEALQHPWLKQKIER-VSTKVIRTLKHRRYYHTLIKKDL 290

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  149 bits (378), Expect = 1e-42
 Identities = 57/194 (29%), Positives = 92/194 (47%), Gaps = 14/194 (7%)

Query: 2   VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            VH DLKPEN++  +K +  +K+ DFGL+  +     +K + G+  +AAPEV  GK   G
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-G 203

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRM 115
              D+WS GV+ Y LL G  PF  EN     + +K   + +     S +S   +D I ++
Sbjct: 204 YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQL 175
           L+ DP  R+TI +  +HPW             P    Q        +++ +K  +D    
Sbjct: 264 LLADPNTRMTIHQALEHPWLT-------PGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPE 316

Query: 176 VESLRNRLQNEATV 189
                 R+ N +++
Sbjct: 317 PLPPLGRISNYSSL 330

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  147 bits (372), Expect = 5e-42
 Identities = 51/140 (36%), Positives = 80/140 (57%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPEN+LLD   ++KI DFG +  + D     T CG+P+Y APEV+S K Y    
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT--YTLCGTPDYIAPEVVSTKPY-NKS 181

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           +D WS G+++Y +L G  PF D N    ++KI       P   +   +DL+ R++  D  
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLS 241

Query: 122 KRI-----TIPEIRQHPWFQ 136
           +R+        +++ HPWF+
Sbjct: 242 QRLGNLQNGTEDVKNHPWFK 261

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  145 bits (368), Expect = 2e-41
 Identities = 44/176 (25%), Positives = 75/176 (42%), Gaps = 8/176 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY--AG 59
           ++HRD+K  N+LL     VK+ DFG ++IM   +   +  G+P + APEVI         
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVILAMDEGQYD 192

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRMLI 117
            +VDVWS G+    L     P  + N  +    I           H S   R+ +   L 
Sbjct: 193 GKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252

Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQA-KKIDEEILKEVVKMGFDQ 172
             P  R T   + +H +     P  + +      + A +++D    +++ K+ F +
Sbjct: 253 KIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQE 308

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  146 bits (370), Expect = 3e-41
 Identities = 49/169 (28%), Positives = 86/169 (50%), Gaps = 7/169 (4%)

Query: 2   VVHRDLKPENLLLDSKWN--VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAG 59
           +VH D+KPEN++ ++K    VKI DFGL+  +     +K +  +  +AAPE++  +   G
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-G 206

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRM 115
              D+W+ GV+ Y LL G  PF  E+     + +K   +       S +SP A+D I  +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKE 164
           L  +P KR+T+ +  +HPW +       +  P     + ++  +E   +
Sbjct: 267 LQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYAD 315

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  144 bits (363), Expect = 9e-41
 Identities = 69/174 (39%), Positives = 88/174 (50%), Gaps = 8/174 (4%)

Query: 1   MVVHRDLKPENLLL---DSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLY 57
            +VHRDLKPENLL    D    + I+DFGLS +   G  L T+CG+P Y APEV++ K Y
Sbjct: 127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
               VD WS GVI Y LLCG  PF DEN   LF++I    Y   S     +S  A+D I 
Sbjct: 187 -SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 245

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
            ++  DP KR T  +  QHPW          +    + Q  K   +   K+   
Sbjct: 246 HLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQSVSEQIKKNFAKSKWKQAFN 299

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (359), Expect = 6e-40
 Identities = 64/200 (32%), Positives = 97/200 (48%), Gaps = 15/200 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLS-NIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           VV+RD+K ENL+LD   ++KI DFGL    + DG  +KT CG+P Y APEV+    Y G 
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GR 184

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
            VD W  GV++Y ++CG LPF +++   LF+ I       P  LSP A+ L+  +L  DP
Sbjct: 185 AVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDP 244

Query: 121 MKRI-----TIPEIRQHPWFQ-----AHLPRYLA---VPPPDTMQQAKKIDEEILKEVVK 167
            +R+        E+ +H +F        + + L     P   +    +  D+E   + + 
Sbjct: 245 KQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRYFDDEFTAQSIT 304

Query: 168 MGFDQNQLVESLRNRLQNEA 187
           +          L    Q E 
Sbjct: 305 ITPPDRYDSLGLLELDQREE 324

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 4e-39
 Identities = 62/190 (32%), Positives = 93/190 (48%), Gaps = 17/190 (8%)

Query: 2   VVHRDLKPENLLLDSKWN---VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYA 58
           + HRD+KPENLL  SK     +K+ DFG +      + L T C +P Y APEV+  + Y 
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY- 190

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDEN----IPNLFKKIKGGIYTLP----SHLSPGARD 110
               D+WS GVI+Y LLCG  PF   +     P +  +I+ G Y  P    S +S   + 
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKM 250

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWFQAHL-----PRYLAVPPPDTMQQAKKIDEEILKEV 165
           LI  +L  +P +R+TI E   HPW          P + +    +  ++ + + EE+   +
Sbjct: 251 LIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSAL 310

Query: 166 VKMGFDQNQL 175
             M  D  Q+
Sbjct: 311 ATMRVDYEQI 320

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 4e-39
 Identities = 46/136 (33%), Positives = 72/136 (52%), Gaps = 8/136 (5%)

Query: 2   VVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRD+K EN+L+D ++  +K+ DFG   +++D  +     G+  Y+ PE I    Y G 
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGR 189

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDP 120
              VWS G++LY ++CG +PF+ +       +I  G       +S   + LI   L + P
Sbjct: 190 SAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQHLIRWCLALRP 243

Query: 121 MKRITIPEIRQHPWFQ 136
             R T  EI+ HPW Q
Sbjct: 244 SDRPTFEEIQNHPWMQ 259

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-37
 Identities = 54/144 (37%), Positives = 78/144 (54%), Gaps = 9/144 (6%)

Query: 1   MVVHRDLKPENLLLDS----KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKL 56
            + H DLKPEN++L      K  +KI DFGL++ +  G+  K   G+P + APE+++ + 
Sbjct: 133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP 192

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLI 112
             G E D+WS GVI Y LL G  PF  +        +    Y       S+ S  A+D I
Sbjct: 193 L-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 113 PRMLIVDPMKRITIPEIRQHPWFQ 136
            R+L+ DP KR+TI +  QHPW +
Sbjct: 252 RRLLVKDPKKRMTIQDSLQHPWIK 275

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 5e-37
 Identities = 35/179 (19%), Positives = 68/179 (37%), Gaps = 46/179 (25%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           ++HRD+KP N+L++S+  +K+ DFG+S  + D     +  G+ +Y +PE + G  Y   +
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-SMANSFVGTRSYMSPERLQGTHY-SVQ 183

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS------------------- 102
            D+WS G+ L  +  G  P    +   L       +    +                   
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMD 243

Query: 103 -------------------------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                      S   +D + + LI +P +R  + ++  H + +
Sbjct: 244 SRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIK 302

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 9e-37
 Identities = 43/152 (28%), Positives = 67/152 (44%), Gaps = 12/152 (7%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYA 58
           ++HRDLK  N+ L     VKI DFGL+ +       H  +   GS  + APEVI  +   
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 59  --GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLP------SHLSPGARD 110
               + DV++ G++LY L+ G LP+ + N  +    + G  Y  P      S+     + 
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKR 244

Query: 111 LIPRMLIVDPMKRITIPEIRQHPWF-QAHLPR 141
           L+   L     +R   P+I          LP+
Sbjct: 245 LMAECLKKKRDERPLFPQILASIELLARSLPK 276

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 1e-36
 Identities = 52/203 (25%), Positives = 85/203 (41%), Gaps = 38/203 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
           V+HRDLKP NLLL++  ++KI DFGL+ +    H    FL     +  Y APE++     
Sbjct: 130 VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKG 189

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT------------------ 99
               +D+WS G IL  +L     F  ++  +    I G + +                  
Sbjct: 190 YTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249

Query: 100 -------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH---LPRYL 143
                        L  +    A DL+ +ML  +P KRI + +   HP+ + +       +
Sbjct: 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPI 309

Query: 144 AVPPPDTMQQAKKIDEEILKEVV 166
           A  P     +   + +E LKE++
Sbjct: 310 AEAPFKFDMELDDLPKEKLKELI 332

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  133 bits (336), Expect = 2e-36
 Identities = 44/143 (30%), Positives = 68/143 (47%), Gaps = 9/143 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VV+RDLKP N+LLD   +V+I+D GL+           S G+  Y APEV+   +     
Sbjct: 128 VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSS 186

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPN---LFKKIKGGIYTLPSHLSPGARDLIPRMLIV 118
            D +S G +L+ LL G  PF      +   + +        LP   SP  R L+  +L  
Sbjct: 187 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 246

Query: 119 DPMKRITIP-----EIRQHPWFQ 136
           D  +R+        E+++ P+F+
Sbjct: 247 DVNRRLGCLGRGAQEVKESPFFR 269

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  132 bits (332), Expect = 5e-36
 Identities = 50/140 (35%), Positives = 78/140 (55%), Gaps = 8/140 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           +++RDLKPENLL+D +  +++ DFG +  ++   +  T CG+P   APE+I  K Y    
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGY-NKA 218

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPM 121
           VD W+ GV++Y +  G  PF  +    +++KI  G    PSH S   +DL+  +L VD  
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLT 278

Query: 122 KRI-----TIPEIRQHPWFQ 136
           KR       + +I+ H WF 
Sbjct: 279 KRFGNLKNGVNDIKNHKWFA 298

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 4e-35
 Identities = 46/162 (28%), Positives = 67/162 (41%), Gaps = 28/162 (17%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
           VVHRDLKP+N+L+ S   +K+ADFGL+ I      L +   +  Y APEV+    Y    
Sbjct: 137 VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATP 195

Query: 62  VDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT---------------------- 99
           VD+WS G I   +      F   +  +   KI   I                        
Sbjct: 196 VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA 255

Query: 100 -----LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                  + +    +DL+ + L  +P KRI+      HP+FQ
Sbjct: 256 QPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 6e-35
 Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 7/147 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAG 59
            VHRDL+  N+L+      K+ADFGL+ ++ D  +           + APE      +  
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-T 192

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 117
            + DVWS G++L  L   G +P+       +  +++ G     P        DL+ +   
Sbjct: 193 IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWR 252

Query: 118 VDPMKRITIPEIRQ--HPWFQAHLPRY 142
            +P +R T   ++     +F +  P+Y
Sbjct: 253 KEPEERPTFEYLQAFLEDYFTSTEPQY 279

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 7e-35
 Identities = 37/180 (20%), Positives = 66/180 (36%), Gaps = 38/180 (21%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKL 56
           ++HRD+K  N+L+     +K+ADFGL+           +       +  Y  PE++ G+ 
Sbjct: 138 ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGER 197

Query: 57  YAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH------------- 103
             GP +D+W  G I+  +   +         +    I     ++                
Sbjct: 198 DYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEK 257

Query: 104 -------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-AHLPRYL 143
                                P A DLI ++L++DP +RI   +   H +F    +P  L
Sbjct: 258 LELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (315), Expect = 4e-34
 Identities = 45/178 (25%), Positives = 68/178 (38%), Gaps = 32/178 (17%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKT-SCGSPNYAAPEVISGKLYAG 59
            ++HRDLKP NLLLD    +K+ADFGL+      +   T    +  Y APE++ G    G
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------------------- 99
             VD+W+ G IL  LL        ++  +   +I   + T                    
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 100 --------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPD 149
                   + S       DLI  + + +P  RIT  +  +  +F     R    P   
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFS---NRPGPTPGCQ 294

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 2e-33
 Identities = 45/166 (27%), Positives = 70/166 (42%), Gaps = 30/166 (18%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAG 59
            V+HRDLKP+NLL++++  +K+ADFGL+               +  Y APE++ G  Y  
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181

Query: 60  PEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT-------------------- 99
             VD+WS G I   ++     F  ++  +   +I   + T                    
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 241

Query: 100 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                    +   L    R L+ +ML  DP KRI+      HP+FQ
Sbjct: 242 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 287

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-33
 Identities = 42/184 (22%), Positives = 80/184 (43%), Gaps = 8/184 (4%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLY 57
            +VHRDL   N+L+ +  +VKI DFGL+ ++      +  +       + A E I  ++Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 115
              + DVWS GV ++ L+  G+ P+D      +   ++ G     P   +     ++ + 
Sbjct: 191 -THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 116 LIVDPMKRITIPEIRQHPWFQAHLP-RYLAVPPPDTMQQAKKIDEEILKEVVKMGFDQNQ 174
            ++D   R    E+       A  P RYL +   + M      D    + ++    D + 
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDSNFYRALMDEE-DMDD 308

Query: 175 LVES 178
           +V++
Sbjct: 309 VVDA 312

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (305), Expect = 2e-32
 Identities = 58/162 (35%), Positives = 82/162 (50%), Gaps = 15/162 (9%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM--RDGHFLKTSCGSPNYAAPEVISGKLYA- 58
           +++RD+K EN+LLDS  +V + DFGLS      +       CG+  Y AP+++ G     
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGH 209

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT----LPSHLSPGARDLIPR 114
              VD WS GV++Y LL G  PF  +   N   +I   I       P  +S  A+DLI R
Sbjct: 210 DKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQR 269

Query: 115 MLIVDPMKRI-----TIPEIRQHPWFQAHLPRYLA---VPPP 148
           +L+ DP KR+        EI++H +FQ      LA   VP P
Sbjct: 270 LLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVPAP 311

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-32
 Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 3/133 (2%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
            +HRDL   N+L+   +  KIADFGLS                 + A E ++        
Sbjct: 148 FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTN 206

Query: 62  VDVWSCGVILYALL-CGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVD 119
            DVWS GV+L+ ++  G  P+       L++K+ +G     P +      DL+ +     
Sbjct: 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREK 266

Query: 120 PMKRITIPEIRQH 132
           P +R +  +I   
Sbjct: 267 PYERPSFAQILVS 279

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  120 bits (302), Expect = 2e-32
 Identities = 44/165 (26%), Positives = 70/165 (42%), Gaps = 30/165 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR-DGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP+NLL++ +  +KIADFGL+               +  Y AP+V+ G      
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYST 180

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--------------------- 99
            +D+WS G I   ++ GT  F   +  +   +I   + T                     
Sbjct: 181 TIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240

Query: 100 --------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                       L     DL+ +ML +DP +RIT  +  +H +F+
Sbjct: 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (303), Expect = 8e-32
 Identities = 47/193 (24%), Positives = 69/193 (35%), Gaps = 30/193 (15%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           + HRD+KP+NLLLD     +K+ DFG +  +  G    +   S  Y APE+I G      
Sbjct: 143 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTS 202

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYT--------------------- 99
            +DVWS G +L  LL G   F  ++  +   +I   + T                     
Sbjct: 203 SIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQI 262

Query: 100 --------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTM 151
                         P A  L  R+L   P  R+T  E   H +F       + +P     
Sbjct: 263 KAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDT 322

Query: 152 QQAKKIDEEILKE 164
                   + L  
Sbjct: 323 PALFNFTTQELSS 335

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 3e-31
 Identities = 32/133 (24%), Positives = 60/133 (45%), Gaps = 5/133 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPE 61
            VHRDL   N+L+      K++DFGL+          T      + APE +  K +   +
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKF-STK 180

Query: 62  VDVWSCGVILYALL-CGTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLIVD 119
            DVWS G++L+ +   G +P+    + ++  ++ KG     P    P   +++     +D
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLD 240

Query: 120 PMKRITIPEIRQH 132
              R +  ++R+ 
Sbjct: 241 AAMRPSFLQLREQ 253

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-31
 Identities = 35/144 (24%), Positives = 58/144 (40%), Gaps = 10/144 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----CGSPNYAAPEVISGKLY 57
            VHRDL   N+LL ++   KI+DFGLS  +R       +         + APE I+   +
Sbjct: 128 FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF 187

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRM 115
              + DVWS GV+++     G  P+       +   + KG     P+       DL+   
Sbjct: 188 -SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLC 246

Query: 116 LIVDPMKRITIPEIR---QHPWFQ 136
              D   R     +    ++ ++ 
Sbjct: 247 WTYDVENRPGFAAVELRLRNYYYD 270

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (296), Expect = 6e-31
 Identities = 52/196 (26%), Positives = 81/196 (41%), Gaps = 35/196 (17%)

Query: 4   HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 63
           HRDLKP NL ++    +KI DFGL+        +     +  Y APE++   ++    VD
Sbjct: 144 HRDLKPSNLAVNEDCELKILDFGLARHT--DDEMTGYVATRWYRAPEIMLNWMHYNQTVD 201

Query: 64  VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSHL------------------- 104
           +WS G I+  LL G   F   +  +  K I   + T  + L                   
Sbjct: 202 IWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQM 261

Query: 105 ------------SPGARDLIPRMLIVDPMKRITIPEIRQHPWF-QAHLPRYLAVPPP-DT 150
                       +P A DL+ +ML++D  KRIT  +   H +F Q H P    V  P D 
Sbjct: 262 PKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQ 321

Query: 151 MQQAKKIDEEILKEVV 166
             +++ +  +  K + 
Sbjct: 322 SFESRDLLIDEWKSLT 337

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (291), Expect = 1e-30
 Identities = 44/170 (25%), Positives = 71/170 (41%), Gaps = 31/170 (18%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIM-RDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           V+HRDLKP+NLL++    +K+A+FGL+               +  Y  P+V+ G      
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYST 181

Query: 61  EVDVWSCGVILYALLCGTLP-FDDENIPNLFKKIKGGIYT-------------------- 99
            +D+WS G I   L     P F   ++ +  K+I   + T                    
Sbjct: 182 SIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPM 241

Query: 100 ---------LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP 140
                    +   L+   RDL+  +L  +P++RI+  E  QHP+F    P
Sbjct: 242 YPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 1e-30
 Identities = 33/137 (24%), Positives = 57/137 (41%), Gaps = 7/137 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYA 58
            VHRDL   N+L+     VKI DFGL+  +           +     + APE +   +Y 
Sbjct: 185 CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY- 243

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPRM 115
             + DVWS G++L+ +   G  P+    +   F K+    + +  P + +     ++   
Sbjct: 244 TIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSC 303

Query: 116 LIVDPMKRITIPEIRQH 132
              D  KR + P +   
Sbjct: 304 WAFDSRKRPSFPNLTSF 320

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} Length = 127

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

 Score =  110 bits (276), Expect = 3e-30
 Identities = 29/150 (19%), Positives = 44/150 (29%), Gaps = 55/150 (36%)

Query: 255 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGH---------YNMKCRWIPGISGHHE 305
           KW  G++ R    EI+  V +ALQ     +              Y +K RW         
Sbjct: 2   KWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKRE- 60

Query: 306 GMVNNPLHSNHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQ------RVQ 359
                                             E+QLY+     ++LD++         
Sbjct: 61  --------------------------GKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYS 94

Query: 360 GPQ-------------FLFLDLCAAFLAQL 376
            P+             F FLDLCA  + +L
Sbjct: 95  HPERTADHGMDDLKSSFPFLDLCAMLVCKL 124

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 5e-30
 Identities = 32/135 (23%), Positives = 59/135 (43%), Gaps = 5/135 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAG 59
           V+HRDL   N L+     +K++DFG++  + D        +     +A+PEV S   Y  
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-S 180

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYT-LPSHLSPGARDLIPRMLI 117
            + DVWS GV+++ +   G +P+++ +   + + I  G     P   S     ++     
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240

Query: 118 VDPMKRITIPEIRQH 132
             P  R     + + 
Sbjct: 241 ERPEDRPAFSRLLRQ 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 38/144 (26%), Positives = 57/144 (39%), Gaps = 10/144 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS----CGSPNYAAPEVISGKLY 57
            VHRDL   N+LL ++   KI+DFGLS  +       T+         + APE I+ + +
Sbjct: 130 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF 189

Query: 58  AGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 115
                DVWS GV ++  L  G  P+     P +   I+ G     P    P    L+   
Sbjct: 190 -SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDC 248

Query: 116 LIVDPMKRITIPEIRQ---HPWFQ 136
            I     R     + Q     ++ 
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYS 272

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 1e-29
 Identities = 37/135 (27%), Positives = 53/135 (39%), Gaps = 6/135 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLYA 58
            VHRDL   N L+     VKIADFGLS  +    + K          +  PE I    Y 
Sbjct: 161 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY- 219

Query: 59  GPEVDVWSCGVILYALLCGTL-PFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRML 116
             E DVW+ GV+L+ +    L P+       +   +  G I   P +      +L+    
Sbjct: 220 TTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCW 279

Query: 117 IVDPMKRITIPEIRQ 131
              P  R +   I +
Sbjct: 280 SKLPADRPSFCSIHR 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  113 bits (283), Expect = 1e-29
 Identities = 35/145 (24%), Positives = 62/145 (42%), Gaps = 9/145 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLY 57
           ++HRD+KP N+++ +   VK+ DFG++  + D            G+  Y +PE   G   
Sbjct: 132 IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV 191

Query: 58  AGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIP 113
                DV+S G +LY +L G  PF  ++  ++  +        PS     LS     ++ 
Sbjct: 192 -DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250

Query: 114 RMLIVDPMKRITIPEIRQHPWFQAH 138
           + L  +P  R       +    + H
Sbjct: 251 KALAKNPENRYQTAAEMRADLVRVH 275

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 37/138 (26%), Positives = 61/138 (44%), Gaps = 8/138 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKL 56
            VHRDL   N +LD K+ VK+ADFGL+  M D      H    +     + A E +  + 
Sbjct: 151 FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ- 209

Query: 57  YAGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPR 114
               + DVWS GV+L+ L+  G  P+ D N  ++   + +G     P +      +++ +
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLK 269

Query: 115 MLIVDPMKRITIPEIRQH 132
                   R +  E+   
Sbjct: 270 CWHPKAEMRPSFSELVSR 287

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 153

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  109 bits (273), Expect = 2e-29
 Identities = 23/107 (21%), Positives = 42/107 (39%), Gaps = 32/107 (29%)

Query: 256 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSN 315
           W LG++S++ P +IM EV +A+++L+  WK +  Y ++ R    ++              
Sbjct: 1   WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTF----------- 49

Query: 316 HYFGDESAIIENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQGPQ 362
                                 K  +QLY+     YLLD + +    
Sbjct: 50  ---------------------SKMSLQLYQVDSRTYLLDFRSIDDEI 75

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 2e-29
 Identities = 29/135 (21%), Positives = 59/135 (43%), Gaps = 5/135 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAG 59
            +HRDL   N L++ +  VK++DFGLS  + D  +  +        ++ PEV+    +  
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-S 179

Query: 60  PEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 117
            + D+W+ GV+++ +   G +P++        + I  G+    P   S     ++     
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWH 239

Query: 118 VDPMKRITIPEIRQH 132
               +R T   +  +
Sbjct: 240 EKADERPTFKILLSN 254

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-29
 Identities = 40/135 (29%), Positives = 62/135 (45%), Gaps = 5/135 (3%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSC--GSPNYAAPEVISGKLYAG 59
            VHRD+   N+L+ S   VK+ DFGLS  M D  + K S       + APE I+ + +  
Sbjct: 129 FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-T 187

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRMLI 117
              DVW  GV ++ +L  G  PF      ++  +I  G    +P +  P    L+ +   
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWA 247

Query: 118 VDPMKRITIPEIRQH 132
            DP +R    E++  
Sbjct: 248 YDPSRRPRFTELKAQ 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-29
 Identities = 36/142 (25%), Positives = 63/142 (44%), Gaps = 7/142 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKLYAG 59
            +HRDL+  N+L+    + KIADFGL+ ++ D      + +     + APE I+      
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYG-TFT 188

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLI 117
            + DVWS G++L  ++  G +P+     P + + ++ G     P +       L+     
Sbjct: 189 IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWK 248

Query: 118 VDPMKRITIPEIRQ--HPWFQA 137
             P  R T   +R     +F A
Sbjct: 249 ERPEDRPTFDYLRSVLEDFFTA 270

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  112 bits (280), Expect = 5e-29
 Identities = 34/139 (24%), Positives = 55/139 (39%), Gaps = 9/139 (6%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS------CGSPNYAAPEVISGK 55
            VHRDL   N+L++S    K++DFGLS  + D     T            + APE I  +
Sbjct: 149 YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYR 208

Query: 56  LYAGPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIP 113
            +     DVWS G++++ ++  G  P+ D    ++   I+       P         L+ 
Sbjct: 209 KF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLML 267

Query: 114 RMLIVDPMKRITIPEIRQH 132
                D   R    +I   
Sbjct: 268 DCWQKDRNHRPKFGQIVNT 286

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 1e-28
 Identities = 51/201 (25%), Positives = 80/201 (39%), Gaps = 40/201 (19%)

Query: 4   HRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVD 63
           HRDLKP NL ++    +KI DFGL+        +     +  Y APEVI   +     VD
Sbjct: 144 HRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEVILNWMRYTQTVD 201

Query: 64  VWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPS--------------------- 102
           +WS G I+  ++ G   F   +  +  K+I     T P+                     
Sbjct: 202 IWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 261

Query: 103 ----------HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-AHLPRYLAVPPP--D 149
                     + SP A +L+ +ML++D  +R+T  E   HP+F+  H            D
Sbjct: 262 EKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQVQKYDD 321

Query: 150 TMQQAKKIDEE----ILKEVV 166
           +     +  +E      KEV+
Sbjct: 322 SFDDVDRTLDEWKRVTYKEVL 342

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  110 bits (276), Expect = 2e-28
 Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 20/168 (11%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS--CGSPNYAAPEVISGKLYAG 59
            +HRDL   N L+     VK+ADFGLS +M    +   +       + APE ++   +  
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-S 194

Query: 60  PEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLI 117
            + DVW+ GV+L+ +   G  P+   ++  +++ ++       P        +L+     
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 254

Query: 118 VDPMKRITIPEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEV 165
            +P  R +  EI Q   F+             TM Q   I +E+ KE+
Sbjct: 255 WNPSDRPSFAEIHQ--AFE-------------TMFQESSISDEVEKEL 287

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 2e-28
 Identities = 52/210 (24%), Positives = 84/210 (40%), Gaps = 47/210 (22%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
            ++HRDLKP N+++ S   +KI DFGL+        +     +  Y APEVI G      
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKE 197

Query: 61  EVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGGIYTLPSH----------------- 103
            VD+WS G I+  ++   + F   +  + + K+   + T                     
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257

Query: 104 -------------------------LSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ-A 137
                                     +  ARDL+ +ML++DP KRI++ +  QHP+    
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317

Query: 138 HLPRYLAVPPP---DTMQQAKKIDEEILKE 164
           + P  +  PPP   D     ++   E  KE
Sbjct: 318 YDPAEVEAPPPQIYDKQLDEREHTIEEWKE 347

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} Length = 171

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

 Score =  106 bits (267), Expect = 2e-28
 Identities = 41/186 (22%), Positives = 67/186 (36%), Gaps = 57/186 (30%)

Query: 224 IEPAVSPVAHRAPGFMDYQG-MGLRGQLPYE-----RKWALGLQSRAHPREIMTEVLKAL 277
           I P   P  HRA   M  QG        P        +W  G++SR++P ++M E+  AL
Sbjct: 10  ILPTSLPQIHRA--NMLAQGSPAASKISPLVTKKSKTRWHFGIRSRSYPLDVMGEIYIAL 67

Query: 278 QELNVGWKKIGH---YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSP 334
           + L   W K      + +K RW           + N  ++N                K P
Sbjct: 68  KNLGAEWAKPSEEDLWTIKLRWKYD--------IGNKTNTNE---------------KIP 104

Query: 335 NVVKFEVQLYKTRDEKYLLDLQRVQGPQ----------------------FLFLDLCAAF 372
           +++K  +QL++     YL+D  +  G +                      + FL L    
Sbjct: 105 DLMKMVIQLFQIETNNYLVDF-KFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKL 163

Query: 373 LAQLRV 378
           + +L V
Sbjct: 164 IMELAV 169

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 4e-28
 Identities = 34/138 (24%), Positives = 52/138 (37%), Gaps = 8/138 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLY 57
            +HRDL   NLLL ++  VKI DFGL   +          +       + APE +  + +
Sbjct: 132 FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF 191

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIYTL--PSHLSPGARDLIPR 114
                D W  GV L+ +   G  P+   N   +  KI      L  P        +++ +
Sbjct: 192 -SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQ 250

Query: 115 MLIVDPMKRITIPEIRQH 132
                P  R T   +R  
Sbjct: 251 CWAHKPEDRPTFVALRDF 268

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 4e-27
 Identities = 34/136 (25%), Positives = 60/136 (44%), Gaps = 7/136 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLY 57
            VHRDL   N+L++S    K++DFGLS ++ D     +          + APE IS + +
Sbjct: 131 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 190

Query: 58  AGPEVDVWSCGVILYALLC-GTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRM 115
                DVWS G++++ ++  G  P+ + +   + K I  G     P         L+ + 
Sbjct: 191 -TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQC 249

Query: 116 LIVDPMKRITIPEIRQ 131
              +  +R    +I  
Sbjct: 250 WQQERARRPKFADIVS 265

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  106 bits (266), Expect = 7e-27
 Identities = 36/174 (20%), Positives = 67/174 (38%), Gaps = 39/174 (22%)

Query: 2   VVHRDLKPENLLLDSK-WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGP 60
           ++HRD+KP N+++D +   +++ D+GL+     G        S  +  PE++        
Sbjct: 150 IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDY 209

Query: 61  EVDVWSCGVILYALLCGTLPFDDEN--------------IPNLFKKIKGGIYTLP----- 101
            +D+WS G +L +++    PF   +                +L+  I      L      
Sbjct: 210 SLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND 269

Query: 102 -------------------SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ 136
                                +SP A D + ++L  D   R+T  E  +HP+F 
Sbjct: 270 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (256), Expect = 1e-25
 Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 6/136 (4%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLYA 58
            +HRDL   N+L+     +KIADFGL+  +    + K +        + APE +  ++Y 
Sbjct: 156 CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY- 214

Query: 59  GPEVDVWSCGVILYALL-CGTLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRML 116
             + DVWS GV+L+ +   G  P+    +  LFK +K G     PS+ +     ++    
Sbjct: 215 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCW 274

Query: 117 IVDPMKRITIPEIRQH 132
              P +R T  ++ + 
Sbjct: 275 HAVPSQRPTFKQLVED 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 1e-25
 Identities = 39/137 (28%), Positives = 61/137 (44%), Gaps = 7/137 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMR---DGHFLKTSCGSPNYAAPEVISGKLYA 58
            +HRDL   N+LL  K  VKI DFGL+  +    D      +     + APE I  ++Y 
Sbjct: 155 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY- 213

Query: 59  GPEVDVWSCGVILYALLCGT-LPFDDENIPNLFKKI--KGGIYTLPSHLSPGARDLIPRM 115
             + DVWS GV+L+ +      P+    I   F +   +G     P + +P     +   
Sbjct: 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDC 273

Query: 116 LIVDPMKRITIPEIRQH 132
              +P +R T  E+ +H
Sbjct: 274 WHGEPSQRPTFSELVEH 290

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (255), Expect = 2e-25
 Identities = 32/146 (21%), Positives = 62/146 (42%), Gaps = 12/146 (8%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLYA 58
            VHRDL   N ++   + VKI DFG++  + +  + +          + +PE +   ++ 
Sbjct: 154 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF- 212

Query: 59  GPEVDVWSCGVILYALLCGT-LPFDDENIPNLFKKI-KGGIYTLPSHLSPGARDLIPRML 116
               DVWS GV+L+ +      P+   +   + + + +GG+   P +      +L+    
Sbjct: 213 TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCW 272

Query: 117 IVDPMKRITIPEIRQ------HPWFQ 136
             +P  R +  EI         P F+
Sbjct: 273 QYNPKMRPSFLEIISSIKEEMEPGFR 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 98.6 bits (244), Expect = 1e-23
 Identities = 45/221 (20%), Positives = 75/221 (33%), Gaps = 58/221 (26%)

Query: 1   MVVHRDLKPENLLLDSK------WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG 54
            ++H D+KPEN+L++          +KIAD G +    + +    S  +  Y +PEV+ G
Sbjct: 146 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT--NSIQTREYRSPEVLLG 203

Query: 55  KLYAGPEVDVWSCGVILYALLCGTLPFDDE------------------------------ 84
             + G   D+WS   +++ L+ G   F+ +                              
Sbjct: 204 APW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNG 262

Query: 85  --------------NIPNL----FKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITI 126
                         NI  L     + +    Y      +    D +  ML +DP KR   
Sbjct: 263 KYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322

Query: 127 PEIRQHPWFQAHLPRYLAVPPPDTMQQAKKIDEEILKEVVK 167
             +  HPW +  L     +  PD        D     E V+
Sbjct: 323 GGLVNHPWLKDTLGM-EEIRVPDRELYGSGSDIPGWFEEVR 362

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 96.8 bits (240), Expect = 2e-23
 Identities = 32/157 (20%), Positives = 52/157 (33%), Gaps = 23/157 (14%)

Query: 2   VVHRDLKPENLLLDSK---WNVKIADFGLSNIMRDG--------HFLKTSCGSPNYAAPE 50
            +HRD+KP+N L+        V I DFGL+   RD            K   G+  YA+  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 51  VISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIKGG--------IYTLPS 102
              G        D+ S G +L     G+LP+         +K +          I  L  
Sbjct: 184 THLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK 242

Query: 103 HLSPGARDLIPRMLIVDPMKRITIPEIRQ---HPWFQ 136
                    +     +    +     +RQ   + + +
Sbjct: 243 GYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 96.0 bits (238), Expect = 3e-23
 Identities = 24/151 (15%), Positives = 49/151 (32%), Gaps = 22/151 (14%)

Query: 2   VVHRDLKPENLLLDSKWN-----VKIADFGLSNIMRDG--------HFLKTSCGSPNYAA 48
           +V+RD+KP+N L+    +     + + DFG+    RD            K   G+  Y +
Sbjct: 122 LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMS 181

Query: 49  PEVISGKLYAGPEVDVWSCGVILYALLCGTLPFDDENIPNLFKKIK--------GGIYTL 100
                G+       D+ + G +    L G+LP+         +K +          +  L
Sbjct: 182 INTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLREL 240

Query: 101 PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 131
            +         +     +          ++ 
Sbjct: 241 CAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.7 bits (237), Expect = 5e-23
 Identities = 25/162 (15%), Positives = 51/162 (31%), Gaps = 32/162 (19%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKL 56
           + HRDLK +N+L+       IAD GL+                  G+  Y APEV+   +
Sbjct: 129 IAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSI 188

Query: 57  Y-----AGPEVDVWSCGVILYALLCGTLPFD---------------DENIPNLFKKIKGG 96
                 +    D+++ G++ + +                       D ++  + K +   
Sbjct: 189 NMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQ 248

Query: 97  IY-------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ 131
                                ++      +   R+T   I++
Sbjct: 249 KLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.8 bits (227), Expect = 1e-21
 Identities = 40/136 (29%), Positives = 55/136 (40%), Gaps = 7/136 (5%)

Query: 2   VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTS---CGSPNYAAPEVISGKLYA 58
            +HRDL   N+LL      KI DFGL+  +++               + APE I      
Sbjct: 166 CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VY 224

Query: 59  GPEVDVWSCGVILYALLCGTLPFDDENIPN--LFKKIKGGIYTL-PSHLSPGARDLIPRM 115
             E DVWS G+ L+ L             +   +K IK G   L P H      D++   
Sbjct: 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTC 284

Query: 116 LIVDPMKRITIPEIRQ 131
              DP+KR T  +I Q
Sbjct: 285 WDADPLKRPTFKQIVQ 300

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} Length = 102

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 82.5 bits (204), Expect = 3e-20
 Identities = 18/125 (14%), Positives = 44/125 (35%), Gaps = 33/125 (26%)

Query: 255 KWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHS 314
            W++   S   P ++M E+ K L   N  +++   + + C    G               
Sbjct: 10  TWSMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDG--------------- 54

Query: 315 NHYFGDESAIIENDGVVKSPNVVKFEVQLYKTRD-EKYLLDLQRVQGPQFLFLDLCAAFL 373
                             + N+V++E+++ K        +  +R+ G    F ++ +   
Sbjct: 55  -----------------HAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIA 97

Query: 374 AQLRV 378
            +L++
Sbjct: 98  NELKL 102

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 40.5 bits (94), Expect = 9e-05
 Identities = 15/71 (21%), Positives = 26/71 (36%), Gaps = 14/71 (19%)

Query: 1   MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVIS-----GK 55
            +VH DL   N+L+  +  + I DF  S  + +                +V +      +
Sbjct: 123 GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEG-------WREILERDVRNIITYFSR 174

Query: 56  LYAGPEVDVWS 66
            Y   E D+ S
Sbjct: 175 TY-RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	379
d2qrda1	127	Snf1-like protein kinase ssp2 {Schizosaccharomyces	100.0
d2v8qa1	153	5'-AMP-activated protein kinase catalytic subunit	100.0
d2qlva1	171	Carbon catabolite-derepressing protein kinase SNF1	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	99.98
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	99.97
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	99.97
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	99.97
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	99.97
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	99.97
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	99.97
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	99.97
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	99.97
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.97
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	99.97
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.97
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.96
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.96
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.96
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	99.96
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	99.96
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	99.95
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	99.95
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.95
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.95
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	99.95
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	99.95
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.95
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.95
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.95
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	99.95
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	99.95
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	99.95
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.95
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	99.94
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.94
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	99.94
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.94
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.94
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.94
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.94
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.93
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.93
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	99.93
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.92
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	99.92
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.91
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.91
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.9
d1ul7a_	102	Map/microtubule affinity-regulating kinase 3 {Mous	99.87
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	98.38
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	91.17
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	90.52
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	89.36
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	84.94

>d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Snf1-like protein kinase ssp2
species: Schizosaccharomyces pombe [TaxId: 4896]

Probab=100.00  E-value=4.7e-40  Score=269.31  Aligned_cols=99  Identities=29%  Similarity=0.517  Sum_probs=83.7

Q ss_pred             cceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecc---------eeeEEEeecCCCCCCCCccCCCCCCCCccCCccce
Q 017029          254 RKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGH---------YNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAI  324 (379)
Q Consensus       254 ~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~---------y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (379)
                      .|||||||||++|.|||.|||||||+||+|||++++         |+|||||+++....                     
T Consensus         1 ~KWhfGIRSrs~P~eiM~eVYrALk~Lg~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~---------------------   59 (127)
T d2qrda1           1 NKWHFGVRCRGDAPEILLAVYRALQRAGAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKR---------------------   59 (127)
T ss_dssp             CCCEESEEEESCHHHHHHHHHHHHHHHTCEECCCCCBTTBCCGGGGEEEEEEECHHHHH---------------------
T ss_pred             CCceeccccCCChHHHHHHHHHHHHHcCCEEeecCcccccccCCceEEEEEeecCCccc---------------------
Confidence            489999999999999999999999999999999987         99999998532100                     


Q ss_pred             eccCccccCCceEEEEEEEEeecCCceeeeeccc------cCC-------------ceehHHHHHHHHHHHhcC
Q 017029          325 IENDGVVKSPNVVKFEVQLYKTRDEKYLLDLQRV------QGP-------------QFLFLDLCAAFLAQLRVL  379 (379)
Q Consensus       325 ~~~~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~------~g~-------------~~~f~~~c~~~i~~L~~~  379 (379)
                            ...++.|||+||||||++++||||||+.      .++             +|+|||+|++||+|||..
T Consensus        60 ------~~~~~~vkm~iQLYqve~~~YLlDFK~dg~e~~~~~~~~~~~~~~~~~~s~~pFldl~a~LI~qL~~~  127 (127)
T d2qrda1          60 ------EGKNTYAYIELQLYEVMPGCFMLDVKSNGYKDIYSHPERTADHGMDDLKSSFPFLDLCAMLVCKLFSA  127 (127)
T ss_dssp             ------TTCCEEEEEEEEEEEEETTEEEEEEEEEEEEESCC-------------CCCTTHHHHHHHHHHHHHHC
T ss_pred             ------cCCCceEEEEEEEEEEcCCcEEEEEccCCcccccCCccccccCccccccCCccHHHHHHHHHHHHhcC
Confidence                  1126689999999999999999999943      222             599999999999999863

>d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3e-39  Score=268.90  Aligned_cols=74  Identities=31%  Similarity=0.704  Sum_probs=69.0

Q ss_pred             eeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCccccCCc
Q 017029          256 WALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVVKSPN  335 (379)
Q Consensus       256 w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  335 (379)
                      ||||||||++|.|||.|||||||+||+|||++++|||||||+++.            .                    +.
T Consensus         1 WhlGIrS~s~P~dIM~eVyrALk~L~~eWk~~~~y~ir~R~~~~~------------~--------------------~~   48 (153)
T d2v8qa1           1 WHLGIRSQSRPNDIMAEVCRAIKQLDYEWKVVNPYYLRVRRKNPV------------T--------------------ST   48 (153)
T ss_dssp             EEESEEECSCHHHHHHHHHHHHHHTTCEEEEEETTEEEEEEECTT------------T--------------------CC
T ss_pred             CccccccCCCHHHHHHHHHHHHHHcCCeEEecCceEEEEEEECCC------------C--------------------Cc
Confidence            999999999999999999999999999999999999999999542            1                    55


Q ss_pred             eEEEEEEEEeecCCceeeeeccccCC
Q 017029          336 VVKFEVQLYKTRDEKYLLDLQRVQGP  361 (379)
Q Consensus       336 ~~~~~lQLYk~~~~~YLlDf~~~~g~  361 (379)
                      .+||+||||||++++||||||+++|+
T Consensus        49 ~~Km~lQLYqv~~~~YLLDfk~i~~~   74 (153)
T d2v8qa1          49 FSKMSLQLYQVDSRTYLLDFRSIDDE   74 (153)
T ss_dssp             EEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred             eeEEEEEEEEEcCCceEEEeeecCcc
Confidence            79999999999999999999999776

>d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Ssp2 C-terminal domain-like
domain: Carbon catabolite-derepressing protein kinase SNF1
species: Saccharomyces cerevisiae [TaxId: 4932]

Probab=100.00  E-value=8e-39  Score=274.75  Aligned_cols=105  Identities=29%  Similarity=0.603  Sum_probs=78.4

Q ss_pred             CCccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEec---ceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceecc
Q 017029          251 PYERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIG---HYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIEN  327 (379)
Q Consensus       251 ~~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~---~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (379)
                      .+++|||||||||++|.|||.|||||||+||++||+++   +|+|||||+++......   .|                 
T Consensus        41 ~~~~kWhfGIRSrs~P~eiM~evykALk~Lg~eWk~~~~~~~~~ir~Rwk~~~~~~~~---~~-----------------  100 (171)
T d2qlva1          41 KSKTRWHFGIRSRSYPLDVMGEIYIALKNLGAEWAKPSEEDLWTIKLRWKYDIGNKTN---TN-----------------  100 (171)
T ss_dssp             ---CCCEESEEECSCHHHHHHHHHHHHHHHTCEECCCC---CCEEEEEEC------------------------------
T ss_pred             cccceeeeecccCCCHHHHHHHHHHHHHHcCCEEeecCCCCceEEEEEeecCCCcccc---cC-----------------
Confidence            34579999999999999999999999999999999986   69999999975421110   01                 


Q ss_pred             CccccCCceEEEEEEEEeecCCceeeeecccc---------------C------CceehHHHHHHHHHHHhc
Q 017029          328 DGVVKSPNVVKFEVQLYKTRDEKYLLDLQRVQ---------------G------PQFLFLDLCAAFLAQLRV  378 (379)
Q Consensus       328 ~~~~~~~~~~~~~lQLYk~~~~~YLlDf~~~~---------------g------~~~~f~~~c~~~i~~L~~  378 (379)
                       +  ..+++|||+||||||++++||||||...               +      .+|+|||+|++||+||||
T Consensus       101 -~--~~~~~vk~~iQLYqv~~~~YLlDFK~~g~e~~~~~~~~~~~~~~~e~~~~Sp~pFldlca~LI~qLAv  169 (171)
T d2qlva1         101 -E--KIPDLMKMVIQLFQIETNNYLVDFKFDGWESSYGDDTTVSNISEDEMSTFSAYPFLHLTTKLIMELAV  169 (171)
T ss_dssp             -------CEEEEEEEEEC---CCEEEEEEEEEEEC--------------CHHHHTSHHHHHHHHHHHHHHHH
T ss_pred             -C--CCCceEEEEEEEEEEcCCceEEEEecCCccccccccccccccCCCcccCcCCccHHHHHHHHHHHHhc
Confidence             0  1166899999999999999999999631               1      249999999999999997

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=278.48  Aligned_cols=136  Identities=42%  Similarity=0.768  Sum_probs=126.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.++.+||+|||++...... .....+||+.|+|||++.+..| +.++||||+||++|+|++|+.|
T Consensus       126 ~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~P  203 (263)
T d2j4za1         126 RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPP  203 (263)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCT
T ss_pred             CeeeeeeccccceecCCCCEeecccceeeecCCC-cccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCC
Confidence            3899999999999999999999999999876543 3456789999999999999877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |.+.+..+++.++.++.+.+|..+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       204 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         204 FEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             TCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             CCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCc
Confidence            9999999999999999999999999999999999999999999999999999999864

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-35  Score=275.31  Aligned_cols=137  Identities=34%  Similarity=0.684  Sum_probs=122.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.+|.+||+|||+|+.....   ....+.+||+.|+|||++.+..| +.++||||+||++|+|++|
T Consensus       128 ~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g  206 (288)
T d1uu3a_         128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAG  206 (288)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHS
T ss_pred             cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhC
Confidence            4899999999999999999999999999876432   23345689999999999998887 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhh------hhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPE------IRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e------ll~hp~f~~~  138 (379)
                      ..||.+.+..+++.+|.++.+.+|..+++++++||.+||+.||.+|||++|      +++||||+..
T Consensus       207 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i  273 (288)
T d1uu3a_         207 LPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV  273 (288)
T ss_dssp             SCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred             CCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence            999999999999999999999999999999999999999999999999998      5789999865

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-34  Score=277.21  Aligned_cols=137  Identities=41%  Similarity=0.728  Sum_probs=127.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccC-CcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRD-GHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~-~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.+|.+||+|||+|+.... .....+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.
T Consensus       125 ~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~  203 (337)
T d1o6la_         125 DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRL  203 (337)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSC
T ss_pred             CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCC
Confidence            489999999999999999999999999987543 455667899999999999999988 889999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      ||.+.+..++++++..+.+.+|..+|+++++||.+||++||.+|++     ++|+++||||++.
T Consensus       204 pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         204 PFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC
Confidence            9999999999999999999999999999999999999999999994     8999999999764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-34  Score=272.27  Aligned_cols=133  Identities=38%  Similarity=0.663  Sum_probs=111.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      ||||||||+|||++.++.+||+|||+++...... ...+.+||+.|+|||++.+..| +.++||||+||++|+|++|..|
T Consensus       135 IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~P  213 (269)
T d2java1         135 VLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPP  213 (269)
T ss_dssp             -----CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCS
T ss_pred             EEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCC
Confidence            8999999999999999999999999998875543 4456789999999999988877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchh
Q 017029           81 FDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWF  135 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f  135 (379)
                      |.+.+..++..+|..+.+ .+|..+|+++++||.+||+.||.+|||++|+++|||+
T Consensus       214 f~~~~~~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         214 FTAFSQKELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999887765 5678899999999999999999999999999999995

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.2e-34  Score=273.05  Aligned_cols=135  Identities=38%  Similarity=0.768  Sum_probs=126.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+|.+||+|||+++...+.  ..+.+||+.|+|||++.+..| +.++||||+||++|+|++|+.|
T Consensus       124 ~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~P  200 (316)
T d1fota_         124 DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTP  200 (316)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCT
T ss_pred             cEEccccCchheeEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCC
Confidence            4899999999999999999999999999887543  356799999999999998888 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.+..++..++..+...+|+.++++++++|.+||..||.+|+     |++++++||||++.
T Consensus       201 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         201 FYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             TCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccC
Confidence            99999999999999999999999999999999999999999996     89999999999864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-34  Score=270.64  Aligned_cols=140  Identities=37%  Similarity=0.732  Sum_probs=116.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++.+||+|||+|+......   ...+.+||+.|+|||++.+..+++.++||||+||++|+|++|
T Consensus       123 ~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G  202 (271)
T d1nvra_         123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG  202 (271)
T ss_dssp             TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred             CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhC
Confidence            48999999999999999999999999998764332   345678999999999999888877889999999999999999


Q ss_pred             CCCCCCCChH-HHHHHHhcCccC--CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           78 TLPFDDENIP-NLFKKIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        78 ~~Pf~~~~~~-~~~~~i~~~~~~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      +.||.+.... .....+......  .+..+|+++++||.+||+.||.+|||++|+++||||++.++
T Consensus       203 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~l~  268 (271)
T d1nvra_         203 ELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK  268 (271)
T ss_dssp             SCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             CCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence            9999775433 333333333322  23468999999999999999999999999999999987654

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-34  Score=271.14  Aligned_cols=137  Identities=35%  Similarity=0.578  Sum_probs=119.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.+|++||+|||+|+..... ......+||+.|+|||++.+..| +.++||||+||++|+|++|..
T Consensus       136 ~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~  214 (293)
T d1yhwa1         136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEP  214 (293)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCC
Confidence            4899999999999999999999999999877543 34456789999999999999887 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhc-Cc--cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKG-GI--YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~-~~--~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.+.......+.. +.  ...|..+++++++||.+||+.||.+|||++|+++||||+..
T Consensus       215 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         215 PYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             TTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             CCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999887766555543 32  34567799999999999999999999999999999999854

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.98  E-value=1.1e-33  Score=274.91  Aligned_cols=135  Identities=37%  Similarity=0.707  Sum_probs=125.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+|.+||+|||+++.....  ..+.+||+.|+|||++.+..| +.++|||||||++|+|++|..|
T Consensus       161 ~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~P  237 (350)
T d1rdqe_         161 DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPP  237 (350)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCC
Confidence            4899999999999999999999999999887543  346789999999999999888 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhhc
Q 017029           81 FDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~~  138 (379)
                      |.+.+...+..+|..+.+.+|..+++++.+||++||+.||.+|+     |++++++||||+..
T Consensus       238 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         238 FFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             SCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCC
Confidence            99999999999999999999999999999999999999999995     99999999999854

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=8.5e-34  Score=271.02  Aligned_cols=137  Identities=47%  Similarity=0.814  Sum_probs=109.4

Q ss_pred             CEEecCCCCCCeEEc---CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLD---SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~---~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||+.   .++.+||+|||+|+....+....+.+||+.|+|||++.+..| +.++||||+||++|+|++|
T Consensus       127 ~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g  205 (307)
T d1a06a_         127 GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCG  205 (307)
T ss_dssp             TCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHS
T ss_pred             eeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhC
Confidence            379999999999995   478999999999998877777778899999999999998887 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+..++...+..+.+.++    ..+|+++++||.+||++||.+|||++|+++||||+..
T Consensus       206 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         206 YPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             SCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             CCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            999999999999999988876554    5789999999999999999999999999999999754

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.7e-33  Score=262.82  Aligned_cols=133  Identities=27%  Similarity=0.597  Sum_probs=114.5

Q ss_pred             CEEecCCCCCCeEEc-CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLD-SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~-~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      +||||||||+|||++ .++.+||+|||+++.... ....+.+||+.|+|||++.+. | +.++||||+||++|+|++|+.
T Consensus       134 ~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-~~~~~~~GT~~Y~aPE~~~~~-~-~~~~DIwSlGvilyel~~g~~  210 (270)
T d1t4ha_         134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEEK-Y-DESVDVYAFGMCMLEMATSEY  210 (270)
T ss_dssp             CCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGTC-C-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEeCCcChhhceeeCCCCCEEEeecCcceeccC-CccCCcccCccccCHHHhCCC-C-CCcCchhhHHHHHHHHHHCCC
Confidence            389999999999997 478999999999986543 344677999999999999864 5 789999999999999999999


Q ss_pred             CCCCC-ChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           80 PFDDE-NIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        80 Pf~~~-~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      ||.+. +...+.+.+..+..  .++...++++++||.+||+.||++|||++|+++||||+
T Consensus       211 Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         211 PYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             TTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            99764 45666777776654  34567899999999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-33  Score=266.80  Aligned_cols=137  Identities=29%  Similarity=0.449  Sum_probs=118.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCccccc-----CCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVIS-----GKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~-----~~~~~~~~~DiWSlGvilyel   74 (379)
                      .||||||||+|||++.+|.+||+|||+|+..... ....+.+||+.|+|||++.     +..| +.++||||+||++|+|
T Consensus       130 ~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyem  208 (288)
T d2jfla1         130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEM  208 (288)
T ss_dssp             TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHH
T ss_pred             CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHH
Confidence            4899999999999999999999999999765433 2345678999999999984     3334 7899999999999999


Q ss_pred             hhCCCCCCCCChHHHHHHHhcCcc---CCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           75 LCGTLPFDDENIPNLFKKIKGGIY---TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        75 ltG~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ++|..||.+.+..+...++..+..   ..|..+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       209 ltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         209 AEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             hhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            999999999888888888877643   3456789999999999999999999999999999999743

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3e-33  Score=268.66  Aligned_cols=137  Identities=40%  Similarity=0.714  Sum_probs=125.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++++||+|||+++..... ......+||+.|+|||++.+..| +.++||||+||++|+|++|+.
T Consensus       123 ~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~  201 (320)
T d1xjda_         123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQS  201 (320)
T ss_dssp             TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSC
T ss_pred             CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCC
Confidence            4799999999999999999999999999876543 33455789999999999999888 789999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChh-hhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIP-EIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~-ell~hp~f~~~  138 (379)
                      ||.+.+..++..++..+.+.+|..+|+++++||.+||+.||.+|||+. ++++||||++.
T Consensus       202 PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         202 PFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             SSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            999999999999999999999999999999999999999999999996 89999999863

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=99.97  E-value=4.2e-33  Score=271.12  Aligned_cols=137  Identities=34%  Similarity=0.652  Sum_probs=126.3

Q ss_pred             CEEecCCCCCCeEEc--CCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLD--SKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~--~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++  .++.+||+|||+|..........+.+||+.|+|||++.+..| +.++||||+||++|+|++|.
T Consensus       147 ~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~  225 (352)
T d1koba_         147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGL  225 (352)
T ss_dssp             TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSC
T ss_pred             CeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCC
Confidence            489999999999998  578999999999999887777778899999999999998887 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+.+..++...+..+.+.+|    ..+|+++++||.+||++||.+|||++|+++||||+..
T Consensus       226 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         226 SPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            99999999999999988877655    4689999999999999999999999999999999865

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.4e-33  Score=264.40  Aligned_cols=137  Identities=34%  Similarity=0.500  Sum_probs=120.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.++.+||+|||+++.........+.+||+.|+|||++.+..| +.++||||+||++|+|++|..|
T Consensus       136 ~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~p  214 (305)
T d1blxa_         136 RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPL  214 (305)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCC
Confidence            389999999999999999999999999988776666778899999999999998888 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCc---------------------------cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           81 FDDENIPNLFKKIKGGI---------------------------YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~---------------------------~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |.+.+..+...++....                           ..++..+++.+++||.+||++||.+|||++|+++||
T Consensus       215 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hp  294 (305)
T d1blxa_         215 FRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHP  294 (305)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSG
T ss_pred             CCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCh
Confidence            99988877776664311                           112345788999999999999999999999999999


Q ss_pred             hhhhc
Q 017029          134 WFQAH  138 (379)
Q Consensus       134 ~f~~~  138 (379)
                      ||++.
T Consensus       295 ff~~i  299 (305)
T d1blxa_         295 YFQDL  299 (305)
T ss_dssp             GGTTC
T ss_pred             hhcCc
Confidence            99854

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=99.97  E-value=6.5e-33  Score=269.52  Aligned_cols=137  Identities=36%  Similarity=0.672  Sum_probs=125.3

Q ss_pred             CEEecCCCCCCeEEcC--CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDS--KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~--~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++.  ++.+||+|||+++.........+.+||+.|+|||++.+..| +.++||||+||++|+|++|.
T Consensus       144 ~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~  222 (350)
T d1koaa2         144 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGL  222 (350)
T ss_dssp             TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSS
T ss_pred             CCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCC
Confidence            4899999999999964  68899999999998877777778899999999999999888 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      .||.+.+..+++..|..+.+.++    ..+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       223 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~  286 (350)
T d1koaa2         223 SPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG  286 (350)
T ss_dssp             CSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999988877665    3589999999999999999999999999999999865

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.97  E-value=1.2e-32  Score=268.98  Aligned_cols=137  Identities=32%  Similarity=0.532  Sum_probs=118.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+|.+||+|||+|+...... ..+.+||+.|+|||++.+...++.++||||+||++|+|++|+.|
T Consensus       127 ~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~P  205 (364)
T d1omwa3         127 FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP  205 (364)
T ss_dssp             TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             CccceeeccceeEEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCC
Confidence            48999999999999999999999999998775543 45678999999999997654448999999999999999999999


Q ss_pred             CCCCCh---HHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCC-----hhhhhcCchhhhc
Q 017029           81 FDDENI---PNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRIT-----IPEIRQHPWFQAH  138 (379)
Q Consensus        81 f~~~~~---~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt-----~~ell~hp~f~~~  138 (379)
                      |.+.+.   ..+.+.+......+|..+|+++++||.+||++||.+|||     ++|+++||||+..
T Consensus       206 f~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         206 FRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             SCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             CCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence            987543   345556666677788899999999999999999999999     6999999999864

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-33  Score=267.72  Aligned_cols=136  Identities=28%  Similarity=0.551  Sum_probs=108.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+|.+||+|||+|+...+. ...+.+||+.|+|||++.+..| +.++||||+||++|||++|+.|
T Consensus       125 ~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~P  202 (322)
T d1s9ja_         125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYP  202 (322)
T ss_dssp             CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCC
T ss_pred             CEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCC
Confidence            4899999999999999999999999999876442 3456799999999999999887 7999999999999999999999


Q ss_pred             CCCCChHHHH------------------------------------------HHHhcCc-cCCC-CCCChhhhccccccc
Q 017029           81 FDDENIPNLF------------------------------------------KKIKGGI-YTLP-SHLSPGARDLIPRML  116 (379)
Q Consensus        81 f~~~~~~~~~------------------------------------------~~i~~~~-~~~p-~~~s~~~~~Li~~mL  116 (379)
                      |.+.+.....                                          ..+.... ...| ..+|.++++||.+||
T Consensus       203 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L  282 (322)
T d1s9ja_         203 IPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCL  282 (322)
T ss_dssp             SSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHT
T ss_pred             CCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHc
Confidence            9875432211                                          0111110 1111 235789999999999


Q ss_pred             CCCCCCCCChhhhhcCchhhhc
Q 017029          117 IVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus       117 ~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +.||.+|||++|+++||||++.
T Consensus       283 ~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         283 IKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             CSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCChhHCcCHHHHhhCHhhCcC
Confidence            9999999999999999999865

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.5e-32  Score=260.18  Aligned_cols=137  Identities=39%  Similarity=0.688  Sum_probs=125.0

Q ss_pred             CEEecCCCCCCeEEcCCC----cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKW----NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~----~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++    .+||+|||++.....+....+.+||+.|+|||++.+..| +.++||||+||++|+|++
T Consensus       133 ~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~  211 (293)
T d1jksa_         133 QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLS  211 (293)
T ss_dssp             TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHH
T ss_pred             ceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHc
Confidence            489999999999998876    599999999998877777778899999999999998877 799999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCCC----CCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTLP----SHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      |..||.+.+..+....+..+.+.++    ..+|+++++||.+||+.||.+|||++|+++||||+..
T Consensus       212 g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         212 GASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             SSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            9999999999999999988877655    5789999999999999999999999999999999854

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=7.2e-33  Score=259.89  Aligned_cols=131  Identities=35%  Similarity=0.678  Sum_probs=116.1

Q ss_pred             CEEecCCCCCCeEEcC-CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDS-KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++. ++.+||+|||+|...... ...+.+||+.|+|||++.+..+++.++||||+||++|+|++|+.
T Consensus       130 ~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~  208 (273)
T d1xwsa_         130 GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI  208 (273)
T ss_dssp             TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCccccCcccceEEecCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence            4899999999999985 479999999999876443 34677899999999999887776788999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ||.+.      ..+..+...++..+|+++++||.+||..||.+|||++|+++||||++.
T Consensus       209 Pf~~~------~~i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         209 PFEHD------EEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             SCCSH------HHHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             CCCCc------hHHhhcccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99863      345667788899999999999999999999999999999999999864

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.97  E-value=1.6e-32  Score=262.37  Aligned_cols=134  Identities=30%  Similarity=0.411  Sum_probs=116.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCC---CCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGK---LYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~---~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++.+||+|||++......   .+.+||+.|+|||++.+.   .| +.++||||+||++|+|++|
T Consensus       135 ~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g  210 (309)
T d1u5ra_         135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAER  210 (309)
T ss_dssp             TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHS
T ss_pred             CEeccCCCcceEEECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHC
Confidence            3899999999999999999999999999876442   456899999999998643   34 7899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHhcCccC--CCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNLFKKIKGGIYT--LPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      ..||.+.+..+...++..+..+  .+..+|+++++||.+||+.||.+|||++|+++||||...
T Consensus       211 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         211 KPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             SCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            9999998888877777665543  245689999999999999999999999999999999854

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.3e-32  Score=259.19  Aligned_cols=138  Identities=30%  Similarity=0.442  Sum_probs=117.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++.+||+|||+++..... ....+.+||+.|+|||++.+..+++.++||||+||++|+|++|..
T Consensus       120 ~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~  199 (299)
T d1ua2a_         120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP  199 (299)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcC
Confidence            3799999999999999999999999999876543 334567899999999999766555899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccCC----------------------------CCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           80 PFDDENIPNLFKKIKGGIYTL----------------------------PSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~~----------------------------p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||.+.+..+...+|.......                            ...+++++.+||.+||+.||++|||++|+++
T Consensus       200 pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         200 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            999998888777765321110                            1246789999999999999999999999999


Q ss_pred             Cchhhhc
Q 017029          132 HPWFQAH  138 (379)
Q Consensus       132 hp~f~~~  138 (379)
                      ||||++.
T Consensus       280 Hp~f~~~  286 (299)
T d1ua2a_         280 MKYFSNR  286 (299)
T ss_dssp             SGGGTSS
T ss_pred             CHhhCCC
Confidence            9999864

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=99.97  E-value=5.3e-32  Score=254.85  Aligned_cols=138  Identities=45%  Similarity=0.777  Sum_probs=122.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccC-----CCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISG-----KLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~-----~~~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+|||++.++.+||+|||+++....+......+||+.|+|||++.+     ...++.++||||+||++|+|+
T Consensus       130 ~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml  209 (277)
T d1phka_         130 NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLL  209 (277)
T ss_dssp             TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred             CCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhc
Confidence            489999999999999999999999999998876666677889999999999863     222378999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +|+.||.+.+.......+..+.+.++.    .+|+++++||.+||+.||.+|||++|+++||||++.
T Consensus       210 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         210 AGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            999999999999988888887765443    689999999999999999999999999999999853

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.4e-32  Score=262.87  Aligned_cols=137  Identities=39%  Similarity=0.717  Sum_probs=117.1

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .|+||||||+|||++.   ++.+||+|||+++.........+.+||+.|+|||++.+..| +.++||||+||++|+|+||
T Consensus       131 ~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg  209 (335)
T d2ozaa1         131 NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCG  209 (335)
T ss_dssp             TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTS
T ss_pred             CCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhC
Confidence            3899999999999986   46799999999998877777778899999999999998887 7899999999999999999


Q ss_pred             CCCCCCCChHHH----HHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhc
Q 017029           78 TLPFDDENIPNL----FKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAH  138 (379)
Q Consensus        78 ~~Pf~~~~~~~~----~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~  138 (379)
                      +.||.+.+....    ...+..+.+.+|.    .+|+++++||.+||+.||++|||+.|+++||||++.
T Consensus       210 ~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         210 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             SCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             CCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            999987654433    3444555555553    589999999999999999999999999999999865

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=9.1e-32  Score=258.33  Aligned_cols=139  Identities=30%  Similarity=0.599  Sum_probs=126.7

Q ss_pred             CEEecCCCCCCeEEcCC--CcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSK--WNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~--~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .|+||||||+|||++.+  +.+||+|||+++.........+.+||+.|+|||.+.+..| +.++||||+||++|+|++|.
T Consensus       122 ~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~  200 (321)
T d1tkia_         122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGI  200 (321)
T ss_dssp             TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSS
T ss_pred             CCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCC
Confidence            48999999999999854  5899999999998877777778899999999999998877 78999999999999999999


Q ss_pred             CCCCCCChHHHHHHHhcCccCCCC----CCChhhhcccccccCCCCCCCCChhhhhcCchhhhccC
Q 017029           79 LPFDDENIPNLFKKIKGGIYTLPS----HLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQAHLP  140 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~~  140 (379)
                      .||.+.+..+++.+|..+.+.++.    .+|+++++||.+||+.||.+|||++|+++||||++..+
T Consensus       201 ~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  266 (321)
T d1tkia_         201 NPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             CTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             CCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence            999999999999999988887763    78999999999999999999999999999999986543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.8e-31  Score=254.25  Aligned_cols=139  Identities=32%  Similarity=0.463  Sum_probs=118.5

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++ .+||+|||++..........+.+|++.|+|||++.+...++.++||||+||++|||++|..
T Consensus       142 ~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~  221 (350)
T d1q5ka_         142 GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP  221 (350)
T ss_dssp             TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSC
T ss_pred             CCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCC
Confidence            489999999999999775 8999999999988777777788999999999998876656899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCc-----------------cC------------CCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGI-----------------YT------------LPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~-----------------~~------------~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+...++....                 ..            ....+++++.+||.+||.+||.+|||+.|++
T Consensus       222 pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  301 (350)
T d1q5ka_         222 IFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC  301 (350)
T ss_dssp             SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            999888776665553210                 01            1235788999999999999999999999999


Q ss_pred             cCchhhhcc
Q 017029          131 QHPWFQAHL  139 (379)
Q Consensus       131 ~hp~f~~~~  139 (379)
                      +||||++..
T Consensus       302 ~Hp~f~~~~  310 (350)
T d1q5ka_         302 AHSFFDELR  310 (350)
T ss_dssp             TSGGGGGGG
T ss_pred             cCHhhcccc
Confidence            999998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.1e-31  Score=251.52  Aligned_cols=138  Identities=33%  Similarity=0.516  Sum_probs=116.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++.+||+|||+|+..... ......+||+.|+|||++....+.+.++||||+||++|+|++|+.
T Consensus       122 ~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~  201 (298)
T d1gz8a_         122 RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA  201 (298)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             CEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCC
Confidence            4899999999999999999999999999877543 445567899999999999888877899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCccC------------------C-----------CCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGIYT------------------L-----------PSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~~------------------~-----------p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+...++......                  .           ...+++++++||.+||++||.+|||++|++
T Consensus       202 Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell  281 (298)
T d1gz8a_         202 LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL  281 (298)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            99998877766555321110                  0           124678899999999999999999999999


Q ss_pred             cCchhhhc
Q 017029          131 QHPWFQAH  138 (379)
Q Consensus       131 ~hp~f~~~  138 (379)
                      +||||++.
T Consensus       282 ~H~ff~~~  289 (298)
T d1gz8a_         282 AHPFFQDV  289 (298)
T ss_dssp             TSGGGTTC
T ss_pred             CCHhhccC
Confidence            99999864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.96  E-value=3e-31  Score=249.68  Aligned_cols=137  Identities=31%  Similarity=0.494  Sum_probs=112.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++.+||+|||++....... ......|++.|+|||++.+..+.+.++||||+||++|+|++|+.
T Consensus       120 ~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~  199 (286)
T d1ob3a_         120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTP  199 (286)
T ss_dssp             TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred             cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCC
Confidence            48999999999999999999999999998765433 23455799999999999887777899999999999999999999


Q ss_pred             CCCCCChHHHHHHHhcCcc-----------------------------CCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           80 PFDDENIPNLFKKIKGGIY-----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                      ||.+.+..+...++.....                             ..+..+++++++||++||++||++|||++|++
T Consensus       200 pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell  279 (286)
T d1ob3a_         200 LFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL  279 (286)
T ss_dssp             SCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHH
T ss_pred             CCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHh
Confidence            9999887776666532111                             12345688899999999999999999999999


Q ss_pred             cCchhhh
Q 017029          131 QHPWFQA  137 (379)
Q Consensus       131 ~hp~f~~  137 (379)
                      +||||++
T Consensus       280 ~Hp~f~~  286 (286)
T d1ob3a_         280 EHAYFKE  286 (286)
T ss_dssp             TSGGGGC
T ss_pred             cCcccCc
Confidence            9999974

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6.1e-31  Score=251.07  Aligned_cols=138  Identities=25%  Similarity=0.445  Sum_probs=114.2

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC-----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG-----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~-----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+|||++.++.+||+|||+++.....     ....+.+||+.|+|||++.+...+++++||||+||++|+|+
T Consensus       137 ~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~  216 (318)
T d3blha1         137 KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMW  216 (318)
T ss_dssp             TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred             CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHh
Confidence            4899999999999999999999999999765432     22345689999999999987655589999999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHhcCccCCCCC--------------------------------CChhhhcccccccCCCCCCC
Q 017029           76 CGTLPFDDENIPNLFKKIKGGIYTLPSH--------------------------------LSPGARDLIPRMLIVDPMKR  123 (379)
Q Consensus        76 tG~~Pf~~~~~~~~~~~i~~~~~~~p~~--------------------------------~s~~~~~Li~~mL~~dP~~R  123 (379)
                      +|+.||.+.+.......+......++..                                .++++.+||.+||++||++|
T Consensus       217 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R  296 (318)
T d3blha1         217 TRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR  296 (318)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTS
T ss_pred             hCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHC
Confidence            9999999988777766664433322211                                25677899999999999999


Q ss_pred             CChhhhhcCchhhhc
Q 017029          124 ITIPEIRQHPWFQAH  138 (379)
Q Consensus       124 pt~~ell~hp~f~~~  138 (379)
                      ||++|+++||||+..
T Consensus       297 ~sa~elL~Hpff~~~  311 (318)
T d3blha1         297 IDSDDALNHDFFWSD  311 (318)
T ss_dssp             CCHHHHHHSGGGSSS
T ss_pred             cCHHHHHcChhhccC
Confidence            999999999999853

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.4e-30  Score=246.87  Aligned_cols=139  Identities=33%  Similarity=0.569  Sum_probs=114.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++.+||+|||+++......    .....+||+.|+|||++.....++.++||||+||++|+|++
T Consensus       129 ~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~  208 (345)
T d1pmea_         129 NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS  208 (345)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHH
T ss_pred             CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhh
Confidence            48999999999999999999999999998664332    34566899999999999766666899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCc--------------------c-----------CCCCCCChhhhcccccccCCCCCCCCC
Q 017029           77 GTLPFDDENIPNLFKKIKGGI--------------------Y-----------TLPSHLSPGARDLIPRMLIVDPMKRIT  125 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~--------------------~-----------~~p~~~s~~~~~Li~~mL~~dP~~Rpt  125 (379)
                      |..||.+.+..+.........                    .           ...+.+++++++||.+||++||.+|||
T Consensus       209 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t  288 (345)
T d1pmea_         209 NRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE  288 (345)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC
T ss_pred             CCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC
Confidence            999999877655444332110                    0           112357889999999999999999999


Q ss_pred             hhhhhcCchhhhcc
Q 017029          126 IPEIRQHPWFQAHL  139 (379)
Q Consensus       126 ~~ell~hp~f~~~~  139 (379)
                      ++|+++||||+...
T Consensus       289 a~e~L~hpf~~~~~  302 (345)
T d1pmea_         289 VEQALAHPYLEQYY  302 (345)
T ss_dssp             HHHHHTSGGGTTTC
T ss_pred             HHHHhcCHhhccCC
Confidence            99999999998664

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=7.4e-31  Score=252.15  Aligned_cols=131  Identities=25%  Similarity=0.398  Sum_probs=111.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+|||++.++.+||+|||+|+......   ...+.+||+.|+|||++.+..| +.++||||+||++|||++ 
T Consensus       184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~  262 (325)
T d1rjba_         184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSL  262 (325)
T ss_dssp             TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTT
T ss_pred             CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhC
Confidence            48999999999999999999999999998765443   2235578999999999988877 789999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHhcC--ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           77 GTLPFDDENIPNLFKKIKGG--IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      |..||.+.+......++...  ..+.|..+++++++||.+||+.||++|||++||++|
T Consensus       263 g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            89999987665554554433  345678899999999999999999999999999876

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.8e-30  Score=247.94  Aligned_cols=136  Identities=32%  Similarity=0.517  Sum_probs=115.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.++.+|++|||+|+.....  .+..+||+.|+|||++.+..+.+.++||||+||++|+|++|..|
T Consensus       141 ~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p  218 (346)
T d1cm8a_         141 GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTL  218 (346)
T ss_dssp             TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcccccCcchhhcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCC
Confidence            4899999999999999999999999999876443  45678999999999998876668999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCcc-------------------------------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIY-------------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~-------------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+.......+.....                               .....+++++.+||.+||..||.+|||++|+
T Consensus       219 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~ei  298 (346)
T d1cm8a_         219 FKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA  298 (346)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHH
T ss_pred             CCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHH
Confidence            998876655444322111                               1234578899999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++||||+..
T Consensus       299 L~Hp~f~~~  307 (346)
T d1cm8a_         299 LAHPYFESL  307 (346)
T ss_dssp             HHSGGGTTT
T ss_pred             hcChhhCcC
Confidence            999999864

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=2.2e-30  Score=243.55  Aligned_cols=135  Identities=25%  Similarity=0.402  Sum_probs=115.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++.+||+|||+++.......    .....||+.|+|||++.+..+ +.++|||||||++|||++
T Consensus       127 ~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt  205 (277)
T d1xbba_         127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFS  205 (277)
T ss_dssp             TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCC-CchhhhccchhhhhHHhh
Confidence            489999999999999999999999999987654322    123468999999999988777 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhh---cCchhh
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIR---QHPWFQ  136 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell---~hp~f~  136 (379)
                       |+.||.+.+..++...+..+. .+.|..+++++++||.+||+.||.+|||+++|+   +|+|+.
T Consensus       206 ~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         206 YGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             TTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence             999999999888888887764 567889999999999999999999999999984   555543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.1e-30  Score=241.80  Aligned_cols=136  Identities=26%  Similarity=0.501  Sum_probs=118.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .||||||||+||||+.++.+||+|||+|+...+...  .....||+.|+|||++.+..| +.++||||+||++|||+| |
T Consensus       129 ~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~  207 (272)
T d1qpca_         129 NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHG  207 (272)
T ss_dssp             TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTT
T ss_pred             CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCC
Confidence            489999999999999999999999999998765432  234578999999999988777 789999999999999999 5


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc--Cchhhh
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQA  137 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~--hp~f~~  137 (379)
                      .+||...+..++...+..+. ...|..+++++.+||.+||+.||++|||++++++  |+||..
T Consensus       208 ~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         208 RIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            66777788888888887764 4567889999999999999999999999999998  788864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.9e-30  Score=242.67  Aligned_cols=132  Identities=30%  Similarity=0.478  Sum_probs=105.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC---cccccccCCCCccCcccccCCC--CCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG---HFLKTSCGSPNYAAPEVISGKL--YAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~---~~~~~~~gt~~y~APE~l~~~~--~~~~~~DiWSlGvilyell   75 (379)
                      .||||||||+|||++.++.+||+|||+|+.....   ....+.+||+.|+|||++.+..  .++.++|||||||++|||+
T Consensus       124 ~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~  203 (276)
T d1uwha_         124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM  203 (276)
T ss_dssp             TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHH
Confidence            4899999999999999999999999999876432   2335568999999999997532  2378999999999999999


Q ss_pred             hCCCCCCCCChHH-HHHHHhcCcc-----CCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           76 CGTLPFDDENIPN-LFKKIKGGIY-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        76 tG~~Pf~~~~~~~-~~~~i~~~~~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||+.||.+.+... +...+..+..     ..+..+++++++||.+||..||.+|||++|++++
T Consensus       204 tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         204 TGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999866544 3444444432     3456789999999999999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=4.5e-30  Score=242.52  Aligned_cols=135  Identities=27%  Similarity=0.421  Sum_probs=118.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++.+||+|||+++.......    ....+||+.|+|||++.+..+ +.++|||||||++|||+|
T Consensus       129 ~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt  207 (285)
T d1u59a_         129 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALS  207 (285)
T ss_dssp             TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHT
T ss_pred             CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHh
Confidence            489999999999999999999999999987754332    234578999999999988777 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhh---hcCchhh
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEI---RQHPWFQ  136 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el---l~hp~f~  136 (379)
                       |..||.+.+..++...+..+. .+.|+.+++++.+||.+||..||++|||+.+|   |+|+|+.
T Consensus       208 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         208 YGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             TSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             999999988888888888765 56788999999999999999999999999887   5678775

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.8e-29  Score=235.90  Aligned_cols=139  Identities=30%  Similarity=0.532  Sum_probs=113.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++.+||+|||.++...... ......+++.|+|||++.+..+.+.++||||+||++|+|++|..
T Consensus       121 ~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~  200 (292)
T d1unla_         121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR  200 (292)
T ss_dssp             TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSC
T ss_pred             CEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCC
Confidence            48999999999999999999999999998875543 33344678899999999887766899999999999999999998


Q ss_pred             C-CCCCChHHHHHHHhcCcc-----------------------------CCCCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           80 P-FDDENIPNLFKKIKGGIY-----------------------------TLPSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        80 P-f~~~~~~~~~~~i~~~~~-----------------------------~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      | |.+.+..+...++.....                             ..+..+++.+++||.+||+.||.+|||++|+
T Consensus       201 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~  280 (292)
T d1unla_         201 PLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA  280 (292)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHH
Confidence            8 456666666665532111                             1223567889999999999999999999999


Q ss_pred             hcCchhhhcc
Q 017029          130 RQHPWFQAHL  139 (379)
Q Consensus       130 l~hp~f~~~~  139 (379)
                      ++||||++..
T Consensus       281 L~Hp~f~~~~  290 (292)
T d1unla_         281 LQHPYFSDFC  290 (292)
T ss_dssp             TTSGGGSSCS
T ss_pred             hcChhhcCCC
Confidence            9999998653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.7e-29  Score=242.51  Aligned_cols=137  Identities=37%  Similarity=0.614  Sum_probs=115.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC--cccccccCCCCccCcccccCCC-CCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG--HFLKTSCGSPNYAAPEVISGKL-YAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~--~~~~~~~gt~~y~APE~l~~~~-~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.+|.+||+|||+++.+...  ....+.+|++.|+|||.+.+.. +.+.++||||+||++|+|++|
T Consensus       149 ~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG  228 (322)
T d1vzoa_         149 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG  228 (322)
T ss_dssp             TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS
T ss_pred             CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhC
Confidence            3799999999999999999999999999876443  2345668999999999997643 347899999999999999999


Q ss_pred             CCCCCCCChH----HHHHHHhcCccCCCCCCChhhhcccccccCCCCCCCC-----ChhhhhcCchhhh
Q 017029           78 TLPFDDENIP----NLFKKIKGGIYTLPSHLSPGARDLIPRMLIVDPMKRI-----TIPEIRQHPWFQA  137 (379)
Q Consensus        78 ~~Pf~~~~~~----~~~~~i~~~~~~~p~~~s~~~~~Li~~mL~~dP~~Rp-----t~~ell~hp~f~~  137 (379)
                      ..||.+.+..    .+.........++|..+++++.+||.+||++||.+||     |++|+++||||+.
T Consensus       229 ~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         229 ASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             SCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            9999875433    3445555666778889999999999999999999999     5899999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.95  E-value=1.7e-29  Score=239.95  Aligned_cols=131  Identities=25%  Similarity=0.411  Sum_probs=105.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccc------cccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLK------TSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~------~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .||||||||+|||++.++.+||+|||+++.........      ...||+.|+|||++.+..| +.++|||||||++|||
T Consensus       148 ~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el  226 (299)
T d1jpaa_         148 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEV  226 (299)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHH
T ss_pred             CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHH
Confidence            47999999999999999999999999998765432211      2357899999999998877 7899999999999999


Q ss_pred             hh-CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           75 LC-GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        75 lt-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +| |..||.+.+..++...+..+. .+.|..+++++.+||.+||+.||.+|||+.|++++
T Consensus       227 ~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         227 MSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            98 899999999988888887664 56677899999999999999999999999999875

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=9.3e-30  Score=237.24  Aligned_cols=131  Identities=24%  Similarity=0.494  Sum_probs=105.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||++.++.+||+|||+++........  ....||+.|+|||++.+..| +.++||||+||++|||+| |
T Consensus       121 ~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~  199 (263)
T d1sm2a_         121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEG  199 (263)
T ss_dssp             TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred             ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCC
Confidence            4799999999999999999999999999877544322  34578999999999998887 789999999999999999 6


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .+||...+..++...+..+. ...|..+++++.+||.+||+.||++|||++|+++|
T Consensus       200 ~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         200 KIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            78888888888888887764 45677889999999999999999999999999886

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.5e-30  Score=239.37  Aligned_cols=131  Identities=29%  Similarity=0.530  Sum_probs=105.9

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .||||||||+||+++.++.+||+|||+++.......  ....+||+.|+|||++.+..| +.++||||+||++|||++ |
T Consensus       128 ~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g  206 (273)
T d1mp8a_         128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHG  206 (273)
T ss_dssp             TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTS
T ss_pred             CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcC
Confidence            479999999999999999999999999987654332  234568999999999988777 789999999999999998 8


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      .+||.+.+..++..++..+. .++|+.+++++.+||.+||..||.+|||+.||++|
T Consensus       207 ~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         207 VKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999988888888775 56788999999999999999999999999999876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.95  E-value=4.8e-29  Score=238.97  Aligned_cols=138  Identities=25%  Similarity=0.448  Sum_probs=111.3

Q ss_pred             CEEecCCCCCCeEEcCCC-cEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCC
Q 017029            1 MVVHRDLKPENLLLDSKW-NVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~-~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~   79 (379)
                      .||||||||+|||++.++ .+||+|||+|............+||+.|+|||++.+...++.++||||+||++|+|++|..
T Consensus       149 gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~  228 (328)
T d3bqca1         149 GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE  228 (328)
T ss_dssp             TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred             ccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCC
Confidence            489999999999998755 6999999999988777777788999999999998876655899999999999999999999


Q ss_pred             CCCCCCh-HHHHHHHhc-------------Ccc------------------------CCCCCCChhhhcccccccCCCCC
Q 017029           80 PFDDENI-PNLFKKIKG-------------GIY------------------------TLPSHLSPGARDLIPRMLIVDPM  121 (379)
Q Consensus        80 Pf~~~~~-~~~~~~i~~-------------~~~------------------------~~p~~~s~~~~~Li~~mL~~dP~  121 (379)
                      ||..... ......+..             ...                        .....+++++++||++||.+||.
T Consensus       229 pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~  308 (328)
T d3bqca1         229 PFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ  308 (328)
T ss_dssp             SSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGG
T ss_pred             CCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChh
Confidence            9976432 222111110             000                        01123678899999999999999


Q ss_pred             CCCChhhhhcCchhhhc
Q 017029          122 KRITIPEIRQHPWFQAH  138 (379)
Q Consensus       122 ~Rpt~~ell~hp~f~~~  138 (379)
                      +|||++|+++||||++.
T Consensus       309 ~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         309 SRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             GSCCHHHHHTSGGGTTS
T ss_pred             HCcCHHHHhcCcccCCC
Confidence            99999999999999864

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.2e-29  Score=240.31  Aligned_cols=131  Identities=29%  Similarity=0.470  Sum_probs=104.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++.+||+|||+|+......   ...+.+||+.|+|||++.+..+ +.++||||+||++|||++|
T Consensus       154 ~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~  232 (299)
T d1ywna1         154 KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSL  232 (299)
T ss_dssp             TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhC
Confidence            48999999999999999999999999998764332   2234579999999999998877 7999999999999999986


Q ss_pred             -CCCCCCCChHH-HHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 -TLPFDDENIPN-LFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 -~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                       ..||.+..... ....+..+ ....|..+++++++||.+||+.||.+|||++|+++|
T Consensus       233 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         233 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             SCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence             67888765443 34444444 456778899999999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.2e-29  Score=244.49  Aligned_cols=138  Identities=33%  Similarity=0.604  Sum_probs=104.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .|+||||||+|||++.++.+|++|||+++...........+||+.|+|||++.+..+ ++++||||+||++|+|++|..|
T Consensus       139 giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~p  217 (355)
T d2b1pa1         139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKIL  217 (355)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCS
T ss_pred             ccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCC
Confidence            489999999999999999999999999988877766777899999999999998877 7899999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccC----------------------C--------------C------CCCChhhhcccccccCC
Q 017029           81 FDDENIPNLFKKIKGGIYT----------------------L--------------P------SHLSPGARDLIPRMLIV  118 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~----------------------~--------------p------~~~s~~~~~Li~~mL~~  118 (379)
                      |.+.+......++......                      .              +      ...++++++||++||.+
T Consensus       218 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~  297 (355)
T d2b1pa1         218 FPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVI  297 (355)
T ss_dssp             SCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCS
T ss_pred             CCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcC
Confidence            9988766655554321110                      0              0      01356789999999999


Q ss_pred             CCCCCCChhhhhcCchhhhcc
Q 017029          119 DPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       119 dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ||++|||++|+|+||||+...
T Consensus       298 dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         298 DPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             STTTSCCHHHHHTSTTTGGGC
T ss_pred             ChhHCcCHHHHhcCcccCCCC
Confidence            999999999999999998753

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=3.5e-29  Score=233.02  Aligned_cols=131  Identities=23%  Similarity=0.395  Sum_probs=116.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc--cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-C
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF--LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-G   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~--~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G   77 (379)
                      .|+||||||+|||+++++.+||+|||+++.......  .....||+.|+|||++.+..| +.++||||+||++|||+| |
T Consensus       120 ~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g  198 (258)
T d1k2pa_         120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLG  198 (258)
T ss_dssp             TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcC
Confidence            489999999999999999999999999987654432  234578999999999998877 789999999999999998 8


Q ss_pred             CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           78 TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        78 ~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      +.||.+.+..++..++..+. ...|..+++++++||.+||+.||++|||++++++|
T Consensus       199 ~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         199 KMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            99999999999999888764 45677889999999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.4e-29  Score=242.27  Aligned_cols=132  Identities=25%  Similarity=0.410  Sum_probs=114.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+|||++.++.+||+|||+++.......   .....||+.|+|||++.++.| +.++|||||||++|||+| 
T Consensus       131 ~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~  209 (317)
T d1xkka_         131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTF  209 (317)
T ss_dssp             TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHC
Confidence            489999999999999999999999999987754332   233468999999999988877 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcCc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHP  133 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp  133 (379)
                      |..||.+.+..++...+..+. .+.|..+++++.+||.+||..||.+|||+.|+++|.
T Consensus       210 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         210 GSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             SCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHH
Confidence            899999988888888887765 567888999999999999999999999999999884

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=6.4e-29  Score=233.95  Aligned_cols=130  Identities=26%  Similarity=0.463  Sum_probs=105.0

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc----ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH----FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~----~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+||||+.++.+||+|||+++......    ......||+.|+|||++.+..+ +.++|||||||++|||++
T Consensus       130 ~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t  208 (283)
T d1mqba_         130 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMT  208 (283)
T ss_dssp             TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHT
T ss_pred             ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHh
Confidence            48999999999999999999999999998765432    1223468999999999998877 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 -GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       |.+||.+.+..++.+.+..+. .+.|..++..+.+||.+||..||++|||+.||++
T Consensus       209 ~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         209 YGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence             566677777778888887664 4667789999999999999999999999999986

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=2.7e-29  Score=242.32  Aligned_cols=136  Identities=33%  Similarity=0.481  Sum_probs=112.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCCCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGTLP   80 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~~P   80 (379)
                      .||||||||+|||++.+|.+|++|||++.....  ...+.+|++.|+|||++.+..+.+.++||||+||++|+|++|..|
T Consensus       141 giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~p  218 (348)
T d2gfsa1         141 DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL  218 (348)
T ss_dssp             TCCCCCCCGGGEEECTTCCEEECCC----CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred             CCcccccCCccccccccccccccccchhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCC
Confidence            389999999999999999999999999976533  345678999999999988877778999999999999999999999


Q ss_pred             CCCCChHHHHHHHhcCccCC-------------------------------CCCCChhhhcccccccCCCCCCCCChhhh
Q 017029           81 FDDENIPNLFKKIKGGIYTL-------------------------------PSHLSPGARDLIPRMLIVDPMKRITIPEI  129 (379)
Q Consensus        81 f~~~~~~~~~~~i~~~~~~~-------------------------------p~~~s~~~~~Li~~mL~~dP~~Rpt~~el  129 (379)
                      |.+.+.......+.......                               ...+++++++||.+||..||.+|||++|+
T Consensus       219 F~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~el  298 (348)
T d2gfsa1         219 FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA  298 (348)
T ss_dssp             CCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             CCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHH
Confidence            99988777766664332211                               12578899999999999999999999999


Q ss_pred             hcCchhhhc
Q 017029          130 RQHPWFQAH  138 (379)
Q Consensus       130 l~hp~f~~~  138 (379)
                      ++||||++.
T Consensus       299 L~Hp~f~~~  307 (348)
T d2gfsa1         299 LAHAYFAQY  307 (348)
T ss_dssp             HTSGGGTTT
T ss_pred             hcCHhhCCC
Confidence            999999864

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=5.1e-29  Score=235.28  Aligned_cols=139  Identities=25%  Similarity=0.452  Sum_probs=113.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcccccCCc--ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CC
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH--FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GT   78 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~--~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~   78 (379)
                      |+||||||+||||+.++.+||+|||+++......  .....+||+.|+|||++.+..+ +.++||||+||++|||++ |.
T Consensus       134 ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~  212 (285)
T d1fmka3         134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGR  212 (285)
T ss_dssp             CCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTC
T ss_pred             eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCC
Confidence            7999999999999999999999999998765443  2234579999999999988877 789999999999999999 56


Q ss_pred             CCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc--CchhhhccCc
Q 017029           79 LPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ--HPWFQAHLPR  141 (379)
Q Consensus        79 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~--hp~f~~~~~~  141 (379)
                      +||.+....++...+..+. .+.|..+++++++||.+||+.||++|||+++|++  ++||+...|.
T Consensus       213 p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~p~  278 (285)
T d1fmka3         213 VPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQ  278 (285)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSCCC
T ss_pred             CCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCCCC
Confidence            6677788888888887664 4678899999999999999999999999999987  7888765443

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.94  E-value=5.2e-29  Score=236.47  Aligned_cols=130  Identities=26%  Similarity=0.359  Sum_probs=112.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc---ccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH---FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~---~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++.+||+|||+|+.+.+..   ...+.+|++.|+|||++.+..| +.++|||||||++|||++|
T Consensus       160 ~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~  238 (301)
T d1lufa_         160 KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSY  238 (301)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHcc
Confidence            47999999999999999999999999998764432   2235678999999999998877 7899999999999999998


Q ss_pred             -CCCCCCCChHHHHHHHhcCcc-CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 -TLPFDDENIPNLFKKIKGGIY-TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 -~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       .+||.+.+..++...+..+.. ..|..+++++.+||.+||+.||++|||+.||++
T Consensus       239 ~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             478999999999888887764 467889999999999999999999999999864

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.94  E-value=7e-29  Score=234.39  Aligned_cols=134  Identities=25%  Similarity=0.433  Sum_probs=112.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc--ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL--KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCGT   78 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~--~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG~   78 (379)
                      .||||||||+|||++.++.+||+|||+|+........  ....|++.|+|||++.+..| +.++||||+||++|||++|.
T Consensus       135 ~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~  213 (287)
T d1opja_         135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYG  213 (287)
T ss_dssp             TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTS
T ss_pred             CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCC
Confidence            3899999999999999999999999999887554322  23458899999999988877 78999999999999999955


Q ss_pred             -CCCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcCchhhh
Q 017029           79 -LPFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQA  137 (379)
Q Consensus        79 -~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~  137 (379)
                       +||.+.+...+.+.+..+ ..+.|..+++++++||.+||+.||.+|||++|+++  +|+.
T Consensus       214 ~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~  272 (287)
T d1opja_         214 MSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFET  272 (287)
T ss_dssp             CCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred             CCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHH
Confidence             456667777777777655 35677889999999999999999999999999965  4543

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.94  E-value=8.8e-29  Score=231.92  Aligned_cols=135  Identities=24%  Similarity=0.399  Sum_probs=106.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCC----cccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDG----HFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~----~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .||||||||+|||++.++.++|+|||.+......    ....+.+||+.|+|||++.+..| ++++||||+||++|+|+|
T Consensus       131 ~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyellt  209 (277)
T d1o6ya_         131 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLT  209 (277)
T ss_dssp             TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHH
T ss_pred             CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHh
Confidence            3899999999999999999999999998765332    23345689999999999998877 789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHhcCccCC----CCCCChhhhcccccccCCCCCCCCChhhhhcCchhh
Q 017029           77 GTLPFDDENIPNLFKKIKGGIYTL----PSHLSPGARDLIPRMLIVDPMKRITIPEIRQHPWFQ  136 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~  136 (379)
                      |..||.+.+..+...++.......    +..+|+++.+||.+||++||.+||+..+.+.|+|.+
T Consensus       210 G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         210 GEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             SSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            999999998888877766554433    357899999999999999999999544445577765

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=3.4e-28  Score=230.65  Aligned_cols=130  Identities=28%  Similarity=0.480  Sum_probs=115.5

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+|||++.++.+||+|||+++.......   ....+|++.|+|||++.++.| +.++|||||||++|||++ 
T Consensus       155 ~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~  233 (299)
T d1fgka_         155 KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTL  233 (299)
T ss_dssp             TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccC
Confidence            489999999999999999999999999987755432   234578999999999988877 799999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |.+||.+.+...++..+..+. +..|..+++++++||.+||+.||.+|||+.||++
T Consensus       234 g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         234 GGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             SCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            799999999998888887664 5677889999999999999999999999999986

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.8e-28  Score=228.58  Aligned_cols=129  Identities=26%  Similarity=0.388  Sum_probs=110.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc----cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF----LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~----~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt   76 (379)
                      .|+||||||+|||++.++.+||+|||+++.......    .....|++.|+|||++.+..+ +.++|||||||++|||+|
T Consensus       131 ~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt  209 (273)
T d1u46a_         131 RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFT  209 (273)
T ss_dssp             TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHT
T ss_pred             CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHh
Confidence            489999999999999999999999999987644322    223467889999999998777 789999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHhcCcc--CCCCCCChhhhcccccccCCCCCCCCChhhhh
Q 017029           77 -GTLPFDDENIPNLFKKIKGGIY--TLPSHLSPGARDLIPRMLIVDPMKRITIPEIR  130 (379)
Q Consensus        77 -G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell  130 (379)
                       |..||.+.+..+...++.....  +.|..+++++++||.+||..||++|||+.||+
T Consensus       210 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~  266 (273)
T d1u46a_         210 YGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR  266 (273)
T ss_dssp             TSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             CCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence             8999999999999888876643  55678999999999999999999999999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.94  E-value=2.4e-28  Score=232.72  Aligned_cols=131  Identities=26%  Similarity=0.384  Sum_probs=114.3

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC-CC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG-TL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG-~~   79 (379)
                      .||||||||+|||++.++.+||+|||+++...........+||+.|+|||.+.+..| +.++|||||||++|||++| .+
T Consensus       147 ~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~  225 (309)
T d1fvra_         147 QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGT  225 (309)
T ss_dssp             TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred             CccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCC
Confidence            489999999999999999999999999987655544456679999999999988887 7899999999999999996 56


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||.+.+..++...+..+ .++.|..+++++++||.+||+.||++|||++|++++
T Consensus       226 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         226 PYCGMTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TTTTCCHHHHHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            89999999998888765 456778899999999999999999999999999987

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=8.7e-28  Score=228.86  Aligned_cols=130  Identities=22%  Similarity=0.379  Sum_probs=114.4

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhhC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLCG   77 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyelltG   77 (379)
                      .||||||||+|||++.++++||+|||+++.......   ....+||+.|+|||.+.+..+ +.++|||||||++|||++|
T Consensus       153 ~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~  231 (308)
T d1p4oa_         153 KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATL  231 (308)
T ss_dssp             TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHT
T ss_pred             CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhC
Confidence            489999999999999999999999999987654332   234478999999999998877 6899999999999999997


Q ss_pred             -CCCCCCCChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           78 -TLPFDDENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        78 -~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                       .+||.+.+..+....+..+. .+.|..+++.+.++|.+||+.||.+|||+.+|++
T Consensus       232 ~~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         232 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             68999999999888887765 4567889999999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.93  E-value=1.2e-27  Score=231.35  Aligned_cols=136  Identities=28%  Similarity=0.571  Sum_probs=103.6

Q ss_pred             CEEecCCCCCCeEEcCCCc------EEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHH
Q 017029            1 MVVHRDLKPENLLLDSKWN------VKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYAL   74 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~------vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyel   74 (379)
                      .|+||||||+|||++.++.      +|++|||.+.....  .....+||+.|+|||++.+..| +.++|+||+||++++|
T Consensus       146 ~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el  222 (362)
T d1q8ya_         146 GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFEL  222 (362)
T ss_dssp             CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHH
T ss_pred             CcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCC-CccccccchHHHHHHH
Confidence            4899999999999987653      99999999986543  3356789999999999998887 7899999999999999


Q ss_pred             hhCCCCCCCCChH------HHHHH---HhcC---------------------------------------ccCCCCCCCh
Q 017029           75 LCGTLPFDDENIP------NLFKK---IKGG---------------------------------------IYTLPSHLSP  106 (379)
Q Consensus        75 ltG~~Pf~~~~~~------~~~~~---i~~~---------------------------------------~~~~p~~~s~  106 (379)
                      ++|+.||......      .....   +...                                       ....+...++
T Consensus       223 ~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (362)
T d1q8ya_         223 ITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAK  302 (362)
T ss_dssp             HHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHH
T ss_pred             HHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCH
Confidence            9999999764321      11111   0000                                       0011122457


Q ss_pred             hhhcccccccCCCCCCCCChhhhhcCchhhhcc
Q 017029          107 GARDLIPRMLIVDPMKRITIPEIRQHPWFQAHL  139 (379)
Q Consensus       107 ~~~~Li~~mL~~dP~~Rpt~~ell~hp~f~~~~  139 (379)
                      ++++||.+||.+||.+|||++|+|+||||++..
T Consensus       303 ~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         303 EISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence            789999999999999999999999999999654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.93  E-value=1.4e-27  Score=222.69  Aligned_cols=129  Identities=24%  Similarity=0.489  Sum_probs=107.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-CCC
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-GTL   79 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-G~~   79 (379)
                      .||||||||+|||++.++.+||+|||+++.....  ..+..+++.|+|||++.+..+ ++++|||||||++|||+| |.+
T Consensus       123 ~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~  199 (262)
T d1byga_         123 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRV  199 (262)
T ss_dssp             TCCCSCCSGGGEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCC
T ss_pred             ceeccccchHhheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCC
Confidence            4899999999999999999999999999876443  345678999999999988777 799999999999999998 899


Q ss_pred             CCCCCChHHHHHHHhcC-ccCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           80 PFDDENIPNLFKKIKGG-IYTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        80 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||...+..++...+.++ ..++|..+++++++||.+||..||.+|||+.+++++
T Consensus       200 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         200 PYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             SCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            99998888888888765 457788899999999999999999999999999874

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.92  E-value=7.5e-27  Score=220.74  Aligned_cols=137  Identities=22%  Similarity=0.230  Sum_probs=105.5

Q ss_pred             CEEecCCCCCCeEEcC---CCcEEEEecCCcccccCCc--------ccccccCCCCccCcccccCCCCCCCccceeeehh
Q 017029            1 MVVHRDLKPENLLLDS---KWNVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV   69 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~---~~~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGv   69 (379)
                      .||||||||+|||++.   +..+||+|||+|+...+..        ...+.+||+.|+|||++.+..+ +.++||||+||
T Consensus       123 ~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~  201 (299)
T d1ckia_         123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGY  201 (299)
T ss_dssp             TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHH
T ss_pred             CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCH
Confidence            4899999999999864   4579999999998875432        1234579999999999998887 79999999999


Q ss_pred             HHHHHhhCCCCCCCCChHHHHHHH---hcC-----ccCCCCCCChhhhcccccccCCCCCCCCChhh---hhcCchhhhc
Q 017029           70 ILYALLCGTLPFDDENIPNLFKKI---KGG-----IYTLPSHLSPGARDLIPRMLIVDPMKRITIPE---IRQHPWFQAH  138 (379)
Q Consensus        70 ilyelltG~~Pf~~~~~~~~~~~i---~~~-----~~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~e---ll~hp~f~~~  138 (379)
                      ++|||++|..||.+.........+   ...     ....+..+|+++.++|.+||..||++||++++   +++|+|.+..
T Consensus       202 ~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~  281 (299)
T d1ckia_         202 VLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  281 (299)
T ss_dssp             HHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             HHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcC
Confidence            999999999999875543332221   111     11234678999999999999999999999874   5677776554

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.92  E-value=7.2e-27  Score=222.92  Aligned_cols=131  Identities=27%  Similarity=0.364  Sum_probs=106.8

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCccc-----ccccCCCCccCcccccCCCCCCCccceeeehhHHHHHh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFL-----KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALL   75 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~-----~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyell   75 (379)
                      .|+||||||+|||+++++.+||+|||+++........     ....||+.|+|||++.+..+ +.++|||||||++|||+
T Consensus       150 ~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~  228 (311)
T d1r0pa_         150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELM  228 (311)
T ss_dssp             TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHH
T ss_pred             CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHH
Confidence            4799999999999999999999999999876543221     23468999999999988777 88999999999999999


Q ss_pred             hCCCCCCC-CChHHHHHHHhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhcC
Q 017029           76 CGTLPFDD-ENIPNLFKKIKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQH  132 (379)
Q Consensus        76 tG~~Pf~~-~~~~~~~~~i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~h  132 (379)
                      ||..||.. .+..++...+..+. ...|..+++++.+||.+||+.||++|||+.|+++|
T Consensus       229 t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         229 TRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             TTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            97777654 34445556665554 45678899999999999999999999999999987

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=2.4e-26  Score=218.97  Aligned_cols=130  Identities=33%  Similarity=0.519  Sum_probs=107.7

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcc---cccccCCCCccCcccccCCCCCCCccceeeehhHHHHHhh-
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHF---LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYALLC-   76 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~---~~~~~gt~~y~APE~l~~~~~~~~~~DiWSlGvilyellt-   76 (379)
                      .||||||||+|||++.++.+|++|||+++.......   ....+||+.|+|||++.+..+ +.++|||||||++|||+| 
T Consensus       165 ~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~  243 (311)
T d1t46a_         165 NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSL  243 (311)
T ss_dssp             TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTT
T ss_pred             CeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhC
Confidence            379999999999999999999999999987754322   233578999999999987766 789999999999999998 


Q ss_pred             CCCCCCCCChHHHHHH-HhcCc-cCCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           77 GTLPFDDENIPNLFKK-IKGGI-YTLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        77 G~~Pf~~~~~~~~~~~-i~~~~-~~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      |.+||.+.+..+.+.+ +..+. ...|..+++++.+||.+||+.||.+|||+++|++
T Consensus       244 g~p~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         244 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             TCCSSTTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6777777666554444 33333 3456788999999999999999999999999986

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.91  E-value=6.8e-26  Score=215.24  Aligned_cols=132  Identities=19%  Similarity=0.303  Sum_probs=97.6

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCc-----ccccccCCCCccCcccccCCCC-----CCCccceeeehhH
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGH-----FLKTSCGSPNYAAPEVISGKLY-----AGPEVDVWSCGVI   70 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~-----~~~~~~gt~~y~APE~l~~~~~-----~~~~~DiWSlGvi   70 (379)
                      .||||||||+||||+.++.+||+|||+++......     .....+||+.|+|||++.+...     .+.++|||||||+
T Consensus       128 ~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvv  207 (303)
T d1vjya_         128 AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV  207 (303)
T ss_dssp             EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHH
T ss_pred             CeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHH
Confidence            38999999999999999999999999998775432     2234679999999999876431     2568999999999


Q ss_pred             HHHHhhCCCCCCCC---------------ChHHHHHHHhcCcc--CCCCC-----CChhhhcccccccCCCCCCCCChhh
Q 017029           71 LYALLCGTLPFDDE---------------NIPNLFKKIKGGIY--TLPSH-----LSPGARDLIPRMLIVDPMKRITIPE  128 (379)
Q Consensus        71 lyelltG~~Pf~~~---------------~~~~~~~~i~~~~~--~~p~~-----~s~~~~~Li~~mL~~dP~~Rpt~~e  128 (379)
                      +|||+||..||...               ........+..+..  .+|..     ....+.+|+.+||+.||.+|||+.|
T Consensus       208 l~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~e  287 (303)
T d1vjya_         208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  287 (303)
T ss_dssp             HHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHH
T ss_pred             HHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHH
Confidence            99999998877431               22233333332222  22222     1234889999999999999999999


Q ss_pred             hhcC
Q 017029          129 IRQH  132 (379)
Q Consensus       129 ll~h  132 (379)
                      |+++
T Consensus       288 i~~~  291 (303)
T d1vjya_         288 IKKT  291 (303)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9763

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.90  E-value=2.7e-25  Score=209.94  Aligned_cols=130  Identities=18%  Similarity=0.240  Sum_probs=103.6

Q ss_pred             CEEecCCCCCCeEEcC-----CCcEEEEecCCcccccCCc--------ccccccCCCCccCcccccCCCCCCCccceeee
Q 017029            1 MVVHRDLKPENLLLDS-----KWNVKIADFGLSNIMRDGH--------FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSC   67 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~-----~~~vKL~DFGls~~~~~~~--------~~~~~~gt~~y~APE~l~~~~~~~~~~DiWSl   67 (379)
                      .||||||||+|||++.     ++.+||+|||+|+...+..        ...+.+||+.|+|||++.+..+ +.++||||+
T Consensus       121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSl  199 (293)
T d1csna_         121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEAL  199 (293)
T ss_dssp             TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHH
T ss_pred             CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHh
Confidence            4899999999999974     5789999999998765331        2234579999999999998877 789999999


Q ss_pred             hhHHHHHhhCCCCCCCCC---hHHHHHHHhcCcc-----CCCCCCChhhhcccccccCCCCCCCCChhhhhc
Q 017029           68 GVILYALLCGTLPFDDEN---IPNLFKKIKGGIY-----TLPSHLSPGARDLIPRMLIVDPMKRITIPEIRQ  131 (379)
Q Consensus        68 GvilyelltG~~Pf~~~~---~~~~~~~i~~~~~-----~~p~~~s~~~~~Li~~mL~~dP~~Rpt~~ell~  131 (379)
                      ||++|+|++|..||.+..   ......++.....     .++..+++++.+++..|+..+|++||+++.+.+
T Consensus       200 G~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         200 GHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            999999999999998643   3333333332221     234678899999999999999999999877654

>d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: TBP-like
superfamily: KA1-like
family: Kinase associated domain 1, KA1
domain: Map/microtubule affinity-regulating kinase 3
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.87  E-value=2e-22  Score=160.08  Aligned_cols=95  Identities=19%  Similarity=0.371  Sum_probs=86.0

Q ss_pred             CccceeeceeccCCHHHHHHHHHHHHHhcCcEEEEecceeeEEEeecCCCCCCCCccCCCCCCCCccCCccceeccCccc
Q 017029          252 YERKWALGLQSRAHPREIMTEVLKALQELNVGWKKIGHYNMKCRWIPGISGHHEGMVNNPLHSNHYFGDESAIIENDGVV  331 (379)
Q Consensus       252 ~~~~w~~gi~s~~~p~~im~ei~~~l~~l~~~wk~~~~y~ik~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (379)
                      .+..|++|++|+.+|.+||.||++||+.+|++|++.++|.++|+|.++.+                              
T Consensus         7 ~rf~wsv~tTS~~~P~eIm~eI~rvL~~lgv~~~~~g~y~l~c~~~~~~~------------------------------   56 (102)
T d1ul7a_           7 GRFTWSMKTTSSMDPSDMMREIRKVLGANNCDYEQRERFLLFCVHGDGHA------------------------------   56 (102)
T ss_dssp             CCCCCCCCCCBCSCHHHHHHHHHHHHHHTTCEEEECSTTCEEEEECSSCG------------------------------
T ss_pred             cceeeeeecCcCCCHHHHHHHHHHHHHHcCcEEEEcCCEEEEEEecCCCC------------------------------
Confidence            36799999999999999999999999999999999999999999873210                              


Q ss_pred             cCCceEEEEEEEEeec-CCceeeeeccccCCceehHHHHHHHHHHHhc
Q 017029          332 KSPNVVKFEVQLYKTR-DEKYLLDLQRVQGPQFLFLDLCAAFLAQLRV  378 (379)
Q Consensus       332 ~~~~~~~~~lQLYk~~-~~~YLlDf~~~~g~~~~f~~~c~~~i~~L~~  378 (379)
                        ...|+|++++|||. ..-|+||||+++|+++.|.++|+.|+++|++
T Consensus        57 --~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~yk~l~~~il~~l~l  102 (102)
T d1ul7a_          57 --ENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFKNIASKIANELKL  102 (102)
T ss_dssp             --GGCEEEEEEEEECSSSSSEEEEEEEEESCHHHHHHHHHHHHHHCCC
T ss_pred             --CceEEEEEEEEEcCCCceEEEEEEEccCCHHHHHHHHHHHHHhccC
Confidence              33599999999996 5899999999999999999999999999974

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=98.38  E-value=1.9e-08  Score=86.91  Aligned_cols=58  Identities=24%  Similarity=0.277  Sum_probs=39.1

Q ss_pred             CEEecCCCCCCeEEcCCCcEEEEecCCcccccCCcccccccCCCCccC------cccccCCCCCCCccceeeeh
Q 017029            1 MVVHRDLKPENLLLDSKWNVKIADFGLSNIMRDGHFLKTSCGSPNYAA------PEVISGKLYAGPEVDVWSCG   68 (379)
Q Consensus         1 ~IiHrDLKpeNILl~~~~~vKL~DFGls~~~~~~~~~~~~~gt~~y~A------PE~l~~~~~~~~~~DiWSlG   68 (379)
                      .|+||||||+|||++.+ .++|+|||++.........       .|..      .+.+ .+.| +.++|+||..
T Consensus       123 giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y-~~~~d~~s~~  186 (191)
T d1zara2         123 GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR-------EILERDVRNIITYF-SRTY-RTEKDINSAI  186 (191)
T ss_dssp             TEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTHH-------HHHHHHHHHHHHHH-HHHH-CCCCCHHHHH
T ss_pred             CEEEccCChhheeeeCC-CEEEEECCCcccCCCCCcH-------HHHHHHHHHHHHHH-cCCC-CCcccHHHHH
Confidence            48999999999999865 5899999999765433210       1111      1122 2445 6789999964

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=91.17  E-value=0.033  Score=49.77  Aligned_cols=28  Identities=25%  Similarity=0.334  Sum_probs=25.3

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      |||+|+.++||+++.+...-|.||+.+.
T Consensus       185 iIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         185 VIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCcchhhhhcccccceeEecccccc
Confidence            7999999999999988777899999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=90.52  E-value=0.057  Score=46.47  Aligned_cols=29  Identities=24%  Similarity=0.291  Sum_probs=24.9

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      ++|+|+.|.|||++.++.+-|.||+.+..
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEeeccCcceeecCCceEEEeechhccc
Confidence            68999999999999776667999998754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=89.36  E-value=0.06  Score=46.06  Aligned_cols=29  Identities=21%  Similarity=0.267  Sum_probs=25.0

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCccc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSNI   30 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~~   30 (379)
                      +||+|+.|.|||++.++.+-|+||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            69999999999999876678999997743

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=84.94  E-value=0.19  Score=46.58  Aligned_cols=27  Identities=19%  Similarity=0.318  Sum_probs=23.5

Q ss_pred             EEecCCCCCCeEEcCCCcEEEEecCCcc
Q 017029            2 VVHRDLKPENLLLDSKWNVKIADFGLSN   29 (379)
Q Consensus         2 IiHrDLKpeNILl~~~~~vKL~DFGls~   29 (379)
                      ++|+|+.|.|||++.++ ++|+||..+.
T Consensus       225 LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         225 LIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             EECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             eeccCCcCCceeEcCCc-eEEechhhcc
Confidence            69999999999998764 8999998764